Citrus Sinensis ID: 044281
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 796 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.966 | 0.924 | 0.428 | 1e-174 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.961 | 0.877 | 0.327 | 1e-99 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.895 | 0.860 | 0.322 | 2e-89 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.919 | 0.895 | 0.326 | 4e-89 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.856 | 0.855 | 0.334 | 5e-83 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.917 | 0.881 | 0.308 | 3e-82 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.366 | 0.355 | 0.458 | 1e-71 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.849 | 0.775 | 0.290 | 4e-71 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.933 | 0.875 | 0.274 | 7e-68 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.925 | 0.898 | 0.283 | 9e-68 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 612 bits (1578), Expect = e-174, Method: Compositional matrix adjust.
Identities = 357/833 (42%), Positives = 492/833 (59%), Gaps = 64/833 (7%)
Query: 2 ALSCLIL---LCFPLLPFLSAANNIT-----LGSSLSSTNK---NSSWLSPSRDFAFGFR 50
+LSC I+ L L F + NI +G SL+++ +SSW SPS DFAFGFR
Sbjct: 3 SLSCSIIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFR 62
Query: 51 QLNDNSDLFLLAIWFNKIPERTIVWHANGDNP----APRGSTLELTATG-LLLKDPGGQA 105
++ N D F L+IWF+KI ++TIVWHA N P GS + LTA G L++ DP GQ
Sbjct: 63 KIQPN-DGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQE 121
Query: 106 IWDGKPDKNVSDAAMLDTGNFVLRASG--NNSDYAWQSFKSPTDTILPTQILDLGSVLVS 163
+W +VS D GNFVL G ++ + W SF++PTDT+LP Q +++G L S
Sbjct: 122 LWRALSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSS 181
Query: 164 RLTETNFSKGRFELHFSN-GSLEFIPVAWPSRFQ---YKSYYTSNTYSSNSSESGHQLVF 219
R TET+F KGRF L + G+L+ + + + Y YY SNT N+ G QLVF
Sbjct: 182 RRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNP--GIQLVF 239
Query: 220 NESAEIYIV-KNDGQIV---QLPQWSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQS 275
N+S EIY++ +N+ + V + P +S P ++ +T G L PK +
Sbjct: 240 NQSGEIYVLQRNNSRFVVKDRDPDFSIAAP----FYIST----GFLLSTIIPKEARRIVG 291
Query: 276 WFPTRTLPDAMCRRLIKETGSGTCGFNSYCSL-RNGRPFCDCPPGHVLVDPNYRYRGCKP 334
D MC G+ CG+N+ CSL N RP C+CP VL DP+ Y C P
Sbjct: 292 GCLLGLCRDNMCSP-DDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLP 350
Query: 335 NF-WQGCGPDDGSINAQ-ELYEIREFNNVEWPLGDYERLEPSNQTECETSCLQDCSCAVA 392
+F Q C P++ + N+ LYE WP GDYE ++ C+ SCL DC CA
Sbjct: 351 DFEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAV 410
Query: 393 IYDGN---SCRKKKLPLSNGWLRDTGFSKVLFKVRKGDFPGFSDNSGSKKGRGPLFLLGA 449
I+ N C KKK PLS+G G S KVR K L + +
Sbjct: 411 IFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVPVTGNRAKKLDWLIIACS 470
Query: 450 FLLGGSILCNAFLLLAILIFFKWRRRK---YENNVQD-------STTSETNLRFFSYDEL 499
LLG S AF++ ++ ++ +N +D +T +E NLR F+Y EL
Sbjct: 471 VLLGTS----AFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGEL 526
Query: 500 KDATDGFKEELGRGSFGIVYKGVLKTASGT--AIAVKKLDRLAQEREREFKSEVSAIGRT 557
+AT F EELGRG+FGIVYKG L+ A G+ +AVKKLDRL + E+EFK+EV IG+
Sbjct: 527 AEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQI 586
Query: 558 HHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLH 617
HHK+LV+L+GFC+E ++++VYEF+ GTLAN +F P+P W R I++ IARG+ YLH
Sbjct: 587 HHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLH 646
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
EEC+ IIHCDIKPQNILLD +++ +ISDFGL+KLL +Q+ T T IRGT+GYVAPEWF+
Sbjct: 647 EECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFR 706
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737
N P+++KVDVYS+GV LLEI+CC+++V++ E IL +WAYDC+ +GRL+ L + D
Sbjct: 707 NSPITSKVDVYSYGVMLLEIVCCKKAVDL----EDNVILINWAYDCFRQGRLEDLTEDDS 762
Query: 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPSSFS 790
AM D + +++ IA+WCIQE+ RP M+ V QMLEG++ V +PP PS +S
Sbjct: 763 EAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPYS 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (935), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 268/819 (32%), Positives = 406/819 (49%), Gaps = 54/819 (6%)
Query: 8 LLCFPLLPFLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNK 67
CF L+ L+ +I LGS L ++ N +W+S + FA GF + +D FLL+IWF +
Sbjct: 16 FFCFFLVS-LATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKP-TDRFLLSIWFAQ 73
Query: 68 IP-ERTIVWHANGDNPAPRGSTLELTATGLLLKDPGGQAIW-DGKPDKNVSDAAMLDTGN 125
+P + TIVW N ++P + + LEL ATG L+ +W + V A M ++GN
Sbjct: 74 LPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSDQNTVVWTSNTSNHGVESAVMSESGN 133
Query: 126 FVLRASGNNSD-YAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFSNGSL 184
F+L + + WQSF P+DT+LP Q L + L S + + ++ + SL
Sbjct: 134 FLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHYSLKMLQQHTSL 193
Query: 185 EF-----IPVAWPSRFQY-----KSYYTSNTYSSNSSESGHQLVFNESA--EIYIVKNDG 232
I + + + Y S T + + ++V+ ES+ +Y+ KN
Sbjct: 194 SLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPV 253
Query: 233 QIVQLPQWSKLIPRTDHYF--RATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRRL 290
+ S + T + R L+ +G L Y + + + W P C
Sbjct: 254 DDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDI- 312
Query: 291 IKETGSGTCGFNSYCSLRNGRPFCDCP--PGHVLVDPNYRYRGCKPN--FWQGCGPDDGS 346
+G CG N C+L + DC PG V + + C N Q C + +
Sbjct: 313 -----AGICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQEC---ESN 363
Query: 347 INAQELYEIREFNNVEWPLGDYERLEP----SNQTECETSCLQDCSCAVAIY----DGNS 398
IN ++I + + +E SN +C CL DC C ++Y +
Sbjct: 364 INRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLDDEKPY 423
Query: 399 CRKKKLPLSNGWLRDTGFSKVLFKVRKGDFPGFSDNSGSKKGRGPLFLLGAFLLGGSILC 458
C K L+ G RD G S + K R + + N+ K R L L+ ++
Sbjct: 424 CWILK-SLNFGGFRDPG-STLFVKTRANESYPSNSNNNDSKSRKSHGLRQKVLVIPIVVG 481
Query: 459 NAFL--LLAILIFFKW-RRRKYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSF 515
L LL +L+++ R+R + ++S + F+Y +L++ T+ F + LG G F
Sbjct: 482 MLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGF 541
Query: 516 GIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNR 575
G VYKG + A T +AVK+LDR EREF +EV+ IG HH +LV+L G+C E +R
Sbjct: 542 GTVYKGTV--AGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHR 599
Query: 576 LLVYEFMGNGTLANLIFAIPKP----DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKP 631
LLVYE+M NG+L IF+ + DW R I++ A+G+AY HE+C IIHCDIKP
Sbjct: 600 LLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKP 659
Query: 632 QNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFG 691
+NILLD F K+SDFGL+K++ + S TMIRGTRGY+APEW N P++ K DVYS+G
Sbjct: 660 ENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYG 719
Query: 692 VTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLM 751
+ LLEI+ RR+++M + E WAY G +D +A+ + K L
Sbjct: 720 MLLLEIVGGRRNLDMSYDAED-FFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALK 778
Query: 752 IAMWCIQEDPSKRPTMKVVLQMLEGLLDVPN-PPGPSSF 789
+A WCIQ++ S RP+M V+++LEG D N PP P +
Sbjct: 779 VAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTI 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (847), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 260/805 (32%), Positives = 407/805 (50%), Gaps = 92/805 (11%)
Query: 21 NNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWF-NKIPERTIVWHANG 79
+ I LGS + ++ N +W SP+ F+ F + + + FL A+ F +P +W A
Sbjct: 25 STIPLGSVIYASGSNQNWPSPNSTFSVSFVP-SPSPNSFLAAVSFAGSVP----IWSAGT 79
Query: 80 DNPAPRGSTLELTATGLLLKDPGGQAIWDGKPDK-NVSDAAMLDTGNFVLRASGNNSDYA 138
+ RGS T+ L L + G +WD K D+ V+ ++ DTG F+L N S
Sbjct: 80 VDS--RGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILL--NNRSVPV 135
Query: 139 WQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFSNGSLEFIPVAWPSRFQYK 198
W SF +PTDTI+ +Q G +L S L F+L S + + W + Y
Sbjct: 136 WSSFDNPTDTIVQSQNFTAGKILRSGLYS-------FQLERSGN----LTLRWNTSAIYW 184
Query: 199 SYYTSNTYSSNSSESGHQLVFNESAEIYI--VKNDGQIVQLPQWSKLIPRTDHYFRATLD 256
++ ++++SSN S L N I+ + +IV +S ++ + LD
Sbjct: 185 NHGLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIV----YSGDYGDSNTFRFLKLD 240
Query: 257 FDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRRLIKETGSGTCGFNSYCSLRNGRPFCDC 316
DG L Y SS +++ P A+ + L+ G CG CS + P C C
Sbjct: 241 DDGNLRIY-----SSASRNSGPVNAHWSAVDQCLVY----GYCGNFGICSYNDTNPICSC 291
Query: 317 PPGHV-LVDPNYRYRGCKPNF-WQGCGPDDGSINAQELYEIREFNNVEWPLGDYERLEPS 374
P + VD N R +GCK C G+ +L R F + P + E +
Sbjct: 292 PSRNFDFVDVNDRRKGCKRKVELSDC---SGNTTMLDLVHTRLFTYEDDP--NSESFF-A 345
Query: 375 NQTECETSCLQD--CSCAVAIYDGNSCRKKKLPLS--NGW----LRDTGFSKV------- 419
+ C +CL C +V++ DG+ +K P S G+ + T + KV
Sbjct: 346 GSSPCRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVAN 405
Query: 420 -LFKVRKGDFPGFSDNSGSKKGRGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRKYE 478
L + KGD DN+ + +++ +++ L+A+ I W +
Sbjct: 406 TLERATKGD-----DNNSK---------VHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKN 451
Query: 479 NNVQDSTTSETNLRF-------FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAI 531
++ T L + F+Y EL+ T FKE+LG G FG VY+GVL T +
Sbjct: 452 PRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNR--TVV 509
Query: 532 AVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLI 591
AVK+L+ + Q E++F+ EV+ I THH +LV+L+GFC + +RLLVYEFM NG+L N +
Sbjct: 510 AVKQLEGIEQG-EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFL 568
Query: 592 FAIPKPD---WNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFG 648
F W R I+L A+G+ YLHEEC I+HCDIKP+NIL+D F+AK+SDFG
Sbjct: 569 FTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFG 628
Query: 649 LSKLLFSDQSRTH-TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEME 707
L+KLL +R + + +RGTRGY+APEW N+P+++K DVYS+G+ LLE++ +R+ ++
Sbjct: 629 LAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS 688
Query: 708 LEEESRAILTDWAYDCYVEGRLDVLIDS--DEAAMADRSRLHKWLMIAMWCIQEDPSKRP 765
E+ + + WAY+ + +G ++D+ E D ++ + + + WCIQE P +RP
Sbjct: 689 -EKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRP 747
Query: 766 TMKVVLQMLEGLLDVPNPPGPSSFS 790
TM V+QMLEG+ ++ NP P + S
Sbjct: 748 TMGKVVQMLEGITEIKNPLCPKTIS 772
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 330 bits (845), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 276/846 (32%), Positives = 400/846 (47%), Gaps = 114/846 (13%)
Query: 1 MALSCLILLCFPLLPFLSAANNIT-LGSSLSSTNKNSSWLSPSR-DFAFGFRQLNDNSDL 58
++ +C++ L P +++ +I LGSSL + SS L S F+ GF ++ ++
Sbjct: 9 LSTACILSFFIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTHA-- 66
Query: 59 FLLAIWFNKIP-----ERTIVWHANGDNPA-PRGSTLELTATG-LLLKDPGGQAIW--DG 109
F ++W++K +TIVW AN D P R S L L G ++L D G A+W DG
Sbjct: 67 FTFSVWYSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRADG 126
Query: 110 KPDKNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETN 169
V A +LDTGN V+ SG N+ WQSF SPTDT LPTQ++ + LV T +
Sbjct: 127 NNFTGVQRARLLDTGNLVIEDSGGNT--VWQSFDSPTDTFLPTQLITAATRLVP--TTQS 182
Query: 170 FSKGRFELHFSNGSL--------EFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNE 221
S G + FS+ S+ + + WP Q + Y NS+ G ++ +
Sbjct: 183 RSPGNYIFRFSDLSVLSLIYHVPQVSDIYWPDPDQ--NLYQDGRNQYNSTRLG--MLTDS 238
Query: 222 SAEIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRT 281
DGQ + + R R TLD DG L Y+ + ++ SW +
Sbjct: 239 GVLASSDFADGQALVASDVGPGVKR-----RLTLDPDGNLRLYSM---NDSDGSWSVSMV 290
Query: 282 LPDAMCRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCG 341
C G CG N C + P C CPPG+ +P GC C
Sbjct: 291 AMTQPCNI------HGLCGPNGICHY-SPTPTCSCPPGYATRNPGNWTEGCMAIVNTTC- 342
Query: 342 PDDGSINAQELYEIREFNNVEWPLGDY-----ERLEPSNQTECETSCLQDCSCAVAIYD- 395
+ Y+ R V P D+ + L + C C+ DC+C Y
Sbjct: 343 ---------DRYDKRSMRFVRLPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQE 393
Query: 396 -GNSCRKK-------------------KLP----LSNGWL-RDTGFSKV-----LFKVRK 425
SC K KLP +SN + R F V ++ K
Sbjct: 394 GTGSCYPKAYLFSGRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNK 453
Query: 426 GDFPGFSDNSGSKKGRGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRKYE--NNVQD 483
F D + G F F+ ++ +F+ A K R E + +
Sbjct: 454 SIREPFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKG 513
Query: 484 STTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER 543
+N R +SY EL AT FK ELGRG G VYKGVL+ +AVKKL+ + Q +
Sbjct: 514 YKAMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVLE--DDRHVAVKKLENVRQGK 571
Query: 544 EREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWN 600
E F++E+S IGR +H +LV++ GFC E +RLLV E++ NG+LAN++F+ DW
Sbjct: 572 E-VFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWE 630
Query: 601 LRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL---FSDQ 657
R I+L +A+GLAYLH EC +IHCD+KP+NILLD F KI+DFGL KLL S Q
Sbjct: 631 GRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQ 690
Query: 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEM-----ELEEES 712
+ +H +RGT GY+APEW ++P++AKVDVYS+GV LLE++ R E+ E+
Sbjct: 691 NVSH--VRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSML 748
Query: 713 RAILTDWAYDCYVEGR----LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 768
R ++ +EG +D +DS + + + +A+ C++ED SKRPTM+
Sbjct: 749 RKLVR--MLSAKLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTME 806
Query: 769 VVLQML 774
+Q L
Sbjct: 807 HAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 258/771 (33%), Positives = 372/771 (48%), Gaps = 89/771 (11%)
Query: 35 NSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPA--PRGSTLELT 92
N + LS F GF + S + L I + +P T VW AN P P STLELT
Sbjct: 30 NQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSSTLELT 89
Query: 93 ATG-LLLKDPGGQAIWDGKPDKNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILP 151
+TG L++ + +W + +D +TGN +L ++ WQSF +PTDT LP
Sbjct: 90 STGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLIL--INDDGSPVWQSFDNPTDTWLP 147
Query: 152 TQILDLGSVLVSRLTETNFSKGRFELHFSNGSLEFIPVAWPSRFQYKSYYTSNT-YSSNS 210
+ + + S + + S G + L S PS +++ Y T Y S
Sbjct: 148 GMNVTGLTAMTSWRSLFDPSPGFYSLRLS-----------PSFNEFQLVYKGTTPYWSTG 196
Query: 211 SESGHQLVFNESAEI-YIVKNDGQIVQLPQWS--KLIPRTD-----HYFRATLDFDGVLA 262
+ +G V I YI + P S ++P D R + +G L
Sbjct: 197 NWTGEAFVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLK 256
Query: 263 EYA-HPKNSSTNQSWFPTRTLPDAMCRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHV 321
+Y P+ S N W P+ CR CG +CS +P C C G
Sbjct: 257 QYTWDPQTQSWNMFWLQ----PEDPCRVY------NLCGQLGFCSSELLKP-CACIRGF- 304
Query: 322 LVDPNYRYRGCKPNFWQGCGPDDG-----SINAQELYEIREFNNVEWPLGDYERLEPSNQ 376
P ++ GC ++G S + + ++R +V+ RL+ S +
Sbjct: 305 --RPRNDAAWRSDDYSDGCRRENGDSGEKSDTFEAVGDLRYDGDVK-----MSRLQVS-K 356
Query: 377 TECETSCLQDCSCAVAIYDGNSCRKKKLPLSNGWLRDTGFSKVLFKVRKGDFPGFSDNSG 436
+ C +CL + SC V Y K+K + K+L + P NS
Sbjct: 357 SSCAKTCLGNSSC-VGFY-----HKEK----------SNLCKILLES-----PNNLKNSK 395
Query: 437 SKKGRGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRKYENNVQDSTT-SETNLRFFS 495
+ + L GSI F LL LI K R++ + QD + NL+ FS
Sbjct: 396 GNISKSIIILCSVV---GSISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVLNLKVFS 452
Query: 496 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIG 555
+ EL+ AT+GF +++G G FG V+KG L S T +AVK+L+R E EF++EV IG
Sbjct: 453 FKELQSATNGFSDKVGHGGFGAVFKGTLP-GSSTFVAVKRLERPGSG-ESEFRAEVCTIG 510
Query: 556 RTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKP-DWNLRIRISLEIARGL 613
H +LV+L GFC E L+RLLVY++M G+L++ L PK W R RI+L A+G+
Sbjct: 511 NIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKGI 570
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAP 673
AYLHE C IIHCDIKP+NILLD ++AK+SDFGL+KLL D SR +RGT GYVAP
Sbjct: 571 AYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAP 630
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEIICCRRSV--------EMELEEESRAILTDWAYDCYV 725
EW +P++ K DVYSFG+TLLE+I RR+V E E E E + WA +
Sbjct: 631 EWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPE-KWFFPPWAAREII 689
Query: 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776
+G +D ++DS + + + +A+WCIQ++ RP M V++MLEG
Sbjct: 690 QGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 258/836 (30%), Positives = 395/836 (47%), Gaps = 106/836 (12%)
Query: 1 MALSCLILLCFPLLPFLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFL 60
+ L+ +CF F+ ++ + S + + + + +S + GF + +S+ F
Sbjct: 5 LTLTSFFFICF----FIHGSSAVDTISGDFTLSGDQTIVSSDGTYEMGFFKPGSSSN-FY 59
Query: 61 LAIWFNKIPERTIVWHANGDNPAP--RGSTLELTATGLLLKDPGGQA-IWDGKPDKNVS- 116
+ +W+ ++ + TI+W AN D S +++ L+L D Q +W + S
Sbjct: 60 IGMWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSV 118
Query: 117 ---DAAMLDTGNFVLRASGNN--SDYAWQSFKSPTDTILP-TQI-LDLGSVLVSRLTE-- 167
+A + D GN VLR G++ ++ WQSF P DT LP +I LD + RLT
Sbjct: 119 SALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWK 178
Query: 168 --TNFSKGRFELHFSNGSLEFIPVAWPSRFQYKSYYT-SNTYSSNSSESGHQLVFNESAE 224
+ S G F L + YK + SN Y S+ + +F+ E
Sbjct: 179 SLEDPSPGLFSLELDEST------------AYKILWNGSNEYWSSGPWNPQSRIFDSVPE 226
Query: 225 IYIVKNDGQIVQLPQWSKLIPRTDHYF-----------RATLDFDGVLAEYAHPKNSSTN 273
+ ++ + +S TD YF R +D G + ++ + N
Sbjct: 227 M-------RLNYIYNFSFFSNTTDSYFTYSIYNQLNVSRFVMDVSGQIKQFTWLEG---N 276
Query: 274 QSWFPTRTLPDAMCRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHVLVDPNYRYRGCK 333
++W + P C+ CG CS ++ PFC CP G +R
Sbjct: 277 KAWNLFWSQPRQQCQVY------RYCGSFGICSDKS-EPFCRCPQG---------FRPMS 320
Query: 334 PNFWQGCGPDDGSINAQELY----EIREFNNV-EWPLGD-YERLEPSNQTECETSCLQDC 387
W G + EL +I +F + L D E L ++ + C ++C DC
Sbjct: 321 QKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTSLSICASACQGDC 380
Query: 388 SCAVAIYDGNSCR-----KKKLPLSNGWLRDTGFSKVLFKVR--KGDFPGFSDNSGSKKG 440
SC YD S + K L L L D +F +R D P SG
Sbjct: 381 SCKAYAYDEGSSKCLVWSKDVLNLQQ--LEDENSEGNIFYLRLAASDVPNVG-ASGKSNN 437
Query: 441 RGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRKYENNVQDSTTSETNLRFFSYDELK 500
+G +F G++L + +++ +L+ R + L FSY EL+
Sbjct: 438 KGLIF--------GAVLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDGTLSAFSYRELQ 489
Query: 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHK 560
+AT F ++LG G FG V+KG L +S IAVK+L+ ++Q E++F++EV IG H
Sbjct: 490 NATKNFSDKLGGGGFGSVFKGALPDSSD--IAVKRLEGISQG-EKQFRTEVVTIGTIQHV 546
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD-----WNLRIRISLEIARGLAY 615
+LV+L GFC E +LLVY++M NG+L + +F + W LR +I+L ARGLAY
Sbjct: 547 NLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAY 606
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
LH+EC IIHCDIKP+NILLD F K++DFGL+KL+ D SR T +RGTRGY+APEW
Sbjct: 607 LHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEW 666
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYV-EGRLDVLID 734
V ++AK DVYS+G+ L E++ RR+ E E+ R WA +G + L+D
Sbjct: 667 ISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVR-FFPSWAATILTKDGDIRSLVD 725
Query: 735 SD-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPSSF 789
E D + + +A WCIQ++ S RP M V+Q+LEG+L+V PP P S
Sbjct: 726 PRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRSI 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 271 bits (694), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 138/301 (45%), Positives = 193/301 (64%), Gaps = 9/301 (2%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA 553
F+Y +L+ AT+ F +LG+G FG VY+G L G+ +AVKKL+ + Q + +EF++EVS
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTL--PDGSRLAVKKLEGIGQGK-KEFRAEVSI 539
Query: 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD----WNLRIRISLEI 609
IG HH HLV+L GFC E +RLL YEF+ G+L IF D W+ R I+L
Sbjct: 540 IGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGT 599
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG 669
A+GLAYLHE+C+ I+HCDIKP+NILLD F+AK+SDFGL+KL+ +QS T +RGTRG
Sbjct: 600 AKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRG 659
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729
Y+APEW N +S K DVYS+G+ LLE+I R++ + E + +A+ EG+L
Sbjct: 660 YLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKMEEGKL 718
Query: 730 DVLIDSDEAAM-ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPSS 788
++D + R+ + + A+WCIQED RP+M V+QMLEG+ V PP S+
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSST 778
Query: 789 F 789
Sbjct: 779 M 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 270 bits (689), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 233/801 (29%), Positives = 360/801 (44%), Gaps = 125/801 (15%)
Query: 53 NDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATGLLLKDPGGQAI--WD-- 108
+D+S F ++ + + +W +N D+P T+ LT G+ + + G I W
Sbjct: 67 DDSSTGFYFSVV--HVDSGSTIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTP 124
Query: 109 --GKPDKNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLT 166
P K++ + D GN +L N S W+SF PTD+I+ Q L LG L ++
Sbjct: 125 VLASPVKSLR---LTDAGNLLLLDHLNVS--LWESFDFPTDSIVLGQRLKLGMFLSGSVS 179
Query: 167 ETNFSKG--RFELHFSNGSLEFIPVA-WPSRFQYKSYYTSNTYSSNSSESGHQLVFNESA 223
++FS G +F + S+G +++ W R ++ SN + + ++
Sbjct: 180 RSDFSTGDYKFLVGESDGLMQWRGQNYWKLRMHIRANVDSNFPV--------EYLTVTTS 231
Query: 224 EIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDG--VLAEYAHPKNSSTNQSWFPTRT 281
+ ++ +G +V + +P + + A +D G +++ ++ KN T S
Sbjct: 232 GLALMARNGTVVVV---RVALPPSSDFRVAKMDSSGKFIVSRFSG-KNLVTEFSG----- 282
Query: 282 LPDAMCRRLIKETGSGTCGFNSYCSLRNG--RPFCDCPPGHVLVDPNYRYRGCKPNFWQG 339
P C+ CG C+L N C CP + +D +G
Sbjct: 283 -PMDSCQIPF------VCGKLGLCNLDNASENQSCSCPD-EMRMDAG---KGV------- 324
Query: 340 CGPDDGSINAQELYEIREFNNVEWPLG-DYERLEPSNQTE-------CETSCLQDCSCAV 391
C P S++ E R + +E LG Y ++ E C C ++CSC
Sbjct: 325 CVPVSQSLSLPVSCEARNISYLELGLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLG 384
Query: 392 AIYDGNSCRKKKLPLSNGWLRDT----------GFSKVLFKVRKGDFPGFSDNSGSKKGR 441
Y+ S + S G L G+ K+ + PG ++ GS
Sbjct: 385 VFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTNAQPPGNNNRGGSS--- 441
Query: 442 GPLFLLGAFLLGGSILCNAFLLLAILIFFKWRR---RKYENNVQDSTTSETNL------- 491
F + A +L + C+ F LL L WRR +Y + + T +
Sbjct: 442 ---FPVIALVL---LPCSGFFLLIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGS 495
Query: 492 -------RFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE 544
+ F ++EL+ AT+ FK ++G G FG VYKG L T IAVKK+
Sbjct: 496 FHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDE--TLIAVKKITNHGLHGR 553
Query: 545 REFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLR 602
+EF +E++ IG H +LV+L GFC LLVYE+M +G+L +F+ P +W R
Sbjct: 554 QEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQER 613
Query: 603 IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662
I+L ARGLAYLH C+ IIHCD+KP+NILL F KISDFGLSKLL ++S T
Sbjct: 614 FDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFT 673
Query: 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTD---- 718
+RGTRGY+APEW N +S K DVYS+G+ LLE++ R++ S ++ D
Sbjct: 674 TMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNC--SFRSRSNSVTEDNNQN 731
Query: 719 ----------------WAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPS 762
+A D + +GR L D K + IA+ C+ E+P+
Sbjct: 732 HSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPA 791
Query: 763 KRPTMKVVLQMLEGLLDVPNP 783
RPTM V+ M EG + + NP
Sbjct: 792 LRPTMAAVVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (661), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 229/835 (27%), Positives = 374/835 (44%), Gaps = 92/835 (11%)
Query: 7 ILLCFPLLPFLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFN 66
+ L F L AAN I G SL + +SP + F GF ++ FL IW+
Sbjct: 13 LFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFL-GIWYG 71
Query: 67 KIPERTIVWHANGDNP-APRGSTLELTATG-LLLKDPGGQAIWDGKPDKNVSD-----AA 119
I ++ +VW AN P + + L ++ G L+L D +W + + ++ +
Sbjct: 72 NIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVS 131
Query: 120 MLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLG------SVLVSRLTETNFSKG 173
+ DTGNFVL + + W+SF PTDT LP + + VS +ET+ S G
Sbjct: 132 IHDTGNFVLSETDTDRP-IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPG 190
Query: 174 RFELHFS-NGSLEFIPVAWPSRFQYKS-YYTSNTYSSNSSES-------GHQLVF--NES 222
+ L +G+ E + +++S + S ++ + S G +L +E+
Sbjct: 191 NYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDET 250
Query: 223 AEIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTL 282
+Y L ++ L T+ R + T + W ++
Sbjct: 251 GSVYFTYVPSDPSVLLRFKVLYNGTEEELRW----------------NETLKKWTKFQSE 294
Query: 283 PDAMCRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCGP 342
PD+ C + + CG C ++ C C G+ V RGC+ C
Sbjct: 295 PDSECDQYNR------CGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKC-E 347
Query: 343 DDGSINAQELYEIREFNNVEWPLGDYERLEPSNQTECETSCLQDCSC-AVAIYDGNSCRK 401
+ S+ E ++ ++ + ++ ++P +C CL++CSC A ++ G C
Sbjct: 348 RNISVGEDEFLTLKSVKLPDFEIPEHNLVDPE---DCRERCLRNCSCNAYSLVGGIGCMI 404
Query: 402 KKLPLSNGWLRDTGFSKVLFKVRKGDFPGFSDNSGSKKGRGPLFLLGAFLLGGSIL---- 457
L + + G S + ++ + +N +K L+G L+G L
Sbjct: 405 WNQDLVDLQQFEAGGSSLHIRLADSEV---GENRKTKIAVIVAVLVGVILIGIFALLLWR 461
Query: 458 ---------------CNAFLLLAILIFFKWRRRKYENNV----QDSTTSETNLRFFSYDE 498
+ +++A L K + +V + + + L FS +
Sbjct: 462 FKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNA 521
Query: 499 LKDATDGF--KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR 556
+ AT+ F + ELGRG FG VYKGVL+ G IAVK+L + + EFK+E+ I +
Sbjct: 522 IAIATNDFCKENELGRGGFGPVYKGVLE--DGREIAVKRLSGKSGQGVDEFKNEIILIAK 579
Query: 557 THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRIRISLEIARGL 613
H++LV+LLG C E ++LVYE+M N +L +F K DW LR I IARGL
Sbjct: 580 LQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGL 639
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM-IRGTRGYVA 672
YLH + + IIH D+K N+LLD + KISDFG++++ +Q+ +T+ + GT GY++
Sbjct: 640 LYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMS 699
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732
PE+ S K DVYSFGV LLEI+ +R+ + E L +A+ Y GR + L
Sbjct: 700 PEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGS--LIGYAWYLYTHGRSEEL 757
Query: 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE---GLLDVPNPP 784
+D + + + +AM C+Q+ ++RP M VL MLE L P P
Sbjct: 758 VDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 9e-68, Method: Compositional matrix adjust.
Identities = 234/825 (28%), Positives = 373/825 (45%), Gaps = 88/825 (10%)
Query: 6 LILLCFPLLPFLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWF 65
L+L CF FLS + N + + +S R F FGF +++ + IW+
Sbjct: 14 LVLSCF----FLSVSLAQERAFFSGKLNDSETIVSSFRTFRFGFFSPVNSTSRYA-GIWY 68
Query: 66 NKIPERTIVWHANGDNPAPRGS-TLELTATG-LLLKDPGGQAIWDG----KPDKNVSDAA 119
N + +T++W AN D P S + ++ G L++ D + +W + N + A
Sbjct: 69 NSVSVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANSTVAE 128
Query: 120 MLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHF 179
+LD+GN VL+ + +++ Y W+SFK PTD+ LP ++ + + K +
Sbjct: 129 LLDSGNLVLKEASSDA-YLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSP 187
Query: 180 SNGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIY--------IVKND 231
+ + + A+P F + ++T + +G +FN ++Y IV +D
Sbjct: 188 GSYTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQ--MFNGLPDVYAGVFLYRFIVNDD 245
Query: 232 --GQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRR 289
G + S T YF +D+ G + S T ++W +P C
Sbjct: 246 TNGSVTM----SYANDSTLRYF--YMDYRGSVIRRDW---SETRRNWTVGLQVPATECDN 296
Query: 290 LIKETGSGTCGFNSYCSLRNGRPFCDC----PPGHVLVDPNYRYRG-CKPNFWQGCGPDD 344
+ CG + C+ R P C C P +++ N + G C C +
Sbjct: 297 YRR------CGEFATCNPRKN-PLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQN 349
Query: 345 GSINAQELYEIREFNNVEWPLGDYERLEPSNQTECETSCLQDCSCAVAIYD-GNSCRKKK 403
+ +A +R L D+ R +++ EC +CLQ CSC A + G C
Sbjct: 350 NNGSADGFLRLRRMK-----LPDFARRSEASEPECLRTCLQTCSCIAAAHGLGYGCM--- 401
Query: 404 LPLSNGWLRDTGFSKVLFKVRKGDFPGFSDNSGSKKGRGPLFLLGAFLLGGSILCNAFLL 463
+ NG L D S+ L + + + K + P+ L+G L GG + A +L
Sbjct: 402 --IWNGSLVD---SQELSASGLDLYIRLAHSEIKTKDKRPI-LIGTILAGGIFVVAACVL 455
Query: 464 LAILIFFKWRRRKYENNVQD-----------STTSETNLRFFSYDELKDATDGF--KEEL 510
LA I K R +K + + + L F + L AT+ F + +L
Sbjct: 456 LARRIVMKKRAKKKGRDAEQIFERVEALAGGNKGKLKELPLFEFQVLAAATNNFSLRNKL 515
Query: 511 GRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCD 570
G+G FG VYKG L+ G IAVK+L R + + E +EV I + H++LV+LLG C
Sbjct: 516 GQGGFGPVYKGKLQ--EGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCI 573
Query: 571 EALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRIRISLEIARGLAYLHEECNVPIIHC 627
R+LVYEFM +L +F + DW R I I RGL YLH + + IIH
Sbjct: 574 AGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHR 633
Query: 628 DIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT-MIRGTRGYVAPEWFKNVPVSAKVD 686
D+K NILLD KISDFGL+++ ++ +T + GT GY+APE+ S K D
Sbjct: 634 DLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSD 693
Query: 687 VYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRL 746
V+S GV LLEII RR+ S + L + + + EG ++ L+D + + +
Sbjct: 694 VFSLGVILLEIISGRRN--------SNSTLLAYVWSIWNEGEINSLVDPEIFDLLFEKEI 745
Query: 747 HKWLMIAMWCIQEDPSKRPTMKVVLQMLEG-LLDVPNPPGPSSFS 790
HK + I + C+QE + RP++ V ML + D+P P P+ S
Sbjct: 746 HKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIADIPEPKQPAFIS 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 796 | ||||||
| 224138692 | 776 | predicted protein [Populus trichocarpa] | 0.959 | 0.984 | 0.648 | 0.0 | |
| 255583185 | 787 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.971 | 0.982 | 0.579 | 0.0 | |
| 357482147 | 800 | Kinase-like protein [Medicago truncatula | 0.948 | 0.943 | 0.534 | 0.0 | |
| 357482135 | 803 | Kinase-like protein [Medicago truncatula | 0.974 | 0.966 | 0.514 | 0.0 | |
| 356540555 | 802 | PREDICTED: G-type lectin S-receptor-like | 0.961 | 0.953 | 0.528 | 0.0 | |
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.962 | 0.956 | 0.528 | 0.0 | |
| 356495581 | 801 | PREDICTED: G-type lectin S-receptor-like | 0.953 | 0.947 | 0.524 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.976 | 0.972 | 0.516 | 0.0 | |
| 356495583 | 809 | PREDICTED: G-type lectin S-receptor-like | 0.968 | 0.953 | 0.5 | 0.0 | |
| 359487487 | 808 | PREDICTED: G-type lectin S-receptor-like | 0.974 | 0.960 | 0.508 | 0.0 |
| >gi|224138692|ref|XP_002326666.1| predicted protein [Populus trichocarpa] gi|222833988|gb|EEE72465.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1017 bits (2630), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/777 (64%), Positives = 612/777 (78%), Gaps = 13/777 (1%)
Query: 23 ITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNP 82
+T SSL+ TN N+ WLSPS DFAFGFRQL NS+LFLLAIWF+ IP RTIVWH+NG+NP
Sbjct: 4 VTPSSSLT-TNGNT-WLSPSGDFAFGFRQLG-NSNLFLLAIWFDIIPARTIVWHSNGNNP 60
Query: 83 APRGSTLELTATGLLLKDPGGQAIWDGKPDKNVSDAAMLDTGNFVLRASGNNSDYAWQSF 142
PRGS +ELT++ L+L +P G IW P V AAMLDTGNFVL+ + ++S Y W++F
Sbjct: 61 LPRGSKVELTSSNLVLTNPKGLIIWQANPATPVISAAMLDTGNFVLKGN-DSSTYIWETF 119
Query: 143 KSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFSNGSLEFIPVAWPSRFQYKSYYT 202
K+PTDTILPTQ LDLGS L SRLTETN+SKGRFEL+FSNGSLE P+AWPS FQY YY+
Sbjct: 120 KNPTDTILPTQTLDLGSKLFSRLTETNYSKGRFELNFSNGSLELNPIAWPSEFQYDHYYS 179
Query: 203 SNTYSSNSSESGHQLVFNESAEIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLA 262
SNTY+++ ESG++LVFNESA +YIVK +G+I Q P W+++ D+Y+RATL FDGV
Sbjct: 180 SNTYNADPYESGYRLVFNESANVYIVKLNGEIAQFPDWNRINYTGDNYYRATLGFDGVFT 239
Query: 263 EYAHPKNSSTNQSWFPTRTLPDAMCRRLIKETGSGTCGFNSYCSLR-NGRPFCDCPPGHV 321
+Y+ PKNS+TNQ W+P +++P MC + + GSG CGFNSYCS++ N +P CDCPPG+V
Sbjct: 240 QYSLPKNSTTNQGWWPVQSIPLDMCTAIFNDIGSGPCGFNSYCSIQENRKPTCDCPPGYV 299
Query: 322 LVDPNYRYRGCKPNFWQGCGPDDGSINAQELYEIREFNNVEWPLGDYERLEPSNQTECET 381
+DPN R GCKP F QGCG DDG + +ELYEIR+F+NV WPL DYERL P NQT+CE
Sbjct: 300 FLDPNNRLGGCKPTFPQGCGLDDGRGDPEELYEIRQFDNVNWPLNDYERLSPYNQTQCEK 359
Query: 382 SCLQDCSCAVAIYDGNSCRKKKLPLSNGWLRDTGFSKVLFKVRKGDFPGFSDNSGSKKGR 441
SCL DCSCAVAI+DG C KK+LPLSNG TGFSK LFKVRK P N GS K +
Sbjct: 360 SCLYDCSCAVAIFDGRQCWKKRLPLSNGRYMRTGFSKTLFKVRKEVPPSGYCNVGSDKEK 419
Query: 442 GPLFLLGAFLLGGSILCNAFLLLA-ILIFFKWRRRKYENNVQDSTTSETNLRFFSYDELK 500
P+ LLGA LLG S N LL+ LI F+ R RK + DS+ + LR F+Y EL+
Sbjct: 420 -PV-LLGA-LLGSSAFLNVILLVVTFLILFRRRERKVKKAGPDSSIYFSTLRSFTYKELE 476
Query: 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHK 560
+ATDGF EELGRGSFGIVYKG ++++SG AIAVKKLD+LAQEREREF++EVSAIG THHK
Sbjct: 477 EATDGFMEELGRGSFGIVYKGFMRSSSGNAIAVKKLDKLAQEREREFRTEVSAIGETHHK 536
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+LV+LLG+CDE +RLL+YEFM NGTLAN +F +P+PDW+ R++I+L +ARGL YLH EC
Sbjct: 537 NLVRLLGYCDEGSHRLLIYEFMSNGTLANFLFTLPRPDWHQRVKIALGVARGLLYLHGEC 596
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680
PIIHCDIKPQNILLD FSA+ISDFGL+KLL S+Q+RT TMIRGTRGYVAPEWFKNVP
Sbjct: 597 EFPIIHCDIKPQNILLDDSFSARISDFGLAKLLLSNQTRTRTMIRGTRGYVAPEWFKNVP 656
Query: 681 VSAKVDVYSFGVTLLEIICCRRSVEMELE--EESRAILTDWAYDCYVEGRLDVLIDSDEA 738
V+AKVDVYSFGV LLEIICCRRSV M+LE EE RAILTDWAYDCY+ GR+ L+D+D+
Sbjct: 657 VTAKVDVYSFGVLLLEIICCRRSVVMDLEEGEEERAILTDWAYDCYIGGRIYHLVDNDKV 716
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPSSFSIAGTG 795
AM D+ RL KW+ ++MWCIQE+PSKRPTMK+VL+MLEG LDV PP S F ++ +G
Sbjct: 717 AMDDKERLKKWVEVSMWCIQEEPSKRPTMKMVLEMLEGFLDV--PPLQSPFPLSSSG 771
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583185|ref|XP_002532358.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223527945|gb|EEF30031.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 891 bits (2302), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/790 (57%), Positives = 575/790 (72%), Gaps = 17/790 (2%)
Query: 1 MALSCLILLCFPLLPFLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFL 60
M +S LI+L LLP LSA NITL SSL + N + SW SPS DFAFGF +L N++LFL
Sbjct: 1 MVVSKLIVLILFLLPPLSAQQNITLSSSLVANNNSPSWTSPSGDFAFGFHKLV-NTNLFL 59
Query: 61 LAIWFNKIPERTIVWHANGDNPAPRGSTLELTATGLLLKDPGGQAIWDGKPDKNVSDAAM 120
LAIWF+KIP++TIVW ANGD PA +GS LE++ GLLL DPGGQ IW+ + VS AAM
Sbjct: 60 LAIWFDKIPDKTIVWDANGDKPAQQGSKLEVSVNGLLLTDPGGQLIWE-QQTATVSYAAM 118
Query: 121 LDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFS 180
LDTGNFVL NNSDY W+SFK+PTDTILP+Q L+ G+ L SRL ETN+S+GRF+L+F
Sbjct: 119 LDTGNFVL--VDNNSDYLWESFKNPTDTILPSQALEPGTFLFSRLAETNYSRGRFQLYFL 176
Query: 181 NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIVQLP-Q 239
NG L+ PV WP++ QY +Y++S T SS+SS SG+QLVFN+S +IY+VK DG V+LP Q
Sbjct: 177 NGDLQLSPVGWPTKVQYGAYFSSGTSSSDSSVSGYQLVFNQS-DIYMVKTDGVTVRLPWQ 235
Query: 240 WSKLIPR-TDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRRLIKETGSGT 298
P +Y+RATLD++GVL +Y PK S +++SW + +P +C + GSG
Sbjct: 236 QQDTAPSLAGNYYRATLDYNGVLTQYVCPKGSGSDRSWSIVQYIPQDICSAIFNGIGSGA 295
Query: 299 CGFNSYCSLRNGRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCGPDDGSINAQELYEIREF 358
CG+NS C+ NGRP C CP G+ +D N + GCKP+F GCG D S N ++LYE RE
Sbjct: 296 CGYNSICTEVNGRPNCACPLGYSFIDQNNLFGGCKPDFPLGCGVADASENMEDLYEFREL 355
Query: 359 NNVEWPLGDYERLEPSNQTECETSCLQDCSCAVAIYDGNSCRKKKLPLSNGWLRDTGFSK 418
V WPLGDYERL P + EC+TSCLQDC CA AIY + C KK++PL+NG L + G S
Sbjct: 356 QYVNWPLGDYERLSPYSVEECKTSCLQDCMCAAAIYGSSICWKKRIPLANGRL-EKGNSL 414
Query: 419 VLFKVRKGD---FPGFSDNSGSKKGRGPLFLLGAFLLGGSILCNAFLLLAI-LIFFKWRR 474
L KVRKG PG + KK + L G+ LG S++ NAF L + LI F
Sbjct: 415 ALIKVRKGAPLAQPGLT--CIKKKKQDKTILFGS--LGTSLVLNAFFLFTVPLILFLKLN 470
Query: 475 RKYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVK 534
RK +Q ST ETNL FSY EL++ATD FKE++GRGS IVYKG+LK + IAVK
Sbjct: 471 RKSNKVLQLSTLLETNLHMFSYKELEEATDNFKEQVGRGSSAIVYKGILKCSPNNVIAVK 530
Query: 535 KLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI 594
KLD+L+QE E+EF++E+ IG+T HK+LV+LLGFC+E +RLLVY+FM GTLAN + I
Sbjct: 531 KLDKLSQEAEKEFRTEMKVIGKTCHKNLVRLLGFCEEGSHRLLVYQFMTRGTLANFLLGI 590
Query: 595 PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654
PKP+WN+R +I LEIARGL YLHEEC PIIHCDIKP+NILLD +F+AKISDFGLSKLL
Sbjct: 591 PKPEWNIRAQIVLEIARGLLYLHEECEAPIIHCDIKPENILLDEYFTAKISDFGLSKLLL 650
Query: 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA 714
S+QSRT T+IRGTRGYVAPEWF+NV V+AKVDVYSFGV LLEIICC+++V +LE+E
Sbjct: 651 SNQSRTMTLIRGTRGYVAPEWFRNVAVTAKVDVYSFGVVLLEIICCKKNVS-KLEDEKDG 709
Query: 715 ILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
ILT+W YDC E RLD +I+ DE A+AD+ RL+ W+ +A+WC QEDPS RP+MK VLQML
Sbjct: 710 ILTEWVYDCLQEERLDAVIEFDEEAVADKERLNSWVRMAIWCTQEDPSTRPSMKTVLQML 769
Query: 775 EGLLDVPNPP 784
EG ++P+ P
Sbjct: 770 EGFTEIPSLP 779
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482147|ref|XP_003611359.1| Kinase-like protein [Medicago truncatula] gi|355512694|gb|AES94317.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2154), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/786 (53%), Positives = 555/786 (70%), Gaps = 31/786 (3%)
Query: 22 NITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDN 81
N+T S+LS+TNKNS WLSPS +FAFGF+QL ++LF+LAIW+NKIPE+TIVW A N
Sbjct: 24 NVTRSSTLSTTNKNS-WLSPSGEFAFGFQQLGTATNLFMLAIWYNKIPEKTIVWSAKNTN 82
Query: 82 -----PAPRGSTLELTATGLLLKDPGGQAIWDGKPDKNVSDAAMLDTGNFVLRASGNNSD 136
AP GS ++LT+ GL L G++IW +P+ VS M DTGNFVL NS
Sbjct: 83 NNNLVQAPTGSQVQLTSGGLTLTTQQGESIWTAQPNTAVSYGIMHDTGNFVL--VNKNSS 140
Query: 137 YAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHF--SNGSLEFIPVAWPSR 194
W+SFK PTDT+LP Q L+LG + SR +ETN++ GRF+L+F + +L P+AWP++
Sbjct: 141 IVWESFKFPTDTLLPNQSLELGGNITSRFSETNYTSGRFQLYFRDDDHNLMLSPLAWPTQ 200
Query: 195 FQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQ----IVQLPQWSKL-IPRTDH 249
+YK YY + +S SS LVF+ES +IY+ N I Q QW L + +
Sbjct: 201 LRYKFYYRIDVNNSASSS----LVFDESGDIYVETNKNGTTRIIPQGTQWKNLDLDPKLY 256
Query: 250 YFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRRLIKETGSGTCGFNSYCSLRN 309
Y+RATLD+ GVL +Y+HP+++ Q W R +PD +C + E GSGTCG+NSYCS+ N
Sbjct: 257 YYRATLDYYGVLTQYSHPRDTKAKQGWTIMRYVPDNICIAIFNEMGSGTCGYNSYCSMEN 316
Query: 310 GRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCGPDDG---SINAQELYEIREFNNVEWPLG 366
RP C CP G+ L+DP+ ++ GC+ NF GCG ++G ++ +ELYE +V+WPL
Sbjct: 317 QRPTCKCPYGYSLIDPSNQFGGCQLNFTLGCGDNNGEGLNVKPEELYEFTVLRDVDWPLS 376
Query: 367 DYERLEPSNQTECETSCLQDCSCAVAIYDGNSCRKKKLPLSNGWLRDTGFSKVLFKVRKG 426
DYE+++P +Q +C+ SCL DC CAVA+++ N+C KK+LP++NG + +G VL K R
Sbjct: 377 DYEKMQPYSQQDCQQSCLHDCMCAVAVFNNNTCWKKRLPIANGRAQ-SGGQLVLVKTRVS 435
Query: 427 DF-PGFSDNSGSKKGRGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRKYENNVQDST 485
F P + + K R L G LL S + N+ LL A++ + ++ VQ +T
Sbjct: 436 PFGPSSTTHDLKKDDRVKPILQG--LLISSTVFNSILLAAVVFMTLLKPKRV---VQAAT 490
Query: 486 TSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASG-TAIAVKKLDRLAQERE 544
ETNL FSYD LK+AT GF EELGRGSFGIVYKG LK S +AVK+LDRL ++RE
Sbjct: 491 LVETNLCSFSYDALKEATWGFSEELGRGSFGIVYKGELKAGSTCNVVAVKRLDRLVEDRE 550
Query: 545 REFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR 604
+EFK+E+ AIG+T HK+LV+L+GFCDE L+R+LVYEFM NG+LAN++F KP WN R+
Sbjct: 551 KEFKTELRAIGKTCHKNLVRLVGFCDEGLHRMLVYEFMSNGSLANILFGETKPIWNQRVG 610
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664
+L IARGL YLHEEC+ PIIHCDIKPQNIL+D +F+AKISDFGL+KLL +DQSRT+TM+
Sbjct: 611 FALGIARGLVYLHEECDTPIIHCDIKPQNILIDEYFTAKISDFGLAKLLLADQSRTNTMV 670
Query: 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVE-MELEEESRAILTDWAYDC 723
RGTRGYVAPEWFKNVPV+AKVDVYSFG LLEI+CCR+SV ME EE +AILTDWA DC
Sbjct: 671 RGTRGYVAPEWFKNVPVTAKVDVYSFGAMLLEIVCCRKSVVLMESGEEEKAILTDWACDC 730
Query: 724 YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
Y+EGR+D L+++D+ A+ D RL KW+ IA+WCIQE P RPTM++V+QMLE ++ VP+P
Sbjct: 731 YMEGRIDALVENDQEALDDIDRLEKWIKIAIWCIQEHPEMRPTMRMVMQMLEDVVKVPDP 790
Query: 784 PGPSSF 789
P P SF
Sbjct: 791 PSPFSF 796
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482135|ref|XP_003611353.1| Kinase-like protein [Medicago truncatula] gi|355512688|gb|AES94311.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2126), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/809 (51%), Positives = 561/809 (69%), Gaps = 33/809 (4%)
Query: 4 SCLILLCFPLLPFLSAANNITLGSSLSSTNKNSS-WLSPSRDFAFGFRQLNDNSDLFLLA 62
S L ++ L + A N++ S LS+TN N++ WLSPS +FAFGFR N ++ F+LA
Sbjct: 5 STLYIIAILFLQLILAFGNVSPSSRLSTTNNNNNPWLSPSGEFAFGFR--NTTTNFFMLA 62
Query: 63 IWFNKIPERTIVWHANGDNP------APRGSTLELTATGLLLKDPGGQAIWDGKPDKNVS 116
IW+N I ++TIVW A N AP GS ++LT+ GL L +P ++IW +P+ VS
Sbjct: 63 IWYNNIHDQTIVWSAKDMNNSNNLVLAPTGSQVQLTSGGLTLTNPQNESIWTAQPNDIVS 122
Query: 117 DAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFE 176
MLD GNFVL N S W+SFK PTDT+LP Q L+LG+ L SR +ETNF+ GRF+
Sbjct: 123 YGTMLDNGNFVL--VNNKSAIVWESFKFPTDTLLPNQSLELGATLTSRFSETNFTSGRFQ 180
Query: 177 LHFSNG--SLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQI 234
L+F++ +L P+AWP++F+Y YY ++++S S LVF+ES +IY+ N
Sbjct: 181 LYFNDDDHNLMLSPLAWPTQFRYNFYYRIEVNNNSASSS---LVFDESGDIYVETNKNGT 237
Query: 235 VQLP----QWSKL-IPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRR 289
++ QW L + +Y+RA LD+ GVL +Y+HP+++ Q W R +PD +C
Sbjct: 238 TRIKPQGTQWKNLDLDPKLYYYRAILDYYGVLTQYSHPRDTKAKQGWTIMRYVPDNICIA 297
Query: 290 LIKETGSGTCGFNSYCSLRNGRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCGPDDG---S 346
+ E GSGTCG+NSYCS+ N RP C CP G+ L+DP+ ++ GC+ NF GCG D+G +
Sbjct: 298 IFNEMGSGTCGYNSYCSMENQRPTCKCPYGYSLIDPSNQFGGCQLNFTLGCGADNGEGLN 357
Query: 347 INAQELYEIREFNNVEWPLGDYERLEPSNQTECETSCLQDCSCAVAIYDGNSCRKKKLPL 406
+ ++LYE NV WPL DYER++P +Q +C+ SCL DC C+V ++ +C KK+ PL
Sbjct: 358 VKPEDLYEFTVLTNVNWPLSDYERMQPYSQHDCQQSCLHDCMCSVVVFSNQNCWKKRSPL 417
Query: 407 SNGWLRDTGFSKVLFKVRKGDFP--GFSDNSGSKKGRGPLFLLGAFLLGGSILCNAFLLL 464
+NG ++G + VL K R G S ++ KK +L L+G ++ N+ LL
Sbjct: 418 ANG-REESGGNLVLIKTRVSPLGKIGASPSTNLKKDNQVNPILRGLLIGSAVF-NSILLA 475
Query: 465 AILIFFKWRRRKYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLK 524
A+++ + ++ V +T ETNL FSYD LK+AT GF EELGRGSFGIV+KG LK
Sbjct: 476 AVVLVTLLKPKRV---VVGTTLLETNLCSFSYDALKEATWGFIEELGRGSFGIVFKGELK 532
Query: 525 TA-SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583
A S +AVK+LDRLAQ+RE+EFK+E+ AIG+T HK+LV+L+G+CDE ++R+LVYEFM
Sbjct: 533 AATSCNVVAVKRLDRLAQDREKEFKTELRAIGKTCHKNLVKLIGYCDEGMHRMLVYEFMN 592
Query: 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAK 643
NG+LAN++F KP WN RI +L IARGL YLHEEC+ PIIHCDIKPQNIL+D +F+AK
Sbjct: 593 NGSLANILFGQTKPTWNQRIGFALGIARGLVYLHEECDTPIIHCDIKPQNILIDEYFTAK 652
Query: 644 ISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS 703
ISDFGL+KLL +DQSRT TMIRGTRGYVAPEWFKNVPV+AKVDVYSFG LLEI+CCR+S
Sbjct: 653 ISDFGLAKLLLADQSRTKTMIRGTRGYVAPEWFKNVPVTAKVDVYSFGAMLLEIVCCRKS 712
Query: 704 VE-MELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPS 762
V ME EE +AILTDWA DCY+EGR+D L+++D+ A+ D RL KW+ IA+WCIQE P
Sbjct: 713 VVLMESGEEEKAILTDWACDCYMEGRIDALVENDQEALDDIDRLEKWIKIAIWCIQEHPE 772
Query: 763 KRPTMKVVLQMLEGLLDVPNPPGPSSFSI 791
RPTM++V+QMLEG++ VPNPP P SFS+
Sbjct: 773 MRPTMRMVMQMLEGVVQVPNPPSPFSFSL 801
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356540555|ref|XP_003538753.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/797 (52%), Positives = 557/797 (69%), Gaps = 32/797 (4%)
Query: 13 LLPFLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERT 72
L + NITL S+LS TN N +WLSPS +FAFGFRQLN +++LF++AIW++KIP +T
Sbjct: 14 FLHVMFVLGNITLSSTLS-TNDNDAWLSPSGEFAFGFRQLN-STNLFVVAIWYDKIPAKT 71
Query: 73 IVWHANGDNP---APRGSTLELTATGLLLKDPGGQAIWDGKPDKNVSDAAMLDTGNFVLR 129
IVW+A + AP GS ++LT GL L P G++IW +P +S AMLDTGNFVL
Sbjct: 72 IVWNAKANETLATAPAGSQVQLTLEGLTLTSPKGESIWKAQPSVPLSYGAMLDTGNFVL- 130
Query: 130 ASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFSNGSLEFIPV 189
NS + W+SFK+PTDT+LP Q L+L L SRL +TN++ GRF+L+F NG L P+
Sbjct: 131 -VNKNSTFEWESFKNPTDTLLPNQFLELDGKLTSRLQDTNYTTGRFQLYFQNGVLLLSPL 189
Query: 190 AWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIV--QLPQW--SKLIP 245
AWP++ +Y+ YY ++S S +LVF+E IY+ + +G + Q P W S L P
Sbjct: 190 AWPTQLRYRYYY-----RIDASHSASRLVFDELGNIYVERVNGTRIRPQGPTWGNSSLDP 244
Query: 246 RTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRRLIKETGSGTCGFNSYC 305
+ ++Y+RATL+F+GV +YAHP+ ++ Q W R +P +C + E GSG+CG+NSYC
Sbjct: 245 K-EYYYRATLEFNGVFTQYAHPRTNNAYQGWTIMRYVPGNICTAIFNEYGSGSCGYNSYC 303
Query: 306 SLRNGRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCGPDDGSINAQELYEIREFNNVEWPL 365
S+ N RP C CP G+ +VDP+ + GC+PNF CG D + +ELYE+ EF + +PL
Sbjct: 304 SMENDRPTCKCPYGYSMVDPSNEFGGCQPNFTLACGVDVKA-QPEELYEMHEFRDFNFPL 362
Query: 366 GDYERLEPSNQTECETSCLQDCSCAVAIYDGNSCRKKKLPLSNG---WLRDTGFSKVLFK 422
GDYE+ +P +Q EC SCL DC CA+A+ GN+C K+LPLSNG + D F + +
Sbjct: 363 GDYEKKQPYSQQECRQSCLHDCICAMAVLGGNTCWMKRLPLSNGRVIHVNDQHFVYIKTR 422
Query: 423 VRKGDF--PGFSDN----SGSKKGRGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRK 476
VR+ DF PG ++ + SKK G +L L+G + + +LL + +F + K
Sbjct: 423 VRR-DFYDPGANEELPPGADSKKEDGAKPILLGSLIGSLVFISISMLLCAVSWFILLKPK 481
Query: 477 YENNVQD-STTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKK 535
V + ETNL F+Y+ L+ AT GF EE+GRGSFGIVYKG L+ AS IAVK+
Sbjct: 482 LTRLVPAIPSLLETNLHSFTYETLEKATRGFCEEIGRGSFGIVYKGQLEAASCNVIAVKR 541
Query: 536 LDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP 595
LDRLAQERE+EF++E+SAIG+T HK+LV+L+GFCDE +NRLLVYEFM NGTLA+++F
Sbjct: 542 LDRLAQEREKEFRAELSAIGKTCHKNLVRLIGFCDEGINRLLVYEFMSNGTLADILFGQS 601
Query: 596 K-PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654
K P WN R+ ++L IARGL YLHEEC+ IIHCDIKPQNIL+D F+AKISDFGL+KLL
Sbjct: 602 KAPIWNTRVGLALGIARGLLYLHEECDSAIIHCDIKPQNILIDEHFNAKISDFGLAKLLL 661
Query: 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSV-EMELEEESR 713
DQ+RT+TMIRGTRGYVAPEWFKN+ V+ KVDVYSFGV LLEIICCRR+V ME EEE +
Sbjct: 662 FDQTRTNTMIRGTRGYVAPEWFKNIAVTVKVDVYSFGVMLLEIICCRRNVLTMEAEEEEK 721
Query: 714 AILTDWAYDCYVEGR-LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
ILTDWAYDCY+EGR +D L+++DE A++D RL KW+ IA WCI E+P RPTM +V+
Sbjct: 722 VILTDWAYDCYIEGRNIDALVENDEEALSDNGRLEKWIKIAFWCINENPEVRPTMGMVML 781
Query: 773 MLEGLLDVPNPPGPSSF 789
MLEG ++VPNPP P S
Sbjct: 782 MLEGFVEVPNPPPPFSM 798
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 804 bits (2077), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/789 (52%), Positives = 543/789 (68%), Gaps = 23/789 (2%)
Query: 1 MALSCLILLCFPLLPFLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFL 60
+ LS +L+ P NIT+G+SLS T++N+SWLSPS DFAFGF L N LFL
Sbjct: 6 LHLSFSLLIMLPPFAVSQTGGNITVGASLS-TSENTSWLSPSGDFAFGFHPLYGNKYLFL 64
Query: 61 LAIWFNKIPERTIVWHANGDNPAPRGSTLELTAT-GLLLKDPGGQAIWDGKPDKNV-SDA 118
LAIW++KIPE+TIVW+ANGD PAP GS LTA G+ L DP G+ +W + V +
Sbjct: 65 LAIWYDKIPEKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETIIGVVAYG 124
Query: 119 AMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELH 178
AM D GNFVL+ SD W+SFK+P DT+LP+Q+LD G L SR +E NFS GRF+L
Sbjct: 125 AMTDKGNFVLQ--DRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSENNFSMGRFQLK 182
Query: 179 FSN-GSLEFIPVAWPSRFQYKSYYTSNTYSS-NSSESGHQLVFNESAEIYIVKNDGQIVQ 236
++ G+LE + PS + + YY S T +SS G+Q+VFNES +YI++ + QI
Sbjct: 183 LTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRENDQIFS 242
Query: 237 LPQWSKLIPRT-DHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRRLIKETG 295
L Q ++ T D Y RATL+FDG+ +Y HPK S+ N+ W P + PD +C+ +G
Sbjct: 243 LTQ--RVTASTGDFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDNICQASFVSSG 300
Query: 296 SGTCGFNSYCSLRNGR-PFCDCPPGHVLVDPNYRYRGCKPNFWQGCGPDDGSINAQELYE 354
SGTCGFNS C L + R P C+CP G+ L+DP+ +Y C+PN+ Q C D+ + ++LY+
Sbjct: 301 SGTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVA-PVEDLYD 359
Query: 355 IREFNNVEWPLGDYERLEPSNQTECETSCLQDCSCAVAIY-DGNSCRKKKLPLSNGWLRD 413
E N +WP DY L+P + +C SCL DC CAVAI+ G+ C KKKLPLSNG ++
Sbjct: 360 FEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQT 419
Query: 414 TGFSKVLFKVRKGDF----PGFSDNSGSKKGRGPLFLLGAFLLGGSILCNAFLLLAILI- 468
K L KVR+ + P F +N KK R L L+G+ LG S+ N L+ AI +
Sbjct: 420 NLDGKALLKVRRSNVNPRSPYFPNN---KKDRDGLILVGSVFLGCSVFVNFLLVCAIFMC 476
Query: 469 -FFKWRRRKYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTAS 527
FF +RRR +D ETNLR F+Y EL +AT+GFKEELGRG+FG+VYKGV+ S
Sbjct: 477 FFFIYRRRTKRIPQKDGAV-ETNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVVHIGS 535
Query: 528 GTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL 587
+AVKKL+ +A++R REFK+EV+ IG+THHK+LV+LLGFC+E RLLVYEFM NG+L
Sbjct: 536 SIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSL 595
Query: 588 ANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDF 647
++ IF KP W +RI+I+ +ARGL YLHEEC+ IIHCDIKPQNILLD +++A+ISDF
Sbjct: 596 SSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYNARISDF 655
Query: 648 GLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEME 707
GL+KLL DQS+THT IRGT+GYVAPEWF+N+PV+ KVDVYS+GV LLEIICCRR+V+ +
Sbjct: 656 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLEIICCRRNVDSK 715
Query: 708 LEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767
E +AILTDWAYDCY EG LD L+ SD A+ D +L ++LMIA WCIQEDPS RPTM
Sbjct: 716 ATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQEDPSLRPTM 775
Query: 768 KVVLQMLEG 776
+ V QMLEG
Sbjct: 776 RKVTQMLEG 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495581|ref|XP_003516653.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2074), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/784 (52%), Positives = 541/784 (69%), Gaps = 25/784 (3%)
Query: 22 NITLGSSLSSTNKNSSWLSPSRDFAFGFRQL-NDNSDLFLLAIWFNKIPERTIVWHANGD 80
N+ L S LS T+ N +W SPS +FAFGFRQL N + LF++AIW++KIP++T+VW A +
Sbjct: 22 NVNLDSRLS-TDGNDAWRSPSGEFAFGFRQLSNFGTKLFMVAIWYDKIPDKTVVWSAKTE 80
Query: 81 ---NPAPRGSTLELTATGLLLKDPGGQAIWDGKPDKNVSDAAMLDTGNFVLRASGNNSDY 137
AP GS +++T GL L P G +IW KP+ VS+ AML+ GNFVL G+ +
Sbjct: 81 YKLATAPTGSHVQITKEGLSLTSPEGDSIWRAKPEATVSEGAMLNNGNFVLLNGGSEYEN 140
Query: 138 AWQSFKSPTDTILPTQILDLG--SVLVSRLTETNFSKGRFELHFSNGSLEFIPVAWPSRF 195
WQSF +PTDT+LP Q L LG VL SR T+TN++ GRF+L+F + ++ P+A+PS+
Sbjct: 141 MWQSFDNPTDTLLPNQSLQLGLGGVLTSRFTDTNYTTGRFQLYFQDFNVMLSPLAFPSQL 200
Query: 196 QYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIVQ-LPQWSKLIPRTDHYFRAT 254
+Y YY + + S + +LVF++S EIY+ G + LPQ + +Y+RAT
Sbjct: 201 RYNPYY--HAINDASVGNASRLVFDKSGEIYVETTGGTRNRILPQVDNTLDTEVNYYRAT 258
Query: 255 LDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRRLIKETGSGTCGFNSYCSLRNGRPFC 314
LDF GV YAHP+N+S W +PD +C + + GSG+CG+NSYCS+ N RP C
Sbjct: 259 LDFSGVFTLYAHPRNTSGQPRWRIMNYVPDNICDAIFNDYGSGSCGYNSYCSMENDRPTC 318
Query: 315 DCPPGHVLVDPNYRYRGCKPNFWQGCGPDDGSINAQELYEIREFNNVEWPLGDYERLEPS 374
+CP G+ LVDP+ GC+PNF CG D +ELYE+ N +PLGDYE++EP
Sbjct: 319 NCPYGYSLVDPSNESGGCQPNFTLACGADVQQ-PPEELYEMHVAKNFNFPLGDYEKVEPY 377
Query: 375 NQTECETSCLQDCSCAVAIYDGNSCRKKKLPLSNGW---LRDTGFSKVLFKVRKGDFPGF 431
+Q EC+ +CL DC CAVAI + ++C K+LPL NG +RD F + ++ +PG
Sbjct: 378 SQQECQQACLHDCMCAVAILEVDTCWMKRLPLGNGRQLPIRDQHFVYIKTRLSPDFYPGL 437
Query: 432 SDNS------GSKKGRGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRKYENNVQDST 485
++ K+ R +LG+ + S++ N+ LL A+ +FF + K + +Q S
Sbjct: 438 ANRELPAAPDSKKENRAKSIILGSLI--ASLVVNSILLAAVALFF-LLKPKLKKVIQASA 494
Query: 486 TSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTA-SGTAIAVKKLDRLAQERE 544
ETNL FS++ LK+AT+ F +ELGRGS GIVYKG L+TA S IAVK+LDRLAQERE
Sbjct: 495 LLETNLHSFSFEALKEATEDFCKELGRGSCGIVYKGKLETADSCNVIAVKRLDRLAQERE 554
Query: 545 REFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR 604
+EF++E+SAIG+T HK+LV+L+GFCD+ +NRLLVYEFM NGTLA+++F KP WNLR+
Sbjct: 555 KEFRTELSAIGKTSHKNLVRLIGFCDQGINRLLVYEFMSNGTLADILFGHSKPIWNLRVG 614
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664
L IARGL YLHEEC+ IIHCDIKPQNIL+D F+AKISDFGL+KLL DQSRT+TMI
Sbjct: 615 FVLGIARGLVYLHEECDSAIIHCDIKPQNILIDEHFNAKISDFGLAKLLLFDQSRTNTMI 674
Query: 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSV-EMELEEESRAILTDWAYDC 723
RGTRGYVAPEWFKNV V+ KVDVYSFGV LLE ICCRRSV ME EEE +AILTDWAYDC
Sbjct: 675 RGTRGYVAPEWFKNVAVTVKVDVYSFGVMLLENICCRRSVMTMEPEEEEKAILTDWAYDC 734
Query: 724 YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
VEGRL L+++D A++D RL +W+ IA+WCIQEDP RPTM V QMLEGL++V NP
Sbjct: 735 CVEGRLHALVENDREALSDIGRLQRWVKIAIWCIQEDPEMRPTMGKVNQMLEGLVEVANP 794
Query: 784 PGPS 787
P P+
Sbjct: 795 PSPN 798
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/802 (51%), Positives = 549/802 (68%), Gaps = 25/802 (3%)
Query: 1 MALSCLILLCFPLLPFLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFL 60
+ LS +L+ P NIT+G+SLS T+ N+SWLSPS DFAFGF QL N DLFL
Sbjct: 6 LHLSFSLLIMLPPFAVSQTGGNITVGASLS-TSDNTSWLSPSGDFAFGFYQLYGNKDLFL 64
Query: 61 LAIWFNKIPERTIVWHANGDNPAPRGSTLELTAT-GLLLKDPGGQAIWDGKPD-KNVSDA 118
LAIW++KIP++TIVW+ANGD PAP GS LTA G+ L DP G+ +W + +V+
Sbjct: 65 LAIWYDKIPDKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETIIGDVAYG 124
Query: 119 AMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELH 178
AM DTGNFVLR SD W+SFK+P DT+LP+Q+LD G L SR +ETNFS GRF+L
Sbjct: 125 AMTDTGNFVLR--DRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSETNFSMGRFQLK 182
Query: 179 F-SNGSLEFIPVAWPSRFQYKSYYTSNTYSS-NSSESGHQLVFNESAEIYIVKNDGQIVQ 236
+G+L + PS + + YY S T +SS G+Q+VFNES +YI++ + QI
Sbjct: 183 LRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRKNDQIFS 242
Query: 237 LPQWSKLIPRT-DHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRRLIKETG 295
L Q ++ T D Y RATL+FDGV +Y HPK S+ N+ W P + PD +C+ G
Sbjct: 243 LTQ--RVTASTGDFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDNICQASSVSAG 300
Query: 296 SGTCGFNSYCSLR-NGRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCGPDDGSINAQELYE 354
SGTCGFNS C L +GRP C+CP G+ L+DP+ +Y C+PN+ Q C D+ + ++LY+
Sbjct: 301 SGTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVA-PVEDLYD 359
Query: 355 IREFNNVEWPLGDYERLEPSNQTECETSCLQDCSCAVAIY-DGNSCRKKKLPLSNGWLRD 413
E N +WP DY L+P + +C SCL DC CAVAI+ G+ C KKKLPLSNG ++
Sbjct: 360 FEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQT 419
Query: 414 TGFSKVLFKVRKGDF----PGFSDNSGSKKGRGPLFLLGAFLLGGSILCNAFLLLAILI- 468
+K L KVR+ + P F +N KK R L L+G+ LG S+ N L+ AI +
Sbjct: 420 IVDAKALLKVRRSNVNPRSPYFPNN---KKDRDGLILVGSVFLGCSVFVNFLLVCAICMG 476
Query: 469 -FFKWRRRKYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTAS 527
FF +RRR +D ETNLR F+Y EL +AT+GFKEELGRG+FG+VY+GV+ S
Sbjct: 477 FFFIYRRRTKRIPQKDGAV-ETNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVVHIGS 535
Query: 528 GTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL 587
+AVKKL+ +A++R REFK+EV+ IG+THHK+LV+LLGFC+E RLLVYEFM NG+L
Sbjct: 536 SIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSL 595
Query: 588 ANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDF 647
++ IF KP W +RI+I+ +ARGL YLHE+ IIHCDIKPQNILLD +A+ISDF
Sbjct: 596 SSFIFQDAKPGWKIRIQIAFGVARGLLYLHEDSQ--IIHCDIKPQNILLDESLNARISDF 653
Query: 648 GLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEME 707
GL+KLL +DQ++T T IRGT+GYVAPEWFKN+PV+ KVD YSFG+ LLE++CCR++ E+
Sbjct: 654 GLAKLLKTDQTKTTTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLELVCCRKNFEIN 713
Query: 708 LEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767
+E + +L DWA DC EG+L++L++ DE AM D R+ +++M+A+WCIQEDPS RP M
Sbjct: 714 AMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQEDPSLRPGM 773
Query: 768 KVVLQMLEGLLDVPNPPGPSSF 789
K V+QMLEG + V PP PSSF
Sbjct: 774 KKVVQMLEGGVQVSVPPDPSSF 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495583|ref|XP_003516654.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/810 (50%), Positives = 548/810 (67%), Gaps = 39/810 (4%)
Query: 1 MALSCLILLCFPLLPFLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDN-SDLF 59
+ L+ LI+ + A +TL S L T+ + +WLSPS +FAFGFRQLNDN + LF
Sbjct: 4 LNLNLLIVTLIYIHHVSLAFAKVTLNSPLF-TDTDDAWLSPSGEFAFGFRQLNDNDTKLF 62
Query: 60 LLAIWFNKIPE-RTIVWHANGDNP---APRGSTLELTATGLLLKDPGGQAIWDGKPDKNV 115
++AIW+N IP+ +T+VW A DN AP GS L++T GL L +P G IW V
Sbjct: 63 MVAIWYNMIPDDQTVVWSARKDNKLATAPAGSKLQITQEGLSLTNPKGDFIWTASSKDFV 122
Query: 116 SDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRF 175
S+ AMLD+GNFVL +S WQSF+ PTDT+LP Q L LG +L SRLT+TN++ GRF
Sbjct: 123 SEGAMLDSGNFVLL--NGSSANVWQSFEHPTDTLLPNQSLQLGGMLTSRLTDTNYTTGRF 180
Query: 176 ELHFSNGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIV 235
+L+F G+L P+AWPS+ +YKSY + S N+S +L+FN S +IY+ +G +
Sbjct: 181 QLYFDGGNLLLSPLAWPSQLRYKSYPVIDA-SGNAS----RLLFNISGDIYVETTNGNRI 235
Query: 236 QLPQWSKLIPRTD---------HYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAM 286
Q PQ K + + +++RATLD GV +YAHP+N++ Q W R +PD +
Sbjct: 236 Q-PQGQKWVSNSSSSLDLNPEMNFYRATLDPSGVFTQYAHPRNNTARQGWIIMRYVPDDI 294
Query: 287 CRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCGPDDGS 346
C + GSG+CG+NSYC + N RP C+C G+ LVDP+ ++ GC+PNF CG D +
Sbjct: 295 CNIIFDRFGSGSCGYNSYCDMENERPTCNCLDGYSLVDPSNQFGGCQPNFTLACGADVQA 354
Query: 347 INAQELYEIREFNNVEWPLGDYERLEPSNQTECETSCLQDCSCAVAIYDGNSCRKKKLPL 406
++LY + + + +P DYE+++P Q EC CL DC CAVAI+ ++C K+LPL
Sbjct: 355 -PPEQLYHMLQSSRYNFPEADYEKIQPYTQQECLQFCLHDCMCAVAIFGLDTCWMKRLPL 413
Query: 407 SNGWLRDTG---FSKVLFKVRKGDFPGFSD------NSGSKKGRGPLFLLGAFLLGGSIL 457
SNG + D F + + + +PG ++ +S + G P+ L+G+ + GS++
Sbjct: 414 SNGRVTDVNDHHFVYIKIRNSRDFYPGVNEELPPGADSNKEDGAKPI-LMGSLI--GSLV 470
Query: 458 CNAFLLLAILIFFKWRRRKYEN-NVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFG 516
N LL + + + + V ++ ETNL FSY+ LK+AT GF EELGRGS G
Sbjct: 471 VNGILLATVALLVLLKPKLKVAVPVAAASLLETNLHSFSYEALKEATWGFSEELGRGSCG 530
Query: 517 IVYKGVLKTA-SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNR 575
IVYKG L+ S IAVK+LDRLAQERE+EF++E+SAIG+T HK+LV+L+GFCD+ +NR
Sbjct: 531 IVYKGKLEAEDSCNVIAVKRLDRLAQEREKEFRTELSAIGKTSHKNLVRLIGFCDQGINR 590
Query: 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635
LLVYEFM NGTLA+++F KP+WN R+ +L IARGL YLHEEC+ PIIHCDIKPQNIL
Sbjct: 591 LLVYEFMSNGTLADILFGHSKPNWNTRVGFALGIARGLVYLHEECDTPIIHCDIKPQNIL 650
Query: 636 LDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLL 695
+D F+ KISDFGL+KLL SDQSRT+TMIRGTRGYVAPEWFKNV V+ KVDVYSFG+ LL
Sbjct: 651 IDEHFNTKISDFGLAKLLLSDQSRTNTMIRGTRGYVAPEWFKNVAVTVKVDVYSFGIMLL 710
Query: 696 EIICCRRSVEMELE-EESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAM 754
EIICCRRSV ME EE +A+L DWA DCY+EGR+D L++++E A++D+ RL KW+ IA+
Sbjct: 711 EIICCRRSVVMEEPGEEEKAVLADWACDCYMEGRIDALVENEEEALSDKERLQKWIKIAI 770
Query: 755 WCIQEDPSKRPTMKVVLQMLEGLLDVPNPP 784
WCI E+P RPT+ +V+QMLEG + V NPP
Sbjct: 771 WCIHENPEMRPTIGMVVQMLEGFVQVSNPP 800
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487487|ref|XP_002269067.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1977), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/795 (50%), Positives = 534/795 (67%), Gaps = 19/795 (2%)
Query: 6 LILLCFPLLP--FLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAI 63
L+L P P F A I LGSSL +++ +SSW SPS +FAFGF QL N +LFLLAI
Sbjct: 12 LLLFVLPSWPSVFSQANPEIRLGSSLIASDNSSSWRSPSGEFAFGFHQLG-NQNLFLLAI 70
Query: 64 WFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLKDPGGQAIWDGKPDKN-VSDAAML 121
WF+KIPE+T+ W+ANGDNPAP GS +ELT+ G L+L DP G IW + N V+ A ML
Sbjct: 71 WFDKIPEKTLAWYANGDNPAPEGSKVELTSDGQLILNDPKGDEIWRPQTTLNGVTHAYML 130
Query: 122 DTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHF-S 180
D GNF L NS + W+SFK+P DT+LPTQ+L++G + SR E+N+SKGRF+L
Sbjct: 131 DAGNFALVNGDQNSTHVWESFKNPVDTVLPTQVLEIGGTVSSRQAESNYSKGRFQLRLLP 190
Query: 181 NGSLEFIPVAWPSRFQYKSYYTSNTY-SSNSSESGHQLVFNESAEIYIVKNDGQIVQLPQ 239
+G+L + Y +YY S TY ++N S SG +++F+E +Y+V G V L
Sbjct: 191 DGNLVLNTFDLQTNTAYDAYYWSKTYDAANRSNSGERVIFDELGHLYVVLQSGDNVTLKS 250
Query: 240 WSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMCRRLIKETGSGTC 299
S +Y+RATLDFDGV Y PK S N SW P +P +C + + G G+C
Sbjct: 251 GSAE-STGGYYYRATLDFDGVFRIYTRPKLQS-NGSWVPFWYVPKDICSEIGGDLGGGSC 308
Query: 300 GFNSYCSL-RNGRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCGPDDGSINAQELYEIREF 358
GFNSYC +GRP C+C PG DP+ + GCK N Q C + G N ++LY+ RE
Sbjct: 309 GFNSYCVPDSSGRPACECLPGFFPADPHNKLNGCKHNLTQKC--EAGGSNMEDLYQKREV 366
Query: 359 NNVEWPL-GDYERLEPSNQTECETSCLQDCSCAVAIYDGNSCRKKKLPLSNGWLRDTGFS 417
+N+ WP ++E+ E ++ C TSCL DC+C VA++ +CRKKK+PLSNG + +
Sbjct: 367 SNLFWPSSANFEKKESLSEDLCWTSCLYDCNCVVAVHKEGTCRKKKMPLSNGRVDWSTRG 426
Query: 418 KVLFKVRK-----GDFPGFSDNSGSKKGRGPLFLLGAFLLGGSILCNAFLLLAILIFFKW 472
K L KV + G+ P KK +G L+G+ LLG S+ N L+ AI + +
Sbjct: 427 KTLVKVPRYDAFSGETPFRDPIREKKKEQGTFILVGSILLGSSVFLNFLLVAAISLVRSY 486
Query: 473 RRRKYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTAS-GTAI 531
+K + S+ ETN+R F+Y+ELK A DGF+EELGRG+FG VYKGVL ++S GT +
Sbjct: 487 PSQKRRELTRASSILETNIRSFTYEELKQAADGFREELGRGAFGTVYKGVLSSSSSGTQV 546
Query: 532 AVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLI 591
AVKKLD+L QE EREFK+EV I THHK+LV+L+GFCDE ++LLVYEFM NGTLA+ +
Sbjct: 547 AVKKLDKLVQEGEREFKTEVRTIAMTHHKNLVRLIGFCDEGPHKLLVYEFMCNGTLASFL 606
Query: 592 FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651
F PDW +R +++ +ARGL YLHEEC+ IIHCDIKPQN+LLD F+A+ISDFGL+K
Sbjct: 607 FGSSAPDWKIRTQMAFGVARGLMYLHEECSTQIIHCDIKPQNVLLDDSFTARISDFGLAK 666
Query: 652 LLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE 711
LL SDQ+RT T IRGT+GYVAPEWF++ P++AKVDVYS+GV LLEII CR+ ++ + E E
Sbjct: 667 LLMSDQTRTLTAIRGTKGYVAPEWFRSKPITAKVDVYSYGVMLLEIISCRKCIDFQTENE 726
Query: 712 SRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVL 771
AILTDWAYDCY RLD L+++D+ A D RL K +M+A+WCIQEDPS RP+M+ V
Sbjct: 727 EEAILTDWAYDCYRGHRLDKLVENDDDARNDMRRLEKLVMVAIWCIQEDPSLRPSMRNVT 786
Query: 772 QMLEGLLDVPNPPGP 786
QMLEG+++VP PP P
Sbjct: 787 QMLEGVVEVPMPPCP 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 796 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.368 | 0.353 | 0.448 | 6.8e-91 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.364 | 0.353 | 0.461 | 7.3e-82 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.584 | 0.561 | 0.372 | 8.9e-70 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.272 | 0.248 | 0.475 | 2.5e-68 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.369 | 0.375 | 0.392 | 7.3e-67 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.376 | 0.353 | 0.389 | 6.4e-66 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.383 | 0.371 | 0.361 | 8.5e-66 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.379 | 0.355 | 0.355 | 1.3e-62 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.369 | 0.361 | 0.372 | 4.8e-60 | |
| TAIR|locus:2197724 | 806 | AT1G61430 [Arabidopsis thalian | 0.371 | 0.367 | 0.371 | 6.3e-59 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 699 (251.1 bits), Expect = 6.8e-91, Sum P(3) = 6.8e-91
Identities = 136/303 (44%), Positives = 202/303 (66%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA 553
F+Y EL+ T FKE+LG G FG VY+GVL + T +AVK+L+ + Q E++F+ EV+
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVL--TNRTVVAVKQLEGIEQG-EKQFRMEVAT 530
Query: 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD---WNLRIRISLEIA 610
I THH +LV+L+GFC + +RLLVYEFM NG+L N +F W R I+L A
Sbjct: 531 ISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTA 590
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH-TMIRGTRG 669
+G+ YLHEEC I+HCDIKP+NIL+D F+AK+SDFGL+KLL +R + + +RGTRG
Sbjct: 591 KGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRG 650
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729
Y+APEW N+P+++K DVYS+G+ LLE++ +R+ ++ E+ + + WAY+ + +G
Sbjct: 651 YLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNHKKFSIWAYEEFEKGNT 709
Query: 730 DVLIDS--DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPS 787
++D+ E D ++ + + + WCIQE P +RPTM V+QMLEG+ ++ NP P
Sbjct: 710 KAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPK 769
Query: 788 SFS 790
+ S
Sbjct: 770 TIS 772
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 679 (244.1 bits), Expect = 7.3e-82, Sum P(3) = 7.3e-82
Identities = 139/301 (46%), Positives = 194/301 (64%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA 553
F+Y +L+ AT+ F +LG+G FG VY+G L G+ +AVKKL+ + Q + +EF++EVS
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLP--DGSRLAVKKLEGIGQGK-KEFRAEVSI 539
Query: 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD----WNLRIRISLEI 609
IG HH HLV+L GFC E +RLL YEF+ G+L IF D W+ R I+L
Sbjct: 540 IGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGT 599
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG 669
A+GLAYLHE+C+ I+HCDIKP+NILLD F+AK+SDFGL+KL+ +QS T +RGTRG
Sbjct: 600 AKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRG 659
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729
Y+APEW N +S K DVYS+G+ LLE+I R++ + E + +A+ EG+L
Sbjct: 660 YLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKMEEGKL 718
Query: 730 DVLIDSD--EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPS 787
++D + D R+ + + A+WCIQED RP+M V+QMLEG+ V PP S
Sbjct: 719 MDIVDGKMKNVDVTDE-RVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSS 777
Query: 788 S 788
+
Sbjct: 778 T 778
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 707 (253.9 bits), Expect = 8.9e-70, P = 8.9e-70
Identities = 190/510 (37%), Positives = 264/510 (51%)
Query: 299 CGFNSYCSLRNGRPFCDCPPGHVLVDPNYRYRGCKPNFWQGCGPDDGSINAQELY----E 354
CG CS ++ PFC CP G +R W G + EL +
Sbjct: 296 CGSFGICSDKS-EPFCRCPQG---------FRPMSQKDWDLKDYSAGCVRKTELQCSRGD 345
Query: 355 IREFNNV-EWPLGDY-ERLEPSNQTECETSCLQDCSCAVAIYD-GNS-CRK-KKLPLSNG 409
I +F + L D E L ++ + C ++C DCSC YD G+S C K L+
Sbjct: 346 INQFFRLPNMKLADNSEVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQ 405
Query: 410 WLRDTGFSKVLFKVR--KGDFP--GFSDNSGSKKXXXXXXXXXXXXXXXSILCNXXXXXX 465
L D +F +R D P G S S +K +L
Sbjct: 406 QLEDENSEGNIFYLRLAASDVPNVGASGKSNNKGLIFGAVLGSLGVIVLVLLV------- 458
Query: 466 XXXXXKWRRRKYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKT 525
++RRRK + T L FSY EL++AT F ++LG G FG V+KG L
Sbjct: 459 VILILRYRRRKRMRGEKGDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPD 514
Query: 526 ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585
+S IAVK+L+ ++Q E++F++EV IG H +LV+L GFC E +LLVY++M NG
Sbjct: 515 SSD--IAVKRLEGISQG-EKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNG 571
Query: 586 TLANLIFAIPKPD-----WNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF 640
+L + +F + W LR +I+L ARGLAYLH+EC IIHCDIKP+NILLD F
Sbjct: 572 SLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQF 631
Query: 641 SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICC 700
K++DFGL+KL+ D SR T +RGTRGY+APEW V ++AK DVYS+G+ L E++
Sbjct: 632 CPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSG 691
Query: 701 RRSVEMELEEESRAILTDWAYDCYV-EGRLDVLIDSD-EAAMADRSRLHKWLMIAMWCIQ 758
RR+ E E+ R WA +G + L+D E D + + +A WCIQ
Sbjct: 692 RRNTEQSENEKVR-FFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQ 750
Query: 759 EDPSKRPTMKVVLQMLEGLLDVPNPPGPSS 788
++ S RP M V+Q+LEG+L+V PP P S
Sbjct: 751 DEESHRPAMSQVVQILEGVLEVNPPPFPRS 780
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 522 (188.8 bits), Expect = 2.5e-68, Sum P(4) = 2.5e-68
Identities = 105/221 (47%), Positives = 139/221 (62%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA 553
F ++EL+ AT+ FK ++G G FG VYKG L T IAVKK+ +EF +E++
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKGTLPDE--TLIAVKKITNHGLHGRQEFCTEIAI 562
Query: 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIAR 611
IG H +LV+L GFC LLVYE+M +G+L +F+ P +W R I+L AR
Sbjct: 563 IGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTAR 622
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
GLAYLH C+ IIHCD+KP+NILL F KISDFGLSKLL ++S T +RGTRGY+
Sbjct: 623 GLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYL 682
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES 712
APEW N +S K DVYS+G+ LLE++ R++ S
Sbjct: 683 APEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNS 723
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 7.3e-67, Sum P(3) = 7.3e-67
Identities = 121/308 (39%), Positives = 181/308 (58%)
Query: 488 ETNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERER 545
+ L F D + +AT GF +LG+G FG VYKG L A G +AVK+L R +++
Sbjct: 447 DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTL--ACGQEVAVKRLSRTSRQGVE 504
Query: 546 EFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLR 602
EFK+E+ I + H++LV++LG+C + R+L+YE+ N +L + IF + DW R
Sbjct: 505 EFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKR 564
Query: 603 IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662
+ I IARG+ YLHE+ + IIH D+K N+LLD +AKISDFGL++ L D++ +T
Sbjct: 565 VEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANT 624
Query: 663 M-IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY 721
+ GT GY++PE+ + S K DV+SFGV +LEI+ RR+ EE + L A+
Sbjct: 625 TRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFR-NEEHKLNLLGHAW 683
Query: 722 DCYVEGRLDVLIDSD-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG---L 777
++E + +ID + D S + + + I + C+Q+DP RP M VV+ ML L
Sbjct: 684 RQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLL 743
Query: 778 LDVPNPPG 785
LD P PG
Sbjct: 744 LD-PRQPG 750
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 6.4e-66, Sum P(3) = 6.4e-66
Identities = 122/313 (38%), Positives = 177/313 (56%)
Query: 481 VQDSTTSETNLRFFSYDELKDATDGF-KE-ELGRGSFGIVYKGVLKTASGTAIAVKKLDR 538
++ + + L FS + + AT+ F KE ELGRG FG VYKGVL+ G IAVK+L
Sbjct: 504 IEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE--DGREIAVKRLSG 561
Query: 539 LAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP- 597
+ + EFK+E+ I + H++LV+LLG C E ++LVYE+M N +L +F K
Sbjct: 562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621
Query: 598 --DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655
DW LR I IARGL YLH + + IIH D+K N+LLD + KISDFG++++
Sbjct: 622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681
Query: 656 DQSRTHTM-IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA 714
+Q+ +T+ + GT GY++PE+ S K DVYSFGV LLEI+ +R+ + E
Sbjct: 682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSL 741
Query: 715 ILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
I +A+ Y GR + L+D + + + +AM C+Q+ ++RP M VL ML
Sbjct: 742 I--GYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLML 799
Query: 775 EG---LLDVPNPP 784
E L P P
Sbjct: 800 ESDTATLAAPRQP 812
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 8.5e-66, Sum P(3) = 8.5e-66
Identities = 115/318 (36%), Positives = 180/318 (56%)
Query: 477 YENNVQDSTTSETNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVK 534
+++++Q S L FF +L+ AT+ F +LG+G FG VYKG L+ G IAVK
Sbjct: 471 WKSDLQSQDVS--GLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQ--DGKEIAVK 526
Query: 535 KLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI 594
+L + + EF +E+ I + H++L++LLG C + +LLVYE+M N +L IF +
Sbjct: 527 RLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDL 586
Query: 595 PKP---DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651
K DW R I IARGL YLH + + ++H D+K NILLD + KISDFGL++
Sbjct: 587 KKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLAR 646
Query: 652 LLFSDQSRTHT-MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEE 710
L +Q + T + GT GY++PE+ S K D+YSFGV +LEII + +
Sbjct: 647 LFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGK 706
Query: 711 ESRAILTDWAYDCYVE-GRLDVLI-DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 768
+++ +L+ +A+D + E G +++L D D++ + + + I + C+Q RP +K
Sbjct: 707 DNKNLLS-YAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIK 765
Query: 769 VVLQMLEGLLDVPNPPGP 786
V+ ML D+P P P
Sbjct: 766 QVMSMLTSTTDLPKPTQP 783
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 471 (170.9 bits), Expect = 1.3e-62, Sum P(3) = 1.3e-62
Identities = 112/315 (35%), Positives = 181/315 (57%)
Query: 482 QDSTTSETNLRFFSYDELKDATDGFKE--ELGRGSFGIVYKGVLKTASGTAIAVKKLDRL 539
+++ T + L ++E+ AT+ F +LG+G FGIVYKG K G +AVK+L +
Sbjct: 502 RENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKG--KLLDGQEMAVKRLSKT 559
Query: 540 AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIF---AIPK 596
+ + EFK+EV I R H +LV+LL C +A ++L+YE++ N +L + +F K
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK 619
Query: 597 PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656
+W +R I IARGL YLH++ IIH D+K NILLD + + KISDFG++++ D
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679
Query: 657 QSRTHTM-IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAI 715
++ +T + GT GY++PE+ + S K DV+SFGV LLEII +R+ + +
Sbjct: 680 ETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNL 739
Query: 716 LTDWAYDCYVEGR-LDVL--IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
L + + EG+ L+++ I +D ++ + + + + I + C+QE RPTM +V+
Sbjct: 740 L-GCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVIL 798
Query: 773 MLEG-LLDVPNPPGP 786
ML +P P P
Sbjct: 799 MLGSESTTIPQPKAP 813
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 4.8e-60, Sum P(3) = 4.8e-60
Identities = 113/303 (37%), Positives = 169/303 (55%)
Query: 490 NLRFFSYDELKDATDGFKEE--LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREF 547
++ FF + T+ F E LG+G FG VYKG L+ G IA+K+L + + EF
Sbjct: 485 DVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQ--DGKEIAIKRLSSTSGQGLEEF 542
Query: 548 KSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRIR 604
+E+ I + H++LV+LLG C E +LL+YEFM N +L IF K DW R
Sbjct: 543 MNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFE 602
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM- 663
I IA GL YLH + + ++H D+K NILLD + KISDFGL+++ Q + +T
Sbjct: 603 IIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRR 662
Query: 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC 723
+ GT GY++PE+ S K D+Y+FGV LLEII +R + EE + +L ++A+D
Sbjct: 663 VVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTLL-EFAWDS 721
Query: 724 YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
+ E L+D D ++ S + + + I + CIQ+ RP + V+ ML +D+P P
Sbjct: 722 WCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKP 781
Query: 784 PGP 786
P
Sbjct: 782 KQP 784
|
|
| TAIR|locus:2197724 AT1G61430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 6.3e-59, Sum P(3) = 6.3e-59
Identities = 113/304 (37%), Positives = 169/304 (55%)
Query: 491 LRFFSYDELKDATDGFK--EELGRGSFGIVYKGVL-KTASGTAIAVKKLDRLAQEREREF 547
L FF + ++ AT+ F +LG G FG VYK K G IAVK+L + + ++EF
Sbjct: 474 LEFFEMNAIQTATNNFSLSNKLGPGGFGSVYKARNGKLQDGREIAVKRLSSSSGQGKQEF 533
Query: 548 KSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRIR 604
+E+ I + H++LV++LG C E +LL+Y F+ N +L +F K DW R
Sbjct: 534 MNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYGFLKNKSLDTFVFDARKKLELDWPKRFE 593
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM- 663
I IARGL YLH + + +IH D+K NILLD + KISDFGL+++ Q + T
Sbjct: 594 IIEGIARGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMFQGTQYQEKTRR 653
Query: 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC 723
+ GT GY++PE+ S K D+YSFGV LLEII ++ EE +A+L +A++C
Sbjct: 654 VVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGKKISSFSYGEEGKALLA-YAWEC 712
Query: 724 YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
+ E R +D A + S + + + I + C+Q +P+ RP +L ML D+P P
Sbjct: 713 WCETREVNFLDQALADSSHPSEVGRCVQIGLLCVQHEPADRPNTLELLSMLTTTSDLPLP 772
Query: 784 PGPS 787
P+
Sbjct: 773 KKPT 776
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4285 | 0.9660 | 0.9242 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 796 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-27 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-21 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-18 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-17 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 8e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-05 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 9e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 1e-53
Identities = 83/269 (30%), Positives = 120/269 (44%), Gaps = 58/269 (21%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
LG G FG VY K +G +A+K + + + E E+ + + +H ++V+L G
Sbjct: 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 569 CDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPIIHC 627
++ + LV E+ G+L +L+ + +RI L+I GL YLH IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 628 DIKPQNILLDH-FFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WFKNVPVSAKV 685
D+KP+NILLD K++DFGLSKLL SD+S T I GT Y+APE S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 686 DVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSR 745
D++S GV L E L L D
Sbjct: 176 DIWSLGVILYE--------------------------------LPELKD----------- 192
Query: 746 LHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
+ +Q+DP KRP+ K +L+ L
Sbjct: 193 ------LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 74/271 (27%), Positives = 120/271 (44%), Gaps = 25/271 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQ 564
E+LG GSFG VY K +G +A+K + + +++RE E+ + + H ++V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKK-TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
L ++ LV E+ G L +L+ + + +I L YLH + I
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---I 118
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
+H D+KP+NILLD K++DFGL++ L + T + GT Y+APE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGKGYGKA 176
Query: 685 VDVYSFGVTLLEIICCRR--SVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
VD++S GV L E++ + + +L E + I S EA
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK-----PKPPFPPPEWDISPEAKD-- 229
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773
L+ + +DP KR T + LQ
Sbjct: 230 -------LI--RKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 87/270 (32%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLV 563
+LG GSFG VYK K +G +AVK L + ++ ++++ + E+ + R H ++V
Sbjct: 3 LLRKLGSGSFGTVYKAKHK-GTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
+L+ ++ + LV E+ G L + + + +I+L+I RGL YLH
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW-FKNVPVS 682
IIH D+KP+NILLD KI+DFGL+K L S T GT Y+APE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
KVDV+S GV L E++ + E + + + L ++ DE +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQL---------IRRILGPPLEFDEPKWSS 228
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
S K L+ C+ +DPSKRPT + +LQ
Sbjct: 229 GSEEAKDLIK--KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 87/281 (30%), Positives = 131/281 (46%), Gaps = 37/281 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKH 561
++LG G+FG VYKG LK T +AVK L A E ER EF E S + + H +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+V+LLG C + +V E+M G L + L K ++++L+IA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES-- 120
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD---QSRTHTM--IRGTRGYVAPEW 675
+H D+ +N L+ KISDFGLS+ ++ D + R I+ ++APE
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPES 175
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLI 733
K+ ++K DV+SFGV L EI M EE + RL
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG--------YRLPRPE 227
Query: 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
+ + L++ LM + C DP RPT +++ L
Sbjct: 228 NCPD-------ELYE-LM--LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 88/279 (31%), Positives = 131/279 (46%), Gaps = 34/279 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKH 561
++LG G+FG VYKG LK G +AVK L A E++ EF E + + H +
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+V+LLG C E +V E+M G L + L PK + + +L+IARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV---APEWFK 677
IH D+ +N L+ KISDFGLS+ L+ D RG + + APE K
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPESLK 176
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW-AYDCYVEG-RLDVLIDS 735
++K DV+SFGV L EI L E+ +++ + G RL +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEI--------FTLGEQPYPGMSNEEVLEYLKNGYRLP-QPPN 227
Query: 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
+ D + + C EDP RPT ++++L
Sbjct: 228 CPPELYD---------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 87/288 (30%), Positives = 131/288 (45%), Gaps = 51/288 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKH 561
++LG G+FG VYKG LK +AVK L A E++ EF E + + H +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTL-----ANLIFAIPKPDWNLRIRISLEIARGLAYL 616
+V+LLG C E ++V E+M G L N + D + +L+IARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSD---LLSFALQIARGMEYL 119
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV---AP 673
+ IH D+ +N L+ KISDFGLS+ L+ D + ++G + + AP
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWMAP 173
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733
E K ++K DV+SFGV L EI L EE +++ +VL
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEI--------FTLGEEPYPGMSN----------AEVL- 214
Query: 734 DSDEAAMADRSRLHK-------WLMIAMWCIQEDPSKRPTMKVVLQML 774
+ RL K + + C EDP RPT ++++L
Sbjct: 215 ----EYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKK--LDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E LGRGSFG VY + K +G +AVK L ++E + E+ + H ++V+
Sbjct: 6 ELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 566 LGFC-DEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
G DE N L ++ E++ G+L++L+ K + + + +I GLAYLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--- 121
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM-IRGTRGYVAPEWFKNVPVS 682
I+H DIK NIL+D K++DFG +K L ++ T +RGT ++APE +
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 683 AKVDVYSFGVTLLEIIC 699
D++S G T++E+
Sbjct: 182 RAADIWSLGCTVIEMAT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 86/294 (29%), Positives = 127/294 (43%), Gaps = 58/294 (19%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQ 564
++LG G+FG VYKG LK G AVK L A E ER +F E + + H ++V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 565 LLGFCDEALNRLLVYEFMGNGTL------ANLIFAIPKPD---WNLRIRISLEIARGLAY 615
LLG C E LV E+M G L + +F P+ + +++IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM-----IRGTRGY 670
L +H D+ +N L+ KISDFGLS+ ++ D IR +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 671 VAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGR 728
+APE K+ ++K DV+SFGV L EI + + EE
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------------------ 215
Query: 729 LDVLIDSDEAAMADRSRL-------HKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
VL + RL + + + C Q DP RPT +++ LE
Sbjct: 216 --VL-----EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 7/191 (3%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
E++G+G FG VYK +G +A+K + ++E++ + +E+ + + H ++V+
Sbjct: 5 LEKIGKGGFGEVYK-ARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVPII 625
G + +V EF G+L +L+ + + +I + E+ +GL YLH II
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
H DIK NILL K+ DFGLS SD +TM+ GT ++APE P K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSA-QLSDTKARNTMV-GTPYWMAPEVINGKPYDYKA 178
Query: 686 DVYSFGVTLLE 696
D++S G+T +E
Sbjct: 179 DIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 66/192 (34%), Positives = 105/192 (54%), Gaps = 11/192 (5%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQLLG 567
LG+GS G+VYK K +G A+KK+ E R + E+ + ++V+ G
Sbjct: 8 VLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 568 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAYLHEECNVPI 624
F E + V E+M G+LA+L+ + K + I+ +I +GL YLH + + I
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
IH DIKP N+L++ KI+DFG+SK+L + + +T + GT Y++PE + S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180
Query: 685 VDVYSFGVTLLE 696
D++S G+TLLE
Sbjct: 181 ADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 23/202 (11%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E++G G+ G VYK A+G +A+KK+ RL ++ + +E+ + H ++V
Sbjct: 23 NLEKIGEGASGEVYKAT-DRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 566 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI-------RISLEIARGLAYL 616
+ L +V E+M G+L ++I N + E+ +GL YL
Sbjct: 81 YDSYLVGDEL--WVVMEYMDGGSLTDII------TQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
H + +IH DIK NILL S K++DFG + L ++S+ ++++ GT ++APE
Sbjct: 133 H---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVI 188
Query: 677 KNVPVSAKVDVYSFGVTLLEII 698
K KVD++S G+ +E+
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 7e-29
Identities = 73/283 (25%), Positives = 119/283 (42%), Gaps = 28/283 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGR-THHKH 561
+LG GSFG VY + +A+K L + + F E+ + H +
Sbjct: 4 ILRKLGEGSFGEVYLARDRKL----VALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRIRISLEIARGLAYLHE 618
+V+L F + + LV E++ G+L +L+ I + + + I +I L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 619 ECNVPIIHCDIKPQNILLDHF-FSAKISDFGLSKLLFSDQSRTH-----TMIRGTRGYVA 672
+ IIH DIKP+NILLD K+ DFGL+KLL S + + GT GY+A
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 673 PEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729
PE S+ D++S G+TL E++ E E + + +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
L S+ ++ + + + +DP R + L
Sbjct: 237 SPLSPSNPELISKAAS-----DLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 57/198 (28%), Positives = 106/198 (53%), Gaps = 7/198 (3%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKHLV 563
+ +GRG+FG+VYKG L +G +A+K++ ++ +E + E+ + H ++V
Sbjct: 4 LGDLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
+ +G + + + ++ E+ NG+L +I +L ++ +GLAYLHE+
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---G 119
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
+IH DIK NIL K++DFG++ L +D S+ + GT ++APE + S
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 684 KVDVYSFGVTLLEIICCR 701
D++S G T++E++
Sbjct: 179 ASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 29/210 (13%)
Query: 509 ELGRGSFGIVYKGVLKTAS----GTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLV 563
ELG+GSFG+VY+G+ K T +A+K ++ A RER EF +E S + + H+V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFA----------IPKPDWNLRIRISLEIARGL 613
+LLG L+V E M G L + + + + P I+++ EIA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF-SDQSRTHTMIRGTRG--- 669
AYL + +H D+ +N ++ + KI DFG+++ ++ +D R +G +G
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 184
Query: 670 --YVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
++APE K+ + K DV+SFGV L E+
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 7e-28
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQEREREF-KSEVSAIGRTHHKHLVQ 564
+++G+GSFG VY V + + G +K++D E+ERE +EV + + +H ++++
Sbjct: 5 IKQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 565 LLGFCD--EALNRLL-VYEFMGNGTLANLI-----FAIPKPD---WNLRIRISLEIARGL 613
+ + E +L V E+ G L+ I P P+ + +++ L L
Sbjct: 64 ---YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----AL 116
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAP 673
YLH I+H DIKPQNI L K+ DFG+SK+L S T++ GT Y++P
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSP 172
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEIICCRR 702
E +N P + K D++S G L E+ +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 70/196 (35%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQEREREF-KSEVSAIGRTHHKHLVQLL 566
LG+GSFG V V K +G A+K L ++ + +E E +E + + R +H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 567 -GFCDEALNRL-LVYEFMGNGTLANLIFAIPK-PDWNLRIRISLEIARGLAYLHEECNVP 623
F E +L LV E+ G L + + + + R + EI L YLH
Sbjct: 60 YAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHSL---G 113
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
II+ D+KP+NILLD K++DFGL+K L S+ SRT+T GT Y+APE
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 684 KVDVYSFGVTLLEIIC 699
VD +S GV L E++
Sbjct: 173 AVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+G+G FG V G + G +AVK L + + F +E S + H +LVQL
Sbjct: 10 LGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQL 65
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRI--SLEIARGLAYLHEECNVP 623
LG + +V E+M G+L + + + + L ++ +L++ G+ YL EE N
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL-EEKN-- 122
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
+H D+ +N+L+ AK+SDFGL+K + S+ + + APE + S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 684 KVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741
K DV+SFG+ L EI R + L++ + + + EG +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA-PEGCPPEVYK------- 230
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
+M W + DP+KRPT K + + L
Sbjct: 231 --------VMKDCWEL--DPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 85/289 (29%), Positives = 140/289 (48%), Gaps = 47/289 (16%)
Query: 509 ELGRGSFGIVYKGV----LKTASGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLV 563
ELG+GSFG+VY+G +K + T +AVK ++ A RER EF +E S + H+V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAI----------PKPDWNLRIRISLEIARGL 613
+LLG + L+V E M +G L + + ++ P P I+++ EIA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG---- 669
AYL+ + +H D+ +N ++ H F+ KI DFG+++ D T +G +G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 670 -YVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728
++APE K+ + D++SFGV L EI L E+ L++ E
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI--------TSLAEQPYQGLSN-------EQV 230
Query: 729 LDVLIDSDEAAMADR--SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
L ++D D R+ + + C Q +P RPT ++ +L+
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 63/226 (27%), Positives = 92/226 (40%), Gaps = 41/226 (18%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQE-------REREFKSEVSAIGR 556
F + +G GSF V K + A+K LD +L +E E+E + R
Sbjct: 5 FGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQLIKEKKVKYVKIEKE------VLTR 57
Query: 557 -THHKHLVQLLG-FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLA 614
H +++L F DE N V E+ NG L I D + EI L
Sbjct: 58 LNGHPGIIKLYYTFQDEE-NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR--------- 665
YLH + IIH D+KP+NILLD KI+DFG +K+L + S
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 666 ----------GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCR 701
GT YV+PE P D+++ G + +++ +
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
+G G+FG VY V +G +AVK ++ + +E E+ + H +LV+ G
Sbjct: 8 IGGGTFGKVYTAV-NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 568 FCDEALNRLLVYEFM---GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
++R VY FM GTL L+ D ++ +L++ GLAYLH I
Sbjct: 67 V---EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG---YVAPEWFKNVPV 681
+H DIKP NI LDH K+ DFG + L ++ + ++ G Y+APE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 682 SAK---VDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYV-EGRLDVLIDSDE 737
D++S G +LE+ +R EL+ E + +V G + DS +
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWS-ELDNE-------FQIMFHVGAGHKPPIPDSLQ 232
Query: 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ + L + C++ DP KRPT +LQ
Sbjct: 233 LSPEGKDFLDR-------CLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 76/289 (26%), Positives = 122/289 (42%), Gaps = 48/289 (16%)
Query: 497 DELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR 556
EL +E+G G FG+V+ G AI K R E +F E + +
Sbjct: 4 SELT-----LVQEIGSGQFGLVWLGYWLEKRKVAI---KTIREGAMSEEDFIEEAQVMMK 55
Query: 557 THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAY 615
H LVQL G C E LV+EFM +G L++ + A K + + L++ G+AY
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
L +IH D+ +N L+ K+SDFG+++ + DQ + T + + +PE
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEV 172
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735
F S+K DV+SFGV + E+ + EG+ S
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEV--------------------------FSEGKTPYENRS 206
Query: 736 DEAAMADRS---RLHKWLM-------IAMWCIQEDPSKRPTMKVVLQML 774
+ + + RL+K + + C +E P RP+ ++L L
Sbjct: 207 NSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQERERE-FKSEVSAIGRTHHKHLVQL 565
E +G+GSFG V K V + + G + K++D E+E++ SEV+ + H ++V+
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR- 63
Query: 566 LGFCDEALNR-----LLVYEFMGNGTLANLIFAIPKPDWNLRI------RISLEIARGLA 614
+ D ++R +V E+ G LA LI K I RI ++ L
Sbjct: 64 --YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALY 119
Query: 615 YLH--EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
H + ++H D+KP NI LD + K+ DFGL+K+L D S T + GT Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMS 178
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEI 697
PE ++ K D++S G + E+
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 81/276 (29%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQERER-EFKSEVSAIGRTHHKHLVQ 564
++G+GSFG+V+K V K A A+K++D RER E E + + ++++
Sbjct: 5 LNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 565 LL-GFCDEA-LNRLLVYEFMGNGTLANLIFAI---PKPD---WNLRIRISLEIARGLAYL 616
F D+ LN +V E+ NG L L+ P P+ W I+I L GLA+L
Sbjct: 64 YYESFLDKGKLN--IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHL 117
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
H + I+H DIK N+ LD + + KI D G++KLL SD + I GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELC 173
Query: 677 KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
++ P + K DV++ GV L E CC + + IL + G +
Sbjct: 174 EDKPYNEKSDVWALGVVLYE--CCTGKHPFDANNQGALILK------IIRGVFPPVSQMY 225
Query: 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+A C+ +D +RP +L+
Sbjct: 226 SQQLAQLIDQ---------CLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 30/268 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
+LG G FG V++G+ K AI + K D L ++++F+ EV A+ R HKHL+ L
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFA 69
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAYLHEECNVP 623
C ++ E M G+L L F L I ++ ++A G+AYL EE N
Sbjct: 70 VCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYL-EEQN-- 124
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IH D+ +NIL+ K++DFGL++L+ D + + + APE + S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-WTAPEAASHGTFST 183
Query: 684 KVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG-RLDVLIDSDEAAMAD 742
K DV+SFG+ L E+ V + YD G R+
Sbjct: 184 KSDVWSFGILLYEMF-TYGQVPYP------GMNNHEVYDQITAGYRM-------PCPAKC 229
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVV 770
++K +M+ W +P RP+ K +
Sbjct: 230 PQEIYK-IMLECWAA--EPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 7/192 (3%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREF-KSEVSAIGRTHHKHLVQLL 566
E +G+GSFG VYK + K + +A+K +D E E E + E+ + + ++ +
Sbjct: 7 ECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
G + ++ E+ G G+ +L+ + + I E+ GL YLHEE IH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-ILREVLLGLEYLHEE---GKIH 121
Query: 627 CDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVD 686
DIK NILL K++DFG+S L S S+ +T + GT ++APE K K D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKAD 180
Query: 687 VYSFGVTLLEII 698
++S G+T +E+
Sbjct: 181 IWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 71/197 (36%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGT--AIAVKKL-DRLAQEREREFKSEVSAIGRTHHKHLVQ 564
+ELG G+FG V KGV SG +AVK L ++EF E S + + H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRIRISLEIARGLAYLHEECNVP 623
L+G C + +LV E G L + + P +L ++ ++A G+AYL E +
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-KELAHQVAMGMAYL-ESKH-- 115
Query: 624 IIHCDIKPQNILL--DHFFSAKISDFGLSKLLF--SDQSRTHTMIRGTRGYVAPEWFKNV 679
+H D+ +N+LL H AKISDFG+S+ L SD R T R + APE
Sbjct: 116 FVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 680 PVSAKVDVYSFGVTLLE 696
S+K DV+S+GVTL E
Sbjct: 174 KFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 60/203 (29%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 506 FKEELGRGSFGIVYKG---VLKTASGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKH 561
F ++LG G FG V L +G +AVK L+ +E+ R +F+ E+ + H++
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 562 LVQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHE 618
+V+ G C++ R L+ E++ +G+L + L + + + S +I +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG----YVAPE 674
+ IH D+ +NIL++ KISDFGL+K+L + + + ++ + APE
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWYAPE 182
Query: 675 WFKNVPVSAKVDVYSFGVTLLEI 697
+ S+ DV+SFGVTL E+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 62/195 (31%), Positives = 107/195 (54%), Gaps = 12/195 (6%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E+LG GS+G VYK + K +G +A+K + +E +E E+S + + ++V+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKE-TGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 566 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNV 622
G F + L +V E+ G G++++++ K I I + +GL YLH +
Sbjct: 64 YGSYFKNTDL--WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SN 118
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
IH DIK NILL+ AK++DFG+S L ++ +T+I GT ++APE + + +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 177
Query: 683 AKVDVYSFGVTLLEI 697
K D++S G+T +E+
Sbjct: 178 NKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 79/284 (27%), Positives = 114/284 (40%), Gaps = 51/284 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
F +ELG G FG+V+ G + AI K+ R E +F E + + H +LVQL
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAI---KMIREGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLE----IARGLAYLHEECN 621
G C + +V E+M NG L N + L L+ + + YL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTR---GYVAPEWFKN 678
IH D+ +N L+ K+SDFGL++ + DQ +T +GT+ + PE F
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDY 175
Query: 679 VPVSAKVDVYSFGVTLLEIICC------RRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732
S+K DV+SFGV + E+ R S +E S RL
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY------------RL--- 220
Query: 733 IDSDEAAMADRSRL--HKWLMIAMWCIQEDPSKRPTMKVVLQML 774
R +L + I C E P RP K +L L
Sbjct: 221 ---------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 33/218 (15%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG----TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 560
F EELG G+FG VYKG L + T++A+K L A+ + + EF+ E + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR---------------IR 604
++V LLG C + +++E++ +G L L+ P D +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD-----QSR 659
I+++IA G+ YL +H D+ +N L+ + KISDFGLS+ ++S QS+
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
+ +R ++ PE + + D++SFGV L EI
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG- 567
ELG G+FG VYK K A A K + ++E +F E+ + H ++V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFA-AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 568 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVPII 625
F + L L+ EF G L +++ + + +IR + ++ L +LH +I
Sbjct: 71 YFYENKLWILI--EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAP-----EWFKNVP 680
H D+K NILL K++DFG+S S + T I GT ++AP E FK+ P
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNP 184
Query: 681 VSAKVDVYSFGVTLLEI 697
K D++S G+TL+E+
Sbjct: 185 YDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 46/277 (16%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQEREREFK-SEVSAIGRTHHKHLVQLLG 567
LG+GS+G VYK V + + A+K++D ++ERE +E+ + +H +++
Sbjct: 8 LGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---S 63
Query: 568 FCDEAL--NRL-LVYEFMGNGTLANLIFAIPKPD--------WNLRIRISLEIARGLAYL 616
+ + L N+L +V E+ G L+ I K W RI +++ RGL L
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQAL 119
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
HE+ I+H D+K NILL KI D G+SK+L + ++T GT Y+APE +
Sbjct: 120 HEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVW 173
Query: 677 KNVPVSAKVDVYSFGVTLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLDVLIDS 735
K P S K D++S G L E+ E +++ + G+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR---------GKYPPIPPI 224
Query: 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ + +Q P RP +L
Sbjct: 225 YSQDLQN---------FIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 69/209 (33%), Positives = 111/209 (53%), Gaps = 27/209 (12%)
Query: 509 ELGRGSFGIVY----KGVLKTASGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLV 563
ELG+GSFG+VY KGV+K T +A+K ++ A RER EF +E S + + H+V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PK---------PDWNLRIRISLEIARGL 613
+LLG + L++ E M G L + + ++ P+ P I+++ EIA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG---- 669
AYL+ +H D+ +N ++ F+ KI DFG+++ D T +G +G
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 670 -YVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
+++PE K+ + DV+SFGV L EI
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 21/210 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE----------FKSEVSAIGRT 557
E +G+G++G VY L +G +AVK+++ A R +SE+ +
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 558 HHKHLVQLLGFCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYL 616
H ++VQ LGF + L ++ E++ G++ + + + + L + ++ GLAYL
Sbjct: 66 DHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL--FSDQSRTHTMIRGTRGYVAPE 674
H + I+H D+K N+L+D KISDFG+SK D + +M +G+ ++APE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM-QGSVFWMAPE 180
Query: 675 WFKN--VPVSAKVDVYSFGVTLLEIICCRR 702
+ SAKVD++S G +LE+ RR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 47/278 (16%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E +G G FG V +G +G +AVK K D AQ F E + + + HHK+LV+L
Sbjct: 12 EIIGEGEFGAVLQG---EYTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRL 64
Query: 566 LGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRIRISLEIARGLAYLHEE 619
LG N L +V E M G L N + + ++ SL++A G+ YL +
Sbjct: 65 LGVILH--NGLYIVMELMSKGNLVNFLRTRGRALVSVIQL---LQFSLDVAEGMEYLESK 119
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
++H D+ +NIL+ AK+SDFGL+++ S + + APE K+
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHK 172
Query: 680 PVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737
S+K DV+S+GV L E+ R+ +M L+E + + + DV +
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV---- 228
Query: 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
LM + W + +P KRP+ + + LE
Sbjct: 229 ------------LMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 78/292 (26%), Positives = 137/292 (46%), Gaps = 56/292 (19%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQ 564
+ +G G FG V +G LK I A+K L + +++R +F +E S +G+ H ++++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-----------IRISLEIARGL 613
L G ++ +++ E+M NG+L D LR + + IA G+
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL----------DKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM-----IRGTR 668
YL E V H D+ +NIL++ K+SDFGLS+ L ++ T IR T
Sbjct: 120 KYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT- 175
Query: 669 GYVAPEWFKNVPVSAKVDVYSFGVTLLEIICC--RRSVEMELEEESRAILTDWAYDCYVE 726
APE ++ DV+SFG+ + E++ R +M ++ +A+ +
Sbjct: 176 ---APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY------- 225
Query: 727 GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
RL +D A L++ LM + C Q+D ++RPT ++ L+ ++
Sbjct: 226 -RLPPPMDCPSA-------LYQ-LM--LDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 14/194 (7%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKHLVQL 565
ELG G+ G+V K VL +G +AVK + RL E K E+ + + + ++V
Sbjct: 8 ELGAGNSGVVSK-VLHRPTGKIMAVKTI-RLEIN-EAIQKQILRELDILHKCNSPYIVGF 64
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAYLHEECNVP 623
G + + E+M G+L ++ + RI +I++ + +GL YLHE+
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEKHK-- 121
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IIH D+KP NIL++ K+ DFG+S L + ++T GT Y+APE + S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSV 178
Query: 684 KVDVYSFGVTLLEI 697
K D++S G++L+E+
Sbjct: 179 KSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 81/282 (28%), Positives = 136/282 (48%), Gaps = 39/282 (13%)
Query: 510 LGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQLL 566
+G G FG V++G+LK A+A+K L E++R +F SE S +G+ H ++++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 567 GFCDEALNRLLVYEFMGNGTLANLI------FAIPKPDWNLRIRISLEIARGLAYLHEEC 620
G + +++ E+M NG L + F+ + LR IA G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYL---S 124
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG--YVAPEWFKN 678
++ +H D+ +NIL++ K+SDFGLS++L D T+T G + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 679 VPVSAKVDVYSFGVTLLEIICC--RRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
++ DV+SFG+ + E++ R +M E +AI D + RL +D
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-----NDGF---RLPAPMDCP 236
Query: 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
A LM+ W Q+D ++RP ++ +L+ LL
Sbjct: 237 SAVYQ--------LMLQCW--QQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-21
Identities = 38/111 (34%), Positives = 50/111 (45%), Gaps = 11/111 (9%)
Query: 70 ERTIVWHANGDNP-APRGSTLELTATG-LLLKDPGGQAIWDGKPDKNVSD--AAMLDTGN 125
+T+VW AN NP TL L + G L+L D G+ +W S A + D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 126 FVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSV-----LVSRLTETNFS 171
VL + WQSF PTDT+LP Q + L S + T+ S
Sbjct: 61 LVLYDNSGK--VLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 65/193 (33%), Positives = 98/193 (50%), Gaps = 7/193 (3%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
K +LG G +G VY+GV K S T +AVK L E E EF E + + H +LVQLL
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 68
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWN--LRIRISLEIARGLAYLHEECNVPI 624
G C ++ EFM G L + + + + N + + ++ +I+ + YL ++
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
IH D+ +N L+ K++DFGLS+L+ D H + + APE S K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 685 VDVYSFGVTLLEI 697
DV++FGV L EI
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTA----IAVKKLDRLAQERERE-FKSEVSAIGRTHHK 560
K ELG G+FG V+ G +AVK L A R+ F+ E + H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR---------------I 605
++V+ G C E ++V+E+M +G L + + PD I
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRS-HGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 606 SLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRT--HT 662
+++IA G+ YL + +H D+ +N L+ + KI DFG+S+ +++ D R HT
Sbjct: 128 AVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 663 M--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
M IR ++ PE + + DV+SFGV L EI
Sbjct: 185 MLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 75/218 (34%), Positives = 109/218 (50%), Gaps = 28/218 (12%)
Query: 499 LKDATDGF--KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR 556
L D T F E +G G++G VYK K G +A+K +D + ++ E E K E + + +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKT-GQLVAIKIMD-IIEDEEEEIKEEYNILRK 58
Query: 557 -THHKHLVQLLGF--------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----I 603
++H ++ G D+ L LV E G G++ +L+ + K L+
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQL--WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 604 RISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663
I E RGLAYLHE +IH DIK QNILL K+ DFG+S L S R +T
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 664 IRGTRGYVAPEWF---KNVPVS--AKVDVYSFGVTLLE 696
I GT ++APE + S A+ DV+S G+T +E
Sbjct: 174 I-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 20/203 (9%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL-----DRLAQERE-REFKSEVSAIGRTHHKH 561
E LG+G++G VY G+ T G IAVK++ + LA E+E + + EV + H +
Sbjct: 6 EVLGKGAYGTVYCGL--TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRIRISLEIARGLAYLHEE 619
+VQ LG C + + EF+ G++++++ F P P+ + + +I G+AYLH
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFC-KYTKQILDGVAYLHNN 121
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLS-KLLFSDQSRTHTMI----RGTRGYVAPE 674
C ++H DIK N++L K+ DFG + +L + TH+ + GT ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 675 WFKNVPVSAKVDVYSFGVTLLEI 697
K D++S G T+ E+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLL 566
LG G+ G V K LK +G A+K + + +++ E+ ++V+
Sbjct: 7 SRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 567 G-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRI------RISLEIARGLAYLHE 618
G F DE+ + + + E+ G+L ++ + K RI +I+ + +GL+YLH
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
IIH DIKP NILL K+ DFG+S L + + T T GT Y+APE +
Sbjct: 124 R---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQG 177
Query: 679 VPVSAKVDVYSFGVTLLEI 697
P S DV+S G+TLLE+
Sbjct: 178 KPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-20
Identities = 83/334 (24%), Positives = 155/334 (46%), Gaps = 34/334 (10%)
Query: 460 AFLLLAI----LIFFKWRR----RKYENNVQDST--TSETNLRFFSYDELKDATDGFKEE 509
AFL+LA+ +F + R ++ EN +D T + + + D KEE
Sbjct: 638 AFLVLALVAFGFVFIRGRNNLELKRVEN--EDGTWELQFFDSKVSKSITINDILSSLKEE 695
Query: 510 --LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
+ RG G YKG +G VK+++ + SE++ +G+ H ++V+L+G
Sbjct: 696 NVISRGKKGASYKGKSIK-NGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIG 750
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHC 627
C L++E++ L+ ++ + W R +I++ IA+ L +LH C+ ++
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRNL---SWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 628 DIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDV 687
++ P+ I++D + L LL +D + YVAPE + ++ K D+
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS-----SAYVAPETRETKDITEKSDI 861
Query: 688 YSFGVTLLEIICCRRSVEMELE-EESRAILTDWAYDCYVEGRLDVLIDS--DEAAMADRS 744
Y FG+ L+E++ + + E S + +WA CY + LD+ ID +++
Sbjct: 862 YGFGLILIELLTGKSPADAEFGVHGS---IVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
+ + + +A+ C DP+ RP VL+ LE
Sbjct: 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL------DRLAQEREREFKSEVSAIGRTHHKHLV 563
+G G+ GIV+K + +G +A+KK+ + + RE K A+ H ++V
Sbjct: 8 IGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNV 622
+LL +LV E+M L+ ++ +P +++ + +G+AY+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP-V 681
I+H D+KP N+L+ KI+DFGL++L ++ R ++ TR Y APE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 682 SAKVDVYSFGVTLLEII 698
VD+++ G E++
Sbjct: 179 DPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 34/273 (12%)
Query: 510 LGRGSFG--IVYKGVLKTASGTAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKHLVQL 565
LG+G+FG +Y+ +T + + K+++ RL+++ R+ +E+ + H +++
Sbjct: 8 LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 566 LG-FCDEALNRLLV-YEFMGNGTLANLIFAIPKP--DWNLRIRISLEIARGLAYLHEECN 621
F D+ N LL+ E+ GTL + I + + + +I ++Y+H+
Sbjct: 65 YNHFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-- 120
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
I+H DIK NI L K+ DFG+SK+L S+ S T++ GT Y++PE + V
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 682 SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741
+ K D+++ G L E++ +R +D L V I
Sbjct: 179 NFKSDIWALGCVLYELLTLKR-----------------TFDATNPLNLVVKIVQGNYTPV 221
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
+ + + +Q+DP KRPT VL
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 22/201 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL-----DRLAQEREREFKSEVSAIGRTHHKHL 562
E LG GSFG VY+G L G AVK++ + QE ++ + E++ + + H ++
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 563 VQLLGFC--DEALNRLLVYEFMGNGTLANLIF---AIPKPDWNLRIRISLEIARGLAYLH 617
VQ LG ++ L L E + G+LA L+ + P+P L R +I GL YLH
Sbjct: 65 VQYLGTEREEDNLYIFL--ELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLH 119
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
+ +H DIK NIL+D K++DFG++K + + S + +G+ ++APE
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSF-KGSPYWMAPEVIA 174
Query: 678 NV-PVSAKVDVYSFGVTLLEI 697
D++S G T+LE+
Sbjct: 175 QQGGYGLAADIWSLGCTVLEM 195
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+LG G FG V++G+ T +AVK L + ++F +E + + H L+QL
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNT--TPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQL 66
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL--RIRISLEIARGLAYLHEECNVP 623
C +V E M G+L + L I ++ ++A G+AYL E N
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EAQN-- 123
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IH D+ +N+L+ K++DFGL++++ D + + APE S
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 684 KVDVYSFGVTLLEII 698
K DV+SFG+ L EI+
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 8e-20
Identities = 57/191 (29%), Positives = 103/191 (53%), Gaps = 7/191 (3%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
E +G+GSFG V+KG+ + +A+K +D E E E + E++ + + ++ +
Sbjct: 10 ERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
G + ++ E++G G+ +L+ A P ++ + + EI +GL YLH E IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLHSEKK---IH 124
Query: 627 CDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVD 686
DIK N+LL K++DFG++ L Q + +T + GT ++APE + +K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183
Query: 687 VYSFGVTLLEI 697
++S G+T +E+
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 68/224 (30%), Positives = 106/224 (47%), Gaps = 41/224 (18%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-REFKSEVS 552
F+ ++LKD E+GRG+FG V K +L SGT +AVK++ E+E + ++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54
Query: 553 AIGRTHH-KHLVQLLG---------FC----DEALNRL--LVYEFMGNGTLANLIFAIPK 596
+ R+ ++V+ G C D +L++ VYE + + I
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILG--- 110
Query: 597 PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656
+I++ + L YL EE IIH D+KP NILLD + K+ DFG+S L
Sbjct: 111 -------KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 657 QSRTHTMIRGTRGYVAPEW---FKNVPVSAKVDVYSFGVTLLEI 697
++T G R Y+APE + DV+S G+TL E+
Sbjct: 162 IAKTRDA--GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 64/197 (32%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 511 GRGSFGIVYKGVLKTASGTAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKHLVQL-L 566
G+G+FG V V K + A+K K + + R +E + +H LV L
Sbjct: 9 GKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 567 GFCDEALNRLLVYEFMGNGTLA-NLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
F DE N LV + + G L +L + + ++ I EI L YLH + II
Sbjct: 68 SFQDEE-NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLHSK---GII 122
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
H DIKP NILLD I+DF ++ + + T + GT GY+APE S V
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTLTTSTS-GTPGYMAPEVLCRQGYSVAV 180
Query: 686 DVYSFGVTLLEIICCRR 702
D +S GVT E + +R
Sbjct: 181 DWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 31/274 (11%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
F +ELG G FG+V+ G K + +A+K ++ A E +F E + + H LVQL
Sbjct: 8 FMKELGSGQFGVVHLG--KWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQL 64
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
G C + +V EFM NG L N + D + + + ++ G+ YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERN--- 119
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
IH D+ +N L+ K+SDFG+++ + D+ + + + + PE F S
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
+K DV+SFGV + E+ + M E++S +V+
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK---MPFEKKS---------------NYEVVEMISRGFRLY 221
Query: 743 RSRL--HKWLMIAMWCIQEDPSKRPTMKVVLQML 774
R +L + C E P RPT +L+ +
Sbjct: 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-19
Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 26/197 (13%)
Query: 527 SGTAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHLVQLL--GFCDEALNRLLVYEF 581
+G +A+K L A E E + F+ E + R +H ++V LL G L V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60
Query: 582 MGNGTLANLIF---AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL-- 636
+ TL ++ A+P + R+ L++ LA H N I+H D+KPQNI++
Sbjct: 61 VPGRTLREVLAADGALPAGE---TGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 637 -DHFFSAKISDFGLSKLL--FSDQ-----SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVY 688
AK+ DFG+ LL D +RT ++ GT Y APE + PV+ D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLY 173
Query: 689 SFGVTLLEIICCRRSVE 705
++G+ LE + +R V+
Sbjct: 174 AWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 48/281 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKHLV 563
E +G G+ +VY + + +A+K++D L + + E + EV A+ + +H ++V
Sbjct: 5 LIEVIGVGATAVVYAAICL-PNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 564 QLLGFCDEALNRLL--VYEFMGNGTLANLI-FAIPKP--DWNLRIRISLEIARGLAYLHE 618
+ + + L V ++ G+L +++ + P+ D + + E+ +GL YLH
Sbjct: 63 KY--YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD---QSRTHTMIRGTRGYVAPEW 675
IH DIK NILL S KI+DFG+S L + GT ++APE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 676 FKNVP-VSAKVDVYSFGVTLLEIICCR---------RSVEMELEEESRAILTDWAYDCYV 725
+ V K D++SFG+T +E+ + + + L+ + ++ T Y Y
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY- 236
Query: 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 766
S+ + MI++ C+Q+DPSKRPT
Sbjct: 237 ------------------SKSFR-KMISL-CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAI--AVKKL--DRLAQEREREFKSEVSAIGRTHHKHLV 563
++LG GSFG+V +G T+ G I AVK L D+L + +F E + + H++L+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLI 59
Query: 564 QLLGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAYLHEEC 620
+L G L ++V E G+L + + + + +++IA G+ YL +
Sbjct: 60 RLYGVVLTHPL--MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK- 116
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTR----GYVAPEWF 676
IH D+ +NILL KI DFGL + L Q+ H ++ + APE
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRAL--PQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 677 KNVPVSAKVDVYSFGVTLLEI 697
+ S DV+ FGVTL E+
Sbjct: 173 RTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 65/196 (33%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
+ +LG G FG V+ G T +AVK L E F E + + H LVQL
Sbjct: 11 ERKLGAGQFGEVWMGTWNGT--TKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLY 67
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAYLHEECNV 622
C E +V E+M G+L L F LR + ++ +IA G+AYL E N
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSL--LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ESRNY 124
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
IH D+ +NIL+ KI+DFGL++L+ D+ + + APE +
Sbjct: 125 --IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 683 AKVDVYSFGVTLLEII 698
K DV+SFG+ L EI+
Sbjct: 183 IKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 59/193 (30%), Positives = 93/193 (48%), Gaps = 7/193 (3%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
F +ELG G FG+V G + AI K+ + E EF E + + H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAI---KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRIRISLEIARGLAYLHEECNVPI 624
G C + +V E+M NG L N + K + + + ++ G+AYL +
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
IH D+ +N L+D K+SDFGLS+ + D+ + + + PE S+K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 685 VDVYSFGVTLLEI 697
DV++FGV + E+
Sbjct: 182 SDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 75/275 (27%), Positives = 132/275 (48%), Gaps = 44/275 (16%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
+GRG+FGIV+ K I +K++ +++ ++ ++E + H ++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVI-IKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 568 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAY-------LHE 618
D+AL ++V E+ GTLA I R L+ L + LH
Sbjct: 67 NFLEDKAL--MIVMEYAPGGTLAEYI--------QKRCNSLLDEDTILHFFVQILLALHH 116
Query: 619 ECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
I+H D+K QNILLD H KI DFG+SK+L S +S+ +T++ GT Y++PE +
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVV-GTPCYISPELCE 174
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737
P + K D+++ G L E+ +R+ E A++ ++
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE---AANLPALVLK-------------IMSGTF 218
Query: 738 AAMADR-SRLHKWLMIAMWCIQEDPSKRPTMKVVL 771
A ++DR S + L+++M + DPSKRP + ++
Sbjct: 219 APISDRYSPDLRQLILSM--LNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 24/202 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTA---IAVKKL-DRLAQEREREFKSEVSAIGRTHHKHLVQL 565
LG G+FG VYKGV +A+K L + + + +E E + H H+V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRI----SLEIARGLAYLHEECN 621
LG C + L+ + M L L+ + N+ + ++IA+G++YL E
Sbjct: 75 LGICLSS-QVQLITQLM---PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE--- 127
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH-----TMIRGTRGYVAPEWF 676
++H D+ +N+L+ KI+DFGL+KLL D+ H I+ ++A E
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMALESI 183
Query: 677 KNVPVSAKVDVYSFGVTLLEII 698
+ + K DV+S+GVT+ E++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKK--LDRLAQEREREFKSEVSAIGRT-------HHK 560
+G GSFG VY G + +SG +AVK+ L ++ + +S + A+ R H+
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 561 HLVQLLGFCDEALNRLLVY-EFMGNGTLANLIF---AIPKPDWNLRIRISLEIARGLAYL 616
++VQ LG + L ++ E++ G++A L+ A + +R +I +GL YL
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYL 122
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL----FSDQSRTH-TMIRGTRGYV 671
H N IIH DIK NIL+D+ KISDFG+SK L S ++ ++G+ ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEII 698
APE K + K D++S G ++E++
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 22/198 (11%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG- 567
++G GS GIV K+ +G +AVKK+D Q+R +EV + H ++V++
Sbjct: 26 KIGEGSTGIVCIATDKS-TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 568 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR------ISLEIARGLAYLHEEC 620
+ L +V EF+ G L +++ R+ + L + + L++LH +
Sbjct: 85 YLVGDEL--WVVMEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ- 134
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680
+IH DIK +ILL K+SDFG + + R +++ GT ++APE +P
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLP 191
Query: 681 VSAKVDVYSFGVTLLEII 698
+VD++S G+ ++E++
Sbjct: 192 YGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 67/226 (29%), Positives = 102/226 (45%), Gaps = 30/226 (13%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQER-------EREFKSEVSAIGRTHHK 560
LG+G FG V A+G A KKLD RL + + E++ +V
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-------SS 52
Query: 561 HLVQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL-RIRI-SLEIARGLAYLH 617
+ L + E + L LV M G L I+ + +P + R + +I GL +LH
Sbjct: 53 RFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
+ I++ D+KP+N+LLD + +ISD GL+ + + GT GY+APE +
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQ 167
Query: 678 NVPVSAKVDVYSFGVTLLEIICCR-----RSVEMELEEESRAILTD 718
VD ++ G TL E+I R R ++E EE R L
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 61/192 (31%), Positives = 100/192 (52%), Gaps = 9/192 (4%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
E +G+GSFG VYKG+ + +A+K +D E E E + E++ + + ++ +
Sbjct: 10 ERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYLHEECNVPII 625
G + ++ E++G G+ +L+ P P I L EI +GL YLH E I
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERK---I 123
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
H DIK N+LL K++DFG++ L Q + +T + GT ++APE K K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKA 182
Query: 686 DVYSFGVTLLEI 697
D++S G+T +E+
Sbjct: 183 DIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
E++G+G+FG VYKGVLK T +AVK L + +R+F E + + H ++V+L+
Sbjct: 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR----ISLEIARGLAYLHEECNV 622
G C + +V E + G+L + K L ++ +SL+ A G+ YL +
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTF---LRKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTR----GYVAPEWFKN 678
IH D+ +N L+ KISDFG+S+ ++ +T+ G + + APE
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 679 VPVSAKVDVYSFGVTLLEI 697
+++ DV+S+G+ L E
Sbjct: 170 GRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 66/199 (33%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHL 562
E+LG G++G+VYK +G +A+KK+ RL E E S E+S + H ++
Sbjct: 4 LEKLGEGTYGVVYKAR-DKKTGEIVALKKI-RLDNEEE-GIPSTALREISLLKELKHPNI 60
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECN 621
V+LL LV+E+ L + P P NL I ++ RGLAY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVP 680
I+H D+KPQNIL++ K++DFGL++ TH ++ T Y APE
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSK 174
Query: 681 V-SAKVDVYSFGVTLLEII 698
S VD++S G E+I
Sbjct: 175 HYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 55/190 (28%), Positives = 100/190 (52%), Gaps = 6/190 (3%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
++G GS GIV +K+ SG +AVKK+D Q+R +EV + H+++V++
Sbjct: 27 KIGEGSTGIVCIATVKS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 569 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCD 628
+V EF+ G L +++ + + + L + + L+ LH + +IH D
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQ---GVIHRD 141
Query: 629 IKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVY 688
IK +ILL H K+SDFG + + R +++ GT ++APE +P +VD++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIW 200
Query: 689 SFGVTLLEII 698
S G+ ++E++
Sbjct: 201 SLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLV 563
+ +G G++G VYK A+G +A+K KL+ + + E+S + H ++V
Sbjct: 7 LIQRIGSGTYGDVYKAR-DIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIV 63
Query: 564 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECN 621
G ++L +V E+ G G+L ++ P L+I + E +GLAYLHE
Sbjct: 64 AYFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE--- 119
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF---KN 678
IH DIK NILL K++DFG+S L + ++ + I GT ++APE +
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERK 178
Query: 679 VPVSAKVDVYSFGVTLLE 696
K D+++ G+T +E
Sbjct: 179 GGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 82/287 (28%), Positives = 138/287 (48%), Gaps = 41/287 (14%)
Query: 507 KEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLV 563
+E +G G FG V +G LK +A+K L E++R +F SE S +G+ H +++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLI------FAIPKPDWNLRIRISLEIARGLAYLH 617
L G ++ +++ EFM NG L + + F + + LR IA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLS 123
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTR---GYVAP 673
E + +H D+ +NIL++ K+SDFGLS+ L D S T+T G + + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEIICC--RRSVEMELEEESRAILTDWAYDCYVEGRLDV 731
E ++ DV+S+G+ + E++ R +M ++ AI D+ RL
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--------RLPP 232
Query: 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
+D A LH+ LM+ W Q+D + RP ++ L+ ++
Sbjct: 233 PMDCPTA-------LHQ-LMLDCW--QKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 81/306 (26%), Positives = 134/306 (43%), Gaps = 70/306 (22%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--------EVSAIGR-TH 558
++LG G+FG VY K +G +A+KK+ +++F S EV ++ +
Sbjct: 5 KQLGDGTFGSVYLARNKE-TGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNE 56
Query: 559 HKHLVQLLGFCDEAL---NRL-LVYEFMGNGTLANLIFA-IPKPDWNLRIR-ISLEIARG 612
H ++V+L E + L V+E+M G L L+ KP IR I +I +G
Sbjct: 57 HPNIVKLK----EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
LA++H H D+KP+N+L+ KI+DFGL++ + S +T TR Y A
Sbjct: 112 LAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS--RPPYTDYVSTRWYRA 166
Query: 673 PEWF-KNVPVSAKVDVYSFGVTLLEIICCR-----RSVEMELEEESR--AIL-----TDW 719
PE ++ S+ VD+++ G + E+ R S E+++ + ++L DW
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS---EIDQLYKICSVLGTPTKQDW 223
Query: 720 ------------AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767
+ + L LI + D L+ ++ DP KRPT
Sbjct: 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAID-------LI--KDMLRWDPKKRPTA 274
Query: 768 KVVLQM 773
LQ
Sbjct: 275 SQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHLV 563
++G G++G+VYK K +G +A+KK+ + E+ + +H +++
Sbjct: 5 GKIGEGTYGVVYKARDKL-TGEIVAIKKIKL--RFESEGIPKTALREIKLLKELNHPNII 61
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNV 622
+LL + LV+EFM + L LI + I+ ++ +GLA+ H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV- 681
I+H D+KP+N+L++ K++DFGL++ S R +T TR Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGY 176
Query: 682 SAKVDVYSFGVTLLEII 698
S VD++S G E++
Sbjct: 177 STPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/193 (33%), Positives = 98/193 (50%), Gaps = 19/193 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
+G+G FG V G + G +AVK K D AQ F +E S + + H +LVQLLG
Sbjct: 14 IGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLG 66
Query: 568 FCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIARGLAYLHEECNVPI 624
E L +V E+M G+L + + + + + ++ SL++ + YL E N
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EAN-NF 123
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
+H D+ +N+L+ AK+SDFGL+K S Q ++ T APE + S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 685 VDVYSFGVTLLEI 697
DV+SFG+ L EI
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 58/191 (30%), Positives = 102/191 (53%), Gaps = 7/191 (3%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
E++G+GSFG V+KG+ + +A+K +D E E E + E++ + + ++ +
Sbjct: 10 EKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
G + ++ E++G G+ +L+ P + + I EI +GL YLH E IH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLHSEKK---IH 124
Query: 627 CDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVD 686
DIK N+LL K++DFG++ L Q + +T + GT ++APE K +K D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 183
Query: 687 VYSFGVTLLEI 697
++S G+T +E+
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 40/248 (16%)
Query: 506 FKEELGRGSFGIVY----KGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH 561
K ELG G+FG V+ +L +AVK L ++ ++F+ E + H+H
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL----------------RIRI 605
+V+ G C E L+V+E+M +G L N PD + + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 606 SLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-----SRT 660
+ +IA G+ YL ++ +H D+ +N L+ KI DFG+S+ ++S RT
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA 720
IR ++ PE + + D++SFGV L EI + +L A
Sbjct: 185 MLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------A 233
Query: 721 YDCYVEGR 728
+C +GR
Sbjct: 234 IECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTA--IAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
LG G FG V +G L G+ +AVK KLD EF SE + + H ++++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 566 LGFCDEALNR------LLVYEFMGNGTLANLIFA-----IPK--PDWNLRIRISLEIARG 612
+G C EA + +++ FM +G L + + +P+ P L ++ ++IA G
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL-LKFMVDIALG 125
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRTHTMIRGTRGYV 671
+ YL N IH D+ +N +L + ++DFGLSK ++S D R + + ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEI 697
A E + ++K DV++FGVT+ EI
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHLV 563
+G G++G+V K K A+G +A+KK E + + K EV + + H+++V
Sbjct: 7 GVVGEGAYGVVLKCRNK-ATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 564 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEEC 620
L RL LV+E++ TL L+ A P P +R ++ + +AY H
Sbjct: 64 NLKEAFRRK-GRLYLVFEYVER-TLLELLEASPGGLPPDAVR-SYIWQLLQAIAYCHSH- 119
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF-KNV 679
IIH DIKP+NIL+ K+ DFG ++ L + + T TR Y APE +
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 680 PVSAKVDVYSFGVTLLEII 698
VDV++ G + E++
Sbjct: 178 NYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 30/207 (14%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS---EVSAIGRTHH-KHLV 563
EELGRG++G+V K + +GT +AVK++ A +E K ++ R+ + V
Sbjct: 7 EELGRGAYGVVDK-MRHVPTGTIMAVKRIR--ATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 564 QLLG---------FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLA 614
G C E ++ L +F L IP+ + +I++ I + L
Sbjct: 64 TFYGALFREGDVWICMEVMDTSL-DKFYKKVYDKGL--TIPED---ILGKIAVSIVKALE 117
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
YLH + +V IH D+KP N+L++ K+ DFG+S L ++ T+ G + Y+APE
Sbjct: 118 YLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPE 173
Query: 675 WF----KNVPVSAKVDVYSFGVTLLEI 697
K DV+S G+T++E+
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 27/208 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTA----IAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQ 564
LG G+FG VY+G+ + G A +AVK L ++ E +F E + + +H+++V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 565 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPD--WNLR----IRISLEIARGLAYLH 617
L+G E L R ++ E M G L + L P+P+ +L + + ++A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 618 EECNVPIIHCDIKPQNILLDHFFS---AKISDFGLSKLLFSDQSRTHTMIRGTRG----- 669
E IH DI +N LL AKI+DFG+++ D R +G R
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPIK 186
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
++ PE F + ++K DV+SFGV L EI
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 4e-18
Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 8/111 (7%)
Query: 35 NSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTAT 94
+ +S + F GF L +D L I + RT+VW AN DNP TL L +
Sbjct: 7 GQTLVSGNSLFELGFFTLIMQNDYNL--ILYKSSS-RTVVWVANRDNPVSDSCTLTLQSD 63
Query: 95 G-LLLKDPGGQAIW--DGKPDKNVSDAAMLDTGNFVLRASGNNSDYAWQSF 142
G L+L D G+ +W + +LD GN V+ ++ ++ WQSF
Sbjct: 64 GNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIY--DSDGNFLWQSF 112
|
Length = 114 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 17/221 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKHLVQLL 566
LG+G FG V ++ A+G A KKL++ ++ + ++ E + + H + +V L
Sbjct: 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNV 622
+ LV M G L I+ + P + +I GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
II+ D+KP+N+LLD+ + +ISD GL+ L QS+T GT G++APE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYD 175
Query: 683 AKVDVYSFGVTLLEIICCR-----RSVEMELEEESRAILTD 718
VD ++ GVTL E+I R R ++E +E + IL D
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 83/285 (29%), Positives = 139/285 (48%), Gaps = 45/285 (15%)
Query: 510 LGRGSFGIVYKGVLKTASG--TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQLL 566
+G G FG V G LK +A+K L E++R +F SE S +G+ H +++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-----EIARGLAYLHEECN 621
G ++ ++V E+M NG+L + K D + I L IA G+ YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTV-IQLVGMLRGIASGMKYL---SD 124
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG------YVAPEW 675
+ +H D+ +NIL++ K+SDFGLS++L D +T TRG + APE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWTAPEA 180
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICC--RRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733
++ DV+S+G+ + E++ R EM ++ +AI + Y RL +
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI--EEGY------RLPAPM 232
Query: 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
D A LH+ LM+ W Q+D ++RP + ++ +L+ L+
Sbjct: 233 DCPAA-------LHQ-LMLDCW--QKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD---RLAQERER---EFKSEVSAIGRTHHKH 561
++LG G+F Y +GT +AVK++ + E+E + E+ + R +H H
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
++++LG E + L E+M G++++L+ + I + ++ RGL+YLHE
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 622 VPIIHCDIKPQNILLDHF-FSAKISDFGLSKLLFSDQSRT---HTMIRGTRGYVAPEWFK 677
IIH D+K N+L+D +I+DFG + L + + + GT ++APE +
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 678 NVPVSAKVDVYSFGVTLLEIIC 699
DV+S G ++E+
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA 553
+ YDE + + LG+G++GIVY ++ IA+K++ + E++
Sbjct: 5 YEYDENGE-----RVVLGKGTYGIVYAA-RDLSTQVRIAIKEIPERDSRYVQPLHEEIAL 58
Query: 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRIRISLEIA 610
H+++VQ LG E + E + G+L+ L+ + K + I + +I
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSA-KISDFGLSKLLFSDQSRTHTMIRGTRG 669
GL YLH+ I+H DIK N+L++ + KISDFG SK L T T GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTLQ 174
Query: 670 YVAPEWFKNVP--VSAKVDVYSFGVTLLEI 697
Y+APE P A D++S G T++E+
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 73/216 (33%), Positives = 103/216 (47%), Gaps = 14/216 (6%)
Query: 510 LGRGSFGIVYKGVLK-TASGTAIAVKKLDRLAQEREREF----KSEVSAIGRTHHKHLVQ 564
LG+GSFG V LK T A+ V K D + Q+ + E K ++ G+ H L Q
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLTQ 60
Query: 565 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
L C + +RL V E++ G L I + D + EI GL +LHE
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---G 116
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
II+ D+K N+LLD KI+DFG+ K T T GT Y+APE P
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQPYGP 175
Query: 684 KVDVYSFGVTLLEIICCRRSVEMELEEES-RAILTD 718
VD ++ GV L E++ + E + E+E ++IL D
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 30/219 (13%)
Query: 499 LKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR 556
L+D F+ E +G G++G VYKG +G A+K +D + ++ E E K E++ + +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKG-RHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKK 68
Query: 557 -THHKHLVQLLGFC--------DEALNRLLVYEFMGNGTLANLIFAIP----KPDWNLRI 603
+HH+++ G D+ L LV EF G G++ +L+ K DW
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQL--WLVMEFCGAGSVTDLVKNTKGNALKEDW--IA 124
Query: 604 RISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663
I EI RGLA+LH +IH DIK QN+LL K+ DFG+S L R +T
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181
Query: 664 IRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEI 697
I GT ++APE + + D++S G+T +E+
Sbjct: 182 I-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKS---EVSAIGRTHHKHLVQ 564
LG+G+FG VY +G +AVK++ D + E ++E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYLCY-DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
G + + E+M G++ + + A + + + +I G+ YLH I
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MI 125
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM--IRGTRGYVAPEWFKNVPVS 682
+H DIK NIL D + K+ DFG SK L + S M + GT +++PE
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 683 AKVDVYSFGVTLLEII 698
K DV+S G T++E++
Sbjct: 186 RKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 66/197 (33%), Positives = 102/197 (51%), Gaps = 17/197 (8%)
Query: 509 ELGRGSFGIVYKGVLKTASGT-AIAVKKLDRLAQER--EREFKSEVSAIGRTHHKHLVQL 565
ELG G+FG V KG+ K +AVK L + + E E + + + + ++V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEECNVP 623
+G C EA + +LV E G L N K + N+ + +++ G+ YL EE N
Sbjct: 62 IGIC-EAESWMLVMELAELGPL-NKFLQKNKHVTEKNI-TELVHQVSMGMKYL-EETN-- 115
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD----QSRTHTMIRGTRGYVAPEWFKNV 679
+H D+ +N+LL AKISDFGLSK L +D +++TH + + APE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG--KWPVKWYAPECMNYY 173
Query: 680 PVSAKVDVYSFGVTLLE 696
S+K DV+SFGV + E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 53/198 (26%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-REFKSEVSAIGRTHH---KHLV 563
E +GRG++G VY+G +G +A+K ++ + + + + EV+ + + ++
Sbjct: 7 ELIGRGAYGAVYRGK-HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLRIRISLEIARGLAYLHEECN 621
+ G + ++ E+ G++ L+ A I + ++ IR E+ L Y+H+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR---EVLVALKYIHK--- 119
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
V +IH DIK NIL+ + + K+ DFG++ LL + S+ T + GT ++APE
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 682 -SAKVDVYSFGVTLLEII 698
K D++S G+T+ E+
Sbjct: 179 YDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 509 ELGRGSFGIVYKGVLKTAS---GTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
ELG G+FG V KGV K AI V K + R+ E E + + + ++V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRM 60
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRIS------LEIARGLAYLHEE 619
+G C EA +LV E G L F K D I +S +++ G+ YL E
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNK--FLSGKKD---EITVSNVVELMHQVSMGMKYL-EG 113
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS--RTHTMIRGTRGYVAPEWFK 677
N +H D+ +N+LL + AKISDFGLSK L +D S + + + + APE
Sbjct: 114 KN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 678 NVPVSAKVDVYSFGVTLLE 696
S++ DV+S+G+T+ E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 57/190 (30%), Positives = 98/190 (51%), Gaps = 6/190 (3%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
++G GS GIV K +G +AVKK+D Q+R +EV + HH+++V +
Sbjct: 29 KIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 569 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCD 628
+V EF+ G L +++ + + + L + R L+YLH N +IH D
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLSVLRALSYLH---NQGVIHRD 143
Query: 629 IKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVY 688
IK +ILL K+SDFG + + + +++ GT ++APE +P +VD++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIW 202
Query: 689 SFGVTLLEII 698
S G+ ++E+I
Sbjct: 203 SLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 76/218 (34%), Positives = 105/218 (48%), Gaps = 18/218 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKH--LVQL 565
LG+GSFG V LK SG AVK K D + Q+ + E I H L QL
Sbjct: 3 LGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 566 LGFCDEALNRLL-VYEFMGNGTLANLIFAIPKP---DWNLRIRISLEIARGLAYLHEECN 621
C + +RL V EF+ G +L+F I K D + EI L +LH++
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK-- 115
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
II+ D+K N+LLDH K++DFG+ K + T T GT Y+APE + +
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLY 173
Query: 682 SAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTD 718
VD ++ GV L E++C E E E++ AIL D
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 68/270 (25%), Positives = 132/270 (48%), Gaps = 27/270 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLV 563
++E LG G+ G VYK + +AVK LD + E +++ SE+ + + +++
Sbjct: 5 YQEILGHGNGGTVYK-AYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYII 62
Query: 564 QLLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
G F E NR+ + EFM G+L ++ IP+ + RI++ + +GL YL +
Sbjct: 63 GFYGAFFVE--NRISICTEFMDGGSL-DVYRKIPEH---VLGRIAVAVVKGLTYL---WS 113
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
+ I+H D+KP N+L++ K+ DFG+S L + ++T+ GT Y+APE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQY 170
Query: 682 SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741
DV+S G++ +E+ R ++++ +++ C ++D D +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPLQLLQC--------IVDEDPPVLP 221
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVL 771
K++ C+++ P +RP + ++
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 72/219 (32%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 499 LKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR 556
L+D F+ E +G G++G VYKG +G A+K +D E E E K E++ + +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKK 58
Query: 557 -THHKHLVQLLGF--------CDEALNRLLVYEFMGNGTLANLIFAIP----KPDWNLRI 603
+HH+++ G D+ L LV EF G G++ +LI K +W
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQL--WLVMEFCGAGSVTDLIKNTKGNTLKEEW--IA 114
Query: 604 RISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663
I EI RGL++LH+ +IH DIK QN+LL K+ DFG+S L R +T
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171
Query: 664 IRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEI 697
I GT ++APE + K D++S G+T +E+
Sbjct: 172 I-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKHLVQLL 566
+ +G++G V+ K ++G A+K + + R+ + E + + ++V+L
Sbjct: 1 ISKGAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 567 -GFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRIRISLEIARGLAYLHEECNVPI 624
F + N LV E++ G LA+L+ + + RI I+ EI L YLH + I
Sbjct: 60 YSFQGKK-NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLH---SNGI 114
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM-------IRGTRGYVAPEWFK 677
IH D+KP NIL+D K++DFGLSK+ + I GT Y+APE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 678 NVPVSAKVDVYSFGVTLLEIIC 699
S VD +S G L E +
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 57/303 (18%)
Query: 510 LGRGSFGIVYKGV---LKTASG-TAIAVKKLDRLAQERE-REFKSEVSAIGRTHHKHLVQ 564
LG G FG V K LK +G T +AVK L A E R+ SE + + + +H H+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 565 LLGFCDEALNRLLVYEFMGNGTL----------------------ANLIFAIPKPDWNLR 602
L G C + LL+ E+ G+L ++ + + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 603 IRISL--EIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660
IS +I+RG+ YL E + ++H D+ +N+L+ KISDFGLS+ ++ + S
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-- 182
Query: 661 HTMIRGTRG-----YVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAI 715
++ ++G ++A E + + + DV+SFGV L EI+ + + E
Sbjct: 183 --YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240
Query: 716 LTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
L Y R++ + E LM+ W +++P KRPT + + LE
Sbjct: 241 LLKTGY------RMERPENCSEEMYN--------LMLTCW--KQEPDKRPTFADISKELE 284
Query: 776 GLL 778
++
Sbjct: 285 KMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGTAI--AVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
+G+G FG VY G L + G I AVK L+R+ E E F E + H +++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 567 GFC--DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR----ISLEIARGLAYLHEEC 620
G C E L+V +M +G L N I N ++ L++A+G+ YL +
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS---DQSRTHTMIRGTRGYVAPEWFK 677
+H D+ +N +LD F+ K++DFGL++ ++ HT + ++A E +
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 678 NVPVSAKVDVYSFGVTLLEII 698
+ K DV+SFGV L E++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 8e-17
Identities = 36/110 (32%), Positives = 48/110 (43%), Gaps = 7/110 (6%)
Query: 39 LSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LL 97
+S F GF +L I + RT+VW AN DNP+ TL L + G L+
Sbjct: 11 VSSGSLFELGFFKLI-MQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLV 68
Query: 98 LKDPGGQAIW--DGKPDKNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSP 145
+ D G +W + +LD GN VL S N + WQSF P
Sbjct: 69 IYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGN--FLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 54/300 (18%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTA----IAVKKLDRLAQEREREFKSEVSAIGRTHHKH 561
K ELG G+FG V+ S T +AVK L ++F+ E + H+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI-----------------R 604
+V+ G C + ++V+E+M +G L + A PD + +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA-HGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRT--H 661
I+ +IA G+ YL + +H D+ +N L+ KI DFG+S+ ++S D R H
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 662 TM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW 719
TM IR ++ PE + + DV+SFGV L EI + +L
Sbjct: 185 TMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------- 233
Query: 720 AYDCYVEGRLDVLIDSDEAAMADRSRL--HKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777
+C +GR+ +R R+ + I + C Q +P +R +K + ++L L
Sbjct: 234 VIECITQGRV-----------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 506 FKEELGRGSFGIVYK---GVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL 562
F ++LG+G+FG V L+ +G +AVKKL E R+F+ E+ + H ++
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 563 VQLLGFCDEA--LNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
V+ G C A N LV E++ G+L + L + D + + +I +G+ YL +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR--GTRG--YVAPEW 675
+H D+ +NIL++ KI DFGL+K+L Q + + +R G + APE
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVL--PQDKEYYKVREPGESPIFWYAPES 182
Query: 676 FKNVPVSAKVDVYSFGVTLLEI 697
S DV+SFGV L E+
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHL 562
F + LG GSFG V V SG A+K L + + ++ +E + H L
Sbjct: 5 FIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIAR--------G 612
V L G + N LV E++ G L + LR R +AR
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSH----------LRKSGRFPEPVARFYAAQVVLA 113
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
L YLH ++ I++ D+KP+N+LLD KI+DFG +K + + RT+T+ GT Y+A
Sbjct: 114 LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYTLC-GTPEYLA 166
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEIIC 699
PE + VD ++ G+ + E++
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 9/193 (4%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
++LG G FG V+ G T +A+K L + + E F +E + + + H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA 68
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNVPII 625
+ ++ E+M NG+L + + + I ++ +IA G+A++ E N I
Sbjct: 69 VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ERKNY--I 124
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
H D++ NIL+ KI+DFGL++L+ ++ + + APE + K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 686 DVYSFGVTLLEII 698
DV+SFG+ L EI+
Sbjct: 185 DVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 65/198 (32%), Positives = 101/198 (51%), Gaps = 21/198 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
E LG+G+FG V+KG LK + A+ K D L QE + +F SE + + H ++V+L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAYLH-EECNV 622
C + +V E + G L F K D L+ ++ +L+ A G+AYL + C
Sbjct: 60 VCTQRQPIYIVMELVPGGDF--LSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNC-- 114
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKL----LFSDQSRTHTMIRGTRGYVAPEWFKN 678
IH D+ +N L+ KISDFG+S+ ++S I+ T APE
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNY 168
Query: 679 VPVSAKVDVYSFGVTLLE 696
S++ DV+S+G+ L E
Sbjct: 169 GRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 506 FKEELGRGSFGIVYKGVLKTAS---GTAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKH 561
F EELG +FG +YKG L +A+K L D ++ EF+ E S + HH +
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR----------------IR 604
+V LLG + +++E++ G L LI P D +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD-----QSR 659
I+++IA G+ YL +H D+ +NIL+ KISD GLS+ ++S Q +
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
+ IR ++ PE S+ D++SFGV L EI
Sbjct: 186 SLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 49/214 (22%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-----------H 558
LG G++ +VYK +G +A+KK+ + E K I T
Sbjct: 8 LGEGTYAVVYKAR-DKETGRIVAIKKI------KLGERKEAKDGINFTALREIKLLQELK 60
Query: 559 HKHLVQLLG-FC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR------ISLEIA 610
H +++ LL F +N LV+EFM L +I D ++ + L
Sbjct: 61 HPNIIGLLDVFGHKSNIN--LVFEFME-TDLEKVI-----KDKSIVLTPADIKSYMLMTL 112
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRG 669
RGL YLH I+H D+KP N+L+ K++DFGL++ S + TH ++ TR
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRW 167
Query: 670 YVAPEWFKNVPVSAK-----VDVYSFGVTLLEII 698
Y APE A+ VD++S G E++
Sbjct: 168 YRAPELL----FGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 34/284 (11%)
Query: 508 EELGRGSFGIVYKGVLKTA-SGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQL 565
+E+G G FG V G S + VK+L A E+ F EV +H +++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLI-----FAIPKPDWNLRIRISLEIARGLAYLHEEC 620
LG C E++ LLV EF G L N + ++ R++ E+A GL +LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF-SDQSRTHTMIRGTRGYVAPEW---- 675
IH D+ +N L S KI D+GL+ + D T ++APE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 676 ---FKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732
+ K +++S GVT+ E+ ++ L+D V D+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL--------FTAADQPYPDLSDEQVLKQVVREQDIK 229
Query: 733 IDSD--EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
+ + +DR W + +C DP RPT + V ++L
Sbjct: 230 LPKPQLDLKYSDR-----WYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 62/195 (31%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
ELG G+FG VYK K A A K +D ++E ++ E+ + H ++V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLA-AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 569 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYLHEECNVPIIHC 627
N ++ EF G + ++ + +P +IR+ + L YLHE IIH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 628 DIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF-----KNVPVS 682
D+K NIL K++DFG+S R + I GT ++APE K+ P
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 186
Query: 683 AKVDVYSFGVTLLEI 697
K DV+S G+TL+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 560
E+G G++G VYK +G +A+KK+ R+ E RE + + + H
Sbjct: 5 AEIGEGAYGTVYKARDLN-TGRFVALKKV-RVPLSEEGIPLSTLREI-ALLKQLESFEHP 61
Query: 561 HLVQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRIRISLEIARG 612
++V+LL C D L LV+E + + LA + PKP ++ + ++ RG
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRG 119
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
+ +LH I+H D+KPQNIL+ KI+DFGL+++ + + T ++ T Y A
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRA 174
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEI 697
PE + VD++S G E+
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 47/295 (15%)
Query: 506 FKEELGRGSFGIVY----KGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH 561
K ELG G+FG V+ + +AVK L + ++F E + H+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL--------------RIRISL 607
+V+ G C E ++V+E+M +G L + A PD L + I+
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRA-HGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 608 EIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRT--HTM- 663
+IA G+ YL + +H D+ +N L+ KI DFG+S+ ++S D R HTM
Sbjct: 128 QIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 664 -IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD 722
IR ++ PE + + DV+S GV L EI + +L +
Sbjct: 185 PIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233
Query: 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777
C +GR+ R+ + + + C Q +P R +K + +L+ L
Sbjct: 234 CITQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 42/277 (15%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKHL 562
+ELG+G++G VYK VL +G +A+K++ RL + E +F E+ + + ++
Sbjct: 5 VLDELGKGNYGSVYK-VLHRPTGVTMAMKEI-RLELD-ESKFNQIIMELDILHKAVSPYI 61
Query: 563 VQLLG-FCDEALNRLLVY---EFMGNGTLANLI---FAIPKPDWNLRIRISLEIARGLAY 615
V G F E VY E+M G+L L A ++ RI+ + +GL +
Sbjct: 62 VDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
L EE N IIH D+KP N+L++ K+ DFG+S L + ++T+ G + Y+APE
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPER 172
Query: 676 FK------NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729
K N + + DV+S G+++LE+ R E Y + +L
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE------------TYAN-IFAQL 219
Query: 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 766
++D D + +A C+ + P++RPT
Sbjct: 220 SAIVDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKHLVQLL 566
+G G++GIVY+ T SG +A+KK+ R+ ER+ S E++ + H ++V+L
Sbjct: 15 IGEGTYGIVYRA-RDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 567 GFC--DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVP 623
+ LV E+ LA+L+ +P P +++ + L++ RGL YLHE
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--- 128
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLL-FSDQSRTHTMIRGTRGYVAPE-WFKNVPV 681
IIH D+K N+LL KI+DFGL++ + T ++ T Y APE
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTY 186
Query: 682 SAKVDVYSFGVTLLEII 698
+ +D+++ G L E++
Sbjct: 187 TTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 8e-16
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 39/211 (18%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA---------IGRTHHK 560
+G G++G+V V +G +A+KK+ F + A + H+
Sbjct: 8 IGSGAYGVVCSAV-DKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 561 HLVQLLG-FCDEALNRL----LVYEFMGNGT-LANLIFAIPKPDWNLRIR-ISLEIARGL 613
+++ LL + +V E M T L +I + P+P + I+ +I RGL
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKS-PQPLTDDHIQYFLYQILRGL 116
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG--TRGYV 671
YLH N +IH D+KP NIL++ KI DFGL++ + D+ + TR Y
Sbjct: 117 KYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 672 APE----WFKNVPVSAKVDVYSFGVTLLEII 698
APE + + +D++S G E++
Sbjct: 174 APELLLSSSR---YTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLL 566
LG G FG V V + A+K + + ++ SE + +H +V+L
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 567 -GFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRIRISLEIARGLAYLHEECNVPI 624
F D+ +L+ E+ G L ++ ++ R I+ + YLH N I
Sbjct: 60 RTFKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLH---NRGI 114
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
I+ D+KP+N+LLD K+ DFG +K L S Q +T T GT YVAPE N
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNKGYDFS 172
Query: 685 VDVYSFGVTLLEIIC 699
VD +S G+ L E++
Sbjct: 173 VDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG- 567
ELG G+FG VYK K +G A K ++ ++E ++ E+ + +H ++V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 568 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVPII 625
+ D L ++ EF G + ++ + + +I+ I ++ L YLH ++ II
Sbjct: 78 FYWDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKII 132
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAP-----EWFKNVP 680
H D+K N+LL K++DFG+S R + I GT ++AP E K+ P
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191
Query: 681 VSAKVDVYSFGVTLLEI 697
K D++S G+TL+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 46/288 (15%)
Query: 503 TDGFKEE--LGRGSFGIVYKGVLKTASGTAIAVKKLDRL----AQEREREFKSEVSAIGR 556
FK E +G+G F +VYK + G +A+KK+ A+ R+ K E+ + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAI-CLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQ 58
Query: 557 THHKHLVQLL-GFCDEALNRL-LVYEFMGNGTLANLI--FA-----IPKPD-WNLRIRIS 606
H ++++ L F + N L +V E G L+ +I F IP+ W +
Sbjct: 59 LDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV--- 113
Query: 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666
++ L ++H + I+H DIKP N+ + K+ D GL + S + H+++ G
Sbjct: 114 -QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-G 168
Query: 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 726
T Y++PE + K D++S G L E+ + + + L
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-----KMNLYS-------- 215
Query: 727 GRLDVLIDSDEAAMADRSRLHKWL--MIAMWCIQEDPSKRPTMKVVLQ 772
L I+ + + L +++ CI DP KRP + VLQ
Sbjct: 216 --LCKKIEKCDYPPLPADHYSEELRDLVSR-CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 77/295 (26%), Positives = 139/295 (47%), Gaps = 32/295 (10%)
Query: 498 ELKDATDGFKE--ELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQEREREFKSEVSAI 554
ELKD D F++ ELG G+ G+V+K V SG +A K + + + E+ +
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 555 GRTHHKHLVQLLG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARG 612
+ ++V G + D ++ + E M G+L ++ + + ++S+ + +G
Sbjct: 58 HECNSPYIVGFYGAFYSDGEIS--ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 115
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
L YL E+ I+H D+KP NIL++ K+ DFG+S L + + GTR Y++
Sbjct: 116 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMS 170
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732
PE + S + D++S G++L+E+ R + +E + + C VEG
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM-----FGCPVEG----- 220
Query: 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPS 787
D E+ + R R + + P RP M + ++L+ +++ P P PS
Sbjct: 221 -DPAESETSPRPRPPGRPLSSY-----GPDSRPPM-AIFELLDYIVNEPPPKLPS 268
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQER-EREFKSEVSAIGRTHHKHLVQLL 566
LG+G FG V +K +G A KKLD RL ++ E+ E + + + +V L
Sbjct: 1 LGKGGFGEVCAVQVKN-TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIARGLAYLHEECNVPI 624
+ + LV M G L I+ + + + I S +I G+ +LH + I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
++ D+KP+N+LLD + ++SD GL+ L +T T GT GY+APE K P S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVEL--KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 685 VDVYSFGVTLLEIICCR 701
VD ++ G ++ E++ R
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 81/297 (27%), Positives = 129/297 (43%), Gaps = 52/297 (17%)
Query: 510 LGRGSFGIV----YKGVLKTASGTAIAVKKLDRLAQERE-REFKSEVS---AIGRTHHKH 561
LG G+FG V G+ + +AVK L A E++ + SE+ IG+ HK+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLRIRISLE----------- 608
++ LLG C + +V E+ +G L + + A P + E
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 609 ---IARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRTHTMI 664
+ARG+ +L + IH D+ +N+L+ KI+DFGL++ + D R T
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 665 RGTRGYVAPE-WFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC 723
R ++APE F V + + DV+SFGV L EI S I + +
Sbjct: 195 RLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGS-------PYPGIPVEELFKL 246
Query: 724 YVEG-RLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
EG R++ + + E LM W E PS+RPT K +++ L+ +L
Sbjct: 247 LKEGYRMEKPQNCTQELYH---------LMRDCW--HEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLD-RLAQEREREFK 548
F L++ T LGRG FG V+ K T + VK L + + EF+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 549 SEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL------- 601
E+ + HK++V+LLG C EA ++ E+ G L + A D L
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 602 --RIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659
++ + +IA G+ +L N +H D+ +N L+ K+S LSK +++ +
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
++APE + S K DV+SFGV + E+
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 508 EELGRGSFG--IVYK-GVLKTASGTAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKHLV 563
LG G FG +Y +G +AVK L R Q+ +K E++ + +H+++V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 564 QLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEE 619
+ G C E + L+ E++ G+L + + PK NL + + +I G+AYLH +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG--YVAPEWFK 677
IH D+ +N+LLD+ KI DFGL+K + G + A E K
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 678 NVPVSAKVDVYSFGVTLLEII 698
S DV+SFGVTL E++
Sbjct: 184 ENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 18/200 (9%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKHLVQ 564
E++G G++G+VYK + + T IA+KK+ RL QE E + E+S + H ++V+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNET-IALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 565 L--LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL--EIARGLAYLHEEC 620
L + ++ L LV+E++ + L + + P N R+ + +I RG+AY H
Sbjct: 66 LQDVVHSEKRL--YLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 621 NVPIIHCDIKPQNILLDHFFSA-KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WFKN 678
++H D+KPQN+L+D +A K++DFGL++ F RT T T Y APE +
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 679 VPVSAKVDVYSFGVTLLEII 698
S VD++S G E++
Sbjct: 179 RHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 12/194 (6%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
E++G+G+ G VY + A+G +A+K+++ Q ++ +E+ + H ++V L
Sbjct: 25 EKIGQGASGTVYTAI-DVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 568 ---FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
DE +V E++ G+L +++ + + + E + L +LH +
Sbjct: 84 SYLVGDELW---VVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QV 136
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
IH DIK NILL S K++DFG + +QS+ TM+ GT ++APE K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 685 VDVYSFGVTLLEII 698
VD++S G+ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 80/291 (27%), Positives = 130/291 (44%), Gaps = 50/291 (17%)
Query: 510 LGRGSFGIVYKGVLKTASGTA-----IAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLV 563
LG G+FG VY+G G +AVK L + A ++E+ EF E + +H ++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFA-----IPKPDWNLR--IRISLEIARGLAYL 616
+LLG C + ++ E M G L + + P L+ + I L++A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 617 HEECNVPIIHCDIKPQNILL-----DHFFSAKISDFGLSKLLF-SDQSRTHTMIRGTR-- 668
+ + IH D+ +N L+ D KI DFGL++ ++ SD R G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----KEGEGLL 175
Query: 669 --GYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYV- 725
++APE + + + DV+SFGV + EI + L ++ L + +V
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEI--------LTLGQQPYPALNNQEVLQHVT 227
Query: 726 -EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
GRL E + LM W +DPS+RPT + ++L+
Sbjct: 228 AGGRL----QKPENCPDKIYQ----LMTNCW--AQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGT----AIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHL 562
LG+GSFG K +L GT AI + K D + Q+ + E + V A+ L
Sbjct: 8 LGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP-FL 63
Query: 563 VQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
QL C + ++RL V E++ G L I + K + + EIA GL +LH +
Sbjct: 64 TQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK-- 120
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
II+ D+K N++LD KI+DFG+ K T T GT Y+APE P
Sbjct: 121 -GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPY 178
Query: 682 SAKVDVYSFGVTLLEIICCRRSVEMELEEE 711
VD ++FGV L E++ + + E E+E
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 12/194 (6%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHLVQL 565
+G GS+G+V K K +G +A+KK L E ++ K E+ + + H++LV L
Sbjct: 9 VGEGSYGMVMKCKHKE-TGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
+ LV+EF+ + L +L D + + +I RG+ + H + II
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNII 122
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF-KNVPVSAK 684
H DIKP+NIL+ K+ DFG ++ L + +T TR Y APE +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 685 VDVYSFGVTLLEII 698
VD+++ G + E++
Sbjct: 182 VDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
++LG G FG V+ G + A+ K ++ E F E + + H LVQL
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKLRHDKLVQLYA 68
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAYLHEECNVP 623
E +V E+M G+L L F L+ + ++ ++A G+AY+ E N
Sbjct: 69 VVSEE-PIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMNY- 123
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IH D++ NIL+ KI+DFGL++L+ ++ + + APE +
Sbjct: 124 -IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 684 KVDVYSFGVTLLEIICCRR------SVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737
K DV+SFG+ L E++ R + LE+ R DC +
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS----------- 231
Query: 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
LH+ LM+ W ++DP +RPT + + LE
Sbjct: 232 --------LHE-LMLQCW--KKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 4e-15
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE---REFKSEVSAIGRTHHKHLVQ 564
++G G++G VYK K +G +A+KK+ R+ E+E E+ + + H ++V+
Sbjct: 5 AQIGEGTYGQVYKARNKK-TGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 565 LLGFCDEAL--NRLLVYEFMG---NGTLAN--LIFAIPKPDWNLRIRISLEIARGLAYLH 617
L + +V+E+M G L + + F ++ ++ GL YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES----QIK-CYMKQLLEGLQYLH 117
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT--MIRGTRGYVAPE- 674
+ I+H DIK NIL+++ K++DFGL++ S +T +I T Y PE
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPEL 172
Query: 675 WFKNVPVSAKVDVYSFGVTLLEII 698
+VD++S G L E+
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGT--AIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
LG+G FG V + LK+ G+ +AVK K D + EF E + + H ++++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 566 LGFC--DEALNRL----LVYEFMGNGTLANLIFA--IPKPDWNLR----IRISLEIARGL 613
+G A RL ++ FM +G L + I + + L +R ++IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRTHTMIRGTRGYVA 672
YL + IH D+ +N +L+ + ++DFGLSK ++S D R + ++A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEII 698
E + + DV++FGVT+ EI+
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 33/275 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
E +GRG+FG V+ G L+ A T +AVK + L + + +F E + + H ++V+L+
Sbjct: 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPII 625
G C + +V E + G + P+ I++ A G+ YL + I
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTR----GYVAPEWFKNVPV 681
H D+ +N L+ KISDFG+S+ ++ + G + + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 682 SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE--GRLDVLIDSDEAA 739
S++ DV+SFG+ L E L A L++ +E RL +A
Sbjct: 174 SSESDVWSFGILLWE--------AFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAV 225
Query: 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
LM W + DP +RP+ V Q L
Sbjct: 226 YR--------LMERCW--EYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 51/191 (26%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
E++G+G+ G VY + A+G +A+K+++ Q ++ +E+ + + ++V L
Sbjct: 25 EKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHC 627
+V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLHSN---QVIHR 139
Query: 628 DIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDV 687
DIK NILL S K++DFG + +QS+ TM+ GT ++APE KVD+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 688 YSFGVTLLEII 698
+S G+ +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKHLVQ 564
E++G G++G+VYK K +G +A+KK+ RL E E + E+S + +H ++V+
Sbjct: 6 EKIGEGTYGVVYKARNKL-TGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRIS--LEIARGLAYLHEECNV 622
LL LV+EF+ + L + A P L + S ++ +GLA+ H
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV- 681
++H D+KPQN+L++ + K++DFGL++ F RT+T T Y APE
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 682 SAKVDVYSFGVTLLEII 698
S VD++S G E++
Sbjct: 179 STAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
++LG G FG V+ G + T +AVK L + + F E + + H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNS--TKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 568 FCDEALNRLLVYEFMGNGTLANLI-------FAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+ ++ E+M G+L + + +PK I S +IA G+AY+ +
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK-----LIDFSAQIAEGMAYIERK- 122
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680
IH D++ N+L+ KI+DFGL++++ ++ + + APE
Sbjct: 123 --NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 681 VSAKVDVYSFGVTLLEII 698
+ K DV+SFG+ L EI+
Sbjct: 181 FTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 64/245 (26%), Positives = 113/245 (46%), Gaps = 47/245 (19%)
Query: 506 FKEELGRGSFGIVY----KGVLK---------TASGTAIAVKKLDRLAQERER-EFKSEV 551
KE+LG G FG V+ +G+ + +AVK L + R +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 552 SAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLI--------FA----IPKPDW 599
+ R + ++++LLG C ++ E+M NG L + F IP
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 600 NLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD--- 656
+ ++++IA G+ YL ++ +H D+ +N L+ + ++ KI+DFG+S+ L+S
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 657 --QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI-ICCRRSVEMELEEESR 713
Q R IR ++A E + DV++FGVTL E+ C+ E+
Sbjct: 186 RIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEMFTLCK--------EQPY 233
Query: 714 AILTD 718
++L+D
Sbjct: 234 SLLSD 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 506 FKEELGRGSFGIVYKG-VLKTASGTAIAVKKL-DRLAQEREREFKSEVSAIGRT-HHKHL 562
F++ +G G+FG V K + K A+K++ + +++ R+F E+ + + HH ++
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLI-----------FAIPKPDWNLR-----IRIS 606
+ LLG C+ L E+ +G L + + FAI + + +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666
++ARG+ YL ++ IH D+ +NIL+ + AKI+DFGLS+ + TM R
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 185
Query: 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
++A E + DV+S+GV L EI+
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 560
E++G G++G+VYK K +G +A+KK+ RL E E RE +S + +H
Sbjct: 5 EKIGEGTYGVVYKARDKL-TGEIVALKKI-RLETEDEGVPSTAIRE----ISLLKELNHP 58
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAYLHE 618
++V+LL LV+EF+ + L + + P + + ++ +G+AY H
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
++H D+KPQN+L+D + K++DFGL++ F RT+T T Y APE
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILLG 173
Query: 679 VP-VSAKVDVYSFGVTLLEII 698
S VD++S G E++
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 509 ELGRGSFGIVYK----GVLKTASGTAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKHLV 563
++G+G+FG V++ G+L T +AVK L + + + + +F+ E + + H ++V
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLI--------------------FAIPKPDWNLRI 603
+LLG C L++E+M G L + + +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 604 R--ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS------ 655
+ I+ ++A G+AYL E +H D+ +N L+ KI+DFGLS+ ++S
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
++ IR ++ PE + + DV+++GV L EI
Sbjct: 189 SENDA-IPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 15/224 (6%)
Query: 498 ELKDATDGFKE--ELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQEREREFKSEVSAI 554
ELKD D F+ ELG G+ G+V K V SG +A K + + + E+ +
Sbjct: 1 ELKD--DDFERISELGAGNGGVVTK-VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 555 GRTHHKHLVQLLG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARG 612
+ ++V G + D ++ + E M G+L ++ + + ++S+ + RG
Sbjct: 58 HECNSPYIVGFYGAFYSDGEIS--ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
LAYL E+ I+H D+KP NIL++ K+ DFG+S L + + GTR Y++
Sbjct: 116 LAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMS 170
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAIL 716
PE + S + D++S G++L+E+ R + +E AI
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 58/195 (29%), Positives = 103/195 (52%), Gaps = 17/195 (8%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHK----HLVQ 564
ELG G+ G+V K VL SG +A +KL L E + ++++ + H+ ++V
Sbjct: 8 ELGAGNGGVVTK-VLHRPSGLIMA-RKLIHL--EIKPAIRNQIIRELKVLHECNSPYIVG 63
Query: 565 LLG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
G + D ++ + E M G+L ++ + N+ +IS+ + RGL YL E+
Sbjct: 64 FYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--H 119
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
I+H D+KP NIL++ K+ DFG+S L + + GTR Y++PE + +
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYT 176
Query: 683 AKVDVYSFGVTLLEI 697
+ D++S G++L+E+
Sbjct: 177 VQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 6/190 (3%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
++G GS GIV K SG +AVK +D Q+R +EV + H+++V++
Sbjct: 28 KIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 569 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCD 628
++ EF+ G L +++ + + + + + L YLH + +IH D
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT-VCESVLQALCYLHSQ---GVIHRD 142
Query: 629 IKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVY 688
IK +ILL K+SDFG + D + +++ GT ++APE P +VD++
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIW 201
Query: 689 SFGVTLLEII 698
S G+ ++E++
Sbjct: 202 SLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-REFKSEVSAIGRTHH-KHLVQL 565
E+G G+ G VYK K +G +AVK++ R + E + ++ + ++H ++V+
Sbjct: 21 GEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRI--RISLEIARGLAYLHEECN 621
G+ + + E M L L+ I P P+ I ++++ I + L YL E+
Sbjct: 80 YGYFITDSDVFICMELMST-CLDKLLKRIQGPIPE---DILGKMTVAIVKALHYLKEKHG 135
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE------W 675
V IH D+KP NILLD + K+ DFG+S L S+ T G Y+APE
Sbjct: 136 V--IHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 676 FKNVPVSAKVDVYSFGVTLLEI 697
+ A DV+S G++L+E+
Sbjct: 192 NPKYDIRA--DVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTA-IAVKKLDRLAQERE-REFKSEVSAIGRTHHKHLVQL 565
+E+G G FG V G + + A + VK+L A +E +F E H +L+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK-----PDWNLRIRISLEIARGLAYLHEEC 620
LG C E LLV EF G L + + K PD R++ EIA GL +LH+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-----SRTHTMIRGTRGYVAPEW 675
IH D+ +N LL + KI D+GLS + + + +R ++APE
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPEL 173
Query: 676 FKNV-------PVSAKVDVYSFGVTLLEI 697
V + + +V+S GVT+ E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 51/191 (26%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
E++G+G+ G VY + A+G +A+++++ Q ++ +E+ + + ++V L
Sbjct: 26 EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHC 627
+V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIHR 140
Query: 628 DIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDV 687
DIK NILL S K++DFG + +QS+ TM+ GT ++APE KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 688 YSFGVTLLEII 698
+S G+ +E+I
Sbjct: 200 WSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 46/233 (19%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTA------------------IAVKKLDRLAQERER-E 546
F E+LG G FG V+ L A G +AVK L A + R +
Sbjct: 9 FVEKLGEGQFGEVH---LCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 547 FKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLA-----------NLIFAIP 595
F EV + R ++ +LLG C ++ E+M NG L L
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 596 KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655
++ + ++ +IA G+ YL E N +H D+ +N L+ ++ KI+DFG+S+ L+S
Sbjct: 126 SLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 656 D-----QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRR 702
Q R IR ++A E + K DV++FGVTL EI+ CR
Sbjct: 183 SDYYRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 491 LRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTA---IAVKKLDRLAQERER-E 546
LR ELK + LG G+FG VYKG+ T +A+K L+ + E
Sbjct: 1 LRILKETELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 55
Query: 547 FKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRI 605
F E + H HLV+LLG C +L V + M +G L + + L +
Sbjct: 56 FMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114
Query: 606 SLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR 665
++IA+G+ YL E ++H D+ +N+L+ KI+DFGL++LL D+ +
Sbjct: 115 CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--D 169
Query: 666 GTR---GYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
G + ++A E + + DV+S+GVT+ E++
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 508 EELGRGSFGIVYKGVL--KTASGTAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKHLV 563
+++G GSFG K +L G +K+++ +++ + E + EV+ + H ++V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKP-----DWNLRIRISLEIARGLAY 615
Q +E N +V ++ G L I A + P DW ++I L +
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKH 116
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
+H+ I+H DIK QNI L + K+ DFG++++L S T I GT Y++PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEI 172
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCRRSVE 705
+N P + K D+++ G L E+ + + E
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 49/191 (25%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
E++G+G+ G V+ + A+G +A+K+++ Q ++ +E+ + + ++V L
Sbjct: 25 EKIGQGASGTVFTAI-DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHC 627
+V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLHAN---QVIHR 139
Query: 628 DIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDV 687
DIK N+LL S K++DFG + +QS+ TM+ GT ++APE KVD+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 688 YSFGVTLLEII 698
+S G+ +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD-------RLAQEREREFKSEVSAIG----R 556
E LG G+FG VYK K +A+K+++ + +ER++ VS + +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 557 THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD--------WNLRIRISLE 608
H ++V+ E +V + + L ++ + WN+ +++ L
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL- 124
Query: 609 IARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTR 668
L YLH+E I+H D+ P NI+L I+DFGL+K T + GT
Sbjct: 125 ---ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLTSVVGTI 177
Query: 669 GYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
Y PE KN P K DV++FG L ++
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 492 RFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGT---AIAVKKL-DRLAQEREREF 547
R EL+ + LG G FG V+KG+ + +A+K + DR ++ +E
Sbjct: 2 RILKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56
Query: 548 KSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRIS 606
+ A+G H ++V+LLG C A + LV + G+L + + D +
Sbjct: 57 TDHMLAMGSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC 115
Query: 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-THTMIR 665
++IA+G+ YL E ++H ++ +NILL +I+DFG++ LL+ D + ++ +
Sbjct: 116 VQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
++A E + + DV+S+GVT+ E++
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 13/212 (6%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGT----AIAVKKLDRLAQEREREFKS-EVSAIGRTHHK 560
F LG+GSFG K +L GT AI + K D + Q+ + E E + +
Sbjct: 4 FLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 561 HLVQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
+ L C + ++RL V E++ G L I + + + + EIA GL +LH +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
II+ D+K N++LD KI+DFG+ K D T T GT Y+APE
Sbjct: 121 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAYQ 176
Query: 680 PVSAKVDVYSFGVTLLEIICCRRSVEMELEEE 711
P VD ++FGV L E++ + E E E+E
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 19/196 (9%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
+LG G+ G V K V +GT +A K + A+ R K + + H ++ F
Sbjct: 12 DLGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSF 68
Query: 569 CDEALNR---LLVYEFMGNGTLANLIFAIPKPDWNLRI----RISLEIARGLAYLHEECN 621
LN + EFM G+L I K + + +I++ + GL YL+
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
I+H DIKP NIL++ K+ DFG+S L + + T GT Y++PE +
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQGGKY 179
Query: 682 SAKVDVYSFGVTLLEI 697
+ K DV+S G++++E+
Sbjct: 180 TVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 43/224 (19%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
+GRG+FG V+ V +G A+K L D + + + ++E + +V+L
Sbjct: 9 IGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 567 -GFCDEALNRL-LVYEFMGNGTLANL--IFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
F DE L LV E+M G L NL + + R I+ E+ L +H +
Sbjct: 68 YSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIA-ELVLALDSVH---KL 120
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSK-------------------------LLFSDQ 657
IH DIKP NIL+D K++DFGL K + D
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 658 SRTHTMIR---GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
+ GT Y+APE + P + D +S GV L E++
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 11/214 (5%)
Query: 503 TDGFKEELGRGSFGIVYKGVLK-TASGTAIAVKKLDRLAQERERE---FKSEVSAIGRTH 558
F LG+GSFG V K T AI + K D + Q+ + E + V A+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL-QDK 59
Query: 559 HKHLVQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLH 617
L QL C + ++RL V E++ G L I + K + + EI+ GL +LH
Sbjct: 60 PPFLTQLHS-CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
II+ D+K N++LD KI+DFG+ K D T T GT Y+APE
Sbjct: 119 RR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIA 174
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE 711
P VD +++GV L E++ + + E E+E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 53/285 (18%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQEREREF-KSEVSAIGRTHHKHLV 563
F +G+GS+G V V G +KKL+ R A RER+ + E + + H ++V
Sbjct: 4 FVRVVGKGSYGEV-SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 564 Q--------------LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEI 609
++GFC+ + E G N + +W ++I
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV-----EW------FVQI 111
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG 669
A L YLHE+ I+H D+K QN+ L K+ D G++++L + T+I GT
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPY 167
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCY--VEG 727
Y++PE F N P + K DV++ G + E+ + + + D Y +EG
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK----------DMNSLVYRIIEG 217
Query: 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+L + + + L+ M + P KRP++K +L+
Sbjct: 218 KLPPMPKDYSPELGE-------LIATMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 24/201 (11%)
Query: 510 LGRGSFGIVY--KGVLKTASGTAIAVKKL--------DRLAQEREREFKSEVSAIGRTHH 559
LG+GSFG V+ + + +G A+K L DR+ + ER+ +EV +H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NH 57
Query: 560 KHLVQL-LGFCDEALNRLLVYEFMGNGTL-ANLIFAIPKPDWNLRIRISLEIARGLAYLH 617
+V+L F E L+ +F+ G L L + + +++ ++ E+A L +LH
Sbjct: 58 PFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLH 115
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
++ II+ D+KP+NILLD K++DFGLSK + + ++ GT Y+APE
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVN 171
Query: 678 NVPVSAKVDVYSFGVTLLEII 698
+ D +SFGV + E++
Sbjct: 172 RRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 16/199 (8%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE---REFKSEVSAIGRTHHKHLVQ 564
E++G G++G+VYKG K +G +A+KK+ RL E E E+S + H ++V
Sbjct: 6 EKIGEGTYGVVYKGRNKK-TGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 565 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP---DWNLRIRISLEIARGLAYLHEEC 620
L + +RL L++EF+ + L + ++PK D L +I +G+ + H
Sbjct: 64 LQDVLMQE-SRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR- 120
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680
++H D+KPQN+L+D+ K++DFGL++ F R +T T Y APE P
Sbjct: 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 681 -VSAKVDVYSFGVTLLEII 698
S VD++S G E+
Sbjct: 178 RYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 30/210 (14%)
Query: 506 FKEELGRGSFGIVYK----GVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTH-- 558
F + LG G+FG V + G+ K+ + +AVK L A ERE SE+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM--SHLG 96
Query: 559 -HKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD-----WNLRIRISLEIARG 612
H+++V LLG C L++ E+ G L N F K + +L + S ++A+G
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLN--FLRRKRESFLTLEDL-LSFSYQVAKG 153
Query: 613 LAYL-HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG-TR-- 668
+A+L + C IH D+ +N+LL H KI DFGL++ + +D ++ +++G R
Sbjct: 154 MAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLP 206
Query: 669 -GYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
++APE N + + DV+S+G+ L EI
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKHLVQ 564
+ + +G+FG VY K ++G A+K K D +A+ + K+E + + V
Sbjct: 2 KPISKGAFGSVYLAK-KRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 565 LLGFCDEALNRL-LVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNV 622
L + ++ + L LV E++ G A+LI + P+ + I+ E+ G+ LH+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLHQR--- 116
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
IIH DIKP+N+L+D K++DFGLS+ ++ GT Y+APE V
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDD 171
Query: 683 AKVDVYSFGVTLLEII 698
D +S G + E +
Sbjct: 172 KMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKHLVQ 564
LGRG+FG VY +G +AVK++ D +QE +E + E+ + H +VQ
Sbjct: 10 LGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 565 LLGFC--DEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
G C D +L ++ E+M G++ + + A N+ R + +I +G++YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM- 126
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM---------IRGTRGYVA 672
I+H DIK NIL D + K+ DFG SK R T+ + GT +++
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASK-------RIQTICMSGTGIKSVTGTPYWMS 177
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEII 698
PE K DV+S T++E++
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 55/168 (32%), Positives = 76/168 (45%), Gaps = 32/168 (19%)
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKL----LFSDQSRTHTMIRGTRGYVAPEWFKNV 679
+IH DIK NILL K+ DFG SK+ + D RT GT YVAPE ++
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC---GTPYYVAPEIWRRK 220
Query: 680 PVSAKVDVYSFGVTLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
P S K D++S GV L E++ +R + E +EE L GR D L S
Sbjct: 221 PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA---------GRYDPLPPSISP 271
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM------LEGLLDV 780
M + I + DP +RP+ +L M + GLL++
Sbjct: 272 EMQE---------IVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEI 310
|
Length = 496 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 493 FFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLD---RLAQEREREFKS 549
F D K TD E+G GSFG VY + +A+KK+ + + E+ ++
Sbjct: 8 FSKDDPEKLFTD--LREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 550 EVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLE 608
EV + + H + ++ G LV E+ G+ ++++ KP + I I
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHG 123
Query: 609 IARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTR 668
+GLAYLH IH DIK NILL + K++DFG + L+ S GT
Sbjct: 124 ALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTP 175
Query: 669 GYVAPEWFKNV---PVSAKVDVYSFGVTLLEI 697
++APE + KVDV+S G+T +E+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 65/247 (26%), Positives = 111/247 (44%), Gaps = 48/247 (19%)
Query: 506 FKEELGRGSFGIV---------------YKGVLKTASGTAIAVKKLDRLAQERER-EFKS 549
FKE+LG G FG V + ++ +AVK L A + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 550 EVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---------------- 593
EV + R ++++LLG C + ++ E+M NG L + +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 594 ---IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS 650
+P ++ + ++L+IA G+ YL ++ +H D+ +N L+ + KI+DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 651 KLLFSD-----QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII-CCRRSV 704
+ L++ Q R IR ++A E + DV++FGVTL EI+ C+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 705 EMELEEE 711
EL +E
Sbjct: 242 YGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
+GRG FG V + V + A+G A+K + + LAQE F+ E + ++ + QL
Sbjct: 9 VGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISL-EIARGLAYLHEECNVPI 624
+ N LV E+ G L +L+ D ++ + L E+ + +H+ +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-AQFYLAELVLAIHSVHQ---MGY 123
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
+H DIKP+N+L+D K++DFG + L +++ + GT Y+APE + K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 685 ------VDVYSFGVTLLEIICCR 701
D +S GV E+I R
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 510 LGRGSFGIVYKGVL-KTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG G FG V +G L + S +AVK K+ + +F SE + H ++++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 567 GFCDEALNR------LLVYEFMGNGTLANLIFAIPKPDW------NLRIRISLEIARGLA 614
G C + + +++ FM +G L + + D + ++ +IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRTHTMIRGTRGYVAP 673
YL + IH D+ +N +L+ + ++DFGLSK +++ D R + + ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEI 697
E + + K DV+SFGVT+ EI
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
+LG+G FG V+ G + AI K ++ E F E + + H+ LVQL
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 69
Query: 569 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRI------SLEIARGLAYLHEECNV 622
E +V E+M G+L + + K + +R+ + +IA G+AY+ E N
Sbjct: 70 VSEE-PIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY 123
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
+H D++ NIL+ K++DFGL++L+ ++ + + APE +
Sbjct: 124 --VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 683 AKVDVYSFGVTLLEI 697
K DV+SFG+ L E+
Sbjct: 182 IKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 76/279 (27%), Positives = 122/279 (43%), Gaps = 49/279 (17%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL-----DRLAQEREREFKSEVSAIGRT-HHKHLV 563
+G G+ G VYK V+ +G A+K + D + ++ RE I R +H ++V
Sbjct: 82 IGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICREI-----EILRDVNHPNVV 135
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
+ D ++ EFM G+L A D ++ +I G+AYLH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIA----DEQFLADVARQILSGIAYLHRR---H 188
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
I+H DIKP N+L++ + KI+DFG+S++L ++ + GT Y++PE
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHG 247
Query: 684 KV-----DVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY----DCYVEGRLDVLID 734
D++S GV++LE R + + DWA C
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-------GDWASLMCAICMS--------Q 292
Query: 735 SDEA-AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
EA A A R H I+ C+Q +P+KR + +LQ
Sbjct: 293 PPEAPATASREFRH---FISC-CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 74/280 (26%), Positives = 118/280 (42%), Gaps = 47/280 (16%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
+LG+G FG V+ G + AI K + E F E + + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKKLRHDKLVPLYAV 69
Query: 569 CDEALNRLLVYEFMGNGTLANLI-------FAIPKPDWNLRIRISLEIARGLAYLHEECN 621
E +V EFMG G+L + + +P+ + ++ +IA G+AY+ E N
Sbjct: 70 VSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ-----LVDMAAQIADGMAYI-ERMN 122
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
IH D++ NIL+ KI+DFGL++L+ ++ + + APE
Sbjct: 123 Y--IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 682 SAKVDVYSFGVTLLEIICCRR-----SVEME-LEEESRAILTDWAYDCYVEGRLDVLIDS 735
+ K DV+SFG+ L E++ R V E LE+ R C
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC------------ 228
Query: 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
LH+ + + C ++DP +RPT + + LE
Sbjct: 229 -------PESLHELMKL---CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 68/208 (32%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 510 LGRGSFGIVYKGVLK-TASGTAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHLVQL 565
LG+GSFG V LK T AI K D + ++ + E + V A+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 566 LGFCDEALNRLL--VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
FC L V E++ G L I + + D + EI GL +LH++
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---G 116
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
II+ D+K N+LLD KI+DFG+ K + + + T GT Y+APE K +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNE 175
Query: 684 KVDVYSFGVTLLEIICCRRSVEMELEEE 711
VD +SFGV L E++ + E E+E
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKHLVQ 564
LG+G+FG VY +G +AVK++ D + E +E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 565 LLGFCDEALNRLL--VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
G + + R L E M G++ + + + N+ + + +I G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM-- 126
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD-QSRTHTM-IRGTRGYVAPEWFKNVP 680
I+H DIK NIL D + K+ DFG SK L + S T + GT +++PE
Sbjct: 127 -IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 681 VSAKVDVYSFGVTLLEII 698
K D++S G T++E++
Sbjct: 186 YGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG+G+FG V V + A+G A+K L + +A++ +E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 567 GFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRIRI-SLEIARGLAYLHEE 619
+ + +RL V E+ G L +F+ R R EI L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALGYLHS- 113
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
C+ +++ D+K +N++LD KI+DFGL K SD + T GT Y+APE ++
Sbjct: 114 CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 170
Query: 680 PVSAKVDVYSFGVTLLEIICCR 701
VD + GV + E++C R
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAI--AVK--KLDRLAQEREREFKSEVSAIGRTHHKHL 562
+G G FG VY+GV + I AVK K RE+ F E + + H H+
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRI----SLEIARGLAYLHE 618
V+L+G E V+ M L L + ++L + S +++ LAYL
Sbjct: 70 VKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE- 124
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
+ +H DI +N+L+ K+ DFGLS+ L + + + ++APE
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 679 VPVSAKVDVYSFGVTLLEII 698
++ DV+ FGV + EI+
Sbjct: 183 RRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 498 ELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT 557
E+ + +++LG G FG V+ + A+ K ++ E F +E + +
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTL 58
Query: 558 HHKHLVQLLGFCDEALNRLLVY---EFMGNGTLANLIFA-----IPKPDWNLRIRISLEI 609
H LV+L + + +Y EFM G+L + + + P P I S +I
Sbjct: 59 QHDKLVKL----HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQI 111
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG 669
A G+A++ + IH D++ NIL+ KI+DFGL++++ ++ +
Sbjct: 112 AEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 168
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
+ APE + K DV+SFG+ L+EI+
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 28/225 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKHLVQ 564
LG+G FG V ++ A+G A KKL++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 565 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIARGLAYLHEECN 621
L + E + L LV M G L I+ + P D + + EI GL LH E
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-- 121
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR---GTRGYVAPEWFKN 678
I++ D+KP+NILLD + +ISD GL+ + IR GT GY+APE KN
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAV-----EIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 679 VPVSAKVDVYSFGVTLLEIICCR-----RSVEMELEEESRAILTD 718
+ D + G + E+I + R +++ EE R + D
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLAQERE-REFKSEVSAIGRT-HHKHL 562
F++ +G G+FG V + ++K A+K L A E + R+F E+ + + HH ++
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK-------PDWNLR------------I 603
+ LLG C+ NR +Y + NL+ + K P + +
Sbjct: 66 INLLGACE---NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 604 RISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663
+ + ++A G+ YL E+ IH D+ +N+L+ ++KI+DFGLS+ + TM
Sbjct: 123 QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTM 177
Query: 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
R ++A E + K DV+SFGV L EI+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKHLVQ 564
LG+G FG V ++ A+G A K+L++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKRLEK---KRIKKRKGESMALNEKQILEKVNSQFVV 63
Query: 565 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECN 621
L + E + L LV M G L I+ + P + + + EI GL LH E
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLS-KLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680
++ D+KP+NILLD + +ISD GL+ K+ + R GT GY+APE N
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQR 177
Query: 681 VSAKVDVYSFGVTLLEIICCR-----RSVEMELEEESRAILTD 718
+ D + G + E+I + R +++ EE R +L
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 15/194 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLD-----RLAQEREREFKSEVSAIGRTHHKHLVQ 564
+G G+FG V+ V S A+K + RL QE+ +E + H +++
Sbjct: 9 VGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQH--VHNEKRVLKEVSHPFIIR 65
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
L + ++ E++ G L + + + + + + EI L YLH + I
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EI 122
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
++ D+KP+NILLD K++DFG +K L + RT T+ GT Y+APE ++ +
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC-GTPEYLAPEVIQSKGHNKA 178
Query: 685 VDVYSFGVTLLEII 698
VD ++ G+ + E++
Sbjct: 179 VDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLV 563
E LG GSFG V K +G A+K L + L ++ + E S + H +V
Sbjct: 23 GETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 564 QLL-GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
++ F DE NR+ + EF+ G L + + ++ E+ YLH +
Sbjct: 82 NMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KD 138
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
II+ D+KP+N+LLD+ K++DFG +K + RT T+ GT Y+APE ++
Sbjct: 139 --IIYRDLKPENLLLDNKGHVKVTDFGFAKKV---PDRTFTLC-GTPEYLAPEVIQSKGH 192
Query: 682 SAKVDVYSFGVTLLEII 698
VD ++ GV L E I
Sbjct: 193 GKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 66/206 (32%), Positives = 93/206 (45%), Gaps = 9/206 (4%)
Query: 510 LGRGSFGIVYKGVLK-TASGTAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHLVQL 565
LG+GSFG V+ LK T AI K D + + + E + V ++ H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
N V E++ G L I + K D + EI GL +LH + I+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIV 118
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
+ D+K NILLD KI+DFG+ K ++T T GT Y+APE + V
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTSV 177
Query: 686 DVYSFGVTLLEIICCRRSVEMELEEE 711
D +SFGV L E++ + EEE
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKHLVQ 564
LG+G FG V ++ A+G A KKL++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFVV 63
Query: 565 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECN 621
L + E + L LV M G L I+ + + + + + EI GL LH+E
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
I++ D+KP+NILLD +ISD GL+ + Q+ + GT GY+APE KN
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERY 178
Query: 682 SAKVDVYSFGVTLLEII 698
+ D ++ G L E+I
Sbjct: 179 TFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 66/220 (30%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGT-AI-AVKKLDRLAQEREREFKSE---VSAIGRTHHKHLVQ 564
LGRG FG V K AI A+KK D +A++ E H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 565 LLGFCDEALNRL-LVYEFMGNGTLANLI----FAIPKPDWNLRIRISLEIARGLAYLHEE 619
L C + + + V E+ G L I F+ P+ + + + GL YLHE
Sbjct: 67 LFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-----YAACVVLGLQYLHEN 120
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
I++ D+K N+LLD KI+DFGL K RT T GT ++APE
Sbjct: 121 ---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEVLTET 176
Query: 680 PVSAKVDVYSFGVTLLEIICCRRSVEMELEEES-RAILTD 718
+ VD + GV + E++ + EEE +I+ D
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKHLVQLL 566
+G GSFG +Y K+ S + +K++D +E+E K EV + + H ++V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFF 65
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIF----AIPKPDWNLRIRISLEIARGLAYLHEECNV 622
E +V E+ G L I + D L + +I+ GL ++H+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLGLKHIHDR--- 120
Query: 623 PIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
I+H DIK QNI L + AK+ DFG+++ L +T + GT Y++PE +N P
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNRPY 179
Query: 682 SAKVDVYSFGVTLLEIICCRRSVE 705
+ K D++S G L E+ + E
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 510 LGRGSFGIVYKGVLK-TASGTAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHLVQL 565
LG+GSFG V LK T AI V K D + Q+ + + + + A+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 566 LGFCDEALNRLL-VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
C + +RL V E++ G L I K D + E+ L +LH +
Sbjct: 62 HC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GV 117
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
I+ D+K NILLD K++DFG+ K + T T GT Y+APE + +
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELEYGPS 176
Query: 685 VDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTD 718
VD ++ GV + E++ + E + E++ +IL D
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRT-HHKHLVQL 565
+G+GSFG V K G AVK L + L ++ ++ +E + + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 566 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRIRISLEIARGLAYLHEEC 620
+ + +L V +F+ G L F + + P+ R + EIA L YLH
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGG---ELFFHLQRERSFPEPRARFYAA-EIASALGYLH--- 113
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680
++ I++ D+KP+NILLD ++DFGL K + QS T T GT Y+APE + P
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 681 VSAKVDVYSFGVTLLEII------CCRRSVEM 706
VD + G L E++ CR EM
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 34/203 (16%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKHLV 563
+G G+FG+V +G +A+KK+ + LA+ RE K + H++++
Sbjct: 18 VGMGAFGLVCSAR-DQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LLKHLRHENII 72
Query: 564 QLLGFCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
L D ++ L V E +G L L+ + P ++ +I RGL Y+H
Sbjct: 73 SL---SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-FLYQILRGLKYVH-- 125
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE----W 675
+ ++H D+KP NIL++ KI DFGL+++ Q T TR Y APE W
Sbjct: 126 -SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTW 180
Query: 676 FKNVPVSAKVDVYSFGVTLLEII 698
K +VD++S G E++
Sbjct: 181 QK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAI----AVKKL-DRLAQEREREFKSEVSAIGRTHHKHLVQ 564
LG G+FG VYKG L G + A+K+L + + + +E E + + H+ +
Sbjct: 15 LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPK---PDWNLRIRISLEIARGLAYLHEECN 621
LLG C + +L + + M G L + + + L ++IA+G+ YL E
Sbjct: 74 LLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYLEER-- 128
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
++H D+ +N+L+ KI+DFGL+KLL +D+ H G V +W +
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH----AEGGKVPIKWMALESI 183
Query: 682 -----SAKVDVYSFGVTLLEII 698
+ + DV+S+GVT+ E++
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 496 YDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA 553
+D D +D ++ E +G+G++G V+K VL +G+ AVK LD + + + E ++E +
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPI-HDIDEEIEAEYNI 67
Query: 554 I-GRTHHKHLVQLLG--FCDEALN---RLLVYEFMGNGTLANLIFAIPKPDWNLR----I 603
+ + H ++V+ G + + N LV E G++ +L+ K +
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 604 RISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663
I E GL +LH IH D+K NILL K+ DFG+S L S + R +T
Sbjct: 128 YILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184
Query: 664 IRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEI 697
+ GT ++APE + A+ DV+S G+T +E+
Sbjct: 185 V-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 497 DELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAI 554
+ L D TD ++ E +G+G++G VYK V G+ AVK LD ++ E E ++E + +
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYK-VTNKKDGSLAAVKILDPISDVDE-EIEAEYNIL 72
Query: 555 -GRTHHKHLVQLLGFCDEALNRL-----LVYEFMGNGTLANLIFAIPKPDWNLRIRISLE 608
+H ++V+ G +A + LV E G++ L+ + L +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 609 IAR----GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664
I GL +LH N IIH D+K NILL K+ DFG+S L S + R +T +
Sbjct: 133 ILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 665 RGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEI 697
GT ++APE + A+ DV+S G+T +E+
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKHLVQ 564
LG+G+FG VY +G +A K++ D + E +E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 565 LLG-FCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
G D A L ++ E+M G++ + + A ++ + + +I G++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM-- 126
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR---GTRGYVAPEWFKNV 679
I+H DIK NIL D + K+ DFG SK L + T IR GT +++PE
Sbjct: 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 680 PVSAKVDVYSFGVTLLEII 698
K DV+S G T++E++
Sbjct: 185 GYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 15/224 (6%)
Query: 479 NNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR 538
+ +DS +++ R +++K F LG GSFG V K +A+K+ ++
Sbjct: 10 HKKKDSDSTKEPKR---KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK 66
Query: 539 LAQEREREFK---SEVSAIGRTHHKHLVQLLG-FCDEALNRLLVYEFMGNGTLANLIFAI 594
++++ SE + +H V L G F DE+ LV EF+ G +
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY-LYLVLEFVIGGEFFTFLRRN 125
Query: 595 PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654
+ ++ + +I YL ++ I++ D+KP+N+LLD K++DFG +K++
Sbjct: 126 KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV- 181
Query: 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
+RT+T+ GT Y+APE NV D ++ G+ + EI+
Sbjct: 182 --DTRTYTLC-GTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR------LAQEREREFKSEVSAIGRT-HHK 560
E +G G++G+V + T SG +A+KK+ LA+ RE K I R H
Sbjct: 11 ENIGSGAYGVVCSAI-DTRSGKKVAIKKIPHAFDVPTLAKRTLRELK-----ILRHFKHD 64
Query: 561 HLVQLLGFC----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAY 615
+++ + + + +V + M + L ++I + +P IR L ++ RGL Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHS-DQPLTEEHIRYFLYQLLRGLKY 122
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS---DQSRTHTMIRGTRGYVA 672
+H +IH D+KP N+L++ +I DFG+++ L S + T TR Y A
Sbjct: 123 IHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 673 PEWFKNVP-VSAKVDVYSFGVTLLEII 698
PE ++P + +D++S G E++
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT----------HH 559
+G G++G V T +G +A+KKL R F+S + A RT H
Sbjct: 23 VGSGAYGQVCSAFD-TKTGRKVAIKKLSR-------PFQSAIHA-KRTYRELRLLKHMDH 73
Query: 560 KHLVQLLG-FC-DEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGL 613
++++ LL F +L LV MG L N++ D +++ + +I RGL
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQF-LVYQILRGL 131
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAP 673
Y+H + IIH D+KP NI ++ KI DFGL++ + T TR Y AP
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 184
Query: 674 EWFKN-VPVSAKVDVYSFGVTLLEIICCR 701
E N + + VD++S G + E++ +
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 28/211 (13%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKL-D--RLAQEREREFKSEVSAIGR-THHKHL 562
++LG+G++GIV+K + + + +A+KK+ D R A + +R F+ E+ + H ++
Sbjct: 12 LQKLGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNI 69
Query: 563 VQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNL-----RIRISLEIARGLAY 615
V+LL ++ LV+E+M L +I A N+ + I ++ + L Y
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRA------NILEDVHKRYIMYQLLKALKY 122
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR----GTRGYV 671
+H NV IH D+KP NILL+ K++DFGL++ L + + TR Y
Sbjct: 123 IHSG-NV--IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 672 APE-WFKNVPVSAKVDVYSFGVTLLEIICCR 701
APE + + VD++S G L E++ +
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFK---SEVSA-IGRTHHKHLVQL 565
+G+GSFG V K A G AVK L + A +++E K +E + + H LV L
Sbjct: 3 IGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 566 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIR---ISLEIARGLAYLHEECN 621
+ + ++L V +++ G L F + + R + EIA L YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGG---ELFFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
+ II+ D+KP+NILLD ++DFGL K T T GT Y+APE + P
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLRKQPY 173
Query: 682 SAKVDVYSFGVTLLEIIC------CRRSVEM 706
VD + G L E++ R + EM
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKHLVQL 565
E+G GSFG VY + + +AVKK+ + E+ ++ EV + + H + ++
Sbjct: 28 EIGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVPI 624
G + LV E+ G+ ++L+ KP + I I+ +GLAYLH +
Sbjct: 87 KGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV---PV 681
IH DIK NILL K++DFG + S S ++ + GT ++APE +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFV-GTPYWMAPEVILAMDEGQY 197
Query: 682 SAKVDVYSFGVTLLEI 697
KVDV+S G+T +E+
Sbjct: 198 DGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 509 ELGRGSFGIVYKGVLK-TASGTAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKH 561
ELG+G++GIV T+ +A+KK+ LA+ RE K G HK+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG---HKN 63
Query: 562 LVQLLGF---CDEALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLH 617
+ L N L +YE + L +I + P D + + I +I GL Y+H
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIH 122
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG---TRGYVAPE 674
NV +H D+KP N+L++ KI DFGL++ + + TR Y APE
Sbjct: 123 S-ANV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 675 -WFKNVPVSAKVDVYSFGVTLLEII 698
+ +DV+S G L E++
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 42/240 (17%)
Query: 506 FKEELGRGSFGIVY----KGVLKTA-----------SGTAIAVKKLDRLAQERER-EFKS 549
FKE+LG G FG V+ +G+ K +AVK L A + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 550 EVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL-----------ANLIFAIPKPD 598
E+ + R ++++LL C + ++ E+M NG L A +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 599 WNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQ 657
++ I ++ +IA G+ YL ++ +H D+ +N L+ ++ KI+DFG+S+ L+S D
Sbjct: 129 YSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 658 SRTHTMIRGTRGYVAPEWFKNVPV-----SAKVDVYSFGVTLLEIIC-CRRSVEMELEEE 711
R I+G R + W + + DV++FGVTL EI+ C+ +L +E
Sbjct: 186 YR----IQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 493 FFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLD---RLAQEREREFKS 549
FF D K TD E+G GSFG VY + +A+KK+ + + E+ ++
Sbjct: 18 FFKEDPEKLFTD--LREIGHGSFGAVYFA-RDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 74
Query: 550 EVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLE 608
EV + R H + ++ G LV E+ G+ ++L+ KP + I I+
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHG 133
Query: 609 IARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTR 668
+GLAYLH +IH DIK NILL K++DFG + + S GT
Sbjct: 134 ALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTP 185
Query: 669 GYVAPEWFKNV---PVSAKVDVYSFGVTLLEI 697
++APE + KVDV+S G+T +E+
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 67/220 (30%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG+G+FG V V + A+G A+K L + +A++ +E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 567 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL---EIARGLAYLHEECNV 622
+ + +RL V E+ G L F + + R EI L YLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 114
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
+++ DIK +N++LD KI+DFGL K SD + T GT Y+APE ++
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 683 AKVDVYSFGVTLLEIICCR---------RSVEMELEEESR 713
VD + GV + E++C R R E+ L EE R
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHLV 563
++G GS+G+V+K + +G +A+KK + E + K E+ + + H +LV
Sbjct: 7 SKIGEGSYGVVFKCRNRE-TGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 564 QLLGFCDEALNRL----LVYEFMGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLH 617
L+ E R LV+E+ + T+ N + P+ P+ ++ +I + + + + H
Sbjct: 64 NLI----EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCH 117
Query: 618 EE-CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
+ C IH D+KP+NIL+ K+ DFG +++L + +T TR Y APE
Sbjct: 118 KHNC----IHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVATRWYRAPELL 172
Query: 677 -KNVPVSAKVDVYSFGVTLLEIIC 699
+ VDV++ G E++
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 510 LGRGSFGIVYKGVLKTAS-GTAIAVKKLDRLAQERE-REFKSEVSAIGRT-HHKHLVQLL 566
+G G+FG V K +K A+K++ A + + R+F E+ + + HH +++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 567 GFCDEALNRLLVYEFMGNGTLANLI-----------FAIPKPDWNLR-----IRISLEIA 610
G C+ L E+ +G L + + FAI + + + ++A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGY 670
RG+ YL ++ IH D+ +NIL+ + AKI+DFGLS+ + TM R +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRW 177
Query: 671 VAPEWFKNVPVSAKVDVYSFGVTLLEII 698
+A E + DV+S+GV L EI+
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKHLVQ 564
LG+G FG V ++ A+G A KKL++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFVV 63
Query: 565 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIARGLAYLHEECN 621
L + E + L LV M G L I+ + P D I + E+ GL L E
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR---GTRGYVAPEWFKN 678
I++ D+KP+NILLD +ISD GL+ + ++ +R GT GY+APE N
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAPEVINN 175
Query: 679 VPVSAKVDVYSFGVTLLEII 698
+ D + G + E+I
Sbjct: 176 EKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG+G+FG V V + ASG A+K L + +A++ +E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 567 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL---EIARGLAYLHEECNV 622
+ + +RL V E++ G L F + + R EI L YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGG---ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
I++ D+K +N++LD KI+DFGL K +D + T GT Y+APE ++
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 683 AKVDVYSFGVTLLEIICCR 701
VD + GV + E++C R
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--EVSAIGRTH---HKHLV 563
E+G G++G VYK SG +A+K + E + EV+ + R H ++V
Sbjct: 7 EIGVGAYGTVYKA-RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 564 QLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNL-RIR-ISLEIARGLAYL 616
+L+ C D LV+E + + L + +P P I+ + + RGL +L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
H C I+H D+KP+NIL+ K++DFGL+++ + T ++ T Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVL 179
Query: 677 KNVPVSAKVDVYSFGVTLLEI 697
+ VD++S G E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 52/300 (17%)
Query: 510 LGRGSFGIVYKGVL------KTASGTAIAVKKLDRLAQERE-REFKSEVSA---IGRTHH 559
LG G FG V K +AVK L A +++ + SE+ IG+ H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA--------------IPKPDWNLR--I 603
K+++ LLG C + ++ E+ G L + A +P+ + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 604 RISLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRTH 661
+ ++ARG+ YL ++C IH D+ +N+L+ KI+DFGL++ + + D +
Sbjct: 138 SCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY 721
T R ++APE + + + DV+SFGV L EI S I + +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS-------PYPGIPVEELF 246
Query: 722 DCYVEG-RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780
EG R+D + H+ MI C PS+RPT K +++ L+ +L V
Sbjct: 247 KLLKEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 513 GSFGIVYKGVLKTASGT---AIAVKKL-DRLAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
G+FG ++ G+L + VK + D ++ + E + H++++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 569 CDEALNRLLV-YEFMGNGTLANLIFAIPK-PDWNLRIRIS--------LEIARGLAYLHE 618
C E V Y +M G L L + + N +S ++IA G++YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNL-KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM-------IRGTRGYV 671
+IH DI +N ++D KI+D LS+ LF H + ++ ++
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHCLGDNENRPVK----WM 186
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEII 698
A E N S+ DV+SFGV L E++
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKHLVQLL 566
+G+G+FG VY+ V K + A+K L + ++E E + + RT ++
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 567 G--FCDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRIRISLEIARGLAYLHEE 619
G F + + L LV ++M G L + + K + + I+ E+ L +LH+
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGG---ELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY 115
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WFKN 678
I++ D+KP+NILLD + DFGLSK +D T+T GT Y+APE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVLLDE 171
Query: 679 VPVSAKVDVYSFGVTLLEIIC 699
+ VD +S GV + E+ C
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
+ +G G++G VYK +G AVK + + + E+ + H ++V G
Sbjct: 15 QRVGSGTYGDVYKA-RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 568 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVPI 624
E L + E+ G G+L + I+ + P L+I + E +GLAYLH +
Sbjct: 74 SYLSREKL--WICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF---KNVPV 681
+H DIK NILL K++DFG++ + + ++ + I GT ++APE KN
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGY 186
Query: 682 SAKVDVYSFGVTLLEI 697
+ D+++ G+T +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 39/229 (17%)
Query: 498 ELKDATDGFKEELGRGSFGIVYKG-VLKTASG---TAIAVKKL-DRLAQEREREFKSEVS 552
E+ +T F EELG FG VYKG + TA G A+A+K L D+ EFK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 553 AIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIF-------------------A 593
R H ++V LLG + +++ + + L +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 594 IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL 653
+ D+ + I +IA G+ +L ++H D+ +N+L+ + KISD GL + +
Sbjct: 121 LEPADF---VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 654 FSDQ-----SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
++ + IR +++PE S D++S+GV L E+
Sbjct: 175 YAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 74/309 (23%)
Query: 510 LGRGSFGIVYKGVLKTASG---------TAIAVKKLDRLAQERE-REFKSEVSA---IGR 556
LG G FG V V+ A G T +AVK L A E++ + SE+ IG+
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 557 THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA------------IPKPDWNLRIR 604
HK+++ LLG C + ++ E+ G L + A P+ L +
Sbjct: 83 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 605 ----ISLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQS 658
+ ++ARG+ YL ++C IH D+ +N+L+ KI+DFGL++ + D
Sbjct: 141 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS----VEME-----LE 709
+ T R ++APE + + + DV+SFGV L EI S V +E L+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256
Query: 710 EESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 769
E R D +C ++ M+ C PS+RPT K
Sbjct: 257 EGHR---MDKPSNC----------------------TNELYMMMRDCWHAVPSQRPTFKQ 291
Query: 770 VLQMLEGLL 778
+++ L+ +L
Sbjct: 292 LVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 27/204 (13%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKHLVQ 564
+++G G++G V L +G +A+KKL R Q +R ++ E+ + H++++
Sbjct: 21 KQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIG 78
Query: 565 LLGF--CDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRIRISL---EIARGLAY 615
LL D +L+R LV FMG L L+ K + RI ++ +GL Y
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLM----KHEKLSEDRIQFLVYQMLKGLKY 133
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
+H IIH D+KP N+ ++ KI DFGL++ +D T ++ TR Y APE
Sbjct: 134 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ--TDSEMTGYVV--TRWYRAPEV 186
Query: 676 FKN-VPVSAKVDVYSFGVTLLEII 698
N + + VD++S G + E++
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRT-HHKHLVQL 565
+G+GSFG V K+ G+ AVK L + L ++ + +E + + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRI---SLEIARGLAYLHEECNV 622
A V +++ G L F + + L R + E+A + YLH ++
Sbjct: 62 HYSFQTAEKLYFVLDYVNGG---ELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SL 115
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
II+ D+KP+NILLD ++DFGL K + T T GT Y+APE + P
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPYD 174
Query: 683 AKVDVYSFGVTLLEII 698
VD + G L E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKHLVQL 565
E+LG GS+ VYKG+ + +G +A+K + + E F + E S + H ++V L
Sbjct: 11 EKLGEGSYATVYKGISRI-NGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYLHEECNVPI 624
V+E+M + LA + P +R+ + ++ RGLAY+H + I
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HI 124
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WFKNVPVSA 683
+H D+KPQN+L+ + K++DFGL++ S S+T++ T Y P+ S+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAK-SIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 684 KVDVYSFGVTLLEII 698
+D++ G +E++
Sbjct: 184 ALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLD-----RLAQEREREFKSEVSAIGRTHHKHLVQ 564
+G G++G+V +G +A+KK+ Q RE K + R H++++
Sbjct: 13 IGEGAYGMVCSAT-HKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFKHENIIG 67
Query: 565 LLGFCD-------EALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYL 616
+L D E+ N + +V E M L LI + +++ + +I RGL Y+
Sbjct: 68 IL---DIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFL-YQILRGLKYI 122
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL--LFSDQSRTHTMIRGTRGYVAPE 674
H NV +H D+KP N+LL+ KI DFGL+++ D + T TR Y APE
Sbjct: 123 HS-ANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 675 WFKNVPVSAK-VDVYSFGVTLLEIICCR 701
N K +D++S G L E++ R
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 17/196 (8%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKHLVQL 565
E+G GSFG VY + +A+KK+ + + E+ ++ EV + + H + +Q
Sbjct: 22 EIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVPI 624
G LV E+ G+ ++L+ KP + I ++ +GLAYLH + +
Sbjct: 81 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNM 136
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV---PV 681
IH D+K NILL K+ DFG + ++ GT ++APE +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQY 191
Query: 682 SAKVDVYSFGVTLLEI 697
KVDV+S G+T +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTA---IAVKKL-DRLAQEREREFKSEVSAIGRTHHKHLVQL 565
LG G+FG VYKG+ +A+K L + + + +E E + ++ +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECN 621
LG C + +L V + M G L + + I D + ++IA+G++YL E
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL---LNWCVQIAKGMSYLEE--- 127
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
V ++H D+ +N+L+ KI+DFGL++LL D++ H G V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH----ADGGKVPIKWMALESI 183
Query: 682 -----SAKVDVYSFGVTLLEII 698
+ + DV+S+GVT+ E++
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKHLVQL 565
E+LG GS+ VYKG K +G +A+K + RL +E F + E S + H ++V L
Sbjct: 11 EKLGEGSYATVYKGKSKV-NGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIP---KPDWNLRIRISLEIARGLAYLHEECNV 622
LV+E++ + L + P P+ N+++ + ++ RGL+Y+H+
Sbjct: 69 HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPE-NVKLFL-FQLLRGLSYIHQRY-- 123
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WFKNVPV 681
I+H D+KPQN+L+ K++DFGL++ S S T++ T Y P+ +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAK-SVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 682 SAKVDVYSFGVTLLEII 698
S +D++ G +E+I
Sbjct: 182 STCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 43/211 (20%)
Query: 510 LGRGSFGIV---YKGVLKTASGTAIAVKKLDR------LAQEREREFKSEVSAIGRTHHK 560
+G G+ GIV Y V G +A+KKL R A+ RE + +HK
Sbjct: 24 IGSGAQGIVCAAYDTVT----GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHK 75
Query: 561 HLVQLLG-FC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI---RISLEIAR 611
+++ LL F +E + LV E M ANL I + + R+S + +
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVI-----QMDLDHERMSYLLYQ 126
Query: 612 ---GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTR 668
G+ +LH + IIH D+KP NI++ + KI DFGL++ + T ++ TR
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TR 181
Query: 669 GYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC 699
Y APE + VD++S G + E+I
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 70/293 (23%), Positives = 117/293 (39%), Gaps = 61/293 (20%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD--------RLAQEREREFKSEVSAIGRTHH 559
E LG+G+F +YKGVL+ S I + F S + + H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL-RIRISLEIARGLAYLHE 618
KHLV+L G C ++V E++ G L + ++ ++ ++A L YL +
Sbjct: 61 KHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 619 ECNVPIIHCDIKPQNILLDHF-------FSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
+ ++H ++ +NIL+ + K+SD G+ + S + R + ++
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----PWI 171
Query: 672 APEWFKNVPVSAKV--DVYSFGVTLLEIICCR--------RSVEMELEEESRAILTDWAY 721
APE +N S + D +SFG TLLE IC S E E + + L
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKERFYQDQHRL----- 225
Query: 722 DCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
M D + L + C DP+KRP+ + +L+ L
Sbjct: 226 -----------------PMPDCAELANLINQ---CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 498 ELKDATDGFKEELGRGSFGIVYKGVLKTASGTA--IAVKKL-DRLAQEREREFKSEVSAI 554
EL + + + LG G FG + +G LK S +A+ L + ++ R F +E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 555 GRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLE----IA 610
G+ H ++V+L G ++V E+M NG L + + K + L + +A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSF---LRKHEGQLVAGQLMGMLPGLA 117
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT-HTMIRGTRG 669
G+ YL E + +H + +L++ KIS F L D+S +T + G
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSP 171
Query: 670 --YVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
+ APE + S+ DV+SFG+ + E++
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG+G+FG V V + A+G A+K L + +A++ +E + + H L L
Sbjct: 3 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 567 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL---EIARGLAYLHEECNV 622
+ + +RL V E+ G L F + + R EI L YLH E NV
Sbjct: 61 KYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
++ D+K +N++LD KI+DFGL K D + T GT Y+APE ++
Sbjct: 118 --VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYG 174
Query: 683 AKVDVYSFGVTLLEIICCR 701
VD + GV + E++C R
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 509 ELGRGSFGIVY------KGVLKTASGTAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKH 561
+LG G FG V +G +G +AVK L + K E+ + +H++
Sbjct: 11 DLGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 562 LVQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIP--KPDWNLR--IRISLEIARGLAY 615
+V+ G C E L+ EF+ +G+L + P K NL+ ++ +++I +G+ Y
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDY 124
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG----YV 671
L +H D+ +N+L++ KI DFGL+K + +D+ + ++ +
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--YYTVKDDLDSPVFWY 179
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEII 698
APE DV+SFGVTL E++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLL 566
+G G++G V T +G +AVKKL R Q +R ++ E+ + H++++ LL
Sbjct: 25 VGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 82
Query: 567 GF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+E + LV MG L N++ D +++ I +I RGL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH--- 137
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN-V 679
+ IIH D+KP N+ ++ KI DFGL++ +D T + TR Y APE N +
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV--ATRWYRAPEIMLNWM 193
Query: 680 PVSAKVDVYSFGVTLLEIICCR 701
+ VD++S G + E++ R
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 508 EELGRGSFGIVYKGVLK------TASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH 561
E LG+G+F ++KG+ + T + +K LD+ + F S + + HKH
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRIS--LEIARGLAY-LHE 618
LV G C ++V E++ G+L + K + NL I IS LE+A+ LA+ LH
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNL-INISWKLEVAKQLAWALHF 115
Query: 619 ECNVPIIHCDIKPQNILL----DHFFSA----KISDFGLSKLLFSDQSRTHTMIRGTRGY 670
+ + H ++ +N+LL D K+SD G+S + + ++ +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-----ILLERIPW 170
Query: 671 VAPEWFKNVP-VSAKVDVYSFGVTLLEIIC 699
V PE +N +S D +SFG TL EI
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 29/205 (14%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--------RERE----FKSE--VSAIG 555
+G G+FG+V+ V G +A+KK+ + Q RE + FK + +SA+
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 556 RTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLA 614
H+ +E +V E M L +I + P+P + +++ L +I RGL
Sbjct: 67 ILQPPHI----DPFEEIY---VVTELM-QSDLHKIIVS-PQPLSSDHVKVFLYQILRGLK 117
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
YLH + I+H DIKP N+L++ KI DFGL+++ D+S+ T T+ Y APE
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 675 WFKNVP-VSAKVDVYSFGVTLLEII 698
++ VD++S G E++
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIG------RTHHKHL 562
E+G G++G V+K G +A+K++ R+ E S + + H ++
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 563 VQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAY 615
V+L C D LV+E + + L + +P+P + ++ RGL +
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
LH ++H D+KPQNIL+ K++DFGL++ ++S Q T + T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMAL-TSVVVTLWYRAPEV 180
Query: 676 FKNVPVSAKVDVYSFGVTLLEI 697
+ VD++S G E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHKH 561
++G G++G VYK K +G +A+KK+ RL E+E RE K + + +H++
Sbjct: 14 QIGEGTYGQVYKARDKD-TGELVALKKV-RLDNEKEGFPITAIREIK----ILRQLNHRN 67
Query: 562 LVQL----------LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR 611
+V L L F + LV+E+M + + L + + ++
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
GL Y H +H DIK NILL++ K++DFGL++L S++SR +T T Y
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 672 APE-WFKNVPVSAKVDVYSFGVTLLEI 697
PE +DV+S G L E+
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKHLVQLL 566
+G G+ GIV T G +AVKKL R Q + +R ++ E+ + +HK+++ LL
Sbjct: 29 IGSGAQGIVC-AAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLL 86
Query: 567 GF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYLHEE 619
+E + LV E M ANL I + R+ L ++ G+ +LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 140
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
+ IIH D+KP NI++ + KI DFGL++ ++ T ++ TR Y APE +
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGM 197
Query: 680 PVSAKVDVYSFGVTLLEII 698
VD++S G + E++
Sbjct: 198 GYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 44/197 (22%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FK----SEVSAIGRTHHKHL 562
+LG G+FG VYK +G +A+KK+ E++ F E+ + + H ++
Sbjct: 14 GKLGEGTFGEVYKARQI-KTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 563 VQLLGFC----DEALNRL----LVYEFMG---NGTLANLIFAIPKPDWNL---RIR-ISL 607
V L+ D++ + +V +M +G L N P L +I+ L
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-------PSVKLTESQIKCYML 122
Query: 608 EIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ---------- 657
++ G+ YLHE I+H DIK NIL+D+ KI+DFGL++
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 658 SRTHTMIRGTRGYVAPE 674
+R +T + TR Y PE
Sbjct: 180 TRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRT-HHKHLVQL 565
+G+GSFG V K A AVK L + L ++ E+ SE + + + H LV L
Sbjct: 3 IGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 566 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL---EIARGLAYLHEECN 621
F + ++L V +++ G L + + + L R EIA L YLH +
Sbjct: 62 -HFSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIASALGYLH---S 114
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
+ I++ D+KP+NILLD ++DFGL K T T GT Y+APE P
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173
Query: 682 SAKVDVYSFGVTLLEII 698
VD + G L E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 45/235 (19%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASG---------TAIAVKKLDRLAQERE 544
FS D+L + LG G FG V V+ A G +AVK L A E++
Sbjct: 12 FSRDKLT-----LGKPLGEGCFGQV---VMAEALGIDKDKPKEAVTVAVKMLKDDATEKD 63
Query: 545 -REFKSEVSA---IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA------- 593
+ SE+ IG+ HK+++ LLG C + ++ E+ G L + A
Sbjct: 64 LSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 121
Query: 594 -------IPKPDWNLR--IRISLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAK 643
+P + + + ++ARG+ YL ++C IH D+ +N+L+ K
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMK 177
Query: 644 ISDFGLSKLLFS-DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
I+DFGL++ + + D + T R ++APE + + + DV+SFGV + EI
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 30/234 (12%)
Query: 476 KYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKK 535
+YE + T +D +K +GRG+FG V + V +S A+K
Sbjct: 27 RYEKAAEKITKLRMKAE--DFDVIK--------VIGRGAFGEV-QLVRHKSSKQVYAMKL 75
Query: 536 LDRLAQERERE---FKSEVSAIGRTHHKHLVQL-LGFCDEALNRLLVYEFMGNGTLANLI 591
L + + + F E + + + +VQL F D+ +V E+M G L NL+
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY-LYMVMEYMPGGDLVNLM 134
Query: 592 --FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649
+ IP+ W + E+ L +H ++ IH D+KP N+LLD K++DFG
Sbjct: 135 SNYDIPE-KWA--RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 188
Query: 650 SKLLFSD-QSRTHTMIRGTRGYVAPEWFKNVPVSA----KVDVYSFGVTLLEII 698
+ ++ R T + GT Y++PE K+ + D +S GV L E++
Sbjct: 189 CMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 53/205 (25%), Positives = 101/205 (49%), Gaps = 38/205 (18%)
Query: 513 GSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHKHLVQL 565
G++G+VY+ K +G +A+KKL ++ +E+E RE + H ++V +
Sbjct: 16 GTYGVVYRARDKK-TGEIVALKKL-KMEKEKEGFPITSLREINILLKL----QHPNIVTV 69
Query: 566 ----LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRIS------LEIARGLA 614
+G L+++ +V E++ + L +L+ + +P S L++ G+A
Sbjct: 70 KEVVVG---SNLDKIYMVMEYVEH-DLKSLMETMKQP-----FLQSEVKCLMLQLLSGVA 120
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
+LH+ I+H D+K N+LL++ KI DFGL++ + + +T + T Y APE
Sbjct: 121 HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYRAPE 176
Query: 675 WFKNVPV-SAKVDVYSFGVTLLEII 698
S +D++S G E++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-09
Identities = 34/113 (30%), Positives = 51/113 (45%), Gaps = 20/113 (17%)
Query: 603 IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK--------LLF 654
+ I +I + Y+H + ++H D+KP NILL F I D+G + LL
Sbjct: 116 LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 655 SDQSRTHTM---------IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
D + I GT Y+APE VP S D+Y+ GV L +++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 33/159 (20%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKHLVQL 565
++LG GS+ VYKG K +G +A+K++ RL E F + E S + H ++V L
Sbjct: 11 DKLGEGSYATVYKGRSKL-TGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 566 --LGFCDEALNRLLVYEFM-----------GNGTLANLIFAIPKPDWNLRIRISLEIARG 612
+ + L LV+E++ G G + N+R+ + ++ RG
Sbjct: 69 HDIIHTKKTLT--LVFEYLDTDLKQYMDDCGGGLSMH----------NVRLFL-FQLLRG 115
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651
LAY H+ ++H D+KPQN+L+ K++DFGL++
Sbjct: 116 LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 63/207 (30%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR------------------LAQEREREFKSEV 551
LG+GSFG V LK G AVK L + LA E F + +
Sbjct: 3 LGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 552 SAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR 611
+T +HL V EF+ G L I + D + EI
Sbjct: 62 YCTFQTK-EHL-------------FFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC 107
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
GL +LH + II+ D+K N++LD KI+DFG+ K +R T GT Y+
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYI 163
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEII 698
APE + + + VD +SFGV L E++
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFK-SEVSAIGRTHHKHLVQLL 566
E+LG G++ VYKG +T +G +A+K++ A+E E+S + H+++V+L
Sbjct: 6 EKLGEGTYATVYKGRNRT-TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 567 GFCDEALNRLLVYEFMGNGTLANL-IFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPI 624
+LV+E+M + + D N + ++ +G+A+ HE +
Sbjct: 65 DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLL------FSDQS-----RTHTMIRGTRGYVAP 673
+H D+KPQN+L++ K++DFGL++ FS++ R ++ G+R Y
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY--- 178
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEII 698
S +D++S G + E+I
Sbjct: 179 --------STSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 608 EIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGT 667
EI+ L +LH++ II+ D+KP+NILLD K++DFGL K + + THT GT
Sbjct: 108 EISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GT 163
Query: 668 RGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
Y+APE VD +S G + +++
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 46/199 (23%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKHLV 563
++++GRG F VY+ G +A+KK+ D + + + E+ + + +H +++
Sbjct: 7 EKKIGRGQFSEVYRATC-LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK-----PDWNLRIRISLEIARGLAYLHE 618
+ E +V E G L+ +I K P+ + + +++ L ++H
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFVQLCSALEHMHS 124
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
++H DIKP N+ + K+ D GL + S + H+++ GT Y++PE
Sbjct: 125 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHE 180
Query: 679 VPVSAKVDVYSFGVTLLEI 697
+ K D++S G L E+
Sbjct: 181 NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 26/202 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFC 569
+GRG FG VY G K +G A+K LD+ +R + + E A+ + + ++ L+
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDK---KRIKMKQGETLAL---NERIMLSLVSTG 54
Query: 570 DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR------------ISLEIARGLAYLH 617
D + Y F L+ ++ + D + + + EI GL ++H
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF- 676
N +++ D+KP NILLD +ISD GL+ FS + + H + GT GY+APE
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFS-KKKPHASV-GTHGYMAPEVLQ 168
Query: 677 KNVPVSAKVDVYSFGVTLLEII 698
K V + D +S G L +++
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTA-IAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQL 565
+E+G G FG V + T +G A + VK+L A +E+ EF + H +++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-------IRISLEIARGLAYLHE 618
LG C EA+ LLV+E+ G L + + + W+ R R++ EIA G+ ++H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSY---LSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF-SDQSRTHTMIRGTRGYVAPEW-- 675
+H D+ +N L + K+ D+G+ + D T ++APE
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 676 -FKNVPVSAK----VDVYSFGVTLLEIICC 700
F ++A+ +V++ GVTL E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFEN 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFC 569
+GRG FG VY G K +G A+K LD+ +R + + E A+ + + ++ L+
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDK---KRIKMKQGETLAL---NERIMLSLVSTG 54
Query: 570 DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR------------ISLEIARGLAYLH 617
D + Y F L ++ + D + + + EI GL ++H
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF- 676
N +++ D+KP NILLD +ISD GL+ FS + + H + GT GY+APE
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFS-KKKPHASV-GTHGYMAPEVLQ 168
Query: 677 KNVPVSAKVDVYSFGVTLLEII 698
K + D +S G L +++
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 606 SLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR 665
+ E+ L LH+ +I+ D+KP+NILLD+ + DFGL KL D +T+T
Sbjct: 99 TAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC- 154
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
GT Y+APE + VD ++ GV L E++
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--------EVSAIGR-THHK 560
+G G+F V K +G A+K + ++ FKS E+ A+ R + H
Sbjct: 7 IGEGTFSEVLK-AQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 561 HLVQLLGFC-DEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYLH 617
++++L+ D RL LV+E M + L LI +P R++ + ++ + L ++H
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WF 676
I H DIKP+NIL+ K++DFG + ++S +T TR Y APE
Sbjct: 118 RN---GIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLL 171
Query: 677 KNVPVSAKVDVYSFGVTLLEII 698
+ K+D+++ G EI+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-09
Identities = 51/168 (30%), Positives = 78/168 (46%), Gaps = 13/168 (7%)
Query: 512 RGSFGIVYKGVLKTASGTAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
RG+FG VY G K + AVK K D + + + ++E A+ + +V L
Sbjct: 14 RGAFGKVYLG-RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72
Query: 569 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCD 628
A N LV E++ G + +L+ D + ++ E+A L YLH IIH D
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRD 129
Query: 629 IKPQNILLDHFFSAKISDFGLSK------LLFSDQSRTHTMIRGTRGY 670
+KP N+L+ + K++DFGLSK L D T +M + Y
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDY 177
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 43/279 (15%)
Query: 508 EELGRGSFGIVYKGV-LKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
+ +G G++G VYK + T AI V KL+ E + E+ + H ++V
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVPII 625
G + EF G G+L + I+ + P +I +S E +GL YLH + +
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK- 684
H DIK NILL K++DFG+S + + ++ + I GT ++APE V K
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEV---AAVERKG 184
Query: 685 -----VDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD--E 737
D+++ G+T +E+ EL+ +D + L ++ S+
Sbjct: 185 GYNQLCDIWAVGITAIEL--------AELQPP--------MFDLHPMRALFLMTKSNFQP 228
Query: 738 AAMADRSR----LHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ D+ + H ++ +A+ ++P KRPT + +LQ
Sbjct: 229 PKLKDKMKWSNSFHHFVKMAL---TKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 74/294 (25%), Positives = 130/294 (44%), Gaps = 64/294 (21%)
Query: 508 EELGRGSFGIVYKGVLK-----------TASGTAIAVKKLDRLAQEREREFKSEVSAIGR 556
E LGRG+ +Y G+L + +K LD ++ F S + +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 557 THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD-----WNLRIRISLEIAR 611
HKH+V L G C + ++V EF+ G L +F K D W + +++ ++A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPW--KFKVAKQLAS 116
Query: 612 GLAYLHEECNVPIIHCDIKPQNILL-------DHFFSAKISDFGLSKLLFSDQSRTHTMI 664
L+YL ++ ++H ++ +NILL + K+SD G+ + S Q +
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI- 172
Query: 665 RGTRGYVAPEWF---KNVPVSAKVDVYSFGVTLLEIICCRRSVEME---LEEESRAILTD 718
++APE KN+ ++A D +SFG TL E IC + ++ L E+ R
Sbjct: 173 ----PWIAPECVEDSKNLSIAA--DKWSFGTTLWE-ICYNGEIPLKDKTLAEKER----- 220
Query: 719 WAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ EG+ +L+ +AD LM C+ DP++RP + +++
Sbjct: 221 -----FYEGQC-MLVTPSCKELAD-------LMTH--CMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 53/227 (23%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--------------EVSAIG 555
LG G++G V K T +G +A+KK+ + + E+ +
Sbjct: 17 LGEGTYGKVEKA-YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 556 RTHHKHLVQLLG-FCDEA-LNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRIS------- 606
H++++ L+ + + +N LV + M L ++ + +IR++
Sbjct: 76 EIKHENIMGLVDVYVEGDFIN--LVMDIM-ASDLKKVV--------DRKIRLTESQVKCI 124
Query: 607 -LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK-----LLFSDQSRT 660
L+I GL LH +H D+ P NI ++ KI+DFGL++ S+
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 661 HTMIRG--------TRGYVAPE-WFKNVPVSAKVDVYSFGVTLLEII 698
TM R T Y APE VD++S G E++
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 34/160 (21%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKHLVQ 564
E++G G++G V+K + + +A+K++ RL + E S E+ + HK++V+
Sbjct: 6 EKIGEGTYGTVFKAKNRE-THEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 565 L-------------LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR 611
L +CD+ L + Y NG D + ++ +
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKK---YFDSCNG----------DIDPEIVKSFMFQLLK 110
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651
GLA+ H ++H D+KPQN+L++ K++DFGL++
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 32/91 (35%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666
+++ G+ ++HE+ ++H DIK +NI L K+ DFG ++LL S + T + G
Sbjct: 107 VQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-G 162
Query: 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
T YV PE ++N+P + K D++S G L E+
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL----AQEREREFKSEVSAIGRTHHKHL 562
++++GRG F VY+ +A+KK+ A+ R+ K E+ + + +H ++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKP-VALKKVQIFEMMDAKARQDCVK-EIDLLKQLNHPNV 64
Query: 563 VQLLG--FCDEALNRLLVYEFMGNGTLANLIFAIPK-----PDWNLRIRISLEIARGLAY 615
++ L D LN +V E G L+ +I K P+ + + +++ + +
Sbjct: 65 IKYLDSFIEDNELN--IVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLCSAVEH 121
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
+H ++H DIKP N+ + K+ D GL + S + H+++ GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 676 FKNVPVSAKVDVYSFGVTLLEI 697
+ K D++S G L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 18/196 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL-DRLAQEREREFK-SEVSAIGRTHHKHLVQLLG 567
+G G++G+V K K + +A+KK D E +E E+ + +++V+L
Sbjct: 9 VGEGAYGVVLKCRHKE-TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL-- 65
Query: 568 FCDEALNR----LLVYEFMGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEECN 621
EA R LV+E++ L L+ +P P +R I ++ + + + H+
Sbjct: 66 --KEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN-- 119
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
I+H DIKP+N+L+ H K+ DFG ++ L + +T TR Y +PE P
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 682 SAKVDVYSFGVTLLEI 697
VD++S G L E+
Sbjct: 179 GKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 41/247 (16%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
+GRG+FG V + V K +G A+K K D L +E+ ++E + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
+ LN L+ EF+ G + L+ K D IA + + + IH
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 627 CDIKPQNILLDHFFSAKISDFGL---------------------SKLLFSD---QSRTHT 662
DIKP N+LLD K+SDFGL S F + + + T
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 663 MIR----------GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES 712
R GT Y+APE F + D +S GV + E++ E +E+
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 713 RAILTDW 719
+ +W
Sbjct: 245 YKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 52/298 (17%)
Query: 510 LGRGSFGIVYK----GVLKT--ASGTAIAVKKLDRLAQERE-REFKSEVS---AIGRTHH 559
LG G FG V + G+ K+ +AVK L A +++ + SE+ IG+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLRIRISLE--------- 608
K+++ LLG C + ++ E+ G L + A P PD+ I E
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 609 -----IARGLAYLH-EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRTH 661
+ARG+ YL C IH D+ +N+L+ KI+DFGL++ + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY 721
+ R ++APE + + + DV+SFG+ + EI S I + +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS-------PYPGIPVEELF 246
Query: 722 DCYVEG-RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
EG R+D + H+ M+ C P++RPT K +++ L+ +L
Sbjct: 247 KLLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 602 RIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-RT 660
R+ I+ EI L +LH+ + II+ DIK +NILLD ++DFGLSK +++ R
Sbjct: 108 RVYIA-EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 661 HTMIRGTRGYVAPEWFKNVPV--SAKVDVYSFGVTLLEII 698
++ GT Y+APE + VD +S GV E++
Sbjct: 164 YSFC-GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGT-AIAVKKLDRLAQEREREFKSEVSAIGRT--HHKHLVQLL 566
+GRGS+ V LK A+ V K + + + + ++ + T +H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 567 GFCDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRIRISLEIARGLAYLHEECN 621
C + +RL V EF+ G +L+F + + P+ + R S EI+ L +LHE
Sbjct: 63 S-CFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARF-YSAEISLALNFLHER-- 115
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
II+ D+K N+LLD K++D+G+ K T T GT Y+APE +
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEILRGEDY 173
Query: 682 SAKVDVYSFGVTLLEIICCR 701
VD ++ GV + E++ R
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKHLVQL 565
++LG G++ V+KG K + +A+K++ RL E + EVS + H ++V L
Sbjct: 11 DKLGEGTYATVFKGRSKL-TENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 566 LGFCDEALNRLLVYEFMGN---------GTLANLIFAIPKPDWNLRIRISLEIARGLAYL 616
LV+E++ + G L ++ N++I ++ RGL+Y
Sbjct: 69 HDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSM--------HNVKI-FMFQLLRGLSYC 119
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-W 675
H+ I+H D+KPQN+L++ K++DFGL++ S ++T++ T Y P+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLARAK-SVPTKTYSNEVVTLWYRPPDVL 175
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCR 701
+ S +D++ G L E+ R
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE---REFKSEVSAIGR-THHKHLV 563
E++G G++G VYK K +G +A+KK RL + E E+S + + ++V
Sbjct: 7 EKIGEGTYGKVYKARDKN-TGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 564 QLLGF--CDEALNRL---LVYEFMGNGTLANLIFAIPKP----DWNLRIRISLEIARGLA 614
+LL +E + LV+E++ + + P ++ +G+A
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSA-KISDFGLSKLLFSD--QSRTHTMIRGTRGYV 671
+ H+ ++H D+KPQN+L+D KI+D GL + FS +S TH ++ T Y
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIV--TLWYR 178
Query: 672 APE-WFKNVPVSAKVDVYSFGVTLLEII 698
APE + S VD++S G E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 510 LGRGSFGIV---YKGVLKTASGTAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKHLV 563
+G G+ GIV Y +L+ +A+KKL R Q + +R ++ E+ + +HK+++
Sbjct: 32 IGSGAQGIVCAAYDAILERN----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 564 QLLGF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYL 616
LL +E + +V E M ANL I + R+ L ++ G+ +L
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
H + IIH D+KP NI++ + KI DFGL++ + T ++ TR Y APE
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 197
Query: 677 KNVPVSAKVDVYSFGVTLLEIIC 699
+ VD++S G + E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHLVQLL 566
+GRG+FG V + V +S A+K L + + + F E + + +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
+ +V E+M G L NL+ P+ + + E+ L +H ++ +IH
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA-EVVLALDAIH---SMGLIH 165
Query: 627 CDIKPQNILLDHFFSAKISDFGLS-KLLFSDQSRTHTMIRGTRGYVAPEWFKNVP----V 681
D+KP N+LLD K++DFG K+ + R T + GT Y++PE K+
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 682 SAKVDVYSFGVTLLEII 698
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKHLVQL 565
E+LG G++ V+KG K +A+K++ RL E + EVS + H ++V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 566 LGFCDEALNRLLVYEFMGNGTLANL-----IFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+ LV+E++ + I ++ N++I + +I RGLAY H
Sbjct: 70 HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMH----NVKIFL-YQILRGLAYCHRR- 123
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WFKNV 679
++H D+KPQN+L++ K++DFGL++ S ++T++ T Y P+ +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAK-SVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 680 PVSAKVDVYSFGVTLLEIICCR-----RSVEMEL 708
S ++D++ G E+ R +VE EL
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKHLVQLLG 567
+G G++G V T +AVKKL R Q R E+ + H++++ LL
Sbjct: 23 VGSGAYGSVCSA-YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 568 FCD-----EALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
E N + LV MG L N++ D +++ I ++ RGL Y+H +
Sbjct: 82 VFTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQFLI-YQLLRGLKYIH---S 136
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN-VP 680
IIH D+KP N+ ++ +I DFGL++ +D T + TR Y APE N +
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYV--ATRWYRAPEIMLNWMH 192
Query: 681 VSAKVDVYSFGVTLLEII 698
+ VD++S G + E++
Sbjct: 193 YNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 19/157 (12%)
Query: 511 GRGSFGIVYKGVLKTAS-GTAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKHLVQLL 566
GRG++G VYK K G A+KK ++ +S E++ + H+++V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 567 GFCDEALNRL--LVYEFMGNGTLANLIF-----AIPKPDWNLRIRISLEIARGLAYLHEE 619
E ++ L++++ + + F + P ++ + +I G+ YLH
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-SLLWQILNGVHYLHSN 127
Query: 620 CNVPIIHCDIKPQNILL----DHFFSAKISDFGLSKL 652
++H D+KP NIL+ KI D GL++L
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKHLVQL 565
++LG G++ VYKG K + +A+K++ RL E + EVS + H ++V L
Sbjct: 12 DKLGEGTYATVYKGRSKL-TDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 566 LGFCDEALNRLLVYEFMGN---------GTLANLIFAIPKPDWNLRIRISLEIARGLAYL 616
+ LV+E++ G N+ N+++ + ++ RGL Y
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINM--------HNVKLFL-FQLLRGLNYC 120
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-W 675
H ++H D+KPQN+L++ K++DFGL++ S ++T++ T Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYSNEVVTLWYRPPDIL 176
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCR-----RSVEMEL 708
+ S ++D++ G E+ R +VE +L
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 51/178 (28%), Positives = 88/178 (49%), Gaps = 27/178 (15%)
Query: 603 IRISLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661
+ S ++A+G+++L + C IH D+ +NILL H KI DFGL++ + +D ++
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRND---SN 269
Query: 662 TMIRGTR----GYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILT 717
+++G ++APE N + + DV+S+G+ L EI S + +S+
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---- 325
Query: 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
Y EG + S E A ++ + K C DP KRPT K ++Q++E
Sbjct: 326 --FYKMIKEG---YRMLSPECAPSEMYDIMK------SCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 27/202 (13%)
Query: 510 LGRGSFGIV---YKGVLKTASGTAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKHLV 563
+G G+ GIV Y VL +A+KKL R Q + +R ++ E+ + +HK+++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 79
Query: 564 QLLGF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYL 616
LL +E + LV E M ANL I + R+ L ++ G+ +L
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
H + IIH D+KP NI++ + KI DFGL++ + T ++ TR Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 190
Query: 677 KNVPVSAKVDVYSFGVTLLEII 698
+ VD++S G + E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
+GRG+FG V + V K +G A+KKL + L +E+ ++E + + +V+L
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 567 -GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
F DE L+ E++ G + L+ K D IA + + + I
Sbjct: 68 YSFQDE-NYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLL---------------------------FSDQS 658
H DIKP N+LLD K+SDFGL L S +
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 659 RTHTMIR----------GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
+ T R GT Y+APE F + + D +S GV + E++
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 35/208 (16%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFK-----SEVSAIG--------- 555
+G GSFG+VY+ + S +A+KK+ + Q + RE + ++ I
Sbjct: 74 IGNGSFGVVYEAICIDTS-EKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 556 -RTHHKH--LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARG 612
+ + K+ L ++ F + +++ + + N L + + S ++ R
Sbjct: 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL----------YSYQLCRA 182
Query: 613 LAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
LAY+H + I H D+KPQN+L+D + + K+ DFG +K L + Q R+ + I +R Y
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYI-CSRFYR 237
Query: 672 APE-WFKNVPVSAKVDVYSFGVTLLEII 698
APE + +D++S G + E+I
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 41/215 (19%)
Query: 507 KEELGRGSFGIVYKGVLKTASG-------TAIAVKKL---DRLAQEREREFKSEVS--AI 554
++ LG+GSFG VY K A I V +L + + +E + S++ AI
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 555 GRTHHKHLVQ-----LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRIRIS 606
+ H L + + +C+ + E G + + +W +++ +
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT------LSENQVCEWFIQLLL- 117
Query: 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS--DQSRTHTMI 664
G+ Y+H+ I+H D+K +NI L + KI DFG+S+LL D + T T
Sbjct: 118 -----GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT-- 166
Query: 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC 699
GT Y++PE K+ +K D++S G L E+ C
Sbjct: 167 -GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 46/192 (23%), Positives = 90/192 (46%), Gaps = 31/192 (16%)
Query: 597 PDWNLRI----RISLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651
W L + R S ++A+G+ +L + C IH D+ +N+LL AKI DFGL++
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 652 LLFSDQSRTHTMIRGTR----GYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEME 707
+ +D ++ +++G ++APE + + + DV+S+G+ L EI +S
Sbjct: 261 DIMND---SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS---- 313
Query: 708 LEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767
IL + + V+ + + D + + ++ M C +P++RPT
Sbjct: 314 ---PYPGILVNSKFYKMVK-------RGYQMSRPDFAPPEIYSIMKM-CWNLEPTERPTF 362
Query: 768 KVVLQMLEGLLD 779
+ Q+++ L
Sbjct: 363 SQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 6/109 (5%)
Query: 608 EIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK-LLFSDQSRTHTMIRG 666
EI L +LH+ + I++ DIK +NILLD ++DFGLSK L ++ RT++ G
Sbjct: 113 EIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-G 168
Query: 667 TRGYVAPEWFKNVPVSAK-VDVYSFGVTLLEIICCRRSVEMELEEESRA 714
T Y+APE + K VD +S G+ + E++ +E E +++
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQERE-REFKSEVSAIGRTHHKHLVQ 564
++G+G +G V+ K +G +A+K++ + L + E R +E + T + LV+
Sbjct: 7 TQVGQGGYGQVFLA-KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWN-LRIRISLEIARGLAYLHEECNVP 623
LL + L E++ G L+ + + R ++ E+ + LHE +
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA-EMFEAVDALHE---LG 121
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IH D+KP+N L+D K++DFGLSK + + ++++ G+ Y+APE +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVLRGKGYDF 177
Query: 684 KVDVYSFGVTLLEIIC 699
VD +S G L E +C
Sbjct: 178 TVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 510 LGRGSFG-IVYKGVLKTASGTAIAVKKLDRLAQEREREF-KSEVSAIGR-THHKHLVQLL 566
+GRGS+ ++ + KT A+ V K + + + + ++ ++E + ++H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 567 GFCDEALNRLL-VYEFMGNGTLANLIFAIPK----PDWNLRIRISLEIARGLAYLHEECN 621
C + +RL V E++ G +L+F + + P+ + R S EI+ L YLHE
Sbjct: 63 S-CFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER-- 115
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
II+ D+K N+LLD K++D+G+ K T T GT Y+APE +
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDY 173
Query: 682 SAKVDVYSFGVTLLEIICCRRSVEM 706
VD ++ GV + E++ R ++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 606 SLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT-M 663
S ++ARG+ +L +C IH D+ +NILL KI DFGL++ ++ D
Sbjct: 180 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVE--MELEEESRAILTDWAY 721
R ++APE + + + DV+SFGV L EI S +++ EE L D
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--- 292
Query: 722 DCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
+ + E A + R +M+A W Q DP +RPT ++++L LL
Sbjct: 293 --------GTRMRAPENATPEIYR----IMLACW--QGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 5/94 (5%)
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664
I +I GL YLH + IIH D+K +NI ++ I D G ++ F + +
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ--FPVVAPAFLGL 216
Query: 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
GT APE ++K D++S G+ L E++
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 41/247 (16%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
+GRG+FG V + V K +G A+K K D L +E+ ++E + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
+ N L+ EF+ G + L+ K D IA + + + IH
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 627 CDIKPQNILLDHFFSAKISDFGLSKLL-------------------FSDQS-----RTHT 662
DIKP N+LLD K+SDFGL L FS Q+ + T
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 663 MIR----------GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES 712
+ GT Y+APE F + D +S GV + E++ E +E+
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 713 RAILTDW 719
+ +W
Sbjct: 245 YRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 43/143 (30%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 569 CDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRIRISLEIARGLAYLHEECNVP 623
C + +RL LV E++ G +L+F + + P+ + R + EI L +LHE
Sbjct: 64 CFQTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER---G 116
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
II+ D+K N+LLD K++D+G+ K T T GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGEEYGF 175
Query: 684 KVDVYSFGVTLLEIICCRRSVEM 706
VD ++ GV + E++ R ++
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 8e-07
Identities = 56/233 (24%), Positives = 86/233 (36%), Gaps = 55/233 (23%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKHLVQ 564
+ LG+G G V+ LK +G A+K LD+ + + K +E + H L
Sbjct: 7 KLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYL 616
L LV ++ G L L+ P +S E+AR L YL
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGK------CLSEEVARFYAAEVLLALEYL 119
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR----------- 665
H + I++ D+KP+NILL +SDF LSK + +
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS---DVEPPPVSKALRKGSRRSSV 173
Query: 666 --------------------GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
GT Y+APE + VD ++ G+ L E++
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 5/109 (4%)
Query: 608 EIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGT 667
EI L +LH+ + II+ DIK +NILLD ++DFGLSK D+ GT
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 668 RGYVAPEWFK--NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA 714
Y+AP+ + + VD +S GV + E++ ++ E+ S+A
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKHLVQLL 566
+G G++G V + K +G +A+KKL R Q +R ++ E++ + H++++ LL
Sbjct: 23 VGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80
Query: 567 GF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
DE + LV +M T I P + ++ + ++ GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQ--TDLQKIMGHPLSEDKVQYLV-YQMLCGLKYIHS-- 135
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN-V 679
IIH D+KP N+ ++ KI DFGL++ +D T ++ TR Y APE N +
Sbjct: 136 -AGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRWYRAPEVILNWM 190
Query: 680 PVSAKVDVYSFGVTLLEII 698
+ VD++S G + E++
Sbjct: 191 HYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 603 IRISLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661
I S ++ARG+ +L +C IH D+ +NILL KI DFGL++ ++ D
Sbjct: 176 ISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 662 T-MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
R ++APE + + + DV+SFGV L EI
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664
I + R + YLHE IIH DIK +NI ++H + DFG + + +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSV 704
GT APE P VD++S G+ L E+ C S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHLVQL- 565
+GRG+FG V LK A A+K L++ + E F+ E + ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNAD-KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
F DE N LV ++ G L L+ F P+ R ++ E+ + +H+ +
Sbjct: 68 YAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIAIDSVHQ---LH 122
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP--- 680
+H DIKP NIL+D +++DFG L D + ++ GT Y++PE + +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 681 --VSAKVDVYSFGVTLLEII 698
+ D +S GV + E++
Sbjct: 183 GKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL-----DRLAQERE-REFKSEVSAIGRTHHKHLV 563
+GRG++GIV + + +A+KK+ +R+ +R RE K + H++++
Sbjct: 13 IGRGAYGIVCSAK-NSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENVI 67
Query: 564 QLLGF----CDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYLH 617
+ EA N + +VYE M T + I + + + L ++ RGL Y+H
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELMD--TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
+ ++H D+KP N+LL+ KI DFGL++ S++ T TR Y APE
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT-SEKGDFMTEYVVTRWYRAPELLL 181
Query: 678 NVP-VSAKVDVYSFGVTLLEII 698
N + +DV+S G E++
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHLVQLL 566
+GRG+FG V + V ++ A+K L + + + F E + + +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
+ +V E+M G L NL+ P+ R + E+ L +H ++ IH
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIH---SMGFIH 165
Query: 627 CDIKPQNILLDHFFSAKISDFGLSKLLFSD-QSRTHTMIRGTRGYVAPEWFKNVP----V 681
D+KP N+LLD K++DFG + + R T + GT Y++PE K+
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 682 SAKVDVYSFGVTLLEII 698
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 513 GSFGIVYKGVLKTASGTAIAVKKLDR----LAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
G++G VY V + A+KK+++ L + ++ F E + + +V + F
Sbjct: 12 GAYGAVYL-VRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM--F 67
Query: 569 CDEALNRLL--VYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPII 625
C R L V E++ G A L+ I P R+ + E L YLH N I+
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEYLH---NYGIV 123
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKL-------------------LFSDQSRTHTMIRG 666
H D+KP N+L+ K++DFGLSK+ F D+ + G
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ-----VCG 178
Query: 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
T Y+APE VD ++ G+ L E +
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 53/191 (27%)
Query: 606 SLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM- 663
S ++A+G+ +L +C IH D+ +NILL KI DFGL++ ++ D
Sbjct: 185 SFQVAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI----------------ICCRRSVEME 707
R ++APE + + + DV+SFGV L EI C R
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------ 294
Query: 708 LEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767
L+E +R D+ + LD C +PS+RPT
Sbjct: 295 LKEGTRMRAPDYTTPEMYQTMLD-------------------------CWHGEPSQRPTF 329
Query: 768 KVVLQMLEGLL 778
+++ L LL
Sbjct: 330 SELVEHLGNLL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 608 EIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT--HTMIR 665
++ R L Y+H NV H D+KP+NIL + KI DFGL+++ F+D T
Sbjct: 111 QLLRALKYIHT-ANV--FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 666 GTRGYVAPE-----WFKNVPVSAKVDVYSFGVTLLEII 698
TR Y APE + K P +D++S G E++
Sbjct: 168 ATRWYRAPELCGSFFSKYTPA---IDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 35/158 (22%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--------DRLAQER-EREFKSEVSAIGRTHHK 560
+G+G+FG V + V K +G A+K L D+LA + ER+ +E +
Sbjct: 9 IGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE------SDSP 61
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+V L +A L+ EF+ G L ++ ++ S ++ R + EC
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDT---FSEDVTR---FYMAEC 110
Query: 621 NVPI--------IHCDIKPQNILLDHFFSAKISDFGLS 650
+ I IH DIKP NIL+D K+SDFGLS
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 40/165 (24%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHKHL 562
+G+G+FG V+K K + +A+KK+ + E+E RE K + H+++
Sbjct: 20 IGQGTFGEVFKARHKK-TKQIVALKKV-LMENEKEGFPITALREIK----ILQLLKHENV 73
Query: 563 VQLLGFCD---EALNR-----LLVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIAR-- 611
V L+ C NR LV+EF + LA L+ N ++ +L EI +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS-------NKNVKFTLSEIKKVM 125
Query: 612 -----GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651
GL Y+H I+H D+K NIL+ K++DFGL++
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 32/160 (20%), Positives = 71/160 (44%), Gaps = 12/160 (7%)
Query: 545 REFKSEVSAIGRTHHKHLVQLLGF----CDEALNRLLVYEFMGNGTLANLIFAIPKPDWN 600
++E+ + R +++++ GF D+ L+ E+ G L ++ +
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK 122
Query: 601 LRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660
++ ++++ +GL L++ N P + ++ + L+ + KI GL K+L S +
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180
Query: 661 HTMIRGTRGYVAPEWFKNV--PVSAKVDVYSFGVTLLEII 698
+ Y + + ++ + K D+YS GV L EI
Sbjct: 181 VNFM----VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 34/102 (33%), Positives = 47/102 (46%), Gaps = 4/102 (3%)
Query: 603 IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS-KLLFSDQSRTH 661
I I + LAYLH IIH D+K +NI LD +A + DFG + KL +
Sbjct: 188 ITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS 703
GT +PE P AK D++S G+ L E+ +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 46/223 (20%)
Query: 510 LGRGSFGIVYKGVLKTASGTA-----------------------IAVKKLDRLAQERERE 546
LG+G+ +Y G L+ G + +K LD ++
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 547 FKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLI----FAIPKPDWNLR 602
F S + + H HL + G C ++V EF+ +G L + +P W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPV-AW--K 119
Query: 603 IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSA-------KISDFGLSKLLFS 655
I ++ ++A L+YL ++ ++H ++ +NILL A K+SD G+S S
Sbjct: 120 ITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 656 DQSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEI 697
+ R + ++APE +S D +SFG TLLEI
Sbjct: 177 REERVERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 23/182 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL---L 566
LG GS G+V+ V + +AVKK+ + + E+ I R H ++V++ L
Sbjct: 13 LGCGSNGLVFSAV-DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 567 GFCDEALNRLL-----------VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAY 615
G L + V E+M LAN++ P + + R+ ++ RGL Y
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 616 LHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRG--TRGYVA 672
+H NV +H D+KP N+ ++ KI DFGL++++ S + G T+ Y +
Sbjct: 130 IHS-ANV--LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 673 PE 674
P
Sbjct: 187 PR 188
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 29/170 (17%)
Query: 608 EIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--THTMIR 665
+I L +H ++H D+K NI L K+ DFG SK +SD +
Sbjct: 177 QIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ-YSDSVSLDVASSFC 232
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD--- 722
GT Y+APE ++ S K D++S GV L E++ R + + E + YD
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP 292
Query: 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
C V + L+D + ++P+ RPT + +L
Sbjct: 293 CPVSSGMKALLDP--------------------LLSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-05
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 40/224 (17%)
Query: 508 EELGRGSFGIVY----KGVLKTASGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHL 562
+++G G FG V+ K + AI+ + L +ERE+ + EV+ + HK++
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL----KEREKSQLVIEVNVMRELKHKNI 74
Query: 563 VQLLG-FCDEALNRL-LVYEFMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYL 616
V+ + F ++A +L ++ EF G L+ I K + + + I+ ++ LAY
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 617 HEECNVP----IIHCDIKPQNILLDHFFS-----------------AKISDFGLSKLLFS 655
H + P ++H D+KPQNI L AKI DFGLSK +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI-G 193
Query: 656 DQSRTHTMIRGTRGYVAPEWFKNVPVS--AKVDVYSFGVTLLEI 697
+S H+ + GT Y +PE + S K D+++ G + E+
Sbjct: 194 IESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
|
Length = 1021 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 9e-05
Identities = 15/67 (22%), Positives = 27/67 (40%), Gaps = 3/67 (4%)
Query: 359 NNVEWPLGDYERLEPSNQTECETSCLQDCSCAVAIYDGNS--CRKKKLPLSNGWLRDTGF 416
+V+ P + + EC +CL +CSC Y+ S C L+N +G
Sbjct: 18 PDVKLPDNAS-AITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGG 76
Query: 417 SKVLFKV 423
+ ++
Sbjct: 77 GTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 9e-05
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 23/165 (13%)
Query: 558 HHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLH 617
+ + ++L +L+ +++ +G L +L+ K +I ++ L LH
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAK----ISDFGLSKLLFSDQSRTHT--MIRGTRGYV 671
IIH DIK +N+L + AK + D+GL K T GT Y
Sbjct: 127 ---KHNIIHNDIKLENVL---YDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLDYF 173
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEIICCR----RSVEMELEEES 712
+PE K D ++ GV E++ + + EL+ ES
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAI-AVKKLDRLAQERERE---FKSEVSAIGRTHHKHLVQL 565
+GRG+FG V V+K I A+K L++ + E F+ E + + + + L
Sbjct: 9 IGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 566 -LGFCDEALNRL-LVYEFMGNGTLANLI--FAIPKPDWNLRIRISLEIARGLAYLHEECN 621
F DE N L LV ++ G L L+ F P+ R I+ E+ + +H+
Sbjct: 67 HYAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIHQ--- 120
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV-- 679
+ +H DIKP N+LLD +++DFG + D + ++ GT Y++PE + +
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 680 ---PVSAKVDVYSFGVTLLEII 698
+ D +S GV + E++
Sbjct: 181 GMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 44/205 (21%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 509 ELGRGSFGIVYKGVLK-TASGTAIAVKK--LDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+G+ ++ + K + T +AVKK LD ++E + + E+ + H +++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 566 LGFCDEALNRL-LVYEFMGNGTLANLI---FAIPKPDWNLRIRISL-EIARGLAYLHEEC 620
+ + L +V M G+ +L+ F P+ L I L ++ L Y+H +
Sbjct: 65 V-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPE--LAIAFILKDVLNALDYIHSK- 120
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG------YVAPE 674
IH +K +ILL +S S + R + + +++PE
Sbjct: 121 --GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 675 WF-KNVP-VSAKVDVYSFGVTLLEI 697
+N+ + K D+YS G+T E+
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 57/238 (23%), Positives = 94/238 (39%), Gaps = 57/238 (23%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
+G G+FG V V K + A+K L D L + + K+E + ++ +V+L
Sbjct: 9 IGIGAFGEVCL-VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 567 -GFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
F D+ N V +++ G + +L+ I + D R I+ E+ + +H +
Sbjct: 68 YSFQDKD-NLYFVMDYIPGGDMMSLLIRLGIFEEDL-ARFYIA-ELTCAIESVH---KMG 121
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGL---------------------------------- 649
IH DIKP NIL+D K++DFGL
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 650 -------SKLLFSDQSR--THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
+ R H+++ GT Y+APE + D +S GV L E++
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 15/106 (14%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYK----GVLKTASGTAIAVKKLDRLAQERERE-FK 548
F D L+ F + LG G+FG V + G+ K + +AVK L A ERE
Sbjct: 35 FPRDNLQ-----FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALM 89
Query: 549 SEV---SAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLI 591
SE+ S +G HK++V LLG C L++ E+ G L N +
Sbjct: 90 SELKILSHLG--QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 37/105 (35%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYK----GVLKTASGTAIAVKKLDRLAQERE-REFK 548
F D LK + LGRG+FG V + G+ K+AS +AVK L A E +
Sbjct: 4 FPRDRLK-----LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM 58
Query: 549 SEVSA---IGRTHHKHLVQLLGFCDEALNRLLV-YEFMGNGTLAN 589
+E+ IG HH ++V LLG C + L+V E+ G L+N
Sbjct: 59 TELKILIHIG--HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSN 101
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 10/99 (10%)
Query: 603 IRISLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ---S 658
+ + ++ARG+ +L + C +H D+ +N+LL KI DFGL++ + D S
Sbjct: 240 LSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
+ T + ++APE + + DV+S+G+ L EI
Sbjct: 296 KGSTFL--PVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 506 FKEELGRGSFGIVYK----GVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRT-HH 559
F + LG G+FG V + G+ K+ + +AVK L A ERE SE+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLI 591
++V LLG C L++ E+ G L N +
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 39/105 (37%), Positives = 52/105 (49%), Gaps = 12/105 (11%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYK----GVLKTASGTAIAVKKLDRLAQERE-REFK 548
F D LK + LGRG+FG V + G+ KTA+ +AVK L A E R
Sbjct: 4 FPRDRLK-----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 58
Query: 549 SEVSA-IGRTHHKHLVQLLGFCDEALNRLLV-YEFMGNGTLANLI 591
SE+ I HH ++V LLG C + L+V EF G L+N +
Sbjct: 59 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 33/124 (26%), Positives = 56/124 (45%), Gaps = 10/124 (8%)
Query: 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYL-HEECNVPIIHCDIKPQNILL 636
+ LI P + + S ++A G+ +L + C +H D+ +N+L+
Sbjct: 217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLI 272
Query: 637 DHFFSAKISDFGLSKLLFSDQ---SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVT 693
KI DFGL++ + D S+ T + ++APE N + DV+SFG+
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGIL 330
Query: 694 LLEI 697
L EI
Sbjct: 331 LWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 510 LGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHLVQL 565
+GRG+FG V V+K +G A+K L++ + E F+ E + + + L
Sbjct: 9 IGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 566 -LGFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
F DE N LV ++ G L L+ F P+ R ++ E+ + +H+ +
Sbjct: 67 HYAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVHQ---L 121
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
+H DIKP N+LLD +++DFG L +D + + GT Y++PE
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT---H 661
++ ++ + Y+H E IIH DIK +N+L++ + DFG + F+ S + H
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA--CFARGSWSTPFH 319
Query: 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLE 696
I GT APE P + VD++S G+ + E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 796 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.81 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.02 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.95 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.93 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.93 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.92 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.88 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.82 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.63 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.63 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.61 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.29 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.28 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.12 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.06 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.04 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.28 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.25 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.86 | |
| PLN02236 | 344 | choline kinase | 95.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.76 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.76 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.63 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.58 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.82 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-53 Score=457.44 Aligned_cols=287 Identities=46% Similarity=0.754 Sum_probs=250.2
Q ss_pred CccccCHHHHHHHHHhHH--HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccc
Q 044281 490 NLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567 (796)
Q Consensus 490 ~~~~~~~~~l~~~~~~~~--~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g 567 (796)
..+.|+++++..||++|. ..||+|+||.||+|.+. ++..||||++.....+..++|.+|+.++.+++|||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence 678899999999999998 58999999999999986 45899999987654331566999999999999999999999
Q ss_pred cccccc-cceeEEeecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 044281 568 FCDEAL-NRLLVYEFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKI 644 (796)
Q Consensus 568 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl 644 (796)
||.+.. +++||||||++|+|.++|+... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999999 4999999999999999999865 8899999999999999999999998888999999999999999999999
Q ss_pred eecCCcccccCCCCcceeec-cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh
Q 044281 645 SDFGLSKLLFSDQSRTHTMI-RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC 723 (796)
Q Consensus 645 ~DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 723 (796)
+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+...... ...+..|+...
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~-~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG-ELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc-cccHHHHHHHH
Confidence 999999765431 1111112 79999999999999999999999999999999999999887654222 22267889899
Q ss_pred hhcCccceeccchhh-hhhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 724 YVEGRLDVLIDSDEA-AMADR-SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 724 ~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
+.++++.+++|+... ..... .++.++..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999999876 44443 7899999999999999999999999999999766544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=392.58 Aligned_cols=251 Identities=35% Similarity=0.545 Sum_probs=209.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeE-EEEEEecchhhhh--HHHHHHHHHHhcccCccCcccccccccccc-cceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTA-IAVKKLDRLAQER--EREFKSEVSAIGRTHHKHLVQLLGFCDEAL-NRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~-vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~ 581 (796)
+.+.||+|+||+||+|.++ |+. ||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 4566999999999999986 455 9999997643222 569999999999999999999999999988 79999999
Q ss_pred cCCCCHHHHHhc--CCCCchhHHHHHHHHHHHHhhHhhhcCCCC-eeeCCCCCCCEEEcCCC-cEEEeecCCcccccCCC
Q 044281 582 MGNGTLANLIFA--IPKPDWNLRIRISLEIARGLAYLHEECNVP-IIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 582 ~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~-iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~ 657 (796)
|++|+|.++++. ...+++..+++++.|||+||.|||++ + ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999988 57899999999999999999999998 6 99999999999999997 99999999998764322
Q ss_pred CcceeeccCCCccccccccc--CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 658 SRTHTMIRGTRGYVAPEWFK--NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
...+...||+.|||||++. ...++.|+||||||++||||+||+.||......... ......+....+..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~-------~~v~~~~~Rp~~p~- 269 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA-------SAVVVGGLRPPIPK- 269 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcCCCCCCCc-
Confidence 2333467999999999999 669999999999999999999999999876552221 12222222222222
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.....+..++.+||+.||..||++.+|+.+|+.+..
T Consensus 270 --------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 270 --------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred --------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 134567778889999999999999999999987655
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=389.63 Aligned_cols=262 Identities=29% Similarity=0.409 Sum_probs=220.0
Q ss_pred HHHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 498 ELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 498 ~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
++......+.+.||+|.||+|+.|.++ ....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..+..++|
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEc--CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 455566678899999999999999996 3458999999764 3345789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhc--CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 578 VYEFMGNGTLANLIFA--IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
|||||+.|+|.++|.. ...+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||+...+
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999987 46788999999999999999999998 999999999999999999999999999996665
Q ss_pred CCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
+.........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+....+ ..|
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l--------e~G------- 420 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL--------ERG------- 420 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH--------hcc-------
Confidence 55555555556889999999999999999999999999999999 56666655444432222 122
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCC
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPN 782 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (796)
.+-..+..+...+.+++..||+.+|++|||++.+...|+.+.....
T Consensus 421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 1222344456778889999999999999999999999988765443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=362.77 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=207.6
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCccccccccccccc-ceeEEeecCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN-RLLVYEFMGN 584 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~e~~~~ 584 (796)
..+||+|..|+|||+.++ .+++.+|+|.+... .....+++.+|++++++.+||+||+++|.|..... ..++||||++
T Consensus 84 ~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHK-PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhcccCCCcEEEEEEEc-CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 468999999999999987 47899999999442 34456789999999999999999999999998884 9999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
|+|++++...+++++...-+|+.+|++||.|||+.. +||||||||+|||++..|.+||+|||.++.+... .....
T Consensus 163 GSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tf 237 (364)
T KOG0581|consen 163 GSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTF 237 (364)
T ss_pred CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccc
Confidence 999999999899999999999999999999999742 8999999999999999999999999999987544 34556
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhH--HHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELE--EESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
+||..|||||.+.+..|+.++||||||+.++|+..|+-|+..... .....++ . .+.+......+.
T Consensus 238 vGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll-----~--------~Iv~~ppP~lP~ 304 (364)
T KOG0581|consen 238 VGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL-----C--------AIVDEPPPRLPE 304 (364)
T ss_pred cccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH-----H--------HHhcCCCCCCCc
Confidence 799999999999999999999999999999999999999876411 0111111 1 112211111112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....++..++..||++||.+||++.+++++
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2466788999999999999999999998864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=361.65 Aligned_cols=203 Identities=31% Similarity=0.457 Sum_probs=183.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.++||+|+|++||+|+++. ++..||||.+.+. ..+..+.+..|+++|+.++|||||++++++..++..+|||||+.
T Consensus 14 ~~~~iG~GsfavVykg~h~~-~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKK-SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCN 92 (429)
T ss_pred ehhhccCcceEEEEEeEecc-CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCC
Confidence 45679999999999999985 5699999999765 45566778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC------CcEEEeecCCcccccCCC
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF------FSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~------~~~kl~DfGla~~~~~~~ 657 (796)
+|+|.++|+.++.+++.+...++.|||.||++||++ +||||||||+||||+.. -.+||+|||+|+.+..
T Consensus 93 gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~-- 167 (429)
T KOG0595|consen 93 GGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP-- 167 (429)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc--
Confidence 999999999999999999999999999999999999 99999999999999864 4589999999998753
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA 714 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~ 714 (796)
.......+|++-|||||+++.++|+.|+|+||+|++|||+++|+.||+.....+...
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 223346789999999999999999999999999999999999999999887776544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=391.65 Aligned_cols=263 Identities=27% Similarity=0.416 Sum_probs=220.2
Q ss_pred HHHHHHHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCccccccccccc
Q 044281 498 ELKDATDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEA 572 (796)
Q Consensus 498 ~l~~~~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 572 (796)
++......+.++||+|+||+||+|.... .+.+.||||.+++.... ...+|++|+++++.++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 3444445577899999999999997542 34568999999886655 778999999999999999999999999999
Q ss_pred ccceeEEeecCCCCHHHHHhcCC--------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC
Q 044281 573 LNRLLVYEFMGNGTLANLIFAIP--------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH 638 (796)
Q Consensus 573 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~ 638 (796)
+.++||+|||..|||.++|..+. .++..+.+.||.|||.||+||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999999997431 267788999999999999999998 8999999999999999
Q ss_pred CCcEEEeecCCcccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHH
Q 044281 639 FFSAKISDFGLSKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAIL 716 (796)
Q Consensus 639 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l 716 (796)
+..|||+||||+|.....+... ...-.-+++|||||.+..++||.+||||||||+|||+++ |+.|+.+...++....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~- 717 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC- 717 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH-
Confidence 9999999999999876544332 223345789999999999999999999999999999998 8889887776664433
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 717 TDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
+.+|++-. .+.....++..++..||+.+|.+||+++||-..|+...+.
T Consensus 718 -------i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 -------IRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -------HHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 34454422 2344556788899999999999999999999999886544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=384.04 Aligned_cols=270 Identities=24% Similarity=0.391 Sum_probs=227.8
Q ss_pred ccccCHHHHHHHHHhHH-----------HhhCCCccceEEEEEeeCCC--CeEEEEEEecchh-hhhHHHHHHHHHHhcc
Q 044281 491 LRFFSYDELKDATDGFK-----------EELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRLA-QEREREFKSEVSAIGR 556 (796)
Q Consensus 491 ~~~~~~~~l~~~~~~~~-----------~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~ 556 (796)
..-++|++-.+|...|. ++||.|.||+|++|.++... ...||||.|+... ++...+|+.|+.+|.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 34577887777776664 46999999999999988543 3579999998643 4556799999999999
Q ss_pred cCccCcccccccccccccceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEE
Q 044281 557 THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635 (796)
Q Consensus 557 l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIl 635 (796)
+.||||++|.|+.......+||.|||+||+|+.+|+.+ ..+++.+..-+.++||.||+||.+. ++|||||.++|||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL 763 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL 763 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence 99999999999999999999999999999999999876 5789999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCCcceeecc--CCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHH
Q 044281 636 LDHFFSAKISDFGLSKLLFSDQSRTHTMIR--GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEES 712 (796)
Q Consensus 636 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~ 712 (796)
|+.+..+|++|||++|.+.++.....+..- -+.+|.|||.+...++|.++||||||+++||.++ |.+|+.....++.
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 999999999999999988665533333332 3679999999999999999999999999999987 8899876665554
Q ss_pred hHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 713 RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
...+ +...+-..++.+...+.+|++.|||+|-.+||.+.+|+.+|++++..
T Consensus 844 IkaI-----------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 844 IKAI-----------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHH-----------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 3322 11222334666778889999999999999999999999999987765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=338.95 Aligned_cols=259 Identities=25% Similarity=0.312 Sum_probs=211.0
Q ss_pred HHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecc--hhhhhHHHHHHHHHHhcccCccCcccccc-ccccccc-c
Q 044281 500 KDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLVQLLG-FCDEALN-R 575 (796)
Q Consensus 500 ~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~ 575 (796)
..+.+.+.++||+|.||+|||+... .+|..+|.|.+.- ...+..++...|+.+|++++|||||++++ -+.++.. +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3456778899999999999999865 5789999999863 33455678999999999999999999998 5555555 8
Q ss_pred eeEEeecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCC-CCeeeCCCCCCCEEEcCCCcEEEeecCCc
Q 044281 576 LLVYEFMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECN-VPIIHCDIKPQNILLDHFFSAKISDFGLS 650 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla 650 (796)
+|||||+..|+|..+++. .+.++++..++++.|++.||.++|.... .-|+||||||.||+|+++|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 899999999999999863 4578999999999999999999999432 13999999999999999999999999999
Q ss_pred ccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 651 KLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 651 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
+.+.+.... ....+|||.||+||.+.+.+|+.|+||||+||++|||.....||.+..-.+... .+.+|...
T Consensus 176 r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~--------KI~qgd~~ 246 (375)
T KOG0591|consen 176 RFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCK--------KIEQGDYP 246 (375)
T ss_pred hHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHH--------HHHcCCCC
Confidence 988655433 345779999999999999999999999999999999999999999874333222 22333322
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.+ +...++..+..++..|+..||+.||+...+++-+..
T Consensus 247 ~~--------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 PL--------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CC--------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 124566778889999999999999996555555543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.79 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=206.3
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-------hHHHHHHHHHHhcccCccCccccccccccccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-------REREFKSEVSAIGRTHHKHLVQLLGFCDEALN 574 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 574 (796)
..+-+.+.||+|+||.|-+|..+ .+++.||||++++.... ......+|+++|++++|||||++.+++...+.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~-~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEK-KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEc-ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34456688999999999999865 68999999999753211 23346799999999999999999999999999
Q ss_pred ceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC---CcEEEeecCCcc
Q 044281 575 RLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF---FSAKISDFGLSK 651 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~DfGla~ 651 (796)
.||||||++||+|.+.+-....+.+..-..++.|++.|+.|||+. ||+||||||+|||+..+ -.+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999999998888888899999999999999999 99999999999999765 779999999999
Q ss_pred cccCCCCcceeeccCCCcccccccccCCCC---CccchhHHHHHHHHHHHhCCCCCchhhHHH-HhHHHHHHHHHhhhcC
Q 044281 652 LLFSDQSRTHTMIRGTRGYVAPEWFKNVPV---SAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTDWAYDCYVEG 727 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~k~DVwS~Gv~l~elltg~~p~~~~~~~~-~~~~l~~~~~~~~~~~ 727 (796)
... ....+.+.+||+.|.|||++.++.. ..++|+||+||+||-+++|..||.....+. ....+ ..|
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI--------~~G 397 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI--------LKG 397 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH--------hcC
Confidence 765 3445667899999999999987653 347899999999999999999998654432 22222 222
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+... . .....+-.++..+++.+||..||++|||+.|+++
T Consensus 398 ~y~f--~----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RYAF--G----PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccc--c----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 2111 0 1123345577888999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=369.86 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=212.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+|...+.||+|||+.||.++.. .+|+.||+|++.+..- ...+...+|+++.+.|+|||||+++++|++.+..|||.
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~-~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDL-DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEc-CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3445678999999999999863 4789999999976332 23467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|++++++|..+++.+..+++..+..+..||+.||.|||++ +|||||||..|+||+++.++||+|||||..+..+..+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999999999999999999999999999999999 8999999999999999999999999999988665444
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
..+.+|||.|+|||++....++..+||||+||++|-||.|++||+.....+....+.. .+..+
T Consensus 175 -k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------~~Y~~---------- 237 (592)
T KOG0575|consen 175 -KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------NEYSM---------- 237 (592)
T ss_pred -cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh------cCccc----------
Confidence 3456899999999999999999999999999999999999999998766655444321 11111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.....+..+++..+|+.||.+|||+++|+..
T Consensus 238 --P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 --PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11233456678999999999999999999854
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.50 Aligned_cols=239 Identities=26% Similarity=0.344 Sum_probs=203.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.++||+|+||+||+++.+ ++++.+|+|.+++.. ....+..++|..+|.+++||.||+++..|++...+|||+||
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 35688999999999999876 688999999997643 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+.||.|..+|.+...+++..+.-++.+|+.||.|||+. +||||||||+|||||++|+++|+||||++....... ..
T Consensus 107 ~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~-~t 182 (357)
T KOG0598|consen 107 LNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD-AT 182 (357)
T ss_pred cCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-cc
Confidence 99999999999999999999999999999999999998 999999999999999999999999999996544333 33
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...........+. .+++ ...
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~--------~~k~---------~~~ 245 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL--------KGKL---------PLP 245 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh--------cCcC---------CCC
Confidence 44789999999999999999999999999999999999999999876554333321 1111 011
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRP 765 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RP 765 (796)
+.....+...++...++.||++|-
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhc
Confidence 122334566788889999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.44 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=206.5
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
..++|+|+||.|||.+.+ .+|+.||||++..... ...+-.++|+++|++++|+|+|.++.+|.....++||+||++.
T Consensus 7 LgkvGEGSYGvV~KCrnk-~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNK-DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhccccCcceEEEEeccC-CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 457999999999999977 4799999999965433 2235678999999999999999999999999999999999988
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
.-|.++-......+.+...+++.|+++|+.|+|++ ++|||||||+||||+.++.+||+|||+|+.+.. .....+.+
T Consensus 86 TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDY 161 (396)
T KOG0593|consen 86 TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDY 161 (396)
T ss_pred HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhh
Confidence 55555555555788899999999999999999999 999999999999999999999999999998864 34455667
Q ss_pred cCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hh-hcCcc-----c
Q 044281 665 RGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CY-VEGRL-----D 730 (796)
Q Consensus 665 ~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~-~~~~~-----~ 730 (796)
+.|+.|.|||.+.+ .+|...+||||+||++.||++|...|.+...-+....|...... .+ .++.. +
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 88999999999987 78999999999999999999999988777655544433322111 11 11111 1
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+.-+.......-+....-+++++..|++.||.+|++-++++.
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111111233346888999999999999999999874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.34 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=215.4
Q ss_pred HHHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhH-HHHHHHHHHhcccCccCcccccccccccccce
Q 044281 498 ELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-REFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 498 ~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
|+.+....+.++||+|-||+|.+...+ .+..||||+++..+..+. .+|..|+++|.+++|||||+++|+|..++..+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEec--CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 444445567899999999999999875 468999999988666554 89999999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 577 LVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
+|+|||++|+|.+++..+ +...-....+|+.|||.||+||.+. +++||||.++|+|+|.++++||+|||+++.+.
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999999877 3445566788999999999999998 99999999999999999999999999999765
Q ss_pred CCC-CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHH--hCCCCCchhhHHHHhHHHHHHHHHhhhcCccce
Q 044281 655 SDQ-SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII--CCRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731 (796)
Q Consensus 655 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ell--tg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (796)
... .+.....+-+++|||||.+..++++.++|||+||+++||++ +..+|+.....+..... .......+....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven----~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN----AGEFFRDQGRQV 764 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh----hhhhcCCCCcce
Confidence 544 34444556788999999999999999999999999999985 57788876544432222 222222222222
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 732 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.+. .+.-+..++.+++++||..|-++||+++++...|...
T Consensus 765 ~l~------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VLS------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ecc------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 211 1233456778899999999999999999999998753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=377.34 Aligned_cols=256 Identities=28% Similarity=0.486 Sum_probs=213.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCe----EEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGT----AIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.||+|.||.||.|...+.++. .||||.+.+. +.+...+|.+|..+|+.++|||||+++|+|.+....+|++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 3456799999999999998876664 4899999775 4566789999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcC-------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 580 EFMGNGTLANLIFAI-------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 580 e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
|||++|+|..+|++. ..+.....+.++.|||+|+.|||+. ++|||||.++|+||++...+||+|||||+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999875 3578889999999999999999998 899999999999999999999999999996
Q ss_pred ccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCC-CCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 653 LFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCR-RSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 653 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~-~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
+.+.+. +......-+.+|||||.+..+.++.|+|||||||+|||++|.. .|+......+... .....|+++
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-------~~~~ggRL~ 924 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-------DVLEGGRLD 924 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-------HHHhCCccC
Confidence 654443 2222334567999999999999999999999999999999954 5665443333211 122334332
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.+..+.+++.+++..||+.+|++||++..|++.++.+.+.
T Consensus 925 ----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 925 ----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 2455667888999999999999999999999999877654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=340.44 Aligned_cols=265 Identities=26% Similarity=0.282 Sum_probs=210.9
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-hHHHHHHHHHHhcccC-ccCcccccccccccc-ccee
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTH-HKHLVQLLGFCDEAL-NRLL 577 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~l 577 (796)
...|...++||.|+||.||+|+-. .+++.||||++++.... .+--=++|++.|++++ |||||+|..++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~-~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeec-CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346778899999999999999865 46889999999764332 2233478999999998 999999999998888 8999
Q ss_pred EEeecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 578 VYEFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
|||||+. +|.++++.+. .+++..+..|+.||++||+|+|++ |+.|||+||+|||+..+..+||+|||+||.....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 9999976 9999998764 679999999999999999999999 9999999999999999999999999999976543
Q ss_pred CCcceeeccCCCcccccccc-cCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----hhc-----
Q 044281 657 QSRTHTMIRGTRGYVAPEWF-KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----YVE----- 726 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~~~----- 726 (796)
...+.++.|+.|.|||++ +.+-|+.+.|+||+|||++|+.+.+..|.+..+-+...-+-+..... +.+
T Consensus 164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 445667789999999987 56789999999999999999999999998766554433332222111 111
Q ss_pred ----CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 ----GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 ----~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
-+............. .....+.++++.+|++-||.+|||+++.+++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111111111111 2366788899999999999999999999986
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=355.44 Aligned_cols=258 Identities=30% Similarity=0.397 Sum_probs=211.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCC---eEEEEEEecc---hhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~---~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.++||+|+||+||+|.++..++ ..||||..+. .......+|.+|+++|++++|||||+++|++.....+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 44889999999999999986644 2389999874 34566789999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|++.||+|.++|...+ .++..++++++.+.|.||+|||+. ++|||||.++|+|++.++.+||+||||++... ..
T Consensus 241 El~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--~~ 315 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--QY 315 (474)
T ss_pred EecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc--ce
Confidence 9999999999999877 599999999999999999999998 99999999999999999999999999998543 11
Q ss_pred ccee-eccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 RTHT-MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 ~~~~-~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.... ...-+..|+|||.+....++.++|||||||++||+++ |..|+.+....+....+. .++.....
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~-------~~~~r~~~---- 384 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV-------KNGYRMPI---- 384 (474)
T ss_pred eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-------hcCccCCC----
Confidence 1111 2235789999999999999999999999999999999 788888766554433321 11111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPP 784 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp 784 (796)
+......+..++..||+.+|++||+|.++.+.|+.+.....++
T Consensus 385 -----~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 385 -----PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred -----CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 1122344556777999999999999999999999877765554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=338.66 Aligned_cols=265 Identities=24% Similarity=0.267 Sum_probs=211.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCccccccccccc--ccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 579 (796)
+.-.++||+|+||.|||++.. .+|+.||+|++.... ........+|+.+|++++||||++|.+...+. ...|||+
T Consensus 119 feki~kIGeGTyg~VYkAr~~-~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDL-ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHhcCcchhheeEeeec-ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 334578999999999999854 579999999996543 33346678999999999999999999998776 6789999
Q ss_pred eecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||++ +|.-++... -+++..++..++.||+.||+|+|+. +|+|||||.+|||||++|.+||+|||||+++.....
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99988 888888764 4789999999999999999999998 999999999999999999999999999999887777
Q ss_pred cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----hhcCccc--e
Q 044281 659 RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----YVEGRLD--V 731 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~~~~~~~--~ 731 (796)
...+..+-|..|.|||++.|. .|+.+.|+||.||||.||+.|+..+.+..+.++...|....-.. |.-.++. .
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 778888889999999999875 79999999999999999999999999887766655544322211 1111111 1
Q ss_pred eccchhh-----hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 732 LIDSDEA-----AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 732 ~~d~~~~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+.+... .+.-.......+.|+..+|..||.+|.|+.++++.
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111100 00011122356778888999999999999998864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.19 Aligned_cols=249 Identities=27% Similarity=0.345 Sum_probs=209.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 579 (796)
..|.+.||+|+|++|++++.+ .+++.+|||++.+.. +...+....|-.+|.+| .||.|++|+-.|++...+|+|+
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~-~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREK-ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred cchhheeccccceeEEEeeec-CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 457899999999999999976 478999999997643 23345677888999999 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++|+|.++|...+.+++.....++.+|+.||+|||++ |||||||||+|||||+++++||+|||-|+.+......
T Consensus 154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999999999999999999999999999999999998 9999999999999999999999999999998643321
Q ss_pred ----------ce--eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 660 ----------TH--TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 660 ----------~~--~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
.. ...+||..|.+||++..+..+..+|+|+|||+||+|+.|..||....+-..-..+....+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~----- 305 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE----- 305 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc-----
Confidence 11 3478999999999999999999999999999999999999999876543322222211111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
.+....+.+.+|+.+.|..||.+|+|.++|.++.
T Consensus 306 -------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 306 -------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1111224556688888999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.57 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=209.9
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
.++||+|+.|.||.+... .+++.||||++........+-+.+|+.+|+..+|+|||+++..+...+++|+|||||++|+
T Consensus 278 ~~kigqgaSG~vy~A~~~-~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKI-STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred hhhhccccccceeeeeec-cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 367999999999999854 5788999999988777777788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccC
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 666 (796)
|.+.+... .+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... .....+|
T Consensus 357 LTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVG 431 (550)
T KOG0578|consen 357 LTDVVTKT-RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVG 431 (550)
T ss_pred hhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccC
Confidence 99988764 488999999999999999999999 999999999999999999999999999998765554 3445679
Q ss_pred CCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 044281 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRL 746 (796)
Q Consensus 667 t~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 746 (796)
|+.|||||+.....|..|.||||||++++||+-|..||-.+.+-....++. .+|... ........
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~ng~P~--------lk~~~klS 496 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TNGTPK--------LKNPEKLS 496 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------hcCCCC--------cCCccccC
Confidence 999999999999999999999999999999999999997655543333332 122211 11123344
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 747 HKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 747 ~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.+++.+||+.|+++||++.|+|++
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 567789999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.36 Aligned_cols=250 Identities=32% Similarity=0.439 Sum_probs=201.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccc--cceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL--NRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e~~ 582 (796)
...+.||+|+||.||++.... +|...|||..........+.+.+|+.+|.+++|||||+.+|...... ..+++|||+
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhccccCccceEEEEEEecC-CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 345789999999999998763 48899999987653333667899999999999999999999855544 588999999
Q ss_pred CCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccccC--CCC
Q 044281 583 GNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFS--DQS 658 (796)
Q Consensus 583 ~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~--~~~ 658 (796)
++|+|.+++.... .+++..+.++..||++||+|||++ +|+||||||+|||++. ++.+||+|||+++.... ...
T Consensus 99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999999876 799999999999999999999998 9999999999999999 79999999999997763 223
Q ss_pred cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchh-hHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.......||+.|||||++..+ ....++|||||||++.||+||+.|+... ...+ +......+...+
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~-------~~~~ig~~~~~P------ 242 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE-------ALLLIGREDSLP------ 242 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH-------HHHHHhccCCCC------
Confidence 334467899999999999963 3345999999999999999999998753 1111 111111111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
..+.....+..+++.+|++.||++|||+.++++..
T Consensus 243 ---~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 ---EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ---CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11223445677899999999999999999999876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.67 Aligned_cols=284 Identities=24% Similarity=0.264 Sum_probs=216.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
|.-.++||+|.||.||+|+.. .+|+.||||+++.... .......+|++.|+.++|+||+.+++++...+.+-||+||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~-~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDT-ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhcCcceEEEEEEEec-CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 445678999999999999965 5899999999965322 2245789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+. +|...+++.. .+.-.+...++.++++|++|+|++ .|+||||||.|+|++.+|.+||+|||+|+.+.......
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 976 9999998764 567788999999999999999999 89999999999999999999999999999886544332
Q ss_pred eeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC--ccceeccchh
Q 044281 661 HTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG--RLDVLIDSDE 737 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d~~~ 737 (796)
. ..+-|..|.|||.+.|. .|+...|+||.||++.||+-|..-|.+...-++...+-...-....+. .+..+.|...
T Consensus 159 ~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 159 T-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred c-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 2 22579999999999875 689999999999999999998887777665444333322111111110 1111222111
Q ss_pred h--------hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCCCCCccccCCC
Q 044281 738 A--------AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPSSFSIAGT 794 (796)
Q Consensus 738 ~--------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp~p~~~~~~~~ 794 (796)
- ...-....+..++++..++..||.+|++++|++++= -..+.|.|-.|...+..++
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhCcCCcc
Confidence 1 101123345668999999999999999999998873 2344555655565555544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=337.92 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=210.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
|.+.+.||+|.||.||||+-+ .+.+.||+|.+.+. .++..+.+.+|+++++.++|||||.+++.|+...++++|.||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK-~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRK-YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred hhHHHHhcCCccceeeecccc-cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 567789999999999999965 57899999999763 334567799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+.+ +|..+|.....++++.+..|+.++..||.|||++ +|+|||+||+|||++..+.+|++|||+|+.+... ....
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl 157 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL 157 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence 987 9999999999999999999999999999999999 8999999999999999999999999999987553 3345
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
+.+.|||-|||||...+++|+..+|.||+||++||+++|++||.....-.....| .. |+. ..
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I-------~~--------d~v---~~ 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI-------LK--------DPV---KP 219 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH-------hc--------CCC---CC
Confidence 6678999999999999999999999999999999999999999865433222111 11 111 11
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+..++...+++||..|.|..+++.+
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 22445567788889999999999999998864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.80 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=205.0
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecc--hhhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
.....+.+.||+|.||+||+|.+. -.||||+++. ...+..+.|++|+..+++-+|.||+-+.|+|..+.. .||
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh----GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH----GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred HHHhhccceeccccccceeecccc----cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 333445678999999999999985 2699999964 334567899999999999999999999999999887 999
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC-
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD- 656 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~- 656 (796)
..++++.+|..+|+.. .+++..+.+.||+|||+|+.|||.+ +|||||||..||++.++++|||+||||+..-..-
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 9999999999999865 4788899999999999999999998 9999999999999999999999999999753211
Q ss_pred CCcceeeccCCCcccccccccC---CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
.........|...|||||+++. .+|+.++||||||+++|||++|..|+.....+.... .-|+-....
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif----------mVGrG~l~p 612 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF----------MVGRGYLMP 612 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE----------EecccccCc
Confidence 1111222346778999999964 479999999999999999999999998443332111 111111111
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
|.... .....+++.+|+..||..++++||.+.+|+.+|+.++.
T Consensus 613 d~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 DLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 21111 22334567778999999999999999999999988765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.33 Aligned_cols=258 Identities=28% Similarity=0.388 Sum_probs=200.6
Q ss_pred HHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccc-cc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEAL-NR 575 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~ 575 (796)
.+.+.++||+|+||.||+|... ..+++.||||++.... ......+.+|+.++..+ +||||++++++|.... ..
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 3456688999999999999742 2345689999997533 23346789999999999 8999999999887644 57
Q ss_pred eeEEeecCCCCHHHHHhcC-------------------------------------------------------------
Q 044281 576 LLVYEFMGNGTLANLIFAI------------------------------------------------------------- 594 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~------------------------------------------------------------- 594 (796)
++||||+++|+|.+++...
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 8999999999999988642
Q ss_pred -CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-ceeeccCCCcccc
Q 044281 595 -PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVA 672 (796)
Q Consensus 595 -~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~a 672 (796)
..+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ......++..|+|
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2366778889999999999999998 9999999999999999999999999999865433221 1223346788999
Q ss_pred cccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHH
Q 044281 673 PEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLM 751 (796)
Q Consensus 673 PE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 751 (796)
||.+.+..++.++|||||||++|||++ |..||......+.. ......+..... +......+.+
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~l~~ 308 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-------CQRLKDGTRMRA---------PENATPEIYR 308 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-------HHHHhcCCCCCC---------CCCCCHHHHH
Confidence 999999999999999999999999997 88998754322110 011112211110 1122345778
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 752 IAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 752 l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
++.+||+.||++|||+.+|+++|+.++.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.75 Aligned_cols=239 Identities=29% Similarity=0.435 Sum_probs=200.8
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCH
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL 587 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 587 (796)
+=||.|+-|.||+|+++ ++.||||+++... ..+++.|++|+|+||+.+.|+|....-.+|||||++.|-|
T Consensus 130 eWlGSGaQGAVF~Grl~---netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH---NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhccCcccceeeeecc---CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 45999999999999986 6899999986532 3478899999999999999999999999999999999999
Q ss_pred HHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCC
Q 044281 588 ANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGT 667 (796)
Q Consensus 588 ~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 667 (796)
...|+....++-.....+..+||.|+.|||.+ .|||||||.-||||..+..+||+|||-++..... .+.....||
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGT 274 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGT 274 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhh
Confidence 99999999999999999999999999999999 8999999999999999999999999999876433 334456799
Q ss_pred CcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHH
Q 044281 668 RGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLH 747 (796)
Q Consensus 668 ~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 747 (796)
..|||||++++.+.++|+|||||||+|||||||..|+........ | |. +-...+.-..+....+
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---I-------wG------VGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---I-------WG------VGSNSLHLPVPSTCPD 338 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---E-------Ee------ccCCcccccCcccCch
Confidence 999999999999999999999999999999999999864322110 0 00 0011111122334445
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 748 KWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 748 ~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
-+.-++.+||+..|.+||++++|+.+|+-.
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 667788999999999999999999999743
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=309.31 Aligned_cols=233 Identities=27% Similarity=0.306 Sum_probs=198.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||.|+||.|.+++.+. ++..+|+|++++..- +..+...+|..+|+.+.||+++++.+.+.+...++|||||+
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~-~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKH-SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred heeeeccCccceEEEEEEcc-CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 44679999999999999874 689999999987443 33456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|.|..+|+..+++++..+.-+|.||+.||+|||+. .|++|||||+|||+|.+|.+||+|||+|+..... .-
T Consensus 127 ~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~ 199 (355)
T KOG0616|consen 127 PGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TW 199 (355)
T ss_pred CCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----EE
Confidence 9999999999999999999999999999999999998 8999999999999999999999999999976332 45
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
+.+|||.|+|||++..+++..++|-|||||++|||+.|..||....+.... +.+.++++. .+
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY--------~KI~~~~v~----------fP 261 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY--------EKILEGKVK----------FP 261 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH--------HHHHhCccc----------CC
Confidence 678999999999999999999999999999999999999999887664332 222333321 12
Q ss_pred HHHHHHHHHHHHHhcccCCCCC
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKR 764 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~R 764 (796)
......+.+++...+|.|-.+|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh
Confidence 2333445567777778888877
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=330.49 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=204.3
Q ss_pred HHHhHHHhhCCCccceEEEEEeeC--CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
..+.+.+.||+|+||.||+|.++. ..+..||+|.++... ......|.+|+..+.+++||||+++++++......++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 345567889999999999998653 345789999987643 23456799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999998764 4688999999999999999999998 89999999999999999999999999876542222
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+....+ .++....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~--------~~~~~~~----- 228 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV--------EDGFRLP----- 228 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--------HCCCCCC-----
Confidence 111122335678999999999999999999999999999875 99998765443321111 1111100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.+......+.+++..||+.+|++||++.+|++.|+++
T Consensus 229 ----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 ----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112334577799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=332.87 Aligned_cols=246 Identities=17% Similarity=0.242 Sum_probs=200.0
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhh---HHHHHHHHHHhcccCccCcccccccccc----cccceeEEe
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKHLVQLLGFCDE----ALNRLLVYE 580 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e 580 (796)
..||+|++|.||+|.. +++.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 3599999999999987 57899999997643222 4678899999999999999999999866 346789999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|.+++.....+++....+++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+....
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999999998888999999999999999999999742 67899999999999999999999999998653321
Q ss_pred eeeccCCCcccccccccC--CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 661 HTMIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+. ..+....
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~-------~~~~~~~------- 242 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII-------NKNNSLK------- 242 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hcCCCCC-------
Confidence 22357889999999976 689999999999999999999999998654433221110 0110000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01123346778999999999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=323.47 Aligned_cols=258 Identities=25% Similarity=0.331 Sum_probs=205.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
|.+.++||.|.-++||+|+... .++.||||++.-..- ...+.+.+|+..+..++||||++++..|..+..+|+||.||
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p-~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIP-TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred eeEEEEEeccceeEeeeeeecc-cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 4567899999999999999874 569999999965332 23578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
.+|++.++++.. ..+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.+||+|||.+..+.....+.
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999864 4688889999999999999999999 99999999999999999999999999988776544322
Q ss_pred e---eeccCCCccccccccc--CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 661 H---TMIRGTRGYVAPEWFK--NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 661 ~---~~~~gt~~y~aPE~~~--~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
. ...+||+.|||||+++ ...|+.|+||||||++..||.+|..||...-+.... +.. ..+....+.-.
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~t------Lqn~pp~~~t~ 255 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLT------LQNDPPTLLTS 255 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHH------hcCCCCCcccc
Confidence 2 4467999999999964 347999999999999999999999999754433211 110 11221111111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.............+.+++..||++||++|||++++++.
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11111222333467778899999999999999998853
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=324.47 Aligned_cols=265 Identities=28% Similarity=0.403 Sum_probs=201.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcc--cCccCcccccccccccc----cceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR--THHKHLVQLLGFCDEAL----NRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lv 578 (796)
.+.+.||+|+||.||||++. ++.||||++.. +..+.|++|-.+... ++|+||+++++.-.... +.+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~---~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD---NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhcc---CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 35688999999999999985 68999999965 345678888777765 58999999999987666 78999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC------CCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC------NVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~------~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
+||.+.|+|.++|..+ .++|....+|+..+++||+|||+.. +++|+|||||.+||||.+++++.|+|||+|.+
T Consensus 287 t~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 9999999999999864 6899999999999999999999864 67899999999999999999999999999998
Q ss_pred ccCCCCcc-eeeccCCCcccccccccCCC-CC-----ccchhHHHHHHHHHHHhCCCCCc--------hhhHHHHhH-HH
Q 044281 653 LFSDQSRT-HTMIRGTRGYVAPEWFKNVP-VS-----AKVDVYSFGVTLLEIICCRRSVE--------MELEEESRA-IL 716 (796)
Q Consensus 653 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~s-----~k~DVwS~Gv~l~elltg~~p~~--------~~~~~~~~~-~l 716 (796)
+....... ....+||.+|||||++.+.- +. .+.||||+|.+||||++.-.-++ ...+.+... .-
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 86544322 23477999999999997642 22 37999999999999998553322 112211110 00
Q ss_pred HHHHHHh-hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 717 TDWAYDC-YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 717 ~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.+..+.. ..+...+.+.+.-.. ...+..+.+.+..||..||+.|.|+.=|-+.+..+...
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 0111111 122222333332222 24456778899999999999999999999888776544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.32 Aligned_cols=261 Identities=27% Similarity=0.382 Sum_probs=218.2
Q ss_pred HHHHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 497 DELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 497 ~~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
-|+.+....+.++||.|.||.||.|+++.. .-.||||.|+... -..++|+.|+.+|+.++|||+|+|+|+|......|
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKky-slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeecc-ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 345555555678999999999999999854 5789999998754 34689999999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 577 LVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
||.|||.+|+|.++|... ..++--..+.++.||+.||+||... ++|||||.++|+|+.++..+||+||||++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999864 3556667889999999999999998 89999999999999999999999999999997
Q ss_pred CCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
.+....+....-++.|.|||.+....++.|+|||+|||+||||.| |..|+.+..... ++..+..|-.
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq--------VY~LLEkgyR---- 484 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYGLLEKGYR---- 484 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH--------HHHHHhcccc----
Confidence 776655555556889999999999999999999999999999998 677776543322 3333332211
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
...+..+..++.++++.||+-+|.+||++.|+.+.+|.++.
T Consensus 485 -----M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 485 -----MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -----ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 11133345678889999999999999999999999988754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=339.19 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=205.1
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch----hh-hhHHHHHHHHHHhcccC-ccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL----AQ-EREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 576 (796)
.+.+.+.||+|.||+|++|... .+++.||+|.+++. .. ...+.+.+|+.++++++ ||||++++.++......+
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 3456678999999999999876 46799999977653 11 23456778999999998 999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC-CcEEEeecCCcccccC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF-FSAKISDFGLSKLLFS 655 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~ 655 (796)
+||||+.+|+|.+.+.+..++.+..+..++.||+.|++|+|+. +|+||||||+|||++.+ +++||+|||++....
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 9999999999999999988999999999999999999999998 99999999999999999 999999999999774
Q ss_pred CCCcceeeccCCCcccccccccCCC-CC-ccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVP-VS-AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
.........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+......... .+..+....
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~--------ki~~~~~~~-- 242 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR--------KIRKGEFKI-- 242 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH--------HHhcCCccC--
Confidence 2334456678999999999999987 86 78999999999999999999998743322111 112221110
Q ss_pred cchhhhhhcHHH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 044281 734 DSDEAAMADRSR-LHKWLMIAMWCIQEDPSKRPTMKVVL 771 (796)
Q Consensus 734 d~~~~~~~~~~~-~~~l~~l~~~Cl~~dp~~RPt~~evl 771 (796)
+... ..++..++.+|++.||.+|+|+.+|+
T Consensus 243 --------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 243 --------PSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111 45677899999999999999999999
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.60 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=199.2
Q ss_pred HhHHHhhCCCccceEEEEEeeC---------------CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT---------------ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLG 567 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~---------------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g 567 (796)
+.+.++||+|+||.||++.++. .++..||+|.+.... .....+|.+|+.++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 4456789999999999997542 234579999987532 334568999999999999999999999
Q ss_pred cccccccceeEEeecCCCCHHHHHhcC-------------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCC
Q 044281 568 FCDEALNRLLVYEFMGNGTLANLIFAI-------------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCD 628 (796)
Q Consensus 568 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~D 628 (796)
++.+....++||||+++++|.+++... ..+++...++++.||+.||+|||+. +|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence 999999999999999999999988643 2357788999999999999999998 899999
Q ss_pred CCCCCEEEcCCCcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh--CCCCCc
Q 044281 629 IKPQNILLDHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC--CRRSVE 705 (796)
Q Consensus 629 lk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt--g~~p~~ 705 (796)
|||+|||+++++.+||+|||+++.+..... .......++..|+|||.+.+..++.++||||||+++|||++ +..|+.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 999999999999999999999986543322 11223345788999999998899999999999999999987 456665
Q ss_pred hhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 706 MELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 706 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
........... .............. .+......+.+++.+||+.||++||||.+|++.|+.
T Consensus 244 ~~~~~~~~~~~----~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 ELTDEQVIENA----GEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCHHHHHHHH----HHHhhhcccccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 44332221111 11111111000000 011223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=331.43 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=219.2
Q ss_pred HHHHHHHhHHHhhCCCccceEEEEEeeCC-CC--eEEEEEEecc-hhhhhHHHHHHHHHHhcccCccCcccccccccccc
Q 044281 498 ELKDATDGFKEELGRGSFGIVYKGVLKTA-SG--TAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL 573 (796)
Q Consensus 498 ~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~-~~--~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 573 (796)
++.++...+.+.||+|-||.||+|+..+. .| -.||||..+. ......+.|++|..+|+.++|||||+++|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 44455556678999999999999987654 23 3689999876 334557789999999999999999999999976 4
Q ss_pred cceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 574 NRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
..|+|||.++-|.|..+|+.. ..++......++.||..||+|||+. +.|||||.++|||+...--+||+|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 689999999999999999865 4788889999999999999999998 899999999999999999999999999999
Q ss_pred ccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccce
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (796)
+..+.........-++.|||||.+.-.+++.++|||.|||.+|||++ |.+||.+... ..+-.
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sDVI~ 603 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SDVIG 603 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cceEE
Confidence 87777666666667889999999999999999999999999999987 7889875322 22223
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 732 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.++...+...++.+...+..++.+||..||.+||++.++...|+.+++
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 334444445566677788889999999999999999999998877655
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.78 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=208.6
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
.+.||+|.||.||||... .+++.||+|.+.-... ...+++.+|+.++.+++++||.+++|.+..+..++++|||+.+|
T Consensus 18 ~~~IgrGsfG~Vyk~~d~-~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG 96 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDN-KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG 96 (467)
T ss_pred chhccccccceeeeeeec-cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence 478999999999999965 5789999999975433 44578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeecc
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR 665 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 665 (796)
++.++|.....+++....-|..+++.||.|||.+ +.+|||||+.|||+..+|.+||+|||++..+.....+. ...+
T Consensus 97 sv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfv 172 (467)
T KOG0201|consen 97 SVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFV 172 (467)
T ss_pred chhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cccc
Confidence 9999999887778888888999999999999999 89999999999999999999999999999876655555 5677
Q ss_pred CCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHH
Q 044281 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSR 745 (796)
Q Consensus 666 gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 745 (796)
||+.|||||++....|+.|+||||||++.+||.+|..|+....+..... ++............
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-----------------lIpk~~PP~L~~~~ 235 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-----------------LIPKSAPPRLDGDF 235 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----------------eccCCCCCcccccc
Confidence 9999999999998899999999999999999999999987554422222 22211111222245
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 746 LHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 746 ~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...+.+++..||++||+.||++.++++.
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 5667889999999999999999998854
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.38 Aligned_cols=257 Identities=28% Similarity=0.386 Sum_probs=201.1
Q ss_pred HHHhHHHhhCCCccceEEEEEe----eCCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVL----KTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~----~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 575 (796)
..+.+.+.||+|+||.||+++. ...++..||||+++... ....+.+.+|+.++..+ +||||++++++|......
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3456778999999999999974 22356789999996532 23446788999999999 899999999999999999
Q ss_pred eeEEeecCCCCHHHHHhcCC------------------------------------------------------------
Q 044281 576 LLVYEFMGNGTLANLIFAIP------------------------------------------------------------ 595 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 595 (796)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999886421
Q ss_pred ---------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 596 ---------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 596 ---------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
.+++..+++++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 367788899999999999999998 89999999999999999999999999998664333211
Q ss_pred -eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 661 -HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 661 -~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||......... ......+.....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~~~~~~~------ 338 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-------YKMIKEGYRMLS------ 338 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH-------HHHHHhCccCCC------
Confidence 122335678999999999999999999999999999998 77887644322111 111111111000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
+.....++.+++.+||+.||++||+|.+|+++|++.
T Consensus 339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 001124577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.91 Aligned_cols=248 Identities=21% Similarity=0.265 Sum_probs=208.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
...+||+|+||.||+++-+ .+|..+|+|+|++... ...+..+.|-.+|....++.||+|+..|++...+||||||+
T Consensus 145 ~Lk~IgkGAfGeVrLarKk-~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKK-DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hheeeccccceeEEEEEEc-cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 3467999999999999966 5899999999987543 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC------
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD------ 656 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~------ 656 (796)
+||++..+|.....+++..+..++.+++.|+.-||+. |+|||||||+|+|||..|++||+||||+.-+...
T Consensus 224 PGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 224 PGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred CCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 9999999999999999999999999999999999998 9999999999999999999999999999543110
Q ss_pred ----------------CCc-----c-------------------eeeccCCCcccccccccCCCCCccchhHHHHHHHHH
Q 044281 657 ----------------QSR-----T-------------------HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLE 696 (796)
Q Consensus 657 ----------------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~e 696 (796)
... . ....+|||.|||||++.+..|+..+|.||||||+||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 000 0 011359999999999999999999999999999999
Q ss_pred HHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 044281 697 IICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT---MKVVLQ 772 (796)
Q Consensus 697 lltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~evl~ 772 (796)
||.|-+||..+.+.+....+..|......... .....+..+++.+|+. ||++|-- ++||-+
T Consensus 381 mLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999999999888777777654322111 1112566778888888 9999976 555544
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=326.58 Aligned_cols=248 Identities=32% Similarity=0.493 Sum_probs=194.0
Q ss_pred HHhhCCCccceEEEEEee---CCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 507 KEELGRGSFGIVYKGVLK---TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.||.|.||.||+|.+. ...+..|+||.++... ....+.|.+|++.+++++||||++++|++......++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 457999999999999987 2345789999996533 334788999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-c
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-R 659 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~ 659 (796)
++|+|.++|... ..+++..+..|+.||++||.|||+. +++|++|+++||++++++.+||+|||+++....... .
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999886 6889999999999999999999998 899999999999999999999999999987632222 2
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
..........|+|||.+.+..++.++||||||+++|||++ |+.|+......+.... +.++....
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~--------~~~~~~~~------- 225 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK--------LKQGQRLP------- 225 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH--------HHTTEETT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccce-------
Confidence 2223446778999999999999999999999999999999 6788765433321111 11222111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
.+......+..++.+||+.+|++||+|.+|++.|
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111234567899999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=376.26 Aligned_cols=257 Identities=26% Similarity=0.533 Sum_probs=205.0
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
.+.||+|+||.||+|+.. .+++.||||+++..... ..+|++.+++++|||||+++|+|.+....++||||+++|+
T Consensus 695 ~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 695 ENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred ccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 357999999999999875 36789999998653321 2346888999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccC
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 666 (796)
|.++++. ++|..+.+++.|||+||+|||+.+..+|+||||||+||+++.++.+++. ||.+...... ....+
T Consensus 770 L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~ 840 (968)
T PLN00113 770 LSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFI 840 (968)
T ss_pred HHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccc
Confidence 9999963 7899999999999999999997666799999999999999999988876 6665433211 12357
Q ss_pred CCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh--hhcHH
Q 044281 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA--MADRS 744 (796)
Q Consensus 667 t~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~--~~~~~ 744 (796)
|+.|+|||++.+..++.++|||||||++|||++|+.|++..... ...+..|+............+|+.... ....+
T Consensus 841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (968)
T PLN00113 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918 (968)
T ss_pred cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence 89999999999999999999999999999999999998543221 112334444433333444444443322 23456
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+..++.+++.+||+.||++||||.||+++|+++..
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 67788999999999999999999999999998765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.17 Aligned_cols=242 Identities=25% Similarity=0.298 Sum_probs=199.3
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.||+|+||.||++..+ .+++.||+|+++... ......+.+|+.++++++||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999865 468899999997532 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 99999998888899999999999999999999998 99999999999999999999999999997532221 222345
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+ ..+... .+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~----------~p~~ 217 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEEIR----------FPRT 217 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH--------HcCCCC----------CCCC
Confidence 6899999999999999999999999999999999999999765433322111 111110 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRP-----TMKVVLQ 772 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 772 (796)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 234567899999999999999 7988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=339.01 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=201.4
Q ss_pred HHHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 575 (796)
..+.+.+.||+|+||.||+++.. ..++..||+|++.... ......+.+|+.+++.+ +|+||++++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 34556789999999999998753 1234589999997532 33356788999999999 899999999999999999
Q ss_pred eeEEeecCCCCHHHHHhcC-------------------------------------------------------------
Q 044281 576 LLVYEFMGNGTLANLIFAI------------------------------------------------------------- 594 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~------------------------------------------------------------- 594 (796)
++||||+++|+|.+++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999988532
Q ss_pred ---------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc-eeec
Q 044281 595 ---------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT-HTMI 664 (796)
Q Consensus 595 ---------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~ 664 (796)
..+++..+++++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++......... ....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1356778899999999999999998 99999999999999999999999999998654332211 1223
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
.++..|+|||++.+..++.++|||||||++|||++ |+.||........... ....+..... +.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~-------~~~~~~~~~~---------~~ 338 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK-------MVKRGYQMSR---------PD 338 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH-------HHHcccCccC---------CC
Confidence 35678999999999999999999999999999997 9999875433221111 1111100000 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.....+.+++.+||+.||.+|||+.+|+++|++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11245778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=333.97 Aligned_cols=264 Identities=25% Similarity=0.360 Sum_probs=204.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||+++.+ .++..+|+|.+.... ......+.+|++++++++|+||+++++++......++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred ceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 344578999999999999875 467899999986532 233567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 160 (331)
T cd06649 86 DGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 160 (331)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---ccc
Confidence 99999999988888899999999999999999999852 6999999999999999999999999999865322 123
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcc-------------
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL------------- 729 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~------------- 729 (796)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+....... ..+..
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDG-EEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc-ccCCccccCccccccccc
Confidence 3468999999999999999999999999999999999999997554433222111000000 00000
Q ss_pred ------------------ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 730 ------------------DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 730 ------------------~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
..+................+.+++.+||+.||++|||+.++++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000001112345688899999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.98 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=210.0
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
-.+.+.+.||+|.||.|-++... ..|+.||||.+++... +..-.+.+|+++|..++||||+.++.+|+..+...||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~-~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEH-KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhc-cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35678899999999999999854 4789999999976443 3445688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||..+|.|.+++.....+++..+..++.||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++-++.. .
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--K 206 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc--c
Confidence 99999999999999999999999999999999999999999 899999999999999999999999999987643 3
Q ss_pred cceeeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
....+.+|++-|.+||++.+.+| .+.+|-|||||+||-|+.|..||++.........+...++ .+
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY---rE----------- 272 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY---RE----------- 272 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc---cC-----------
Confidence 34567789999999999999998 5789999999999999999999998765443333322111 11
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
++......-+++|||-.+|++|.|+.+|...
T Consensus 273 -----P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 -----PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -----CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1112234568999999999999999999865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.65 Aligned_cols=243 Identities=21% Similarity=0.242 Sum_probs=200.9
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||++..+ .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred eeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 34578999999999999875 468899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++|.+++.....+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..... .
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~ 155 (291)
T cd05612 83 VPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T 155 (291)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence 99999999998888899999999999999999999998 9999999999999999999999999999865332 1
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+... .
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~~----------~ 217 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--------LAGKLE----------F 217 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCcC----------C
Confidence 2346899999999999999999999999999999999999999765443322211 111110 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~~ 773 (796)
+......+.+++.+||+.||.+||+ ++++++.
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111345677999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=331.41 Aligned_cols=240 Identities=23% Similarity=0.274 Sum_probs=195.6
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
||+|+||.||++... .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999875 467899999986532 2344678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccC
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 666 (796)
|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 999998888899999999999999999999998 89999999999999999999999999998643222 22234568
Q ss_pred CCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 044281 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRL 746 (796)
Q Consensus 667 t~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 746 (796)
|+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+... .+....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--------~~~~~~----------~~~~~~ 217 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--------LQEPLR----------FPDGFD 217 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--------HcCCCC----------CCCcCC
Confidence 99999999999999999999999999999999999999765433221111 111100 011123
Q ss_pred HHHHHHHHHhcccCCCCCCCH---HHHHH
Q 044281 747 HKWLMIAMWCIQEDPSKRPTM---KVVLQ 772 (796)
Q Consensus 747 ~~l~~l~~~Cl~~dp~~RPt~---~evl~ 772 (796)
..+.+++.+||+.||++||++ .++++
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 456778999999999999864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.67 Aligned_cols=251 Identities=28% Similarity=0.396 Sum_probs=203.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.++||+|+||.||+|..+ ..++.|++|.+... .....++.+|++++++++|+||+++++++......+++|||+++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred EEeeecCCcccceEEEEEEe-cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 45578999999999999976 35789999998753 33456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 585 GTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 585 gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|.+++... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||+++...........
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 9999998753 3578899999999999999999998 8999999999999999999999999999876433222222
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....+..|+|||.+.+..++.++|||||||++|||++ |..|+.....++....+ ..+.... .
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~---------~ 226 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKGYRME---------R 226 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCCCC---------C
Confidence 2234668999999999999999999999999999998 88888654433221111 1110000 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
+......+.+++.+||+.+|++||++.+++++|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=334.87 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=211.6
Q ss_pred hHHHhhCCCccceEEEEEeeCCCC---eEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.-.++||+|+||+||||.+-.+.. -+||+|.+.... .+...++++|+.+|.+++||||+||+|+|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 345689999999999998865422 378999986543 445689999999999999999999999998877 889999
Q ss_pred ecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+.|+|.++++.+ ..+..+..+.+..|||+||.|||++ +++||||.++||||..-.++||.|||+++++..+...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999864 5788899999999999999999998 8999999999999999999999999999998766543
Q ss_pred cee-eccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 660 THT-MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 660 ~~~-~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
... ...-.+.|||-|.++...|+.++|||||||++||++| |.+|++....++....+ +.|.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll--------e~ge--------- 917 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL--------EKGE--------- 917 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH--------hccc---------
Confidence 332 2334678999999999999999999999999999998 77898877666544433 1221
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
+-..++.....+..++.+||..|+..||+++++...+.+....
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1223445566788899999999999999999999888765543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=334.32 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=204.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||.||+|... .+++.||+|+++.... .....+.+|+.++..++||||+++++++.+....++||||+
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 4568999999999999876 4678999999975432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 84 ~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~ 156 (333)
T cd05600 84 PGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YAN 156 (333)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccC
Confidence 9999999998888889999999999999999999998 899999999999999999999999999986533 223
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..+... +.........
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------~~~~~~~~~~ 226 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------LQRPVYDDPR 226 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----------ccCCCCCccc
Confidence 456899999999999999999999999999999999999999866554433222211100 0000000001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....++.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1234567789999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=326.08 Aligned_cols=264 Identities=21% Similarity=0.224 Sum_probs=202.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||+++.+ .+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred eEEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 34578999999999999875 467899999986532 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++.+..+......+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 83 EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9988776665556788999999999999999999998 8999999999999999999999999999876443333334
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHH--------HHhhhcCccceecc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA--------YDCYVEGRLDVLID 734 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~--------~~~~~~~~~~~~~d 734 (796)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... ..............
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 4568999999999999899999999999999999999999997654332221111100 00000000000000
Q ss_pred chh------hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 735 SDE------AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 735 ~~~------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+.. ...........+.+++.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00001112346888999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.75 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=204.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCC----CeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTAS----GTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
..+.+.||+|+||.||+|...... ...|++|.+.... .....+|.+|+..+.+++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 446788999999999999875322 2679999986533 23456799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcE
Q 044281 579 YEFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSA 642 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 642 (796)
|||+++++|.+++... ..+++...+.++.||+.||+|||+. +++|+||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 9999999999998754 3467788899999999999999998 89999999999999999999
Q ss_pred EEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHH
Q 044281 643 KISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWA 720 (796)
Q Consensus 643 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~ 720 (796)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i---- 239 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI---- 239 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999986543322 22233446788999999998999999999999999999998 99998765443322111
Q ss_pred HHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 721 YDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 721 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
..+.... .+.....++.+++.+||+.||.+||++.+|++.|+++
T Consensus 240 ----~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 ----RSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ----HcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111111 1123346778899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.74 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=203.8
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.....+.+.||+|++|.||+|... +++.||+|.++... ...+++.+|+.++++++|+||+++++++......+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 344556688999999999999864 45789999987533 345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 581 FMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999997654 688999999999999999999998 899999999999999999999999999987653222
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
........+..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV--------DQGYRM------- 223 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC-------
Confidence 21112223457999999999999999999999999999999 88888654433221111 111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.........+.+++.+|++.+|.+||++.++++.|+.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011223567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.09 Aligned_cols=245 Identities=23% Similarity=0.320 Sum_probs=207.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||.|+-|.|-+|++. .+|+.+|||++.+.. ......+.+|+.+|+.+.|||++++++++.+..++|||.||+
T Consensus 16 LgkTLG~Gstg~vrlakh~-~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHA-ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred ccccccCCCCceehhhhcc-cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 4577999999999999975 589999999997642 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|.|.+++-.++++.+..+.+++.||+.|+.|+|.. +|+||||||+|+|||.++++||+|||||-+-.. .....
T Consensus 95 ~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gklLe 169 (786)
T KOG0588|consen 95 PGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKLLE 169 (786)
T ss_pred CCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--Ccccc
Confidence 9999999999999999999999999999999999998 899999999999999999999999999986432 33445
Q ss_pred eccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
+.+|++.|.|||++++.+| ..++||||.|||||.||+|+.||+.+.... ++ ..+..|..+.
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---LL-----lKV~~G~f~M---------- 231 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---LL-----LKVQRGVFEM---------- 231 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---HH-----HHHHcCcccC----------
Confidence 6789999999999999998 468999999999999999999998554322 22 1222333221
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
+.....++.+++.+|+..||++|.|++||+++-
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 122234566799999999999999999999863
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.97 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=206.3
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccccccc
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 575 (796)
...+.+.+.||+|+||.||+|.... .+++.||+|.++..... ....+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4456778999999999999998642 23578999999765443 457899999999999999999999999999999
Q ss_pred eeEEeecCCCCHHHHHhcC--------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc
Q 044281 576 LLVYEFMGNGTLANLIFAI--------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS 641 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 641 (796)
++||||+++++|.+++... ..+++..+..++.||+.|+.|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 9999999999999998753 2467888999999999999999998 8999999999999999999
Q ss_pred EEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHH
Q 044281 642 AKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDW 719 (796)
Q Consensus 642 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~ 719 (796)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~--- 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI--- 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---
Confidence 99999999986533221 11223345788999999999999999999999999999998 99998655433321111
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
..+..... +......+.+++.+||+.||++||++.||++.|++
T Consensus 238 -----~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 -----TQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----HcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 12221111 11223467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=324.46 Aligned_cols=248 Identities=26% Similarity=0.299 Sum_probs=198.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
..+.||+|+||.||++... .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 3467999999999999876 468899999986532 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 999999887643 3578899999999999999999998 89999999999999999999999999998653222 2
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||...........+.. ....... .
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~~----------~ 223 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR----RVKEDQE----------E 223 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH----Hhhcccc----------c
Confidence 2344689999999999999999999999999999999999999976433221111111 0011100 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~~ 773 (796)
........+.+++.+||+.||++||+ ++++++.
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11122346678999999999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=315.99 Aligned_cols=266 Identities=24% Similarity=0.294 Sum_probs=207.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh--------------hHHHHHHHHHHhcccCccCcccccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--------------REREFKSEVSAIGRTHHKHLVQLLGFC 569 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l~g~~ 569 (796)
+.+.++||+|.||.|-+|... .+++.||||++.+.... ..+...+|+.+|++++|+|||+|+.+.
T Consensus 99 y~l~~eiG~G~yGkVkLar~~-~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDE-VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred eehhhhhcCCccceEEEEeec-CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 456688999999999999865 47899999999753221 124788999999999999999999998
Q ss_pred ccc--ccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeec
Q 044281 570 DEA--LNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDF 647 (796)
Q Consensus 570 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 647 (796)
.+. +..|||+||+..|.+...-...+.+...++++++.++..||+|||.+ +||||||||+|+||+++|++||+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeecc
Confidence 664 57799999999998766555555589999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCC----CcceeeccCCCcccccccccCCC----CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH
Q 044281 648 GLSKLLFSDQ----SRTHTMIRGTRGYVAPEWFKNVP----VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW 719 (796)
Q Consensus 648 Gla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~ 719 (796)
|.+....... ........|||.|+|||...++. .+.+.||||+||+||.|+.|+.||..+...+...-|.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv-- 332 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV-- 332 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh--
Confidence 9998663221 11122367999999999987733 3568999999999999999999998776544322221
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH--cCcCCCCCCCCCcc
Q 044281 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE--GLLDVPNPPGPSSF 789 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~--~~~~~~~pp~p~~~ 789 (796)
...+.....++.-+.+.+++.++|++||+.|.+..+|..+.= .-.+.+.+.+|..+
T Consensus 333 --------------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~c 390 (576)
T KOG0585|consen 333 --------------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPSSC 390 (576)
T ss_pred --------------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcccc
Confidence 111111222344567778999999999999999999988763 33344555555554
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=330.26 Aligned_cols=243 Identities=26% Similarity=0.293 Sum_probs=198.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.||+|+||.||++..+ .+++.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 36899999999999865 468899999997532 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 99999998888889999999999999999999998 89999999999999999999999999987542222 222345
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+. ..... .+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--------~~~~~----------~p~~ 217 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--------MEEIR----------FPRT 217 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--------cCCCC----------CCCC
Confidence 68999999999999999999999999999999999999997654433221110 01100 0111
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
....+.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 234567799999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.93 Aligned_cols=203 Identities=27% Similarity=0.388 Sum_probs=176.2
Q ss_pred HHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 500 KDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 500 ~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
....+.+.++||+|+||.||++..+ .++..+|+|.+... .......+.+|++++++++|+||+++++++......++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 3445566788999999999999875 46788999988653 233456799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++++|.+++.....+++.....++.|++.||.|||+.. +|+|+||||+|||+++++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 999999999999988778899999999999999999999742 6999999999999999999999999999765322
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMEL 708 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~ 708 (796)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1223468899999999999999999999999999999999999987544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.97 Aligned_cols=258 Identities=25% Similarity=0.399 Sum_probs=207.3
Q ss_pred HHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
.+.+.+.||+|+||.||++... ..++..+|+|.+..........+.+|+.++++++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 3445678999999999999753 234567999999876656667899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCC-------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEe
Q 044281 579 YEFMGNGTLANLIFAIP-------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKIS 645 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 645 (796)
|||+++++|.+++.... .+++..++.++.||+.||+|||++ +++||||||+||++++++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence 99999999999987432 478999999999999999999998 89999999999999999999999
Q ss_pred ecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHh
Q 044281 646 DFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDC 723 (796)
Q Consensus 646 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~ 723 (796)
|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+....
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~-------- 234 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC-------- 234 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------
Confidence 9999986543321 11222335778999999999999999999999999999998 8888865543322111
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 724 YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 724 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
...+...... ......+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 235 i~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQRP---------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1122211111 11224578899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.07 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=202.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+......+++|||++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred eEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 345688999999999999864 46789999986532 235688999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|.+++... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||+++..........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999998753 4678889999999999999999998 899999999999999999999999999987643322222
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....++..|+|||.+....++.++|||||||++|||++ |+.||...........+ ..+....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~~~--------- 224 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL--------QRGYRMP--------- 224 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH--------HcCCCCC---------
Confidence 22345678999999999999999999999999999998 88888654433322111 1111000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
........+.+++.+|++.+|++||+++++.++|+..
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011224577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=330.15 Aligned_cols=243 Identities=26% Similarity=0.301 Sum_probs=199.3
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.||+|+||.||++..+ .+++.||+|++.... ......+.+|+.+++.++||||+++.+++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 35899999999999865 468899999997532 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
|+|...+.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 99999998888899999999999999999999998 89999999999999999999999999987543221 222345
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+... .+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~--------~~~~~~----------~p~~ 217 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEDIK----------FPRT 217 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh--------ccCCcc----------CCCC
Confidence 6899999999999999999999999999999999999999765443322111 001100 0111
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
....+.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 234567799999999999997 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.89 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=199.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||.||++..+ ++..+|+|.+... .....+|.+|+.++++++||||+++++++......++||||+++
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred EEeeEecCCcCceEEEEEec--cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 34578999999999999875 4568999988643 23356789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999998754 4678999999999999999999998 89999999999999999999999999998654332222222
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ .++... .. +
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i--------~~~~~~--~~-------~ 223 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI--------SRGFRL--YR-------P 223 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCCC--CC-------C
Confidence 335668999999998899999999999999999999 88888765433222111 111110 00 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
......+.+++.+||+.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112246788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.18 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=206.7
Q ss_pred hHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.+.||+|+||.||++.... .++..+++|.+........+.+.+|+..+++++|+||+++++++......++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence 345789999999999997532 2456799999987666666789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 044281 581 FMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKI 644 (796)
Q Consensus 581 ~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl 644 (796)
|+++++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||++++++.+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence 99999999998653 2378899999999999999999998 8999999999999999999999
Q ss_pred eecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHH
Q 044281 645 SDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYD 722 (796)
Q Consensus 645 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~ 722 (796)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-------- 236 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE-------- 236 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------
Confidence 99999986543321 12223446788999999999999999999999999999998 999986554332111
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 723 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
....+..... .......+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1122222111 11123467789999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=332.88 Aligned_cols=244 Identities=25% Similarity=0.279 Sum_probs=201.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||++..+ .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred eEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 345678999999999999876 467899999997532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 999999999998888889999999999999999999998 8999999999999999999999999999865332
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.... ..++....
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--------i~~~~~~~--------- 234 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK--------ILAGRLKF--------- 234 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH--------HhcCCcCC---------
Confidence 1234689999999999999999999999999999999999999976544322111 11222110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~~ 773 (796)
+.....++.+++.+||+.||.+||+ +.+++++
T Consensus 235 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 -PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111235677999999999999997 6777644
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=332.38 Aligned_cols=245 Identities=23% Similarity=0.279 Sum_probs=202.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|..+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4456789999999999998775555789999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---- 184 (340)
T PTZ00426 112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---- 184 (340)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----
Confidence 999999999998888899999999999999999999998 8999999999999999999999999999865322
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+... +
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i--------~~~~~~--~------- 247 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI--------LEGIIY--F------- 247 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH--------hcCCCC--C-------
Confidence 23456899999999999999999999999999999999999999865443221111 111110 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
+......+.+++.+|++.||++|+ +++++++.
T Consensus 248 -p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 -PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111123456799999999999995 89988765
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=313.45 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=207.4
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
..+.+.++||+|+||.||+|..+. +..+++|.+.........++.+|+.+++.++|+||+++++++......++||||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 346677899999999999999763 789999999876555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999764 3578999999999999999999998 8999999999999999999999999999876432221
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. .+...
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~--------~~~~~-------- 223 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT--------AGYRM-------- 223 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH--------hCCcC--------
Confidence 123345778999999998899999999999999999998 788886554332221111 11000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
..+......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 -PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 01122335677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.01 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=203.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCC--CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|.++.. +...||||.++... .....+|.+|+.++++++|+||+++++++.+....+++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 44567899999999999987643 34589999986533 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+++++|.+++... ..+++..+++++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999998764 4688999999999999999999998 8999999999999999999999999999977522211
Q ss_pred -ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 660 -THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+....+ ..+....
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~------ 228 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV--------EDGYRLP------ 228 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH--------HcCCCCC------
Confidence 1112335678999999999999999999999999999998 88888654333221111 1111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.+......+.+++.+||+.+|++||++.+|+++|+++
T Consensus 229 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112234677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.55 Aligned_cols=247 Identities=27% Similarity=0.368 Sum_probs=198.8
Q ss_pred hhCCCccceEEEEEee-CCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 509 ELGRGSFGIVYKGVLK-TASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
+||+|+||.||+|.++ ..++..+|+|+++... ....+++.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999764 3356889999986432 2345689999999999999999999998854 5678999999999
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce--ee
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH--TM 663 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~--~~ 663 (796)
+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998877889999999999999999999998 899999999999999999999999999987644332211 12
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..++..|+|||.+....++.++|||||||++|||++ |+.||......+....+ ..+..... +
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i--------~~~~~~~~---------~ 220 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI--------ESGERMEC---------P 220 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HCCCCCCC---------C
Confidence 234578999999988889999999999999999998 89998765433221111 11111111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.....++.+++.+||+.||++||++.+|.++|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1223467789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=333.18 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=201.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchhh-hhHHHHHHHHHHhcccC-ccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 576 (796)
.+.+.+.||+|+||.||+|+... ..+..||||++..... ...+.+.+|+++++++. ||||+++++++.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 44567899999999999998532 2345799999965332 33467999999999995 999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcC--------------------------------------------------------------
Q 044281 577 LVYEFMGNGTLANLIFAI-------------------------------------------------------------- 594 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~-------------------------------------------------------------- 594 (796)
|||||+++|+|.++|...
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 999999999999887542
Q ss_pred ----------------------------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC
Q 044281 595 ----------------------------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF 640 (796)
Q Consensus 595 ----------------------------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~ 640 (796)
..+++..++.++.||++||+|||+. +|+|+||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 1356777889999999999999998 899999999999999999
Q ss_pred cEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHH
Q 044281 641 SAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTD 718 (796)
Q Consensus 641 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~ 718 (796)
.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+.........
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~----- 349 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF----- 349 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-----
Confidence 9999999999865433221 1222346788999999999999999999999999999997 88888654322111
Q ss_pred HHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 719 WAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
......+.... .+......+.+++.+||+.||++||++.+|+++|+.+.+
T Consensus 350 --~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 --YNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 01111111000 011223567789999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=325.05 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=202.4
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCC---CeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTAS---GTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
...+...+.||+|+||.||+|++...+ ...||+|.++... ....+++.+|+.+++.++|+||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 334455678999999999999865322 1248999986532 34457899999999999999999999999764 578
Q ss_pred eEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 577 LVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
+++||+++|+|.+++... ..+++..+++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999864 4678899999999999999999998 899999999999999999999999999997654
Q ss_pred CCCcce-eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 656 DQSRTH-TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 656 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
...... .....+..|+|||.+.+..++.++|||||||++|||++ |+.|+......+....+ ..+... .
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~--~ 231 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERL--P 231 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------hCCCCC--C
Confidence 332211 12234678999999999999999999999999999998 89998754433221111 111100 0
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
. +......+.+++.+||+.+|.+||++.++++.|..+...
T Consensus 232 ~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 232 Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred C-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0 111223567799999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=289.40 Aligned_cols=243 Identities=24% Similarity=0.312 Sum_probs=206.8
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|-||.||.|+.+ .++-.||+|++.+..- +.++++.+|+++-..|+||||+++++++.+....||++||.
T Consensus 26 igr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred ccccccCCccccEeEeeec-cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 5678999999999999976 4678999999976432 33578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHh--cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIF--AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+.|+|...|. ....+++.....++.|+|.||.|+|.. +||||||||+|+|++.++..||+|||.+..-. ...
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~k 178 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNK 178 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---CCC
Confidence 9999999999 456788999999999999999999998 89999999999999999999999999987432 334
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+||..|.+||...+..++..+|+|++|++.||++.|.+||+.....+....+... .+..
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-----------~~~~------ 241 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-----------DLKF------ 241 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----------cccC------
Confidence 45678999999999999999999999999999999999999999987755544433210 0111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+..-.....+++.+|+..+|.+|.+..|+++.
T Consensus 242 -p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 -PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11223456679999999999999999999864
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=310.85 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=197.2
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+.||+|+||.||+|+.+. +++.+|+|..... ..+....+.+|++++++++|+||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA-DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEec-CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 469999999999998763 6789999987643 23445679999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce-eec
Q 044281 587 LANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH-TMI 664 (796)
Q Consensus 587 L~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 664 (796)
|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99998754 4688999999999999999999998 899999999999999999999999999986432211111 111
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+...........+. .+... ..+.
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~--------~~~~~---------~~~~ 219 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE--------QGVRL---------PCPE 219 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH--------cCCCC---------CCcc
Confidence 23457999999999999999999999999999998 778876543332211110 11000 0011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
.....+.+++.+|++.+|++|||+.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=298.80 Aligned_cols=275 Identities=22% Similarity=0.232 Sum_probs=207.1
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh--hHHHHHHHHHHhcccCccCccccccccc--ccccceeEEeec
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKHLVQLLGFCD--EALNRLLVYEFM 582 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~~ 582 (796)
.+.|++|+||.||+|+.+ .+++.||+|+++...+. -.-.-++|+.+|.+.+|||||.+..+.. +-+..||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk-~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDK-KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred HhhcccCcceeEEEeccC-CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 467999999999999976 57899999999753321 1235689999999999999999977764 345689999999
Q ss_pred CCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++ +|..++...+ ++...+..-+..|+++|++|||++ .|+|||||++|+|+.+.|.+||+|||+|+.+... ....
T Consensus 160 Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~ 234 (419)
T KOG0663|consen 160 EH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPY 234 (419)
T ss_pred Hh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cccC
Confidence 87 9999998875 778888899999999999999999 8999999999999999999999999999987543 4456
Q ss_pred eeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec-------
Q 044281 662 TMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI------- 733 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------- 733 (796)
+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||++++..|.+..+-++...+....-.. .+...+...
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP-te~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP-SEAIWPGYSELPAVKK 313 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC-ccccCCCccccchhhc
Confidence 677789999999999775 58999999999999999999999998776654443332211111 111100000
Q ss_pred -------cchhhhhhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCCCCCcc
Q 044281 734 -------DSDEAAMADRS-RLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPSSF 789 (796)
Q Consensus 734 -------d~~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp~p~~~ 789 (796)
-.......... ..+.-++++-..+..||.+|.|++|.++.= =..+.|.|-.|..|
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~-~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE-YFRETPLPIDPSMF 376 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc-ccccCCCCCChhhc
Confidence 00111111111 235567788888999999999999988751 23344555555444
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=326.25 Aligned_cols=259 Identities=27% Similarity=0.381 Sum_probs=201.7
Q ss_pred HHHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccc-ccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDE-ALN 574 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~ 574 (796)
..+.+.+.||+|+||.||+|.... .+++.||+|+++... ....+.+..|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 346677899999999999996432 235789999987533 23345788899999999 89999999998864 456
Q ss_pred ceeEEeecCCCCHHHHHhcC------------------------------------------------------------
Q 044281 575 RLLVYEFMGNGTLANLIFAI------------------------------------------------------------ 594 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 594 (796)
.++++||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999988542
Q ss_pred -CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-ceeeccCCCcccc
Q 044281 595 -PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVA 672 (796)
Q Consensus 595 -~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~a 672 (796)
..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2568888999999999999999998 9999999999999999999999999999876433221 2223446778999
Q ss_pred cccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHH
Q 044281 673 PEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLM 751 (796)
Q Consensus 673 PE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 751 (796)
||++.+..++.++|||||||++|||++ |..||......+. + ......+..... +.....++.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~----~~~~~~~~~~~~---------~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---F----CRRLKEGTRMRA---------PEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---H----HHHHhccCCCCC---------CccCCHHHHH
Confidence 999999999999999999999999998 9888865322211 0 011111111100 1122356788
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 752 IAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 752 l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
++.+||+.+|++||++.||+++|+.+++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.97 Aligned_cols=239 Identities=26% Similarity=0.316 Sum_probs=203.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.++||+|.||+|+++.++. +++.+|||.+++.. ....+..+.|.+++... +||.|++++.+++..++++.|||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred EEEEEeccCcCceEEEEEEcC-CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence 456789999999999999884 67899999998743 34456778888888877 69999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|..||+ ..++.....+++..+.-++..|+.||.|||++ +||+||||.+|||||.+|++||+||||++..... ...
T Consensus 450 y~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~~ 524 (694)
T KOG0694|consen 450 YVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GDR 524 (694)
T ss_pred ecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC-CCc
Confidence 999999 34444557889999999999999999999999 9999999999999999999999999999964322 234
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
..+.+||+.|||||++.+..|+.++|.|||||+|||||.|..||.++++++.-..|.. | ...
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~---------------d---~~~ 586 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN---------------D---EVR 586 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------C---CCC
Confidence 5668899999999999999999999999999999999999999999888775544421 1 122
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTM 767 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 767 (796)
++.....+.+.++.+++.++|++|--+
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCC
Confidence 344556677889999999999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.33 Aligned_cols=260 Identities=24% Similarity=0.300 Sum_probs=208.7
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccc-----cce
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL-----NRL 576 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 576 (796)
.++.+.+.||+|||+-||+++. ..+++.+|+|++.-...+..+..++|+...++++|||++++++++..+. ..|
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~-~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKG-LSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred ceEEEeeeecCCCceeeeeecc-cCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3456778999999999999873 3578899999998777777888999999999999999999999985444 479
Q ss_pred eEEeecCCCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 577 LVYEFMGNGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
|+++|...|+|.+.+... ..+++.+.+.|+.+|.+||++||+.. ++++||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999988653 36889999999999999999999973 3599999999999999999999999999986
Q ss_pred ccCCCC--------cceeeccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH
Q 044281 653 LFSDQS--------RTHTMIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY 721 (796)
Q Consensus 653 ~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 721 (796)
..-.-. ........|..|.|||.+. +..+++++|||||||+||+|+.|..||+....+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------- 247 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------- 247 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence 532110 1112234688999999995 456789999999999999999999999864332
Q ss_pred HhhhcCccceeccc-hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 722 DCYVEGRLDVLIDS-DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 722 ~~~~~~~~~~~~d~-~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.+.+...+.. ....+......+.+.+++.+|+|.||.+||++.+++..++.++
T Consensus 248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1222222221 1111222336788899999999999999999999999998764
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.49 Aligned_cols=241 Identities=27% Similarity=0.319 Sum_probs=192.9
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcc-cCccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGR-THHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||+|..+ .+++.||+|.++... ....+.+..|..++.. .+||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999875 467899999997532 2233455666666665 489999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 999999998888899999999999999999999998 89999999999999999999999999998643322 22334
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .... .. .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~-~~---------~~~ 217 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--------LNDR-PH---------FPR 217 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCC-CC---------CCC
Confidence 56899999999999999999999999999999999999999865543322211 0100 00 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMK-VVL 771 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~-evl 771 (796)
.....+.+++.+||+.||++||++. +++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1234566789999999999999976 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=307.33 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=198.6
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcc--cCccCcccccccccccc----cceeEEe
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR--THHKHLVQLLGFCDEAL----NRLLVYE 580 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lv~e 580 (796)
.+.||+|.||+||+|.++ |+.||||++... .++.+.+|.++.+. ++|+||+.+++.-..+. .++||.+
T Consensus 216 ~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR---GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEecCccccceeecccc---CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 467999999999999996 889999999653 34566677666664 69999999999876554 5689999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhc-----CCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE-----CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~-----~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
|.++|||.++|.. ..++.+..++++..+|.||+|||.+ +++.|.|||||+.||||.+++.+.|+|+|||.....
T Consensus 290 YHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred cccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 9999999999987 6788899999999999999999975 478899999999999999999999999999987655
Q ss_pred CC---CcceeeccCCCcccccccccCCC----C--CccchhHHHHHHHHHHHhCC----------CCCchhhHHHHhHHH
Q 044281 656 DQ---SRTHTMIRGTRGYVAPEWFKNVP----V--SAKVDVYSFGVTLLEIICCR----------RSVEMELEEESRAIL 716 (796)
Q Consensus 656 ~~---~~~~~~~~gt~~y~aPE~~~~~~----~--s~k~DVwS~Gv~l~elltg~----------~p~~~~~~~~~~~~l 716 (796)
+. .......+||.+|||||++...- + -..+||||||.++||+...- .||....+.+.. +
T Consensus 369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs--~ 446 (513)
T KOG2052|consen 369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS--F 446 (513)
T ss_pred cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC--H
Confidence 43 22345578999999999996532 2 23699999999999997521 233221110000 0
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCC
Q 044281 717 TDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPN 782 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (796)
+.....+= ++.+-...+....+.+.+..+.+++..||..+|.-|-|+-.|.+.|.++.+.++
T Consensus 447 -eeMrkVVC---v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 447 -EEMRKVVC---VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred -HHHhccee---ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 00000000 011111122334456778889999999999999999999999999988876543
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.31 Aligned_cols=248 Identities=28% Similarity=0.414 Sum_probs=199.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||.||+|... ++..+|+|.+.... ....+|.+|+.++++++||||+++++++......+++|||+++
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred EEeeEecCcccceEEEEEec--CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45578999999999999764 34579999987532 2356799999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++|.+++... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++............
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999764 4688999999999999999999998 89999999999999999999999999998664433222222
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..++..|+|||.+.+..++.++||||||+++|||++ |..|+......+....+ ..+..... .
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~---------~ 223 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV--------SQGLRLYR---------P 223 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--------hcCCCCCC---------C
Confidence 335678999999998899999999999999999998 88888654432211111 11111100 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112356788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=341.00 Aligned_cols=249 Identities=21% Similarity=0.230 Sum_probs=201.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||++......++.||+|.+..........+.+|+.+++.++|||||++++++......+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 44567899999999999986654477889998765545555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-
Q 044281 584 NGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS- 658 (796)
Q Consensus 584 ~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~- 658 (796)
+|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999988754 34578888999999999999999998 899999999999999999999999999987643322
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~--------~~~~~~~~------ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--------LYGKYDPF------ 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCCC------
Confidence 2233456899999999999999999999999999999999999999765433221111 11111100
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+......+.+++.+||+.||++||++.++++
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112345778999999999999999999864
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=315.66 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=202.1
Q ss_pred HHHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
..+.+.++||+|+||.||+|.... .+++.||+|+++..... ..+.+.+|+.++..++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346678899999999999998642 23578999999754332 3467899999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC
Q 044281 577 LVYEFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF 640 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~ 640 (796)
+++||+++++|.+++... ..+++..+.+++.|++.||.|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999999998532 2467788899999999999999998 899999999999999999
Q ss_pred cEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHH
Q 044281 641 SAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTD 718 (796)
Q Consensus 641 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~ 718 (796)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..|+......+....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--- 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM--- 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999986543322 11223345778999999998899999999999999999998 7778765443322111
Q ss_pred HHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 719 WAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
...+..... +......+..++..||+.+|++||++.+|++.|+.
T Consensus 239 -----i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 -----IRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----HHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111111 11223456789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.06 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=210.5
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecc--hhhhhHHHHHHHHHHhcccCccCccccccccccccc-ceeEE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN-RLLVY 579 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~ 579 (796)
.|...+.+|+|+||.++..+.+. +++.+++|++.- ......+..++|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~-~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKS-DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred hhhhhhhcCccccchhhhhhhcc-CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 35567899999999999988764 567999998854 233344578999999999999999999999999988 89999
Q ss_pred eecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 580 EFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
+|++||+|.+.|...+ .++++..+.++.||+.|+.|||++ .|+|||||+.||+++.++.+||.|||+|+.+..+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998654 678899999999999999999987 89999999999999999999999999999987655
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.. ...+.||+.||.||.+.+.+|..|+|||||||++|||++-+.+|...........+.. .+
T Consensus 161 ~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~------------~~----- 222 (426)
T KOG0589|consen 161 SL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR------------GL----- 222 (426)
T ss_pred hh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh------------cc-----
Confidence 33 3456799999999999999999999999999999999999999988766543332211 11
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....+..+..++..++..|++.+|+.||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112234556778889999999999999999999865
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=325.31 Aligned_cols=243 Identities=23% Similarity=0.293 Sum_probs=197.5
Q ss_pred HhhCCCccceEEEEEeeC--CCCeEEEEEEecchhh----hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 508 EELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.||+|+||.||++.... .+++.||+|.++.... .....+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 569999999999997532 3578999999975321 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++|.+++.....+.+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 99999999998888888889999999999999999998 899999999999999999999999999875432222 22
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+... .
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~--------~~~~~~----------~ 219 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI--------LKGKLN----------L 219 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC----------C
Confidence 3356899999999999999999999999999999999999999765433221111 111110 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQ 772 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 772 (796)
+......+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111234567899999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=315.72 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=201.9
Q ss_pred hHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.++||+|+||.||++... ..++..+++|.+..........+.+|+++++.++|+||+++++++......+++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 45688999999999999643 23467899999887666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC---------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEe
Q 044281 581 FMGNGTLANLIFAIP---------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKIS 645 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~---------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 645 (796)
|+++++|.+++.... .+++..++.++.||+.||+|||+. +++|+||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence 999999999987542 478899999999999999999998 89999999999999999999999
Q ss_pred ecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHh
Q 044281 646 DFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDC 723 (796)
Q Consensus 646 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~ 723 (796)
|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.....
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------- 237 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI------- 237 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-------
Confidence 9999986543221 11122335678999999999999999999999999999998 88888654333221111
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 724 YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 724 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
..+..... +......+.+++.+||+.||.+||++.+|++.|++
T Consensus 238 -~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 -TQGRELER---------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -HcCccCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111000 11122456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.11 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=200.0
Q ss_pred HhHHHhhCCCccceEEEEEee---CCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLK---TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
..+.++||+|+||.||+|... ...+..|++|.+.... .+....+.+|+.++++++|+||+++++++..+...+++|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 345678999999999999853 2345789999997432 334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcC-----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcE
Q 044281 580 EFMGNGTLANLIFAI-----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSA 642 (796)
Q Consensus 580 e~~~~gsL~~~l~~~-----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 642 (796)
||+++++|.+++... ..+++...+.++.|++.||+|||+. +|+|+||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 999999999998532 2367888899999999999999998 89999999999999999999
Q ss_pred EEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHH
Q 044281 643 KISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWA 720 (796)
Q Consensus 643 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~ 720 (796)
||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......+....+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 239 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV---- 239 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999987543321 12223345678999999998899999999999999999998 88888654432221111
Q ss_pred HHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 721 YDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 721 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
..+.... .+.....++.+++.+||+.||++||++.+|+++|.+
T Consensus 240 ----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111110 011122456779999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=315.84 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=199.6
Q ss_pred HHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 503 TDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
.+.+.++||+|+||.||+|..+ ..++..||+|++.... .....+|.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 3455678999999999998754 2345689999986432 2344678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCC----------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeec
Q 044281 578 VYEFMGNGTLANLIFAIP----------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDF 647 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~----------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 647 (796)
||||+++++|.+++.... .+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999986532 356788899999999999999998 8999999999999999999999999
Q ss_pred CCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhh
Q 044281 648 GLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYV 725 (796)
Q Consensus 648 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 725 (796)
|+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+ .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~--------~ 235 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV--------M 235 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------H
Confidence 999865432221 1122345778999999999999999999999999999999 67888654433221111 1
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 726 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
++..... +......+.+++.+||+.+|++|||+.|++++|++
T Consensus 236 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111 11123457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.36 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=199.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCe----EEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGT----AIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.||+|+||+||+|.... +++ .+++|.+..... ....++..|+..+++++|+||+++++++.. ...++++
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred eeccccCccCCcceEEEEEcC-CCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 345789999999999998753 233 578888864332 334678889999999999999999998864 4578999
Q ss_pred eecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999999999764 5689999999999999999999998 899999999999999999999999999987643322
Q ss_pred -cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 -RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...........+ ..+.... .+.
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~--~~~ 234 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL--------EKGERLA--QPQ 234 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCcCC--CCC
Confidence 22233456788999999999999999999999999999998 88898765443322211 1111111 000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.....+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 235 -------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 235 -------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 112345678899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.70 Aligned_cols=264 Identities=19% Similarity=0.220 Sum_probs=197.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.++||+|+||.||+|..+ .+++.||+|.++.... .....+.+|+.++++++|+||+++++++......++||||+
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred ceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 344578999999999999865 4678999999864322 23456789999999999999999999999988999999999
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~ 160 (288)
T cd07871 86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTY 160 (288)
T ss_pred Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccc
Confidence 85 898888654 3578889999999999999999998 99999999999999999999999999998643222 122
Q ss_pred eeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----hhc----Ccccee
Q 044281 662 TMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----YVE----GRLDVL 732 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~~~----~~~~~~ 732 (796)
....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+....... +.. ......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 33457899999999865 568999999999999999999999997665443322221111000 000 000000
Q ss_pred ccchh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 733 IDSDE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 733 ~d~~~----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.. ..........+..+++.+|++.||.+|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000001123456789999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.08 Aligned_cols=243 Identities=25% Similarity=0.297 Sum_probs=198.0
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.||+|+||.||++..+ .+++.||+|.+.... ......+..|++++..++|+||+++.+++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999865 468899999997532 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhh-cCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHE-ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
|+|..++.....+++..+..++.||+.||+|||+ . +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 9999999888889999999999999999999997 5 899999999999999999999999999875432221 2233
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i--------~~~~~~----------~p~ 217 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEEIR----------FPR 217 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH--------hcCCCC----------CCC
Confidence 56899999999999999999999999999999999999999765443322211 011100 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
.....+.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1234567799999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.25 Aligned_cols=250 Identities=29% Similarity=0.379 Sum_probs=200.9
Q ss_pred HhhCCCccceEEEEEeeCCC--CeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
++||+|+||.||+|+....+ +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999865443 36899999975443 34568999999999999999999999876 4567999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce--e
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH--T 662 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~--~ 662 (796)
++|.+++.....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998888899999999999999999999998 899999999999999999999999999987643332111 1
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ..+.... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~--------~~~~~~~---------~ 219 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML--------ESGERLP---------R 219 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--------HcCCcCC---------C
Confidence 1223567999999999999999999999999999998 89998755433221111 1111000 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+......+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1122346778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.62 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=202.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCC--CeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
...+.||+|+||.||+|+.+... ...+++|.++... ....+.+.+|++++++++|+|++++++++......++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 34578999999999999876432 2479999986542 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++..........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 88 MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999998764 5688999999999999999999998 89999999999999999999999999998664332222
Q ss_pred ee--eccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcC-ccceeccch
Q 044281 661 HT--MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEG-RLDVLIDSD 736 (796)
Q Consensus 661 ~~--~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~ 736 (796)
.. ....+..|+|||.+.+..++.++|||||||++|||++ |+.|+......+....+ ..+ ....
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i--------~~~~~~~~----- 231 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI--------NDGFRLPA----- 231 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--------hcCCCCCC-----
Confidence 11 1223457999999998899999999999999999997 99998654433221111 111 1100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.......+.+++.+||+.+|++||+|.+|++.|++++
T Consensus 232 -----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 232 -----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1112346788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=302.63 Aligned_cols=264 Identities=27% Similarity=0.296 Sum_probs=204.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh--hHHHHHHHHHHhcccCccC-cccccccccccc------c
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKH-LVQLLGFCDEAL------N 574 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------~ 574 (796)
+...++||+|+||+||+|+.+. +|+.||+|+++-..++ ......+|+.++++++|+| ||++.+++...+ .
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~-~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKR-TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEec-CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3445779999999999999774 6799999999754332 3356789999999999999 999999998877 7
Q ss_pred ceeEEeecCCCCHHHHHhcCC----CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCc
Q 044281 575 RLLVYEFMGNGTLANLIFAIP----KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS 650 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 650 (796)
.++|+||++. +|..++...+ .++...+..++.||++||+|||++ +|+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 7899999965 9999998765 466678999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcc
Q 044281 651 KLLFSDQSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729 (796)
Q Consensus 651 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (796)
+...- ..+..+..++|..|.|||++.+. .|+...||||+||+++||++++..|.+..+.+....+-......-.+...
T Consensus 168 ra~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 96532 23445666789999999999887 79999999999999999999999998877655444333322221111110
Q ss_pred c--eeccchh---hhh-------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 730 D--VLIDSDE---AAM-------ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 730 ~--~~~d~~~---~~~-------~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
. .+.+... ... ..........+++.+|++.+|.+|.|++.++++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0011000 000 000111356779999999999999999999986
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=310.90 Aligned_cols=248 Identities=28% Similarity=0.413 Sum_probs=198.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
..+.+.||+|+||.||++..+ ++..+|+|.+.... .....|.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred cchhhhhccCCCceEEEeEec--CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 446788999999999999865 45689999986532 234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++|.+++... ..+++..++.++.||+.||+|||+. +++||||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999998764 4678999999999999999999998 8999999999999999999999999999865432222212
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+... ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~---------~~ 222 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV--------SAGYRL---------YR 222 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH--------HcCCcC---------CC
Confidence 2224457999999999999999999999999999999 78888654433221111 111000 00
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
+.....++.+++.+||+.+|++||||.++++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111344678899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=323.74 Aligned_cols=243 Identities=25% Similarity=0.296 Sum_probs=197.8
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
++||+|+||.||+|..+ .+++.||+|.+.... ....+.+..|.+++..+ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 36999999999999865 467899999997532 23345677888888865 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|...+.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 999999998888899999999999999999999998 89999999999999999999999999997543222 12234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i--------~~~~~~----------~p~ 217 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI--------LHDDVL----------YPV 217 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC----------CCC
Confidence 56899999999999999999999999999999999999999876544322211 111100 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRP-------TMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RP-------t~~evl~~ 773 (796)
.....+.+++..||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1224567899999999999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.57 Aligned_cols=237 Identities=28% Similarity=0.354 Sum_probs=193.8
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||++..+ .+++.||||.+.... ....+.+..|..++..+ +||||+++++++......++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999875 467899999997532 23345677888888876 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 999999998888899999999999999999999998 89999999999999999999999999987543222 22234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i--------~~~~~~----------~~~ 217 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--------LNDEVV----------YPT 217 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--------hcCCCC----------CCC
Confidence 56899999999999999999999999999999999999999866544322211 111110 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTM 767 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~ 767 (796)
.....+.+++.+||+.||++||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 123456789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=317.99 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=193.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhccc---CccCccccccccc-----ccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRT---HHKHLVQLLGFCD-----EAL 573 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 573 (796)
+.+.+.||+|+||.||++.....+++.||+|+++... ......+.+|+.+++.+ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 3456789999999999998754567899999986432 12234556676666654 7999999999874 345
Q ss_pred cceeEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 574 NRLLVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
..++||||++ ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6789999997 5898888654 3578899999999999999999998 89999999999999999999999999998
Q ss_pred cccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcc--
Q 044281 652 LLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL-- 729 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~-- 729 (796)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.........+...
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 65432 22234558999999999999999999999999999999999999998765443332222211100000000
Q ss_pred ----ceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 730 ----DVLIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 730 ----~~~~d~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
...+.... ...........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000 00001122345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.46 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=197.1
Q ss_pred hhCCCccceEEEEEeeCC-CCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 509 ELGRGSFGIVYKGVLKTA-SGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
.||+|+||.||+|.++.. ++..||+|.+..... ...+.|.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 489999999999987533 356799999865432 334679999999999999999999998864 56799999999999
Q ss_pred HHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce--ee
Q 044281 587 LANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH--TM 663 (796)
Q Consensus 587 L~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~--~~ 663 (796)
|.+++.. ...+++..+++++.||+.||+|||++ +++|+||||+||++++++.+||+|||+++.......... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999875 45689999999999999999999998 899999999999999999999999999986543322111 11
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..++..|+|||.+.+..++.++|||||||++||+++ |..||......+....+ ..+.... .+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~---------~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI--------EQGKRLD---------CP 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--------HCCCCCC---------CC
Confidence 223578999999998899999999999999999996 99998765433221111 1111110 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22345667799999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.85 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=202.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCC-eEEEEEEecch-hhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASG-TAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~-~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||+|..+.... ..+++|.++.. .....+.|.+|++++.++ +||||+++++++......++++||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 456789999999999998764322 35788888742 234456789999999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCC----------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEe
Q 044281 582 MGNGTLANLIFAIP----------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKIS 645 (796)
Q Consensus 582 ~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 645 (796)
+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 99999999996532 467889999999999999999998 89999999999999999999999
Q ss_pred ecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhh
Q 044281 646 DFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCY 724 (796)
Q Consensus 646 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~ 724 (796)
|||++...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+.... .
T Consensus 162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~--------~ 231 (297)
T cd05089 162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK--------L 231 (297)
T ss_pred CcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------H
Confidence 99998743211 11111223567999999999899999999999999999998 9999876543321111 1
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCCC
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPG 785 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp~ 785 (796)
..+.... .+......+.+++.+||+.+|.+||++.++++.|+.++....+..
T Consensus 232 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 232 PQGYRME---------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred hcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 1110000 011123457789999999999999999999999998887655543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=321.61 Aligned_cols=242 Identities=28% Similarity=0.313 Sum_probs=194.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcc-cCccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGR-THHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||+||+|..+ .+++.||||.++... ......+..|..++.. ++||||+++++++.+....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 36899999999999876 467899999997642 2234556677777776 499999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 999999998877889999999999999999999998 99999999999999999999999999987532221 12234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. .... . .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~--------~~~~--~--------~~~ 217 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR--------MDNP--C--------YPR 217 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCC--C--------CCc
Confidence 568999999999999999999999999999999999999997654433221110 0000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMK-VVLQ 772 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~-evl~ 772 (796)
.....+.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1234567789999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.73 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=203.6
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||+||++... .+++.||||++..... .....+.+|+.++..++|+||+++++++.++...++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred eEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 34578999999999999875 4688999999975322 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC----
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ---- 657 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~---- 657 (796)
+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 83 MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 99999999998888899999999999999999999998 99999999999999999999999999998764432
Q ss_pred ------------------------CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHh
Q 044281 658 ------------------------SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESR 713 (796)
Q Consensus 658 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~ 713 (796)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 11223456899999999999999999999999999999999999999876544332
Q ss_pred HHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 044281 714 AILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT-MKVVLQM 773 (796)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~evl~~ 773 (796)
..+..+... ..... .......+..++.+|++ ||.+||+ +.++++.
T Consensus 240 ~~i~~~~~~----~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 240 NKIINWKES----LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHhccCCc----ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 222111000 00000 00123456778889997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.66 Aligned_cols=252 Identities=26% Similarity=0.408 Sum_probs=199.2
Q ss_pred HHHhhCCCccceEEEEEeeCCC--CeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccccc------c
Q 044281 506 FKEELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN------R 575 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 575 (796)
+.+.||+|+||.||+|.+.... +..||+|+++.. .......+.+|+..++.++|+||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4578999999999999876432 478999998643 23345689999999999999999999998866554 6
Q ss_pred eeEEeecCCCCHHHHHhcC------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCC
Q 044281 576 LLVYEFMGNGTLANLIFAI------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 649 (796)
++++||+++++|..++... ..+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999988542 3578889999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 650 SKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 650 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..|+......+.... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~--------~~~~ 231 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY--------LRHG 231 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcC
Confidence 9876433221 1122335678999999999999999999999999999999 8888865433221111 1111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
..... +......+.+++.+||+.||.+||++.||++.|+.+
T Consensus 232 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=317.40 Aligned_cols=268 Identities=25% Similarity=0.341 Sum_probs=200.4
Q ss_pred hHHHhhCCCccceEEEEEee---CCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccc--ccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLK---TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 578 (796)
.+.+.||+|+||+||++..+ ..+++.||+|.+.... ......|.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 45678999999999887532 2457789999987543 23456788999999999999999999987654 357899
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++++|.+++... .+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999998764 589999999999999999999998 899999999999999999999999999987643222
Q ss_pred c--ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 R--THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 ~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
. ......++..|+|||.+.+..++.++||||||+++|||++|..|+.......... + ...........+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-I-GPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-h-cccccccchhhhhhhhhcC
Confidence 1 1122335667999999998899999999999999999999999875432211000 0 0000000000011111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.....+.....++.+++.+||+.+|++|||+++|+++|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111112223457788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.45 Aligned_cols=270 Identities=23% Similarity=0.314 Sum_probs=198.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCccccccccccc-----cccee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA-----LNRLL 577 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 577 (796)
.+.+.||+|+||.||+|+.+ .+++.||||++.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred EEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 34578999999999999865 468899999986432 23345788999999999999999999987543 24699
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
||||++ ++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999996 68999998888899999999999999999999998 89999999999999999999999999998653322
Q ss_pred C--cceeeccCCCcccccccccC--CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------Hhhhc
Q 044281 658 S--RTHTMIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVE 726 (796)
Q Consensus 658 ~--~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~~ 726 (796)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... ..+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1 11234568999999999876 6789999999999999999999999975443221111111000 00000
Q ss_pred Cccceeccchhh------hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcCcC
Q 044281 727 GRLDVLIDSDEA------AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGLLD 779 (796)
Q Consensus 727 ~~~~~~~d~~~~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~~~ 779 (796)
......+..... ..........+.+++.+||+.||++|||++|+++. ++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000000000000 00000112456789999999999999999999965 444433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.34 Aligned_cols=240 Identities=25% Similarity=0.388 Sum_probs=190.1
Q ss_pred hhCCCccceEEEEEeeCC-----------------------CCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccc
Q 044281 509 ELGRGSFGIVYKGVLKTA-----------------------SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~-----------------------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 565 (796)
.||+|+||.||+|.+... ....|++|.+.........+|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999986321 123689999976555556788999999999999999999
Q ss_pred cccccccccceeEEeecCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC----
Q 044281 566 LGFCDEALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF---- 640 (796)
Q Consensus 566 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~---- 640 (796)
++++.+....++||||+++++|..++.. .+.+++..+..++.||++||+|||+. +|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999865 46788999999999999999999998 899999999999998643
Q ss_pred ---cEEEeecCCcccccCCCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHH-hCCCCCchhhHHHHhHH
Q 044281 641 ---SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEII-CCRRSVEMELEEESRAI 715 (796)
Q Consensus 641 ---~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~ell-tg~~p~~~~~~~~~~~~ 715 (796)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 3899999998644222 12246778999998875 56899999999999999995 68888875543332111
Q ss_pred HHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 716 LTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
+ .. ..... ......+.+++.+||+.+|++||+|.+|++.|+
T Consensus 234 ~----~~---~~~~~------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 Y----EK---KHRLP------------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H----Hh---ccCCC------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 00 00000 011235778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=303.54 Aligned_cols=261 Identities=24% Similarity=0.296 Sum_probs=202.7
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc-----cccceeEE
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE-----ALNRLLVY 579 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lv~ 579 (796)
.+.||+|+||.|..+..+ .+++.||||++.+. .....+...+|+++|+.++|+||+.+.+.+.. -...|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 467999999999999876 57899999999743 33345678899999999999999999998854 34679999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC-C
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-S 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-~ 658 (796)
|+| ..+|...++..+.++......+..||++||+|+|+. +|+||||||.|+|++.+..+||+|||+|+...... .
T Consensus 106 elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 999 459999999988899999999999999999999998 99999999999999999999999999999875432 2
Q ss_pred cceeeccCCCccccccccc-CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh-------hhcCccc
Q 044281 659 RTHTMIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC-------YVEGRLD 730 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~~~ 730 (796)
...+..+.|..|.|||++. ...|+.+.||||.||++.||++|+..|.+.........+....... +......
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 2335677899999999874 5689999999999999999999999998766544444333222111 0000000
Q ss_pred eeccc-------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 731 VLIDS-------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 731 ~~~d~-------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.+ ...... +......++++.+||..||.+|+|++|.++.
T Consensus 262 ~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 000000 1122356789999999999999999999875
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.21 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=199.5
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCC-------------CCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTA-------------SGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLG 567 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~-------------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g 567 (796)
..+.+.++||+|+||.||++..+.. ....||+|.++.. .......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 3456678899999999999875421 1235899998653 2334567999999999999999999999
Q ss_pred cccccccceeEEeecCCCCHHHHHhcC------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEE
Q 044281 568 FCDEALNRLLVYEFMGNGTLANLIFAI------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635 (796)
Q Consensus 568 ~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIl 635 (796)
++......++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999999999998643 2367888999999999999999998 8999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh--CCCCCchhhHHHH
Q 044281 636 LDHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC--CRRSVEMELEEES 712 (796)
Q Consensus 636 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt--g~~p~~~~~~~~~ 712 (796)
+++++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||+++||++ +..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999986543221 11122345678999999999999999999999999999998 5567765433322
Q ss_pred hHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 713 RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
.... .............. .+......+.+++.+||+.||++||+|.+|++.|+
T Consensus 242 ~~~~----~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENT----GEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH----HHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111 11111110000000 01112346888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.79 Aligned_cols=256 Identities=25% Similarity=0.282 Sum_probs=194.0
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccc-----cceeEEee
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL-----NRLLVYEF 581 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv~e~ 581 (796)
.+++|.|+||.||+|++.. +++.||||+.-.... .--+|+++|++++|||||+++-++.... ...+||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eEEEeecccceEEEEEEcC-CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 3679999999999999875 478999999844222 2245899999999999999998874332 23589999
Q ss_pred cCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC-CcEEEeecCCcccccCC
Q 044281 582 MGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF-FSAKISDFGLSKLLFSD 656 (796)
Q Consensus 582 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~~ 656 (796)
|+. +|...++. ...++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||+|||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 987 88888874 46677777788999999999999997 99999999999999965 99999999999998766
Q ss_pred CCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhh----------
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYV---------- 725 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~---------- 725 (796)
+.. ....-|+.|.|||.+.+. .|+.+.||||.||++.||+-|+..|.++........+.......-.
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 554 344568899999999874 7999999999999999999999999887665544444332211100
Q ss_pred -cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 726 -EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 726 -~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+-+.+.+...............+.++++.++++.+|.+|.++.|++.+
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111111111111122333567889999999999999999998854
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.16 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=197.9
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+.||+|+||.||+|..+ ++..+|+|.+.... ......+.+|+.+++.++|+||+++++++......++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999864 57899999986543 2334578999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeecc
Q 044281 587 LANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR 665 (796)
Q Consensus 587 L~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 665 (796)
|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++...............
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99988754 4578999999999999999999998 8999999999999999999999999999754332222222233
Q ss_pred CCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 666 gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
++..|+|||++.+..++.++||||||+++||+++ |..||...........+ ..+.... ....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~--------~~~~~~~---------~~~~ 218 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV--------EKGYRMS---------CPQK 218 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--------HcCCCCC---------CCCC
Confidence 4678999999999999999999999999999998 88888655433221111 1111000 0111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
....+.+++.+|++.+|++||++.+++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=334.22 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=208.3
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCccccccc-ccc------ccccee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGF-CDE------ALNRLL 577 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~-~~~------~~~~~l 577 (796)
+.+.|.+|||+.||.+.... .+..+|+|++-...+...+..++|+.+|++|+ |+|||.+++. ... .-+.+|
T Consensus 41 V~~vLAEGGFa~VYla~~~~-~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVK-GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEccCCcEEEEEEEecC-CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 45779999999999998763 34899999997777788899999999999996 9999999993 321 235689
Q ss_pred EEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 578 VYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
.||||.+|.|.+++..+ ..+++.++++|+.++++|+++||.. +++|||||||-+||||..+++.||||||.|.-...
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 99999999999999853 4699999999999999999999986 67899999999999999999999999999874322
Q ss_pred CCCcce--------eeccCCCcccccccc---cCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhh
Q 044281 656 DQSRTH--------TMIRGTRGYVAPEWF---KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCY 724 (796)
Q Consensus 656 ~~~~~~--------~~~~gt~~y~aPE~~---~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 724 (796)
...... -...-|+.|+|||.+ .+.++++|+|||||||+||-|+....||+.....
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------------- 264 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------------- 264 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------------
Confidence 211100 112368999999977 6889999999999999999999999999854221
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCC
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPP 784 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp 784 (796)
.+++..-.-...+.+.+.+..||..||+.||++||++-+|++.+-.+...+.|-
T Consensus 265 ------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 265 ------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred ------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 111211122223578889999999999999999999999999998877665443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.63 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=200.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccc-----cceeE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL-----NRLLV 578 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv 578 (796)
+.+.||+|+||.||++... .+++.||||++... .....+.+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 4 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred ccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 4578999999999999865 46889999998653 2233467889999999999999999999998776 78999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
+||+. ++|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99997 58888888778899999999999999999999998 899999999999999999999999999987544333
Q ss_pred cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHH---------------HH
Q 044281 659 RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA---------------YD 722 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~---------------~~ 722 (796)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 333445678999999999874 47999999999999999999999997655433222221110 00
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 723 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+...... ...............+++.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 239 HILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 000000000011124567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=331.36 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=196.2
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||+||+|... .+++.||||++.... ......+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred EEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 3467999999999999865 468899999996532 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC----
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS---- 658 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~---- 658 (796)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 84 PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999998888889999999999999999999998 999999999999999999999999999864321000
Q ss_pred ------------------------------------------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHH
Q 044281 659 ------------------------------------------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLE 696 (796)
Q Consensus 659 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~e 696 (796)
.......||+.|+|||.+.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00123469999999999999999999999999999999
Q ss_pred HHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHH--hcccCCCCCCCHHHHHHH
Q 044281 697 IICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMW--CIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 697 lltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--Cl~~dp~~RPt~~evl~~ 773 (796)
|++|+.||......+....+..+. .... +.. ......++.+++.+ |+..+|..||++.++++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~------~~~~--~~~------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWE------NTLH--IPP------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccc------cccC--CCC------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999997655433222221110 0000 000 00112334455554 666777789999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.33 Aligned_cols=202 Identities=27% Similarity=0.342 Sum_probs=175.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||+||++... .+++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred EeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 4568999999999999865 468899999997532 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC----
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS---- 658 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~---- 658 (796)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 84 PGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999976432110
Q ss_pred ------------------------------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhh
Q 044281 659 ------------------------------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMEL 708 (796)
Q Consensus 659 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~ 708 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 00123469999999999999999999999999999999999999998665
Q ss_pred HHH
Q 044281 709 EEE 711 (796)
Q Consensus 709 ~~~ 711 (796)
..+
T Consensus 241 ~~~ 243 (363)
T cd05628 241 PQE 243 (363)
T ss_pred HHH
Confidence 443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=327.49 Aligned_cols=191 Identities=24% Similarity=0.295 Sum_probs=167.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||++... .+++.||+|.... ..+.+|++++++++||||+++++++......++|+|++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~-~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEEC-CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 445678999999999999865 4688999997532 356889999999999999999999999999999999985
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 68988888877889999999999999999999998 89999999999999999999999999997543333233334
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVE 705 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~ 705 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 569999999999999999999999999999999999998764
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.69 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=200.1
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.++||+|+||.||+|..+ +...||+|+++... ...+.|.+|+.++++++|+||+++++++.+ ...++||||+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 3556788999999999999865 33579999997532 234678999999999999999999998754 5579999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||+++.+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999753 3578899999999999999999998 89999999999999999999999999998664333222
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....++..|+|||...+..++.++||||||+++|||++ |..||......+....+ ..+...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~--------~~~~~~--------- 222 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRM--------- 222 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH--------hcCCCC---------
Confidence 223346678999999999999999999999999999999 77787654433221111 111000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.........+.+++.+|++.+|++||++.++++.|+...
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 011223456778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.20 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=196.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCC-eEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccc------ccce
Q 044281 506 FKEELGRGSFGIVYKGVLKTASG-TAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA------LNRL 576 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~-~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 576 (796)
+.++||+|+||.||+|+...... ..+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999998764322 36899988653 234457889999999999999999999987432 2468
Q ss_pred eEEeecCCCCHHHHHhc------CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCc
Q 044281 577 LVYEFMGNGTLANLIFA------IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS 650 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 650 (796)
+++||+++|+|.+++.. ...+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 23478899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 651 KLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 651 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
+.+..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~--------~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD--------YLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------HHHcCC
Confidence 87643322 11122345678999999999999999999999999999999 788886543322111 111221
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.... .......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 232 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110 112234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.59 Aligned_cols=243 Identities=28% Similarity=0.321 Sum_probs=197.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||+||++..+ .+++.||+|.++... ......+..|.+++..+ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999875 467899999997642 23345677888888877 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....... ....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 999999998888899999999999999999999998 999999999999999999999999999875322221 2233
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...........+ ...... .+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i--------~~~~~~----------~~~ 217 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--------LEDEVR----------YPR 217 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH--------HcCCCC----------CCC
Confidence 45899999999999999999999999999999999999999765443322111 111110 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTM-----KVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~-----~evl~~ 773 (796)
.....+.+++.+||+.||.+||++ .++++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 123456789999999999999999 887653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.73 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=202.4
Q ss_pred HHHHHHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchhh-hhHHHHHHHHHHhcccC-ccCccccccccccc
Q 044281 499 LKDATDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKHLVQLLGFCDEA 572 (796)
Q Consensus 499 l~~~~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 572 (796)
+......+.+.||+|+||.||+|++.. ..++.||+|+++.... ...+.+.+|++++.++. |+||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 333445567899999999999998642 2456899999975432 22457899999999997 99999999999999
Q ss_pred ccceeEEeecCCCCHHHHHhcC----------------------------------------------------------
Q 044281 573 LNRLLVYEFMGNGTLANLIFAI---------------------------------------------------------- 594 (796)
Q Consensus 573 ~~~~lv~e~~~~gsL~~~l~~~---------------------------------------------------------- 594 (796)
...++|+||+++|+|.++++..
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999999988642
Q ss_pred ----------------------------------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCE
Q 044281 595 ----------------------------------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNI 634 (796)
Q Consensus 595 ----------------------------------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NI 634 (796)
+.+++...+.++.||+.||+|||+. +|+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 1245667888999999999999987 899999999999
Q ss_pred EEcCCCcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHH
Q 044281 635 LLDHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEES 712 (796)
Q Consensus 635 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~ 712 (796)
|+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986533222 11223346788999999999899999999999999999998 8888764332221
Q ss_pred hHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 713 RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.. .....+.... .+.....++.+++.+||+.+|.+||++++|++.|+.++
T Consensus 351 ~~-------~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FY-------NAIKRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH-------HHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 1111111000 01112356778999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.23 Aligned_cols=241 Identities=25% Similarity=0.409 Sum_probs=191.2
Q ss_pred HhhCCCccceEEEEEeeCCC-----------CeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 508 EELGRGSFGIVYKGVLKTAS-----------GTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~-----------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
+.||+|+||.||+|+....+ ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 36899999999999864321 2368999987655555668899999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc-------EEEeecC
Q 044281 577 LVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS-------AKISDFG 648 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~-------~kl~DfG 648 (796)
+||||+++++|..++... ..+++..+++++.||++||+|||+. +|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988754 5689999999999999999999998 8999999999999987664 8999999
Q ss_pred CcccccCCCCcceeeccCCCccccccccc-CCCCCccchhHHHHHHHHHHH-hCCCCCchhhHHHHhHHHHHHHHHhhhc
Q 044281 649 LSKLLFSDQSRTHTMIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVTLLEII-CCRRSVEMELEEESRAILTDWAYDCYVE 726 (796)
Q Consensus 649 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gv~l~ell-tg~~p~~~~~~~~~~~~l~~~~~~~~~~ 726 (796)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|..|+......+.... ..
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---------~~ 223 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---------YE 223 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---------Hh
Confidence 98755322 2234778899999987 567899999999999999998 47777754332221110 01
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 727 GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 727 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
+... .. ......+.+++.+||+.||++||++.+|++.|+
T Consensus 224 ~~~~-~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQCM-LV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCcc-CC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1100 00 111245678999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=309.59 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=195.4
Q ss_pred HhhCCCccceEEEEEeeCCCC-eEEEEEEecch-hhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASG-TAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~-~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.||+|+||.||+|.++..+. ..+++|.++.. .......+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998764322 35788988753 234456889999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCC----------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecC
Q 044281 585 GTLANLIFAIP----------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFG 648 (796)
Q Consensus 585 gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfG 648 (796)
++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 467889999999999999999997 99999999999999999999999999
Q ss_pred CcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 649 LSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 649 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
+++.... .........+..|+|||++....++.++|||||||++|||++ |..||......+....+ ..+
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~--------~~~ 227 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--------PQG 227 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH--------hCC
Confidence 9863221 111112234567999999998899999999999999999997 89998654332211111 111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
... + ........+.+++.+||+.+|.+|||+.++++.|++++
T Consensus 228 ~~~---~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL---E------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---C------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 0 01112245678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=322.98 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=195.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||++..+ .+++.+|+|.++... ......+.+|+.++.++ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 36899999999999876 467899999997532 23345677888888776 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 999999988888899999999999999999999998 89999999999999999999999999997532222 12234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH-hHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES-RAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+........... .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----------~p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----------IP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----------CC
Confidence 5689999999999999999999999999999999999999953211100 000011111111111111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPT------MKVVLQ 772 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt------~~evl~ 772 (796)
......+..++.+||+.||++||+ +.++++
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 122345678999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=308.01 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=199.1
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.++||+|+||.||++..+ ++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HhhhhheeccccCceEEEEEec--CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 4567789999999999999765 466799999875332 3467999999999999999999999875 45679999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++++|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++..+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999998764 3578999999999999999999998 89999999999999999999999999998764332222
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ..+...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~--------- 222 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV--------ERGYRM--------- 222 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC---------
Confidence 222335668999999998899999999999999999999 88888654333221111 111000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
..+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011223457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.78 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=201.5
Q ss_pred hHHHhhCCCccceEEEEEeeCC----CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTA----SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.||+|+||.||+|+.... ....+++|.+.... ......+.+|+.+++.++||||+++++.+......++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 3457899999999999986421 23578999886533 234567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcC------------------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEE
Q 044281 580 EFMGNGTLANLIFAI------------------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635 (796)
Q Consensus 580 e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIl 635 (796)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 999999999988642 2467888999999999999999998 8999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHh
Q 044281 636 LDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESR 713 (796)
Q Consensus 636 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~ 713 (796)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....++..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999865433221 1122345678999999998899999999999999999998 88888655443322
Q ss_pred HHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 714 AILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
..+ ..+... + .+......+.+++.+||+.+|++||++.++++.|++++.
T Consensus 240 ~~~--------~~~~~~---~------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 NLL--------KTGYRM---E------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHH--------hCCCCC---C------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111 111000 0 011223467789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=323.23 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=190.8
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.++||+|+||.||+++.. .+++.||||.+.... ......+.+|+++++.++|+||+++++++......++||||+++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 4578999999999999865 467899999986432 23356789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
++|... ....+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.... ......
T Consensus 157 ~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 228 (353)
T PLN00034 157 GSLEGT----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSS 228 (353)
T ss_pred Cccccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cccccc
Confidence 998643 2345677889999999999999998 89999999999999999999999999998764322 122345
Q ss_pred cCCCcccccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 665 RGTRGYVAPEWFKN-----VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 665 ~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.||..|+|||.+.. ...+.++|||||||++|||++|+.||......+........ ......
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~--------- 294 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-----CMSQPP--------- 294 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----hccCCC---------
Confidence 68999999998843 23456899999999999999999999743222111111000 000000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........++.+++.+||+.||++||++.|+++.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111233567889999999999999999999986
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.38 Aligned_cols=241 Identities=27% Similarity=0.307 Sum_probs=194.0
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||++..+ .+++.||+|.++... ......+..|..++... +|+||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 36999999999999876 467899999997532 22345567788787754 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|..++.....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 999999998878889999999999999999999998 9999999999999999999999999998743211 122334
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+.. . .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~--------~~~~~-~---------~~~ 217 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--------RVDTP-H---------YPR 217 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCC-C---------CCC
Confidence 56899999999999999999999999999999999999999765443322111 11100 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMK-VVL 771 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~-evl 771 (796)
....++.+++.+||+.||++||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1234567799999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.87 Aligned_cols=245 Identities=27% Similarity=0.328 Sum_probs=194.5
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
||+|+||+||++..+ .+++.+|+|.+..... ...+.+..|+.++++++|+||+++.+++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999865 4678999999965322 233567889999999999999999999999999999999999999
Q ss_pred HHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 587 LANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 587 L~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+..... ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 9888743 34688999999999999999999998 899999999999999999999999999986543322 223
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+. .....+.. ..+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~~----------~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----QRILNDSV----------TYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH----HhhcccCC----------CCc
Confidence 3468999999999999999999999999999999999999997543221111110 00000000 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
......+.+++.+||+.||++|| +++++++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 12335667899999999999999 77888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.13 Aligned_cols=250 Identities=23% Similarity=0.265 Sum_probs=200.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||+||++..+ .+++.||+|+++.... .....+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred eEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 34578999999999999865 4688999999976432 3446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+.......
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999876 6789999999999999999999998 89999999999999999999999999998765444333
Q ss_pred eeeccCCCccccccccc------CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 661 HTMIRGTRGYVAPEWFK------NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~------~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.. ........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------~~~~~~~~- 231 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN-------FQRFLKFP- 231 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc-------CCCccCCC-
Confidence 34456899999999986 45678999999999999999999999976544332221111 00000000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+..++..|++ +|++||++.++++.
T Consensus 232 ------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 232 ------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 011123456678888998 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.28 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=203.2
Q ss_pred HHhHHHhhCCCccceEEEEEeeCC---------------CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTA---------------SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLL 566 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~---------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 566 (796)
.+.+.++||+|+||.||++..... .+..||+|.+.... .....++.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 345678999999999999876532 22468999987543 33457899999999999999999999
Q ss_pred ccccccccceeEEeecCCCCHHHHHhcCC-----------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEE
Q 044281 567 GFCDEALNRLLVYEFMGNGTLANLIFAIP-----------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635 (796)
Q Consensus 567 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIl 635 (796)
+++..+...++++||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence 99999999999999999999999997654 688999999999999999999998 8999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh--CCCCCchhhHHHH
Q 044281 636 LDHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC--CRRSVEMELEEES 712 (796)
Q Consensus 636 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt--g~~p~~~~~~~~~ 712 (796)
+++++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ +..|+........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 99999999999999986543321 12233446778999999998899999999999999999998 5667754433222
Q ss_pred hHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 713 RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
... ....+........... ......++.+++.+||+.||++|||+.+|++.|+.
T Consensus 243 ~~~----~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 243 IEN----AGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHH----HHhccccccccccCCC------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111 1111111111111110 11223568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.32 Aligned_cols=250 Identities=24% Similarity=0.308 Sum_probs=196.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||++..+ .+++.||+|.++... ......+..|..++..+ +||||+++++++.+....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 36899999999999876 467899999997532 22345688899999888 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 999999998878899999999999999999999998 99999999999999999999999999987532222 22234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH-hHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES-RAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+......++... .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 225 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------IP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------CC
Confidence 5689999999999999999999999999999999999999964221110 000011111211221111 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPT------MKVVLQ 772 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt------~~evl~ 772 (796)
.....++.+++.+||+.||.+||+ +.++++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112345678999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.84 Aligned_cols=262 Identities=26% Similarity=0.347 Sum_probs=205.9
Q ss_pred HHHHHhHHHhhCCCccceEEEEEee------CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccc
Q 044281 500 KDATDGFKEELGRGSFGIVYKGVLK------TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDE 571 (796)
Q Consensus 500 ~~~~~~~~~~LG~G~fG~Vy~g~~~------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 571 (796)
....+.+.+.||+|+||.||++... ..++..||+|.+.... .....++.+|+.++..+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3444556788999999999999742 1234579999986532 34456799999999999 89999999999999
Q ss_pred cccceeEEeecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEE
Q 044281 572 ALNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635 (796)
Q Consensus 572 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIl 635 (796)
....+++|||+++++|.+++... ..+++..++.++.||++||.|||++ +|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 99999999999999999998753 2467788899999999999999998 8999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHh
Q 044281 636 LDHFFSAKISDFGLSKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESR 713 (796)
Q Consensus 636 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~ 713 (796)
+++++.+||+|||+++.+....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999999999998764332211 222345678999999999999999999999999999998 77777654333322
Q ss_pred HHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCC
Q 044281 714 AILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781 (796)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (796)
..+ ..+.... ........+.+++.+||+.+|.+||+|.+|++.|++++...
T Consensus 250 ~~~--------~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 250 KLL--------KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHH--------HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 111 1111100 01123356778999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.68 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=201.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCC---eEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
..+.++||+|+||+||+|.....+. ..||+|.+... ......++.+|+.+++.++|+||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence 3455789999999999998653322 25899998653 33345688999999999999999999999875 4578999
Q ss_pred eecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999999764 4689999999999999999999998 899999999999999999999999999987643322
Q ss_pred cc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 RT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 ~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.. .....++..|+|||.+.+..++.++|||||||++|||++ |..|+...........+ ..+.....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~~---- 232 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL--------EKGERLPQ---- 232 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCcCCC----
Confidence 11 111234678999999999999999999999999999998 88888654333221111 11111100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (796)
.......+.+++.+||+.||++||++.++++.|+.+...+
T Consensus 233 -----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 -----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1112345678999999999999999999999998876555
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=307.17 Aligned_cols=255 Identities=20% Similarity=0.323 Sum_probs=204.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||++... .+++.++||.+... ......++.+|+.+++.++|+||+++++++.++...+++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 456788999999999999865 36789999988642 22334688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 581 FMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 581 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
|+++++|.+++.. ...+++..++.++.||++||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998863 34678999999999999999999998 8999999999999999999999999998865433
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.. ......++..|+|||.+.+..++.++||||||+++|||++|..|+........ ... ........ +
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-----~~~~~~~~-----~- 226 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC-----KKIEQCDY-----P- 226 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh-----hhhhcCCC-----C-
Confidence 22 12234588899999999999999999999999999999999999865432211 000 00001000 0
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
..........+.+++.+||+.+|++||||.+|+++++++
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 001112345677899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=329.31 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=198.2
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||+||++... .+++.||||++.... ......+.+|+.++..++|+||+++++++.++...++||||+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred EEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 4578999999999999875 468899999997532 233456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc---
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--- 659 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~--- 659 (796)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 84 PGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999998888899999999999999999999998 8999999999999999999999999999765321100
Q ss_pred ----------------------------------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCc
Q 044281 660 ----------------------------------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVE 705 (796)
Q Consensus 660 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~ 705 (796)
......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0012458999999999999999999999999999999999999998
Q ss_pred hhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 044281 706 MELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT---MKVVLQM 773 (796)
Q Consensus 706 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~evl~~ 773 (796)
.....+....+..+.. .. .+.. .......+.+++.+|+. +|.+|++ +.++++.
T Consensus 241 ~~~~~~~~~~i~~~~~------~~--~~~~------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 241 SDNPQETYRKIINWKE------TL--QFPD------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCHHHHHHHHHcCCC------cc--CCCC------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 6654432222211100 00 0000 00112345667788886 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.41 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=202.8
Q ss_pred HHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 499 LKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 499 l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+..+.+.++||+|+||.||+|..+ +++.||+|.+.... .....+.+|+.++++++|+|++++++++. ....+++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 34556677789999999999999864 56789999987543 23467899999999999999999999874 4568999
Q ss_pred EeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 579 YEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
|||+++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999998653 3578899999999999999999998 8999999999999999999999999999876433
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~--- 224 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL--------ERGYRMPR--- 224 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--------HcCCCCCC---
Confidence 3222223345678999999999899999999999999999999 99998755433221111 11110000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
......++.+++.+|++.+|++||+++++++.|+.
T Consensus 225 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=324.55 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=197.3
Q ss_pred HHHhhCCCccceEEEEEeeC--CCCeEEEEEEecchh----hhhHHHHHHHHHHhccc-CccCcccccccccccccceeE
Q 044281 506 FKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLA----QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.||+|+||.||++.... .+++.||+|.+.+.. ....+.+..|+.++..+ +|+||+++++++......++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 45789999999999987532 357899999986532 12345678899999999 599999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999998888899999999999999999999998 899999999999999999999999999986544333
Q ss_pred cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.. ...... ..
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----~~~~~~------~~- 229 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----RILKCD------PP- 229 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH----HHhcCC------CC-
Confidence 333345699999999999875 478999999999999999999999964322111111111 001100 00
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
.+......+.+++.+||+.||++|| +++++++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 ---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0111234566789999999999999 77777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.71 Aligned_cols=255 Identities=27% Similarity=0.363 Sum_probs=202.5
Q ss_pred HhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecch-hhhhHHHHHHHHHHhccc-CccCccccccccccccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 577 (796)
+.+.+.||+|+||.||++.... .....+|+|.+... ......++.+|+.++.++ +|+||+++++++......++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 3455789999999999998653 23468999998753 233446789999999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc
Q 044281 578 VYEFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS 641 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 641 (796)
+|||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+|+||||+||++++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCe
Confidence 99999999999998542 3578889999999999999999998 8999999999999999999
Q ss_pred EEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHH
Q 044281 642 AKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDW 719 (796)
Q Consensus 642 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~ 719 (796)
+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......+....+
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--- 247 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL--- 247 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH---
Confidence 999999999876433221 1122335678999999999999999999999999999998 88888654433222111
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
..+... ..+......+.+++.+|++.+|++|||+.++++.|+.++
T Consensus 248 -----~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 248 -----KEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111110 011122356778999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=325.03 Aligned_cols=240 Identities=24% Similarity=0.271 Sum_probs=195.2
Q ss_pred HhhCCCccceEEEEEee--CCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLK--TASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~--~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||++... ..+++.+|+|++..... .....+..|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 46999999999998753 24678999999976432 233567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceec
Confidence 999999998877899999999999999999999998 899999999999999999999999999986533222 2234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ...... .+.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i--------~~~~~~----------~p~ 219 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI--------LKAKLG----------MPQ 219 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH--------HcCCCC----------CCC
Confidence 56899999999999989999999999999999999999999765443322111 111110 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKV 769 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~e 769 (796)
.....+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12245667999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.12 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=199.1
Q ss_pred hHHHhhCCCccceEEEEEee---CCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccc--cccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLK---TASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDE--ALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~ 579 (796)
.+.+.||+|+||.||++..+ ..+++.||+|++........+.+.+|++++++++|+||+++++++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 45578999999999999753 34678999999977666666789999999999999999999997643 34678999
Q ss_pred eecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 87 EYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999999999764 4689999999999999999999998 899999999999999999999999999987643322
Q ss_pred cc--eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH--------HHHHHHHHhhhcCc
Q 044281 659 RT--HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA--------ILTDWAYDCYVEGR 728 (796)
Q Consensus 659 ~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~--------~l~~~~~~~~~~~~ 728 (796)
.. .....++..|+|||.+.+..++.++|||||||++|||++|..+........... .+.........++.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC
Confidence 11 111223456999999999999999999999999999999876653321110000 00000000000000
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
...........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 244 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 244 ---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0001112234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.44 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=202.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCC--CeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|.....+ +..+|+|.++... ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 445678999999999999875332 3479999986532 3345689999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+++++|.+++... ..+++.+++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.+......
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 86 YMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999765 4678899999999999999999998 8999999999999999999999999999876543322
Q ss_pred ceee--ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 660 THTM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 660 ~~~~--~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.... ..++..|+|||.+.+..++.++||||||+++||+++ |..||......+....+ .++...
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~--------~~~~~~------ 228 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI--------EEGYRL------ 228 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH--------hCCCcC------
Confidence 2111 223567999999999899999999999999999887 99998654433221111 111000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.........+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.38 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=201.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.+.||+|+||.||+|+.. .+++.||+|++..........+.+|+.++++++|+||+++++.+......++|+||+
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hcchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4556788999999999999865 467899999997654445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.+..... ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccC
Confidence 9999999998777889999999999999999999998 999999999999999999999999999986643221 122
Q ss_pred eccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 663 MIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
...++..|+|||.+. ...++.++|||||||++|||++|+.|+......+....+ ...... .+...
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~---~~~~~- 232 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSNFQ---PPKLK- 232 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCCCC---CCCCc-
Confidence 345788999999884 445788999999999999999999998644322111100 000000 00000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
........+.+++.+||+.+|++||++++|++.|
T Consensus 233 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 -DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0112335677899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.66 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=201.4
Q ss_pred HHHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
..+.+.++||+|+||.||+|..+. ..+..||+|.+.... ......+.+|+..+++++|+||+++++++.+....+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 345567889999999999997542 235689999986433 233456889999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcC----------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEee
Q 044281 577 LVYEFMGNGTLANLIFAI----------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISD 646 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 646 (796)
+||||+++|+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999999642 3346678889999999999999998 899999999999999999999999
Q ss_pred cCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhh
Q 044281 647 FGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCY 724 (796)
Q Consensus 647 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~ 724 (796)
||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..|+.....++....+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~-------- 234 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------- 234 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------
Confidence 999986543222 11122335678999999999999999999999999999999 67787654433221111
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
..+..... +......+.+++.+||+.||++|||+.++++.|++.+
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111110 0112356788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.73 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=201.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCC--CeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|..+... +..||||.+... ......+|..|+.++++++||||+++++++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 345678999999999999876432 247999998754 33445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+++++|.+++... ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999998764 5678999999999999999999998 9999999999999999999999999999865432221
Q ss_pred c-eee-cc--CCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 660 T-HTM-IR--GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 660 ~-~~~-~~--gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
. ... .. .+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+ .. ......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i----~~---~~~~~~--- 232 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI----EQ---DYRLPP--- 232 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH----Hc---CCcCCC---
Confidence 1 111 11 2457999999999999999999999999999886 99998755433221111 00 000000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.......+.+++.+||+.+|++||+|.+|+++|+++
T Consensus 233 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 -------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111224567799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=322.77 Aligned_cols=238 Identities=28% Similarity=0.312 Sum_probs=190.9
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHH-HhcccCccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVS-AIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||+||++..+ .+++.||+|++..... ....++..|.. +++.++||||+++++.+......++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36899999999999875 4688999999975322 22334555544 5677899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|+|..++.....+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 999999998888889999999999999999999998 8999999999999999999999999998754222 222334
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+.... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~~~~----------~~ 217 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--------LNKPLRL----------KP 217 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH--------HcCCCCC----------CC
Confidence 56899999999999999999999999999999999999999765433321111 1111100 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMK 768 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~ 768 (796)
.....+.+++.+||+.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234567899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=322.22 Aligned_cols=242 Identities=26% Similarity=0.294 Sum_probs=192.9
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHH-HhcccCccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVS-AIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||+||++... .+++.+|+|++.... ......+..|.. +++.++||||+++++.+......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 36899999999999865 468899999996532 223345555654 4677899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|+|...+.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 999999998888899999999999999999999998 8999999999999999999999999998753221 122334
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+... + .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~--------~~~~~~--~--------~~ 217 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI--------LHKPLV--L--------RP 217 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH--------HcCCcc--C--------CC
Confidence 56899999999999999999999999999999999999999765433321111 111111 0 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.....+.+++.+|++.+|.+||++.+.++
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 12345667899999999999998864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.80 Aligned_cols=249 Identities=27% Similarity=0.311 Sum_probs=198.6
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
...+.||+|+||+||++... .+++.||+|++..... .....+.+|+.++++++|+||+++++.+..+...++||||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred eEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 34567999999999999865 4688999999965322 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999999888653 4688999999999999999999998 899999999999999999999999999986533221
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....|+..|+|||.+.+..++.++||||+||++|||++|+.||...........+.. ...... .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~----------~ 222 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER----RVKEDQ----------E 222 (285)
T ss_pred -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH----Hhhhcc----------c
Confidence 2234689999999999999999999999999999999999999976543222111111 011100 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
.........+.+++.+||+.||.+|| ++.++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 01122345677899999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.38 Aligned_cols=244 Identities=27% Similarity=0.321 Sum_probs=196.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCc-cCcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHH-KHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.||+|+||.||+|..+ .+++.||||++.... ....+.+..|.+++..++| ++|+++.+++...+..++||||
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred EEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 4578999999999999865 467899999997532 2344678889999999866 4688899999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 83 ~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 158 (324)
T cd05587 83 VNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTT 158 (324)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cce
Confidence 99999999998888889999999999999999999998 99999999999999999999999999987532211 223
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. ..... .
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--------~~~~~----------~ 220 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--------EHNVS----------Y 220 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--------cCCCC----------C
Confidence 34568999999999999999999999999999999999999997655433222211 11110 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTM-----KVVLQ 772 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~evl~ 772 (796)
+......+.+++.+||+.||.+||+. .++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11123456789999999999999976 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=291.24 Aligned_cols=252 Identities=27% Similarity=0.347 Sum_probs=203.6
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecc--hhhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
...+.+.++||+|.|+.||+.... .+|+.+|+|++.. .+....+++.+|+.+-+.++||||+++...+.+....+||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~-~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhc-cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 344667899999999999998755 5788888888743 3334567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccccC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLLFS 655 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~ 655 (796)
+|+|.|++|..-|-.+-..++..+-..++||+++|.|.|.+ +|||||+||+|+|+-. ...+||+|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999999987776655566777888999999999999999 9999999999999953 4458999999999876
Q ss_pred CCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.........|||+|||||+++..+++..+|||+-||+||-|+.|..||..+..+.....+....+. . ++
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd--------~--~~ 233 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD--------Y--PS 233 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC--------C--CC
Confidence 233334456999999999999999999999999999999999999999987666544444322111 1 11
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.. -..-.++...++.+||..||.+|.|+.|.+.
T Consensus 234 ~~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PE----WDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cc----cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11 1112244567899999999999999998764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=304.71 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=200.7
Q ss_pred HhhCCCccceEEEEEeeCCCCe--EEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGT--AIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
++||+|++|.||+|.+....++ .||+|.+..... ...+.+.+|+..+++++|+||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 4689999999999987653343 699999977555 556789999999999999999999999988 888999999999
Q ss_pred CCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc--c
Q 044281 585 GTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--T 660 (796)
Q Consensus 585 gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~--~ 660 (796)
++|.+.+.... .+++...+.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997754 678999999999999999999998 8999999999999999999999999999876443221 1
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+....+. ..+....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~~-------- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID-------KEGERLE-------- 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hcCCcCC--------
Confidence 123446788999999999999999999999999999999 999986544333211110 0010000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
.+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112346778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.54 Aligned_cols=263 Identities=22% Similarity=0.237 Sum_probs=193.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||+|..+ .+++.||||++..... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred ceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 345678999999999999875 4678999999865332 22346788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+ ++|.+++... ..++...+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 160 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY 160 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence 6 5777776553 5678889999999999999999998 89999999999999999999999999997543221 222
Q ss_pred eeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHH-HhHHHHHHHHHhhhcC------------
Q 044281 662 TMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTDWAYDCYVEG------------ 727 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~-~~~~l~~~~~~~~~~~------------ 727 (796)
....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+.. ........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL-VLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH-HhCCCChhhccchhhccccc
Confidence 33457899999999865 458899999999999999999999997542211 1111100 00000000
Q ss_pred --ccceeccchh-hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 --RLDVLIDSDE-AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 --~~~~~~d~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000000 000001122456789999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=305.59 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=202.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred ccceeeeecCCCceEEEEEec---CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 456688999999999999863 78999999976544 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999997665 689999999999999999999998 899999999999999999999999999986632211
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+..|+|||.+.+..++.++||||||++++||++ |..||......+....+ ..+.....
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~-------- 220 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV--------EKGYRMEA-------- 220 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------hcCCCCCC--------
Confidence 2234668999999998899999999999999999997 88888655433221111 11110000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
+......+.+++.+||+.+|++||++++++++|+.+
T Consensus 221 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 -PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111235677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.29 Aligned_cols=254 Identities=20% Similarity=0.318 Sum_probs=202.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.++||+|+||.||+|+... +++.||||.+... .......+.+|+.+++.++||||+++++++......++++||
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLL-DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeC-CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456789999999999998763 6789999987532 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 582 MGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 582 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
+++++|.+++.. ...++...+..++.||++||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999988853 24478888999999999999999998 99999999999999999999999999998764332
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+......... + . ..........
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--~---~-~~~~~~~~~~------ 227 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--L---C-QKIEQCDYPP------ 227 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH--H---H-HHHhcCCCCC------
Confidence 2 112345788999999999888999999999999999999999998654321110 0 0 0111111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01112335678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=310.79 Aligned_cols=254 Identities=29% Similarity=0.450 Sum_probs=202.6
Q ss_pred HHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
.+.+.+.||+|+||.||+|..+. .++..||+|.+.... ......+.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 34455789999999999998753 234789999986543 2345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcC----------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeec
Q 044281 578 VYEFMGNGTLANLIFAI----------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDF 647 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 647 (796)
||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+|+||||+||++++++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCc
Confidence 99999999999998643 2367889999999999999999998 8999999999999999999999999
Q ss_pred CCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhh
Q 044281 648 GLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYV 725 (796)
Q Consensus 648 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 725 (796)
|+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+....+ .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~--------~ 235 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV--------I 235 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH--------h
Confidence 99986543322 12223346788999999998899999999999999999998 88888654443322111 1
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 726 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.+..... +......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 236 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 11124567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.54 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=198.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCC--eEEEEEEecch-hhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+|+||.||+|..+. ++ ..+++|.+... .......+.+|+.++.++ +|+||+++++++......++||
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred ceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 3456789999999999998763 34 35688887653 234456889999999999 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 044281 580 EFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAK 643 (796)
Q Consensus 580 e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 643 (796)
||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEE
Confidence 999999999998643 2467889999999999999999998 999999999999999999999
Q ss_pred EeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHH
Q 044281 644 ISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYD 722 (796)
Q Consensus 644 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~ 722 (796)
|+|||+++..... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 165 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~------ 236 (303)
T cd05088 165 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL------ 236 (303)
T ss_pred eCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH------
Confidence 9999998642111 11111224667999999988889999999999999999998 99998654433211111
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 723 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
..+.... .+......+.+++.+||+.+|++||++.+++++|+.+++.
T Consensus 237 --~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 237 --PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred --hcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1110000 0011223567899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.67 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=199.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||++..+ .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|||
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 345578999999999999876 468899999996532 2234567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 124 y~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 124 YMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 99999999988764 467888889999999999999998 89999999999999999999999999998764433323
Q ss_pred eeeccCCCcccccccccCC----CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 661 HTMIRGTRGYVAPEWFKNV----PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~----~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+ ........+.
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~~~~~~~~~-- 269 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI--------MDHKNSLTFP-- 269 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH--------HcCCCcCCCC--
Confidence 3445699999999998654 4789999999999999999999999865543222111 1111000000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~ 773 (796)
........+.+++.+||+.+|.+ ||++.++++.
T Consensus 270 ----~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 ----DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01122356677999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.62 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=206.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCe--EEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGT--AIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
..+.|+||+|.||.|++|.+....|+ .||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 34668999999999999999876665 6899999764433 56899999999999999999999999988 78899999
Q ss_pred ecCCCCHHHHHhc--CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 581 FMGNGTLANLIFA--IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 581 ~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
.++.|+|.+.|.+ ...+.......++.|||.||.||..+ ++|||||.++|+||-....+||+||||.+.+...+.
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999987 34667788899999999999999998 899999999999999999999999999998865443
Q ss_pred c-ceee-ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 659 R-THTM-IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 659 ~-~~~~-~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
. .+.. ..-+..|.|||.++...++.++|||+|||++|||+| |..|+.+........ .+|.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~-----------------~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK-----------------NIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH-----------------hccc
Confidence 2 2222 234678999999999999999999999999999999 456776544332222 2233
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
...-..+..+.+.+.+++..||..+|.+|||+..|.+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 333334566788999999999999999999999997443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.27 Aligned_cols=243 Identities=27% Similarity=0.278 Sum_probs=192.5
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHH-HhcccCccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVS-AIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||++..+ .+++.||+|.+..... .....+..|.. +++.++|+||+++++++...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36899999999999875 4678999999975321 22334444544 4677899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|.+++.....+.......++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 999999998877788888889999999999999998 89999999999999999999999999997543222 22334
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. ..... + ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--------~~~~~--~--------~~ 217 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--------NKPLQ--L--------KP 217 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--------hCCcC--C--------CC
Confidence 568999999999999999999999999999999999999997654433221111 11110 0 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+.+++.+|++.||.+||++.+.++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 123456778999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=309.96 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=198.1
Q ss_pred hHHHhhCCCccceEEEEEeeCC----CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTA----SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.||+|+||.||+|.+... .+..|++|.+.... ......|..|+.++++++|+||+++++++.+....++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 3457899999999999988641 45789999886433 334567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC-------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC---cEEEeecCC
Q 044281 580 EFMGNGTLANLIFAIP-------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF---SAKISDFGL 649 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~DfGl 649 (796)
||+++++|.+++.... .+++..+++++.||+.||+|||+. +++|+||||+||+++.++ .+||+|||+
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999987542 478899999999999999999998 899999999999998754 599999999
Q ss_pred cccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 650 SKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 650 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||...........+. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-------~~~ 238 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-------GGG 238 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cCC
Confidence 98763222111 112223567999999999999999999999999999997 888887654433211110 011
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
... .+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 239 ~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 RLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 100 01122346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.84 Aligned_cols=256 Identities=27% Similarity=0.357 Sum_probs=202.4
Q ss_pred HHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 576 (796)
...+.+.||+|+||.||++... ..++..||+|+++... ....+.+.+|+.+++++ +|+||+++++++......+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 3445678999999999999752 2345689999987543 23346789999999999 7999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 577 LVYEFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
++|||+++++|.+++.... .+++.++..++.||+.||+|||+. +|+|+||||+|||+++++.+||+|||+++...
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999997543 379999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 655 SDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 655 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......+.... ....+....
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-------~~~~~~~~~- 264 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-------LIKEGYRMA- 264 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH-------HHHcCCcCC-
Confidence 33221 1122345778999999999999999999999999999998 8888865433221111 111111000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.+.....++.+++.+|++.+|++|||+.++++.|++.
T Consensus 265 --------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 --------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0011234677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=310.66 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=203.9
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCC---CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccc-cccce
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTA---SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDE-ALNRL 576 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~ 576 (796)
..+.+.+.||+|+||.||+|..... .+..|++|++.... ......+.+|+.++++++|+||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 3445668899999999999997642 26789999987542 3345678999999999999999999998765 56789
Q ss_pred eEEeecCCCCHHHHHhcC--------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecC
Q 044281 577 LVYEFMGNGTLANLIFAI--------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFG 648 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfG 648 (796)
+++||+++++|.+++... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999998653 3578999999999999999999998 89999999999999999999999999
Q ss_pred CcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhc
Q 044281 649 LSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVE 726 (796)
Q Consensus 649 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~ 726 (796)
+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+....+ ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~ 234 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL--------KD 234 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH--------Hc
Confidence 99866433321 1222345778999999999899999999999999999999 99998765433221111 11
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 727 GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 727 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+.... . .......+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 235 ~~~~~--~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYRLA--Q-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCC--C-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11000 0 01122457789999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=305.53 Aligned_cols=249 Identities=23% Similarity=0.283 Sum_probs=200.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-----hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
...+.||+|++|.||++... .+++.+++|.+.... ......+.+|++++++++||||+++++++.+....++|+
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred cccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 34578999999999999865 467899999885421 123457899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++++|.+++.....+++.....++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||+++........
T Consensus 84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999998878888999999999999999999998 8999999999999999999999999999865432222
Q ss_pred ce--eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 660 TH--TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 660 ~~--~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||............ .......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~~~~------- 226 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-------ATQPTNP------- 226 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH-------hccCCCC-------
Confidence 11 2345788999999999999999999999999999999999998654322211110 0000000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+......+.+++.+||+.+|.+|||+.+++++
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 --QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111223456779999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.58 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=192.8
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHh---cccCccCcccccccccccccceeEE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAI---GRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.||+|+||.||++..+ .+++.||||.++... ....+.+.+|++++ +.++||||+++++++......++||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred EEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 3467999999999999875 468899999997532 22234566665554 5678999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++++|...+.. ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 82 E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 82 EYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred cCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999999888764 4689999999999999999999998 99999999999999999999999999987532222 1
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i--------~~~~~~--------- 219 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI--------VNDEVR--------- 219 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC---------
Confidence 223456899999999999999999999999999999999999999765443322211 111110
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
.+......+.+++.+||+.||.+|| ++.++++.
T Consensus 220 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 -YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0111234567799999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=304.25 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=201.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||.||+++.+ .+++.|++|.+... .......+.+|++++++++|+|++++++++.+....++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred EeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 4567999999999999876 46789999998642 33456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~ 158 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FA 158 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-hh
Confidence 99999999764 5678899999999999999999998 999999999999999999999999999987644322 12
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....+++.|+|||++.+..++.++||||||+++|||++|+.||........... ...+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~--------- 221 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK--------IIRGVFPPV--------- 221 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHcCCCCCC---------
Confidence 334578899999999999999999999999999999999999976553321111 111111111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11233567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.20 Aligned_cols=239 Identities=28% Similarity=0.328 Sum_probs=193.8
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.||+|+||.||+|..+ .+++.||+|.+.... ......+..|..++..+ +|++|+++++++...+..++||||
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 4567999999999999875 467899999997532 22334567788888776 689999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 83 ~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~ 158 (323)
T cd05616 83 VNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTT 158 (323)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Ccc
Confidence 99999999998888899999999999999999999998 89999999999999999999999999997543222 122
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. +.... .
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--------~~~~~----------~ 220 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--------EHNVA----------Y 220 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCCC----------C
Confidence 34568999999999999999999999999999999999999998665443222211 11110 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTM 767 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~ 767 (796)
+.....++..++.+|++.||.+|++.
T Consensus 221 p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11223466789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.21 Aligned_cols=259 Identities=27% Similarity=0.343 Sum_probs=203.0
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCC------CCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCccccccccccc
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTA------SGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEA 572 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 572 (796)
...+.+.+.||+|+||.||++..... +...+|+|.++... .....++.+|+.++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 34556778999999999999975321 23579999997532 33456788999999999 799999999999999
Q ss_pred ccceeEEeecCCCCHHHHHhcCC----------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE
Q 044281 573 LNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL 636 (796)
Q Consensus 573 ~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll 636 (796)
...++||||+++++|.+++.... .+++.++++++.||+.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999997532 477889999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCcccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhH
Q 044281 637 DHFFSAKISDFGLSKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRA 714 (796)
Q Consensus 637 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~ 714 (796)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+.....++...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999998654322111 112234568999999999999999999999999999998 778876543332211
Q ss_pred HHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 715 ILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+ ..+.... .+......+.+++.+||+.+|.+||+|.+|++.|+.+++
T Consensus 254 ~~--------~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 254 LL--------KEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HH--------HcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11 1111100 011223467779999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=305.18 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=197.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.++||+|+||.||++..+ .+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 445678999999999999865 34579999886532 23467899999999999999999999875 456789999999
Q ss_pred CCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999764 3478899999999999999999998 899999999999999999999999999986643322222
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....++..|+|||...+..++.++||||||+++|||++ |+.|+......+....+ ..+... .
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~---------~ 223 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV--------ERGYRM---------P 223 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCC---------C
Confidence 22345678999999998999999999999999999999 88888754433221111 111000 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011223567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=311.19 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=199.0
Q ss_pred HhHHHhhCCCccceEEEEEee---------------CCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLK---------------TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLG 567 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~---------------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g 567 (796)
+.+.+.||+|+||.||++... ..+...+|+|.+.... .....+|.+|+.+++.++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 456688999999999998532 1234579999997543 334568999999999999999999999
Q ss_pred cccccccceeEEeecCCCCHHHHHhcCC-----------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE
Q 044281 568 FCDEALNRLLVYEFMGNGTLANLIFAIP-----------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL 636 (796)
Q Consensus 568 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll 636 (796)
++......+++|||+++++|.+++.... .+++..+..++.||+.||+|||+. +++|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence 9999999999999999999999987542 356778999999999999999998 89999999999999
Q ss_pred cCCCcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh--CCCCCchhhHHHHh
Q 044281 637 DHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC--CRRSVEMELEEESR 713 (796)
Q Consensus 637 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt--g~~p~~~~~~~~~~ 713 (796)
++++.+||+|||+++.+...... ......++..|+|||...++.++.++|||||||++|||++ |..|+......+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 99999999999999865433221 1122334678999999888899999999999999999998 66777654333221
Q ss_pred HHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 714 AILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.... ............. .+......+.+++.+||+.||++||+|.+|++.|+.
T Consensus 244 ~~~~----~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 244 ENTG----EFFRDQGRQVYLP------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHH----HHHhhccccccCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111 1111110000000 011123567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=318.54 Aligned_cols=259 Identities=28% Similarity=0.367 Sum_probs=199.2
Q ss_pred HHHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCccccccccccc-cc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEA-LN 574 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 574 (796)
..+.+.+.||+|+||.||+|... ..+++.||||+++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 34667789999999999999742 2356899999997532 23356788999999999 789999999988654 45
Q ss_pred ceeEEeecCCCCHHHHHhcC------------------------------------------------------------
Q 044281 575 RLLVYEFMGNGTLANLIFAI------------------------------------------------------------ 594 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 594 (796)
.+++|||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999988642
Q ss_pred -------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-cceeeccC
Q 044281 595 -------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-RTHTMIRG 666 (796)
Q Consensus 595 -------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~g 666 (796)
..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++....... .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1256778889999999999999998 999999999999999999999999999986533222 11122345
Q ss_pred CCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHH
Q 044281 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSR 745 (796)
Q Consensus 667 t~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 745 (796)
+..|+|||.+.+..++.++||||||+++|||++ |..|+......... .....++...... ...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~---------~~~ 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------CRRLKEGTRMRAP---------DYT 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-------HHHHhccCCCCCC---------CCC
Confidence 678999999999999999999999999999997 88887643221110 0111111111100 011
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 746 LHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 746 ~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
...+.+++.+||+.+|++|||+.+|++.|+.+++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2357789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=308.11 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=193.4
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
||+|+||.||++..+ .+++.+|+|.+..... .....+..|++++++++||||+++.+++..+...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999876 4688999999965322 223456679999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 587 LANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 587 L~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....... .....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 99888654 3578888999999999999999998 99999999999999999999999999998654322 22334
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...........+ . .......... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~-~~~~~~~~~~---------~~~~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---K-RRTLEDEVKF---------EHQN 221 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---H-HHhhcccccc---------cccc
Confidence 6899999999999989999999999999999999999998653321111111 0 0011111100 0011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
...++.+++.+||+.||++||+++|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 234567899999999999999997766444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.86 Aligned_cols=249 Identities=23% Similarity=0.283 Sum_probs=196.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.++||+|+||+||++..+ .+++.||||.+.... ......+.+|++++++++||||+++++++.+....++||||+
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred EeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 4578999999999999865 468899999986532 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc---
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--- 659 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~--- 659 (796)
++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 84 PGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999998888889999999999999999999998 9999999999999999999999999999643211000
Q ss_pred -------------------------------------------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHH
Q 044281 660 -------------------------------------------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLE 696 (796)
Q Consensus 660 -------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~e 696 (796)
......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0012458999999999999999999999999999999
Q ss_pred HHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 044281 697 IICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKR---PTMKVVLQM 773 (796)
Q Consensus 697 lltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~evl~~ 773 (796)
|++|+.||......+....+..+.. .+ ...+ ......++.+++.+|++ +|.+| |++.++++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~------~~-~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRE------TL-YFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCC------cc-CCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999976554332222211100 00 0000 00122356678888887 66665 699998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.23 Aligned_cols=248 Identities=21% Similarity=0.272 Sum_probs=193.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.++||+|+||+||+|+.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 3467999999999999865 467899999997532 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC-----
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ----- 657 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~----- 657 (796)
++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 84 PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999998877888899999999999999999998 89999999999999999999999999975331100
Q ss_pred -----------------------------------------CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHH
Q 044281 658 -----------------------------------------SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLE 696 (796)
Q Consensus 658 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~e 696 (796)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 044281 697 IICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT---MKVVLQ 772 (796)
Q Consensus 697 lltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~evl~ 772 (796)
|++|+.||......+....+..+.. ... . + .......++.+++.+++ .+|++|++ +.++++
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~------~~~-~--p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQT------SLH-I--P-----PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCC------CcC-C--C-----CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999986554332222211100 000 0 0 00111233445555554 49999997 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.67 Aligned_cols=238 Identities=24% Similarity=0.283 Sum_probs=190.4
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHH-HhcccCccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVS-AIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
++||+|+||.||+++.+ .+++.||+|.+..... .....+..|.. +++.++|+||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999875 4678999999965322 22344555554 5778899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|...+.....+....+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 999999988777888889999999999999999998 89999999999999999999999999987532222 22234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+ ...... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------~~~~~~----------~~~ 217 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI--------LHKPLQ----------LPG 217 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH--------hcCCCC----------CCC
Confidence 56899999999999999999999999999999999999999765433221111 111110 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMK 768 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~ 768 (796)
.....+.+++.+||+.||.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2234577899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.21 Aligned_cols=241 Identities=23% Similarity=0.399 Sum_probs=190.5
Q ss_pred HhhCCCccceEEEEEeeCC------CCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 508 EELGRGSFGIVYKGVLKTA------SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.||+|+||.||+|..+.. ....|++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 4699999999999986432 1235888988765555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc--------EEEeecCCccc
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS--------AKISDFGLSKL 652 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~--------~kl~DfGla~~ 652 (796)
+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +|++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999764 4578999999999999999999998 9999999999999987765 69999999875
Q ss_pred ccCCCCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCC-CCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCR-RSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~-~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
... .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+............ ... .
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---------~~~-~ 222 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---------EDR-H 222 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---------Hcc-c
Confidence 432 1224578889999999874 5799999999999999999996 444432222111100 000 0
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
. .+.....++.+++.+||+.||++|||++++++.|+
T Consensus 223 ~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 Q---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 01112245778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.72 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=196.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||++..+ .+++.+|+|.+.+.. ......+.+|+.+++.++||||+++++++.++...++|||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred CeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 344578999999999999876 467899999986532 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 124 y~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 124 YMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 99999999998754 578888999999999999999998 99999999999999999999999999998764333323
Q ss_pred eeeccCCCcccccccccCCC----CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 661 HTMIRGTRGYVAPEWFKNVP----VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~----~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...........+. .......+
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~--------~~~~~~~~--- 268 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM--------DHKNSLNF--- 268 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCcccCC---
Confidence 34567999999999997643 7889999999999999999999998665433221111 10000000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~ 773 (796)
.........+..++..|++.++.+ ||++.|+++.
T Consensus 269 ---p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 ---PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 001112344566788888765544 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.21 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=190.9
Q ss_pred HhhCCCccceEEEEEeeC-CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 508 EELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
+.||+|+||.||+|.... .++..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 245679999986543 233457899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC-----CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-
Q 044281 586 TLANLIFAIP-----KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR- 659 (796)
Q Consensus 586 sL~~~l~~~~-----~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~- 659 (796)
+|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987532 456778889999999999999998 8999999999999999999999999999754332221
Q ss_pred ceeeccCCCcccccccccCC-------CCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccce
Q 044281 660 THTMIRGTRGYVAPEWFKNV-------PVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (796)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+..... .. +....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~-~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-------VR-EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------hh-cccCC
Confidence 12234467889999998642 35789999999999999996 99898654433221111 00 11111
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 732 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
..++... ....+.+.+++..|+ .+|++|||+.||++.|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 112234566888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.00 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=201.8
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhH--HHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||+||++... .+++.+|+|.+........ ....+|+.++++++|+||+++++++.+....++||||++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 4568999999999999976 4678999999976544332 244669999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|.+++.....+++..++.++.||++||++||+. +|+|+||||+||++++++.++|+|||.+... .........
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~~ 157 (260)
T PF00069_consen 82 GGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFNP 157 (260)
T ss_dssp TEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccccccc
Confidence 999999999778889999999999999999999998 9999999999999999999999999999864 222233344
Q ss_pred ccCCCccccccccc-CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFK-NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..++..|+|||++. +...+.++||||+|+++++|++|..|+...........+......... . .....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----~------~~~~~ 226 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP-----S------SSQQS 226 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH-----H------HTTSH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc-----c------ccccc
Confidence 56889999999998 889999999999999999999999999865222222222111110000 0 00000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......+.+++.+||+.||++||++.++++.
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112678889999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.08 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=202.0
Q ss_pred HHHhHHHhhCCCccceEEEEEee---CCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccc--ccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLK---TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNR 575 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 575 (796)
.++...++||+|+||.||++... ..++..||+|.++... ......+.+|+.++++++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34556678999999999999753 2357899999987543 33456799999999999999999999998765 567
Q ss_pred eeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 576 LLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999998664 4579999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCc--ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHh--------HHHHHHHHHhh
Q 044281 655 SDQSR--THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESR--------AILTDWAYDCY 724 (796)
Q Consensus 655 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~--------~~l~~~~~~~~ 724 (796)
..... ......++..|+|||.+.+..++.++||||||+++|||++++.|.......... ..... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR-LVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH-HHHHH
Confidence 43321 112344677899999999889999999999999999999987664322111000 00000 00111
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.++... .........+.+++.+||+.+|++||++.++++.|+.+
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 00112345788899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=333.15 Aligned_cols=250 Identities=27% Similarity=0.309 Sum_probs=198.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccc-------
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------- 573 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 573 (796)
.+.+.+.||+|+||+||++... .+++.||||.+... .......+.+|+..+..++|+|++++...+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 3456688999999999999865 46889999998543 3344567889999999999999999887764332
Q ss_pred -cceeEEeecCCCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecC
Q 044281 574 -NRLLVYEFMGNGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFG 648 (796)
Q Consensus 574 -~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfG 648 (796)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 257999999999999998653 3578889999999999999999998 89999999999999999999999999
Q ss_pred CcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 649 LSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 649 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
+++.+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.... ...+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~--------~~~~ 260 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK--------TLAG 260 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--------HhcC
Confidence 9987643221 222345689999999999999999999999999999999999999976544322111 1111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....+ +......+..++.+||+.||.+||++.+++++
T Consensus 261 ~~~~~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDPL---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111 11223467789999999999999999999864
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=309.63 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=200.4
Q ss_pred HhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.+.||+|+||.||++.... .++..||+|.+.... .....+|.+|+.++++++|+||+++++++..+...+++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 3455789999999999998642 356799999987533 33456799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcC----------------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE
Q 044281 579 YEFMGNGTLANLIFAI----------------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL 636 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~----------------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll 636 (796)
+||+++++|.+++... ..+++..++.++.||+.||+|||+. +++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence 9999999999998643 2367788899999999999999998 89999999999999
Q ss_pred cCCCcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhH
Q 044281 637 DHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRA 714 (796)
Q Consensus 637 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~ 714 (796)
++++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999886533221 11122234667999999999999999999999999999998 777886543332111
Q ss_pred HHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 715 ILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
....+..... +.....++.+++.+||+.+|++|||+.|+++.|++
T Consensus 244 --------~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 244 --------YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1112221110 11123567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.03 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=193.6
Q ss_pred HhhCCCccceEEEEEeeCC--CCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCccccccccc-ccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCD-EALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||+|..... ....+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 3689999999999986532 3468999998643 2344568899999999999999999999775 4556789999999
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC---c
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS---R 659 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~---~ 659 (796)
+++|.+++... ..+.+..+..++.||++||+|||+. +++||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999764 3567788889999999999999998 899999999999999999999999999986543221 1
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCC-CCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRR-SVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~-p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......++..|+|||.+.+..++.++|||||||++|||++|+. |+......+.... ...+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~------ 223 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY--------LLQGRRLLQ------ 223 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------HhcCCCCCC------
Confidence 1122345778999999998899999999999999999999654 4543322211111 111110000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+......+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 224 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0111245778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.69 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=201.1
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
..+...+.||+|+||.||+|... .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 34556688999999999999875 457899999987433 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++++|.+++.. ..+++..+..++.||++|+.|||+. +++|+||+|+||++++++.+||+|||++..+..... .
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 9999999998865 4678899999999999999999998 899999999999999999999999999986543221 1
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+........... ...+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--------~~~~~~~~--------- 220 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL--------IPKNSPPT--------- 220 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh--------hhcCCCCC---------
Confidence 2234578899999999999999999999999999999999999865433221111 11111000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+.+++.+||+.+|++||+|.+|+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011223457789999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.57 Aligned_cols=244 Identities=24% Similarity=0.302 Sum_probs=192.2
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||++..+ .+++.+|+|+++... ......+.+|+.++.++ +|+||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 36899999999999876 467899999997642 23345688899998888 69999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 999999998878899999999999999999999998 89999999999999999999999999997532222 22234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ............... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~----------~p~ 224 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIR----------IPR 224 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCC----------CCC
Confidence 568999999999999999999999999999999999999996422111000 001111111111110 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTM 767 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~ 767 (796)
.....+.+++.+||+.||++||++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 122456779999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.27 Aligned_cols=248 Identities=32% Similarity=0.474 Sum_probs=203.3
Q ss_pred HhhCCCccceEEEEEeeC--CCCeEEEEEEecchhhhh-HHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.||+|+||.||++.... ..+..|++|.+....... .+.+.+|++.+..++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998763 126789999997654333 67899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC---------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 585 GTLANLIFAI---------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 585 gsL~~~l~~~---------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 6789999999999999999999998 899999999999999999999999999987754
Q ss_pred CCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 656 DQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 656 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
... .......++..|+|||.+....++.++||||||+++|||++ |..||......+....+ ..+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~-- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL--------RKGYRLP-- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCCC--
Confidence 332 22233457889999999998899999999999999999999 58888765433222111 1111100
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
.+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 228 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 -------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112456778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=313.14 Aligned_cols=263 Identities=23% Similarity=0.353 Sum_probs=201.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.+.||+|+||.||++... .++..+|+|.+... ......++.+|++++.+++||||+++++++..+...++||||++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred eEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 34578999999999999865 46788999988643 23345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|.+++.....+++..+..++.||++||.|||+.. +++|+||||+|||+++++.+||+|||++....... ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 9999999988888899999999999999999999732 79999999999999999999999999987653221 223
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc---------------
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR--------------- 728 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~--------------- 728 (796)
..++..|+|||.+.+..++.++||||||+++|||++|+.||...........+............
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 45788999999998888999999999999999999999998654432221111100000000000
Q ss_pred -----cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 -----LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 -----~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...+................+.+++.+||+.+|++|||+.+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000001123457889999999999999999999877
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=305.95 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=203.1
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCC--CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
..+.+.+.||+|+||.||+|..... +...|++|...... ....+.+.+|+.++++++|+||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 3445667899999999999987533 23478999887644 4455689999999999999999999998875 557899
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999764 3579999999999999999999998 89999999999999999999999999998764433
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
........++..|+|||.+....++.++||||||++++|+++ |..||......+....+ ..+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~--------~~~~~~~~---- 229 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI--------ENGERLPM---- 229 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------HcCCcCCC----
Confidence 222222334568999999988899999999999999999986 99998765433221111 11111000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.......+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 230 -----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 230 -----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11223467779999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.72 Aligned_cols=250 Identities=25% Similarity=0.309 Sum_probs=200.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.++||+|+||.||+|... .++..+++|.+..........+.+|+++++.++|+|++++++++..+...++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 456678999999999999875 4678999999976655666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++|..++.. ...+++..+..++.||++||.|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 161 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence 9999988765 45689999999999999999999998 999999999999999999999999999976533221 223
Q ss_pred eccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 663 MIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
...++..|+|||.+. +..++.++|||||||++|||++|+.||......+....+. .........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~--- 230 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA--------KSEPPTLAQ--- 230 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh--------hcCCCCCCC---
Confidence 345889999999984 4557889999999999999999999987544322111110 000000000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.+|.+||++.++++.
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 ----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123467789999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.49 Aligned_cols=263 Identities=28% Similarity=0.362 Sum_probs=205.5
Q ss_pred HHHHHHHhHHHhhCCCccceEEEEEeeC------CCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccc
Q 044281 498 ELKDATDGFKEELGRGSFGIVYKGVLKT------ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFC 569 (796)
Q Consensus 498 ~l~~~~~~~~~~LG~G~fG~Vy~g~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 569 (796)
++....+.+.+.||+|+||.||++.... .....||+|.++... ....+++.+|++++.++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3444556778899999999999997532 122478999887532 33457899999999999 899999999999
Q ss_pred cccccceeEEeecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCC
Q 044281 570 DEALNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQN 633 (796)
Q Consensus 570 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~N 633 (796)
......++++||+++|+|.+++... ..+.+..++.++.||++||+|||+. +|+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 9999999999999999999998753 2467888999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHH
Q 044281 634 ILLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEE 711 (796)
Q Consensus 634 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~ 711 (796)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865432211 1122234567999999999999999999999999999998 778876544333
Q ss_pred HhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 712 SRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
....+ ..+..... ......++.+++.+||+.+|++||++.++++.|+.+...
T Consensus 245 ~~~~~--------~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 245 LFKLL--------KEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHH--------HcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 22111 11111110 112234677899999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=304.61 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=202.1
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
..+.+.++||+|+||.||++..+ +++.++||.+.... ....++.+|+.++++++|+||+++++++......++||||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34456688999999999999865 45789999987533 3356799999999999999999999999988899999999
Q ss_pred cCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++++|.+++.... .+++..+..++.||+.||+|||++ +++|+||||+||++++++.+||+|||+++.+......
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999997653 688999999999999999999998 8999999999999999999999999999876432222
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
.......+..|+|||.+.+..++.++||||||++++||++ |+.||...........+ ..+... ..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~~--~~---- 225 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV--------ERGYRM--PR---- 225 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCC--CC----
Confidence 2222234568999999999999999999999999999999 88888654332211111 111000 00
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01113467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=285.18 Aligned_cols=248 Identities=28% Similarity=0.358 Sum_probs=203.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--------hhhHHHHHHHHHHhccc-CccCcccccccccccccce
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--------QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 576 (796)
-.++||.|..+.|.+..++ .++.+.|+|++.... ....++-.+|+.+|+++ -||+|+++.++++.+...+
T Consensus 21 pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred hHHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 4578999999999998876 577889999885321 12234567899999998 6999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+|+|.|+.|.|.++|.+.-.++++...+|+.|+.+|++|||.. +|+||||||+|||+|++.++||+|||+|..+...
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 9999999999999999988999999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcceeeccCCCccccccccc------CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 657 QSRTHTMIRGTRGYVAPEWFK------NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
......+|||+|+|||.+. ...|+...|.||.||++|-|+.|-.||.......... .+.+|+.+
T Consensus 177 --ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR--------~ImeGkyq 246 (411)
T KOG0599|consen 177 --EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR--------MIMEGKYQ 246 (411)
T ss_pred --hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH--------HHHhcccc
Confidence 3445678999999999885 3468899999999999999999999997544332222 22333322
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
-- .+.-.+......+++.+||+.||.+|.|.+|+++.
T Consensus 247 F~------speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 247 FR------SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11 01112334566789999999999999999998853
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.20 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=195.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||++... .+++.||||.+..... .....+.+|+.++++++|+||+++++.+.++...++||||
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred eEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 34578999999999999865 4688999999975322 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC----
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ---- 657 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~---- 657 (796)
+++|+|.+++.....++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999998888888999999999999999999998 89999999999999999999999999985331000
Q ss_pred --------------------------------------CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh
Q 044281 658 --------------------------------------SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC 699 (796)
Q Consensus 658 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt 699 (796)
........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 000112468999999999999999999999999999999999
Q ss_pred CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 044281 700 CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP---TMKVVLQM 773 (796)
Q Consensus 700 g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---t~~evl~~ 773 (796)
|+.||......+....+..+.. .. .... .......+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~------~~-~~~~-------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWET------TL-HIPS-------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCc------cc-cCCC-------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999987654433222211100 00 0000 0111233445666655 4999999 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=317.28 Aligned_cols=240 Identities=28% Similarity=0.327 Sum_probs=193.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 580 (796)
++.+.||+|+||+||++..+ .+++.||+|++.... ....+.+..|..++..+. |++|+++.+++.+....++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred eEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 34578999999999999865 468899999997532 233456788888888875 5778889999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 999999999998888899999999999999999999998 89999999999999999999999999987543222 12
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--------~~~~~---------- 219 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--------EHNVS---------- 219 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCCC----------
Confidence 233458999999999999999999999999999999999999998655433222111 11110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTM 767 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 767 (796)
.+......+.+++.+||+.+|.+|++.
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 011123456779999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.87 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=205.2
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
...+.+.+.||+|+||+||++... .+++.||+|.+.... ....+.+.+|+++++.++|+||+++++++......++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 345667789999999999999865 467899999876432 334578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++++|.+++...+.+++.....++.+++.||.|||+.. +++|+||||+||++++++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999999988778899999999999999999999742 79999999999999999999999999987543221
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH----hHHHHHHHHHhhhcCccceeccc
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES----RAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~----~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+.........+ ...
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----- 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPP----- 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCC-----
Confidence 1234688999999999888999999999999999999999999975443211 01111111111110 000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
..........+.+++.+|++.||++|||+.|++++.
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 ---RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000111334677899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.93 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=200.6
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
...+.+.++||+|+||.||++... ++..+++|.+... ....+.+.+|+.++++++|+||+++.+++.+ ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec--CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 344556788999999999999854 4567999988753 2345678999999999999999999999887 77899999
Q ss_pred ecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 581 FMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 581 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999763 3578889999999999999999998 899999999999999999999999999986643322
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.......++..|+|||.+....++.++|+|||||++||+++ |+.||...........+ ..+....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~~~------ 223 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ERGYRMP------ 223 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------hCCCCCC------
Confidence 22222345678999999998899999999999999999999 88888754333221111 1111100
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
........+.+++.+|++.+|++||++.+++++|+.
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=310.26 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=203.5
Q ss_pred HhHHHhhCCCccceEEEEEeeC---CCCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccc--ccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT---ASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDE--ALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~---~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 577 (796)
..+.+.||+|+||.||++.+.. .+++.+|||.+...... ....|.+|++.++.++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 4456789999999999998642 34689999999765443 46789999999999999999999999877 557899
Q ss_pred EEeecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 578 VYEFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999997654 689999999999999999999998 8999999999999999999999999999876532
Q ss_pred CCc--ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH-------HHHHHHHHhhhcC
Q 044281 657 QSR--THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA-------ILTDWAYDCYVEG 727 (796)
Q Consensus 657 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~-------~l~~~~~~~~~~~ 727 (796)
... ......++..|+|||.+.+..++.++||||||++++||++|+.|+.......... ............+
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 221 1112334567999999998899999999999999999999999876432221100 0000000111111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
. ....+.....++.+++.+||+.+|++||||.||+++|+++
T Consensus 243 ~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 E---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred C---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0 0001112235678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.50 Aligned_cols=253 Identities=22% Similarity=0.279 Sum_probs=201.7
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.+.||+|+||.||+|... .+++.||+|.++.........+.+|+.+++.++||||+++++.+......++|+||+
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4567789999999999999865 467899999987654445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++.+.+.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... ....
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 164 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccc
Confidence 9999999998888899999999999999999999998 89999999999999999999999999987654322 1223
Q ss_pred eccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 663 MIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
...|+..|+|||.+. ...++.++|||||||++|||++|+.|+............ . .......... .
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~---~----~~~~~~~~~~----~ 233 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---T----KSNFQPPKLK----D 233 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh---h----ccCCCCCccc----c
Confidence 346889999999984 456889999999999999999999998654322211111 0 0000000000 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+|++.+|++||++.+|+++
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 01122456789999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.35 Aligned_cols=245 Identities=27% Similarity=0.366 Sum_probs=195.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccc-cccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFC-DEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||++..+ +..+++|.++... ..+.+.+|+.++++++|+|++++++++ .++...++++||+
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 445678999999999999753 6789999986532 346789999999999999999999975 4556789999999
Q ss_pred CCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++++|.+++.... .+++..++.++.||+.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999987643 478899999999999999999998 89999999999999999999999999988643322
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....+..|+|||++.+..++.++|||||||++|||++ |+.|+......+....+ ..+.....
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~------- 220 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--------EKGYKMDA------- 220 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------hcCCCCCC-------
Confidence 12234568999999999999999999999999999998 88888654332221111 11111110
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.......+..++.+|++.+|++|||+.++++.|+.+
T Consensus 221 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 --PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111234567799999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.84 Aligned_cols=239 Identities=26% Similarity=0.444 Sum_probs=190.7
Q ss_pred HhhCCCccceEEEEEeeCCCC---------eEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 508 EELGRGSFGIVYKGVLKTASG---------TAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~---------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.||+|+||.||+|.+..... ..|++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999864321 35788887654333 6789999999999999999999999988 778999
Q ss_pred EeecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-------cEEEeecCCc
Q 044281 579 YEFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-------SAKISDFGLS 650 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-------~~kl~DfGla 650 (796)
|||+++++|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765 788999999999999999999998 899999999999999888 7999999999
Q ss_pred ccccCCCCcceeeccCCCcccccccccCC--CCCccchhHHHHHHHHHHHhC-CCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 651 KLLFSDQSRTHTMIRGTRGYVAPEWFKNV--PVSAKVDVYSFGVTLLEIICC-RRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 651 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+......+..... ...
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~--------~~~ 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY--------QDQ 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH--------hcC
Confidence 86533 1223466789999999876 789999999999999999995 6666544322111100 000
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
. .. +......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 223 ~--~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H--RL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--CC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 0001156778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.68 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=200.9
Q ss_pred HHhHHHhhCCCccceEEEEEee------CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCccccccccccccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLK------TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALN 574 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 574 (796)
.+.+.++||+|+||.||++... ......+|+|.++... .....++.+|+.+++++ +|+||+++++++.....
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 3446688999999999999742 1234579999987532 33456789999999999 69999999999999899
Q ss_pred ceeEEeecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC
Q 044281 575 RLLVYEFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH 638 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~ 638 (796)
.+++|||+++|+|.+++... ..+++....+++.||+.||.|||++ +|+|+||||+|||+++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~ 169 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTE 169 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcC
Confidence 99999999999999999653 2467888999999999999999998 9999999999999999
Q ss_pred CCcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHH
Q 044281 639 FFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAIL 716 (796)
Q Consensus 639 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l 716 (796)
++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 249 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999865432211 1112234567999999999999999999999999999999 78888654433322211
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 717 TDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
..+..... +......+.+++.+||+.+|++||++.++++.|+++..
T Consensus 250 --------~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 250 --------REGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred --------HcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111100 11123456789999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=320.37 Aligned_cols=253 Identities=21% Similarity=0.238 Sum_probs=197.0
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.+.||+|+||.||++..+ .+++.+|+|.+.... ......+.+|+.+++.++||||+++++.+.++...++||
T Consensus 44 ~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 44 DYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 3445578999999999999876 467899999986532 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 999999999998764 477888889999999999999998 9999999999999999999999999999876544333
Q ss_pred ceeeccCCCcccccccccCCC----CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 660 THTMIRGTRGYVAPEWFKNVP----VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+. .........
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~~~~~~~-- 269 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM-------NHKNSLTFP-- 269 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCcccCC--
Confidence 334567999999999997543 7899999999999999999999998655432221111 000000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVLQML 774 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~L 774 (796)
........+..++.+|++.++.+ ||++.++++..
T Consensus 270 -----~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 270 -----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 01123345667888899844443 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.20 Aligned_cols=251 Identities=28% Similarity=0.400 Sum_probs=187.7
Q ss_pred hhCCCccceEEEEEeeCC-CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 509 ELGRGSFGIVYKGVLKTA-SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+||+|+||.||+|..... ....+++|.+.... ......|.+|+..++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 699999999999975432 34578999876432 3345678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCC-----CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-cc
Q 044281 587 LANLIFAIP-----KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-RT 660 (796)
Q Consensus 587 L~~~l~~~~-----~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 660 (796)
|.+++.... ..++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997643 235778889999999999999998 899999999999999999999999999875433221 11
Q ss_pred eeeccCCCcccccccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 661 HTMIRGTRGYVAPEWFKN-------VPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
.....++..|+|||++.. ..++.++|||||||++|||++ |..|+......+.... ...++. ..+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~~~~~~-~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ-------VVREQD-IKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH-------HhhccC-ccC
Confidence 122345678999998743 456889999999999999999 6677764433221111 111111 111
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
..+.. .......+.+++..|+ .||++|||+++|+++|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 1122244555777788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.32 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=197.8
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
++||+|+||.||++.... ++.|++|.+...... ....+.+|+.++++++|+||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC--CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999998753 789999998764333 45689999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce-eec
Q 044281 587 LANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH-TMI 664 (796)
Q Consensus 587 L~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 664 (796)
|.+++... ..+++.....++.+++.||+|||++ +++||||||+||+++.++.+||+|||+++.......... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99998653 4678889999999999999999998 899999999999999999999999999986542221111 122
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+...........+ ..+. .. ..+.
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~--------~~~~--~~-------~~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI--------ESGY--RM-------PAPQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH--------hcCC--CC-------CCCc
Confidence 34567999999999999999999999999999999 77887654433222111 0100 00 0011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.....+.+++.+|++.+|.+|||+.||++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.19 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=200.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||.||+|+.. .+++.|++|.+..........+.+|+.+++.++|+||+++++.+..+...++||||+++
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeEEEecCCCCeEEEEEEEC-CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 34467999999999999854 46789999999765555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
++|.+++.. ..+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++........ .....
T Consensus 102 ~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 176 (296)
T cd06654 102 GSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (296)
T ss_pred CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcc
Confidence 999999865 3578889999999999999999998 899999999999999999999999999886533221 12234
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
.+++.|+|||.+.+..++.++|||||||++|||++|+.||........... ....+. ..+. .+..
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-------~~~~~~-~~~~-------~~~~ 241 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGT-PELQ-------NPEK 241 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-------HhcCCC-CCCC-------Cccc
Confidence 578899999999998899999999999999999999999976543221111 001110 0000 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....+.+++.+||+.+|++||++.+|++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 23456779999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.48 Aligned_cols=256 Identities=21% Similarity=0.332 Sum_probs=204.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|... .+++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+....++|||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 345678999999999999976 46889999988532 22335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 581 FMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 581 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
|+++++|.+++.. ...+++..++.++.+|++||+|||+. +|+|+||+|+||+++.++.++|+|||+++.+...
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998864 24578899999999999999999998 9999999999999999999999999998865433
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+........ .. ......+.....
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~-~~~~~~~~~~~~---- 228 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SL-CKKIEKCDYPPL---- 228 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-----HH-HhhhhcCCCCCC----
Confidence 221 2234578899999999999999999999999999999999999864431110 00 011111111110
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
........+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus 229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01123346778999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=302.40 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=196.0
Q ss_pred hhCCCccceEEEEEeeC-----CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 509 ELGRGSFGIVYKGVLKT-----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.||+|+||.||+|+... .+++.+++|.+.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998653 123679999886533 234568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-----cEEEeecCCc
Q 044281 583 GNGTLANLIFAI-------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-----SAKISDFGLS 650 (796)
Q Consensus 583 ~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-----~~kl~DfGla 650 (796)
++++|.+++... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998642 3467889999999999999999987 899999999999999877 8999999999
Q ss_pred ccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 651 KLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 651 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
+....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+ ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~--------~~~~ 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV--------TAGG 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH--------hcCC
Confidence 86543221 11222345678999999999999999999999999999998 88888654332211111 1111
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
... ........+.+++.+||+.+|.+||++.+|+++|++
T Consensus 231 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RLQ---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccC---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 011223567789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.46 Aligned_cols=255 Identities=19% Similarity=0.235 Sum_probs=194.3
Q ss_pred HHHhhCCC--ccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 506 FKEELGRG--SFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G--~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.++||+| +|++||++..+ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeec-ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45789999 78999999876 578999999996532 23445778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++++||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999998653 4588999999999999999999998 8999999999999999999999999875543221111
Q ss_pred ------ceeeccCCCcccccccccC--CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccce
Q 044281 660 ------THTMIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731 (796)
Q Consensus 660 ------~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (796)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||............ . .+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~---~-----~~~~~~ 229 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK---L-----NGTVPC 229 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH---h-----cCCccc
Confidence 0112346778999999976 46899999999999999999999999754322111000 0 000000
Q ss_pred eccc------------------------------------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 732 LIDS------------------------------------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 732 ~~d~------------------------------------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.++. .............+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 0000011223356788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=298.54 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=201.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+|..+. +++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 4567889999999999999763 578999999976433 6789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence 9999999975 45789999999999999999999998 899999999999999999999999999987643321 222
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+ ...... .. ..+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~-~~------~~~ 222 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------PNKPPP-TL------SDP 222 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--------ccCCCC-CC------Cch
Confidence 344788999999999999999999999999999999999998754333211111 000000 00 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......+.+++.+||+.+|++|||+++|++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1233467789999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.82 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=200.3
Q ss_pred HHHhhCCCccceEEEEEeeCC----CCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 506 FKEELGRGSFGIVYKGVLKTA----SGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
..+.||+|+||.||+|+.+.. +.+.|++|.+...... ...++.+|++++++++|+||+++++++.+....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 346799999999999986432 3468999998764433 45689999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC---------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 581 FMGNGTLANLIFAIP---------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~---------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
|+++++|.+++.... .+++..+..++.||+.||+|||+. +|+|+||||+||++++++.++|+|||+++
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999997655 688999999999999999999998 89999999999999999999999999987
Q ss_pred cccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 652 LLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
..............++..|+|||.+.+...+.++||||||+++|||++ |..||.......... ....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~--------~~~~~~~~ 237 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN--------RLQAGKLE 237 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH--------HHHcCCcC
Confidence 554333222333346778999999998889999999999999999999 677875433222111 11111111
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
... .......+.+++.+||+.+|++||++.+++++|.+
T Consensus 238 ~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 LPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 100 11122467789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.57 Aligned_cols=256 Identities=27% Similarity=0.371 Sum_probs=202.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCC---CeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTAS---GTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
.+.+.+.||+|+||.||+|..+..+ ...+|+|.+.... .....++.+|+..+++++|+||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 3455688999999999999876422 2368999886543 3345688999999999999999999999987 788999
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
+||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+|+||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999764 4688999999999999999999997 99999999999999999999999999998764332
Q ss_pred Ccce-eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 658 SRTH-TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 658 ~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.... ....++..|+|||.+....++.++||||||+++||+++ |+.|+.....++....+ ..+....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~---- 231 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL--------EKGERLP---- 231 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--------hCCCCCC----
Confidence 2111 11223568999999988899999999999999999998 99998765443322211 1111100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+......+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 232 -----~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 -----QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011122356778999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.91 Aligned_cols=244 Identities=27% Similarity=0.356 Sum_probs=201.0
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCHH
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLA 588 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 588 (796)
+||+|.||+||-|++. .+...+|||.+........+-+++|+...++++|+|||+++|.+.+++..-+.||.++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~-~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM-DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccc-cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 5999999999999876 467789999998766666778999999999999999999999999999999999999999999
Q ss_pred HHHhcC-CCC--chhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc-CCCcEEEeecCCcccccCCCCcceeec
Q 044281 589 NLIFAI-PKP--DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 589 ~~l~~~-~~~--~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
++|... +++ ++.++-.+..||++||.|||++ .|||||||-+|||++ =.|.+||+|||-++.+..-.. ...+.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence 999875 444 6778888999999999999999 899999999999997 479999999999998754333 23345
Q ss_pred cCCCcccccccccCC--CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 665 RGTRGYVAPEWFKNV--PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~--~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
.||..|||||++..+ .|..++|||||||++.||.||++||.......... ++-|... .....+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------FkVGmyK------vHP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------FKVGMYK------VHPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------hhhccee------cCCCCc
Confidence 699999999999765 48899999999999999999999996543221110 0001100 112234
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.+...+...++++|+.+||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 556677888999999999999999999985
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.92 Aligned_cols=248 Identities=29% Similarity=0.475 Sum_probs=198.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||.||++... .+..+|+|.+.... ....+|.+|++++++++|+|++++++++......+++|||+++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred EEEeeecCcccceEEEEEEe--CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 34578999999999999875 36789999986532 2345789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++|.+++... ..++++.+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999998764 4578999999999999999999998 89999999999999999999999999998654332222222
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..++.+|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ .++. ....+
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~--~~~~~------- 223 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI--------NAGF--RLYKP------- 223 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH--------hCCC--CCCCC-------
Confidence 234678999999999999999999999999999998 88888654433221111 1110 00001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
......+.+++.+||+.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112356788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.21 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=199.9
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch----------hhhhHHHHHHHHHHhcc-cCccCcccccccccccc
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL----------AQEREREFKSEVSAIGR-THHKHLVQLLGFCDEAL 573 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~ 573 (796)
.+.+.||+|+||.||+|..+..+++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.++.
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 45678999999999999987646789999987532 12234567788888875 79999999999999999
Q ss_pred cceeEEeecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCC
Q 044281 574 NRLLVYEFMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 649 (796)
..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.. +++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999988743 346788899999999999999999632 799999999999999999999999999
Q ss_pred cccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcc
Q 044281 650 SKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729 (796)
Q Consensus 650 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (796)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+ .++..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI--------VEAVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH--------hhccC
Confidence 98754332 233456888999999999988999999999999999999999998754433221111 11111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
... . .......+.+++.+||+.||++||++.||.++|+
T Consensus 231 ~~~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPL----P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcC----C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 100 0 1112345778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.53 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=194.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.+.||+|+||.||+|... .+++.||+|.+... ......++.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred hheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 35578999999999999865 46789999998643 23445679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|..+ ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 83 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (279)
T cd06619 83 GGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKT 152 (279)
T ss_pred CCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccC
Confidence 9998654 2467788889999999999999998 99999999999999999999999999998653321 223
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..++..|+|||.+.+..++.++||||||+++|||++|+.||............... ........... ....
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~--------~~~~ 223 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPV--------LPVG 223 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhccCCCC--------CCCC
Confidence 46889999999999999999999999999999999999998653321111000000 01111110000 0011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....++.+++.+|++.+|++||+++|+++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 123456789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=335.83 Aligned_cols=256 Identities=24% Similarity=0.336 Sum_probs=198.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.++||+|+||.||+|... .+++.||+|++.... ....+.|.+|++++++++||||+++++++.+++..+++|||
T Consensus 5 eIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred EEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 34578999999999999865 468899999996532 23346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-----------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCc
Q 044281 582 MGNGTLANLIFAI-----------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS 650 (796)
Q Consensus 582 ~~~gsL~~~l~~~-----------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 650 (796)
+++++|.+++... ...++..+++++.||++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999988642 2345677889999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCC-----------------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHh
Q 044281 651 KLLFSDQS-----------------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESR 713 (796)
Q Consensus 651 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~ 713 (796)
+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 87621110 0112246899999999999999999999999999999999999999753322110
Q ss_pred HHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHcCcC
Q 044281 714 AILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVLQMLEGLLD 779 (796)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~evl~~L~~~~~ 779 (796)
.. . .+.++. ...........+.+++.+|++.||++|| +++++++.|+..++
T Consensus 241 ~~------~--------~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 241 YR------D--------VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh------h--------hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 0 000000 0000112234567789999999999995 67778888876544
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=302.60 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=200.3
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.++||+|+||.||+|... .+++.+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||+
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 4567788999999999999875 467899999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++++|..++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 99999888764 35688999999999999999999998 89999999999999999999999999987543221 122
Q ss_pred eeccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 662 TMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
....+++.|+|||.+. ...++.++|||||||++|||++|+.|+...........+ .........
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~--- 236 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--------AKSEPPTLS--- 236 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH--------hcCCCccCC---
Confidence 3345788999999984 345788999999999999999999998654332211110 111110000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 237 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 ----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011223456789999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.37 Aligned_cols=252 Identities=20% Similarity=0.232 Sum_probs=194.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.++||+|+||.||++..+ .+++.+|+|.+.+.. ......+.+|+.++..++|+||+++++++.+....++||||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred eEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 34578999999999999876 457899999996532 22234588899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 999999999976 45788899999999999999999998 89999999999999999999999999997654433333
Q ss_pred eeeccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 661 HTMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+. ....... +..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~-------~~~~~~~-~p~ 231 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-------NHKERFQ-FPA 231 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCCcccc-CCC
Confidence 33456999999999986 3468899999999999999999999997654433222111 0100000 000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQED--PSKRPTMKVVLQM 773 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~d--p~~RPt~~evl~~ 773 (796)
. .......+.+++.+|+..+ +..||++.++++.
T Consensus 232 ~-----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 Q-----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c-----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0112234556777766544 4447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.27 Aligned_cols=245 Identities=26% Similarity=0.375 Sum_probs=198.5
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCH
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL 587 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 587 (796)
..||+|+||.||++... .++..||||.+........+.+.+|+..++.++|+||+++++.+..++..++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEEC-CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 56999999999999865 46789999998765555667799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCC
Q 044281 588 ANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGT 667 (796)
Q Consensus 588 ~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 667 (796)
.+++.. ..+++.....++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........ ......++
T Consensus 107 ~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 107 TDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 998854 4578899999999999999999998 899999999999999999999999999976543222 12234588
Q ss_pred CcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHH
Q 044281 668 RGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLH 747 (796)
Q Consensus 668 ~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 747 (796)
..|+|||.+.+..++.++||||||+++|||++|+.||...........+. .. ....+. . ......
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~--------~~-~~~~~~----~--~~~~~~ 246 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR--------DN-LPPRVK----D--SHKVSS 246 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hc-CCCccc----c--ccccCH
Confidence 99999999998899999999999999999999999987544332211110 00 000000 0 111233
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 748 KWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 748 ~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+..++.+|++.||.+|||++++++.
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 56678889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=316.04 Aligned_cols=241 Identities=24% Similarity=0.288 Sum_probs=189.4
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhccc---CccCcccccccccccccceeEEeecC
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRT---HHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
||+|+||+||+|..+ .+++.||||++..... .....+..|..++.+. +||||+++++.+.+....++||||++
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 799999999999865 4688999999965322 2223455566666654 69999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|+|..++.....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 999999998888899999999999999999999998 89999999999999999999999999997543222 22234
Q ss_pred ccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+ ..+... +. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i--------~~~~~~-~~--------~ 218 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI--------AFGKVR-FP--------K 218 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH--------HcCCCC-CC--------C
Confidence 5689999999998765 4899999999999999999999999765443321111 111110 00 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRP----TMKVVLQ 772 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RP----t~~evl~ 772 (796)
......+.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234566799999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.41 Aligned_cols=264 Identities=24% Similarity=0.311 Sum_probs=200.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.++||+|+||.||++..+ .+++.||+|++..... ...+.+.+|+++++.++|+||+++++++..+...++|+||+
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 34578999999999999875 3578999999864322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|..+......+++..++.++.||++||+|||+. +++|+||+|+||++++++.+||+|||++....... ....
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (286)
T cd07846 83 DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT 158 (286)
T ss_pred CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccC
Confidence 9999998887766789999999999999999999998 89999999999999999999999999998654332 2223
Q ss_pred eccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhh-------hcC------c
Q 044281 663 MIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCY-------VEG------R 728 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~-------~~~------~ 728 (796)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+........ ... .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 3457889999999875 4578899999999999999999998865543322221111110000 000 0
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....................+.+++.+||+.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000111234568889999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.83 Aligned_cols=263 Identities=20% Similarity=0.219 Sum_probs=195.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.++||+|+||.||+|..+ .+++.||+|.++.... .....+.+|+.++++++|+||+++++++..+...++||||++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred EEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 34578999999999999875 3578999999864332 233467889999999999999999999999999999999998
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....... ...
T Consensus 88 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 162 (309)
T cd07872 88 K-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYS 162 (309)
T ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccc
Confidence 5 787777654 4578888999999999999999998 999999999999999999999999999976433221 222
Q ss_pred eccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hhhcCccceecc
Q 044281 663 MIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVEGRLDVLID 734 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~~~~~~~~d 734 (796)
...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... .+.........+
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 3457889999998865 46899999999999999999999999765443322222111000 000000000000
Q ss_pred chh-----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 735 SDE-----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 735 ~~~-----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
... ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000 000001123456789999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.89 Aligned_cols=252 Identities=20% Similarity=0.244 Sum_probs=193.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||+||++..+ .+++.||+|.+.+.. ....+.+.+|+.++..++|+||+++++++.++...++||||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred eEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 34578999999999999876 467899999997532 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999976 45788899999999999999999998 89999999999999999999999999997664433333
Q ss_pred eeeccCCCcccccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 661 HTMIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+. .......+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~-------~~~~~~~~~~~ 232 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-------NHKEHFQFPPD 232 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCCcccCCCc
Confidence 333568999999999863 457889999999999999999999997654333221111 00000000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQ--EDPSKRPTMKVVLQM 773 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~--~dp~~RPt~~evl~~ 773 (796)
.....+.+..++.+|+. .++..||++.++++.
T Consensus 233 ------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 ------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 01122344556666554 444458899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=300.85 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=194.7
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCccccccccccc------ccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEA------LNR 575 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~ 575 (796)
.+.+.+.||+|+||.||+|... .+++.||+|.+.... .....+.+|+.++.++ +|+||+++++++... ...
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 3456688999999999999875 467899999986543 3456788999999998 799999999998653 357
Q ss_pred eeEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccc
Q 044281 576 LLVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 653 (796)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 8999999999999998864 3578899999999999999999998 8999999999999999999999999999865
Q ss_pred cCCCCcceeeccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
.... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+...........+ ... .
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-------~~~-~ 232 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-------PRN-P 232 (272)
T ss_pred cccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------hcC-C
Confidence 3322 1223456889999999986 346788999999999999999999999654332221111 000 0
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
..... .......+.+++.+||+.+|.+|||+.++++
T Consensus 233 ~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 1112345778999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.33 Aligned_cols=250 Identities=28% Similarity=0.356 Sum_probs=210.1
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh---hHHHHHHHHHHhcccC-ccCcccccccccccccceeE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE---REREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv 578 (796)
.+.+.++||+|.||.||+++.+ .+|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.+.++.....++|
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred cEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 4556689999999999999976 46899999999764432 3468999999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC----CcEEEeecCCccccc
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF----FSAKISDFGLSKLLF 654 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~kl~DfGla~~~~ 654 (796)
||++.+|.|.+.+... .+++..+..++.||+.+++|||+. +|+||||||+|+|+... +.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999998876 488999999999999999999998 99999999999999643 579999999999876
Q ss_pred CCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
. .......+||+.|+|||++....|+..+||||+||++|.|++|..||......+....+ ..+... +
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i--------~~~~~~--f- 257 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI--------LRGDFD--F- 257 (382)
T ss_pred C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH--------HcCCCC--C-
Confidence 5 45566788999999999999999999999999999999999999999987765543322 122221 0
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....-....+.+.+++..|+..||.+|+|+.++++.
T Consensus 258 ---~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 258 ---TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111112234566779999999999999999999995
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=324.11 Aligned_cols=259 Identities=21% Similarity=0.262 Sum_probs=188.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccccc--------ccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--------LNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~ 575 (796)
+.+.++||+|+||.||+|... .+++.||||++.... ....+|+.+++.++|+||+++++++... ...
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 345678999999999999875 467899999885422 2345799999999999999998876321 235
Q ss_pred eeEEeecCCCCHHHHHh----cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCc
Q 044281 576 LLVYEFMGNGTLANLIF----AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLS 650 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla 650 (796)
++||||+++ +|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 689999985 6666554 345788999999999999999999998 899999999999999664 7999999999
Q ss_pred ccccCCCCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----h-
Q 044281 651 KLLFSDQSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----Y- 724 (796)
Q Consensus 651 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~- 724 (796)
+.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|..||......+....+....... +
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 86643222 2234679999999998764 68999999999999999999999997654433222221110000 0
Q ss_pred ------hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 725 ------VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 725 ------~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+-....+.........+.....++.+++.+||+.||.+|||+.|+++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000000111111111233567889999999999999999999844
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.08 Aligned_cols=249 Identities=33% Similarity=0.480 Sum_probs=200.9
Q ss_pred HHHhhCCCccceEEEEEeeCCC---CeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTAS---GTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~---~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.||+|+||.||++...... +..||+|.+...... ..+.+.+|+..+..++|+||+++++++.+....+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4578999999999999976432 488999999765433 567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC--CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++++|.+++..... +++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999986554 89999999999999999999998 8999999999999999999999999999876544222
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......+++.|+|||.+.+..++.++||||+|++++||++ |..|+...........+ ..+.....
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~------ 225 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL--------KKGYRLPK------ 225 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------hcCCCCCC------
Confidence 2222336789999999988899999999999999999998 67777653322211111 11111100
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
......++.+++.+|++.+|++|||+.++++.|
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111335677899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.08 Aligned_cols=252 Identities=19% Similarity=0.244 Sum_probs=195.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||+++.+ .+++.||+|.+.... ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred eEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 34578999999999999875 467899999996532 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 999999999986 45788899999999999999999998 99999999999999999999999999998765443333
Q ss_pred eeeccCCCcccccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 661 HTMIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.. ...+.. +..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~~--~p~ 231 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN------HEERFQ--FPS 231 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc------CCCccc--CCC
Confidence 334569999999999875 5678999999999999999999999976544332211110 000100 000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVLQM 773 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~ 773 (796)
. .....+++.+++.+|++.++++ |+++.++++.
T Consensus 232 ~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 232 H-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0112345666788888765544 5688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.61 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=186.9
Q ss_pred hhCCCccceEEEEEeeCC-CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 509 ELGRGSFGIVYKGVLKTA-SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+||+|+||.||+|..... ....+++|.+.... ....+.|.+|+..++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975432 23456777776432 3446789999999999999999999999999999999999999999
Q ss_pred HHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC-Ccce
Q 044281 587 LANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-SRTH 661 (796)
Q Consensus 587 L~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-~~~~ 661 (796)
|.+++... ...++.....++.||++||+|||+. +++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99998753 2456667789999999999999998 89999999999999999999999999986432211 1122
Q ss_pred eeccCCCcccccccccC-------CCCCccchhHHHHHHHHHHHhC-CCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 662 TMIRGTRGYVAPEWFKN-------VPVSAKVDVYSFGVTLLEIICC-RRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-------~~~s~k~DVwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
....++..|+|||++.. ..++.++||||||+++|||+++ ..|+......+.... ...+ ....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~~~~-~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH-------VIKD-QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHhh-cccccC
Confidence 33457889999999853 2457899999999999999975 556654332221111 1111 111122
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
++.... ...+.+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 221111 12245666888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=300.83 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=201.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||++..+. +++.+|+|.++.......+.|.+|++++++++|+||+++++.+..+...++||||++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 5677889999999999998763 678999999976655666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 161 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRD 161 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccc
Confidence 99999998764 4689999999999999999999998 899999999999999999999999999876533222 122
Q ss_pred eccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 663 MIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
...+++.|+|||.+. ...++.++||||||+++|||++|+.||...........+ ..+....+ +
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~-~--- 229 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI--------LKSEPPTL-D--- 229 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH--------hcCCCCCc-C---
Confidence 345888999999975 345788999999999999999999999765433211111 11111000 0
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......+.+++..||+.+|.+||++.+|++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 ---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011123456778999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.82 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=198.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCC---eEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
..+.||+|+||.||+|.....+. ..||+|.+..... ....++.+|+.+++.++|+||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 44679999999999998754322 2578998865432 3345789999999999999999999998754 46799999
Q ss_pred cCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+|+||||+||++++++.+||+|||+++.........
T Consensus 90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 99999999987654 678899999999999999999998 89999999999999999999999999998764332211
Q ss_pred -eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 661 -HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 661 -~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...........+ ..+.... .
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~--~---- 232 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL--------EKGERLP--Q---- 232 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HCCCCCC--C----
Confidence 122335678999999999999999999999999999997 88888654333222111 1111000 0
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.......+..++..||..+|++||++.++++.|+.+...
T Consensus 233 ---~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 233 ---PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011223567789999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.34 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=201.6
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+...+.||+|+||.||+|..+ .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.++...++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3445678999999999999865 357899999986432 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 999999998875 4578888999999999999999998 899999999999999999999999999987643322 12
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....++..|+|||.+.+..++.++|||||||++|||++|+.|+...........+ ..+... ..
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--------~~~~~~---------~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI--------PKNNPP---------TL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh--------hcCCCC---------CC
Confidence 2345788899999999989999999999999999999999998755433221111 011110 11
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 22334567789999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.76 Aligned_cols=247 Identities=27% Similarity=0.356 Sum_probs=198.8
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---------hhHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---------EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
+...||+|+||.||+|... .+++.+|+|.+..... +..+.+.+|+.++++++|+||+++++++.+....+
T Consensus 4 ~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred ccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 4567999999999999865 3578999998854221 12357889999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+++||+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999998888889999999999999999999998 8999999999999999999999999999876532
Q ss_pred CCc-----ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccce
Q 044281 657 QSR-----THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731 (796)
Q Consensus 657 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (796)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...........+ .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~ 231 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--------GENASPE 231 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH--------hccCCCc
Confidence 211 112245788999999999999999999999999999999999999754322211110 0110000
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 732 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......+..++.+||+.||.+||++.+|++.
T Consensus 232 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 232 ---------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---------CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 011223566789999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=304.32 Aligned_cols=262 Identities=24% Similarity=0.263 Sum_probs=197.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-----hHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-----REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.||+|+||.||+|... .+++.|++|.+...... ....+..|++++++++|+||+++++++.+....++|||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeccccEEEEEEEC-CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 4567999999999999865 35789999999654322 24567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+ +++|.+++.... .+++..+..++.||++||.|||++ +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 99 899999998765 789999999999999999999998 899999999999999999999999999987644322
Q ss_pred ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc-----Cccceec
Q 044281 660 THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE-----GRLDVLI 733 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~ 733 (796)
......+++.|+|||.+.+ ..++.++|||||||++|||++|..+|......+....+.......... .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 1222346778999998865 467899999999999999999987776544322211111100000000 0000000
Q ss_pred cc-----hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 734 DS-----DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 734 d~-----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.. .............+.+++.+||+.+|++|||+.||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 00000112234678889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.08 Aligned_cols=247 Identities=26% Similarity=0.314 Sum_probs=195.5
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
..+.||+|+||.||++..+ .+++.||+|.+.... ......+.+|+.++++++|+|++++++.+......++||||+
T Consensus 4 ~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 3467999999999999876 468899999986532 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 999999988654 3578889999999999999999998 999999999999999999999999999976533221
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||................ .... . .
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~----~~~~-~---------~ 223 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KEVQ-E---------E 223 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh----hhhh-h---------h
Confidence 223468999999999999999999999999999999999999997543211111110000 0000 0 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQ 772 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 772 (796)
........+.+++..||+.||++||| +.|+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01112235677899999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.74 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=200.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
+.+.||.|+||.||+|... .+++.|++|.+........+.+.+|+.+++.++|+|++++++++......++|+||++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDV-ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEecCCCeEEEEEEEc-CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 3467999999999999864 468899999997655555678899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeecc
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR 665 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 665 (796)
+|.+++... .+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......... .....
T Consensus 102 ~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 176 (296)
T cd06655 102 SLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (296)
T ss_pred cHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcC
Confidence 999988654 588999999999999999999998 8999999999999999999999999998865433221 22345
Q ss_pred CCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHH
Q 044281 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSR 745 (796)
Q Consensus 666 gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 745 (796)
++..|+|||.+.+..++.++|||||||++|||++|+.||...........+. ......+.. +...
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~--------~~~~~~~~~-------~~~~ 241 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--------TNGTPELQN-------PEKL 241 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hcCCcccCC-------cccC
Confidence 7889999999999999999999999999999999999997654433221110 000000000 1112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 746 LHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 746 ~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...+.+++.+||+.||++||++.+|++.
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2356678999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=303.63 Aligned_cols=247 Identities=25% Similarity=0.312 Sum_probs=196.3
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.||+|+||+||++... .+++.+|+|.+..... .....+.+|+.++++++|+|++++.+.+..++..+++|||++
T Consensus 5 ~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 5 YRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 367999999999999876 4688999999865322 223567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 158 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SI 158 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cc
Confidence 99999888653 3689999999999999999999998 89999999999999999999999999997653221 12
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....|+..|+|||.+.+..++.++|+||||+++|||++|..||...........+.. ....+.. . .
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~----~~~~~~~--~--------~ 224 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR----RVLETEE--V--------Y 224 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hhhcccc--c--------c
Confidence 334689999999999999999999999999999999999999976543322221111 1111110 0 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~~ 773 (796)
.......+.+++..|++.||++||+ +.++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1112335677899999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=307.39 Aligned_cols=193 Identities=22% Similarity=0.341 Sum_probs=158.9
Q ss_pred HhhCCCccceEEEEEeeC-CCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccc--cccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDE--ALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~~ 584 (796)
++||+|+||+||+|..+. .+++.+|+|.+.... ....+.+|+.++++++||||+++++++.. ....+++|||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 579999999999998653 356799999986532 23457889999999999999999998854 4557899999865
Q ss_pred CCHHHHHhcC---------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE----cCCCcEEEeecCCcc
Q 044281 585 GTLANLIFAI---------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSK 651 (796)
Q Consensus 585 gsL~~~l~~~---------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~DfGla~ 651 (796)
+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 787776422 2477888999999999999999998 89999999999999 456889999999998
Q ss_pred cccCCCC--cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCch
Q 044281 652 LLFSDQS--RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEM 706 (796)
Q Consensus 652 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~ 706 (796)
....... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 7643322 122345689999999999774 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.92 Aligned_cols=261 Identities=23% Similarity=0.268 Sum_probs=190.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhccc---CccCcccccccccc-----ccc
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKHLVQLLGFCDE-----ALN 574 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~~ 574 (796)
.+.+.||+|+||+||++..+ .+++.||+|.++.... .....+.+|+.+++++ +|+||+++++++.. ...
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred eEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 34577999999999999876 4688999999864321 1223456677666654 79999999998754 345
Q ss_pred ceeEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 575 RLLVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
.+++|||+++ +|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 6899999985 888888654 3578999999999999999999998 899999999999999999999999999986
Q ss_pred ccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc---c
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR---L 729 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~---~ 729 (796)
..... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||...........+............ .
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 54322 223345788999999999999999999999999999999999998765443322222111100000000 0
Q ss_pred ---ceeccc---hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 730 ---DVLIDS---DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 730 ---~~~~d~---~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.....+ .......+...+.+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0000111123356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=298.21 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=202.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||.||++.... +++.+++|.+..........+.+|+.++++++|+||+++++++......+++|||+++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIA-TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred EEEEEecCCCceEEEEeEecC-CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 345779999999999998753 5678999999765555667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++|.+++... ..++...+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++........ ....
T Consensus 85 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 160 (262)
T cd06613 85 GSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKS 160 (262)
T ss_pred CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-cccc
Confidence 9999998776 6789999999999999999999998 899999999999999999999999999986543221 2223
Q ss_pred ccCCCcccccccccCC---CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 664 IRGTRGYVAPEWFKNV---PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~---~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
..++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+. ..... ... ..
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--------~~~~~---~~~--~~ 227 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--------KSNFP---PPK--LK 227 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hccCC---Ccc--cc
Confidence 4578899999999877 88999999999999999999999987554332211110 00000 000 00
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+.+++.+||+.+|.+|||+++|+.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 112334567889999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=299.56 Aligned_cols=248 Identities=27% Similarity=0.375 Sum_probs=201.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||.|+||.||+|... .+++.|++|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 456688999999999999875 468899999986543 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.+..... ...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 999999998765 788999999999999999999998 899999999999999999999999999987654322 222
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
...++..|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..+....+.+
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~--------~~~~~~~~~~-------- 220 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI--------PKNNPPSLEG-------- 220 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh--------hhcCCCCCcc--------
Confidence 345788999999999989999999999999999999999999755432211111 1111111110
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......+.+++.+||+.+|++|||++++++.
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0023456779999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=321.22 Aligned_cols=191 Identities=24% Similarity=0.227 Sum_probs=163.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||++... ..++.||||.... ..+.+|++++++++|+|||++++++......++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHP-DYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEEC-CCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 344578999999999999876 4578999996432 345789999999999999999999999999999999995
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-ce
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-TH 661 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~ 661 (796)
++|..++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 6888887654 4689999999999999999999998 8999999999999999999999999999876433221 22
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCc
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVE 705 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~ 705 (796)
....||+.|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 24568999999999999999999999999999999999886553
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=320.23 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=195.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||.||++..+ .+++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 3467999999999999876 468899999997532 233457888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC----
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS---- 658 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~---- 658 (796)
++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 84 PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred CCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999875432110
Q ss_pred ------------------------------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhh
Q 044281 659 ------------------------------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMEL 708 (796)
Q Consensus 659 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~ 708 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00113468999999999999999999999999999999999999998665
Q ss_pred HHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 044281 709 EEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT---MKVVLQM 773 (796)
Q Consensus 709 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~evl~~ 773 (796)
.......+..+ .....+.+ ......++.+++.+++. ||.+|++ +.++++.
T Consensus 241 ~~~~~~~i~~~--------~~~~~~p~------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQETYRKVMNW--------KETLVFPP------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHHHHHHcC--------CCceecCC------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 54332222110 00000110 00122345556666654 9999995 5666554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=303.50 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=198.6
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
...||+|+||.||++... .+++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++++||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEc-CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 347999999999999865 4678999999865444556678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccC
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 666 (796)
|..++.. ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ ......+
T Consensus 105 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 179 (297)
T cd06659 105 LTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVG 179 (297)
T ss_pred HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceec
Confidence 9987755 5678999999999999999999998 899999999999999999999999999876543221 2233558
Q ss_pred CCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 044281 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRL 746 (796)
Q Consensus 667 t~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 746 (796)
+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ....... .. ......
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~-~~------~~~~~~ 244 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDSPPPK-LK------NAHKIS 244 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hccCCCC-cc------ccCCCC
Confidence 89999999999989999999999999999999999998754433221111 0000000 00 001122
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 747 HKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 747 ~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.+++.+||+.+|.+||++.++++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 456778999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=298.59 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=196.1
Q ss_pred HHHhhCCCccceEEEEEeeC--CCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccc------cc
Q 044281 506 FKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------NR 575 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 575 (796)
+.+.||+|+||.||+|.++. .+++.||||.+... .....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 45789999999999998753 34689999998653 2334567899999999999999999999875432 23
Q ss_pred eeEEeecCCCCHHHHHhcC------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCC
Q 044281 576 LLVYEFMGNGTLANLIFAI------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 649 (796)
++++||+++|+|.+++... ..+++...+.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 6889999999998887532 2467888999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 650 SKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 650 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
++....... .......++..|++||.+....++.++||||||+++|||++ |+.|+......+....+ ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~--------~~~ 231 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL--------IKG 231 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH--------HcC
Confidence 987643321 11122335678999999999899999999999999999999 77887654433221111 111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.... ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1000 0112335788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=302.70 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=200.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||+|..+ .+++.||+|++.... ....+.+.+|+.++++++|+|++++++++......++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 34567999999999999876 458899999986432 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++.|..++.....+++..+..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (286)
T cd07847 83 DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT 158 (286)
T ss_pred CccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-ccc
Confidence 9999988887777889999999999999999999998 899999999999999999999999999987644322 122
Q ss_pred eccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh-------hhcCcc-ceec
Q 044281 663 MIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC-------YVEGRL-DVLI 733 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~~-~~~~ 733 (796)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... +..... ....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3346788999999876 567899999999999999999999997654433222221111000 000000 0000
Q ss_pred cchhhhh-----hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 734 DSDEAAM-----ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 734 d~~~~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+..... ........+.+++.+||+.+|++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000 001123567889999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=296.65 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=202.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||.+... .+++.+++|.+... ......++.+|+.++++++|+||+++++++.+....+++|||+
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred eEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 34578999999999998865 46789999987643 3444567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999999999765 4678899999999999999999998 899999999999999999999999999987644332 2
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..+.....
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--------~~~~~~~~-------- 221 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------VQGNYTPV-------- 221 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HcCCCCCC--------
Confidence 23345889999999999888999999999999999999999999765433221111 11111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
......++.+++.+||+.+|++||++.++++.+
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234577899999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.96 Aligned_cols=265 Identities=22% Similarity=0.267 Sum_probs=203.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||+|..+. +++.|++|.++... ......+.+|++++++++|+||+++++++..+...+++|||+
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKA-TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eEEEEecccCCeeEEEEEeCC-CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 345789999999999998763 57899999986532 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++.+..++.....+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++............
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 83 ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9988877777667789999999999999999999998 8999999999999999999999999999876554432333
Q ss_pred eccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH--------hhhcCc-----
Q 044281 663 MIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD--------CYVEGR----- 728 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~--------~~~~~~----- 728 (796)
...++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+...... ......
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 45678899999999888 8899999999999999999999998754333221111110000 000000
Q ss_pred cceeccch-hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVLIDSD-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~~d~~-~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+.. .....+.....++.+++.+||+.+|++||++++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 0001111225678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.35 Aligned_cols=241 Identities=25% Similarity=0.318 Sum_probs=199.1
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.||.|+||.||.+... .+.+.||||+++-... +.-.+++.|+..|++++|||++.+.|+|......|||||||-
T Consensus 31 LrEIGHGSFGAVYfArd~-~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL 109 (948)
T ss_pred HHHhcCCccceeEEeecc-CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh
Confidence 367999999999999865 4678999999975433 345689999999999999999999999999999999999996
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
| +-.+++.-. +++.+..+..|..+.++||+|||++ +.||||||+.|||+++.|.|||+|||.|.++.+ ..
T Consensus 110 G-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----An 180 (948)
T KOG0577|consen 110 G-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----AN 180 (948)
T ss_pred c-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----hh
Confidence 4 777777643 5677788889999999999999999 899999999999999999999999999987643 33
Q ss_pred eccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 663 MIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
..+|||.|||||++. .+.|+-|+||||||++..||.-.++|...........-|. ....+ .
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA--------QNesP--------t 244 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--------QNESP--------T 244 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH--------hcCCC--------C
Confidence 467999999999884 6789999999999999999999999876554332221111 11111 1
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....++.+.+..++..||++-|.+|||..++++.
T Consensus 245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1256778889999999999999999999988764
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.50 Aligned_cols=246 Identities=27% Similarity=0.338 Sum_probs=194.7
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCH
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL 587 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 587 (796)
..||+|+||.||+|... .++..|++|.+........+.+.+|+.++++++|+||+++++++..+...++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDL-STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEec-CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 46999999999999865 46789999998776556667899999999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCC--chhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccccCCCCcceee
Q 044281 588 ANLIFAI-PKP--DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 588 ~~~l~~~-~~~--~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
.+++... ..+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999764 344 7788889999999999999998 9999999999999986 67999999999986543222 2223
Q ss_pred ccCCCcccccccccCCC--CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 664 IRGTRGYVAPEWFKNVP--VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
..++..|+|||++.+.. ++.++||||||+++|||++|+.|+........... .... ..... ..
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~----~~~~--~~~~~---------~~ 233 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF----KVGM--FKIHP---------EI 233 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh----hhhh--hccCC---------CC
Confidence 35788999999987644 78999999999999999999999864322111100 0000 00000 01
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.....++..++.+||+.+|.+|||+.++++.
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11233457789999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=312.53 Aligned_cols=188 Identities=20% Similarity=0.268 Sum_probs=160.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+|... .+++.||+|..... ....|+.++++++|+||+++++++......++|+||+.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 445678999999999999875 45789999985432 23568999999999999999999999999999999995
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~ 214 (357)
T PHA03209 141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFL 214 (357)
T ss_pred -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--cccc
Confidence 588887764 45689999999999999999999998 8999999999999999999999999999753221 1222
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSV 704 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~ 704 (796)
...||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 345899999999999999999999999999999999976655
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=298.26 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=197.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh------hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA------QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
..+.||+|+||+||+|... +++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++++
T Consensus 4 ~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 3467999999999999753 67899999885321 222356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC--
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-- 657 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-- 657 (796)
||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999998877788999999999999999999998 89999999999999999999999999998653211
Q ss_pred ---CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 658 ---SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 658 ---~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
........++..|+|||.+.+..++.++||||||+++|||++|+.||...........+.. ..+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~-- 230 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA------HRGLMPRL-- 230 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh------ccCCCCCC--
Confidence 1112234588899999999999999999999999999999999999975433221111100 00111111
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+......+..++.+||+.+|++||++.++++
T Consensus 231 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 -------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1123356678999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=316.06 Aligned_cols=263 Identities=20% Similarity=0.207 Sum_probs=198.2
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeC-CCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
...+.+.+.||+|+||.||++.... ..+..|++|.+... ..+.+|++++++++|+||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3446667889999999999997542 34578999988653 24568999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS- 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~- 658 (796)
|++. ++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9986 68888887777899999999999999999999998 899999999999999999999999999986544322
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccce-------
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV------- 731 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~------- 731 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... .........
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCccchh
Confidence 222345689999999999999999999999999999999999999965432111111111000 000000000
Q ss_pred ----------eccc--h-hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 732 ----------LIDS--D-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 732 ----------~~d~--~-~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...+ . ............+..++.+||+.||++|||+.|++.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0 0000000112356678999999999999999999876
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=297.38 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=199.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.++||+|+||.||++... .+++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+......+++|||+++
T Consensus 4 ~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred EEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 4578999999999999865 46789999988542 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 585 GTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 585 gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|.+++... ..++......++.||+.||.|||+. +|+|+||||+||++++++.++|+|||++........ ...
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YAC 158 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccc
Confidence 9999988653 3578889999999999999999998 999999999999999999999999999986643222 222
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
...+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ..+....+ +
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~---------~ 221 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV--------CQGSYKPL---------P 221 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH--------hcCCCCCC---------C
Confidence 345888999999999999999999999999999999999999765433221111 11211111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......+.+++.+||+.||++||++.+|+..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.11 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=197.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||++... .+++.||+|.+... .......+.+|+.++++++|+||+++++.+......++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 456789999999999999875 46789999988653 2334568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 583 GNGTLANLIFAI---PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 583 ~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
++++|..++... ..+++..+..++.||+.||.|||+.. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999988763 36889999999999999999999742 89999999999999999999999999997653221
Q ss_pred ceeeccCCCcccccccccCCC------CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 660 THTMIRGTRGYVAPEWFKNVP------VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~------~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
.....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||...........+. ....+....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~-- 229 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-----AIVDGDPPT-- 229 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH-----HHhhcCCCC--
Confidence 22234788999999986543 5889999999999999999999996543222111110 011111111
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......+..++.+||+.+|++||++.++++.
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 -------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 112244567789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.87 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=200.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||++
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred ceeeeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 345578999999999999864 4688999999976555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~ 174 (297)
T cd06656 100 GGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (297)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCc
Confidence 9999999865 4578889999999999999999998 899999999999999999999999999986543322 1223
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+ ...+. .. ...+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------~~~~~-~~-------~~~~~ 239 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGT-PE-------LQNPE 239 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------ccCCC-CC-------CCCcc
Confidence 45788999999999999999999999999999999999999654332111000 00000 00 00111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+.+++.+||+.+|++||++.+|++.
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223456778999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.07 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=197.9
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccc-cccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDE-ALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~ 581 (796)
.+.+.||+|++|.||++..+ .+++.+++|++.... ....+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred eEEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 34578999999999999875 457899999986432 2345678999999999999999999988764 4457899999
Q ss_pred cCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++++|.+++... ..+++.+++.++.|++.|++|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 9999999998763 4578999999999999999999998 899999999999999999999999999987643322
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......+++.|+|||.+.+..++.++||||||++++||++|+.||...........+ ..+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~--------~~~~~~~-------- 221 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI--------IEGKLPP-------- 221 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------HhcCCCC--------
Confidence 223345788999999999999999999999999999999999998754432211111 1111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......+.+++.+|++.+|++||++.++++.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112233567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.39 Aligned_cols=246 Identities=28% Similarity=0.371 Sum_probs=199.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-----hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
..+.||+|+||.||+|+.+ .+++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++..+...++++|
T Consensus 4 ~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred ccceeeecCCceEEEEEEc-CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 4467999999999999875 367899999886432 2345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++++|.+++.....+++..+..++.||++||+|||+. +|+|+||+|+||+++.++.+||+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 83 LVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 999999999998877789999999999999999999998 89999999999999999999999999998754332 2
Q ss_pred eeeccCCCcccccccccCCC-CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....++..|+|||.+.... ++.++|+||||+++|||++|+.||............ . .......+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~----~~~~~~~~------- 223 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI---G----RSKELPPI------- 223 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH---H----hcccCCCc-------
Confidence 23445788999999998776 899999999999999999999998654322111100 0 00111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.+|.+||++.++++.
T Consensus 224 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 --PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11123456778999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.16 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=207.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
..+.++||+|+||.|||+.++ ..|+.+|||.+.- ....+++..|+.++++.+.+++|+++|.+-....+|+||||+.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 345689999999999999987 4789999999865 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
.|++.++++.+ +.+.+..+..+...-++||+|||.. .-||||||+.|||++.+|.+||+|||.|-.+.. ......
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKRN 187 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKRN 187 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhhC
Confidence 99999999865 5788999999999999999999997 789999999999999999999999999976532 223344
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec-cchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI-DSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-d~~~~~~~ 741 (796)
.+.||+.|||||++..-.|..++||||||+...||.-|+.|+....+.... ..+. .+.+.-..
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI----------------FMIPT~PPPTF~K 251 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI----------------FMIPTKPPPTFKK 251 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee----------------EeccCCCCCCCCC
Confidence 567999999999999999999999999999999999999998653322111 1111 11222234
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.....++-++++.||-+.|++|-|+-++++.
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 56677889999999999999999999887764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=312.25 Aligned_cols=261 Identities=23% Similarity=0.271 Sum_probs=192.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccc------cc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------NR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 575 (796)
+.+.+.||+|+||.||++... .+++.||+|++... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 344578999999999999865 46889999998643 2334567889999999999999999999886443 46
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++||||+++ +|...+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 102 YLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred EEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 899999976 5655553 2477888899999999999999998 999999999999999999999999999985432
Q ss_pred CCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHH---------------HH
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTD---------------WA 720 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~---------------~~ 720 (796)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.. ..
T Consensus 176 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 176 NF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred Cc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 21 22334689999999999999999999999999999999999999975533221110000 00
Q ss_pred HHhhhc-Ccc-----ceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 721 YDCYVE-GRL-----DVLIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 721 ~~~~~~-~~~-----~~~~d~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...... ... ........ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 000 00000000 000011123457789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.53 Aligned_cols=243 Identities=28% Similarity=0.421 Sum_probs=194.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||++.. .++.||+|.++... ....+.+|+.++++++|+|++++++++... ..+++|||++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred ceeeeeeccCCCCceEeccc---CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 44567899999999999874 57789999986532 245789999999999999999999998654 5799999999
Q ss_pred CCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|.+++.... .+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999997643 578889999999999999999998 99999999999999999999999999997543211
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+... +.
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~---~~----- 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV--------EKGYRM---EP----- 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--------hCCCCC---CC-----
Confidence 12234567999999998899999999999999999998 88888655443322111 111111 00
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.......+.+++.+||+.+|++||++.++++.|++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11223566789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.82 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=191.2
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-----hhhhHHHHHHHHHHhcccCccCcccccccccc--cccceeE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE--ALNRLLV 578 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 578 (796)
..+.||+|+||.||++... .++..|++|++... ..+....+.+|+.++++++|+||+++++++.+ ....+++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred ccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 4578999999999999865 45789999988532 12334578899999999999999999998765 3566899
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
+||+++++|.+++.....+++...+.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999998877788999999999999999999988 899999999999999999999999999986543211
Q ss_pred --cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 --RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||.......... ..........
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-------~~~~~~~~~~----- 229 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-------KIATQPTNPQ----- 229 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-------HHhcCCCCCC-----
Confidence 11223457889999999999999999999999999999999999997543221111 0000110000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+....+.+..++ .||..+|++||+|+||++.
T Consensus 230 ----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 230 ----LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0111122333344 6888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=311.29 Aligned_cols=260 Identities=23% Similarity=0.258 Sum_probs=192.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccc------ccce
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA------LNRL 576 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 576 (796)
.+.+.||+|+||.||++... ..++.||||++... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 34578999999999999865 46789999999653 223346788899999999999999999987543 3468
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||+++ +|.+.+.. .+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 99 lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 99 LVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred EEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 99999975 66666543 477888999999999999999998 9999999999999999999999999999865322
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH---------------HH
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW---------------AY 721 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~---------------~~ 721 (796)
.......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+........ ..
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred --cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 2223456899999999999999999999999999999999999999754432211111000 00
Q ss_pred Hhhhc-Ccccee-----c-cchh--hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 722 DCYVE-GRLDVL-----I-DSDE--AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 722 ~~~~~-~~~~~~-----~-d~~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..... .....+ . +... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 000000 0 0000 000111123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=323.54 Aligned_cols=260 Identities=20% Similarity=0.219 Sum_probs=187.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC------ccCccccccccccc-ccce
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH------HKHLVQLLGFCDEA-LNRL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~-~~~~ 576 (796)
+.+.++||+|+||+||++... .+++.||||+++... ....++..|+.++..++ |.+++++++++... .+.+
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 445578999999999999875 367899999996532 22334455665555554 45688888888654 4678
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC----------------
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF---------------- 640 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~---------------- 640 (796)
+|||++ +++|.+++.....+++..+..|+.||+.||.|||++. +|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 999987 6789888888788999999999999999999999732 899999999999998765
Q ss_pred cEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHH
Q 044281 641 SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA 720 (796)
Q Consensus 641 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 720 (796)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....
T Consensus 286 ~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred eEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 49999999876422 22334578999999999999999999999999999999999999997655433222221110
Q ss_pred --------HH--------hhh-cCccceeccchhh-------hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 721 --------YD--------CYV-EGRLDVLIDSDEA-------AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 721 --------~~--------~~~-~~~~~~~~d~~~~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.. .+. .+.+....++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00 000 0000000000000 0000111245778999999999999999999987
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.11 Aligned_cols=264 Identities=23% Similarity=0.266 Sum_probs=200.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||+|... .+++.|++|++.... ......+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred eEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 34578999999999999875 357899999986543 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|.+++... ..+++.++..++.||++||+|||+. +++|+||||+||++++++.++|+|||++...........
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99999998653 5688999999999999999999998 899999999999999999999999999987654433333
Q ss_pred eeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----hhcC----cccee
Q 044281 662 TMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----YVEG----RLDVL 732 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~~~~----~~~~~ 732 (796)
....++..|+|||.+.+. .++.++||||+|++++||++|..+|......+....+....... +.+. ....+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 445688999999998654 46899999999999999999987776544332221111100000 0000 00000
Q ss_pred ccc-h---hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 733 IDS-D---EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 733 ~d~-~---~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
... . ............+.+++.+|++.+|++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0 0000011223678889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.52 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=199.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEe--cch--hhhhHHHHHHHHHHhcccCccCccccccccccccc--ceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKL--DRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN--RLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l--~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lv 578 (796)
+|.++||+|+|-+||||.+. .+|.+||=-.+ ++. .....+.|..|+++|+.|+|+||++++..+.+... ..+|
T Consensus 43 k~~evLGrGafKtVYka~De-~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDE-EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeecccc-ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 35688999999999999874 56777753222 221 22334789999999999999999999999977766 5689
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~ 657 (796)
+|.|..|+|..+++..++.+.+...+++.||++||.|||++ .++|||||||-+||+|+. .|.|||+|+|||.++....
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999999999999999999999999999999999997 679999999999999984 6899999999999875433
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
. ..+.|||.|||||... ..|.+.+||||||+.++||+|+.-|+..-... ...+..+..|..+..+....
T Consensus 201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------AQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------HHHHHHHHcCCCHHHhhccC
Confidence 2 3378999999999998 78999999999999999999999998643221 11334444554444333221
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
-.++.+++.+||.. .++|||+.|+|+
T Consensus 270 --------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 --------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 12456799999998 999999999985
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.95 Aligned_cols=259 Identities=23% Similarity=0.240 Sum_probs=191.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCccccccccccc------ccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA------LNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 575 (796)
+...+.||+|+||.||++... .+++.||||++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 445678999999999999865 467899999987532 22345678899999999999999999987543 346
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 96 ~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 96 YLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred EEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 8999987 6789887754 4688999999999999999999998 899999999999999999999999999986533
Q ss_pred CCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hhhcC
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVEG 727 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~~ 727 (796)
. .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...... .....
T Consensus 171 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred C----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 2 223458999999999977 57899999999999999999999999754332221111110000 00000
Q ss_pred -------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 -------RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+.......... ........+.+++.+|++.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 000112346789999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.50 Aligned_cols=252 Identities=27% Similarity=0.368 Sum_probs=197.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh----------hhHHHHHHHHHHhcccCccCcccccccccccccc
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ----------EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 575 (796)
..+.||+|+||.||+|... .+++.||+|.++.... ...+.+.+|+.++++++|+|++++++++......
T Consensus 5 ~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 5 KGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred ecceecccCceEEEEEeec-CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 3467999999999999865 4688999998753211 1134688899999999999999999999999999
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++||||+++++|.+++.....+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 99999999999999998878889999999999999999999998 899999999999999999999999999986543
Q ss_pred CCCc-ceeeccCCCcccccccccCCC--CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 656 DQSR-THTMIRGTRGYVAPEWFKNVP--VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 656 ~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
.... ......++..|+|||.+.... ++.++||||||+++||+++|..|+......+.... .. .......
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~-~~~~~~~ 232 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-------LG-NKRSAPP 232 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH-------hh-ccccCCc
Confidence 2211 123345788999999987654 88999999999999999999999864332211110 00 0110111
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.. .........+.+++.+||+.+|++||++.+|++.
T Consensus 233 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111 0111234567778999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=309.60 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=202.4
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-c-----cCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-H-----KHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~ 576 (796)
+|.+.+.||+|+||.|.|+... .+++.||||++++. .....+-..|+.+|..++ | -|+|++++++...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~-~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH-KTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEec-CCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 4556789999999999999865 67899999999874 334566788999999986 4 38999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC--CcEEEeecCCccc
Q 044281 577 LVYEFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF--FSAKISDFGLSKL 652 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~--~~~kl~DfGla~~ 652 (796)
||+|.++. +|.++|+... .++......++.||+.||.+||+. +|||+||||+||||.+. -.+||+|||.|..
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999855 9999998764 577899999999999999999998 99999999999999753 4699999999985
Q ss_pred ccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------H---
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY-------D--- 722 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-------~--- 722 (796)
.. ........++.|.|||++.+.+|+.+.||||||||++||++|...|.++.+.+....+.+..- +
T Consensus 341 ~~----q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ES----QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cC----CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 42 122255678899999999999999999999999999999999888887776655444433211 0
Q ss_pred ----hhhc-Cccce-eccch-----------------------h------hhhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 044281 723 ----CYVE-GRLDV-LIDSD-----------------------E------AAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767 (796)
Q Consensus 723 ----~~~~-~~~~~-~~d~~-----------------------~------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 767 (796)
.+.. ..... ..... + ........-..+++++.+|++.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0111 00000 00000 0 000011233467899999999999999999
Q ss_pred HHHHHH
Q 044281 768 KVVLQM 773 (796)
Q Consensus 768 ~evl~~ 773 (796)
.+.+++
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999875
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.33 Aligned_cols=261 Identities=23% Similarity=0.239 Sum_probs=193.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccc------ccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA------LNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 575 (796)
+.+.+.||+|+||.||++... ..++.||||++... .......+.+|+.+++.++|+||+++++++... ...
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred eeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 445578999999999999865 46789999999653 223346788999999999999999999987543 346
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 105 YIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 899999975 67666643 477888999999999999999998 999999999999999999999999999986532
Q ss_pred CCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH---------------H
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW---------------A 720 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~---------------~ 720 (796)
. .......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+....+... .
T Consensus 179 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 179 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred C--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 2 1223346899999999999999999999999999999999999999765433221111100 0
Q ss_pred HHhhhcC-c-----cceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 721 YDCYVEG-R-----LDVLIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 721 ~~~~~~~-~-----~~~~~d~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+. . ...+..... ...........+.+++.+|++.||.+|||+.++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0 000000000 000011123467789999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.72 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=200.2
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||.||++..+ .+++.|++|.+..... .....+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 5 ~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred EeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 4578999999999999876 4678999999875432 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC-----
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ----- 657 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~----- 657 (796)
++++|.+++.....+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 84 EGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999998888889999999999999999999998 89999999999999999999999999987421110
Q ss_pred ---------CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 658 ---------SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 658 ---------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
........++..|+|||.+.+..++.++||||||+++|||++|+.||......+..... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~--------~~~~ 232 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--------ISDD 232 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------Hhcc
Confidence 00111235788999999999889999999999999999999999999755433211111 1111
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
... +.. .......+..++.+||+.+|++||++.++.+.|+.
T Consensus 233 ~~~---~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 IEW---PEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cCC---CCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 100 000 01123456789999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.62 Aligned_cols=250 Identities=28% Similarity=0.380 Sum_probs=200.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
...+.||+|+||.||+|... .+++.|++|.+..... ...+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred eeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 34578999999999999865 3578999999865433 35678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce-
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH- 661 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 661 (796)
++++|.+++.....+++..+..++.|+++||.|||+. +|+|+||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999998877789999999999999999999998 899999999999999999999999999987654332221
Q ss_pred --eeccCCCcccccccccCCC---CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 662 --TMIRGTRGYVAPEWFKNVP---VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 662 --~~~~gt~~y~aPE~~~~~~---~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
....++..|+|||.+.+.. ++.++||||||++++|+++|+.||........... . ...+....+..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~------~-~~~~~~~~~~~-- 229 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF------H-VGAGHKPPIPD-- 229 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH------H-HhcCCCCCCCc--
Confidence 1345788999999998766 89999999999999999999999965422111110 0 00011111100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.......+..++.+||+.+|.+||++.+++.
T Consensus 230 -----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 -----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111345567999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.78 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=194.2
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-----hhhhHHHHHHHHHHhcccCccCccccccccccc--ccceeE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLV 578 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 578 (796)
+.+.||+|+||.||+|... .+++.|++|.+... .....+.+.+|+.++++++|+||+++++++.+. ...+++
T Consensus 6 ~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred EeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 4578999999999999865 46889999987531 122346788999999999999999999988664 456799
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++++|.+++.....+++...++++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999998877788899999999999999999998 899999999999999999999999999986543211
Q ss_pred --cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 --RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||...........+ .....
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~~-------- 226 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-------ATQPT-------- 226 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH-------hcCCC--------
Confidence 1122345888999999999888999999999999999999999998754222111100 00000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....+......+..++.+|+. +|++||++++|++.
T Consensus 227 -~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 -NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011122334566778888885 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=297.15 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=199.9
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
.+.||+|++|.||++... .+++.+++|++........+.+.+|+.+++.++|+||+++++++......++++||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 24 FVKIGEGSTGIVCIATDK-STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred ceEeccCCCeEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 358999999999999865 4678999999876555556678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccC
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 666 (796)
|.+++.. ..+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||++........ ......|
T Consensus 103 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 177 (285)
T cd06648 103 LTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVG 177 (285)
T ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccC
Confidence 9999877 5688899999999999999999998 899999999999999999999999999876543322 1223458
Q ss_pred CCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 044281 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRL 746 (796)
Q Consensus 667 t~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 746 (796)
+..|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..+....... .....
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~-------~~~~~ 242 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--------RDNLPPKLKN-------LHKVS 242 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH--------HhcCCCCCcc-------cccCC
Confidence 89999999999989999999999999999999999998754432221111 1111000000 11123
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 747 HKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 747 ~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.+++.+||+.+|++||++.++++.
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccC
Confidence 467889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.93 Aligned_cols=261 Identities=24% Similarity=0.285 Sum_probs=193.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|++|.||+|..+ .+++.||+|+++... ......+.+|+.++++++|+||+++++++.++...++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred EeeEecccCceEEEEEEEC-CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 4567999999999999875 467899999986432 2234678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcC---CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFAI---PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++|.+++... ..+++..+..++.||++||+|||+. +|+|+||||+||++++++.+||+|||++....... ..
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 5888887643 4578999999999999999999998 99999999999999999999999999998653322 12
Q ss_pred eeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH----hhhc--------C
Q 044281 661 HTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD----CYVE--------G 727 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~----~~~~--------~ 727 (796)
.....+++.|+|||.+.+. .++.++||||||+++|||++|+.||.................. .+.. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2233568899999988654 5789999999999999999999999755432211111000000 0000 0
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......... .........++.+++.+||+.||++|||+.+|++.
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 00011123466789999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.50 Aligned_cols=194 Identities=22% Similarity=0.338 Sum_probs=158.6
Q ss_pred HhhCCCccceEEEEEeeC-CCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccc--ccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCD--EALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~~~~ 584 (796)
.+||+|+||.||+|..+. .++..||+|.++... ....+.+|+.++++++||||+++++++. .+...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999998653 355789999987532 2346788999999999999999999884 35567899999875
Q ss_pred CCHHHHHhcC---------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE----cCCCcEEEeecCCcc
Q 044281 585 GTLANLIFAI---------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSK 651 (796)
Q Consensus 585 gsL~~~l~~~---------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~DfGla~ 651 (796)
+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777766421 2467888999999999999999998 89999999999999 567899999999998
Q ss_pred cccCCCC--cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchh
Q 044281 652 LLFSDQS--RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEME 707 (796)
Q Consensus 652 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~ 707 (796)
....... .......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7644322 122345689999999998764 5799999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=295.14 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=198.8
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh------hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA------QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
..+.||+|+||.||++... .+++.||+|.+.... ....+.+.+|++.+++++|+||+++++++.+....++|+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred ccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3467999999999999864 568899999986432 123568899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~ 658 (796)
||+++++|.+++.....+++.....++.||+.||.|||+. +++|+||+|+||+++.++ .+||+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 83 EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred eccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999998877889999999999999999999998 999999999999998775 599999999987644321
Q ss_pred c---ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 659 R---THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 659 ~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
. ......++..|+|||.+.+..++.++||||+|++++||++|..||...........+. .......
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~------- 228 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF----KIASATT------- 228 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH----HHhccCC-------
Confidence 1 1223457889999999998899999999999999999999999986433211111110 0000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
....+......+.+++.+|++.+|++||++.++++
T Consensus 229 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 --APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111223356778999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.96 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=198.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc--cccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE--ALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~ 581 (796)
+.+.||.|+||.||++... .+++.+++|.+... .....+.+.+|+.++++++|+||+++++++.. ....+++|||
T Consensus 4 ~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 4567999999999999865 46789999998642 23445678899999999999999999997753 4557899999
Q ss_pred cCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcC--CCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 582 MGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEEC--NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 582 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
+++++|.+++.. ...+++..++.++.||+.||+|||..+ ..+++|+||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 999999999865 357889999999999999999999321 23899999999999999999999999999987654
Q ss_pred CCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+.......... ....+....
T Consensus 163 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~~---- 229 (265)
T cd08217 163 DSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS--------KIKEGKFRR---- 229 (265)
T ss_pred Cccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHH--------HHhcCCCCC----
Confidence 3321 223458899999999999899999999999999999999999997654322111 111111111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......+.+++.+|++.+|++||++.+|+++
T Consensus 230 -----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 -----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=284.17 Aligned_cols=250 Identities=22% Similarity=0.242 Sum_probs=204.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.++.+.||+|.-|+||++.++. ++...|+|++.+... +.......|-+||+.++||.++.|++.++.+...+|+||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecC-CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 3456789999999999999874 558999999987443 334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC---
Q 044281 581 FMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS--- 655 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~--- 655 (796)
|++||+|..+++.++ .+++..+.-++.+|+-||+|||.. |||.|||||+||||.++|++-|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998764 688899999999999999999998 999999999999999999999999998865411
Q ss_pred -----C------------------------C-C----------------------cceeeccCCCcccccccccCCCCCc
Q 044281 656 -----D------------------------Q-S----------------------RTHTMIRGTRGYVAPEWFKNVPVSA 683 (796)
Q Consensus 656 -----~------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~s~ 683 (796)
. . . ......+||-.|+|||++++..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0 0011245888999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCC
Q 044281 684 KVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSK 763 (796)
Q Consensus 684 k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~ 763 (796)
++|.|+|||++|||+.|..||.+....+....+. .+ .+.-...+.-...+.+++++.|.+||.+
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv---~~-------------~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV---GQ-------------PLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh---cC-------------CCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999999999887665443332 11 1111112233456778999999999999
Q ss_pred CCC----HHHHHHH
Q 044281 764 RPT----MKVVLQM 773 (796)
Q Consensus 764 RPt----~~evl~~ 773 (796)
|.- +.||.++
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 998 7777653
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.65 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=200.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.+.||+|+||.||++..+ .+++.+++|.+.... .....++.+|++++++++|+||+++++.+......++++||++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 45688999999999999875 467899999986543 3455789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhh-cCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHE-ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|.+++... ..++......++.|+++||+|||+ . +++|+||||+||++++++.+||+|||.+.........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 157 (265)
T cd06605 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157 (265)
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence 99999999876 678889999999999999999999 6 8999999999999999999999999998765322211
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ........ ...+....+ .
T Consensus 158 -~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~-~~~~~~~~~--------~ 225 (265)
T cd06605 158 -TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIFELLQY-IVNEPPPRL--------P 225 (265)
T ss_pred -cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHH-HhcCCCCCC--------C
Confidence 15578899999999999999999999999999999999999865421000 00011111 111111000 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.+|++|||+.++++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11134567789999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.19 Aligned_cols=261 Identities=20% Similarity=0.223 Sum_probs=195.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.++||+|+||.||+|..+ .+++.||+|.+.... ......+.+|+.++++++|+||+++++++......++||||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 34578999999999999865 467899999986432 2223567889999999999999999999999999999999997
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|.+++... ..+++..+..++.||++||+|||+. +|+|+||||+||++++++.+||+|||++........ ...
T Consensus 88 -~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 162 (301)
T cd07873 88 -KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYS 162 (301)
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-ccc
Confidence 5888887654 4678899999999999999999998 999999999999999999999999999976432221 122
Q ss_pred eccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc------
Q 044281 663 MIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS------ 735 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~------ 735 (796)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+........ +.....+...
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSNEEFKSY 241 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhhcccccccc
Confidence 33468899999998654 578899999999999999999999976554332222111110000 0000000000
Q ss_pred ---hh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 736 ---DE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 736 ---~~----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.. ...........+.+++.+|++.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00001112345678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.32 Aligned_cols=261 Identities=18% Similarity=0.240 Sum_probs=192.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||.||+|... .+|+.+++|.+.... ......+.+|+.++++++|+||+++++++.+....++++||++
T Consensus 4 ~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eEEEecccCCeEEEEEEEC-CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 4567999999999999875 468899999986432 2223567889999999999999999999999999999999997
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+ +|.+++.. ...+++..+..++.||++||.|||+. +|+|+||||+||+++.++.+||+|||+++...... ....
T Consensus 83 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 83 Q-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 4 77777654 45789999999999999999999998 89999999999999999999999999998653322 1222
Q ss_pred eccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhH-HHHhHHHHHHH-------HHhhhc----Ccc
Q 044281 663 MIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELE-EESRAILTDWA-------YDCYVE----GRL 729 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~-~~~~~~l~~~~-------~~~~~~----~~~ 729 (796)
...++..|+|||.+.+. .++.++|||||||++|||++|+.|+..... .+....+.... +..... ...
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 34578899999998765 478999999999999999999988643322 21111111000 000000 000
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
...................+.+++.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000111123456778999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.93 Aligned_cols=248 Identities=26% Similarity=0.334 Sum_probs=192.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCccccccccc-----ccccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCD-----EALNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~lv 578 (796)
.+.+.||+|+||.||++..+ .+++.+|+|.++... ....++.+|+.++.++ +|+||+++++++. .+...++|
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeccCCCcEEEEEEEC-CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 34578999999999999876 467899999986532 2345788899999998 6999999999873 34567999
Q ss_pred EeecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 579 YEFMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
|||+++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999988753 34678888999999999999999998 89999999999999999999999999998654
Q ss_pred CCCCcceeeccCCCcccccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcc
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (796)
.... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+...........+ .....
T Consensus 176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~--------~~~~~ 246 (286)
T cd06638 176 STRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI--------PRNPP 246 (286)
T ss_pred cCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc--------cccCC
Confidence 3221 2233458999999999853 45788999999999999999999998754332211100 00100
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....++ ......+..++.+||+.||++|||+.||++.
T Consensus 247 ~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 247 PTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 111111 1122457789999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.51 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=199.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||++... .+++.+++|.+... ......++.+|+.++++++|+||+++++++......++|+||+
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred eEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 34578999999999999876 46789999998643 2334568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++++|.+++.... .+++...++++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 9999999887543 568889999999999999999998 899999999999999999999999999986543221 1
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....+++.|+|||.+.+...+.++|||||||+++||++|+.|+......+....+ ..+....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--------~~~~~~~--------- 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI--------IRGSYPP--------- 220 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH--------hcCCCCC---------
Confidence 22345788999999999999999999999999999999999998755433221111 1111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......+.+++.+||+.+|++||+|.+|++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111233467789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=296.32 Aligned_cols=263 Identities=23% Similarity=0.235 Sum_probs=199.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCccccccccccc--ccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 581 (796)
+.++||+|+||.||+|+.. .+++.+|+|++.... ......+.+|+.++++++|+|++++++++... ...++|+||
T Consensus 3 ~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 3467999999999999876 357899999997653 33346788999999999999999999999887 789999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++ +|.+++... ..+++..++.++.||++||+|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 985 898888765 5789999999999999999999998 89999999999999999999999999998765543323
Q ss_pred eeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc-------------
Q 044281 661 HTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE------------- 726 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~------------- 726 (796)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..........
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 334456788999998765 467899999999999999999999997655433222221111000000
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......................+.+++.+||+.+|++||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000011111125678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=292.99 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=199.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.++||+|+||.||+|... .+++.||+|.+.... ......+.+|+..+.+++|+||+++++++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3455678999999999999865 367899999986432 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 999999998865 4578999999999999999999998 999999999999999999999999999876543221 12
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....++..|+|||.+.+..++.++|||||||++|||++|..|+...........+ ..+.... .
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~---------~ 221 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI--------PKNNPPT---------L 221 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH--------hcCCCCC---------C
Confidence 2345788999999999888999999999999999999999998754332211111 1111111 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223456778999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=295.23 Aligned_cols=261 Identities=25% Similarity=0.298 Sum_probs=196.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.++||+|++|.||+|..+ .+++.|++|++.... ......+.+|+..+++++|+|++++++++.++...+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred hheEecCCCCeEEEEEEEc-CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 4578999999999999875 368899999986432 2234578899999999999999999999999999999999995
Q ss_pred CCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++|.+++...+ .+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||+++....... ..
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 156 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY 156 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence 68999987765 789999999999999999999998 899999999999999999999999999976533221 12
Q ss_pred eeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc---------C---c
Q 044281 662 TMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE---------G---R 728 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~---------~---~ 728 (796)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.......... + .
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 223467889999988664 57899999999999999999999987554332211111110000000 0 0
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....... ............+.+++.+|++.+|.+|||++|+++.
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 237 FPKWARQ-DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccc-chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 0001111223567789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=329.03 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=192.7
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc--cccceeE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE--ALNRLLV 578 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 578 (796)
.+.+.+.||+|+||+||++... .+++.+|+|.+... .......|..|+.++++++|||||++++++.. ....+||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 3455678999999999999976 46789999988642 23345678999999999999999999998744 4567899
Q ss_pred EeecCCCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCC----CCeeeCCCCCCCEEEcC------------
Q 044281 579 YEFMGNGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECN----VPIIHCDIKPQNILLDH------------ 638 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~----~~iiH~Dlk~~NIll~~------------ 638 (796)
|||+++++|.++|... ..+++..++.|+.||+.||+|||+... .+|+||||||+||||+.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 9999999999998652 468999999999999999999998521 25999999999999964
Q ss_pred -----CCcEEEeecCCcccccCCCCcceeeccCCCcccccccccC--CCCCccchhHHHHHHHHHHHhCCCCCchhhHHH
Q 044281 639 -----FFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE 711 (796)
Q Consensus 639 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~ 711 (796)
...+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.......
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred cccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 3458999999998653322 1233468999999999854 458999999999999999999999996543221
Q ss_pred HhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 712 SRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.. + ..+..+. .+ . .......+.+++..||+.+|.+||++.++++
T Consensus 251 ql--i-----~~lk~~p--~l---p-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 251 QL--I-----SELKRGP--DL---P-----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HH--H-----HHHhcCC--CC---C-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11 1 0011110 00 0 0112345778999999999999999999984
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.06 Aligned_cols=242 Identities=25% Similarity=0.283 Sum_probs=198.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||++.... +++.+|+|.+.... ......+.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 345789999999999998763 67899999986532 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++|.+++.....++...+..++.||+.||.|||+. +|+|+||+|+||++++++.+||+|||+++..... .
T Consensus 83 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~ 155 (290)
T cd05580 83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T 155 (290)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence 99999999998888899999999999999999999998 9999999999999999999999999999876433 2
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....+++.|+|||.+.+...+.++||||||+++|||++|+.||...........+ ..+... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~----------~ 217 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI--------LEGKVR----------F 217 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hcCCcc----------C
Confidence 2345788999999999888999999999999999999999998765432211111 111110 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQ 772 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 772 (796)
+......+.+++.+||+.||.+|| +++|+++
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111234667799999999999999 6777663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=301.34 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=203.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+...||.|+||.|||++.+ .++...|.|.+...+....++|+-|+.+|+...||+||+|++.|...+.++++.|||.|
T Consensus 35 eIiGELGDGAFGKVyKA~nk-et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHhhhcCccchhhhhhhcc-cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 34567999999999999876 45666788888877778888999999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
|.++.++-.. ..++..++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+...... ......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDs 189 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDS 189 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hhhhcc
Confidence 9999887654 5788999999999999999999999 9999999999999999999999999998643221 222345
Q ss_pred ccCCCcccccccc-----cCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 664 IRGTRGYVAPEWF-----KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 664 ~~gt~~y~aPE~~-----~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
..|||.|||||+. ...+|+.++||||||++|.||..+.+|.....+.....-+ .....+.++.
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi--------aKSePPTLlq---- 257 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--------AKSEPPTLLQ---- 257 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH--------hhcCCCcccC----
Confidence 6799999999986 4678999999999999999999999987654443321111 1111122222
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+..+...+.+++.+||.+||+.||++.++++.
T Consensus 258 ---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ---cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 23455667789999999999999999998864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.72 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=197.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccC---ccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTH---HKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~ 579 (796)
+...+.||+|+||.||+|... .+++.+++|.+... ......++.+|+.++++++ |+|++++++++......++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 345678999999999999975 46789999998653 2334567888999998886 999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++++|.+++... .+++...+.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 999999999998664 688999999999999999999998 8999999999999999999999999999876543322
Q ss_pred ceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
.....|+..|+|||.+.++ .++.++|||||||++|||++|..||...........+ .......+.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~----- 223 (277)
T cd06917 158 -RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI--------PKSKPPRLE----- 223 (277)
T ss_pred -cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc--------ccCCCCCCC-----
Confidence 2334588899999998754 5789999999999999999999999754332211110 000001000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||++||++.+++++
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 ---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00133467789999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=291.18 Aligned_cols=247 Identities=27% Similarity=0.368 Sum_probs=200.5
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
||+|+||.||++... .+++.+++|.+..... .....+.+|++++++++|+||+++++.+......++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999875 4588999999865433 345678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-------c
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-------R 659 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-------~ 659 (796)
|.+++.....+++..+..++.||++||+|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 999998877889999999999999999999998 899999999999999999999999999886543321 1
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......++..|+|||.+.....+.++||||||+++|||++|+.||......+....+ ..+.... .
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~----~--- 221 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--------LNGKIEW----P--- 221 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hcCCcCC----C---
Confidence 223345788999999998888999999999999999999999999765543322111 1111110 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
........+..++.+||+.+|++|||+.++.+.|+.
T Consensus 222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 -EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred -ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000123567789999999999999999777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=294.79 Aligned_cols=264 Identities=20% Similarity=0.213 Sum_probs=197.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCccccccccccc--ccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 579 (796)
+.+.+.||+|+||.||+|..+ .+++.+++|.++.... .....+.+|+.++++++||||+++++++... ...++||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 456688999999999999875 4678999999864322 2234677899999999999999999998777 8899999
Q ss_pred eecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++ +|.+++.... .+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99975 9988887644 589999999999999999999998 89999999999999999999999999998764432
Q ss_pred cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------Hhh------
Q 044281 659 RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY-------DCY------ 724 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~------ 724 (796)
.......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...........+..... ..+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 122234468899999998764 468999999999999999999999976544332222111100 000
Q ss_pred hcCccceeccchhhhhhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 725 VEGRLDVLIDSDEAAMADRS-RLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.................+.. ....+.+++.+||+.+|++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000111111 24557789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=324.01 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=207.6
Q ss_pred HHHHHHhHHHhhCCCccceEEEEEeeCCC------CeEEEEEEecchhh-hhHHHHHHHHHHhccc-CccCccccccccc
Q 044281 499 LKDATDGFKEELGRGSFGIVYKGVLKTAS------GTAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKHLVQLLGFCD 570 (796)
Q Consensus 499 l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 570 (796)
+.+....+.+.||+|.||.|++|...... ...||||.++.... ...+.+..|+++|..+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33333355669999999999999865221 45899999976443 4457899999999998 7999999999999
Q ss_pred ccccceeEEeecCCCCHHHHHhcCC----------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCE
Q 044281 571 EALNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNI 634 (796)
Q Consensus 571 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NI 634 (796)
+....++|+||+..|+|.++|+..+ .+.....+.++.|||.|++||++. +++||||.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9999999999999999999998655 377888999999999999999998 899999999999
Q ss_pred EEcCCCcEEEeecCCcccccCCCCcceeecc--CCCcccccccccCCCCCccchhHHHHHHHHHHHhCC-CCCchhhHHH
Q 044281 635 LLDHFFSAKISDFGLSKLLFSDQSRTHTMIR--GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCR-RSVEMELEEE 711 (796)
Q Consensus 635 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~-~p~~~~~~~~ 711 (796)
|+.++..+||+|||+|+...+.......... -+..|||||.+....|+.|+|||||||+||||+|.. .|+......+
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 9999999999999999976554433322222 356799999999999999999999999999999955 5554321111
Q ss_pred HhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 712 SRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+ ....+.+|..... +....+++..+++.||+.+|++||++.++++.|+.++
T Consensus 530 ------~-l~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 530 ------E-LLEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred ------H-HHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1 1223344443221 2233567778999999999999999999999998843
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=294.44 Aligned_cols=261 Identities=25% Similarity=0.288 Sum_probs=193.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
..+.||+|+||.||+|+.+ .+++.|+||++.... ......+.+|++++++++|+||+++++++.+....++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeecCCCceEEEEEEEC-CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 3467999999999999875 467899999886432 2233578899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++....... ...
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 5888888653 4678999999999999999999998 89999999999999999999999999988653322 112
Q ss_pred eeccCCCcccccccccCCC-CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhh----------h--cCc
Q 044281 662 TMIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCY----------V--EGR 728 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~----------~--~~~ 728 (796)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...........+........ . ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2334678899999887654 68899999999999999999999875543322111111000000 0 000
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........... ........+.+++.+||+.||++|||++++++.
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 238 FPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 011122456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.06 Aligned_cols=244 Identities=25% Similarity=0.308 Sum_probs=194.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+...+.||+|+||.||+|... .+++.||+|.+... ......++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 455678999999999999875 36789999988542 22344678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|++ |+|.+++.. ...+++..+..++.||+.||.|||+. +|+|+||+|+||++++++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 997 567666653 45689999999999999999999998 8999999999999999999999999998764322
Q ss_pred ceeeccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 660 THTMIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+...........+ .......
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~----- 233 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNDSPT----- 233 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH--------hcCCCCC-----
Confidence 2235788999999884 456889999999999999999999998754433221111 0000000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.........+.+++.+||+.+|++||++.+|+++
T Consensus 234 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 ---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0112234567889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=291.88 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=201.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.+.||.|+||+||+|.... ++..+++|++.... ......+.+|++.++.++|+|++++++.+..+...++++|+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 455789999999999998653 67899999986432 2345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC---CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-
Q 044281 584 NGTLANLIFAI---PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR- 659 (796)
Q Consensus 584 ~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~- 659 (796)
+++|.+++... ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..+......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999764 4588999999999999999999998 8999999999999999999999999999876543322
Q ss_pred --ceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 660 --THTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
......++..|+|||.+... .++.++|||||||++|||++|+.||............ . ..... .....
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~---~-----~~~~~-~~~~~ 230 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT---L-----QNDPP-SLETG 230 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH---h-----cCCCC-CcCCc
Confidence 22334588999999999877 7899999999999999999999999754332211110 0 00000 00000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.........+.+++.+||+.||++||++.++++.
T Consensus 231 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 231 ---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ---cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011234567789999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.81 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=207.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
|.+.+.||+|.|..|-++++- -+|+.||||++.+..- -....+.+|++.|+.++|||||+|+.+......+|||+|.
T Consensus 20 YDLekTlG~GHFAVVKLArHV-FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhh-cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 446678999999999988754 5799999999976433 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc-CCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~ 659 (796)
-.+|+|.++|.++ ..+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- +-|-+||.|||++-.+...+
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-- 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-- 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence 9999999998765 5688999999999999999999998 799999999999875 56889999999998765433
Q ss_pred ceeeccCCCcccccccccCCCCC-ccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVS-AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
..+..+|+..|.|||++.+..|+ +++|||||||+||-|++|+.||+.....+....|.+-.+
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY----------------- 236 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY----------------- 236 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-----------------
Confidence 34567899999999999999886 578999999999999999999987666554444432211
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.....++.+++..||+.||.+|.+.+||+..
T Consensus 237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2234455678889999999999999999998764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.59 Aligned_cols=248 Identities=27% Similarity=0.378 Sum_probs=201.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||.||+|..+. +++.+++|.+..... ....+.+|++.+++++|+|++++++.+......++++||+++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred hHhHhccCCCCeEEEEEEEcc-CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 355789999999999998763 578999999976443 567789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++........ ....
T Consensus 100 ~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~ 175 (286)
T cd06614 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNS 175 (286)
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcc
Confidence 99999998876 889999999999999999999997 999999999999999999999999999876543222 1223
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+. ......... ..
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~-------~~ 240 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT--------TKGIPPLKN-------PE 240 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hcCCCCCcc-------hh
Confidence 347889999999998899999999999999999999999987554332211110 111111000 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+.+++.+|++.+|.+||++.+|++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 123457789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=298.22 Aligned_cols=247 Identities=23% Similarity=0.265 Sum_probs=197.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||.||++.... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+......++||||+
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EeeeecCCccEEEEEEEEcC-CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 44679999999999998763 678999999965332 24467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR- 659 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~- 659 (796)
.+++|.+++... ..+++..+..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999998754 4678899999999999999999998 8999999999999999999999999998754322110
Q ss_pred ---------------------------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH
Q 044281 660 ---------------------------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES 712 (796)
Q Consensus 660 ---------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~ 712 (796)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 01123578899999999999999999999999999999999999975544322
Q ss_pred hHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 044281 713 RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT----MKVVLQ 772 (796)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt----~~evl~ 772 (796)
...+ ...... ..........+.+++.+||+.||++||+ +.++++
T Consensus 241 ~~~~--------~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 FSNI--------LKKEVT--------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHH--------hcCCcc--------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111 011100 0001113456788999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.19 Aligned_cols=254 Identities=25% Similarity=0.303 Sum_probs=198.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+...+.||+|+||.||+++.. .++..||+|++... .......+.+|++++++++|+|++++++++.++...++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 445678999999999999865 36789999998642 22334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+++ +|.+++.. ...+++..+..++.||+.||.|||+. +|+|+||+|+||++++++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 9975 77776654 45688999999999999999999998 899999999999999999999999999875432
Q ss_pred ceeeccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 660 THTMIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.....+++.|+|||++. .+.++.++|||||||++|||++|+.|+...........+ . ..+. ..
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~----~~~~-~~----- 243 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---A----QNES-PT----- 243 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---H----hccC-CC-----
Confidence 12335788999999974 457899999999999999999999998654332211111 0 0000 00
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~p 783 (796)
.........+.+++.+||+.+|.+||++.+|++.+-.....+.+
T Consensus 244 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 244 ---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred ---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 00112334577899999999999999999999876554444333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=319.78 Aligned_cols=198 Identities=19% Similarity=0.305 Sum_probs=158.1
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEe--------------c---chhhhhHHHHHHHHHHhcccCccCcccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKL--------------D---RLAQEREREFKSEVSAIGRTHHKHLVQL 565 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l--------------~---~~~~~~~~~~~~E~~~l~~l~h~niv~l 565 (796)
.+.+.++||+|+||+||++..+..++...+.|.+ . .........+.+|+.++++++|+||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 4556678999999999998876444433333311 0 0111234568899999999999999999
Q ss_pred cccccccccceeEEeecCCCCHHHHHhcC-----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC
Q 044281 566 LGFCDEALNRLLVYEFMGNGTLANLIFAI-----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF 640 (796)
Q Consensus 566 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~ 640 (796)
++++......++|+|++. ++|.+++... ..........++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 229 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 229 EEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304 (501)
T ss_pred eEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 999999999999999985 4676666432 2233556778999999999999998 899999999999999999
Q ss_pred cEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 044281 641 SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSV 704 (796)
Q Consensus 641 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~ 704 (796)
.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999876544333333456899999999999999999999999999999999988543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=288.90 Aligned_cols=245 Identities=26% Similarity=0.375 Sum_probs=197.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||.||++... .+++.+|+|.+... .......+.+|+.++++++|+|++++++.+......++||||++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred EEEEecccCceEEEEEEEc-CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 4567999999999999865 46789999998643 23345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC-CcEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF-FSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++|.+++... ..+++..+..++.|+++||+|||++ +++|+||+|+||+++++ +.+||+|||++....... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~ 157 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--K 157 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--c
Confidence 99999999764 3578899999999999999999998 99999999999999855 468999999998764322 1
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ..+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~------- 222 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI--------MSGTFAPIS------- 222 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH--------HhcCCCCCC-------
Confidence 22345788999999999988999999999999999999999998765433211111 111111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......+..++.+||+.+|++|||+.|+++.
T Consensus 223 --~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 --DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=296.26 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=199.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||++... .+++.|++|.+........+.+.+|+.++++++|||++++++.+......++|+||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 345578999999999999854 3578899999865444556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++........ ....
T Consensus 100 ~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~ 174 (293)
T cd06647 100 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (293)
T ss_pred CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cccc
Confidence 99999998753 577889999999999999999998 899999999999999999999999999876543322 2223
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..+++.|+|||.+.+..++.++||||||+++||+++|+.||...........+ ...+. .. .....
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~~~-~~-------~~~~~ 239 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGT-PE-------LQNPE 239 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcCCC-CC-------CCCcc
Confidence 45788999999999888999999999999999999999999755432211110 00000 00 00111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+.+++.+||+.+|++||++.+++.+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123456779999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=286.79 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=202.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
..+.||+|++|.||++..+. +++.+++|++..........+.+|+..+++++|+|++++++++......++++||++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeccCCceEEEEEEECC-CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 34679999999999998753 67899999997765556678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 586 TLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 586 sL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
+|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+........ ....
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~ 157 (253)
T cd05122 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM 157 (253)
T ss_pred cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence 999999876 5789999999999999999999997 899999999999999999999999999987654332 2344
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
.++..|+|||.+.+..++.++||||||++++||++|+.|+............. ......... ...
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~-------~~~ 222 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--------TNGPPGLRN-------PEK 222 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--------hcCCCCcCc-------ccc
Confidence 57889999999998889999999999999999999999987653322211110 001111111 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....+.+++.+||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 13567789999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=290.76 Aligned_cols=250 Identities=29% Similarity=0.390 Sum_probs=204.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.+.||+|++|.||+++.+. +++.|++|++..... .....+.+|+..+.+++|+|++++++++......++|+||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 345789999999999999764 688999999876443 446789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhh-cCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHE-ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++|.+++.....++...++.++.|+++||+|||+ . +++|+||+|+||++++++.++|+|||++.......... .
T Consensus 83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~ 158 (264)
T cd06623 83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-N 158 (264)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-c
Confidence 99999999887889999999999999999999999 7 89999999999999999999999999998764433222 2
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+............ .. ........ ..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~-~~~~~~~~---------~~ 224 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QA-ICDGPPPS---------LP 224 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HH-HhcCCCCC---------CC
Confidence 345788999999999999999999999999999999999998765321111111 01 01111110 01
Q ss_pred HH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 743 RS-RLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 743 ~~-~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.. ....+..++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 34577889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.49 Aligned_cols=246 Identities=25% Similarity=0.365 Sum_probs=198.6
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
..+||+|+||.||++..+ .+++.||+|++..........+.+|+.+++.++|+|++++++++...+..+++|||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEc-CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 367999999999999876 4688999999876555556779999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccC
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 666 (796)
|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....... .......+
T Consensus 104 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 178 (292)
T cd06657 104 LTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 178 (292)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence 9998754 4578899999999999999999998 89999999999999999999999999987654322 12233457
Q ss_pred CCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 044281 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRL 746 (796)
Q Consensus 667 t~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 746 (796)
++.|+|||.+.+..++.++||||||+++|||++|..|+......+....+.. . ....+.. .....
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~--------~-~~~~~~~------~~~~~ 243 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--------N-LPPKLKN------LHKVS 243 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------h-CCcccCC------cccCC
Confidence 8999999999888899999999999999999999999875543322211110 0 0000000 01112
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 747 HKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 747 ~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.+++.+||+.+|.+||++.++++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 345678899999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=291.88 Aligned_cols=243 Identities=27% Similarity=0.302 Sum_probs=198.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
..++||+||||.||-.+.+ .+|+.+|.|++.+... +++.-.++|-.+|.+++.+.||.+-..++..+.+++|+..|
T Consensus 189 ~~RvlGkGGFGEV~acqvr-aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVR-ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred eeEEEecccccceeEEEEe-cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 3468999999999988866 5899999999976433 34456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
.||+|.-+|.+.. .++++.+.-++.+|+.||++||.. +||.|||||+|||||+.|+++|+|+|||..+...+.
T Consensus 268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-- 342 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-- 342 (591)
T ss_pred cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc--
Confidence 9999999998765 789999999999999999999998 899999999999999999999999999997755443
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+||.+|||||++.+..|+...|.||+||+||||+.|+.||...........+. +...+ + ...
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd----rr~~~-------~---~~e 408 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD----RRTLE-------D---PEE 408 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH----HHHhc-------c---hhh
Confidence 333479999999999999999999999999999999999999997654332221111 11111 0 112
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMK 768 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 768 (796)
.+....++...+....|++||++|---.
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCC
Confidence 2334445556677778899999986443
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=293.94 Aligned_cols=247 Identities=27% Similarity=0.353 Sum_probs=192.3
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCccccccccccc-----ccceeEE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEA-----LNRLLVY 579 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~lv~ 579 (796)
+.+.||+|+||.||++..+ .+++.+|+|.+.... .....+.+|+.+++++ +|+|++++++++... ...++|+
T Consensus 26 ~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred EEEEeecCCCeEEEEEEEC-CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 4467999999999999865 468899999986532 2345678899999988 899999999998654 3579999
Q ss_pred eecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 580 EFMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 580 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 99999999998863 35678999999999999999999998 899999999999999999999999999986543
Q ss_pred CCCcceeeccCCCcccccccccCC-----CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNV-----PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
.... .....++..|+|||.+... .++.++|||||||++|||++|+.|+...........+ ..+...
T Consensus 181 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~--------~~~~~~ 251 (291)
T cd06639 181 TRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI--------PRNPPP 251 (291)
T ss_pred cccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH--------hcCCCC
Confidence 2221 1234578899999998643 3688999999999999999999998754332211111 111111
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+.+ .......+.+++.+||+.+|++||++.++++.
T Consensus 252 ~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 252 TLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 11223457889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=287.88 Aligned_cols=243 Identities=24% Similarity=0.272 Sum_probs=195.9
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
||.|+||.||+++.. .+++.+++|.+.... ....+.+.+|+.++++++|+||+++++.+.++...++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999975 357899999986532 2344679999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccC
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 666 (796)
|.+++.....+++..+..++.||++||+|||+. +++|+||+|+||+++.++.+||+|||+++...... ......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 999998877889999999999999999999998 89999999999999999999999999998764332 1223457
Q ss_pred CCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 044281 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRL 746 (796)
Q Consensus 667 t~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 746 (796)
+..|+|||.+.+..++.++|+||||+++|||++|..|+.....+... .. .....+... ...+....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~-----~~~~~~~~~--------~~~~~~~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-IY-----NDILKGNGK--------LEFPNYID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-HH-----HHHhccCCC--------CCCCcccC
Confidence 88999999998888999999999999999999999999765421110 00 000100000 00111114
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 044281 747 HKWLMIAMWCIQEDPSKRPT-----MKVVLQ 772 (796)
Q Consensus 747 ~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 772 (796)
..+..++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 56788999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=290.62 Aligned_cols=245 Identities=26% Similarity=0.279 Sum_probs=199.3
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||.||++..+ .+++.+|+|.+.... ....+.+.+|++.+++++||||+++++++.++...++|+||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred EEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 4568999999999999865 467899999997532 234578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
.+++|.+++.....+++..+..++.||++||.|||+. +++|+||+|+||++++++.++|+|||++....... ...
T Consensus 83 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~ 157 (258)
T cd05578 83 LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTT 157 (258)
T ss_pred CCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--ccc
Confidence 9999999998877889999999999999999999998 89999999999999999999999999998764332 223
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+............ ....... ...+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~----------~~~~ 222 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-----AKQETAD----------VLYP 222 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-----HHhcccc----------ccCc
Confidence 345788999999999888999999999999999999999999865432111111 0000000 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTM--KVVL 771 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~--~evl 771 (796)
......+.+++.+||+.||.+||++ +|++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1223567789999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.73 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=192.9
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccc------cccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDE------ALNR 575 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~ 575 (796)
.+.+.+.||+|+||.||+|... .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. ....
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 3445678999999999999976 467899999986543 3345788899999988 79999999999853 4567
Q ss_pred eeEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccc
Q 044281 576 LLVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 653 (796)
+++|||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||+|+||++++++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 9999999999999998754 3577888899999999999999998 8999999999999999999999999998865
Q ss_pred cCCCCcceeeccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
..... ......++..|+|||.+. ...++.++|||||||++|||++|+.||...........+ ....
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~--------~~~~ 242 (282)
T cd06636 172 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNP 242 (282)
T ss_pred hcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH--------hhCC
Confidence 32211 223345888999999986 356788999999999999999999999654332211110 0000
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
. ...........+.+++.+||+.||.+||++.|+++
T Consensus 243 ~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 P--------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C--------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00001123346788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.36 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=192.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHh-cccCccCcccccccccccccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAI-GRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.||+|+||.||+|... .+++.||+|.+.... ......+..|..++ ...+|+|++++++++...+..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 46899999999999875 467899999986532 12233445555444 45589999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|.+++.....+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+++.... ...
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 999999998878889999999999999999999998 899999999999999999999999999875432 223
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..++..|+|||.+.+..++.++||||||+++|||++|..||...........+ ..+.... .. ....
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~--~~----~~~~ 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--------LSRRINW--PE----EVKE 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhcccCC--CC----cccc
Confidence 35788999999999888999999999999999999999999765443221111 1111100 00 0011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
.....+..++.+||+.+|++||++.++.+.|+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 22356788999999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=295.34 Aligned_cols=263 Identities=21% Similarity=0.263 Sum_probs=194.0
Q ss_pred HHhhCCC--ccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 507 KEELGRG--SFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 507 ~~~LG~G--~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.++||+| +||+||++... .+++.||+|.+... .....+.+.+|+.+++.++|+||+++++++..+...++|+||+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHT-PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEc-CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 3567777 89999999864 46899999998642 2334578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
.+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999998764 3578888899999999999999998 89999999999999999999999998654432211110
Q ss_pred ------eeeccCCCcccccccccCC--CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHH------------
Q 044281 661 ------HTMIRGTRGYVAPEWFKNV--PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA------------ 720 (796)
Q Consensus 661 ------~~~~~gt~~y~aPE~~~~~--~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~------------ 720 (796)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0112245679999999764 47899999999999999999999997654322111000000
Q ss_pred -HHh-------hh---------cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 721 -YDC-------YV---------EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 721 -~~~-------~~---------~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
... +. .+....+.+..............+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00 000000111111112223455678899999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.50 Aligned_cols=249 Identities=28% Similarity=0.375 Sum_probs=195.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccc------cce
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEAL------NRL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------~~~ 576 (796)
+.+.+.||+|+||.||+|..+. +++.+++|.+..... ....+.+|+.+++++ +|+||+++++++.... ..+
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKK-TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred eeheeeecCCCCeEEEEEEECC-CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 4456789999999999998763 578999999875433 346799999999998 7999999999996644 479
Q ss_pred eEEeecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 577 LVYEFMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
+||||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 99999999999998865 34788999999999999999999998 899999999999999999999999999876
Q ss_pred ccCCCCcceeeccCCCcccccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
...... ......++..|+|||.+.. ..++.++|||||||+++||++|+.||........... ...+
T Consensus 163 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~ 233 (275)
T cd06608 163 LDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK--------IPRN 233 (275)
T ss_pred cccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH--------hhcc
Confidence 533221 2223457889999998753 3467899999999999999999999975432221111 0111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....+ .........+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 PPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 1112244567889999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.00 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=197.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||.||+|..+. ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred EEEEecCCCcceEEEEEEcC-CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 45679999999999999764 67889999986532 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~ 660 (796)
+++|.+++.... .+++..+..++.|+++||.|||+. +++|+||||+||++++++ .+||+|||.+........ .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-L 158 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-c
Confidence 999999987643 478999999999999999999998 899999999999999885 469999999987643222 2
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....|++.|+|||.+.+..++.++||||||++++||++|..|+.......... .. ..+.....
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------~~-~~~~~~~~-------- 222 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL-------KI-CQGYFAPI-------- 222 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-------HH-hcccCCCC--------
Confidence 223458889999999998889999999999999999999999987543322111 11 11111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+|++.+|++|||+.++++.
T Consensus 223 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.09 Aligned_cols=260 Identities=23% Similarity=0.249 Sum_probs=192.5
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccC-ccCccccccccccc--ccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKHLVQLLGFCDEA--LNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~e~ 581 (796)
+.++||+|+||.||+|..+ .+++.||+|+++... ........+|+..+.++. |+|++++++++.+. ...++|+||
T Consensus 3 ~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred eEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4567999999999999875 467899999986532 222334567888888885 99999999999877 888999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++ ++|.+.+... ..+++..+..++.||+.||+|||+. +++|+||+|+||++++ +.+||+|||+++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 97 4777777653 5689999999999999999999998 8999999999999999 9999999999987643322
Q ss_pred eeeccCCCccccccccc-CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHH-------HHhhhcCcccee
Q 044281 661 HTMIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEGRLDVL 732 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~~~ 732 (796)
.....++..|+|||.+. +..++.++|||||||++|||++|..||......+....+.... ............
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 22345788999999765 4567899999999999999999999997654433221111100 000000000000
Q ss_pred ccchh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 733 IDSDE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 733 ~d~~~----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.. ...........+.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 000112335778899999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=290.01 Aligned_cols=253 Identities=28% Similarity=0.350 Sum_probs=195.3
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccc--ccceeEEeecC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLVYEFMG 583 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~~~ 583 (796)
.+.||.|++|.||++..+. +++.+|+|.+.... ......+.+|++++++++|+||+++++++... ...++||||++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEeccCCceEEEEEEECC-CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 4679999999999999764 67899999987532 24457799999999999999999999988543 46799999999
Q ss_pred CCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 584 NGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 584 ~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++|.+++.. ...++......++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 9999888653 34578889999999999999999998 899999999999999999999999999876532221
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHH-HhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .......+. .......+.+..
T Consensus 161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~-- 232 (287)
T cd06621 161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELKDEP-- 232 (287)
T ss_pred --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----hcCCchhhccCC--
Confidence 23346788999999999999999999999999999999999997552200 000011111 111111111110
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+.+++.+||+.+|++|||+.||++.
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0011234567889999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=294.52 Aligned_cols=261 Identities=21% Similarity=0.258 Sum_probs=191.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.+.||+|++|.||+|..+ .+++.||+|.+..... .....+.+|++++++++|+||+++++++.+....++||||+++
T Consensus 9 ~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence 4568999999999999865 4678999999865322 2234577899999999999999999999999999999999985
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|.+++... ..+++.....++.||++||.|||+. +|+|+||||+||++++++.+||+|||+++...... .....
T Consensus 88 -~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (291)
T cd07844 88 -DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSN 162 (291)
T ss_pred -CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-ccccc
Confidence 898888654 4678899999999999999999998 89999999999999999999999999987542211 11122
Q ss_pred ccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhH-HHHhHHHHHHHHH----hhhc-----Ccccee
Q 044281 664 IRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELE-EESRAILTDWAYD----CYVE-----GRLDVL 732 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~-~~~~~~l~~~~~~----~~~~-----~~~~~~ 732 (796)
..++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..... .+....+...... .+.. ......
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 346788999999875 4589999999999999999999999865431 1111111000000 0000 000000
Q ss_pred ---cc-chhh-hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 733 ---ID-SDEA-AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 733 ---~d-~~~~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.. .... ..........+.+++.+|++.+|++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000 0001111256678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=293.00 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=195.9
Q ss_pred HHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecc--hhhhhHHHHHHHHHHhccc-CccCcccccccccccccc
Q 044281 499 LKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 499 l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 575 (796)
++...+...++||.||.+.||++.-. +.+.+|+|++.. ...+....|.+|+..|.++ .|.+||+|++|-..++.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s--~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNS--DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecC--CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 34445667789999999999998743 557888888754 3445567899999999999 599999999999999999
Q ss_pred eeEEeecCCCCHHHHHhcCCC--CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccc
Q 044281 576 LLVYEFMGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 653 (796)
||||||-+ -+|..+|.+... +.| .+..+..|++.|+.++|++ +|||.||||.|+|+-. |.+||+|||+|..+
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 99999864 599999987643 234 6778899999999999999 9999999999999876 79999999999988
Q ss_pred cCCCCcc-eeeccCCCcccccccccCC-----------CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH
Q 044281 654 FSDQSRT-HTMIRGTRGYVAPEWFKNV-----------PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY 721 (796)
Q Consensus 654 ~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 721 (796)
..+.... ....+||+.||+||.+... +.+.++||||+||+||+|+.|+.||..-...- +
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--------a- 580 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--------A- 580 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH--------H-
Confidence 7666433 3467899999999998532 25679999999999999999999996432111 1
Q ss_pred HhhhcCccceeccchhhhh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 722 DCYVEGRLDVLIDSDEAAM-ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 722 ~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
++..+.++.-..+ .....-.++++++..||+.||.+|||+.++++.
T Consensus 581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1122222211100 011111238899999999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.26 Aligned_cols=243 Identities=22% Similarity=0.250 Sum_probs=187.7
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHh---cccCccCcccccccccccccceeEEeec
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAI---GRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.||+|+||.||++... .+++.+|+|.+.... ......+.+|..++ ...+|+|++.+.+.+...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4899999999999865 468899999886432 11223344444333 3447999999999999989999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++....... ..
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 9999999998888899999999999999999999998 89999999999999999999999999997553222 12
Q ss_pred eccCCCccccccccc-CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...|+..|+|||.+. +..++.++|||||||++|||++|..||......... .+.... ... . ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~----~~~------~----~~~ 218 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT----LTV------N----VEL 218 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh----hcC------C----cCC
Confidence 245899999999986 456899999999999999999999999643221111 010000 000 0 001
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
+.....++.+++.+||+.||++|| ++++++++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 122345677899999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=300.46 Aligned_cols=267 Identities=24% Similarity=0.300 Sum_probs=195.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccc-----ccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA-----LNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv 578 (796)
.+.+.||+|+||.||+|+.. .+++.||+|.++... ......+.+|+.++++++|+||+++++++... ...+++
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred EEEEEEEecCCeEEEEEEEc-CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 34578999999999999865 468899999986432 23346688899999999999999999986543 357899
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
+||+++ +|..++.. ..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 87 QELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred ehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 999975 88777754 4688899999999999999999998 899999999999999999999999999986543222
Q ss_pred c--ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc-
Q 044281 659 R--THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID- 734 (796)
Q Consensus 659 ~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d- 734 (796)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+........ ......+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS-QEDLNCIISL 240 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-HHHHHHhhch
Confidence 1 1223467899999998754 5689999999999999999999999965432221111110000000 000000000
Q ss_pred ----------chh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcCc
Q 044281 735 ----------SDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGLL 778 (796)
Q Consensus 735 ----------~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~~ 778 (796)
... ..........++.+++.+||+.+|++|||+.++++. ++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000 000011224567889999999999999999999987 65543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.79 Aligned_cols=243 Identities=28% Similarity=0.356 Sum_probs=192.2
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
||+|+||+||++..+ .+++.+|+|.+.... ......+.+|++++++++||||+++++.+......++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999865 468899999986532 2234567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 587 LANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 587 L~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++...... ......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGR 154 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccccc
Confidence 999997655 688999999999999999999998 8999999999999999999999999999865432 122234
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
.++..|+|||.+.+..++.++||||||+++++|++|+.||...........+.. ..... ....+..
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~------~~~~~~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------RTLEM------AVEYPDK 220 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--------ccccc------cccCCcc
Confidence 577899999999988899999999999999999999999965432111111100 00000 0001112
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRP-----TMKVVLQ 772 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 772 (796)
....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 244567899999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.32 Aligned_cols=258 Identities=17% Similarity=0.176 Sum_probs=183.2
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCC--CeEEEEEEecchhhhh-----------HHHHHHHHHHhcccCccCcccccccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRLAQER-----------EREFKSEVSAIGRTHHKHLVQLLGFC 569 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~~ 569 (796)
.+.+.+.||+|+||.||+|...... +..+++|......... ......+...+..++|+|++++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 3456688999999999999875321 3456666542211110 11233445566778999999999876
Q ss_pred cccc----cceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEe
Q 044281 570 DEAL----NRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKIS 645 (796)
Q Consensus 570 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 645 (796)
.... ..++++|+... ++.+.+......++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred eEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEE
Confidence 5443 23577776643 6666666555567888899999999999999998 89999999999999999999999
Q ss_pred ecCCcccccCCCC------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHH-HhHHHHH
Q 044281 646 DFGLSKLLFSDQS------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTD 718 (796)
Q Consensus 646 DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~-~~~~l~~ 718 (796)
|||+++.+..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||....... .......
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 9999987643221 11123469999999999999999999999999999999999999997653211 1111100
Q ss_pred HHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 719 WAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
........+... .......+.+++..|++.+|++||++.++++.|+
T Consensus 249 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 249 DFIKRLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 011111111110 0111355778999999999999999999999873
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=294.95 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=196.8
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhccc-CccCccccccccccc--ccce
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEA--LNRL 576 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~ 576 (796)
..+.+.+.||+|+||.||+|... .+++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 34566789999999999999875 45789999988542 223345677899999999 999999999988643 4579
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||++ ++|..++... .+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||+++.....
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5998888765 778899999999999999999998 9999999999999999999999999999876443
Q ss_pred CC----cceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hh
Q 044281 657 QS----RTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CY 724 (796)
Q Consensus 657 ~~----~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~ 724 (796)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...... .+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 32 12233458899999998865 56789999999999999999999998654433222111111000 00
Q ss_pred hcCccceeccc----hh--hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 725 VEGRLDVLIDS----DE--AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 725 ~~~~~~~~~d~----~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+++. .. ...........+.+++.+||+.||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000 00 000011134567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=284.21 Aligned_cols=244 Identities=27% Similarity=0.338 Sum_probs=200.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.++||+|+||.||++..+ .+++.+++|.+.... .....++.+|++++++++|+||+++++++.+....++|+||++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred EeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 4578999999999999865 467899999986532 2335678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 584 NGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 584 ~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999998866 35678899999999999999999998 8999999999999999999999999999876543
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......+....+ ..+....+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~------- 221 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV--------QRGKYPPI------- 221 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hcCCCCCC-------
Confidence 222345788999999999999999999999999999999999999765443221111 11111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+..++.+|++.+|++||++.++++.
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 --PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12334567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.42 Aligned_cols=260 Identities=23% Similarity=0.264 Sum_probs=193.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccc------ccce
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA------LNRL 576 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 576 (796)
...+.||+|+||.||++... .+++.||+|.+... .......+.+|+.++++++|+||+++++++... ...+
T Consensus 19 ~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 19 QNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred EEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 34577999999999999865 46889999998642 223345678899999999999999999987543 3468
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||+.+ +|.+.+... ++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 98 LVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred EEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 99999964 888877644 78888999999999999999998 8999999999999999999999999999865432
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH---------------HH
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW---------------AY 721 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~---------------~~ 721 (796)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ..
T Consensus 172 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 172 FM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 21 22345788999999999999999999999999999999999999754332211111000 00
Q ss_pred HhhhcCc------cceeccch----hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 722 DCYVEGR------LDVLIDSD----EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 722 ~~~~~~~------~~~~~d~~----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....... ...+.... ............+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00000000 0000011234567889999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=275.32 Aligned_cols=278 Identities=22% Similarity=0.258 Sum_probs=198.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCC---eEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccc-cccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDE-ALNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~---~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv 578 (796)
+...+||+|.||.|||++-+..++ +.+|+|+++.... ..-....+|+.+++.++|+||+.+..++.. +...+|+
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 345679999999999996543332 3789999975322 112456889999999999999999999877 7788999
Q ss_pred EeecCCCCHHHHHhcC-----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC----CcEEEeecCC
Q 044281 579 YEFMGNGTLANLIFAI-----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF----FSAKISDFGL 649 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~kl~DfGl 649 (796)
+||.+. +|.++|+.+ ..++-.....|..||+.|+.|||++ -|+||||||.||||..+ |.+||+|+|+
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999987 888888643 3567788899999999999999999 89999999999999877 9999999999
Q ss_pred cccccCCCC--cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHH---------hHHHH
Q 044281 650 SKLLFSDQS--RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEES---------RAILT 717 (796)
Q Consensus 650 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~---------~~~l~ 717 (796)
++++...-. .....++-|..|.|||.+.+. .||.+.||||.||++.||++.++.|........ ...+.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 998865432 234567789999999999875 589999999999999999998877754322111 01111
Q ss_pred HHHHHhhhcCcccee---ccc------hhhhhhc----HH-------HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 718 DWAYDCYVEGRLDVL---IDS------DEAAMAD----RS-------RLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~---~d~------~~~~~~~----~~-------~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
+..- ...+...+.+ .+- ....... .. .....++++..+|+.||.+|.|+++.++.. -.
T Consensus 263 ~vLG-~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF 340 (438)
T KOG0666|consen 263 EVLG-TPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-YF 340 (438)
T ss_pred HHcC-CCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-cc
Confidence 1000 0000000000 000 0000000 00 011256788999999999999999988764 23
Q ss_pred cCCCCCCCCCc
Q 044281 778 LDVPNPPGPSS 788 (796)
Q Consensus 778 ~~~~~pp~p~~ 788 (796)
.+.+.||.|.+
T Consensus 341 ~~d~lpp~pt~ 351 (438)
T KOG0666|consen 341 TEDPLPPLPTS 351 (438)
T ss_pred ccCCCCCCccc
Confidence 34556777765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=280.04 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=203.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCC----CeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCccccccccccc-ccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTAS----GTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEA-LNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv 578 (796)
.....+-+|.||.||+|+++..+ .+.|.+|.++....+ ....++.|...+..+.|||+..+.+++.+. ...+++
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 34467899999999999876432 356778887654333 346789999999999999999999998654 566899
Q ss_pred EeecCCCCHHHHHhcC--------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCc
Q 044281 579 YEFMGNGTLANLIFAI--------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS 650 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 650 (796)
|.++.-|+|..+|... +.+...+...++.|++.|++|||++ +|||.||.++|+++|+..++||+|-.++
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhc
Confidence 9999999999999721 2455667788999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 651 KLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 651 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
|.+.+.+... .+....+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.|....+ ++|.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl--------kdGy 515 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL--------KDGY 515 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--------hccc
Confidence 9876554332 234456789999999999999999999999999999998 77788766666644433 2332
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
. -..+.++.+++..++..||..+|++||++++++.-|.+
T Consensus 516 R---------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 516 R---------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred e---------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1 11244566788999999999999999999999998865
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.16 Aligned_cols=266 Identities=22% Similarity=0.269 Sum_probs=198.9
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccc-----cccee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA-----LNRLL 577 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 577 (796)
...+.||+|+||.||++... .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ...++
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eEEEEeccCCCeEEEEEEec-CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 34467999999999999865 57889999998653 222345677899999999999999999988654 34799
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
++||+. ++|.+++.....+++.....++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 87 v~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 999996 68999988878899999999999999999999998 89999999999999999999999999998654332
Q ss_pred CcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hhhcCcc
Q 044281 658 SRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVEGRL 729 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~~~~ 729 (796)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.||...........+...... .......
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 12233457889999998865 56899999999999999999999999755432222211111000 0000000
Q ss_pred c-------eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcC
Q 044281 730 D-------VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGL 777 (796)
Q Consensus 730 ~-------~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~ 777 (796)
. ...+.... ........++.+++.+||+.+|++|||++++++. ++.+
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00000000 0111234567889999999999999999999987 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=297.00 Aligned_cols=268 Identities=23% Similarity=0.289 Sum_probs=204.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccc-----ccee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL-----NRLL 577 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 577 (796)
.+.+.||+|+||.||+++.. .+++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..++
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred eeeeeecCCCCeEEEEEEeC-CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 35578999999999999865 457899999987643 334567899999999999999999999998775 7899
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
+|||++ ++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||++++++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 999998 48999988877899999999999999999999998 89999999999999999999999999998765433
Q ss_pred C--cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhh-------hcC
Q 044281 658 S--RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCY-------VEG 727 (796)
Q Consensus 658 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~-------~~~ 727 (796)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+........ ...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1 122334578899999999888 889999999999999999999999976654433222211110000 000
Q ss_pred ccceeccc---h---hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcC
Q 044281 728 RLDVLIDS---D---EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGL 777 (796)
Q Consensus 728 ~~~~~~d~---~---~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~ 777 (796)
.....+.. . ............+.+++.+||+.+|++||++.++++. +++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00000000 0 0000011134567889999999999999999999985 5543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=291.74 Aligned_cols=265 Identities=23% Similarity=0.263 Sum_probs=196.0
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccc-------
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------- 573 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 573 (796)
.+.+.+.||+|+||.||+|..+. +++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKD-TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhheeeeecccCCEEEEEEEECC-CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 34456789999999999999763 67899999986532 223356788999999999999999999887654
Q ss_pred ---cceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCC
Q 044281 574 ---NRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649 (796)
Q Consensus 574 ---~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 649 (796)
..++|+||+++ ++..++... ..+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999986 666666553 4689999999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 650 SKLLFSDQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 650 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
+...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+....+.......... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 241 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA-V 241 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh-h
Confidence 98765443333333346778999998865 457899999999999999999999997654433222222211110000 0
Q ss_pred ccee--------ccchhh-----hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVL--------IDSDEA-----AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~--------~d~~~~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...+ .+.... ..........+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 000000 00000123567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.03 Aligned_cols=258 Identities=22% Similarity=0.248 Sum_probs=189.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.+.||+|+||.||+|... .+++.|++|.+..... .....+.+|+.+++.++|+||+++.+++..+...++|+||+.
T Consensus 9 ~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07870 9 NLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH- 86 (291)
T ss_pred EEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence 4568999999999999865 3578999999865332 223467889999999999999999999999999999999996
Q ss_pred CCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++|.+.+.. ...+.+..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||+++....... ....
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~ 162 (291)
T cd07870 87 TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSS 162 (291)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CCCC
Confidence 577666554 34577888889999999999999998 899999999999999999999999999976432221 1223
Q ss_pred ccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhh-------------cCcc
Q 044281 664 IRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYV-------------EGRL 729 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~-------------~~~~ 729 (796)
..++..|+|||.+.+. .++.++|||||||++|||++|+.||........ .+.. ...... ....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEK-IWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHH-HHHHcCCCChhhhhhhhhccccc
Confidence 3468899999998764 578899999999999999999999975433211 1100 000000 0000
Q ss_pred ceeccc----hhhh-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 730 DVLIDS----DEAA-MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 730 ~~~~d~----~~~~-~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
...... .... .........+.+++.+|++.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 0000 000111345667899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=296.43 Aligned_cols=264 Identities=20% Similarity=0.208 Sum_probs=197.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhh--------------HHHHHHHHHHhcccCccCcccccccccc
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER--------------EREFKSEVSAIGRTHHKHLVQLLGFCDE 571 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g~~~~ 571 (796)
+.+.||+|+||+||+|..+ .+++.||||.+....... ...+.+|++++++++|+||+++++++..
T Consensus 13 ~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 3467999999999999865 467899999986432211 1257889999999999999999999999
Q ss_pred cccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 572 ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 572 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
....++||||+. ++|.+++.....+++.....++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||+++
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcccee
Confidence 999999999997 59999998877889999999999999999999998 89999999999999999999999999998
Q ss_pred cccCCC-------------CcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHH
Q 044281 652 LLFSDQ-------------SRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILT 717 (796)
Q Consensus 652 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~ 717 (796)
...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 654111 1111223467889999998764 46899999999999999999999997665443322221
Q ss_pred HHHHHhhhc----C-ccc--eeccc---hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 718 DWAYDCYVE----G-RLD--VLIDS---DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 718 ~~~~~~~~~----~-~~~--~~~d~---~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
......... . ... ..... .............+.+++.+||+.+|++||++.|++..-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 111100000 0 000 00000 000000112245678899999999999999999999753
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=287.82 Aligned_cols=250 Identities=28% Similarity=0.397 Sum_probs=191.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
..++||+|+||.||++... .+++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||++
T Consensus 8 ~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 4578999999999999865 467899999986532 234567899999999996 9999999999999899999999986
Q ss_pred CCCHHHHH---h--cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 584 NGTLANLI---F--AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 584 ~gsL~~~l---~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
. ++.++. . ....+++.....++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4 554433 2 2356888999999999999999999742 799999999999999999999999999976543221
Q ss_pred cceeeccCCCcccccccccCC---CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 659 RTHTMIRGTRGYVAPEWFKNV---PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ..+ ... ..+....+.
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~----~~~-~~~~~~~~~-- 232 (288)
T cd06616 164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF--DQL----TQV-VKGDPPILS-- 232 (288)
T ss_pred --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH--HHH----hhh-cCCCCCcCC--
Confidence 1233578899999999776 68999999999999999999999986543110 000 010 011111110
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..........+.+++.+||+.+|++|||+.+|++.
T Consensus 233 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 ---NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112234567889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=291.29 Aligned_cols=263 Identities=25% Similarity=0.312 Sum_probs=192.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|++|.||+|..+ .+++.||+|++.... ......+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred EEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 34567999999999999875 367899999986432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC--CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccccCCCCc
Q 044281 583 GNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 583 ~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~ 659 (796)
+ ++|.+++..... .++.....++.||+.||+|||+. +++|+||+|+||++++ ++.+||+|||++....... .
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 6 578777765443 46778889999999999999998 8999999999999985 5679999999997653321 1
Q ss_pred ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC--ccceecc--
Q 044281 660 THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG--RLDVLID-- 734 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d-- 734 (796)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+........... ....+.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 1223346889999999876 4578999999999999999999999976543322211111000000000 0000000
Q ss_pred -------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 735 -------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 735 -------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.............++.+++.+|++.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000112234557889999999999999999999863
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=290.50 Aligned_cols=254 Identities=22% Similarity=0.251 Sum_probs=198.6
Q ss_pred HHHhhCCCccceEEEEEee--CCCCeEEEEEEecchhh----hhHHHHHHHHHHhccc-CccCcccccccccccccceeE
Q 044281 506 FKEELGRGSFGIVYKGVLK--TASGTAIAVKKLDRLAQ----EREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~--~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.||+|+||.||+++.. ..+++.||||.+..... .....+.+|++++.++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 4567999999999998754 23567899999865321 2335688999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++++|.+++.....+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999998777788999999999999999999997 899999999999999999999999999987654433
Q ss_pred cceeeccCCCcccccccccCCC--CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVP--VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.......++..|+|||.+.+.. .+.++||||||+++|||++|..|+...........+ ...... .. ..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~-~~------~~ 230 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI---SRRILK-SK------PP 230 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH---HHHHHc-cC------CC
Confidence 2233345888999999987765 788999999999999999999998543211111111 111000 00 00
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 231 ----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 ----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011122456678999999999999999999888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=290.25 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=187.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHH-hcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSA-IGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||.||+++.+ .+++.||+|+++... ......+..|+.. ++.++|+||+++++++..+...+++|||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred EEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 4567999999999999876 468999999986532 2334456666665 556789999999999999999999999997
Q ss_pred CCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 584 NGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 584 ~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
++|.+++.. ...+++..++.++.||+.||+|||++. +++||||||+||++++++.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 688777754 246789999999999999999999853 79999999999999999999999999998653221
Q ss_pred ceeeccCCCcccccccccC----CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 660 THTMIRGTRGYVAPEWFKN----VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
......++..|+|||.+.+ ..++.++|+|||||++|||++|+.|+....... ..+.. . ..+....+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~----~-~~~~~~~~~-- 229 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQ----V-VEEPSPQLP-- 229 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHH----H-HhcCCCCCC--
Confidence 1222457889999998865 456889999999999999999999986422110 00100 0 011111100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.......+.+++.+||+.+|++||++.++++
T Consensus 230 ------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 ------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112356778999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=286.38 Aligned_cols=261 Identities=26% Similarity=0.311 Sum_probs=195.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||+||+|+.. .+++.|+||++..... .......+|+..+++++ |+|++++++++..+...++||||+
T Consensus 3 ~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 4578999999999999975 3578999999865432 22334567899999998 999999999999999999999999
Q ss_pred CCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|.+++.... .+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC--Cc
Confidence 789998887654 789999999999999999999998 89999999999999999999999999998654322 22
Q ss_pred eeccCCCccccccccc-CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH---------HHHhhhcCccce
Q 044281 662 TMIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW---------AYDCYVEGRLDV 731 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~---------~~~~~~~~~~~~ 731 (796)
....++..|+|||.+. +..++.++|+||||++++||++|+.||......+........ ............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2345788999999885 456799999999999999999999988655433221111110 000000001110
Q ss_pred eccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 732 LIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 732 ~~d~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+.... ...........+.+++.+||+.+|++|||++|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 000011113568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=289.49 Aligned_cols=261 Identities=23% Similarity=0.279 Sum_probs=196.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.++||+|++|.||+|+.+ .+++.||||.++.... .....+.+|+.++++++|+||+++++++......++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred EeeeeccCCceEEEEEEEC-CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 4578999999999999975 4688999999865432 2345678899999999999999999999999999999999985
Q ss_pred CCHHHHHhcC---CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 585 GTLANLIFAI---PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 585 gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||+++...... ...
T Consensus 83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~ 157 (284)
T cd07836 83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTF 157 (284)
T ss_pred -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-ccc
Confidence 888887653 3578999999999999999999998 89999999999999999999999999997653322 122
Q ss_pred eeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hhhc-----Cc
Q 044281 662 TMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVE-----GR 728 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~-----~~ 728 (796)
....++..|++||.+.+. .++.++||||||+++|||++|+.||......+....+...... .+.. ..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 234468899999988664 5789999999999999999999999765443322222111100 0000 00
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+... ..........+.+++.+|++.||.+||++.++++.
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 238 FPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 00111224567789999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=287.01 Aligned_cols=261 Identities=25% Similarity=0.275 Sum_probs=199.3
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
..+.||+|++|.||++... .+++.+++|.+..... .....+.+|+.++++++|+||+++++++..+...++|+||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 3467999999999999865 4688999999865432 245678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+ +|.+++... ..+++..+..++.||++||.|||+. +|+|+||||+||++++++.+||+|||.+....... ....
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 156 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT 156 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence 5 888877663 5788999999999999999999998 89999999999999999999999999998765443 1222
Q ss_pred eccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc-------
Q 044281 663 MIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID------- 734 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d------- 734 (796)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+....... .........+
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP-DPEVWPKFTSLARNYKF 235 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-chHhcccchhhhhhhhh
Confidence 34577889999999876 78999999999999999999999986654332211111100000 0000000000
Q ss_pred ------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 735 ------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 735 ------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.............++.+++.+||+.||.+||++++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000011122345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=282.59 Aligned_cols=246 Identities=27% Similarity=0.398 Sum_probs=201.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|++|.||+++.+ .+++.|++|.+..... .....+.+|++++.+++|+|++++++++......+++|||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred eeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 34578999999999999865 4578999999976543 34568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++......... ..
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 9999999998888899999999999999999999998 8999999999999999999999999999876443321 23
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
...++..|+|||...+..++.++||||+|++++||++|+.|+............ ........ +
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~---------~ 220 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--------VQDDHPPL---------P 220 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--------hccCCCCC---------C
Confidence 345788999999998888999999999999999999999998754322111110 00111100 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
......+..++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112346678999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=294.98 Aligned_cols=264 Identities=21% Similarity=0.253 Sum_probs=193.4
Q ss_pred HHHhhCCCccceEEEEEeeCC-CCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCccccccccccc--ccceeEE
Q 044281 506 FKEELGRGSFGIVYKGVLKTA-SGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLVY 579 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 579 (796)
+.+.||+|+||.||+|..+.. +++.||+|.+.... ......+.+|+.++.+++||||+++++++... ...++||
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 456799999999999997642 57899999997632 33346778899999999999999999999887 7889999
Q ss_pred eecCCCCHHHHHhcC-----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC----CCcEEEeecCCc
Q 044281 580 EFMGNGTLANLIFAI-----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH----FFSAKISDFGLS 650 (796)
Q Consensus 580 e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~----~~~~kl~DfGla 650 (796)
||+++ +|.+++... ..++...+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99975 666665422 2578888999999999999999998 8999999999999999 999999999999
Q ss_pred ccccCCCC--cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHH------hHHHHHHHH
Q 044281 651 KLLFSDQS--RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEES------RAILTDWAY 721 (796)
Q Consensus 651 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~------~~~l~~~~~ 721 (796)
+....... .......++..|+|||.+.+. .++.++||||||++++||++|+.||........ ...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87643322 122334578899999988764 578999999999999999999999875432210 000000000
Q ss_pred Hh----------hhc---------Cccceecc-chhhhhhcH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 722 DC----------YVE---------GRLDVLID-SDEAAMADR--SRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 722 ~~----------~~~---------~~~~~~~d-~~~~~~~~~--~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.. ..+ ........ ......... ....++.+++.+|++.||++|||+.|++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 000 00000000 000010111 233568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=281.36 Aligned_cols=248 Identities=28% Similarity=0.383 Sum_probs=202.1
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCccccccccccc--ccceeEEeec
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLVYEFM 582 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~~ 582 (796)
.+.||+|++|.||+|..+. +++.|++|.+..... ...+.+.+|+..+++++|+||+++++.+... ...++++||+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 5 GELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeEeeecCceEEEEEEECC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 4679999999999998763 688999999865442 4567899999999999999999999999888 8889999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-ce
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-TH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~ 661 (796)
++++|.+++.....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||.+......... ..
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 84 SGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999998888899999999999999999999997 8999999999999999999999999999876544321 12
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....++..|+|||.+.+...+.++||||||+++++|++|+.|+........ . ............ .
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~~~---------~ 225 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--A----LYKIGSSGEPPE---------I 225 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--H----HHhccccCCCcC---------C
Confidence 334578899999999988899999999999999999999999976541110 0 111100011111 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11224567889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=289.02 Aligned_cols=262 Identities=23% Similarity=0.226 Sum_probs=191.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhccc-CccCccccccccccccc-----cee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRT-HHKHLVQLLGFCDEALN-----RLL 577 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~-----~~l 577 (796)
..+.||+|+||.||+|... .+++.||+|.++.... .....+.+|+.+++.+ +|+||+++++++..... .++
T Consensus 5 ~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred EeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 4567999999999999875 4688999998865322 2235788899999999 56999999999877665 799
Q ss_pred EEeecCCCCHHHHHhcC-----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcc
Q 044281 578 VYEFMGNGTLANLIFAI-----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSK 651 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~ 651 (796)
||||+++ +|.+++... ..+++..++.++.||++||.|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 9999986 788877542 3468999999999999999999998 8999999999999998 8999999999998
Q ss_pred cccCCCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC--c
Q 044281 652 LLFSDQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG--R 728 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~--~ 728 (796)
....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||...........+........... .
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 160 AFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred ecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 6533221 1122346788999998865 4579999999999999999999999876543322211111000000000 0
Q ss_pred ccee-----c---cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVL-----I---DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~-----~---d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.... . .+............++.+++.+||+.||.+||++.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0 0000000111234567889999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=285.27 Aligned_cols=243 Identities=22% Similarity=0.226 Sum_probs=187.9
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHH---HhcccCccCcccccccccccccceeEEeec
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVS---AIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.||+|+||.||++... .+++.||+|.+..... .....+..|.. .++...|+||+++++++......++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 4899999999999865 4678999999865321 12223344433 444467999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++....... ..
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 9999999998878899999999999999999999998 89999999999999999999999999997653222 12
Q ss_pred eccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............ ....... . ..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~------~----~~ 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----RMTLTMA------V----EL 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----HHhhccC------C----CC
Confidence 34589999999999754 6899999999999999999999999754221111000 0000000 0 00
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
+......+.+++.+|++.+|.+|| ++.++++.
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111235677899999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=282.27 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=195.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-----hhhhHHHHHHHHHHhcccCccCccccccccccc--cccee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLL 577 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 577 (796)
.+.+.||+|+||.||+|... .+++.|++|.+... ..+....+.+|++++++++|+||+++++++.+. ...++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 35678999999999999865 46889999987421 223446789999999999999999999988654 45789
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
++||+++++|.+++.....+++....+++.||+.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999999999998777788999999999999999999998 89999999999999999999999999998653221
Q ss_pred --CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 658 --SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 658 --~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
........++..|+|||.+.+..++.++|||||||+++||++|+.||.......... . ....+..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~----~~~~~~~------ 227 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF---K----IATQPTK------ 227 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH---H----HHcCCCC------
Confidence 111223458889999999999889999999999999999999999997543222111 1 0001100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
...+....+.+.+++.+|++ +|.+||+..+++.
T Consensus 228 ---~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 ---PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11122334567789999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=287.43 Aligned_cols=246 Identities=26% Similarity=0.333 Sum_probs=200.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.+.||+|+||.||++..+ .+++.|++|.+... .....+.+.+|+.++++++ |+||+++++++......++|||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred eEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 34567999999999999876 36889999998653 2234567889999999998 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC--
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-- 658 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-- 658 (796)
|+++++|.+++.....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999999888899999999999999999999998 899999999999999999999999999987643321
Q ss_pred -----------------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH
Q 044281 659 -----------------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY 721 (796)
Q Consensus 659 -----------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 721 (796)
.......++..|+|||.+.+..++.++||||||++++|+++|+.|+............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----- 234 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI----- 234 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-----
Confidence 1222345788999999999888999999999999999999999999765432211111
Q ss_pred HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 044281 722 DCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM----KVVLQ 772 (796)
Q Consensus 722 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~----~evl~ 772 (796)
..... ..+......+.+++.+||+.+|.+||++ +++++
T Consensus 235 ---~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 ---LKLEY----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HhcCC----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000 0111123567789999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=295.68 Aligned_cols=264 Identities=21% Similarity=0.278 Sum_probs=196.9
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccc----cccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDE----ALNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 578 (796)
.+.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++|+||+++++++.. ....++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 34578999999999999866 4688999999875322 334667889999999999999999998753 3457899
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+. ++|.+++.....+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 87 MDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred Eehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99996 58999998777799999999999999999999998 899999999999999999999999999986543322
Q ss_pred c---ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------HhhhcC
Q 044281 659 R---THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVEG 727 (796)
Q Consensus 659 ~---~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~~~ 727 (796)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..... ......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1 1123468889999999865 4689999999999999999999999976543221111111000 000000
Q ss_pred ccceeccchh------hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDE------AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+....+... ...........+..++.+||+.+|++||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 000011234678889999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=309.38 Aligned_cols=268 Identities=21% Similarity=0.240 Sum_probs=216.4
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
..+.+.++||+|+||.|..++++ .+++.+|+|++++... .....|..|-.+|..-+.+-|+++...|++...+|+|
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEee-ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 34556789999999999999987 4788999999987432 2346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||||+||+|..++.+..++++..+..++..|..||.-||+. |+|||||||+|||||..|++||+|||.+..+..+..
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 99999999999999888899999999999999999999998 999999999999999999999999999999988887
Q ss_pred cceeeccCCCccccccccc----C-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 659 RTHTMIRGTRGYVAPEWFK----N-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
......+|||.|++||++. + +.|...+|.||+||++|||+.|..||..+...+....|..+.... ...
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l-------~FP 303 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL-------SFP 303 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc-------CCC
Confidence 7777888999999999995 3 578999999999999999999999999887776655554431111 111
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHH-------HcCcCCCCCCCCCc
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT---MKVVLQML-------EGLLDVPNPPGPSS 788 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~evl~~L-------~~~~~~~~pp~p~~ 788 (796)
+ ...-+++...+++..+. +|+.|-. +.++-.+- +++.+..+|-.|..
T Consensus 304 ~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 304 D-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred c-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 0 11122334445555443 7888888 88876543 33444455555543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=288.34 Aligned_cols=251 Identities=24% Similarity=0.251 Sum_probs=195.7
Q ss_pred HHHhhCCCccceEEEEEeeC--CCCeEEEEEEecchhh----hhHHHHHHHHHHhccc-CccCcccccccccccccceeE
Q 044281 506 FKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLAQ----EREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.||+|+||.||++.... .+++.||+|.+..... ...+.+.+|++++.++ +|+||+++.+++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 45689999999999997642 3678999999865322 2346788899999999 699999999999998899999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++++|.+++.....+++.....++.||++||.|||+. +++||||+|+|||+++++.+||+|||+++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999998878888999999999999999999998 899999999999999999999999999987644433
Q ss_pred cceeeccCCCcccccccccCC--CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 RTHTMIRGTRGYVAPEWFKNV--PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+.. .......
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~~~-------- 229 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---RILKSEP-------- 229 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---HhhccCC--------
Confidence 333345688999999998753 468899999999999999999999864322111111111 1100000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
..+......+..++.+||+.||++|| +..++++.
T Consensus 230 ---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 ---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00111234567799999999999997 66776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=290.63 Aligned_cols=263 Identities=24% Similarity=0.262 Sum_probs=194.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCccccccccccc--ccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e 580 (796)
.+.+.||+|+||.||+|..+ .+++.||+|.++.... .....+.+|+.++++++|+||+++++++.+. ...++|||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 34567999999999999976 4688999999864322 2234567899999999999999999998654 45799999
Q ss_pred ecCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+.+ +|.+++.. ...+++..+..++.||++||+|||+. +++|+||||+||++++++.+||+|||++....... .
T Consensus 89 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~ 163 (309)
T cd07845 89 YCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-K 163 (309)
T ss_pred cCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc-C
Confidence 9975 78888765 35688999999999999999999998 89999999999999999999999999998764332 1
Q ss_pred ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh-------hhcCcc--
Q 044281 660 THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC-------YVEGRL-- 729 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~~-- 729 (796)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... +.....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 2222345778999999865 567999999999999999999999997655443332222211000 000000
Q ss_pred -ceeccchhh--hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 730 -DVLIDSDEA--AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 730 -~~~~d~~~~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+...... ..........+.+++.+|++.||++|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 00001124456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=290.94 Aligned_cols=265 Identities=21% Similarity=0.250 Sum_probs=192.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCccccccccccccc-------
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN------- 574 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------- 574 (796)
+.+.++||+|+||.||++..+ .+++.||||.+.... ......+.+|++++++++||||+++++++.....
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred eEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 344578999999999999865 468899999885432 2223456789999999999999999999866543
Q ss_pred -ceeEEeecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 575 -RLLVYEFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 575 -~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
.++||||+.+ +|.+.+.... .+++..++.++.||+.||+|||++ +++|+||||+||++++++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4999999975 7877776543 688999999999999999999998 899999999999999999999999999987
Q ss_pred ccCCCCc---ceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH----hh
Q 044281 653 LFSDQSR---THTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD----CY 724 (796)
Q Consensus 653 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~----~~ 724 (796)
....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+...... .+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 6433221 11234467889999988764 4788999999999999999999998766544332222111100 00
Q ss_pred hcCccce------eccchh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 725 VEGRLDV------LIDSDE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 725 ~~~~~~~------~~d~~~----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....... ...... ...........+.+++.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 000000 000000122456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=287.99 Aligned_cols=261 Identities=16% Similarity=0.148 Sum_probs=192.2
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.++++++|+||+++++++.+....+++|||+++
T Consensus 7 ~~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hHhhcCCceEEEEEecC---CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34556666666666543 6889999998653 344557899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC----
Q 044281 585 GTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS---- 658 (796)
Q Consensus 585 gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~---- 658 (796)
++|.+++... ..+++.....++.|+++||+|||++ +|+|+||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999753 4578888899999999999999998 899999999999999999999999999876532221
Q ss_pred --cceeeccCCCcccccccccC--CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH-HHHHHHHHhh-------hc
Q 044281 659 --RTHTMIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA-ILTDWAYDCY-------VE 726 (796)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~-~l~~~~~~~~-------~~ 726 (796)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.||.......... .+.......+ ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 11123446778999999876 358899999999999999999999997543221110 0000000000 00
Q ss_pred Cccce--------eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 GRLDV--------LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 ~~~~~--------~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..... .................+.+++.+||+.||++|||++++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 000001111223344578889999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=287.62 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=193.9
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
++...+.||+|+||.||+|+.. .+++.+++|.+... ......++.+|+++++.++|+|++++++++......++||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3445678999999999999976 35789999998532 2234467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9997 577776653 44678899999999999999999998 8999999999999999999999999998765322
Q ss_pred cceeeccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 659 RTHTMIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+......+....+ ..+....
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~---- 233 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNESPA---- 233 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--------hhcCCCC----
Confidence 2335788999999974 356788999999999999999999998654322211111 0111100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
.........+.+++.+||+.+|++||++.++++..
T Consensus 234 ----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 ----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ----cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00112334567899999999999999999999774
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=284.57 Aligned_cols=261 Identities=26% Similarity=0.278 Sum_probs=199.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||.||+|+.. .+++.+++|.+.... ......+..|+.++++++|+|++++++++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eehcccccCcceEEEeeec-CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3467999999999999875 458899999997643 2334678889999999999999999999999999999999998
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||+++....... ...
T Consensus 82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 5899999876 5789999999999999999999998 899999999999999999999999999986643221 222
Q ss_pred eccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------Hhh-----hcCcc
Q 044281 663 MIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY-------DCY-----VEGRL 729 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~-----~~~~~ 729 (796)
...++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+..... ..+ .....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 33457789999998776 889999999999999999999999876543332221111100 000 00000
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........ ....+.....+.+++.+||+.+|++||++++++..
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 237 PKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 01111124568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=271.02 Aligned_cols=238 Identities=26% Similarity=0.292 Sum_probs=198.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.|.++||+|.||+|-+++.+ .+++.+|+|++++.- ......-+.|-++|+..+||.+..+...++..+++++||||
T Consensus 171 dfLKvLGkGTFGKVIL~rEK-at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREK-ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hHHHHhcCCccceEEEEeec-ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 46789999999999999865 578999999997632 23345567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
..||.|.-+|.....+++....-+..+|+.||.|||+. +||.||||.+|.|+|.+|++||+|||+.+.--. .....
T Consensus 250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~t~ 325 (516)
T KOG0690|consen 250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGDTT 325 (516)
T ss_pred ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-cccee
Confidence 99999999998888888888888999999999999998 999999999999999999999999999985322 33455
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...+|||.|+|||++....|..++|.|.+||++|||++|+.||.....+..-.++.. .+-+ .
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------ed~k------------F 387 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------EDLK------------F 387 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------hhcc------------C
Confidence 678899999999999999999999999999999999999999987665543333210 0001 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRP 765 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RP 765 (796)
+.....+...++.-.|.+||.+|.
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhc
Confidence 222233445577778899999995
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=280.64 Aligned_cols=246 Identities=27% Similarity=0.385 Sum_probs=201.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||.||++... .+++.+++|++..... .....+.+|++.++.++|+|++++++.+......++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred EEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 4467999999999999975 3678999999975432 455678999999999999999999999999899999999999
Q ss_pred CCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 584 NGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 584 ~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++|.+++... ..+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence 99999999764 6788999999999999999999998 99999999999999999999999999998764433 1
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+......+.... ........+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~------- 223 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK--------ILKGQYPPI------- 223 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH--------HhcCCCCCC-------
Confidence 22334578899999999998999999999999999999999999876543221111 111111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.+|++|||+.++++.
T Consensus 224 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 --PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=295.86 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=204.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+...||+|.|++|.++++.. ++..||||.+++..- .....+.+|+++|..++|||||+++.+......+|+||||.
T Consensus 59 ~i~~tig~g~f~~V~La~~~~-t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHIL-TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeccceeEEEEeeEecC-CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 455789999999999999774 689999999977432 23345899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
.+|.+.+++.++.......+..++.|+.+|++|+|++ .|+|||||++||||+.+.++||+|||++..+. ......
T Consensus 138 ~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~lq 212 (596)
T KOG0586|consen 138 SGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLMLQ 212 (596)
T ss_pred cCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--cccccc
Confidence 9999999999998888899999999999999999999 89999999999999999999999999998764 334455
Q ss_pred eccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
..+|++.|.|||++.+..+ .+++|+||+|++||-|++|..||++....+.+... ..++. ..
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv--------l~gk~----------rI 274 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV--------LRGKY----------RI 274 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh--------eeeee----------cc
Confidence 6789999999999999887 57999999999999999999999876443322211 11111 01
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+..-..++-++++++|-.+|.+|+++.++.+.
T Consensus 275 p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 275 PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11222345678899999999999999998753
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=283.96 Aligned_cols=260 Identities=24% Similarity=0.276 Sum_probs=192.8
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhccc---CccCccccccccccccc-----c
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKHLVQLLGFCDEALN-----R 575 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~ 575 (796)
+.+.||+|+||.||+|+.+. +++.+|+|++..... .....+.+|+.++.++ +|+|++++++++..... .
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred EEEEecccCceEEEEEEECC-CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 34679999999999999763 578999999964322 2234566777766555 69999999999987776 8
Q ss_pred eeEEeecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccc
Q 044281 576 LLVYEFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 653 (796)
+++|||+.+ +|.+++.... .+++..+..++.||++||+|||+. +++|+||+|+||++++++.+||+|||++...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999975 8888887643 588999999999999999999998 8999999999999999999999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----hhcCcc
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----YVEGRL 729 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~~~~~~ 729 (796)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..||......+....+....... +.....
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 43322 122346888999999999999999999999999999999999987655443322221111000 000000
Q ss_pred --ceeccc---hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 730 --DVLIDS---DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 730 --~~~~d~---~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
...... .............+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 0001111223456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=286.30 Aligned_cols=241 Identities=26% Similarity=0.326 Sum_probs=190.0
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.++||+|+||+||+|+.. .+++.|++|++.... ......+.+|+.+++.++|+|++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred ceeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 356999999999999865 468899999986422 2334578899999999999999999999999999999999996
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++..... ..
T Consensus 105 -~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~ 175 (313)
T cd06633 105 -GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----AN 175 (313)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CC
Confidence 477776654 45688999999999999999999998 899999999999999999999999999864321 22
Q ss_pred eccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 663 MIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
...++..|+|||.+. ...++.++|||||||++|||++|..|+...........+ .. .......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~-------~~-~~~~~~~------ 241 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQ-NDSPTLQ------ 241 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------Hh-cCCCCCC------
Confidence 345788999999984 456889999999999999999999998654332211111 00 0111000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+..++.+||+.+|.+||++.++++.
T Consensus 242 --~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 --SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122346779999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=319.83 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=199.9
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
..||.|.||.||-++.. .+|+-.|||-+.-. .........+|+.++..++|||+|+++|+-.+.+..+|.|||+++|
T Consensus 1241 ~~Ig~G~fG~VYtavN~-~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNL-DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred cccCCcceeeeEEeecC-CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 46999999999999854 57889999977532 2333467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC---ccee
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS---RTHT 662 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~---~~~~ 662 (796)
+|.+++....-.++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|++|||.|..+..+.. ....
T Consensus 1320 sLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred cHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 9999999887777777788889999999999999 999999999999999999999999999998765532 1223
Q ss_pred eccCCCcccccccccCC---CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 663 MIRGTRGYVAPEWFKNV---PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~---~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
...||+.|||||++.+. ...-+.||||+||++.||+||++|+.....+- .|+ -.+..|..+++...
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIM----y~V~~gh~Pq~P~~---- 1465 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIM----YHVAAGHKPQIPER---- 1465 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHH----hHHhccCCCCCchh----
Confidence 46799999999999653 46678999999999999999999997543321 111 11233444333222
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...+-.+++..|++.||++|-++.|+++.
T Consensus 1466 -----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1466 -----LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 34455679999999999999888877765
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=289.38 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=191.3
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccc------cceeE
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------NRLLV 578 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lv 578 (796)
.+.||+|+||.||+|+.. .+++.||+|++.... ......+.+|+.++++++|+||+++++++.... ..++|
T Consensus 20 ~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 467999999999999865 467899999986532 223456889999999999999999999986543 45899
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
+||+.. +|..++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 99 MPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred eccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 999964 6766542 3578899999999999999999998 8999999999999999999999999999864321
Q ss_pred cceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHH-------HHhhhcCccc
Q 044281 659 RTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEGRLD 730 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~ 730 (796)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.... ..........
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred --CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 123356788999999876 468999999999999999999999997654322211111100 0000000000
Q ss_pred eeccc---hhh---hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcCcCC
Q 044281 731 VLIDS---DEA---AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGLLDV 780 (796)
Q Consensus 731 ~~~d~---~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~~~~ 780 (796)
..... ... ....+.....+.+++.+||+.||++||++.++++. ++...+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00000 000 00001123457789999999999999999999955 6665554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=276.23 Aligned_cols=237 Identities=28% Similarity=0.296 Sum_probs=194.6
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
||+|+||.||++... .+++.+++|.+..... .....+..|+.++++++|+||+++++.+..+...+++|||+++++
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999875 4678999999865432 245678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccC
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG 666 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 666 (796)
|.+++.....+++.....++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++....... .......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 999998887889999999999999999999997 89999999999999999999999999998764332 12233457
Q ss_pred CCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 044281 667 TRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRL 746 (796)
Q Consensus 667 t~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 746 (796)
+..|+|||.+.+...+.++|+||||+++||+++|+.||...........+ ..+.. ..+....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--------~~~~~----------~~~~~~~ 217 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--------LKDPL----------RFPEFLS 217 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------hcCCC----------CCCCCCC
Confidence 88999999999888999999999999999999999999755432211111 11110 0011113
Q ss_pred HHHHHHHHHhcccCCCCCCCHHH
Q 044281 747 HKWLMIAMWCIQEDPSKRPTMKV 769 (796)
Q Consensus 747 ~~l~~l~~~Cl~~dp~~RPt~~e 769 (796)
..+.+++.+||+.||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 56678999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=278.88 Aligned_cols=235 Identities=20% Similarity=0.222 Sum_probs=183.1
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcc-cCccCcccccccccccccceeEEeecCCCCHH
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQLLGFCDEALNRLLVYEFMGNGTLA 588 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 588 (796)
||+|+||.||++..+ .+++.+|+|.+........ |+..... .+|+|++++++.+...+..++||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEc-CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 599999999999865 4678899999865321111 2222221 27999999999999999999999999999999
Q ss_pred HHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCcccccCCCCcceeeccCC
Q 044281 589 NLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQSRTHTMIRGT 667 (796)
Q Consensus 589 ~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt 667 (796)
+++.....+++..+..++.||++||.|||+. +++||||||+||+++.++ .++|+|||+++...... ...++
T Consensus 98 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~ 169 (267)
T PHA03390 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYDGT 169 (267)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCCCC
Confidence 9998877899999999999999999999998 899999999999999988 99999999988653221 23578
Q ss_pred CcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHH
Q 044281 668 RGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLH 747 (796)
Q Consensus 668 ~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 747 (796)
..|+|||.+.+..++.++||||||+++|||++|+.||.....+... +..+.... .... . .......
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~--~~~~-~---------~~~~~~~ 235 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD--LESLLKRQ--QKKL-P---------FIKNVSK 235 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--HHHHHHhh--cccC-C---------cccccCH
Confidence 8999999999999999999999999999999999999744322211 11111110 0000 0 0112335
Q ss_pred HHHHHHHHhcccCCCCCCC-HHHHHH
Q 044281 748 KWLMIAMWCIQEDPSKRPT-MKVVLQ 772 (796)
Q Consensus 748 ~l~~l~~~Cl~~dp~~RPt-~~evl~ 772 (796)
.+.+++.+||+.+|.+||+ ++++++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 6778999999999999995 688874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=288.06 Aligned_cols=262 Identities=24% Similarity=0.269 Sum_probs=190.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccc--------c
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEAL--------N 574 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------~ 574 (796)
.+.++||+|+||.||+|+.+ .+++.+++|++..... .....+.+|++++++++|+||+++++++.+.. .
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 34577999999999999865 4678999999854322 12346788999999999999999999875443 3
Q ss_pred ceeEEeecCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccc
Q 044281 575 RLLVYEFMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 653 (796)
.++|+||+.. +|...+.. ...+++..+..++.||++||.|||+. +|+|+||||+||++++++.+||+|||+++..
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 5899999875 66666654 45789999999999999999999998 8999999999999999999999999999865
Q ss_pred cCCCCc----------ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH
Q 044281 654 FSDQSR----------THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD 722 (796)
Q Consensus 654 ~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~ 722 (796)
...... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 432211 1123456888999998865 45899999999999999999999999765443322222111000
Q ss_pred h----hhc-Ccccee--------ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 723 C----YVE-GRLDVL--------IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 723 ~----~~~-~~~~~~--------~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
. +.. ..+... ....... ........+.+++.+|++.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 000 000000 0000000 01112256788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=283.37 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=189.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||+|..+. +++.||||.++... .....++..|+.++.+. .|+||+++++++......+++|||+
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred eeeeEeeccCCeEEEEEEECC-CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 456789999999999999763 57899999996532 23345667777767666 4999999999999999999999998
Q ss_pred CCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++ +|.+++.. ...+++..+..++.||++||+|||+.. +|+||||+|+||++++++.+||+|||++..+..... .
T Consensus 97 ~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--~ 171 (296)
T cd06618 97 ST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--K 171 (296)
T ss_pred Cc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--c
Confidence 64 77776655 346788999999999999999999732 899999999999999999999999999986543222 1
Q ss_pred eeccCCCcccccccccCCC----CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 662 TMIRGTRGYVAPEWFKNVP----VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~----~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||........ .+.. . ..........
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~----~-~~~~~~~~~~--- 241 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VLTK----I-LQEEPPSLPP--- 241 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HHHH----H-hcCCCCCCCC---
Confidence 2234778999999997654 78999999999999999999999865322110 1100 0 1111111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+++.+++.+||+.||.+||++.+++++
T Consensus 242 ----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 ----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00123567889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=277.47 Aligned_cols=247 Identities=25% Similarity=0.320 Sum_probs=192.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-----hhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.++||+|+||.||++.... .+..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3456789999999999998653 3444555555431 122334677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 579 YEFMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
|||+++++|.+++.. ...+++..++.++.|+++||.|||+. +++|+||+|+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988863 35688999999999999999999998 9999999999999975 569999999998764
Q ss_pred CCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+........... ...+....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~--------~~~~~~~~--- 224 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR--------IVEGPTPS--- 224 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH--------HHcCCCCC---
Confidence 3322 22334578899999999888899999999999999999999999865432221111 11111111
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 112233567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=293.39 Aligned_cols=263 Identities=23% Similarity=0.353 Sum_probs=197.0
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccccc------cceeEE
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEAL------NRLLVY 579 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lv~ 579 (796)
.+.||+|+||.||+|+.+ .+|+.||||.++..... ..+...+|++++++++|+|||+++++-.+.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnk-etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNK-ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeeccc-ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 478999999999999965 58999999999774433 3456788999999999999999999876554 558999
Q ss_pred eecCCCCHHHHHhcC---CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc--CCC--cEEEeecCCccc
Q 044281 580 EFMGNGTLANLIFAI---PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD--HFF--SAKISDFGLSKL 652 (796)
Q Consensus 580 e~~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~--~~~--~~kl~DfGla~~ 652 (796)
||+.+|||...|.+. ..+++...+.+..++..||.|||++ +|+||||||.||++- ++| ..||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999764 4689999999999999999999998 999999999999984 333 479999999997
Q ss_pred ccCCCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhh------
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYV------ 725 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~------ 725 (796)
+..+. .....+||..|++||.+.. +.|+..+|.|||||++||.+||..||.......... ...+....
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~---~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK---EIMWHIITKKPSGV 248 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc---hhhhhhhccCCCce
Confidence 75444 6677889999999999985 889999999999999999999999997643321100 01111100
Q ss_pred --------cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHcCc
Q 044281 726 --------EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP--TMKVVLQMLEGLL 778 (796)
Q Consensus 726 --------~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP--t~~evl~~L~~~~ 778 (796)
+|.+.-...-............++.+.+..++.-+|++|= ...+....+..|+
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 1111100000011122344455666677777788888887 5555555554443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=260.52 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=193.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+...||.|..|.|++...+ .+|..+|||.+.+... +..+.++..+.++.+-+ +|.||+-+|+|..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hHHhhcCCCccceEEEEEc-ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 4567999999999999987 4689999999976443 34567788888777664 8999999999999999999999985
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
. .++.++... .++++..+-++...+.+||.||.+.+ +|||||+||+|||+|+.|++|++|||++-.+.. +...+
T Consensus 175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--SkAht 249 (391)
T KOG0983|consen 175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SKAHT 249 (391)
T ss_pred H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--ccccc
Confidence 4 566666543 45777777889999999999999875 999999999999999999999999999987643 33444
Q ss_pred eccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 663 MIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
...|-+.|||||.+. ...|+.++||||||+.|+||.||+-||.....+-.. + ..+.+. ....++.
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--l-----tkvln~-ePP~L~~---- 317 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--L-----TKVLNE-EPPLLPG---- 317 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--H-----HHHHhc-CCCCCCc----
Confidence 556888999999985 457899999999999999999999999875433211 1 111111 1111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++..||++|+.+||...++++.
T Consensus 318 --~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 --HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11245567889999999999999999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=303.44 Aligned_cols=246 Identities=32% Similarity=0.434 Sum_probs=184.2
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccc---------------
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDE--------------- 571 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------------- 571 (796)
+.||+||||.|||++.+. +|+.+|||++.-.. ......+.+|++.+++++|||||+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKl-DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKL-DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHhcCCCCceEEEEeecc-cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 469999999999998764 79999999996543 3345678999999999999999999875310
Q ss_pred ---------------------------------------------------------------c----------------
Q 044281 572 ---------------------------------------------------------------A---------------- 572 (796)
Q Consensus 572 ---------------------------------------------------------------~---------------- 572 (796)
+
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence 0
Q ss_pred -------------------------ccceeEEeecCCCCHHHHHhcCCCC-chhHHHHHHHHHHHHhhHhhhcCCCCeee
Q 044281 573 -------------------------LNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPIIH 626 (796)
Q Consensus 573 -------------------------~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~i~~~ia~~l~yLH~~~~~~iiH 626 (796)
.-+||=||||+...|.+++...... .....++++.+|+.||+|+|+. +|||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIH 720 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIH 720 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceee
Confidence 1236778888887777777655433 4677899999999999999998 8999
Q ss_pred CCCCCCCEEEcCCCcEEEeecCCccccc-----------------CCCCcceeeccCCCcccccccccCC---CCCccch
Q 044281 627 CDIKPQNILLDHFFSAKISDFGLSKLLF-----------------SDQSRTHTMIRGTRGYVAPEWFKNV---PVSAKVD 686 (796)
Q Consensus 627 ~Dlk~~NIll~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~D 686 (796)
|||||.||++|++..|||+|||+|.... .......+..+||.-|+|||++.+. .|+.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999998721 0011234556799999999999765 4999999
Q ss_pred hHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 044281 687 VYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 766 (796)
Q Consensus 687 VwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt 766 (796)
+||+||+|+||+. ||....+ ....+ ..++.+.++.- .....++...-.+++.++++.||.+|||
T Consensus 801 mYSLGIVlFEM~y---PF~TsME--Ra~iL-----~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLY---PFGTSME--RASIL-----TNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hHHHHHHHHHHhc---cCCchHH--HHHHH-----HhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCC
Confidence 9999999999984 3443221 11111 22233443332 1111223334467999999999999999
Q ss_pred HHHHHHH
Q 044281 767 MKVVLQM 773 (796)
Q Consensus 767 ~~evl~~ 773 (796)
+.|++.-
T Consensus 865 A~eLL~s 871 (1351)
T KOG1035|consen 865 ATELLNS 871 (1351)
T ss_pred HHHHhhc
Confidence 9998753
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=288.13 Aligned_cols=264 Identities=20% Similarity=0.221 Sum_probs=191.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccccc-----------
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA----------- 572 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------- 572 (796)
+.+.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.++++++|+||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred eEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 334578999999999999865 46889999998665555567789999999999999999999876543
Q ss_pred ---ccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc-CCCcEEEeecC
Q 044281 573 ---LNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFG 648 (796)
Q Consensus 573 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~DfG 648 (796)
...++||||++ ++|.+++.. ..+++.....++.||+.||.|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 34689999997 588887764 3578899999999999999999998 899999999999997 45678999999
Q ss_pred CcccccCCCCc--ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH----
Q 044281 649 LSKLLFSDQSR--THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY---- 721 (796)
Q Consensus 649 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~---- 721 (796)
+++.+...... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99865332211 1122357889999998754 5678899999999999999999999975543222111110000
Q ss_pred ---HhhhcCccceec-----cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 722 ---DCYVEGRLDVLI-----DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 722 ---~~~~~~~~~~~~-----d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
............ ..............++.+++.+||+.||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000000000 0000000011223567789999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=262.08 Aligned_cols=256 Identities=24% Similarity=0.299 Sum_probs=197.8
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecCCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
.+.||+|+++.|--++. ..++.++|||++.+..........+|++++... .|+||++|+.+|+++...|||||-|.||
T Consensus 83 ~e~LGeGAyasVqtcv~-i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVS-IQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeee-eccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 36899999999987763 357899999999987666678899999999988 5999999999999999999999999999
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc---EEEeecCCcccccC--CCC--
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS---AKISDFGLSKLLFS--DQS-- 658 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~DfGla~~~~~--~~~-- 658 (796)
+|..+|.++..+++..+.++..+|+.||.+||.. +|.||||||+|||-.+... +||+||.+..-+.- +-+
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999999999999999999999999999999998 9999999999999976544 79999988764321 111
Q ss_pred --cceeeccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHH-------HHhHHHHHHHHHhh
Q 044281 659 --RTHTMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEE-------ESRAILTDWAYDCY 724 (796)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~-------~~~~~l~~~~~~~~ 724 (796)
....+.+|+..|||||+.. ...|+.++|.|||||+||-|++|..||.+.-.+ +.-........+.+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 2223456888999999763 346889999999999999999999999764321 11111112222223
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.+|..+ ...+.. .....+..+++...+..|+.+|-++.+++.
T Consensus 319 QEGkYe----FPdkdW--ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 319 QEGKYE----FPDKDW--AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred hccCCc----CChhhh--HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 333321 111111 112234455666777899999999999887
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=262.59 Aligned_cols=262 Identities=27% Similarity=0.374 Sum_probs=200.9
Q ss_pred CccccCHHHHHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccc
Q 044281 490 NLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLG 567 (796)
Q Consensus 490 ~~~~~~~~~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g 567 (796)
.+-.|+-++|++. ..||.|+||+|+|-.++ ..|+.+|||+++... ...+.+++.|.....+- +.||||+++|
T Consensus 57 ~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 57 HLHTFTSDNLQDL-----GEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred cccccccchHHHH-----HHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 3445666666553 67999999999998876 578999999997643 35567888898876665 7999999999
Q ss_pred cccccccceeEEeecCCCCHHHHHh-----cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcE
Q 044281 568 FCDEALNRLLVYEFMGNGTLANLIF-----AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSA 642 (796)
Q Consensus 568 ~~~~~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 642 (796)
.+-.+...|+.||.|.- ||+.+-+ +...++++..-.|......||.||.++. .|||||+||+|||+|..|.+
T Consensus 131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 99999999999999954 6665543 2457788888888888999999999874 89999999999999999999
Q ss_pred EEeecCCcccccCCCCcceeeccCCCccccccccc--CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHH
Q 044281 643 KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK--NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA 720 (796)
Q Consensus 643 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 720 (796)
||+|||++-.+...- ..+.-.|-..|||||.+. +..|+.++||||||++|||+.||+-|+..-...-.+ +
T Consensus 208 KLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq--l---- 279 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ--L---- 279 (361)
T ss_pred eeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH--H----
Confidence 999999987654322 223334777899999994 446899999999999999999999998754332111 1
Q ss_pred HHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 721 YDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 721 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....|..+.+..... ..+....+.+++-.|+-+|.++||...++.++
T Consensus 280 -~~Vv~gdpp~l~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 -CQVVIGDPPILLFDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -HHHHcCCCCeecCccc----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1122333333332221 23455678889999999999999999998754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=274.02 Aligned_cols=244 Identities=27% Similarity=0.326 Sum_probs=200.6
Q ss_pred HHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCccccccccccccc
Q 044281 499 LKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALN 574 (796)
Q Consensus 499 l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 574 (796)
+.....+|..+||+|+||.|.++..+ .+.+.+|||++++.- ....+--+.|-++|+.. +-|.++++..+++.-+.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerk-gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred eeecccceEEEeccCccceeeeeccc-CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34444578889999999999999855 467899999997632 12233445677888876 67899999999999999
Q ss_pred ceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 575 RLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
+|+||||+.+|+|-.++++..++.+..+.-+|.+||-||-+||+. +||.||||.+|||||.+|++||+|||+.+.--
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999999999999999999999999999999999998 99999999999999999999999999998532
Q ss_pred CCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
- ...+....+||+.|+|||++..++|...+|.|||||+||||+.|+.||+++.+++.-..+.+..
T Consensus 502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-------------- 566 (683)
T KOG0696|consen 502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-------------- 566 (683)
T ss_pred c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--------------
Confidence 2 2334456789999999999999999999999999999999999999999998877655553321
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCC
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRP 765 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 765 (796)
...+...+.+.+.+....+.+.|.+|.
T Consensus 567 ----vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ----VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112333444555666667778888774
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=286.68 Aligned_cols=263 Identities=21% Similarity=0.223 Sum_probs=191.1
Q ss_pred HHHhhCCCccceEEEEEeeCCC--CeEEEEEEecchh--hhhHHHHHHHHHHhccc-CccCcccccccccc----cccce
Q 044281 506 FKEELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRLA--QEREREFKSEVSAIGRT-HHKHLVQLLGFCDE----ALNRL 576 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~ 576 (796)
+.+.||+|+||.||++.... . +..||+|++.... ....+.+.+|+.+++++ +|+||+++++++.. ....+
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 4 LIKELGQGAYGIVCSARNAE-TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred EEEEccccCCeEEEEEEeCC-CCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 45679999999999998753 4 6789999986432 22345788899999998 59999999987533 24567
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+++||+. ++|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 8888886 68999998888899999999999999999999998 8999999999999999999999999999865432
Q ss_pred CCc---ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------Hhhh
Q 044281 657 QSR---THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY-------DCYV 725 (796)
Q Consensus 657 ~~~---~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~ 725 (796)
... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+..... ..+.
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 211 1123468899999998865 4689999999999999999999999875443221111110000 0000
Q ss_pred cCcccee---ccc---hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 726 EGRLDVL---IDS---DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 726 ~~~~~~~---~d~---~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....... ... .............+.+++.+|++.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 000 00000001123567889999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=286.33 Aligned_cols=273 Identities=22% Similarity=0.262 Sum_probs=196.5
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccc------ccee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------NRLL 577 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l 577 (796)
+.+.||+|+||.||++... .+++.||||++.... ......+.+|+.++++++|+||+++++++.... ..++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred EEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 4567999999999999865 468899999985422 223456889999999999999999999886554 3489
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 98 v~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~- 171 (343)
T cd07880 98 VMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE- 171 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccC-
Confidence 99998 6789888764 4688999999999999999999998 8999999999999999999999999999865322
Q ss_pred CcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------HhhhcCc-
Q 044281 658 SRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVEGR- 728 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~~~~- 728 (796)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+..... ..+....
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 172 ---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred ---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 123356889999999876 4688999999999999999999999975443221111100000 0000000
Q ss_pred ------cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH--HHHHcCcCCCCCCCCCcc
Q 044281 729 ------LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVL--QMLEGLLDVPNPPGPSSF 789 (796)
Q Consensus 729 ------~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl--~~L~~~~~~~~pp~p~~~ 789 (796)
+........ ..........+.+++.+|++.||++|||+.+++ ..++.....+..+.+..|
T Consensus 249 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd07880 249 KNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPY 316 (343)
T ss_pred HHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCc
Confidence 000000000 000112233577899999999999999999999 344554443333333334
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=287.17 Aligned_cols=258 Identities=24% Similarity=0.278 Sum_probs=192.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccccc------cee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN------RLL 577 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~l 577 (796)
+.+.||+|+||.||+|.... +++.||+|++... .......+.+|+.++++++|+|++++++++..... .++
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EEEEeccCCceEEEEEEECC-CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 45679999999999998763 6789999998642 22334567889999999999999999998866654 799
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
|+||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 98 v~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 98 VTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 99998 5699888875 4688999999999999999999998 8999999999999999999999999999865332
Q ss_pred CcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH---hhhcCc----c
Q 044281 658 SRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD---CYVEGR----L 729 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~---~~~~~~----~ 729 (796)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.+.... .+..+. .
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 223357888999999865 46789999999999999999999999755433222211111000 000000 0
Q ss_pred ceeccchhh------hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 730 DVLIDSDEA------AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 730 ~~~~d~~~~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...+..... ..........+.+++.+|++.+|++|||+.+|++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000 00001124578899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.76 Aligned_cols=259 Identities=22% Similarity=0.264 Sum_probs=191.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc-cccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE-ALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||++..+ .+++.||+|++... .....+.+.+|+.++.+++||||+++.+++.. ....++++||
T Consensus 13 ~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 13 VDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred EEEEeecccCCeEEEEEEEC-CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 34578999999999999865 46889999988542 22334678899999999999999999998865 5578899999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+ +++|.+++.. ..+++.....++.||++||+|||+. +|+|+||+|+||++++++.+||+|||++...... .
T Consensus 92 ~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~ 162 (328)
T cd07856 92 L-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----M 162 (328)
T ss_pred h-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC----c
Confidence 8 4588888765 3467788889999999999999998 8999999999999999999999999998754221 1
Q ss_pred eeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hhhcCccceec
Q 044281 662 TMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVEGRLDVLI 733 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~~~~~~~~ 733 (796)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+.... ....+.....+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 22356788999999866 57899999999999999999999998655432222211111100 00000000000
Q ss_pred cch-hhhh-----hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 734 DSD-EAAM-----ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 734 d~~-~~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
... .... ........+.+++.+||+.+|++||++.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000 001123567889999999999999999998766
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.30 Aligned_cols=257 Identities=24% Similarity=0.258 Sum_probs=188.3
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCccccccccccc------ccceeE
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA------LNRLLV 578 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv 578 (796)
.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++.+++|+||+++++++... ...+++
T Consensus 22 ~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence 467999999999999865 468899999996532 23346788899999999999999999987543 335778
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
++++ +++|.+++... .+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 101 ~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~--- 172 (345)
T cd07877 101 THLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 172 (345)
T ss_pred ehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccccc---
Confidence 8876 77998877653 588999999999999999999998 899999999999999999999999999886432
Q ss_pred cceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------HhhhcCccc
Q 044281 659 RTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVEGRLD 730 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~~~~~~ 730 (796)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..... ..+......
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 173 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred -cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 1223457889999999876 5688999999999999999999999865433221111111000 000000000
Q ss_pred eec---cchhh---hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 731 VLI---DSDEA---AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 731 ~~~---d~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+ ..... ..........+.+++.+|++.||.+||++.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00000 00000123457789999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=267.60 Aligned_cols=221 Identities=19% Similarity=0.142 Sum_probs=176.9
Q ss_pred CccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCHHHHHh
Q 044281 513 GSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIF 592 (796)
Q Consensus 513 G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 592 (796)
|.||.||++..+ .+++.+|+|++.... .+..|...+....||||+++++++.+....+++|||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~-~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDT-RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEc-cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 889999999865 468899999997643 23345555556679999999999999999999999999999999998
Q ss_pred cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCcccc
Q 044281 593 AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672 (796)
Q Consensus 593 ~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 672 (796)
....+++.....++.|++.||.|||+. +|+||||||+||+++.++.++++|||.+..+... .....++..|+|
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 877889999999999999999999998 8999999999999999999999999988655332 122335677999
Q ss_pred cccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHH
Q 044281 673 PEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMI 752 (796)
Q Consensus 673 PE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 752 (796)
||.+.+..++.++||||+|+++|||++|+.|+....... .... .++ .+......+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~---~~~------~~~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHT---TLN------IPEWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------cccc---ccC------CcccCCHHHHHH
Confidence 999988889999999999999999999998764321100 0000 000 011123456789
Q ss_pred HHHhcccCCCCCCCHH
Q 044281 753 AMWCIQEDPSKRPTMK 768 (796)
Q Consensus 753 ~~~Cl~~dp~~RPt~~ 768 (796)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=304.62 Aligned_cols=142 Identities=31% Similarity=0.454 Sum_probs=128.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.++||+|+||.||+|... .+++.||||+++... ......+..|+.++..++|+||+++++++......+|||||+
T Consensus 8 i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 4578999999999999875 468899999986532 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
.+++|.+++.....+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999998777888999999999999999999998 89999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=258.40 Aligned_cols=245 Identities=23% Similarity=0.239 Sum_probs=191.5
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccc----cccceeEEeec
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDE----ALNRLLVYEFM 582 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e~~ 582 (796)
++||-|-.|.|.....+ .+++.+|+|+|.+.. ...+|++..-+. .|+|||.+++++.. ...+++|||.|
T Consensus 68 qvLG~GinGkV~~C~~k-~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHK-RTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEec-cchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 78999999999998876 478899999996643 346677776665 69999999999854 34567999999
Q ss_pred CCCCHHHHHhcCCC--CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccccCCC
Q 044281 583 GNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 583 ~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~~~ 657 (796)
+||.|...+.++.. ++++++-.|+.||+.|+.|||+. +|.||||||+|+|... |-.+||+|||+|+.-..
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-- 216 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-- 216 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC--
Confidence 99999999988765 88999999999999999999998 9999999999999974 56799999999996432
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.......+-|+.|.|||++...+|+..+|+||+||++|-|++|-.||...... .+.......+..|...- ..
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~~gqy~F----P~ 288 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIRTGQYEF----PE 288 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhhccCccC----CC
Confidence 33445566899999999999999999999999999999999999999865321 11111222222222110 00
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
. .-..-++...++++.+|..+|.+|.|+.+++..
T Consensus 289 p--EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 289 P--EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred h--hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0 011223455678888999999999999999865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=267.02 Aligned_cols=257 Identities=25% Similarity=0.292 Sum_probs=196.1
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---h----hhhHHHHHHHHHHhcccCccCccccccccc-cc
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---A----QEREREFKSEVSAIGRTHHKHLVQLLGFCD-EA 572 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~ 572 (796)
...|-+...||+|||+.|||+..- ...+.||||+-.-. . +.-.+...+|..+.+.|.||.||++++++. +.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 344556788999999999999854 35788999986321 1 112345678999999999999999999985 45
Q ss_pred ccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc---CCCcEEEeecCC
Q 044281 573 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD---HFFSAKISDFGL 649 (796)
Q Consensus 573 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~DfGl 649 (796)
+..+-|+||++|.+|+-+|+.+..++++.+..|+.||+.||.||.+. +++|||-||||.||||- .-|.+||+|||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 56789999999999999999999999999999999999999999986 67999999999999995 458899999999
Q ss_pred cccccCCCCc------ceeeccCCCcccccccccCC----CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH
Q 044281 650 SKLLFSDQSR------THTMIRGTRGYVAPEWFKNV----PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW 719 (796)
Q Consensus 650 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~ 719 (796)
++++..+... ......||..|++||.+.-+ +++.|+||||.||++|+.+.|++||.....+.. ++..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--ILqe- 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--ILQE- 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HHhh-
Confidence 9999765432 22335699999999998533 579999999999999999999999976543321 1110
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 044281 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVL 771 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 771 (796)
. ..+....+. + ...+.-..+...++++||+..-++|....++.
T Consensus 697 N-TIlkAtEVq--F------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 N-TILKATEVQ--F------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h-chhcceecc--C------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 0 000111110 0 01112223456689999999999998777664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=282.37 Aligned_cols=238 Identities=24% Similarity=0.256 Sum_probs=192.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+...+|.|+|+.|-.+... .+++..+||++.+.. .+-.+|+.++.+. +|+||+++.+.+.++.+.++|||.+
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hccccccCCCCccceeeeecc-ccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 345567999999999998876 467899999997652 2335566555554 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE-cCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL-DHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll-~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
.++-+.+.+...+... ..+..|+.+|+.|+.|||++ +++||||||+|||+ ++.++++|+|||.++..... .
T Consensus 399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~ 470 (612)
T KOG0603|consen 399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----C 470 (612)
T ss_pred cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----h
Confidence 9998888887766655 77778999999999999998 99999999999999 58999999999999976544 2
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...+-|..|.|||++....+++++|+||||++||+|++|+.||.....+.. ....+..+...
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-------i~~~i~~~~~s----------- 532 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-------IHTRIQMPKFS----------- 532 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-------HHHhhcCCccc-----------
Confidence 233468899999999999999999999999999999999999976543310 11222222211
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..-++...+++.+||+.||.+||+|.++...
T Consensus 533 -~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 -ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2233456679999999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=262.50 Aligned_cols=238 Identities=27% Similarity=0.334 Sum_probs=194.4
Q ss_pred ccceEEEEEeeCCCCeEEEEEEecchhhhh-HHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCHHHHHh
Q 044281 514 SFGIVYKGVLKTASGTAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIF 592 (796)
Q Consensus 514 ~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 592 (796)
+||.||+|+.. .+++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999875 357899999997654443 6789999999999999999999999999999999999999999999998
Q ss_pred cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCcccc
Q 044281 593 AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672 (796)
Q Consensus 593 ~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 672 (796)
....+++..++.++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 776688999999999999999999998 99999999999999999999999999998764432 2234457889999
Q ss_pred cccccCCCCCccchhHHHHHHHHHHHhCCCCCchh-hHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHH
Q 044281 673 PEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLM 751 (796)
Q Consensus 673 PE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 751 (796)
||.+.+..++.++||||||++++||++|..|+... ........ ...+...... .......++.+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~--------~~~~~~~~~~-------~~~~~~~~~~~ 219 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKK--------IGKPKPPFPP-------PEWKISPEAKD 219 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--------HhccCCCCcc-------ccccCCHHHHH
Confidence 99999889999999999999999999999998763 22211111 1111111000 00003356788
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 044281 752 IAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 752 l~~~Cl~~dp~~RPt~~evl~ 772 (796)
++.+|++.+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=252.48 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=197.2
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecc--hhhhhHHHHHHHHHHhcccCccCccccccccccc--------ccce
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--------LNRL 576 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~ 576 (796)
..+||+|.||+||++..+. +++.||+|+.-. ....-.....+|+++|..++|+|++.++..|... ...+
T Consensus 22 ~~kigqGtfgeVFkAr~~n-~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKN-TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHhcCCchHHHHHHHhhcC-ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 4579999999999998774 567788887632 1112234678899999999999999999998532 2368
Q ss_pred eEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 577 LVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
+|+.+++. +|.-+|.+. .+++...+.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+++.+..
T Consensus 101 lVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred eeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 99999987 899888876 5788899999999999999999998 899999999999999999999999999987643
Q ss_pred CC---CcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----hhc-
Q 044281 656 DQ---SRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----YVE- 726 (796)
Q Consensus 656 ~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~~~- 726 (796)
.. ....+..+-|..|.+||.+.+ ..++++.|||.-||++.||+++...+.+...+.....+....... |.+
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 32 222345567999999998876 568999999999999999999999988877766655554322111 111
Q ss_pred --Cccceec--cchhhhh--hcHHHH------HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 --GRLDVLI--DSDEAAM--ADRSRL------HKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 --~~~~~~~--d~~~~~~--~~~~~~------~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
-.+-+.+ .+..... .-.+.+ .+.++++..++..||.+||+..+++..
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0011111 0000000 011122 256788899999999999999988754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-31 Score=274.08 Aligned_cols=193 Identities=29% Similarity=0.523 Sum_probs=169.8
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
++||.|.||+||-|+++ ++|+.||||.+++. ..+.+.++.+|+.+|++++||.||.+.-.|+..+..++|||-+. |
T Consensus 570 evLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred hhccCCcceeeecceec-ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 67999999999999987 58999999999763 34556889999999999999999999999999999999999995 5
Q ss_pred CHHHHHhc--CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccccCCCCcc
Q 044281 586 TLANLIFA--IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 586 sL~~~l~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+..++|-. ..++++.....++.||+.||.|||.. +|+|+||||+|||+.. --++||+|||+|+++....-
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 66665543 46788888888999999999999998 9999999999999964 35799999999998754432
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEME 707 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~ 707 (796)
...++||+.|+|||+++++.|...-|+||.||++|--++|.-||..+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 34578999999999999999999999999999999999999999754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=262.46 Aligned_cols=275 Identities=20% Similarity=0.295 Sum_probs=207.1
Q ss_pred CCccccCHHHHHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-c-c----Cc
Q 044281 489 TNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-H-K----HL 562 (796)
Q Consensus 489 ~~~~~~~~~~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~----ni 562 (796)
...-++...+.....+.+...+|+|.||.|-+...+. .+..||||+++.... -.+..+-|+++++++. + | -+
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~-~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE-TKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecC-CCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 3445566666667778888999999999999988764 488999999987543 3455677899999983 2 2 37
Q ss_pred ccccccccccccceeEEeecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC--
Q 044281 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-- 638 (796)
Q Consensus 563 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-- 638 (796)
|++.+++.-.++.++|+|.+ |.|+.++|.... +++...+..|+.|+++++++||+. +++|-||||+|||+.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE 229 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence 88889999999999999988 558999998764 567889999999999999999998 8999999999999832
Q ss_pred ------------------CCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhC
Q 044281 639 ------------------FFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICC 700 (796)
Q Consensus 639 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg 700 (796)
+-.+||+|||.|..-..+ ...++.|..|.|||++.+..++.++||||+||||.|+.+|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 345899999999854322 2556789999999999999999999999999999999999
Q ss_pred CCCCchhhHHHHhHHH-------HHH------HHHhhhcCccc-----------eeccchh----hhhhcHHHHHHHHHH
Q 044281 701 RRSVEMELEEESRAIL-------TDW------AYDCYVEGRLD-----------VLIDSDE----AAMADRSRLHKWLMI 752 (796)
Q Consensus 701 ~~p~~~~~~~~~~~~l-------~~~------~~~~~~~~~~~-----------~~~d~~~----~~~~~~~~~~~l~~l 752 (796)
...|......|..... ... +...+..++++ ...+... .......+..+++++
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 9988765432211110 000 11111122111 1111111 011223455679999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 044281 753 AMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 753 ~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.+||..||.+|+|+.|+++.
T Consensus 386 l~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHccCccccccHHHHhcC
Confidence 999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=228.05 Aligned_cols=261 Identities=20% Similarity=0.268 Sum_probs=192.2
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
-.++||+|.||+||||+.+ .+++.||+|+.+-. .+.......+|+.+++.++|+|||++++....+..+.+|+||+.
T Consensus 6 kmekigegtygtvfkarn~-~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd 84 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_pred HHHhhcCCcceeeEecccC-CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh
Confidence 3478999999999999865 46889999988542 23334678999999999999999999999999999999999995
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
. +|..+... ...++.+....++.|+++||.+.|++ ++.||||||.|.|++.+|..|++|||+++.+.-. .+...
T Consensus 85 q-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-vrcys 159 (292)
T KOG0662|consen 85 Q-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRCYS 159 (292)
T ss_pred H-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-eEeee
Confidence 4 77777655 46788899999999999999999999 8999999999999999999999999999976432 23334
Q ss_pred eccCCCcccccccccCCC-CCccchhHHHHHHHHHHHhCCCCC-chhhHHHHhHHHHHHHHHhhhcCc---cceeccchh
Q 044281 663 MIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVTLLEIICCRRSV-EMELEEESRAILTDWAYDCYVEGR---LDVLIDSDE 737 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gv~l~elltg~~p~-~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d~~~ 737 (796)
..+-|..|.+|.++.+.+ |+...|+||-||++.|+....+|. .+....+....+-. ......+.. +..+.|...
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~-~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH-HhCCCccccCCccccCCCCcc
Confidence 445688999999998764 788999999999999999766654 44444433333321 111112211 122222211
Q ss_pred hhhhc---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMAD---------RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~---------~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
-...+ +....+-.+++...+.-+|..|.++++.++.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11110 1111122345555666799999999887764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=282.04 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=202.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCccccccccc-----ccccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCD-----EALNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~lv 578 (796)
.|.++||+|.+|.||+++.+ ++++..|+|++... ....+++..|.++++.. .|||++.++|++. .++.+|||
T Consensus 22 ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred EEEEEEeeccceeEEEEeee-ecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 35578999999999999865 57888899988653 34566788899999987 7999999999984 35678999
Q ss_pred EeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 579 YEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
||||.+|+..+++++. .++.|..+..|+..++.|+.+||.+ .++|||||-.|||++.++.+||.|||++..+...
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 9999999999999864 5788999999999999999999998 8999999999999999999999999999876443
Q ss_pred CCcceeeccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccce
Q 044281 657 QSRTHTMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (796)
-.+. .+..||+.|||||++. ...|+.++|+||||++..||--|..|+....+......+
T Consensus 177 ~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--------------- 240 (953)
T KOG0587|consen 177 VGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------------- 240 (953)
T ss_pred cccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---------------
Confidence 3333 3456999999999995 335788999999999999999999998755443322111
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 732 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.-.+.+....+....+++.+++..|+.+|.++||++.+++++
T Consensus 241 pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 112233334466788899999999999999999999988764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=251.42 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=203.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh--hHHHHHHHHHHhcccCccCcccccccccccc-----cceeEEe
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKHLVQLLGFCDEAL-----NRLLVYE 580 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv~e 580 (796)
+.||.|+||.||..++. .+|+.||+|++...... .-+.+.+|+++|..++|.|++..+++.+-.. +.|++.|
T Consensus 59 RPIGYGAFGVVWsVTDP-RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDP-RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCC-CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 56999999999998865 57899999999764322 2467889999999999999999998875443 4678899
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
.|.. +|.++|-....++-....-+..||++||+|||+. +|.||||||.|.|++.|-..||+|||+++....++...
T Consensus 138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 8864 8888888888888888888999999999999998 99999999999999999999999999999887777777
Q ss_pred eeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hhhcCcccee
Q 044281 661 HTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVEGRLDVL 732 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~~~~~~~ 732 (796)
++..+-|..|.|||++++. .|+.+.||||.||++.|++-.+..|....+-+....+.+.... ..-+|....+
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 7767779999999999876 5899999999999999999988888777665555544432221 1112221111
Q ss_pred ccchhh---------hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 733 IDSDEA---------AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 733 ~d~~~~---------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
+....+ ...+...-.+.+.+.+.++..||++|.+..+.+..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111110 001112223456677888999999999999888765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=276.81 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=174.9
Q ss_pred HhHHHhhCCCccceEEEEEee---------------CCCCeEEEEEEecchhhhhHHH--------------HHHHHHHh
Q 044281 504 DGFKEELGRGSFGIVYKGVLK---------------TASGTAIAVKKLDRLAQERERE--------------FKSEVSAI 554 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~---------------~~~~~~vavK~l~~~~~~~~~~--------------~~~E~~~l 554 (796)
+.+.++||+|+||.||+|.+. ...++.||||++........++ +..|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 345578999999999999742 1235689999986543322233 33466777
Q ss_pred cccCccCc-----ccccccccc--------cccceeEEeecCCCCHHHHHhcC------------------------CCC
Q 044281 555 GRTHHKHL-----VQLLGFCDE--------ALNRLLVYEFMGNGTLANLIFAI------------------------PKP 597 (796)
Q Consensus 555 ~~l~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~------------------------~~~ 597 (796)
.+++|.++ ++++++|.. ....+|||||+++++|.++++.. ..+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766554 677887753 35679999999999999988642 123
Q ss_pred chhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCccccccccc
Q 044281 598 DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677 (796)
Q Consensus 598 ~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 677 (796)
++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.+............+++.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 5677889999999999999998 8999999999999999999999999999765433222222233578999999885
Q ss_pred CCCC----------------------CccchhHHHHHHHHHHHhCCC-CCchhhH--HHH---hHHHHHHHHHhhhcCcc
Q 044281 678 NVPV----------------------SAKVDVYSFGVTLLEIICCRR-SVEMELE--EES---RAILTDWAYDCYVEGRL 729 (796)
Q Consensus 678 ~~~~----------------------s~k~DVwS~Gv~l~elltg~~-p~~~~~~--~~~---~~~l~~~~~~~~~~~~~ 729 (796)
.... ..+.||||+||+++||+++.. |+..... .+. ...+..| ........
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~~~ 461 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQKY 461 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--HhhcccCC
Confidence 4321 234799999999999999875 5543211 000 0111111 11111111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDP---SKRPTMKVVLQM 773 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPt~~evl~~ 773 (796)
+... .........+++.++|..+| .+|+|++|++++
T Consensus 462 ----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 ----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1110 11123456678888888765 789999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=284.74 Aligned_cols=256 Identities=23% Similarity=0.252 Sum_probs=166.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCC----CeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccc------ccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTAS----GTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGF------CDEAL 573 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~~~ 573 (796)
+.+.++||+|+||.||+|++.. + +..||+|++...... +.+..| .+....+.+++.++.. +.+..
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~-~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVN-KQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcC-CccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 3445789999999999999763 4 689999998653211 111111 1122223333333222 24566
Q ss_pred cceeEEeecCCCCHHHHHhcCCC--------------------CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCC
Q 044281 574 NRLLVYEFMGNGTLANLIFAIPK--------------------PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQN 633 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~N 633 (796)
..++||||+++++|.+++..... .....+..++.||+.||+|||+. +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 78999999999999998865421 11233567999999999999998 89999999999
Q ss_pred EEEcC-CCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCC----------------------CCCccchhHHH
Q 044281 634 ILLDH-FFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV----------------------PVSAKVDVYSF 690 (796)
Q Consensus 634 Ill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~DVwS~ 690 (796)
||+++ ++.+||+|||+|+.+............+++.|+|||.+... .+..++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99985 68999999999987654443334456789999999965322 23456799999
Q ss_pred HHHHHHHHhCCCCCchhhHHHHhHH------HHHHHHHhhhcCccceeccchhhh--hhcHHHHHHHHHHHHHhcccCCC
Q 044281 691 GVTLLEIICCRRSVEMELEEESRAI------LTDWAYDCYVEGRLDVLIDSDEAA--MADRSRLHKWLMIAMWCIQEDPS 762 (796)
Q Consensus 691 Gv~l~elltg~~p~~~~~~~~~~~~------l~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~ 762 (796)
||+||||+++..+............ +..|... .... ....... ...........+++.+||+.||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL--VEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh--hccc----cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999997766543321111000 0011000 0000 0000000 00000112345799999999999
Q ss_pred CCCCHHHHHHH
Q 044281 763 KRPTMKVVLQM 773 (796)
Q Consensus 763 ~RPt~~evl~~ 773 (796)
+|||+.+++++
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=269.33 Aligned_cols=209 Identities=24% Similarity=0.355 Sum_probs=179.0
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.||-|+||+|.++. +.++...+|+|.|++... ......+.|-.||+.-..+-||+|+..|++.+.+|+||||++|
T Consensus 635 k~iGvGAFGeV~Lv~-KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVR-KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEe-ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 359999999999987 445678899999987543 2345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc---------C
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF---------S 655 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~---------~ 655 (796)
|++-.+|.....+++..+..++.++..|+++.|.. |+|||||||+|||||.+|++||+||||+.-++ .
T Consensus 714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 99999999999999999999999999999999997 99999999999999999999999999986441 0
Q ss_pred -CCC-------------------------------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 044281 656 -DQS-------------------------------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS 703 (796)
Q Consensus 656 -~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p 703 (796)
+.. ......+||+.|+|||++....++..+|.||.|||||||+.|+.|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 000 011234699999999999999999999999999999999999999
Q ss_pred CchhhHHHHhHHHHHHH
Q 044281 704 VEMELEEESRAILTDWA 720 (796)
Q Consensus 704 ~~~~~~~~~~~~l~~~~ 720 (796)
|-...+.+.+..+..|.
T Consensus 871 f~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 871 FLADTPGETQYKVINWR 887 (1034)
T ss_pred ccCCCCCcceeeeeehh
Confidence 98877766555554443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=250.34 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=195.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.++||+|+|.+|.++.++ ++.+.+|+|++++.. .+...-.+.|-.+..+. +||.+|.+..+++....+++|.||
T Consensus 254 ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 4578999999999999887 467899999987632 22234456676666665 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|+|--++..+.+++++.+..+..+|..||.|||+. +||.||||.+|||+|.+|++||+|+|+.+.--.+ ....
T Consensus 333 v~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~-gd~t 408 (593)
T KOG0695|consen 333 VNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTT 408 (593)
T ss_pred ecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC-Cccc
Confidence 99999999999889999999999999999999999999 9999999999999999999999999999864333 3344
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...+||+.|+|||++++..|....|.|++||+++||+.|+.||+....+.....-.++..+.+.+..+. .
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----------i 478 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----------I 478 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc----------c
Confidence 567899999999999999999999999999999999999999975432222222223333333332221 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRP 765 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RP 765 (796)
+....-+...++..-+.+||.+|.
T Consensus 479 prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhc
Confidence 223334455677778899999884
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=262.78 Aligned_cols=244 Identities=21% Similarity=0.225 Sum_probs=201.8
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
..||-|+||.|=++..+.. ...+|+|.+++. ....++....|-.+|...+.|.||+++-.+.+....|++||-+-|
T Consensus 426 aTLGvGgFGRVELV~~~~~-~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQ-KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhcccCccceEEEEEeccc-chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 4599999999999887632 235788888653 344567788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
|.|...|.+++.++..+...++..+.+|++|||++ +||.|||||+|.++|.+|-+||.|||+|+.+... ...-+.
T Consensus 505 GElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~KTwTF 579 (732)
T KOG0614|consen 505 GELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RKTWTF 579 (732)
T ss_pred chhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--Cceeee
Confidence 99999999999999999999999999999999998 9999999999999999999999999999987543 234457
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
+||+.|.|||++.++.++.++|.||||+++|||++|.+||....+......+...... ...+..
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------------i~~Pr~ 643 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------------IEFPRR 643 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------------hhcccc
Confidence 8999999999999999999999999999999999999999988776554444322111 111222
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPT-----MKVVLQM 773 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~~ 773 (796)
......+++++....+|.+|.- +.||-++
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 2334556777777889999986 6666544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-29 Score=273.55 Aligned_cols=239 Identities=30% Similarity=0.352 Sum_probs=185.5
Q ss_pred HHhhCCCccce-EEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecCC
Q 044281 507 KEELGRGSFGI-VYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 507 ~~~LG~G~fG~-Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+++|.|+-|+ ||+|.. ++++||||++-. +......+|+..|+.- +||||||+++.-.+...+||..|.+..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY---EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred HHHcccCCCCcEEEEEee---CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 36799999986 799997 478999999843 2334567899999887 799999999999999999999999965
Q ss_pred CCHHHHHhcC-CC---CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-----CCcEEEeecCCcccccC
Q 044281 585 GTLANLIFAI-PK---PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-----FFSAKISDFGLSKLLFS 655 (796)
Q Consensus 585 gsL~~~l~~~-~~---~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~kl~DfGla~~~~~ 655 (796)
+|.+++... .. ..-...+.+..|+++||++||+. +||||||||.||||+. ...++|+|||+++.+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 999999874 11 11134577889999999999997 9999999999999975 35799999999999876
Q ss_pred CCCcc--eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhC-CCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 656 DQSRT--HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICC-RRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 656 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
+.... .....||.+|+|||.+....-+.++||||+||++|..++| ..||......+. .+.... ..+..+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~------~~L~~L 735 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGN------YTLVHL 735 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCc------cceeee
Confidence 65322 3456699999999999999989999999999999999997 678865433221 111101 111111
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
-. ..++ +..+++.+|+..+|..||++.+|+.
T Consensus 736 ~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 EP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 10 1111 5678999999999999999999873
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=223.36 Aligned_cols=195 Identities=30% Similarity=0.437 Sum_probs=162.5
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.||+|++|.|-+-++. .+|+.+|+|++... ..+.++..++|+.+..+- .+|.+|.++|........++.||.|.-
T Consensus 51 i~elGrGayG~vekmrh~-~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhcCCccchhhheeec-cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 367999999999888776 57899999999653 344567788899887765 899999999999999999999999964
Q ss_pred CCHHHHH----hcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 585 GTLANLI----FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 585 gsL~~~l----~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
||+.+- .....+++...-+|+..+.+||.|||++ ..+||||+||+|||++.+|++||+|||++-.+.+.-..
T Consensus 130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk- 205 (282)
T KOG0984|consen 130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK- 205 (282)
T ss_pred -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-
Confidence 776654 3456788888999999999999999997 48999999999999999999999999999876433222
Q ss_pred eeeccCCCccccccccc----CCCCCccchhHHHHHHHHHHHhCCCCCchh
Q 044281 661 HTMIRGTRGYVAPEWFK----NVPVSAKVDVYSFGVTLLEIICCRRSVEME 707 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~ 707 (796)
+...|-..|||||.+. ...|+.|+||||||+.+.||.+++-|++.-
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 2233566799999884 347899999999999999999999998754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=232.53 Aligned_cols=211 Identities=38% Similarity=0.565 Sum_probs=183.3
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCHH
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLA 588 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 588 (796)
||+|.+|.||++.... +++.+++|++...... ....+.+|+..++.++|++++++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecC-CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998753 5789999999764432 3567999999999999999999999999999999999999999999
Q ss_pred HHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccccCCCCcceeeccC
Q 044281 589 NLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQSRTHTMIRG 666 (796)
Q Consensus 589 ~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~g 666 (796)
+++... ..+++..+..++.++++++.+||+. +++|+||+|.||++++ ++.++|+|||.+........ ......+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 999876 5788999999999999999999998 9999999999999999 89999999999986644321 1223446
Q ss_pred CCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHH
Q 044281 667 TRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSR 745 (796)
Q Consensus 667 t~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 745 (796)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999999887 888999999999999998
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 746 LHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 746 ~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3456688999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=249.88 Aligned_cols=192 Identities=23% Similarity=0.328 Sum_probs=167.5
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh--------hHHHHHHHHHHhcccC---ccCcccccccccccccc
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--------REREFKSEVSAIGRTH---HKHLVQLLGFCDEALNR 575 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 575 (796)
.+.+|+|+||.|+.++++. +...|+||.+.+...- ..-..-.|+++|+.++ |+||++++++|++++..
T Consensus 566 lq~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeccccccceEEEeeecc-cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 3679999999999999885 4789999998663211 1123567999999997 99999999999999999
Q ss_pred eeEEeec-CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 576 LLVYEFM-GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 576 ~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
||+||-. ++-+|.++|.-++.+++..+..|+.||+.|+++||+. +|||||||-+||.++.+|-+||+|||.|....
T Consensus 645 yl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhc
Confidence 9999976 4668999999999999999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCCcceeeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCc
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVE 705 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~ 705 (796)
..+....+||.+|.|||++.+.+| ...-|||++|++||-++....|+.
T Consensus 722 ---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 ---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 344566789999999999999888 456899999999999998888875
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-27 Score=210.21 Aligned_cols=100 Identities=40% Similarity=0.624 Sum_probs=71.2
Q ss_pred CCeEEEeecCCCCCC---CCcEEEEecCc-eEEECCCCCeeeec-CC-CC--ccceEEeecCccEEEEEcCCCCcceeec
Q 044281 70 ERTIVWHANGDNPAP---RGSTLELTATG-LLLKDPGGQAIWDG-KP-DK--NVSDAAMLDTGNFVLRASGNNSDYAWQS 141 (796)
Q Consensus 70 ~~t~VW~ANr~~pv~---~~s~l~l~~~g-l~l~~~~~~~vWst-~~-~~--~~~~a~lldsGNlVl~~~~~~~~~lWQS 141 (796)
++||||+|||++|+. ...+|.|..|| |+|.|.+++++|++ ++ .. .+..|+|+|+|||||++. .+.+||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~--~~~~lW~S 78 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS--SGNVLWQS 78 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET--TSEEEEES
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee--cceEEEee
Confidence 479999999999994 23699999999 99999999999998 43 33 367899999999999874 57799999
Q ss_pred cccCcccccCCccccCc------ceEEeccCCCCCC
Q 044281 142 FKSPTDTILPTQILDLG------SVLVSRLTETNFS 171 (796)
Q Consensus 142 FD~PTDtlLpg~kl~~~------~~L~S~~s~~d~s 171 (796)
|||||||+||||+|+.+ ..++||++.+|||
T Consensus 79 f~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 79 FDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred cCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999873 3499999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=228.44 Aligned_cols=197 Identities=30% Similarity=0.452 Sum_probs=173.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.+.||+|++|.||++... .+++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred eeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 3467999999999999876 34789999999765444 567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC-CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAIPK-PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~~~-~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++|.+++..... +++.....++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+.............
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999987766 89999999999999999999998 89999999999999999999999999998775443112233
Q ss_pred ccCCCcccccccc-cCCCCCccchhHHHHHHHHHHHhCCCCCch
Q 044281 664 IRGTRGYVAPEWF-KNVPVSAKVDVYSFGVTLLEIICCRRSVEM 706 (796)
Q Consensus 664 ~~gt~~y~aPE~~-~~~~~s~k~DVwS~Gv~l~elltg~~p~~~ 706 (796)
..++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4577889999998 677788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=213.00 Aligned_cols=258 Identities=17% Similarity=0.311 Sum_probs=187.6
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCccccccccccccc--ceeEE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALN--RLLVY 579 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~--~~lv~ 579 (796)
.+.+.+++|+|.+++||.|..- .+.+.++||+++... .+.+.+|+++|..+. ||||+++++...++.. ..||+
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~-~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINI-TNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred hHHHHHHHcCccHhhHhccccc-CCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 4567789999999999999844 467899999998643 457899999999997 9999999999877654 46999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~ 658 (796)
||+.+.+...+- +.++...+...+.++++||.|+|+. ||+|||+||.|+++|. .-.++|+|+|+|........
T Consensus 115 E~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 115 EYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 999997766554 4566667788999999999999998 9999999999999995 45699999999997654432
Q ss_pred cceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHH-HHhHHHHH-----HHHHhhh------
Q 044281 659 RTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEE-ESRAILTD-----WAYDCYV------ 725 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~-~~~~~l~~-----~~~~~~~------ 725 (796)
....+.+..|.-||.+.. ..|+..-|+|||||+|.+|+..+.||...... ++...+.. .....+.
T Consensus 189 --YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred --eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 233446778999999865 45788999999999999999999998643221 11111111 0111111
Q ss_pred cCccceeccchhh--------hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 726 EGRLDVLIDSDEA--------AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 726 ~~~~~~~~d~~~~--------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+.+...++....+ .....-...+.++++...|..|-.+|||++|...
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111111000 0000011246777888889999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=241.38 Aligned_cols=280 Identities=19% Similarity=0.214 Sum_probs=210.9
Q ss_pred CCCCCCccccCHHHHHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC------
Q 044281 485 TTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH------ 558 (796)
Q Consensus 485 ~~~~~~~~~~~~~~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------ 558 (796)
......+-.+.+.|+.+..|.+....|+|-|++|..|.... .++.||||++.+.. -..+.=+.|+++|++|+
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~-r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA-RGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPED 492 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccC-CCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchh
Confidence 33334445566778888888888889999999999998664 56799999997743 34456678999999985
Q ss_pred ccCcccccccccccccceeEEeecCCCCHHHHHhcCC---CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEE
Q 044281 559 HKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP---KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635 (796)
Q Consensus 559 h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIl 635 (796)
..|+++++-.|...+++|||+|-+. .+|.++|+..+ .+.......++.|+.-||..|... +|+|.||||+|||
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNIL 568 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceE
Confidence 3489999999999999999999874 58999998653 567788899999999999999987 9999999999999
Q ss_pred EcCC-CcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH
Q 044281 636 LDHF-FSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA 714 (796)
Q Consensus 636 l~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~ 714 (796)
|++. ..+||||||.|.....++ .+++.-+..|.|||++.|.+|+...|+||.||.||||.||+..|.+........
T Consensus 569 VNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred eccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 9975 557999999998654333 334445678999999999999999999999999999999999887655443333
Q ss_pred HHHHHHHH----hhhcCc-cceecc--------------------------c------hhh-----hhhcHHHHHHHHHH
Q 044281 715 ILTDWAYD----CYVEGR-LDVLID--------------------------S------DEA-----AMADRSRLHKWLMI 752 (796)
Q Consensus 715 ~l~~~~~~----~~~~~~-~~~~~d--------------------------~------~~~-----~~~~~~~~~~l~~l 752 (796)
+.++.... .+..|. ..+.+| + .+. ....+..+..+..|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 22221100 000000 001111 1 000 01123455678889
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 044281 753 AMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 753 ~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+..|+..||++|.|..+.|++
T Consensus 726 Ldkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHhccChhhcCCHHHHhcC
Confidence 999999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=226.30 Aligned_cols=255 Identities=25% Similarity=0.261 Sum_probs=184.9
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccc------cccceeEEe
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDE------ALNRLLVYE 580 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lv~e 580 (796)
.+|.|.- .|-.+.+. -.+++||+|++.... ....+...+|...+..++|+|+++++.++.- -.+.|+|||
T Consensus 24 p~~~g~~-~v~~a~D~-v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQ-VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred ccCCCCc-eEEecchh-hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 3566665 44444322 357899999985532 2334667889999999999999999999843 345689999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+|.. +|...+. -.++-++...|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|+.-..+ -.
T Consensus 102 ~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~ 173 (369)
T KOG0665|consen 102 LMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FM 173 (369)
T ss_pred hhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--cc
Confidence 9954 8887776 4566778889999999999999998 9999999999999999999999999999854332 34
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHH---------------HHHHHHHhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAI---------------LTDWAYDCYV 725 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~---------------l~~~~~~~~~ 725 (796)
.+.++.|+.|.|||++.+..+.+.+||||.||++.||++|+..|.+...-+.-.. +...+.....
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 5667889999999999999999999999999999999999988775432221111 1111111111
Q ss_pred cC------ccce-eccchh--hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 726 EG------RLDV-LIDSDE--AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 726 ~~------~~~~-~~d~~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.. ...+ +.|..- ..+.++........++.+||-.||++|.++.+++++
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 0000 111100 011122334456678999999999999999999976
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-26 Score=247.43 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=199.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
+...+|.|.+|.|||++.+ ..++..|+|.++-.......-..+|+-+++..+|+|||.++|.+.....+++.|||+.+|
T Consensus 19 llqrvgsgTygdvyKaRd~-~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDK-RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred heeeecCCcccchhhhccc-ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 4467999999999999976 468899999998776677778889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeecc
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR 665 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 665 (796)
+|.+.-+-...+++.++..++++.++||+|||+. +-+|||||-.|||+++.+.+|++|||.+-.+... ........
T Consensus 98 slQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~Krksfi 173 (829)
T KOG0576|consen 98 SLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKSFI 173 (829)
T ss_pred cccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hhhhhccc
Confidence 9999988888999999999999999999999998 7899999999999999999999999998765321 22234456
Q ss_pred CCCcccccccc---cCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 666 GTRGYVAPEWF---KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 666 gt~~y~aPE~~---~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
||+.|||||+. +.+.|..++|||+.|+...|+--...|.....+......... ..+++. .....
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk------------S~~qpp-~lkDk 240 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK------------SGFQPP-TLKDK 240 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc------------cCCCCC-cccCC
Confidence 99999999987 467899999999999999999877777554433332222111 011111 11112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
....+-+-++++.|+-++|++||+++.+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 233445566888899999999999987654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=226.96 Aligned_cols=130 Identities=28% Similarity=0.433 Sum_probs=109.0
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-----c---cCccccccccc---
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-----H---KHLVQLLGFCD--- 570 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~--- 570 (796)
..|.+.++||-|.|++||++.+. .+.+.||+|+.+.. ..-.+..+.|+++|++++ | ..||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDt-q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDT-QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeec-cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 66777889999999999999754 57789999998653 333456788999999873 2 36999999985
Q ss_pred -ccccceeEEeecCCCCHHHHHhc--CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE
Q 044281 571 -EALNRLLVYEFMGNGTLANLIFA--IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL 636 (796)
Q Consensus 571 -~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll 636 (796)
.+.+.+||+|++.. +|..+|.. .+.++.....+|+.||+.||.|||.+| +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 46688999999944 77777764 367889999999999999999999998 99999999999998
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=194.15 Aligned_cols=107 Identities=34% Similarity=0.581 Sum_probs=94.0
Q ss_pred CCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEEECCCCCeeeecCCC-
Q 044281 35 NSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLKDPGGQAIWDGKPD- 112 (796)
Q Consensus 35 ~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l~~~~~~~vWst~~~- 112 (796)
+++|+|++|.|++|||++.... .++.+|||.+++ +++||.||++.|....++|.|+.+| |+|.|.+|.++|++++.
T Consensus 7 ~~~l~s~~~~f~~G~~~~~~q~-~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~ 84 (116)
T cd00028 7 GQTLVSSGSLFELGFFKLIMQS-RDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR 84 (116)
T ss_pred CCEEEeCCCcEEEecccCCCCC-CeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccC
Confidence 5789999999999999987654 389999999887 8999999999997666799999999 99999999999998753
Q ss_pred -CccceEEeecCccEEEEEcCCCCcceeeccccC
Q 044281 113 -KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSP 145 (796)
Q Consensus 113 -~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~P 145 (796)
.....|+|+|+|||||++. ++.+||||||||
T Consensus 85 ~~~~~~~~L~ddGnlvl~~~--~~~~~W~Sf~~P 116 (116)
T cd00028 85 VNGNYVLVLLDDGNLVLYDS--DGNFLWQSFDYP 116 (116)
T ss_pred CCCceEEEEeCCCCEEEECC--CCCEEEcCCCCC
Confidence 4556799999999999875 367899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-25 Score=263.62 Aligned_cols=195 Identities=18% Similarity=0.203 Sum_probs=138.8
Q ss_pred ccCc-cCcccccccc-------cccccceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeee
Q 044281 556 RTHH-KHLVQLLGFC-------DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626 (796)
Q Consensus 556 ~l~h-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH 626 (796)
.++| .||+++++.+ .+....++++|++ +++|.++|... ..+++..++.++.||++||+|||++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 3455 6888888877 2334567888987 55999999753 4589999999999999999999998 9999
Q ss_pred CCCCCCCEEEcC-------------------CCcEEEeecCCcccccCCCC---------------cceeeccCCCcccc
Q 044281 627 CDIKPQNILLDH-------------------FFSAKISDFGLSKLLFSDQS---------------RTHTMIRGTRGYVA 672 (796)
Q Consensus 627 ~Dlk~~NIll~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y~a 672 (796)
|||||+||||+. ++.+||+|||+++....... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 44566666666654211000 00112357888999
Q ss_pred cccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHH
Q 044281 673 PEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMI 752 (796)
Q Consensus 673 PE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 752 (796)
||++.+..++.++|||||||+||||+++..|+...... +....... ..+. ......+...+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~~~~~~~~---------~~~~-----~~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----MSSLRHRV---------LPPQ-----ILLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----HHHHHHhh---------cChh-----hhhcCHHHHHH
Confidence 99999999999999999999999999988876532111 10100000 0000 01112334567
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 044281 753 AMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 753 ~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.+||+.+|.+||+|.||++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=207.34 Aligned_cols=250 Identities=20% Similarity=0.297 Sum_probs=182.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccc-cccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLG-FCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g-~~~~~~~~~lv~e~ 581 (796)
+.+.+.||+|.||.+-++.++ ++++.+++|.+.... -..++|.+|..---.| .|.||+.-++ .++..+..++++||
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhHHHHhcccceeeEEeeecc-CCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 556788999999999999987 467899999987643 3467899998775555 6999998765 46677777899999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc--CCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD--HFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~DfGla~~~~~~~~~ 659 (796)
++.|+|.+-+.. ..+.+....+++.|+++||.|||+. ++||||||.+||||- +..++||+|||+.+..+.
T Consensus 104 aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~---- 175 (378)
T KOG1345|consen 104 APRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT---- 175 (378)
T ss_pred CccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc----
Confidence 999999988765 3456677788999999999999998 999999999999994 456899999999875422
Q ss_pred ceeeccCCCcccccccccCC-----CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 660 THTMIRGTRGYVAPEWFKNV-----PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
......-+..|.+||..... ...+.+|||.||++++.+++|+.|+......... .|.+..|..+....+.+
T Consensus 176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~----Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP----YWEWEQWLKRKNPALPK 251 (378)
T ss_pred eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch----HHHHHHHhcccCccCch
Confidence 11122235579999987533 2467899999999999999999999854332211 23333344443332222
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.. ....+++.++-.+-+..+|++|--+.++.++
T Consensus 252 ~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 252 KF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hh------cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11 1123455566667788899888555554443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=204.04 Aligned_cols=166 Identities=22% Similarity=0.194 Sum_probs=125.5
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
|+|.+++... ..+++..++.++.||++||.|||++ + ||+|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999864 4689999999999999999999997 3 999999999999999 99998654322
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|||||++.+..++.++|||||||++|||++|+.||........ .+....... .... .. ......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~-~~~~----~~---~~~~~~ 133 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGM-PADD----PR---DRSNLE 133 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHh-ccCC----cc---ccccHH
Confidence 2588999999999999999999999999999999999999865432111 111111110 0000 00 000011
Q ss_pred HHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 744 SRL--HKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 744 ~~~--~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
... .++.+++.+||+.+|++||++.++++.+..+
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 122 2588899999999999999999999998654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=220.43 Aligned_cols=195 Identities=24% Similarity=0.324 Sum_probs=161.4
Q ss_pred hHHHhhCCCccceEEEEEeeCC--CCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
...++||+|.|++||++++... ..+.||+|.+... +....+.+|++.|..+ -+.||+++.+++...+...+|+||
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 3456899999999999987653 5679999999653 3345688999999998 599999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccccCCC---
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQ--- 657 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~--- 657 (796)
+++-...++... ++...+..++..+..||+++|+. |||||||||.|+|.+. .+.-.|.|||+|......+
T Consensus 117 ~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 117 FEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred cCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 999998888866 45778888999999999999999 9999999999999984 5678999999997211000
Q ss_pred ----------------------------------------CcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHH
Q 044281 658 ----------------------------------------SRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLE 696 (796)
Q Consensus 658 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~e 696 (796)
........||+||.|||++.. ..-+.++||||-||+++.
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 001112459999999999864 557899999999999999
Q ss_pred HHhCCCCCchh
Q 044281 697 IICCRRSVEME 707 (796)
Q Consensus 697 lltg~~p~~~~ 707 (796)
+++++.||...
T Consensus 271 lls~~~PFf~a 281 (418)
T KOG1167|consen 271 LLSRRYPFFKA 281 (418)
T ss_pred hhccccccccC
Confidence 99999998643
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=186.34 Aligned_cols=105 Identities=32% Similarity=0.559 Sum_probs=92.5
Q ss_pred CCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEEECCCCCeeeecCCC-
Q 044281 35 NSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLKDPGGQAIWDGKPD- 112 (796)
Q Consensus 35 ~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l~~~~~~~vWst~~~- 112 (796)
+++|+|++|.|++|||.+... .++.+|||++.+ +++||+|||+.|+..+..|.|..+| |+|.|.+|.++|++++.
T Consensus 7 ~~~l~s~~~~f~~G~~~~~~q--~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~ 83 (114)
T smart00108 7 GQTLVSGNSLFELGFFTLIMQ--NDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTG 83 (114)
T ss_pred CCEEecCCCcEeeeccccCCC--CCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccC
Confidence 578999999999999998755 389999999887 8999999999999777899999999 99999999999998753
Q ss_pred -CccceEEeecCccEEEEEcCCCCcceeecccc
Q 044281 113 -KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKS 144 (796)
Q Consensus 113 -~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~ 144 (796)
.+...++|+|+|||||++. .+.+|||||||
T Consensus 84 ~~~~~~~~L~ddGnlvl~~~--~~~~~W~Sf~~ 114 (114)
T smart00108 84 ANGNYVLVLLDDGNLVIYDS--DGNFLWQSFDY 114 (114)
T ss_pred CCCceEEEEeCCCCEEEECC--CCCEEeCCCCC
Confidence 4556799999999999865 45699999997
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=214.79 Aligned_cols=161 Identities=22% Similarity=0.148 Sum_probs=126.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-----hhhhHHHHHHHHHHhcccCccCccc-cccccccccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKHLVQ-LLGFCDEALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~l 577 (796)
+.+.+.||+|+||+||+|..+..+++.||||++... .....+.|.+|++++++++|+|++. +++. ...++
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~L 95 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGL 95 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEE
Confidence 445678999999999999877556788999987532 1223567999999999999999985 4432 45799
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCC-CCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDI-KPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dl-k~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
||||+++++|... .... ...++.|+++||.|||+. +|+|||| ||+|||++.++.+||+|||+|+.+...
T Consensus 96 VmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 96 VRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 9999999999632 1111 146788999999999998 9999999 999999999999999999999977543
Q ss_pred CCc-------ceeeccCCCcccccccccC
Q 044281 657 QSR-------THTMIRGTRGYVAPEWFKN 678 (796)
Q Consensus 657 ~~~-------~~~~~~gt~~y~aPE~~~~ 678 (796)
... ......+++.|+|||.+.-
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 311 1134568889999999853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=197.25 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=190.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecc--hhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.++..+|.+...|+.|+|++. |..+++|++.- ......++|.+|.-.|+-+.||||+.++|.|..+.++.++..|
T Consensus 192 lnl~tkl~e~hsgelwrgrwq---gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ---GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhccCCCccccccccc---CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 346678999999999999985 66788888753 2233347899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC--CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEe--ecCCcccccCCC
Q 044281 582 MGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKIS--DFGLSKLLFSDQ 657 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~--DfGla~~~~~~~ 657 (796)
|+.|+|...|+.... .+-.++.+++.+||+|++|||+.. +-|..--|....+++|++.+++|+ |--++..
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 999999999998753 467789999999999999999974 234445688899999999988775 3222211
Q ss_pred CcceeeccCCCcccccccccCCCCC---ccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVS---AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s---~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
.....-.+.||+||.++.++-+ .++|+|||.+++||+.|...||....+.+....+ ..+|
T Consensus 343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------aleg------- 405 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------ALEG------- 405 (448)
T ss_pred ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------hhcc-------
Confidence 1111236789999999877654 4799999999999999999999866554432221 1122
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+....++.....+.+++.-|+..||.+||.+..|+-+||++.
T Consensus 406 --lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 --LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 122223334456677888899999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=201.90 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=189.0
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCc----cCcccccccc-ccccccee
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHH----KHLVQLLGFC-DEALNRLL 577 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 577 (796)
.+.+.++||+|+||.||++.........+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 345668899999999999986543345788888765433333367888888888763 5888888888 47778899
Q ss_pred EEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC-----CcEEEeecCCc
Q 044281 578 VYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF-----FSAKISDFGLS 650 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~-----~~~kl~DfGla 650 (796)
||+.. +.+|.++.... ..++..+.++|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99976 67999988654 4788999999999999999999998 99999999999999864 46999999999
Q ss_pred c--cccCCCC------cc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH
Q 044281 651 K--LLFSDQS------RT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY 721 (796)
Q Consensus 651 ~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 721 (796)
+ ....... +. ....+||..|.++....+...+.+.|+||++.++.|++.|..|+...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 9 4322221 11 2235599999999999999999999999999999999999999865432211111111111
Q ss_pred HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 722 DCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 722 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
... ... .....+.+... +...+-..+..++|....+...|+.....
T Consensus 255 ~~~--------~~~--~~~~~~~~~~~---~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 255 KLL--------TDR--FGDLKPEEFAK---ILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhc--------ccc--ccCCChHHHHH---HHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 100 000 11112233333 33334457999999999999998765443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=194.37 Aligned_cols=256 Identities=28% Similarity=0.375 Sum_probs=194.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh---hHHHHHHHHHHhcccCcc-CcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE---REREFKSEVSAIGRTHHK-HLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.||.|+||.||++... ..+++|.+...... ....+.+|+..++.+.|+ +++++.+++......++++|+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred eEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 3467899999999999864 68899998764433 367899999999999888 799999999777778999999
Q ss_pred cCCCCHHHHHhcCC---CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCcccccCCC
Q 044281 582 MGNGTLANLIFAIP---KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 582 ~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~ 657 (796)
+.++++.+++.... .+.......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997777664 688889999999999999999998 899999999999999988 79999999998654443
Q ss_pred Cc-----ceeeccCCCcccccccccC---CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcc
Q 044281 658 SR-----THTMIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729 (796)
Q Consensus 658 ~~-----~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (796)
.. ......++..|+|||.+.+ ...+...|+||+|+++++++++..|+...................... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 22 2356679999999999988 578999999999999999999999976554210000000111110000 00
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......... ......+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 1223456678888999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7e-21 Score=217.54 Aligned_cols=253 Identities=21% Similarity=0.214 Sum_probs=188.9
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEec----c-hh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLD----R-LA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~----~-~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.+|.|.+|.|+...... ..+..+.|... . .. .+....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~-~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRS-DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecC-CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4579999999777765432 23333333321 1 11 1112236778888888999999998888887777776799
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC--
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-- 658 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-- 658 (796)
|+++ +|..++.....+....+..++.|++.|+.|+|+. +|.|||||++|++++.++.+||+|||.+..+..+..
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 9999998887888899999999999999999998 999999999999999999999999999998765543
Q ss_pred -cceeeccCCCcccccccccCCCCCcc-chhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 -RTHTMIRGTRGYVAPEWFKNVPVSAK-VDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 -~~~~~~~gt~~y~aPE~~~~~~~s~k-~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
......+|+..|+|||.+.+..|.+. .||||.|+++..|++|+.|+......+... .. ..+..+. -...
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~--~~~~~~~-~~~~ 548 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KT--NNYSDQR-NIFE 548 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hh--hcccccc-cccc
Confidence 33455779999999999999999875 799999999999999999987654433221 00 0000000 0111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...........+...++.++|+.||.+|.||++|++.
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 1112233344566779999999999999999999863
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-20 Score=165.41 Aligned_cols=110 Identities=25% Similarity=0.421 Sum_probs=80.4
Q ss_pred eccccccCCCCCCcceeEEeccceEEEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEecCCCCCCCcceeEEE
Q 044281 201 YTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTR 280 (796)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~~~~~~~~~~~W~~~~ 280 (796)
|++|+|++......+.+..+.....-++.++++.+.. ....+.+.++|++||++|++++|.|. +..++|.+.|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t----~~~~~~s~~~r~~ld~~G~l~~~~w~---~~~~~W~~~~ 73 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYT----YSLSNSSVLSRLVLDSDGQLQRYIWN---ESTQSWSVFW 73 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEE----EecCCCceEEEEEEeeeeEEEEEEEe---cCCCcEEEEE
Confidence 7888888764444433332222222233444443321 12446788999999999999999994 4567899999
Q ss_pred ecCCcccccccccCCCCCCCCCccccCCCCCCccCCCCCceeeC
Q 044281 281 TLPDAMCRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHVLVD 324 (796)
Q Consensus 281 ~~p~~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~Cl~GF~~~~ 324 (796)
++|.++||+ |+.||+||+|+. +..|.|+||+||+|++
T Consensus 74 ~~p~d~Cd~------y~~CG~~g~C~~-~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 74 SAPKDQCDV------YGFCGPNGICNS-NNSPKCSCLPGFEPKN 110 (110)
T ss_pred EecccCCCC------ccccCCccEeCC-CCCCceECCCCcCCCc
Confidence 999999999 699999999985 5678999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=180.47 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=192.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.++||+|.||.++.|+. .-++++||||.-... ...-++..|.+..+.| ..++|...+.|-.++.+-.||+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~N-l~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKN-LYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ceeccccccCcceeeecccc-cccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 45678999999999999984 346899999986442 2334677788887777 5789999999999999999999988
Q ss_pred CCCCHHHHHh-cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-----CCcEEEeecCCcccccCC
Q 044281 583 GNGTLANLIF-AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-----FFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 583 ~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~kl~DfGla~~~~~~ 656 (796)
|.+|.++.. ...+++.++...+|.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+...+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 679999875 456899999999999999999999998 8999999999999963 456899999999987655
Q ss_pred CC------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 657 QS------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 657 ~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
.. +......||.+||+--...+..-+.+.|.-|||-+++..|-|..|+.+....... ..++.+.+.+..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-----~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-----EKYEKIGETKRS 257 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----HHHHHhcccccc
Confidence 43 3345567999999999999999999999999999999999999999865332211 122222222221
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.-++.... .-+++....++.++ ..+-.+-|...-+...+..++
T Consensus 258 T~i~~Lc~--g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 258 TPIEVLCE--GFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred CCHHHHHh--cCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHH
Confidence 11111111 12344444444444 346677788777666655444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=173.89 Aligned_cols=257 Identities=19% Similarity=0.260 Sum_probs=191.8
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCc-cCcccccccccccccceeEEe
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHH-KHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e 580 (796)
..+.+.++||.|+||.+|.|..- .+|+.||||.-+... ...++.-|.++.+.++| ..|..+..+..+...-.+|||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i-~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISI-TSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred cceEEEEeecCCchhheeeeeec-cCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34566788999999999999865 579999999865432 34567778888888864 678888888899999999999
Q ss_pred ecCCCCHHHHHh-cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc---CCCcEEEeecCCcccccCC
Q 044281 581 FMGNGTLANLIF-AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD---HFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 581 ~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~DfGla~~~~~~ 656 (796)
.+ +.+|.++.. ....++.++.+-++-|++.-++|+|.+ +.|||||||+|+|.. ...++.++|||+|+.+.+.
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 87 679988875 346788999999999999999999998 899999999999996 3467899999999987654
Q ss_pred CC------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 657 QS------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 657 ~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
.. +......||.+|.+--...+...+.+.|+-|+|.+|..+.-|..|+.+....... ..++.+.+.++.
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-----QKyEkI~EkK~s 242 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-----QKYEKISEKKMS 242 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----HHHHHHHHhhcC
Confidence 33 2234466999999998888888899999999999999999999999876543322 122333333333
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
..+.....+ ...++...+.-|-+.--++-|....+-+++.
T Consensus 243 ~~ie~LC~G-----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 243 TPIEVLCKG-----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred CCHHHHhCC-----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 333222221 1123444555566666666676665555443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-19 Score=195.56 Aligned_cols=216 Identities=25% Similarity=0.420 Sum_probs=162.9
Q ss_pred hcccCccCcccccccccccccceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCe-eeCCCCC
Q 044281 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPI-IHCDIKP 631 (796)
Q Consensus 554 l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i-iH~Dlk~ 631 (796)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+... ..+++.....+..+|++||+|||.. +| .|+.|++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 45789999999999999999999999999999999999884 5789999999999999999999997 44 9999999
Q ss_pred CCEEEcCCCcEEEeecCCcccccCC-CCcceeeccCCCcccccccccCC-------CCCccchhHHHHHHHHHHHhCCCC
Q 044281 632 QNILLDHFFSAKISDFGLSKLLFSD-QSRTHTMIRGTRGYVAPEWFKNV-------PVSAKVDVYSFGVTLLEIICCRRS 703 (796)
Q Consensus 632 ~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~k~DVwS~Gv~l~elltg~~p 703 (796)
+|+++|..+.+||+|||+....... .........-..-|.|||.+++. ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999999876431 11111222234569999999763 247789999999999999999999
Q ss_pred CchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 704 VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 704 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
|......+....+...+.. .+.. .+-+.... ..+....+..++..||..+|++||++..|-..++.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~---~~~~--~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK---GGSN--PFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh---cCCC--CcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9864433222112111111 0110 11111110 00222368889999999999999999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=177.49 Aligned_cols=138 Identities=17% Similarity=0.120 Sum_probs=107.7
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh--h------------------------HHHHHHHHHHhcccCccC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--R------------------------EREFKSEVSAIGRTHHKH 561 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~h~n 561 (796)
+.||+|+||.||+|... +|+.||||+++..... . ......|++.+.++.|++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 3 GCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 57999999999999875 6899999999653210 0 112245999999998887
Q ss_pred cccccccccccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHh-hhcCCCCeeeCCCCCCCEEEcCCC
Q 044281 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFF 640 (796)
Q Consensus 562 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yL-H~~~~~~iiH~Dlk~~NIll~~~~ 640 (796)
+.....+. ....+|||||++++++.........++......++.|++.+|.|+ |+. +|+||||||+|||++ ++
T Consensus 81 v~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPIL--LKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEEE--ecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 74433322 223489999999987765544446788889999999999999999 576 899999999999998 47
Q ss_pred cEEEeecCCcccc
Q 044281 641 SAKISDFGLSKLL 653 (796)
Q Consensus 641 ~~kl~DfGla~~~ 653 (796)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=171.90 Aligned_cols=139 Identities=17% Similarity=0.090 Sum_probs=109.5
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh--------------------------hHHHHHHHHHHhcccCccC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--------------------------REREFKSEVSAIGRTHHKH 561 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n 561 (796)
+.||+|+||.||+|... +|+.||||+++..... ....+..|...+.++.|++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 3 GCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred ceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 56999999999999865 6899999998653210 0123467899999999998
Q ss_pred cccccccccccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhh-cCCCCeeeCCCCCCCEEEcCCC
Q 044281 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHE-ECNVPIIHCDIKPQNILLDHFF 640 (796)
Q Consensus 562 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~Dlk~~NIll~~~~ 640 (796)
+.....+... ..+|||||++++++.........++......++.|++.++.++|+ . +|+||||||+||+++ ++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CC
Confidence 7554443322 348999999988654433333456778889999999999999999 7 999999999999999 89
Q ss_pred cEEEeecCCccccc
Q 044281 641 SAKISDFGLSKLLF 654 (796)
Q Consensus 641 ~~kl~DfGla~~~~ 654 (796)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-19 Score=177.64 Aligned_cols=170 Identities=13% Similarity=0.064 Sum_probs=127.8
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHH---------HHHHHHHHhcccCccCcccccccccc
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERER---------EFKSEVSAIGRTHHKHLVQLLGFCDE 571 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~g~~~~ 571 (796)
+..+...+.||+|+||.||.... ++..+|+|.+......... .+.+|+..+.+++|++|..+.+++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 34445567899999999998543 3568999999653322222 26899999999999999999888543
Q ss_pred c--------ccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 044281 572 A--------LNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAK 643 (796)
Q Consensus 572 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 643 (796)
. ...+|+|||++|.+|.++.. ++. ....+++.+|..+|+. +++|+|+||+||++++++ ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 2 35789999999999988732 221 3456999999999998 999999999999999988 99
Q ss_pred EeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHH
Q 044281 644 ISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698 (796)
Q Consensus 644 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ell 698 (796)
|+|||.......+... ..+.....+..++|+|+||+.+.-+.
T Consensus 175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988754211111 11334445667999999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-19 Score=202.26 Aligned_cols=250 Identities=23% Similarity=0.281 Sum_probs=181.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHH--hcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSA--IGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
..+.+.||.+.|=+|.+++++ .| .|+||.+-+.. .-..+.|.++++. ...++|||.+++.-.-......|||-+
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~--eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDR--EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred eeeecccCchhhhhhhhccCC--Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 345678999999999999864 45 48999885433 2334455554444 445689999999888888888899999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC--CCC
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS--DQS 658 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~--~~~ 658 (796)
|..+ +|.+.|..++-+...+..-|+.|++.||.-+|.. +|.|+|||.+||||+...=+.|+||.--+...- +..
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9876 8999999988888888899999999999999998 999999999999999999999999987664321 111
Q ss_pred ----cceeeccCCCcccccccccCC----------C-CCccchhHHHHHHHHHHHhC-CCCCchhhHHHHhHHHHHHHHH
Q 044281 659 ----RTHTMIRGTRGYVAPEWFKNV----------P-VSAKVDVYSFGVTLLEIICC-RRSVEMELEEESRAILTDWAYD 722 (796)
Q Consensus 659 ----~~~~~~~gt~~y~aPE~~~~~----------~-~s~k~DVwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~~~ 722 (796)
.-.++...-..|+|||.+... . .+++-||||+||+++||++- +++|+...- + +
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~---a-- 246 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------L---A-- 246 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------H---h--
Confidence 112222333479999988431 2 67889999999999999985 555553211 1 1
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 723 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
++.+. ....+..+....+ ..+..+++.|+|.||++|-++++.++.-.++
T Consensus 247 -Yr~~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 -YRSGN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -HhccC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11111 1111111111111 2456789999999999999999999985554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.2e-18 Score=163.50 Aligned_cols=185 Identities=15% Similarity=0.054 Sum_probs=138.8
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh----hHHHHHHHHHHhcccC-ccCcccccccccccccceeEEee
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE----REREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
...|++|+||+||.+. .++..++.+.++....- ....|.+|+++|++++ |+++++++++ ...+++|||
T Consensus 7 ~~~l~~~~f~~v~~~~---~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 7 NEPLKSDTFGRILLVR---GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ceeecCCCcceEEEee---cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3579999999999654 35778888887654331 1225789999999995 5889999886 446999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCC-CCCCEEEcCCCcEEEeecCCcccccCCCCc-
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDI-KPQNILLDHFFSAKISDFGLSKLLFSDQSR- 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dl-k~~NIll~~~~~~kl~DfGla~~~~~~~~~- 659 (796)
+.+.+|...+.. ....++.|++++|.++|+. +|+|||| ||.|||++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999998654321 1245778999999999998 9999999 799999999999999999999865432210
Q ss_pred ---c--------eeeccCCCcccccccccCC-CCC-ccchhHHHHHHHHHHHhCCCCCchhh
Q 044281 660 ---T--------HTMIRGTRGYVAPEWFKNV-PVS-AKVDVYSFGVTLLEIICCRRSVEMEL 708 (796)
Q Consensus 660 ---~--------~~~~~gt~~y~aPE~~~~~-~~s-~k~DVwS~Gv~l~elltg~~p~~~~~ 708 (796)
. ......++.|+.|+...-. ..+ .+.+.++-|.-+|.++|++.+...+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0112357778888765432 333 56789999999999999998875543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-18 Score=189.92 Aligned_cols=188 Identities=27% Similarity=0.254 Sum_probs=158.8
Q ss_pred hhCCCccceEEEEEe--eCCCCeEEEEEEecchhhhh--HHHHHHHHHHhcccC-ccCcccccccccccccceeEEeecC
Q 044281 509 ELGRGSFGIVYKGVL--KTASGTAIAVKKLDRLAQER--EREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~--~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+|+|.||.|++..- ..+.+..+|+|.+.+..... ......|-.++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999987531 11245678888886543211 114566778888886 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|.|...+.+....+..........++-+++++|+. +|+|||+|++||+++.+|++|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 999999999888888888788888999999999998 8999999999999999999999999999876433322
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCch
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEM 706 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~ 706 (796)
+||.-|||||++. .+..++|-||||++++||++|-.||..
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7899999999998 688899999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-17 Score=171.15 Aligned_cols=226 Identities=22% Similarity=0.297 Sum_probs=143.8
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecc---hhhhhHHHHHHHHHHhcccCc----------cCcccccccc-----
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHH----------KHLVQLLGFC----- 569 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~g~~----- 569 (796)
+.||.|+++.||.+++. .+++++|||.... ......+++++|...+..+.+ -.++..++..
T Consensus 18 ~~i~~g~~~~v~~v~d~-~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDV-ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEETTEEEEEEEET-TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred cccccCCceEEEEEEEc-cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 56999999999999965 5789999998843 333456778888766666432 1222222211
Q ss_pred ----cccc--------cceeEEeecCCCCHHHHHh---cCCC----CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCC
Q 044281 570 ----DEAL--------NRLLVYEFMGNGTLANLIF---AIPK----PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIK 630 (796)
Q Consensus 570 ----~~~~--------~~~lv~e~~~~gsL~~~l~---~~~~----~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk 630 (796)
.... ..+++|+-+ .++|.+++. .... +....++.+..|+++.+++||+. +++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 1111 235677776 458877754 2221 23445677779999999999999 99999999
Q ss_pred CCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccC--------CCCCccchhHHHHHHHHHHHhCCC
Q 044281 631 PQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN--------VPVSAKVDVYSFGVTLLEIICCRR 702 (796)
Q Consensus 631 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwS~Gv~l~elltg~~ 702 (796)
|+|++++.+|.++|+||+.....+... .. ...+..|.+||.... -.++.+.|.|++|+++|.|+|++.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999998776532211 11 335678999997743 257889999999999999999999
Q ss_pred CCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCC
Q 044281 703 SVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKR 764 (796)
Q Consensus 703 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R 764 (796)
||........... .-..+. .-.+.+..++..+|+.+|++|
T Consensus 249 Pf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9986533211100 011122 444566778899999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.8e-17 Score=159.73 Aligned_cols=133 Identities=17% Similarity=0.229 Sum_probs=103.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-----CccCcccccccccccc---cce-eE
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-----HHKHLVQLLGFCDEAL---NRL-LV 578 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~~~-lv 578 (796)
+.||+|+||.||. ++ .++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. ..+ +|
T Consensus 8 ~~LG~G~~~~Vy~--hp-~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HP-EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CC-CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 5799999999996 33 23333 68888654444567899999999999 5799999999998764 223 78
Q ss_pred Eee--cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHh-hHhhhcCCCCeeeCCCCCCCEEEcC----CCcEEEeecCCc
Q 044281 579 YEF--MGNGTLANLIFAIPKPDWNLRIRISLEIARGL-AYLHEECNVPIIHCDIKPQNILLDH----FFSAKISDFGLS 650 (796)
Q Consensus 579 ~e~--~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l-~yLH~~~~~~iiH~Dlk~~NIll~~----~~~~kl~DfGla 650 (796)
+|| .++++|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+||+-+
T Consensus 84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5579999999764 34444 35677888777 999998 8999999999999974 347999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=161.90 Aligned_cols=141 Identities=21% Similarity=0.180 Sum_probs=109.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh------------------------hhHHHHHHHHHHhcccCcc
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ------------------------EREREFKSEVSAIGRTHHK 560 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~------------------------~~~~~~~~E~~~l~~l~h~ 560 (796)
.+.+.||+|+||.||+|.....+|+.||+|.++.... .....+..|+..+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 4557899999999999983334789999999864211 0112457899999999753
Q ss_pred C--cccccccccccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCC-eeeCCCCCCCEEEc
Q 044281 561 H--LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP-IIHCDIKPQNILLD 637 (796)
Q Consensus 561 n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~-iiH~Dlk~~NIll~ 637 (796)
. +.++++. ...++||||+++.+|.................++.||+.++++||+. + |+|+||||+||+++
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~ 183 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH 183 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE
Confidence 3 3344432 23589999999988877654444555666789999999999999998 8 99999999999999
Q ss_pred CCCcEEEeecCCcccc
Q 044281 638 HFFSAKISDFGLSKLL 653 (796)
Q Consensus 638 ~~~~~kl~DfGla~~~ 653 (796)
++.++|+|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 889999999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=181.70 Aligned_cols=194 Identities=24% Similarity=0.249 Sum_probs=153.6
Q ss_pred HHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC---ccCcccccccccccccce
Q 044281 500 KDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 500 ~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~ 576 (796)
....+.+.++||+|+||+||+|... +++.||+|.-+.... -+|.--.+++.+|+ -+-|..+...+.-.+.-+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3344456678999999999999875 489999998754321 11111122233333 233445555666777889
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc-------CCCcEEEeecCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-------HFFSAKISDFGL 649 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~-------~~~~~kl~DfGl 649 (796)
||+||.+.|+|.+++...+.++|...+.++.|+++-+++||.. +|||+||||+|.||. ++..++|+|||-
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 9999999999999999888999999999999999999999998 899999999999994 345699999999
Q ss_pred cccccCCC-CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCC
Q 044281 650 SKLLFSDQ-SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCR 701 (796)
Q Consensus 650 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~ 701 (796)
+..+.--. .......+.|-.+-.+|...|.+.+.+.|-|.++.+++-||.|+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 98764322 23455667889999999999999999999999999999999876
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=5e-16 Score=156.97 Aligned_cols=134 Identities=23% Similarity=0.290 Sum_probs=113.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--------hhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..++|+++.....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 4689999999999986 466788887643211 11246788999999999999988887777778889999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
||+++++|.+++..... .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999865432 7889999999999999998 899999999999999 78999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=152.97 Aligned_cols=130 Identities=22% Similarity=0.323 Sum_probs=107.1
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchh--------hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--------QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.||+|+||.||+|.. ++..+++|...... ......+.+|++++..++|+++.....++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 389999999999985 46789999864311 1123567889999999998887666666666777899999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
|+++++|.+++..... .++.+++++|.+||+. +++|+|++|.||+++ ++.++++|||+++.
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999988755321 7899999999999998 999999999999999 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=156.61 Aligned_cols=196 Identities=21% Similarity=0.235 Sum_probs=134.3
Q ss_pred CccCcccccccccc---------------------------cccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHH
Q 044281 558 HHKHLVQLLGFCDE---------------------------ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIA 610 (796)
Q Consensus 558 ~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia 610 (796)
+|||||++.++|.+ +..+|+||...+. +|..++..+..- ...+.-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s-~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRS-YRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCc-hHHHHHHHHHHH
Confidence 68888888887632 3355888887765 899998875543 445556888999
Q ss_pred HHhhHhhhcCCCCeeeCCCCCCCEEE--cCCC--cEEEeecCCcccccCCCC-----cceeeccCCCcccccccccCCC-
Q 044281 611 RGLAYLHEECNVPIIHCDIKPQNILL--DHFF--SAKISDFGLSKLLFSDQS-----RTHTMIRGTRGYVAPEWFKNVP- 680 (796)
Q Consensus 611 ~~l~yLH~~~~~~iiH~Dlk~~NIll--~~~~--~~kl~DfGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~- 680 (796)
+|+.|||++ +|.|||+|.+|||+ |++. ...|+|||.+---....- ...-..-|...-||||+....+
T Consensus 352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999 99999999999999 3433 468999998753222110 1111233677899999986433
Q ss_pred -----CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHH
Q 044281 681 -----VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMW 755 (796)
Q Consensus 681 -----~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~ 755 (796)
--.|+|.|+.|.+.||++....||....+..... ..+.+.++..+.+.. ...+.+++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-------r~Yqe~qLPalp~~v---------pp~~rqlV~~ 492 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-------RTYQESQLPALPSRV---------PPVARQLVFD 492 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheech-------hhhhhhhCCCCcccC---------ChHHHHHHHH
Confidence 1358999999999999999999998633221110 112333333333321 1234567778
Q ss_pred hcccCCCCCCCHHHHHHHH
Q 044281 756 CIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 756 Cl~~dp~~RPt~~evl~~L 774 (796)
.++.||++||+..-....|
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 8999999999976555444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=151.29 Aligned_cols=136 Identities=18% Similarity=0.139 Sum_probs=106.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh----------------------hhHHHHHHHHHHhcccCccC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ----------------------EREREFKSEVSAIGRTHHKH 561 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~h~n 561 (796)
+.+.+.||+|+||.||++..+ +++.||||++..... .....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 445678999999999999864 689999998643210 01123677888888887774
Q ss_pred --cccccccccccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC
Q 044281 562 --LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 562 --iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~ 639 (796)
++..++. ...++||||+++++|..+... .....++.+++.++.++|+. +|+|+||||+||+++++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 4444432 345899999999998765431 34567889999999999997 99999999999999999
Q ss_pred CcEEEeecCCccccc
Q 044281 640 FSAKISDFGLSKLLF 654 (796)
Q Consensus 640 ~~~kl~DfGla~~~~ 654 (796)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-16 Score=169.03 Aligned_cols=170 Identities=24% Similarity=0.312 Sum_probs=128.1
Q ss_pred cceeEEeecCCCCHHHHHhcCC---CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCc
Q 044281 574 NRLLVYEFMGNGTLANLIFAIP---KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS 650 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 650 (796)
.+++.|+++.-.+|.++|..++ ..++...+.++.|++.|+.| + +.+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 4679999999999999997543 56788899999999999999 4 7999999999999999999999999999
Q ss_pred ccccCCC-----CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhh
Q 044281 651 KLLFSDQ-----SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCY 724 (796)
Q Consensus 651 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~ 724 (796)
....... ....+...||..||+||.+.+..|+.|+||||||++|+|++. -...++... ...-+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------TLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------hhhhh
Confidence 8765544 223455679999999999999999999999999999999986 333332111 11122
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 769 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 769 (796)
.+|.++..+-. . .+ +-..++.+++.+.|.+||++.+
T Consensus 473 r~g~ip~~~~~----d-~p----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 RDGIIPPEFLQ----D-YP----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcCCCChHHhh----c-Cc----HHHHHHHHhcCCCcccCchHHH
Confidence 33333311100 0 11 1234778899999999994443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.3e-15 Score=171.95 Aligned_cols=132 Identities=18% Similarity=0.275 Sum_probs=108.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEe-cch-h------hhhHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKL-DRL-A------QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l-~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
..+.||+|+||+||+|.+. +..+++|+. .+. . ....+.+.+|++++..++|++++....++......++
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccceeccCCcEEEEEEeec---CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 3578999999999999864 233444332 111 1 1123568899999999999999988888777778899
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999998875 3577899999999999998 89999999999999 678999999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-15 Score=173.48 Aligned_cols=207 Identities=22% Similarity=0.266 Sum_probs=141.9
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCH
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL 587 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 587 (796)
+.|..|++|.||..+++. +.+..|+|+-+... +.+- ++.....|.+| |+=
T Consensus 89 klisngAygavylvrh~~-trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKE-TRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred EeeccCCCCceeeeeccc-cccchhhcccccch------hhhc--cccccCCccee---------------------chh
Confidence 568899999999998763 46678884432211 0100 22222333332 454
Q ss_pred HHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC----------
Q 044281 588 ANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ---------- 657 (796)
Q Consensus 588 ~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~---------- 657 (796)
..+++..+.++... +.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 139 ~tllk~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~ 207 (1205)
T KOG0606|consen 139 ATLLKNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE 207 (1205)
T ss_pred hhhcccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence 55566655555433 6789999998 99999999999999999999999999998642110
Q ss_pred ----CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 658 ----SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 658 ----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
......++||+.|+|||++..+.|...+|.|++|+++||.+-|..||.++.+++....+...... |.++
T Consensus 208 k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~-wpE~------ 280 (1205)
T KOG0606|consen 208 KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-WPEE------ 280 (1205)
T ss_pred HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc-cccc------
Confidence 01123467999999999999999999999999999999999999999999877654332211000 1111
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 770 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev 770 (796)
......+...++.+.|+.+|..|--....
T Consensus 281 --------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 281 --------DEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred --------CcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 11122344557777889999999643333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.3e-14 Score=139.84 Aligned_cols=134 Identities=19% Similarity=0.197 Sum_probs=94.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh--hHHH----------------------HHHHHHHhcccCccC--
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE--RERE----------------------FKSEVSAIGRTHHKH-- 561 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n-- 561 (796)
+.||+|+||.||+|... +++.||||.+...... .... ...|...+.++.+..
T Consensus 3 ~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 3 GPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred cccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 57999999999999865 6889999987642211 1111 124455555553332
Q ss_pred cccccccccccccceeEEeecCCCCHHHH-HhcCCCCchhHHHHHHHHHHHHhhHhhh-cCCCCeeeCCCCCCCEEEcCC
Q 044281 562 LVQLLGFCDEALNRLLVYEFMGNGTLANL-IFAIPKPDWNLRIRISLEIARGLAYLHE-ECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 562 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~Dlk~~NIll~~~ 639 (796)
+.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. . +|+|+||||+||+++ +
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 3333332 245899999999543221 11111 11 5678899999999999999 6 899999999999999 8
Q ss_pred CcEEEeecCCcccc
Q 044281 640 FSAKISDFGLSKLL 653 (796)
Q Consensus 640 ~~~kl~DfGla~~~ 653 (796)
+.++|+|||.+...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 99999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.5e-14 Score=132.90 Aligned_cols=133 Identities=21% Similarity=0.166 Sum_probs=113.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCc--cCcccccccccccccceeEEeecCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHH--KHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
+.||+|.++.||++... +..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++++
T Consensus 4 ~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK---DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEec---CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56899999999999864 36899999866433 5678899999999976 58999999888888899999999988
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
.+..+ +......++.++++++++||.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4566778899999999999986445799999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-13 Score=140.69 Aligned_cols=134 Identities=16% Similarity=0.124 Sum_probs=104.3
Q ss_pred HhhC-CCccceEEEEEeeCCCCeEEEEEEecchh-------------hhhHHHHHHHHHHhcccCccCc--ccccccccc
Q 044281 508 EELG-RGSFGIVYKGVLKTASGTAIAVKKLDRLA-------------QEREREFKSEVSAIGRTHHKHL--VQLLGFCDE 571 (796)
Q Consensus 508 ~~LG-~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~ 571 (796)
..|| .|+.|+||++... +..++||+..... ......+.+|+.++.+++|+++ ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 4688 8999999998753 6789999885311 1223567889999999998875 667776543
Q ss_pred ccc----ceeEEeecCC-CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEee
Q 044281 572 ALN----RLLVYEFMGN-GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISD 646 (796)
Q Consensus 572 ~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 646 (796)
... .++|+|++++ .+|.+++... .++. ..+.+|+.+|.+||+. +|+|+||||.|||++.++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 322 2599999997 6898888653 3333 2357899999999998 999999999999999989999999
Q ss_pred cCCccc
Q 044281 647 FGLSKL 652 (796)
Q Consensus 647 fGla~~ 652 (796)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.3e-15 Score=171.19 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=185.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|.|+.|-...........+|+|.+.... .........|..+-..+. |+|++.+++...+....+++.||
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 344569999999998876544455678888876543 222334455777766775 99999999999999999999999
Q ss_pred cCCCCHHHHH-hcCC-CCchhHHHHHHHHHHHHhhHhh-hcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCcccccC-C
Q 044281 582 MGNGTLANLI-FAIP-KPDWNLRIRISLEIARGLAYLH-EECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFS-D 656 (796)
Q Consensus 582 ~~~gsL~~~l-~~~~-~~~~~~~~~i~~~ia~~l~yLH-~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~-~ 656 (796)
..++++.+.+ .... ..+......+..|+..++.|+| .. ++.|+||||+|.+++..+ ..|++|||+|..+.. .
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999998888 4433 5566677888999999999999 66 899999999999999999 999999999998766 2
Q ss_pred -CCcceeeccC-CCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 657 -QSRTHTMIRG-TRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 657 -~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......... ..+.+.... .
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------~~~~~~~~~--~ 250 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------SSWKSNKGR--F 250 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-------eeecccccc--c
Confidence 3344455668 9999999999885 45678999999999999999999987554332111 001111100 0
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
... ...........+...++..+|..|.+.+++..
T Consensus 251 ~~~----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 TQL----PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccC----ccccCChhhhhcccccccCCchhccccccccc
Confidence 000 00111123445667788889999999888753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.8e-12 Score=141.73 Aligned_cols=138 Identities=22% Similarity=0.233 Sum_probs=98.2
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchhhhh----------------------------------------HHHHH
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER----------------------------------------EREFK 548 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~ 548 (796)
.||.|++|.||+|+++ +|+.||||+.+...... +-+|.
T Consensus 124 plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 124 PLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred ceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5999999999999986 68999999985421100 11355
Q ss_pred HHHHHhcccC----ccCcccccccc-cccccceeEEeecCCCCHHHHHhcCC-CCchhHHHHHHHHHHH-HhhHhhhcCC
Q 044281 549 SEVSAIGRTH----HKHLVQLLGFC-DEALNRLLVYEFMGNGTLANLIFAIP-KPDWNLRIRISLEIAR-GLAYLHEECN 621 (796)
Q Consensus 549 ~E~~~l~~l~----h~niv~l~g~~-~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~-~l~yLH~~~~ 621 (796)
+|++.+.+++ |.+-+.+-..+ ......+|||||++|++|.++..... .. .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence 5666665552 22223322222 33456799999999999988765321 11 34556777766 46788887
Q ss_pred CCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 622 ~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
+++|+|+||.||++++++.+++.|||++..+.
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.2e-12 Score=125.20 Aligned_cols=200 Identities=20% Similarity=0.279 Sum_probs=136.7
Q ss_pred HHhcccCccCccccccccccc-----ccceeEEeecCCCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCCC
Q 044281 552 SAIGRTHHKHLVQLLGFCDEA-----LNRLLVYEFMGNGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNV 622 (796)
Q Consensus 552 ~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~~ 622 (796)
..|-++-|.|||++..|+.+. .+..++.|||+.|+|..+|+.. ..+......+++.||..||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 344456799999999987543 3457899999999999999753 3566677788999999999999985 67
Q ss_pred CeeeCCCCCCCEEEcCCCcEEEeecCCccccc---CCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh
Q 044281 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLF---SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC 699 (796)
Q Consensus 623 ~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt 699 (796)
+|+|+++.-+-|++..++-+||.----..... ...........+-++|.+||+=.....+-++|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 89999999999999999999885421111000 000111122346789999999888888899999999999999987
Q ss_pred CCCC-CchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 700 CRRS-VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 700 g~~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+..- -......+....+.. -+..+-+. + -..++..|++..|..||+|++++.+
T Consensus 278 lEiq~tnseS~~~~ee~ia~---------~i~~len~-l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIAN---------VIIGLENG-L-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhh---------heeeccCc-c-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 6643 222111111111110 00000010 0 0125667999999999999987643
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-11 Score=98.98 Aligned_cols=56 Identities=27% Similarity=0.485 Sum_probs=49.3
Q ss_pred cceEEeecccCCCCCcccc-CCCchhhHHHhhcCCCceeeeeec----CCcceecCCCCCc
Q 044281 353 YEIREFNNVEWPLGDYERL-EPSNQTECETSCLQDCSCAVAIYD----GNSCRKKKLPLSN 408 (796)
Q Consensus 353 ~~f~~~~~~~~p~~~~~~~-~~~~~~~C~~~Cl~nCsC~a~~~~----~~~C~~~~~~l~~ 408 (796)
++|+++++|++|+++.... .+.++++|+..||+||||+||+|. +++|.+|...|.|
T Consensus 5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 5799999999999977654 567999999999999999999996 4789999988765
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.2e-11 Score=113.95 Aligned_cols=129 Identities=19% Similarity=0.118 Sum_probs=95.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcc-cccccccccccceeEEeecCCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLV-QLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+.|+.|.++.||++.. .+..+++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEE---CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 4588999999999875 367899999765322 223567888888888665544 445443 234589999999988
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC--CCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC--NVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
+... . .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 78 l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 7643 0 111345678999999999873 22369999999999999 6789999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6e-11 Score=129.99 Aligned_cols=253 Identities=21% Similarity=0.187 Sum_probs=178.8
Q ss_pred HHHHHHHHhHHHhhCC--CccceEEEEEe--eCCCCeEEEEEEecchhh--hhHHHHHHHHHHhccc-CccCcccccccc
Q 044281 497 DELKDATDGFKEELGR--GSFGIVYKGVL--KTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRT-HHKHLVQLLGFC 569 (796)
Q Consensus 497 ~~l~~~~~~~~~~LG~--G~fG~Vy~g~~--~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 569 (796)
.+..+......+.+|. |.+|.||.+.. . .++..+|+|+-+.... .....=.+|+...+++ .|+|.++.....
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~-~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNS-ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcc-cCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 3455555666778999 99999999986 4 3567889988543222 2222234566666666 599999988889
Q ss_pred cccccceeEEeecCCCCHHHHHhcCC-CCchhHHHHHHHHHHH----HhhHhhhcCCCCeeeCCCCCCCEEEcCC-CcEE
Q 044281 570 DEALNRLLVYEFMGNGTLANLIFAIP-KPDWNLRIRISLEIAR----GLAYLHEECNVPIIHCDIKPQNILLDHF-FSAK 643 (796)
Q Consensus 570 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~----~l~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~k 643 (796)
...+..++-+|++. .+|..+..... .++....+.+..+..+ ||.++|.. .++|-|+||.||++..+ ...+
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceee
Confidence 99999999999885 57777776553 3667777788888888 99999998 89999999999999998 8899
Q ss_pred EeecCCcccccCCCC-cc---eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH
Q 044281 644 ISDFGLSKLLFSDQS-RT---HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW 719 (796)
Q Consensus 644 l~DfGla~~~~~~~~-~~---~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~ 719 (796)
+.|||+...+....- .. .....+...|++||...+ .++...|+|++|.+++|..++.......... .
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~- 334 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS-------S- 334 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-------C-
Confidence 999999998865541 11 122346778999999865 6788999999999999999887655322000 1
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
|.....+. +.+... .....++..++..+++.+|..|++.+.+..
T Consensus 335 -W~~~r~~~---ip~e~~-----~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 -WSQLRQGY---IPLEFC-----EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -cccccccc---Cchhhh-----cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111111 111100 011123334778899999999999877653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.9e-10 Score=129.50 Aligned_cols=140 Identities=18% Similarity=0.155 Sum_probs=89.0
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh----------------------------------------hHHHH
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE----------------------------------------REREF 547 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~----------------------------------------~~~~~ 547 (796)
+.||.|++|.||+|++++ +|+.||||+++....+ .+-+|
T Consensus 125 ~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 125 KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 469999999999999873 4899999999642110 01124
Q ss_pred HHHHHHhcccC----ccCccccccccc-ccccceeEEeecCCCCHHHHH--hcCCCCchhHHHHHHHHHHHH-hhHhhhc
Q 044281 548 KSEVSAIGRTH----HKHLVQLLGFCD-EALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRIRISLEIARG-LAYLHEE 619 (796)
Q Consensus 548 ~~E~~~l~~l~----h~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~i~~~ia~~-l~yLH~~ 619 (796)
.+|+..+.+++ +.+.+.+-.++. -....+|||||++|+++.++. .... .+ +..++...++. +..++..
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d---~~~la~~~v~~~~~Qif~~ 279 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TD---MKLLAERGVEVFFTQVFRD 279 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhC
Confidence 44555444442 333333323332 245668999999999997743 2221 11 11222222221 2223334
Q ss_pred CCCCeeeCCCCCCCEEEcCCC----cEEEeecCCcccccC
Q 044281 620 CNVPIIHCDIKPQNILLDHFF----SAKISDFGLSKLLFS 655 (796)
Q Consensus 620 ~~~~iiH~Dlk~~NIll~~~~----~~kl~DfGla~~~~~ 655 (796)
+++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 280 ---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 280 ---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 899999999999999888 999999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9e-10 Score=121.77 Aligned_cols=169 Identities=17% Similarity=0.212 Sum_probs=127.3
Q ss_pred EEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCHHHHHhcCCCCchh
Q 044281 521 GVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWN 600 (796)
Q Consensus 521 g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~ 600 (796)
|..+ .++.+|.|...+...........+-++.|+.++||||++++.........|||+|.+. .|...+.... ..
T Consensus 31 ~t~k-~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~ 104 (690)
T KOG1243|consen 31 GTRK-ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KE 104 (690)
T ss_pred ccee-ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HH
Confidence 4434 4677888888876555445567888999999999999999999999999999999873 6666666543 34
Q ss_pred HHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCC
Q 044281 601 LRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680 (796)
Q Consensus 601 ~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 680 (796)
.....+.||+.||.+||+.+ +++|++|....|+|+..|.-||++|-++.....-.. ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 45567789999999999876 899999999999999999999999988764322111 111111223466666553222
Q ss_pred CCccchhHHHHHHHHHHHhC
Q 044281 681 VSAKVDVYSFGVTLLEIICC 700 (796)
Q Consensus 681 ~s~k~DVwS~Gv~l~elltg 700 (796)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 456999999999999998
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-10 Score=97.30 Aligned_cols=71 Identities=20% Similarity=0.362 Sum_probs=59.5
Q ss_pred cceEEeecccCCCCCccccCCCchhhHHHhhcCCCceeeeeec--CCcceecCCCCCccccccCCcceEEEEEe
Q 044281 353 YEIREFNNVEWPLGDYERLEPSNQTECETSCLQDCSCAVAIYD--GNSCRKKKLPLSNGWLRDTGFSKVLFKVR 424 (796)
Q Consensus 353 ~~f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~~l~~~~~~~~~~~~~~lkv~ 424 (796)
++|.+++++++|+..+.. ...++++|++.|++||+|.||+|. +++|++|..++.+.+.........|+|++
T Consensus 12 ~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 12 DGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 579999999999887655 667999999999999999999996 58999999988887765444577888873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.9e-09 Score=105.54 Aligned_cols=137 Identities=15% Similarity=0.143 Sum_probs=97.2
Q ss_pred HhhCCCccceEEEEEeeCC-----CCeEEEEEEecchh----------------------hhhHHHH----HHHHHHhcc
Q 044281 508 EELGRGSFGIVYKGVLKTA-----SGTAIAVKKLDRLA----------------------QEREREF----KSEVSAIGR 556 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~-----~~~~vavK~l~~~~----------------------~~~~~~~----~~E~~~l~~ 556 (796)
..||.|--+.||.|.-... .+..+|||+.+... ......+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3689999999999975421 24789999874210 0001222 378999998
Q ss_pred cCc--cCcccccccccccccceeEEeecCCCCHHH-HHhcCCCCchhHHHHHHHHHHHHhhHh-hhcCCCCeeeCCCCCC
Q 044281 557 THH--KHLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYL-HEECNVPIIHCDIKPQ 632 (796)
Q Consensus 557 l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~i~~~ia~~l~yL-H~~~~~~iiH~Dlk~~ 632 (796)
+.. -++.+++++ ...+|||||+.+..+.. .+.+ ..++.+....+..+++.+|..| |+. +|+|+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 854 456666654 56689999998754422 2222 2334455677889999999999 676 8999999999
Q ss_pred CEEEcCCCcEEEeecCCcccc
Q 044281 633 NILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 633 NIll~~~~~~kl~DfGla~~~ 653 (796)
||++++ +.++|+|||.+...
T Consensus 155 NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEEC-CcEEEEECCCceeC
Confidence 999974 68999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.3e-10 Score=123.35 Aligned_cols=244 Identities=21% Similarity=0.207 Sum_probs=171.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHH--HHHHHHHHhccc-CccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERER--EFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+...||.|.|+.|++...+..++..+++|.+.+....... .-..|+.+...+ .|.++++....+......++=-||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 3457999999999998866567889999988654332221 224455555555 6899999888888888888999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC-CcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF-FSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++...+.-...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..+.-...
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~--- 422 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG--- 422 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecc---
Confidence 9999877765555677778899999999999999987 89999999999999886 8889999999864211111
Q ss_pred eeccCCCcc-cccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGY-VAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y-~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....+..| .+++......+-.+.|++|||.-+.|.+++....+.... +..+..+.......
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------~~~i~~~~~p~~~~------ 485 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------SLTIRSGDTPNLPG------ 485 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------ceeeecccccCCCc------
Confidence 111123334 366666777889999999999999999988754332110 00111222111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
..+.+..++..++..++..||.+.+...+.+-
T Consensus 486 ----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 486 ----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11334445566888999999999888766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.4e-09 Score=107.77 Aligned_cols=142 Identities=18% Similarity=0.253 Sum_probs=107.8
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCc--cCcccccccccccc---cceeEEee
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHH--KHLVQLLGFCDEAL---NRLLVYEF 581 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lv~e~ 581 (796)
+.|+.|..+.||++... +|+.+++|....... .....+..|+++++.+++ .++.+++.+..... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec--CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 45899999999998764 357899999765332 134578899999999865 34577788776643 56899999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC-----------------------------------------
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC----------------------------------------- 620 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------- 620 (796)
+++.++.+.+.. ..++...+..++.+++++|+.||+..
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999888775532 34566677778888888888888521
Q ss_pred ------------CCCeeeCCCCCCCEEEcC--CCcEEEeecCCccc
Q 044281 621 ------------NVPIIHCDIKPQNILLDH--FFSAKISDFGLSKL 652 (796)
Q Consensus 621 ------------~~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~ 652 (796)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.6e-08 Score=108.38 Aligned_cols=167 Identities=20% Similarity=0.253 Sum_probs=129.6
Q ss_pred cceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccc----ccccceeEEeecCC-CCHHH
Q 044281 515 FGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCD----EALNRLLVYEFMGN-GTLAN 589 (796)
Q Consensus 515 fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~e~~~~-gsL~~ 589 (796)
-.+.||+... -+|..+++|+++....+.......-+++++++.|.|+|++..++. .+..+++||+|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~-~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSN-VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeec-cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3578998865 478999999995543333333445678899999999999999886 34567899999986 56766
Q ss_pred HHhcC---------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 590 LIFAI---------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 590 ~l~~~---------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
+-+.. .+.+++..|.++.|++.||.++|+. |+.-+-|.+++|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65432 2456788999999999999999998 89999999999999999999999999988765
Q ss_pred CCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS 703 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p 703 (796)
.+.... + .--.+-|.=.||.+++.|.+|...
T Consensus 445 ~d~~~~---------------l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEP---------------L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcc---------------h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 443111 1 112467999999999999999644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.3e-09 Score=97.62 Aligned_cols=130 Identities=22% Similarity=0.307 Sum_probs=101.0
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEe-cch-------hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKL-DRL-------AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.+|+-+.+|.+.+. |.++++|.- .+. ..-..+.-.+|+.++.+++--.|....-+..+.....|+||
T Consensus 3 ~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 5788999999998653 344555532 221 11123467889999999877777766667778888899999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
|+++..|.+.+... +..++..+-.-+.-||.. +|+|+||.++||++.... +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888765 255677777788889998 999999999999998765 99999999974
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.8e-09 Score=87.70 Aligned_cols=64 Identities=11% Similarity=0.067 Sum_probs=53.3
Q ss_pred ceEEeecccCCCCCccccCCCchhhHHHhhcC---CCceeeeeec--CCcceecCCCC-CccccccCCcceEEEE
Q 044281 354 EIREFNNVEWPLGDYERLEPSNQTECETSCLQ---DCSCAVAIYD--GNSCRKKKLPL-SNGWLRDTGFSKVLFK 422 (796)
Q Consensus 354 ~f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~--~~~C~~~~~~l-~~~~~~~~~~~~~~lk 422 (796)
.|+++.+|++|++.. .++++|++.|++ ||||.||+|. +.+|.+|..+| .+.+....++..+|+|
T Consensus 10 ~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred eEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 488999999998754 578999999999 9999999994 46899999999 7776655556677776
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.3e-09 Score=125.35 Aligned_cols=200 Identities=19% Similarity=0.182 Sum_probs=143.0
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
-+-.|.++.++.+.-. ..+...+.|..... ...+.+....+-.++-..+||-+++..--+.-....+|+++|..++
T Consensus 811 p~qS~sp~ss~p~~pa-~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPA-GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred cccCCCCcccccCCcc-ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 4667777777765422 23333333332211 1111222333333333345566666555556677889999999999
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc-----------
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF----------- 654 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~----------- 654 (796)
+|...|+..+..+.+-.......+.++++|||.. .+.|+|++|.|++...+++.+++|||......
T Consensus 890 ~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 890 DLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred CchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence 9999999887777666667777888999999997 68999999999999999999999998433211
Q ss_pred ----------CCC---------CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH
Q 044281 655 ----------SDQ---------SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES 712 (796)
Q Consensus 655 ----------~~~---------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~ 712 (796)
... .+......+|+.|.+||...+......+|.|+.|++++|.++|..||.....+..
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~ 1043 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI 1043 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh
Confidence 000 0112345689999999999999999999999999999999999999988776554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.2e-08 Score=91.92 Aligned_cols=140 Identities=21% Similarity=0.279 Sum_probs=103.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEe-cc----h---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL-DR----L---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l-~~----~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.|-+|+-+.|+++.. .|+...||.- .+ . ..-.....++|++.+.+++--.|.-..-++.+...-.|+|
T Consensus 13 ~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred eeeeccceeeEeeecc---CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578899999999886 4777666643 22 1 1122356788999999987666666666677777788999
Q ss_pred eecCC-CCHHHHHhcCC-CCchhH-HHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC---cEEEeecCCcccc
Q 044281 580 EFMGN-GTLANLIFAIP-KPDWNL-RIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF---SAKISDFGLSKLL 653 (796)
Q Consensus 580 e~~~~-gsL~~~l~~~~-~~~~~~-~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~DfGla~~~ 653 (796)
||+++ .++.+++...- ...... ...++..|-+.+.-||.+ .|+|+||..+||++..++ .+.++|||++..-
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 46788876542 222223 367888999999999999 899999999999996543 4589999998753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1e-07 Score=98.74 Aligned_cols=130 Identities=17% Similarity=0.121 Sum_probs=96.2
Q ss_pred eEEEEEeeCCCCeEEEEEEecchhhhh-H----------HHHHHHHHHhcccCccCcc--cccccccc-----cccceeE
Q 044281 517 IVYKGVLKTASGTAIAVKKLDRLAQER-E----------REFKSEVSAIGRTHHKHLV--QLLGFCDE-----ALNRLLV 578 (796)
Q Consensus 517 ~Vy~g~~~~~~~~~vavK~l~~~~~~~-~----------~~~~~E~~~l~~l~h~niv--~l~g~~~~-----~~~~~lv 578 (796)
.|.+..+ +|+.+.||+........ . ..+.+|...+.++...+|. .++++... ...-+||
T Consensus 37 rvvr~~~---~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFEL---AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEE---CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 4666654 47789999775432110 1 2478899999888655544 44556533 2346899
Q ss_pred EeecCCC-CHHHHHhc--CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-------CCcEEEeecC
Q 044281 579 YEFMGNG-TLANLIFA--IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-------FFSAKISDFG 648 (796)
Q Consensus 579 ~e~~~~g-sL~~~l~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-------~~~~kl~DfG 648 (796)
+|++++. +|.+++.. ....+...+..++.+++..+.-||+. +|+|+|++++|||++. +..+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 9999986 89888853 23445567778999999999999999 9999999999999985 5789999999
Q ss_pred Cccc
Q 044281 649 LSKL 652 (796)
Q Consensus 649 la~~ 652 (796)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.5e-07 Score=91.79 Aligned_cols=125 Identities=22% Similarity=0.211 Sum_probs=81.4
Q ss_pred eEEEEEeeCCCCeEEEEEEecchh--------------------------hhhHHHHHHHHHHhcccCcc--Cccccccc
Q 044281 517 IVYKGVLKTASGTAIAVKKLDRLA--------------------------QEREREFKSEVSAIGRTHHK--HLVQLLGF 568 (796)
Q Consensus 517 ~Vy~g~~~~~~~~~vavK~l~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~g~ 568 (796)
.||.|... ++..+|||..+... ........+|.+.|.++... ++.+++++
T Consensus 1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 38888764 67899999874210 00123567899999999765 45666654
Q ss_pred ccccccceeEEeecC--CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHh-hhcCCCCeeeCCCCCCCEEEcCCCcEEEe
Q 044281 569 CDEALNRLLVYEFMG--NGTLANLIFAIPKPDWNLRIRISLEIARGLAYL-HEECNVPIIHCDIKPQNILLDHFFSAKIS 645 (796)
Q Consensus 569 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yL-H~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 645 (796)
....|||||++ +..+..+.... ++......++.+++..+..+ |.. +|+|+||.+.||+++++ .+.|+
T Consensus 79 ----~~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 ----NRNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ----ETTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ----eCCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 34579999998 65554433321 11344566777888866664 566 99999999999999988 99999
Q ss_pred ecCCcccc
Q 044281 646 DFGLSKLL 653 (796)
Q Consensus 646 DfGla~~~ 653 (796)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=87.83 Aligned_cols=106 Identities=22% Similarity=0.251 Sum_probs=85.8
Q ss_pred HHHHHHHHHHhcccCccC--cccccccccccc----cceeEEeecCCC-CHHHHHhcCCCCchhHHHHHHHHHHHHhhHh
Q 044281 544 EREFKSEVSAIGRTHHKH--LVQLLGFCDEAL----NRLLVYEFMGNG-TLANLIFAIPKPDWNLRIRISLEIARGLAYL 616 (796)
Q Consensus 544 ~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yL 616 (796)
.....+|...+.+++... .++.+++..... .-+||+|++++. +|.+++.....++......++.++++.++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346788888888875443 455666665432 337999999874 8999998755567777889999999999999
Q ss_pred hhcCCCCeeeCCCCCCCEEEcCCC---cEEEeecCCccc
Q 044281 617 HEECNVPIIHCDIKPQNILLDHFF---SAKISDFGLSKL 652 (796)
Q Consensus 617 H~~~~~~iiH~Dlk~~NIll~~~~---~~kl~DfGla~~ 652 (796)
|+. +|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 999999999999999887 899999998774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.3e-06 Score=88.68 Aligned_cols=188 Identities=14% Similarity=0.174 Sum_probs=124.5
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCccccccc----c---cccccceeE
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGF----C---DEALNRLLV 578 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~----~---~~~~~~~lv 578 (796)
.+.||+|+-+.+|-.- .-..-+.|+..........+-. ..|... .||-+-.-+.+ . ......-++
T Consensus 16 gr~LgqGgea~ly~l~----e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLG----EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecc----hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4679999999999532 1122345666554333322222 233333 45543321111 1 111123466
Q ss_pred EeecCCCC-HHHHHh------cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 579 YEFMGNGT-LANLIF------AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 579 ~e~~~~gs-L~~~l~------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
|..+++.- +..+.. +.+..+|...++.+..+|.+.+.||++ +.+-+|+.++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77666542 222222 235678999999999999999999999 89999999999999999999999865444
Q ss_pred cccCCCCcceeeccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhC-CCCCch
Q 044281 652 LLFSDQSRTHTMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICC-RRSVEM 706 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg-~~p~~~ 706 (796)
+. .......-.+|...|++||.-. +..-+...|-|.|||++++++.| +.||.+
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 32 2233333456888999999764 44567789999999999999987 778765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.2e-06 Score=83.00 Aligned_cols=136 Identities=17% Similarity=0.097 Sum_probs=102.8
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchh------hhhHHHHHHHHHHhcccCccC--ccccccccc-cc----ccce
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLA------QEREREFKSEVSAIGRTHHKH--LVQLLGFCD-EA----LNRL 576 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~-~~----~~~~ 576 (796)
-|+||-+-|+.-.+. |+.+-+|+-.+.. ......|.+|+..|.++...+ +.+++ ++. .. -.-+
T Consensus 26 ~~rgG~SgV~r~~~~---g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERN---GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeC---CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 467999999987663 4578999875211 235678999999999986443 44555 332 21 1247
Q ss_pred eEEeecCC-CCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc--EEEeecCCcc
Q 044281 577 LVYEFMGN-GTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS--AKISDFGLSK 651 (796)
Q Consensus 577 lv~e~~~~-gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~kl~DfGla~ 651 (796)
||+|-+++ .+|.+++.+. ..++...+..+..++++.++-||+. ++.|+|+.+.||+++.++. ++++||--++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99997754 5898888663 3557777889999999999999998 9999999999999986667 9999997665
Q ss_pred c
Q 044281 652 L 652 (796)
Q Consensus 652 ~ 652 (796)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.8e-06 Score=86.58 Aligned_cols=134 Identities=19% Similarity=0.167 Sum_probs=92.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh----------------------hhHHHHHHHHHHhcccCcc-
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ----------------------EREREFKSEVSAIGRTHHK- 560 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~h~- 560 (796)
+.+..+||.|--+.||.|... .|.++|||.-+.... -......+|.++|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 445678999999999999864 688999996532100 0123457789999988655
Q ss_pred -CcccccccccccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC
Q 044281 561 -HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 561 -niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~ 639 (796)
.+.+.++. +...+||||+++-.|...-- +.+..-.++..|++-+.-+-.. +|||+|+.+-||+++++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 66666654 45579999999866544321 2222333444444444333344 89999999999999999
Q ss_pred CcEEEeecCCcc
Q 044281 640 FSAKISDFGLSK 651 (796)
Q Consensus 640 ~~~kl~DfGla~ 651 (796)
|.+.++||--+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 999999997654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.2e-07 Score=105.64 Aligned_cols=150 Identities=19% Similarity=0.267 Sum_probs=98.9
Q ss_pred HHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce--------eeccCCCcccccccccC
Q 044281 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH--------TMIRGTRGYVAPEWFKN 678 (796)
Q Consensus 607 ~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~ 678 (796)
.+++.|+.|+|... ++||+.|.|++|.++.++..||+.|+.+........... --......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 44568999999875 899999999999999999999999998875543211111 11224557999999999
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCCC-chhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhc
Q 044281 679 VPVSAKVDVYSFGVTLLEIICCRRSV-EMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCI 757 (796)
Q Consensus 679 ~~~s~k~DVwS~Gv~l~elltg~~p~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl 757 (796)
...+.++|+||+|+++|-+..++.+. .......... .....+.........+...++.+=+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 88899999999999999999555543 3221111000 00001111111111222334455566678
Q ss_pred ccCCCCCCCHHHHHH
Q 044281 758 QEDPSKRPTMKVVLQ 772 (796)
Q Consensus 758 ~~dp~~RPt~~evl~ 772 (796)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.2e-06 Score=94.91 Aligned_cols=139 Identities=23% Similarity=0.290 Sum_probs=91.5
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchhhh----------------------------------------hHHHHH
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE----------------------------------------REREFK 548 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~----------------------------------------~~~~~~ 548 (796)
-|+.++-|.||+|+++ +|+.||||+.+..-.+ .+-++.
T Consensus 132 PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 132 PIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred chhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4889999999999997 5899999998632111 011244
Q ss_pred HHHHHhcccC-----ccCcccccccccccccceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHH-hhHhhhcCC
Q 044281 549 SEVSAIGRTH-----HKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARG-LAYLHEECN 621 (796)
Q Consensus 549 ~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~-l~yLH~~~~ 621 (796)
.|...+.+++ .+++.-..-+.+-.+...|+|||++|-.+.+..... ...+ +..++..++++ +..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhc--
Confidence 4555555442 233222222233456778999999999888874321 2333 33344444443 2222223
Q ss_pred CCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 622 ~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
+++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999987643
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.1e-05 Score=66.84 Aligned_cols=57 Identities=21% Similarity=0.404 Sum_probs=46.4
Q ss_pred ceEEeecccCCCCCccccCCCchhhHHHhhcC-CCceeeeeec--CCcceecC-CCCCccc
Q 044281 354 EIREFNNVEWPLGDYERLEPSNQTECETSCLQ-DCSCAVAIYD--GNSCRKKK-LPLSNGW 410 (796)
Q Consensus 354 ~f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~--~~~C~~~~-~~l~~~~ 410 (796)
.|+.++++.+++.........++++|++.|++ +|+|.|+.|. ++.|.+|. .++.+..
T Consensus 5 ~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 5 CFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred eeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 58899999998665543455699999999999 9999999996 68999998 6655554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.9e-05 Score=75.70 Aligned_cols=113 Identities=16% Similarity=0.210 Sum_probs=72.3
Q ss_pred CCeEEEEEEecchhhhhHHH---------HHHHHHHhcccCccCcc---ccccccc-----ccccceeEEeecCCCCHHH
Q 044281 527 SGTAIAVKKLDRLAQERERE---------FKSEVSAIGRTHHKHLV---QLLGFCD-----EALNRLLVYEFMGNGTLAN 589 (796)
Q Consensus 527 ~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv---~l~g~~~-----~~~~~~lv~e~~~~gsL~~ 589 (796)
++..+++|..+......++. ..+++..+.+++...+. .++.+.. -....+|+|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 46778888876533222222 23444444444333222 2222222 2233468999999988766
Q ss_pred HHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 590 LIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 590 ~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
+.. ++. .++..|++++.-||+. |++|+|.+|.|+++++++ +++.||+..+
T Consensus 133 ~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 133 IED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred chh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 532 111 3456677889999998 999999999999999654 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.1e-05 Score=74.20 Aligned_cols=136 Identities=21% Similarity=0.241 Sum_probs=88.3
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhH------------------------HHHHHHHHHhcccC--ccCc
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE------------------------REFKSEVSAIGRTH--HKHL 562 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~------------------------~~~~~E~~~l~~l~--h~ni 562 (796)
.|+.|--+.||+|.- .++..+|||+......... .-...|+..|.++. +-.+
T Consensus 55 ~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 55 CISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 477888889999874 3678999999864321110 11234555565553 3344
Q ss_pred ccccccccccccceeEEeecCCCCH-HHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc
Q 044281 563 VQLLGFCDEALNRLLVYEFMGNGTL-ANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS 641 (796)
Q Consensus 563 v~l~g~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 641 (796)
.+.+++. +-.|||||+....+ .-.|...+ +.......+..++++.+.-|-..+ ++||+||..=|||+. ++.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~-~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP-LELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcccCC-cCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCe
Confidence 4444443 23699999975421 11222221 122256667778888887776633 899999999999999 889
Q ss_pred EEEeecCCccccc
Q 044281 642 AKISDFGLSKLLF 654 (796)
Q Consensus 642 ~kl~DfGla~~~~ 654 (796)
+.|+|++-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999887543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.93 E-value=5e-05 Score=85.06 Aligned_cols=140 Identities=22% Similarity=0.238 Sum_probs=89.7
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-------------------------------------hHHHHHHH
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-------------------------------------REREFKSE 550 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-------------------------------------~~~~~~~E 550 (796)
+.||.-+.|.||+|+++ +|+.||||+-+..-++ .+-+|.+|
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 45999999999999997 5899999987532111 11245566
Q ss_pred HHHhccc----CccCc---ccccccc-cccccceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCC
Q 044281 551 VSAIGRT----HHKHL---VQLLGFC-DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECN 621 (796)
Q Consensus 551 ~~~l~~l----~h~ni---v~l~g~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~ 621 (796)
.+...+. +|-++ |.+=.++ .-...+.|+||||+|..+.++..-. ..++.. .++..+.++. ++.-..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEAY--LEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHHH--HHHHHh
Confidence 6655543 35551 1122223 3345779999999998877764321 223322 3333333332 222122
Q ss_pred CCeeeCCCCCCCEEEcC----CCcEEEeecCCccccc
Q 044281 622 VPIIHCDIKPQNILLDH----FFSAKISDFGLSKLLF 654 (796)
Q Consensus 622 ~~iiH~Dlk~~NIll~~----~~~~kl~DfGla~~~~ 654 (796)
.|++|.|=+|.||++.. ++.+.+-|||+...+.
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 28999999999999983 6789999999988653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.92 E-value=6.4e-05 Score=76.34 Aligned_cols=136 Identities=15% Similarity=0.159 Sum_probs=83.5
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC--cccccccccccccceeEEeecCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH--LVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
+.||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++........+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe-----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 46899999999983 13457788876522 2345688999988886444 466777777777778999999986
Q ss_pred C-HHHHH---------------------hcC--CCCchhHHH-HHHH----------HHHHH-hhHhhhc-CCCCeeeCC
Q 044281 586 T-LANLI---------------------FAI--PKPDWNLRI-RISL----------EIARG-LAYLHEE-CNVPIIHCD 628 (796)
Q Consensus 586 s-L~~~l---------------------~~~--~~~~~~~~~-~i~~----------~ia~~-l~yLH~~-~~~~iiH~D 628 (796)
+ +...+ +.. +........ .+.. .+.+. ..+|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 21111 111 111111100 0000 01111 1222211 123578999
Q ss_pred CCCCCEEEcCCCcEEEeecCCcc
Q 044281 629 IKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 629 lk~~NIll~~~~~~kl~DfGla~ 651 (796)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.90 E-value=3e-05 Score=76.12 Aligned_cols=102 Identities=23% Similarity=0.343 Sum_probs=82.3
Q ss_pred HHHHHHhcccCc-cCcccccccccccccceeEEeecCCCCHHHH---HhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCC
Q 044281 548 KSEVSAIGRTHH-KHLVQLLGFCDEALNRLLVYEFMGNGTLANL---IFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623 (796)
Q Consensus 548 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ 623 (796)
..|..+++.+++ +++++++|+| ..+++.||.+.+++... +.+.-..+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347777888865 5999999999 34789999987766432 222235689999999999999999999855446
Q ss_pred eeeCCCCCCCEEEcCCCcEEEeecCCcccc
Q 044281 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 624 iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 653 (796)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999877644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=3.3e-06 Score=93.24 Aligned_cols=182 Identities=18% Similarity=0.113 Sum_probs=127.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC-cccccccccccccceeEEeecCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH-LVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.+.+++|++++++|.+- .. .+...++.+... ....-++++|.+.+||| .++.++-+..+...++.+++...
T Consensus 246 ~fh~fvK~altknpKkRp-ta-eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRP-TA-EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHhcCCCccCC-Ch-hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 446688999999998652 12 223334544332 44566888999999999 77788888888888999999987
Q ss_pred C-CHHHHH-hcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 585 G-TLANLI-FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 585 g-sL~~~l-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+ +..... ...-.+..-+...+...-++++++||+. .=+|+| ||+..+ ...|..||+.+..+.+.. ...
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 6 211111 0101122223344555667889999986 358888 776665 688999999988664433 334
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSV 704 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~ 704 (796)
...+|+.++|||......+..+.|+|++|+-..++--|..|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 456899999999999999999999999998777776666554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00012 Score=75.47 Aligned_cols=136 Identities=16% Similarity=0.131 Sum_probs=82.1
Q ss_pred hCCCcc-ceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEeecCCCCH
Q 044281 510 LGRGSF-GIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEFMGNGTL 587 (796)
Q Consensus 510 LG~G~f-G~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 587 (796)
|..|.. ..||+... ++..+.||+..... ..+..+|+++++.+. +--+.+++++.......++|||+++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDG---KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcC---CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 444544 78898754 24678888876542 335667888887773 44455777777666678999999999877
Q ss_pred HHHH-------------------hcCCC--Cch----hHHHHHH-HH-------------------HHHHhhHhhh----
Q 044281 588 ANLI-------------------FAIPK--PDW----NLRIRIS-LE-------------------IARGLAYLHE---- 618 (796)
Q Consensus 588 ~~~l-------------------~~~~~--~~~----~~~~~i~-~~-------------------ia~~l~yLH~---- 618 (796)
.... +..+. .+. ....... .. +...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11110 000 0000000 00 0111111211
Q ss_pred cCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 619 ~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
.....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 112458999999999999998778999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00013 Score=74.41 Aligned_cols=139 Identities=19% Similarity=0.172 Sum_probs=80.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC--ccccccccccc---ccceeEEeec
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH--LVQLLGFCDEA---LNRLLVYEFM 582 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~---~~~~lv~e~~ 582 (796)
+.|+.|..+.||+.... + ..+++|..... .....+..|..+++.+.... +.+++.+.... ...+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~--~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD--D-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEET--T-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEEC--C-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 35788999999998753 3 58999998664 34566778888888875433 45666644222 2357999999
Q ss_pred CCCCHHH----------------HHh---cC--C--CCch-h--------HHHHH------------HHHHHH-HhhHhh
Q 044281 583 GNGTLAN----------------LIF---AI--P--KPDW-N--------LRIRI------------SLEIAR-GLAYLH 617 (796)
Q Consensus 583 ~~gsL~~----------------~l~---~~--~--~~~~-~--------~~~~i------------~~~ia~-~l~yLH 617 (796)
++..+.. .+. .. + ...+ . ..... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987776 111 11 0 0110 0 00000 111222 233333
Q ss_pred hc----CCCCeeeCCCCCCCEEEc-CCCcEEEeecCCcc
Q 044281 618 EE----CNVPIIHCDIKPQNILLD-HFFSAKISDFGLSK 651 (796)
Q Consensus 618 ~~----~~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~ 651 (796)
+. ....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 234699999999999999 66667899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00028 Score=66.57 Aligned_cols=130 Identities=21% Similarity=0.287 Sum_probs=85.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+..+.|++|++|.||+|.+. +..+|+|.-... .....+..|+++|..++-.++-+=+-++.+. .+.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR---GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeecc---CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcC
Confidence 34578999999999999874 568999987653 3356788999999988776665433333222 345999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCC-CCEEEcCCCcEEEeecCCccc
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKP-QNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~-~NIll~~~~~~kl~DfGla~~ 652 (796)
..|.+.-... +-++ ...+++. +|.-+. .+|-|..|.- ..++|.++..+.|+||.-|..
T Consensus 97 ~~L~~~~~~~---~rk~----l~~vlE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG---DRKH----LLRVLEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc---cHHH----HHHHHHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8887654432 1122 2233444 333332 2788888864 444444445999999998873
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0003 Score=63.12 Aligned_cols=71 Identities=21% Similarity=0.440 Sum_probs=49.3
Q ss_pred EecCc-eEEECCC-CCeeeecCCC---CccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCccccCcceEEecc
Q 044281 91 LTATG-LLLKDPG-GQAIWDGKPD---KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRL 165 (796)
Q Consensus 91 l~~~g-l~l~~~~-~~~vWst~~~---~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S~~ 165 (796)
...+| +|+.+.. +.++|++++. .....+.|.++|||||++. ++.++|+| +|- +
T Consensus 26 ~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~--~g~~vW~S-----~t~-~-------------- 83 (114)
T smart00108 26 MQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG--DGRVVWSS-----NTT-G-------------- 83 (114)
T ss_pred CCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC--CCCEEEEe-----ccc-C--------------
Confidence 34677 7777654 5899998753 2224688999999999865 35689997 111 1
Q ss_pred CCCCCCCCceeEeee-CCceeeee
Q 044281 166 TETNFSKGRFELHFS-NGSLEFIP 188 (796)
Q Consensus 166 s~~d~s~G~f~l~~~-~~~~~~~~ 188 (796)
..|.+.+.++ +|+++++-
T Consensus 84 -----~~~~~~~~L~ddGnlvl~~ 102 (114)
T smart00108 84 -----ANGNYVLVLLDDGNLVIYD 102 (114)
T ss_pred -----CCCceEEEEeCCCCEEEEC
Confidence 2366788887 79988864
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00035 Score=62.90 Aligned_cols=79 Identities=18% Similarity=0.304 Sum_probs=53.8
Q ss_pred Cc-eEEECCC-CCeeeecCCC---CccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCccccCcceEEeccCCC
Q 044281 94 TG-LLLKDPG-GQAIWDGKPD---KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTET 168 (796)
Q Consensus 94 ~g-l~l~~~~-~~~vWst~~~---~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S~~s~~ 168 (796)
+| +|+.+.. ++++|++++. .....+.|.++|||||.+. ++.++|||=-.
T Consensus 30 dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~--~g~~vW~S~~~------------------------ 83 (116)
T cd00028 30 DYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG--SGTVVWSSNTT------------------------ 83 (116)
T ss_pred eEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC--CCcEEEEeccc------------------------
Confidence 77 7777654 5899998753 2445688999999999765 44689986321
Q ss_pred CCCCCceeEeee-CCceeeeeccCCccccceeeecccc
Q 044281 169 NFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNT 205 (796)
Q Consensus 169 d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (796)
...|.+.+.++ +|+++++-... ...|++..
T Consensus 84 -~~~~~~~~~L~ddGnlvl~~~~~------~~~W~Sf~ 114 (116)
T cd00028 84 -RVNGNYVLVLLDDGNLVLYDSDG------NFLWQSFD 114 (116)
T ss_pred -CCCCceEEEEeCCCCEEEECCCC------CEEEcCCC
Confidence 02467788876 89999875321 34676643
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00091 Score=81.36 Aligned_cols=79 Identities=10% Similarity=0.210 Sum_probs=55.1
Q ss_pred HhhCCCccceEEEEEeeCCCC-eEEEEEEecchh-hhhHHHHHHHHHHhcccC-ccCc--cccccccccc---ccceeEE
Q 044281 508 EELGRGSFGIVYKGVLKTASG-TAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKHL--VQLLGFCDEA---LNRLLVY 579 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~-~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lv~ 579 (796)
+.++.|.+..+|+........ ..+++|+..... ......+.+|+++++.+. |.++ .+++++|.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 457899999999876542211 467777764322 123357889999999885 6665 7778888664 4578999
Q ss_pred eecCCCC
Q 044281 580 EFMGNGT 586 (796)
Q Consensus 580 e~~~~gs 586 (796)
||+++..
T Consensus 124 E~v~G~~ 130 (822)
T PLN02876 124 EYLEGRI 130 (822)
T ss_pred EecCCcc
Confidence 9998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0012 Score=65.12 Aligned_cols=131 Identities=18% Similarity=0.230 Sum_probs=88.7
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh----------------hhhHHHHHHHHHHhcccC------ccCcccc
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA----------------QEREREFKSEVSAIGRTH------HKHLVQL 565 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l 565 (796)
..||+|+.-.||. ++ +.....||+..... ....+++.+|+.....+. +.+|.++
T Consensus 7 ~~i~~G~~R~cy~--HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEE--CC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4689999999995 33 34567788876543 122355666665555554 8899999
Q ss_pred cccccccccceeEEeecCC------CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC
Q 044281 566 LGFCDEALNRLLVYEFMGN------GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 566 ~g~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~ 639 (796)
+|+.+++...-+|+|.+.+ .+|.++++... ++. ... ..+-+-..||-++ .|+.+|++|.||++...
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~---~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELR---QALDEFKRYLLDH---HIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHH---HHHHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence 9999999999999998754 35778885543 333 222 2233334566666 79999999999999643
Q ss_pred --C--cEEEee-cCCc
Q 044281 640 --F--SAKISD-FGLS 650 (796)
Q Consensus 640 --~--~~kl~D-fGla 650 (796)
+ .+.|+| ||-.
T Consensus 155 ~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCCceEEEEEeCCCCc
Confidence 2 467776 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00087 Score=68.72 Aligned_cols=72 Identities=14% Similarity=0.171 Sum_probs=43.9
Q ss_pred hhCCCccc-eEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCcc---Ccccccccccccc---cceeEEee
Q 044281 509 ELGRGSFG-IVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHK---HLVQLLGFCDEAL---NRLLVYEF 581 (796)
Q Consensus 509 ~LG~G~fG-~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~---~~~lv~e~ 581 (796)
.|+.|+.. .||+. +..+++|..+.. .....+.+|.+.+..+... -+.++++...... ..+++||+
T Consensus 4 ~~~~gG~~n~vy~~------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 4 PVDSGGTDNATFRL------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eccCCCcccceEEc------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 46666665 58874 124667775542 2245788899888877532 3444455443322 34789999
Q ss_pred cCCCCHH
Q 044281 582 MGNGTLA 588 (796)
Q Consensus 582 ~~~gsL~ 588 (796)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00094 Score=79.39 Aligned_cols=197 Identities=20% Similarity=0.184 Sum_probs=136.9
Q ss_pred HHHHHHHhcccCccCcccccccccccccc----eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCC
Q 044281 547 FKSEVSAIGRTHHKHLVQLLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622 (796)
Q Consensus 547 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~ 622 (796)
..-|+..+.++.|+|+++++.+-.+.... .+..|++..-++...+......+..+.+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 34567778888999999998887554332 35567888888999998888889999999999999999999997
Q ss_pred CeeeCCCCCC---CEEEcCCCcEEEe--ecCCcccccCCCCcceeeccCCCcccccccccCCCCCc--cchhHHHHHHHH
Q 044281 623 PIIHCDIKPQ---NILLDHFFSAKIS--DFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA--KVDVYSFGVTLL 695 (796)
Q Consensus 623 ~iiH~Dlk~~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--k~DVwS~Gv~l~ 695 (796)
...|.-|..+ +--.+.++...++ ||+.++.+........ ..-+..+.+||......++. ..|+|.+|..+.
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 4444444444 4445666777777 9988876644332211 12344577888887666554 479999999999
Q ss_pred HHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 044281 696 EIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775 (796)
Q Consensus 696 elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~ 775 (796)
.+..|..+........ .+.+. . .. ..+......|+..++++|++..+++.+.-
T Consensus 384 ~~~~~~~i~~~~~~~~-------------------~~l~~----~-~~---~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVPV-------------------SLLDV----L-ST---SELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhcCcccccccchh-------------------hhhcc----c-cc---hhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 9998876543211100 00000 0 00 03455677899999999999999998763
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.002 Score=68.46 Aligned_cols=75 Identities=8% Similarity=0.053 Sum_probs=52.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCc---cCcccccccccc---cccceeEEee
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHH---KHLVQLLGFCDE---ALNRLLVYEF 581 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~---~~~~~lv~e~ 581 (796)
+.||+|..+.||+.... ++ .+.+|..+.. .....|..|...++.+.. -.+.+++++|.. .+..+||||+
T Consensus 20 ~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYDS--QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEcC--CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 45999999999987532 33 4666664331 123578889988888743 367788887754 3567999999
Q ss_pred cCCCCH
Q 044281 582 MGNGTL 587 (796)
Q Consensus 582 ~~~gsL 587 (796)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0016 Score=67.73 Aligned_cols=134 Identities=12% Similarity=0.131 Sum_probs=76.2
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCc-ccccccccccccceeEEeecCCCCHH
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL-VQLLGFCDEALNRLLVYEFMGNGTLA 588 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gsL~ 588 (796)
+..|-...+|+... +++.+++|..............+|..+++.+....+ .++++... .++||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH---PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe---CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 55677889998762 466888887654322211235678888887754433 34444432 36999999987653
Q ss_pred HH--------------H---hcCCC----CchhH-HHHHHHHH---------HHHhhHhhhc-----CCCCeeeCCCCCC
Q 044281 589 NL--------------I---FAIPK----PDWNL-RIRISLEI---------ARGLAYLHEE-----CNVPIIHCDIKPQ 632 (796)
Q Consensus 589 ~~--------------l---~~~~~----~~~~~-~~~i~~~i---------a~~l~yLH~~-----~~~~iiH~Dlk~~ 632 (796)
.. + +..+. .+... ......++ ...+..+... ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1 11111 11111 11111111 1111112111 1235899999999
Q ss_pred CEEEcCCCcEEEeecCCcc
Q 044281 633 NILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 633 NIll~~~~~~kl~DfGla~ 651 (796)
||++++++ ++|+||..+.
T Consensus 157 Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC-CEEEeccccC
Confidence 99999877 7899998876
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0024 Score=65.35 Aligned_cols=74 Identities=19% Similarity=0.157 Sum_probs=45.1
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCc-ccccccccccccceeEEeecCCCCH
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL-VQLLGFCDEALNRLLVYEFMGNGTL 587 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gsL 587 (796)
.|..|-...+|+......+++.+++|....... ......+|+.++..+...++ +++++... ..++|||+++.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 467788889998764321256788897754221 11233467777777744333 34444332 2489999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0058 Score=54.61 Aligned_cols=99 Identities=21% Similarity=0.414 Sum_probs=61.9
Q ss_pred CeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEee-cCCCCCCCCcEEEEecCc-eEEECCCCCeeeecCCCC
Q 044281 36 SSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHA-NGDNPAPRGSTLELTATG-LLLKDPGGQAIWDGKPDK 113 (796)
Q Consensus 36 ~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~A-Nr~~pv~~~s~l~l~~~g-l~l~~~~~~~vWst~~~~ 113 (796)
+++.+.+|.+.|-|-.-++ |-| |+ ...++||.. +..........+.|..+| |+|.|.++.++|++....
T Consensus 12 ~p~~~~s~~~~L~l~~dGn------Lvl-~~--~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~p 82 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN------LVL-YD--SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDYP 82 (114)
T ss_dssp EEEEECETTEEEEEETTSE------EEE-EE--TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTSS
T ss_pred cccccccccccceECCCCe------EEE-Ec--CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCCC
Confidence 4555545788887754221 344 33 235679999 434443345689999999 999999999999986544
Q ss_pred ccceEEeec--CccEEEEEcCCCCcceeeccccCc
Q 044281 114 NVSDAAMLD--TGNFVLRASGNNSDYAWQSFKSPT 146 (796)
Q Consensus 114 ~~~~a~lld--sGNlVl~~~~~~~~~lWQSFD~PT 146 (796)
..+....++ .||++ ... ...+.|.|=+-|+
T Consensus 83 tdt~L~~q~l~~~~~~-~~~--~~~~sw~s~~dps 114 (114)
T PF01453_consen 83 TDTLLPGQKLGDGNVT-GKN--DSLTSWSSNTDPS 114 (114)
T ss_dssp S-EEEEEET--TSEEE-EES--TSSEEEESS----
T ss_pred ccEEEeccCcccCCCc-ccc--ceEEeECCCCCCC
Confidence 555566666 88988 432 2457888866653
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0022 Score=62.77 Aligned_cols=125 Identities=31% Similarity=0.412 Sum_probs=87.2
Q ss_pred HHHhHHHhhCCCcc-ceEEEEEeeCCCCeEEEEEEecch-----------hh----------hhHHHHHHHHHHhcccC-
Q 044281 502 ATDGFKEELGRGSF-GIVYKGVLKTASGTAIAVKKLDRL-----------AQ----------EREREFKSEVSAIGRTH- 558 (796)
Q Consensus 502 ~~~~~~~~LG~G~f-G~Vy~g~~~~~~~~~vavK~l~~~-----------~~----------~~~~~~~~E~~~l~~l~- 558 (796)
....+.+.||.|.- |.|||+.+ +|+.+|+|..... .. .....|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 34456788999999 99999988 4789999993210 00 11235889999999885
Q ss_pred --ccCc--cccccccccc------------------ccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHh
Q 044281 559 --HKHL--VQLLGFCDEA------------------LNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYL 616 (796)
Q Consensus 559 --h~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yL 616 (796)
+.++ |+.+|+..-. ....||.||++... ....+-+.+|.+-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHHHHHHHHHHHH
Confidence 3455 7888876211 11246777765432 12234456777888889
Q ss_pred hhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCc
Q 044281 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS 650 (796)
Q Consensus 617 H~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 650 (796)
|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 988 9999999999985 5689999864
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.00059 Score=55.64 Aligned_cols=46 Identities=26% Similarity=0.553 Sum_probs=36.4
Q ss_pred ecccCCCCCccccCCCchhhHHHhhcCCCceeeeeec--CCcceecCC
Q 044281 359 NNVEWPLGDYERLEPSNQTECETSCLQDCSCAVAIYD--GNSCRKKKL 404 (796)
Q Consensus 359 ~~~~~p~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~ 404 (796)
.+++++..++......+.++|++.|+.||+|.||.|. .+.|+++..
T Consensus 10 ~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred CCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 4666676666554456899999999999999999995 578988766
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.01 Score=63.17 Aligned_cols=138 Identities=15% Similarity=0.175 Sum_probs=81.3
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC--cccccccc------cccccceeEE
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH--LVQLLGFC------DEALNRLLVY 579 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv~ 579 (796)
+.|..|....+|+... ++..+++|+.... .......|++++..+.+.+ +.+++... ...+..++|+
T Consensus 20 ~~i~~G~~n~~y~v~~---~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 20 EGISAGIENTNYFVTT---DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred ecccCccccceEEEEe---CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3477787789998754 2347888987642 2345666777777764333 44554422 2234557999
Q ss_pred eecCCCCHHH-----------HH---hc----CC-------CCchhHHH----------HHHHHHHHHhhHhhh----cC
Q 044281 580 EFMGNGTLAN-----------LI---FA----IP-------KPDWNLRI----------RISLEIARGLAYLHE----EC 620 (796)
Q Consensus 580 e~~~~gsL~~-----------~l---~~----~~-------~~~~~~~~----------~i~~~ia~~l~yLH~----~~ 620 (796)
+|++|..+.. .+ +. .. ...|.... .....+..++.++.+ ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876422 00 00 00 01121110 011123334444443 12
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 621 ~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
...++|+|+.|.||+++++..+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3469999999999999998778999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.015 Score=61.98 Aligned_cols=137 Identities=23% Similarity=0.266 Sum_probs=78.3
Q ss_pred hCCCccceEEEEEeeC-----CCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCc-ccccccccccccceeEEeecC
Q 044281 510 LGRGSFGIVYKGVLKT-----ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL-VQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~ 583 (796)
|..|--..+|+..... ..++.+++|+..... ....+..+|.+++..+....+ .++++++.. .+|+||++
T Consensus 6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 4556667889876532 124788899875532 222345677777777643333 345555542 36899998
Q ss_pred CCCHHHH--------------H---hcCC-CC------c----hhHHHH--------------------------HHHHH
Q 044281 584 NGTLANL--------------I---FAIP-KP------D----WNLRIR--------------------------ISLEI 609 (796)
Q Consensus 584 ~gsL~~~--------------l---~~~~-~~------~----~~~~~~--------------------------i~~~i 609 (796)
|..+... + +... .. . |..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8765321 1 1111 00 0 111100 01122
Q ss_pred HHHhhHhhh------cCCCCeeeCCCCCCCEEEcCC----CcEEEeecCCcc
Q 044281 610 ARGLAYLHE------ECNVPIIHCDIKPQNILLDHF----FSAKISDFGLSK 651 (796)
Q Consensus 610 a~~l~yLH~------~~~~~iiH~Dlk~~NIll~~~----~~~kl~DfGla~ 651 (796)
...+..|.. .....++|+|+.+.||+++++ +.++++||..+.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 222333332 134578999999999999985 889999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.05 Score=58.53 Aligned_cols=31 Identities=23% Similarity=0.269 Sum_probs=26.8
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 621 ~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
..+++|+|+.|.||+++++...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3479999999999999977666899999875
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.084 Score=57.99 Aligned_cols=75 Identities=15% Similarity=0.182 Sum_probs=50.4
Q ss_pred HhhCCCccceEEEEEeeCCCC-eEEEEEEecchh-------hhhHHHHHHHHHHhcccC---ccCcccccccccccccce
Q 044281 508 EELGRGSFGIVYKGVLKTASG-TAIAVKKLDRLA-------QEREREFKSEVSAIGRTH---HKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~ 576 (796)
+.||.|.+..||++... +| +.|+||.-.... ....+.+..|.+.|..+. ..++++++.+. ....+
T Consensus 32 ~elggGn~N~VyrV~~~--~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDT--EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeC--CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCE
Confidence 56999999999999864 34 589999853210 112345666777777652 24566777763 35578
Q ss_pred eEEeecCCCC
Q 044281 577 LVYEFMGNGT 586 (796)
Q Consensus 577 lv~e~~~~gs 586 (796)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.0035 Score=76.38 Aligned_cols=158 Identities=12% Similarity=-0.007 Sum_probs=111.8
Q ss_pred HHHHHHhcccCccCcccccccc--cccccceeEEeecCCCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCC
Q 044281 548 KSEVSAIGRTHHKHLVQLLGFC--DEALNRLLVYEFMGNGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECN 621 (796)
Q Consensus 548 ~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~ 621 (796)
..|...++..+|+++.....-. .+..+.+..++|+..|.+.+.|-+. +.++.......-.+...+..-.|+..+
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 3455555667888877654433 2345668899999999999988653 233333333333333555555555432
Q ss_pred --CCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh
Q 044281 622 --VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC 699 (796)
Q Consensus 622 --~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt 699 (796)
.--+|++||+.|.+|..+..+|+.++|+.++..+ .........+++-|+.|+....-.++.++|+|..|+.+|+.--
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 2368999999999999999999999999984322 2222334457788999999999999999999999999999988
Q ss_pred CCCCCch
Q 044281 700 CRRSVEM 706 (796)
Q Consensus 700 g~~p~~~ 706 (796)
|..++..
T Consensus 1436 ~n~~fi~ 1442 (2724)
T KOG1826|consen 1436 GNAYFIF 1442 (2724)
T ss_pred ccHHHHH
Confidence 8777643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.033 Score=58.51 Aligned_cols=72 Identities=17% Similarity=0.268 Sum_probs=44.3
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc---CccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT---HHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.|+.|....+|+.. .+++.+.||.-... ....|..|.+-|+.| .--.+++++++....+..+||+||++.
T Consensus 23 ~~v~GG~i~~a~~~~---~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD---TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEE--SSSSEEEEEE---TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred EecCCCChhheEEEE---CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 347888899999865 36789999987632 234567777776666 345577888887777777999999987
Q ss_pred C
Q 044281 585 G 585 (796)
Q Consensus 585 g 585 (796)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.058 Score=56.58 Aligned_cols=30 Identities=27% Similarity=0.489 Sum_probs=25.6
Q ss_pred CeeeCCCCCCCEEEcCCCc-EEEeecCCccc
Q 044281 623 PIIHCDIKPQNILLDHFFS-AKISDFGLSKL 652 (796)
Q Consensus 623 ~iiH~Dlk~~NIll~~~~~-~kl~DfGla~~ 652 (796)
.++|+|+++.||++++++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.0094 Score=61.72 Aligned_cols=133 Identities=14% Similarity=0.094 Sum_probs=85.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--h-----hh---------------hHHHHHHHHHHhcccCc--
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--A-----QE---------------REREFKSEVSAIGRTHH-- 559 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~-----~~---------------~~~~~~~E~~~l~~l~h-- 559 (796)
+.+.+.||-|--+.||.+... .|++.++|.-+-. + .. ..-....|...|+.+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~--~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE--EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecC--CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 456678999999999999764 6788888853210 0 00 01234567777777743
Q ss_pred cCcccccccccccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC
Q 044281 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 560 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~ 639 (796)
--+.+.+++ +..++|||++.+-.|...-+-. +..+. ...+..-+.-|-.+ |+||+|..-=||+++++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~---d~~~l---y~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE---DPPTL---YDDLMGLIVRLANH---GLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeecC---ChHHH---HHHHHHHHHHHHHc---CceecccchheeEEecC
Confidence 234444444 3557999999888776543222 11222 22222223334444 99999999999999999
Q ss_pred CcEEEeecCCcc
Q 044281 640 FSAKISDFGLSK 651 (796)
Q Consensus 640 ~~~kl~DfGla~ 651 (796)
+.++++||--..
T Consensus 239 ~~i~vIDFPQmv 250 (465)
T KOG2268|consen 239 DKIVVIDFPQMV 250 (465)
T ss_pred CCEEEeechHhh
Confidence 999999996544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.052 Score=58.97 Aligned_cols=138 Identities=18% Similarity=0.197 Sum_probs=78.3
Q ss_pred hCCCccceEEEEEeeCC---CCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcc-cccccccccccceeEEeecCCC
Q 044281 510 LGRGSFGIVYKGVLKTA---SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLV-QLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~g 585 (796)
|-.|-.-.+|+...... .++.+++|+...... ..-.-.+|..++..+...++. ++++++..+ .|+||+++.
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 44466778888764321 236788998765432 222236688888777544443 456665433 589999876
Q ss_pred CHHHH-----------------HhcCC----C-C-chhHHHHHHHH-----------------HHHHhhHh----hh-cC
Q 044281 586 TLANL-----------------IFAIP----K-P-DWNLRIRISLE-----------------IARGLAYL----HE-EC 620 (796)
Q Consensus 586 sL~~~-----------------l~~~~----~-~-~~~~~~~i~~~-----------------ia~~l~yL----H~-~~ 620 (796)
+|... ++..+ . . .+.+..++..+ +...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65321 11111 0 1 12222222211 11112222 11 12
Q ss_pred CCCeeeCCCCCCCEEEcC-CCcEEEeecCCccc
Q 044281 621 NVPIIHCDIKPQNILLDH-FFSAKISDFGLSKL 652 (796)
Q Consensus 621 ~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~ 652 (796)
...++|+|+++.|||+++ ++.++++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 346899999999999986 47899999988763
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.082 Score=56.00 Aligned_cols=126 Identities=21% Similarity=0.328 Sum_probs=74.2
Q ss_pred CeEEEEEEec-chhhhhHHHHHHHHHHhcccCc--cCcccccccccccc--cceeEEeecCCCCH---------------
Q 044281 528 GTAIAVKKLD-RLAQEREREFKSEVSAIGRTHH--KHLVQLLGFCDEAL--NRLLVYEFMGNGTL--------------- 587 (796)
Q Consensus 528 ~~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lv~e~~~~gsL--------------- 587 (796)
++.+++.+-. ...........+|..+|+.+.- .-+.+.++.|.++. ..+.||+|.++..+
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 6777887331 1222334556677777777632 33455677887776 66999999988322
Q ss_pred ---HHHHhc---CC--------C---------CchhHHHHHH--------HHHHHHhhHhhhcC-----CCCeeeCCCCC
Q 044281 588 ---ANLIFA---IP--------K---------PDWNLRIRIS--------LEIARGLAYLHEEC-----NVPIIHCDIKP 631 (796)
Q Consensus 588 ---~~~l~~---~~--------~---------~~~~~~~~i~--------~~ia~~l~yLH~~~-----~~~iiH~Dlk~ 631 (796)
.++|.. .+ . ..|...++.+ -....-..+|+++. ...++|+|+++
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 122211 00 0 0011111100 01222244454432 35699999999
Q ss_pred CCEEEcCCCcEEEeecCCcccc
Q 044281 632 QNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 632 ~NIll~~~~~~kl~DfGla~~~ 653 (796)
.||++++..-+=|.||+++.+-
T Consensus 208 gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCEEEeCCCeeEEEeccccccC
Confidence 9999999888999999999753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.13 Score=55.08 Aligned_cols=139 Identities=15% Similarity=0.228 Sum_probs=77.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCcc--Ccccccccc------cccccceeEE
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHK--HLVQLLGFC------DEALNRLLVY 579 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~------~~~~~~~lv~ 579 (796)
+.++.|.-..+|+... .++ .+++|+.+... ...+...|++++..+... .+.+++... ...+..++++
T Consensus 28 ~~~~~G~~n~~y~v~t--~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT--DVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred cccCCccccceEEEEe--CCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3466777789998753 233 57788765421 123344555666555322 234444422 1234568999
Q ss_pred eecCCCCHH-----------HHH---hcC-CC-----------CchhHHH------------HHHHHHHHHhhHhhh---
Q 044281 580 EFMGNGTLA-----------NLI---FAI-PK-----------PDWNLRI------------RISLEIARGLAYLHE--- 618 (796)
Q Consensus 580 e~~~~gsL~-----------~~l---~~~-~~-----------~~~~~~~------------~i~~~ia~~l~yLH~--- 618 (796)
||++|..+. ..+ +.. .. ..|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885431 111 100 00 1121110 011123334555532
Q ss_pred -cCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 619 -ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 619 -~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
....+++|+|+++.||++++++.+.|.||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223579999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.24 Score=54.26 Aligned_cols=72 Identities=18% Similarity=0.255 Sum_probs=46.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh----h---hhHHHHHHHHHHhcccC---ccCccccccccccccccee
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA----Q---EREREFKSEVSAIGRTH---HKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~----~---~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 577 (796)
+.||.|....||+... ++..++||.-.... . .....-..|...|+.+. ..++.+++.++. +..++
T Consensus 38 ~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 5689999999999764 34568899764211 0 11222233455555442 357888888887 34678
Q ss_pred EEeecCC
Q 044281 578 VYEFMGN 584 (796)
Q Consensus 578 v~e~~~~ 584 (796)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.15 Score=54.05 Aligned_cols=138 Identities=19% Similarity=0.197 Sum_probs=87.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hh------hH-----------------HHHHHHHHHhcccCccC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QE------RE-----------------REFKSEVSAIGRTHHKH 561 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~------~~-----------------~~~~~E~~~l~~l~h~n 561 (796)
..|..|--.-||.+.-. +|..+|||+.+... .. ++ --...|++.|.+++...
T Consensus 150 GCiSTGKEANVYHat~~--dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEE--DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccCccceeEeeecC--CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 35788888999998754 68889999875311 00 00 11234666666665444
Q ss_pred cccccccccccccceeEEeecCCCCHHH-HHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC
Q 044281 562 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF 640 (796)
Q Consensus 562 iv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~ 640 (796)
|.-.--+.. ....|||+|+..-.... .|+. -.++...+..+-.|++.-+.-|.+.| ++||.||.-=|+|+.+ |
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD-ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-G 301 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccccc-ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-C
Confidence 332111111 12369999986422211 1211 23444556677778888888887777 8999999999998865 7
Q ss_pred cEEEeecCCcccc
Q 044281 641 SAKISDFGLSKLL 653 (796)
Q Consensus 641 ~~kl~DfGla~~~ 653 (796)
.+.|+|-+-+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 8999998877644
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.075 Score=53.35 Aligned_cols=30 Identities=30% Similarity=0.449 Sum_probs=21.6
Q ss_pred CeeeCCCCCCCEEE-cCCCcEEEeecCCccc
Q 044281 623 PIIHCDIKPQNILL-DHFFSAKISDFGLSKL 652 (796)
Q Consensus 623 ~iiH~Dlk~~NIll-~~~~~~kl~DfGla~~ 652 (796)
.+.|+||.+.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8899999999988763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.12 Score=55.73 Aligned_cols=139 Identities=18% Similarity=0.272 Sum_probs=77.0
Q ss_pred hhCCCccceEEEEEeeCCC--CeEEEEEEecchhhhhHHHHHHHHHHhcccCccCc-ccccccccccccceeEEeecCCC
Q 044281 509 ELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL-VQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~g 585 (796)
.|..|-...+|+......+ +..|++|....... ..-.-.+|..+++.+...++ .++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 3455666778887654221 23788888765332 12233567888877765555 3556665332 589998776
Q ss_pred CHHH-------HH----------hcCC-----CC-chhHHHHHHHHH----------------------HHHhhHhhh--
Q 044281 586 TLAN-------LI----------FAIP-----KP-DWNLRIRISLEI----------------------ARGLAYLHE-- 618 (796)
Q Consensus 586 sL~~-------~l----------~~~~-----~~-~~~~~~~i~~~i----------------------a~~l~yLH~-- 618 (796)
.|.. .+ +..+ .+ -|....++..++ .+-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5421 01 1111 01 122222222111 111111111
Q ss_pred ---cCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCccc
Q 044281 619 ---ECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKL 652 (796)
Q Consensus 619 ---~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~ 652 (796)
....-+.|.|+.+.|||+++ ++.++++||..|-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11224799999999999975 57899999988753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.17 Score=55.92 Aligned_cols=50 Identities=16% Similarity=0.221 Sum_probs=37.7
Q ss_pred HHHHHHHHHhcccCccCccccccccccccc-ceeEEeecCCCCHHHHHhcCC
Q 044281 545 REFKSEVSAIGRTHHKHLVQLLGFCDEALN-RLLVYEFMGNGTLANLIFAIP 595 (796)
Q Consensus 545 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~ 595 (796)
.++.-....++.++|+|+...+.+...... ..+|+|++ +.+|.+.+..+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 345566778888999999999998866544 46788887 558888887654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 796 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-22 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-22 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-22 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-22 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-22 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-22 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-21 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-124
Identities = 123/297 (41%), Positives = 173/297 (58%), Gaps = 14/297 (4%)
Query: 490 NLRFFSYDELKDATDGFKEE--LGRGSFGIVYKGVLKTASGTAIAVKKLDR-LAQERERE 546
L+ FS EL+ A+D F + LGRG FG VYKG L GT +AVK+L Q E +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQ 73
Query: 547 FKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP----DWNLR 602
F++EV I H++L++L GFC RLLVY +M NG++A+ + P+ DW R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 603 IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH- 661
RI+L ARGLAYLH+ C+ IIH D+K NILLD F A + DFGL+KL+ D TH
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHV 191
Query: 662 -TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEM-ELEEESRAILTDW 719
T +RGT G++APE+ S K DV+ +GV LLE+I +R+ ++ L + +L DW
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776
E +L+ L+D D + + + +A+ C Q P +RP M V++MLEG
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-115
Identities = 109/322 (33%), Positives = 167/322 (51%), Gaps = 15/322 (4%)
Query: 470 FKWRRRKYENNVQDSTTSETNLRFFSYDELKDATDGFKEE--LGRGSFGIVYKGVLKTAS 527
+ + + S +L++AT+ F + +G G FG VYKGVL+
Sbjct: 5 YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR--D 62
Query: 528 GTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL 587
G +A+K+ + + EF++E+ + H HLV L+GFCDE +L+Y++M NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 588 ANLIFAIPKP----DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAK 643
++ P W R+ I + ARGL YLH IIH D+K NILLD F K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 644 ISDFGLSKLLFSDQSRTH--TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCR 701
I+DFG+SK ++ +TH T+++GT GY+ PE+F ++ K DVYSFGV L E++C R
Sbjct: 180 ITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 702 RSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDP 761
++ L E L +WA + + G+L+ ++D + A L K+ A+ C+
Sbjct: 239 SAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 762 SKRPTMKVVLQMLEGLLDVPNP 783
RP+M VL LE L +
Sbjct: 298 EDRPSMGDVLWKLEYALRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-109
Identities = 106/318 (33%), Positives = 164/318 (51%), Gaps = 34/318 (10%)
Query: 482 QDSTTSETNLRFFSYDELKDATDGFKEE--------LGRGSFGIVYKGVLKTASGTAIAV 533
+ S+T FS+ ELK+ T+ F E +G G FG+VYKG + T +AV
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVAV 59
Query: 534 KKLDRLAQER----EREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLAN 589
KKL + +++F E+ + + H++LV+LLGF + + LVY +M NG+L +
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 590 LIFAIPKP---DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISD 646
+ + W++R +I+ A G+ +LHE IH DIK NILLD F+AKISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 647 FGLSKLLFSDQSRTH--TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSV 704
FGL++ ++T + I GT Y+APE + ++ K D+YSFGV LLEII +V
Sbjct: 177 FGLAR-ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234
Query: 705 EMELEEESRAILTDWAYDCYVEGR-LDVLIDSDEAAMADRSR--LHKWLMIAMWCIQEDP 761
+ E + L D + E + ++ ID M D + +A C+ E
Sbjct: 235 DEHREPQL---LLDIKEEIEDEEKTIEDYIDKK---MNDADSTSVEAMYSVASQCLHEKK 288
Query: 762 SKRPTMKVVLQMLEGLLD 779
+KRP +K V Q+L+ +
Sbjct: 289 NKRPDIKKVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-71
Identities = 69/327 (21%), Positives = 128/327 (39%), Gaps = 40/327 (12%)
Query: 479 NNVQDSTTSETNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKL 536
+ +S + + L + + E RG FG V+K L +AVK
Sbjct: 2 GHHHHHHSSGVD---LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVKIF 55
Query: 537 DRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN----RLLVYEFMGNGTLANLIF 592
++ + + EV ++ H++++Q +G + L+ F G+L++ +
Sbjct: 56 PI-QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 593 AIPKPDWNLRIRISLEIARGLAYLHEE-------CNVPIIHCDIKPQNILLDHFFSAKIS 645
A WN I+ +ARGLAYLHE+ I H DIK +N+LL + +A I+
Sbjct: 115 A-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 646 DFGLSKLLFSDQSRTHTMIR-GTRGYVAPE-----WFKNVPVSAKVDVYSFGVTLLEIIC 699
DFGL+ + +S T + GTR Y+APE ++D+Y+ G+ L E+
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 700 CRRSVEMELEEESRAILTDWA---------YDCYVEGRLDVLIDSDEAAMADRSRLHKWL 750
+ + + +E + + V + ++ + +
Sbjct: 234 RCTAADGPV-DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLC 289
Query: 751 MIAMWCIQEDPSKRPTMKVVLQMLEGL 777
C D R + V + + +
Sbjct: 290 ETIEECWDHDAEARLSAGCVGERITQM 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 7e-66
Identities = 80/300 (26%), Positives = 143/300 (47%), Gaps = 36/300 (12%)
Query: 496 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIG 555
Y E++ +E +GRG+FG+V K + +A+K++ ++ + F E+ +
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR---AKDVAIKQI--ESESERKAFIVELRQLS 56
Query: 556 RTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKPDWNLRIRISLEIARG 612
R +H ++V+L G C + LV E+ G+L N++ +P + L+ ++G
Sbjct: 57 RVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 613 LAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
+AYLH +IH D+KP N+LL KI DFG + D T +G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWM 170
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731
APE F+ S K DV+S+G+ L E+I R+ + E+ + I + + R
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRI----MWAVHNGTRPP- 224
Query: 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL-DVPNPPGPSSFS 790
LI + + LM W +DPS+RP+M+ +++++ L+ P P +
Sbjct: 225 LIKNLPKPIES-------LMTRCW--SKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-65
Identities = 81/296 (27%), Positives = 139/296 (46%), Gaps = 35/296 (11%)
Query: 496 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEVSA 553
+ +L KE++G GSFG V++ G+ +AVK L ER EF EV+
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRIRISLEIA 610
+ R H ++V +G + N +V E++ G+L L+ A + D R+ ++ ++A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGY 670
+G+ YLH N PI+H ++K N+L+D ++ K+ DFGLS+L + + GT +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEW 205
Query: 671 VAPEWFKNVPVSAKVDVYSFGVTLLEIICCRR-SVEMELEEESRAILTDWAYDCYVEG-R 728
+APE ++ P + K DVYSFGV L E+ ++ + + R
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFKCKR 257
Query: 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPP 784
L++ + + I C +P KRP+ ++ +L L+ PP
Sbjct: 258 LEIPRNLNPQ----------VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-61
Identities = 73/312 (23%), Positives = 136/312 (43%), Gaps = 42/312 (13%)
Query: 481 VQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKL---- 536
+ S ++ L + +E++ +++++G+G FG+V+KG L + +A+K L
Sbjct: 3 MGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGD 56
Query: 537 ---DRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA 593
+ E+ +EF+ EV + +H ++V+L G +V EF+ G L + +
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD 114
Query: 594 IPKP-DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF-----FSAKISDF 647
P W++++R+ L+IA G+ Y+ N PI+H D++ NI L AK++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 648 GLSKLLFSDQSRTHTMIRGTRGYVAPEWF--KNVPVSAKVDVYSFGVTLLEIICCRRSVE 705
GLS+ + + + G ++APE + + K D YSF + L I+ +
Sbjct: 174 GLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 706 MELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP 765
E + + R + D + + C DP KRP
Sbjct: 230 -EYSYGKIKFINMIREEGL---RPTIPEDCPP----------RLRNVIELCWSGDPKKRP 275
Query: 766 TMKVVLQMLEGL 777
+++ L L
Sbjct: 276 HFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 6e-61
Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 44/296 (14%)
Query: 496 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKL----DRLAQEREREFKSEV 551
+ EL +E +G G FG VY+ G +AVK D + + E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 552 SAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR 611
H +++ L G C + N LV EF G L ++ + + ++ + +++IAR
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIAR 116
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFS--------AKISDFGLSKLLFSDQSRTHTM 663
G+ YLH+E VPIIH D+K NIL+ KI+DFGL++ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA- 175
Query: 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRR-SVEMELEEESRAILTDWAYD 722
G ++APE + S DV+S+GV L E++ ++ + +
Sbjct: 176 --GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA------ 227
Query: 723 CYVEG-RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777
+ L + E + + C DP RP+ +L L +
Sbjct: 228 --MNKLALPIPSTCPEP----------FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 1e-59
Identities = 75/333 (22%), Positives = 122/333 (36%), Gaps = 45/333 (13%)
Query: 494 FSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSE- 550
+ E D K E +GRG +G VYKG L +AVK + F +E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD---ERPVAVKVFS---FANRQNFINEK 56
Query: 551 -VSAIGRTHHKHLVQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR 604
+ + H ++ + + D + LLV E+ NG+L + DW R
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCR 115
Query: 605 ISLEIARGLAYLHEE------CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD-- 656
++ + RGLAYLH E I H D+ +N+L+ + + ISDFGLS L +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 657 -----QSRTHTMIRGTRGYVAPEWFKNV-------PVSAKVDVYSFGVTLLEIIC-CRRS 703
+ GT Y+APE + +VD+Y+ G+ EI C
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 704 VEMELEEESRAILTDWAYD--CYVEGRLDVLIDS-----DEAAMADRSRLHKWLMIAMWC 756
E E + + + + ++ V + EA + + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 757 IQEDPSKRPTMKVVLQMLEGLLD-VPNPPGPSS 788
+D R T + + + L+ S
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-57
Identities = 78/318 (24%), Positives = 132/318 (41%), Gaps = 55/318 (17%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA 553
F +L E LG+G FG K + +G + +K+L R +E +R F EV
Sbjct: 7 FRPSDLI-----HGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRFDEETQRTFLKEVKV 60
Query: 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARG 612
+ H ++++ +G + + E++ GTL +I ++ W+ R+ + +IA G
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM--------- 663
+AYLH N IIH D+ N L+ + ++DFGL++L+ ++++ +
Sbjct: 121 MAYLH-SMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 664 ----IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW 719
+ G ++APE KVDV+SFG+ L EII
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------- 220
Query: 720 AYDCYVEGRLDVLIDSDEAAMADRSRLH-------KWLMIAMWCIQEDPSKRPTMKVVLQ 772
A Y+ +D ++ + + I + C DP KRP+ +
Sbjct: 221 ADPDYLPRTMDFGLNVRGFL-----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 773 MLEGL---LDVPNPPGPS 787
LE L L P GP
Sbjct: 276 WLETLRMHLAGHLPLGPQ 293
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-57
Identities = 64/295 (21%), Positives = 119/295 (40%), Gaps = 44/295 (14%)
Query: 496 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEVSA 553
+ +L F +L G ++KG + G I VK L + + R+F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 554 IGRTHHKHLVQLLGFCDE--ALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEI 609
+ H +++ +LG C A + L+ +M G+L N++ D + ++ +L++
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG 669
ARG+A+LH I + +++++D +A+IS + S
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 670 YVAPEWFKNVPVSA---KVDVYSFGVTLLEIICCRR-SVEMELEEESRAILTDWAYDCYV 725
+VAPE + P D++SF V L E++ ++ E +
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL-------- 225
Query: 726 EG-RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
EG R + ++ LM EDP+KRP +++ +LE + D
Sbjct: 226 EGLRPTIPPGISP-HVSK-------LMKICM--NEDPAKRPKFDMIVPILEKMQD 270
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-56
Identities = 68/314 (21%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 496 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEVSA 553
+++L+ E +G+G FG VY G G +A++ + +R +++ + FK EV A
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRWH---GE-VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARG 612
+T H+++V +G C + ++ TL +++ D N +I+ EI +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL----LFSDQSRTHTMIRGTR 668
+ YLH + I+H D+K +N+ D+ I+DFGL + + + G
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 669 GYVAPEWFKNV---------PVSAKVDVYSFGVTLLEIICCRRS-VEMELEEESRAILTD 718
++APE + + P S DV++ G E+ E +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--- 255
Query: 719 WAYDCYVEGRLDVLIDSD-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777
G L ++D ++ ++C + +RPT ++ MLE L
Sbjct: 256 ------GTGMKPNLSQIGMGKEISD-------IL--LFCWAFEQEERPTFTKLMDMLEKL 300
Query: 778 LDVPN-PPGPSSFS 790
P F
Sbjct: 301 PKRNRRLSHPGHFW 314
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-53
Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 47/290 (16%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKHLV 563
+ +G GSFG VYKG G +AVK L ++ + FK+EV + +T H +++
Sbjct: 28 VGQRIGSGSFGTVYKGKWH---GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLI-FAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
+G+ +V ++ +L + + + K + I I+ + ARG+ YLH +
Sbjct: 84 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--- 139
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLL-FSDQSRTHTMIRGTRGYVAPEWFKN--- 678
IIH D+K NI L + KI DFGL+ S + G+ ++APE +
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 679 VPVSAKVDVYSFGVTLLEIICCRR----------SVEMELEEESRAILTDWAYDCYVEGR 728
P S + DVY+FG+ L E++ + +EM L+ +C
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC----- 254
Query: 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
+ + C+++ +RP+ +L +E L
Sbjct: 255 -----------------PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-52
Identities = 64/301 (21%), Positives = 119/301 (39%), Gaps = 31/301 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+++G+G +G V+ G + G +AVK +E ++E+ H++++
Sbjct: 41 MVKQIGKGRYGEVWMGKWR---GEKVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 566 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE-- 619
+ + L+ ++ NG+L + + D ++++ GL +LH E
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 620 ---CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH---TMIRGTRGYVAP 673
I H D+K +NIL+ + I+D GL+ SD + GT+ Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 674 E------WFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTD--WAYDCYV 725
E + D+YSFG+ L E+ RR V + EE + D + Y
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 726 EGRLDVLIDSD----EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781
+ R V I + L + + C +P+ R T V + L + +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
Query: 782 N 782
+
Sbjct: 334 D 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-50
Identities = 66/299 (22%), Positives = 121/299 (40%), Gaps = 37/299 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E +G+G +G V++G + G +AVK E+ ++E+ H++++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ---GENVAVKIF-SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 566 LGFC----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE-- 619
+ + L+ + G+L + + + D +RI L IA GLA+LH E
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 620 ---CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI---RGTRGYVAP 673
I H D+K +NIL+ I+D GL+ + ++ GT+ Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 674 EWFKNVPVSA------KVDVYSFGVTLLEIICCRRSVEMELEEE--------SRAILTDW 719
E +VD+++FG+ L E+ S + + + + D
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 720 AYDCYVEG-RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777
V+ R + I + + + L K LM W ++PS R T + + L +
Sbjct: 247 RKVVCVDQQRPN--IPNRWFSDPTLTSLAK-LMKECW--YQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 27/296 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+E +G+G FG V++G + G +AVK +ER ++E+ H++++
Sbjct: 46 LQESIGKGRFGEVWRGKWR---GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 566 LGFC----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE-- 619
+ LV ++ +G+L + + I+++L A GLA+LH E
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 620 ---CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI---RGTRGYVAP 673
I H D+K +NIL+ + I+D GL+ S GT+ Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 674 E------WFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727
E K+ + D+Y+ G+ EI + + + + E
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 728 RLDVLIDSD----EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
R V L I C + + R T + + L L
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 66/268 (24%), Positives = 112/268 (41%), Gaps = 28/268 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLV 563
F E+GRGSF VYKG L T + +A + +L + + FK E + H ++V
Sbjct: 30 FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 564 QLLGFC---DEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
+ + +++ E M +GTL + + +I +GL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 620 CNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
PIIH D+K NI + S KI D GL+ L + ++ + GT ++APE ++
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 204
Query: 679 VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
VDVY+FG+ +LE+ E ++ A + Y G D
Sbjct: 205 -KYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQI----YRRVTSGVKPASFDKVAI 256
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPT 766
+ + CI+++ +R +
Sbjct: 257 PEV-KEIIEG-------CIRQNKDERYS 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 50/292 (17%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
+ LGRG FG+V++ A+K++ +E RE EV A+ + H +V+
Sbjct: 11 QCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 567 GFCDEALN---------RLLVY---EFMGNGTLANLIFA---IPKPDWNLRIRISLEIAR 611
E ++ +Y + L + + I + + ++ + I L+IA
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR------ 665
+ +LH + ++H D+KP NI K+ DFGL + D+ +
Sbjct: 130 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 666 -----GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA 720
GT+ Y++PE S KVD++S G+ L E + S +ME +
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE-LLYPFSTQMERVRTLTDV----- 240
Query: 721 YDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ L M+ + P +RP +++
Sbjct: 241 ----RNLKFPPLFTQKYPCEYV--------MVQ-DMLSPSPMERPEAINIIE 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 35/285 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQ 564
E++GRG+FG V+ G L+ T +AVK + +F E + + H ++V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 565 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
L+G C + +V E + G L + +++ + A G+ YL +
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM-----IRGTRGYVAPEWFKN 678
IH D+ +N L+ KISDFG+S+ ++ T APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNY 289
Query: 679 VPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
S++ DV+SFG+ L E S + ++ + GRL
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG--------GRL------- 334
Query: 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781
+ + LM W +P +RP+ + Q L+ +
Sbjct: 335 PCPELCPDAVFR-LMEQCW--AYEPGQRPSFSTIYQELQSIRKRH 376
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 34/277 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKK--LDRLAQEREREF-KSEVSAIGRTHHKHLVQ 564
+++GRG F VY+ G +A+KK + L + R E+ + + +H ++++
Sbjct: 38 KKIGRGQFSEVYR-AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 565 LLGFCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAYLHEE 619
E N L + E G L+ +I K + + +++ L ++H
Sbjct: 97 YYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
++H DIKP N+ + K+ D GL + S + H+++ GT Y++PE
Sbjct: 156 R---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 211
Query: 680 PVSAKVDVYSFGVTLLEIICCRR---SVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
+ K D++S G L E+ + +M L + I Y S+
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPLPSDHY-----SE 265
Query: 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773
E + CI DP KRP + V +
Sbjct: 266 ELR-----------QLVNMCINPDPEKRPDVTYVYDV 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREF-KSEVSAIGRTHHKHLVQL 565
+G GS+G K + + + G + K+LD + E E++ SEV+ + H ++V+
Sbjct: 12 YTIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 566 LG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAYLHEE 619
D L +V E+ G LA++I K L +R+ ++ L H
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 620 CNVP--IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
+ ++H D+KP N+ LD + K+ DFGL+++L D S T + GT Y++PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRSVE-MELEEESRAILTDWAYDCYVEGRLDVLID-- 734
+ + K D++S G L E+ +E + I EG+ +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI---------REGKFRRIPYRY 240
Query: 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773
SDE I + RP+++ +L+
Sbjct: 241 SDELN-----------EIITRMLNLKDYHRPSVEEILEN 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 60/313 (19%)
Query: 490 NLRFFS-YDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFK 548
+LR+ S ++E+ LG+G+FG V K A+KK+ +E+
Sbjct: 1 SLRYASDFEEIA--------VLGQGAFGQVVKARNAL-DSRYYAIKKIR-HTEEKLSTIL 50
Query: 549 SEVSAIGRTHHKHLVQLLGFCDEALNRL-------------LVYEFMGNGTLANLIFAIP 595
SEV + +H+++V+ E N + + E+ NGTL +LI +
Sbjct: 51 SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN 110
Query: 596 KPDWNLRI-RISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL- 653
R+ +I L+Y+H + IIH D+KP NI +D + KI DFGL+K +
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 654 -------------FSDQSRTHTMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIIC 699
+ I GT YVA E + K+D+YS G+ E +
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE-MI 225
Query: 700 CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQE 759
S ME + + ++ D D+ M ++ + L+
Sbjct: 226 YPFSTGMERVNILKKLR---------SVSIEFPPDFDDNKMKVEKKIIRLLI------DH 270
Query: 760 DPSKRPTMKVVLQ 772
DP+KRP + +L
Sbjct: 271 DPNKRPGARTLLN 283
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 3e-37
Identities = 69/290 (23%), Positives = 112/290 (38%), Gaps = 33/290 (11%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQ 564
KE LG G FG V + + + +G +A+K+ + + RE + E+ + + +H ++V
Sbjct: 18 MKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 565 LLGFCDEALN------RLLVYEFMGNGTLANLIFAIPKPDWNLR---IRISL-EIARGLA 614
D LL E+ G L + + L+ IR L +I+ L
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALR 135
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSA---KISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
YLHE IIH D+KP+NI+L KI D G +K + GT Y+
Sbjct: 136 YLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEFV-GTLQYL 190
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEIIC-------CRRSVEME--LEEESRAILTDWAYD 722
APE + + VD +SFG E I + V+ + E+S + +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
VL + + +L +WL + +R T
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNPN 297
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 68/284 (23%), Positives = 119/284 (41%), Gaps = 35/284 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
F +ELG G FG+V G + +A+K + + + EF E + H+ LVQL
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQ--YDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQL 84
Query: 566 LGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
G C + ++ E+M NG L N L + + + ++ + YL E
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQF-- 141
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ--SRTHTM--IRGTRGYVAPEWFKNVP 680
+H D+ +N L++ K+SDFGLS+ + D+ S + +R + PE
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSK 197
Query: 681 VSAKVDVYSFGVTLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
S+K D+++FGV + EI + E + I RL
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--------LRL-------YR 242
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPN 782
+++ +M + W E +RPT K++L + ++D +
Sbjct: 243 PHLASEKVYT-IMYSCW--HEKADERPTFKILLSNILDVMDEES 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-37
Identities = 71/317 (22%), Positives = 111/317 (35%), Gaps = 53/317 (16%)
Query: 473 RRRKYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIA 532
E + D TS + S+ K+ LG G+ G + + +A
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFC--------PKDVLGHGAEGTIVYRGMFD--NRDVA 52
Query: 533 VKKLDRLAQEREREFKSEVSAIGR-THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLI 591
VK R+ E EV + H ++++ + + + E TL +
Sbjct: 53 VK---RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV 108
Query: 592 FAIPKPDWNLRIR-ISLEIARGLAYLHEECNVPIIHCDIKPQNILL-----DHFFSAKIS 645
L + + GLA+LH N I+H D+KP NIL+ A IS
Sbjct: 109 EQKDFAHLGLEPITLLQQTTSGLAHLHS-LN--IVHRDLKPHNILISMPNAHGKIKAMIS 165
Query: 646 DFGLSKLLFSDQSRTHTM--IRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICC 700
DFGL K L + + GT G++APE + VD++S G +I
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
Query: 701 RR-----SVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMW 755
S++ + A LD L + + L+
Sbjct: 226 GSHPFGKSLQRQANILLGA------------CSLDCLHPEK-----HEDVIARELI--EK 266
Query: 756 CIQEDPSKRPTMKVVLQ 772
I DP KRP+ K VL+
Sbjct: 267 MIAMDPQKRPSAKHVLK 283
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-37
Identities = 77/282 (27%), Positives = 125/282 (44%), Gaps = 27/282 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
K +LG G +G VY+GV K +AVK L E E EF E + + H +LVQL
Sbjct: 224 MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 281
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNVP 623
LG C ++ EFM G L + + + + + + ++ +I+ + YL ++
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 338
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IH ++ +N L+ K++DFGLS+L+ D H + + APE S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 684 KVDVYSFGVTLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741
K DV++FGV L EI S ++L + + D R+ E
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRM-------ERPEG 443
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
++++ LM A W Q +PS RP+ + Q E + +
Sbjct: 444 CPEKVYE-LMRACW--QWNPSDRPSFAEIHQAFETMFQESSI 482
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-36
Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 29/282 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+ +LG+G FG V+ G T +A+K L E F E + + H+ LVQL
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 244
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNVP 623
E +V E+M G+L + + L + ++ +IA G+AY+ E N
Sbjct: 245 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMN-- 300
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
+H D++ NIL+ K++DFGL++L+ ++ + + APE +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 684 KVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741
K DV+SFG+ L E+ R M E + R+
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRM-------PCPPE 405
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
LH LM W +++P +RPT + + LE P
Sbjct: 406 CPESLHD-LMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 41/307 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKTA---SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL 562
+ +LG+G+FG V +G +AVK+L +++R+F+ E+ + H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 563 VQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
V+ G + LV E++ +G L + L + D + + S +I +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GS 145
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ----SRTHTM--IRGTRGYVAP 673
+H D+ +NIL++ KI+DFGL+KLL D+ R I AP
Sbjct: 146 RR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----AP 199
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEII-CCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732
E + S + DV+SFGV L E+ C +S E L L
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE------RDVPALSRL 253
Query: 733 IDSDEAAMADRSRLHK---------WLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
++ E + RL LM W P RP+ + L+ L
Sbjct: 254 LELLE----EGQRLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQLDMLWSGSRG 307
Query: 784 PGPSSFS 790
+F+
Sbjct: 308 CETHAFT 314
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 35/281 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+ELG G FG+V G K +AVK + + + EF E + + H LV+
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQ--YDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKF 68
Query: 566 LGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
G C + +V E++ NG L N L + + + + ++ G+A+L E
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL-ESHQF-- 125
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ--SRTHTM--IRGTRGYVAPEWFKNVP 680
IH D+ +N L+D K+SDFG+++ + DQ S T ++ + APE F
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 681 VSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
S+K DV++FG+ + E+ + E + RL
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG--------HRL-------YR 226
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
+++ +M + W E P KRPT + +L +E L +
Sbjct: 227 PHLASDTIYQ-IMYSCW--HELPEKRPTFQQLLSSIEPLRE 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 70/286 (24%), Positives = 110/286 (38%), Gaps = 36/286 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKHL 562
LG G FG VY+GV G I AVK + + +F SE + H H+
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
V+L+G +E ++ E G L + L + SL+I + +AYL E N
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL-ESIN 133
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ--SRTHTM--IRGTRGYVAPEWFK 677
+H DI +NIL+ K+ DFGLS+ + + + T I+ +PE
Sbjct: 134 C--VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESIN 187
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735
+ DV+ F V + EI+ + +E ++ + RL
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG--------DRL------ 233
Query: 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781
L+ LM W DPS RP ++ L + +
Sbjct: 234 -PKPDLCPPVLYT-LMTRCW--DYDPSDRPRFTELVCSLSDVYQME 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 65/288 (22%), Positives = 108/288 (37%), Gaps = 36/288 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHL 562
+G G FG V++G+ + A+A+K + R +F E + + H H+
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
V+L+G E ++ E G L + L D I + +++ LAYL E
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKR 136
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ--SRTHTM--IRGTRGYVAPEWFK 677
+H DI +N+L+ K+ DFGLS+ + + I+ APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 190
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735
++ DV+ FGV + EI+ ++ + I RL
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------ERL------ 236
Query: 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
L+ LM W DPS+RP + L +L+
Sbjct: 237 -PMPPNCPPTLYS-LMTKCW--AYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 60/193 (31%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFC 569
LG+G++GIVY G + + IA+K++ + E++ HK++VQ LG
Sbjct: 30 LGKGTYGIVYAGRDLS-NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 570 DEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
E + E + G+L+ L+ + K + + +I GL YLH+ I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 627 CDIKPQNILLDHFF-SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV--SA 683
DIK N+L++ + KISDFG SK L T T GT Y+APE P
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYGK 204
Query: 684 KVDVYSFGVTLLE 696
D++S G T++E
Sbjct: 205 AADIWSLGCTIIE 217
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-36
Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 29/282 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+ +LG+G FG V+ G T +A+K L E F E + + H+ LVQL
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 327
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNVP 623
E +V E+M G+L + + L + ++ +IA G+AY+ E N
Sbjct: 328 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMN-- 383
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
+H D++ NIL+ K++DFGL++L+ ++ + + APE +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 684 KVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741
K DV+SFG+ L E+ R M E + R+
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRM-------PCPPE 488
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
LH LM W +++P +RPT + + LE P
Sbjct: 489 CPESLHD-LMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 75/290 (25%), Positives = 126/290 (43%), Gaps = 37/290 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHL 562
++ +G G G V G L+ +A+K L ER+R +F SE S +G+ H ++
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
++L G ++V E+M NG+L L + + + + G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDLG 171
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM------IRGTRGYVAPEW 675
+H D+ +N+L+D K+SDFGLS++L D +T IR T APE
Sbjct: 172 Y--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEA 225
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLI 733
S+ DV+SFGV + E++ M + ++ RL
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG--------YRL---- 273
Query: 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
A M LH+ LM+ W +D ++RP ++ +L+ L+ P
Sbjct: 274 ---PAPMGCPHALHQ-LMLDCW--HKDRAQRPRFSQIVSVLDALIRSPES 317
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 65/293 (22%), Positives = 111/293 (37%), Gaps = 48/293 (16%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG------TAIAVKKLDRLAQEREREFKSEVSAIGRTHH 559
F E LG+G+F ++KGV + T + +K LD+ + F S + + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHE 618
KHLV G C +LV EF+ G+L L + ++ ++ ++A + +L E
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL-E 130
Query: 619 ECNVPIIHCDIKPQNILLDHFFS--------AKISDFGLSKLLFSDQSRTHTMIRGTRGY 670
E + IH ++ +NILL K+SD G+S + I
Sbjct: 131 ENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-LQERIPWV--- 184
Query: 671 VAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEG 727
PE +N + D +SFG TL EI ++ + Y +
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---------KLQFYEDR 234
Query: 728 -RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
+L + L L+ +P RP+ + +++ L L
Sbjct: 235 HQLP---------APKAAELAN-LINNCM--DYEPDHRPSFRAIIRDLNSLFT 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 81/291 (27%), Positives = 138/291 (47%), Gaps = 38/291 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKH 561
++ +G G FG VYKG+LKT+SG +A+K L E++R +F E +G+ H +
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+++L G + +++ E+M NG L L + + + IA G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-ANM 166
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM------IRGTRGYVAPE 674
N +H D+ +NIL++ K+SDFGLS++L D T+T IR T APE
Sbjct: 167 N--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APE 220
Query: 675 WFKNVPVSAKVDVYSFGVTLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDVL 732
++ DV+SFG+ + E++ E+ E +AI RL
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG--------FRL--- 269
Query: 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
M S +++ LM+ W Q++ ++RP ++ +L+ L+ P+
Sbjct: 270 ----PTPMDCPSAIYQ-LMMQCW--QQERARRPKFADIVSILDKLIRAPDS 313
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 66/309 (21%), Positives = 110/309 (35%), Gaps = 53/309 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
F ++LG G F V V G A+K++ Q+ E + E +H ++++L
Sbjct: 33 FIQKLGEGGFSYVDL-VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 566 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNL---RI-RISLEIARGLAYLH 617
+ +C L+ F GTL N I + L +I + L I RGL +H
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR--------GTRG 669
+ H D+KP NILL + D G + + T
Sbjct: 152 AK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 670 YVAPEWF---KNVPVSAKVDVYSFGVTLLEIICCRRS----VEMELEEESRAILTDW--- 719
Y APE F + + + DV+S G L + V + + + A+
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYA-MMFGEGPYDMVFQKGDSVALAVQNQLSIP 267
Query: 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
+ S L + ++ + DP +RP + ++L LE L
Sbjct: 268 QSPRH----------SSA--------LWQ--LLN-SMMTVDPHQRPHIPLLLSQLEALQP 306
Query: 780 VPNPPGPSS 788
P P ++
Sbjct: 307 -PAPGQHTT 314
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 39/274 (14%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
++G GS GIV K SG +AVK +D Q+R +EV + H ++V++
Sbjct: 51 VKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 568 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
E L ++ EF+ G L +++ + + + + + + LAYLH + +I
Sbjct: 110 SYLVGEEL--WVLMEFLQGGALTDIVSQVRLNEEQIAT-VCEAVLQALAYLHAQ---GVI 163
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
H DIK +ILL K+SDFG + D + +++ GT ++APE + +V
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEV 222
Query: 686 DVYSFGVTLLEIICCRRSVEME---LEEE-SRAILTDWAYDCYVEGRLDVLI-DSDEAAM 740
D++S G+ ++E++ + E + +A+ + DS +
Sbjct: 223 DIWSLGIMVIEMV------DGEPPYFSDSPVQAMK---------------RLRDSPPPKL 261
Query: 741 ADRSRLHKWLM--IAMWCIQEDPSKRPTMKVVLQ 772
+ ++ L + + DP +R T + +L
Sbjct: 262 KNSHKVSPVLRDFLE-RMLVRDPQERATAQELLD 294
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 58/289 (20%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
E +G G FG V+K G +K++ E+ + EV A+ + H ++V G
Sbjct: 17 ELIGSGGFGQVFK-AKHRIDGKTYVIKRVK---YNNEKA-EREVKALAKLDHVNIVHYNG 71
Query: 568 -FCDEALNRL---------------LVYEFMGNGTLANLI-----FAIPKPD-WNLRIRI 605
+ + + EF GTL I + K +
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL----EL 127
Query: 606 SLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR 665
+I +G+ Y+H + +I+ D+KP NI L KI DFGL L +D RT +
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYV 725
GT Y++PE + +VD+Y+ G+ L E + E + +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAE-LLHVCDTAFETSKFFTDL---------R 232
Query: 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774
+G + + D E ++ + + P RP +L+ L
Sbjct: 233 DGIISDIFDKKEKT-----------LLQ-KLLSKKPEDRPNTSEILRTL 269
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHL 562
F E +GRG FG VY G L G AVK L+R+ E +F +E + H ++
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 563 VQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+ LLG C + L+V +M +G L N + P I L++A+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASK 147
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD-----QSRTHTM--IRGTRGYVAP 673
+H D+ +N +LD F+ K++DFGL++ ++ ++T ++ A
Sbjct: 148 K--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----AL 201
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEIICCRRSV------EMELEEESRAILTDWAYDCYVEG 727
E + + K DV+SFGV L E++ + ++ + + +L
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELM----TRGAPPYPDVNTFDITVYLLQG--------R 249
Query: 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
RL L++ +M+ W RP+ ++ + +
Sbjct: 250 RL-------LQPEYCPDPLYE-VMLKCW--HPKAEMRPSFSELVSRISAIFS 291
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 76/311 (24%), Positives = 126/311 (40%), Gaps = 52/311 (16%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG----TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 560
LG G+FG VY+G + +AVK L + E++ +F E I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR------IRISLEIARGL 613
++V+ +G ++L R ++ E M G L + L P+P + ++ +IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHF---FSAKISDFGLSKLLFSDQ---SRTHTM--IR 665
YL EE + IH DI +N LL AKI DFG+++ ++ M ++
Sbjct: 154 QYL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDC 723
PE F ++K D +SFGV L EI +E +
Sbjct: 211 WM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEF 257
Query: 724 YVEG-RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL---D 779
G R+ + +++ +M W Q P RP ++L+ +E D
Sbjct: 258 VTSGGRM-------DPPKNCPGPVYR-IMTQCW--QHQPEDRPNFAIILERIEYCTQDPD 307
Query: 780 VPNPPGPSSFS 790
V N P +
Sbjct: 308 VINTALPIEYG 318
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 75/290 (25%), Positives = 134/290 (46%), Gaps = 37/290 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHL 562
+ +G G FG V G LK S ++A+K L E++R +F E S +G+ H ++
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
++L G ++ ++V E+M NG+L + L + + + IA G+ YL +
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL-SDMG 167
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM------IRGTRGYVAPEW 675
+H D+ +NIL++ K+SDFGL ++L D +T IR T +PE
Sbjct: 168 Y--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEA 221
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLI 733
++ DV+S+G+ L E++ EM ++ +A+ RL
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG--------YRL---- 269
Query: 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
M + L++ LM+ W Q+D + RP + ++ +L+ L+ P
Sbjct: 270 ---PPPMDCPAALYQ-LMLDCW--QKDRNNRPKFEQIVSILDKLIRNPGS 313
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 60/307 (19%), Positives = 114/307 (37%), Gaps = 43/307 (14%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQ 564
+ LG+G+ V++G K +G A+K + ++ R + E + + +HK++V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 565 LLGFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAYLHE 618
L +E R L+ EF G+L ++ P + L + + ++ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 619 ECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
I+H +IKP NI+ D K++DFG ++ D + ++ GT Y+ P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEYLHPD 185
Query: 675 WFKNVPV--------SAKVDVYSFGVTLLEIIC---------CRRSVEMELEEESRAILT 717
++ + A VD++S GVT R + + + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 718 DWAYDCYVEGRLDVLIDSDEAAMADRSR-----LHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ D SR L L ++ D K
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN---ILEADQEKCWGFDQFFA 302
Query: 773 MLEGLLD 779
+L
Sbjct: 303 ETSDILH 309
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 69/298 (23%), Positives = 121/298 (40%), Gaps = 38/298 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTA---SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL 562
F ++LG+G+FG V +G +AVKKL +E R+F+ E+ + H ++
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 563 VQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
V+ G C A R L+ E++ G+L + L + D ++ + +I +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-GT 132
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ----SRTHTM--IRGTRGYVAP 673
IH D+ +NIL+++ KI DFGL+K+L D+ + I AP
Sbjct: 133 KR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----AP 186
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEII--CCRRSVEMELEEESRAILTDWAYDC-----YVE 726
E S DV+SFGV L E+ + ++
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 727 --GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPN 782
GRL ++ +M W + ++RP+ + + ++ + D
Sbjct: 247 NNGRL-------PRPDGCPDEIYM-IMTECW--NNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 41/302 (13%)
Query: 491 LRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLAQERER-E 546
LR E K + LG G+FG VYKG+ +A+K+L + E
Sbjct: 9 LRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 547 FKSEVSAIGRTHHKHLVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIR 604
E + + H+ +LLG C + L+ + M G L + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664
++IA+G+ YL E+ ++H D+ +N+L+ KI+DFGL+KLL +++ H
Sbjct: 122 WCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-- 176
Query: 665 RGTRGYV---APEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDW 719
G + + A E + + + DV+S+GVT+ E++ + E S +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 235
Query: 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
RL ++ +M W D RP + ++ +
Sbjct: 236 -------ERL-------PQPPICTIDVYM-IMRKCW--MIDADSRPKFRELIIEFSKMAR 278
Query: 780 VP 781
P
Sbjct: 279 DP 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 78/283 (27%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
F +E+G G FG+V+ G +A+K + A E +F E + + H LVQL
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNK--DKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 68
Query: 566 LGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
G C E LV EFM +G L++ L + + L++ G+AYL EE V
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EEACV-- 125
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ--SRTHTM--IRGTRGYVAPEWFKNVP 680
IH D+ +N L+ K+SDFG+++ + DQ S T T ++ +PE F
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSR 181
Query: 681 VSAKVDVYSFGVTLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
S+K DV+SFGV + E+ + E I T RL
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------FRL-------YK 226
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781
+ +++ +M W +E P RP +L+ L + +
Sbjct: 227 PRLASTHVYQ-IMNHCW--RERPEDRPAFSRLLRQLAEIAESG 266
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 506 FKEELGRGSFGIVYKGVLK---TASGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKH 561
+LG G FG V +G +AVK L A + R +K E+ + +H+H
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 562 LVQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
+++ G C++A LV E++ G+L + + + + +I G+AYL
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYL-HA 152
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ----SRTHTM--IRGTRGYVAP 673
+ IH D+ +N+LLD+ KI DFGL+K + R + AP
Sbjct: 153 QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----AP 206
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEII-CCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732
E K DV+SFGVTL E++ C S + + + + L
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA------QGQMTVLRL 260
Query: 733 IDSDEAAMADRSRLHK---------WLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
+ E RL + LM W + + S RPT + ++ +L+ + +
Sbjct: 261 TELLE----RGERLPRPDKCPAEVYHLMKNCW--ETEASFRPTFENLIPILKTVHEKYQG 314
Query: 784 PGPS 787
PS
Sbjct: 315 QAPS 318
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 68/274 (24%), Positives = 126/274 (45%), Gaps = 39/274 (14%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
E++G+G+ G VY + A+G +A+++++ Q ++ +E+ + + ++V L
Sbjct: 26 EKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 568 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
+ L +V E++ G+L +++ + + + E + L +LH +I
Sbjct: 85 SYLVGDEL--WVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVI 138
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
H DIK NILL S K++DFG + +QS+ TM+ GT ++APE KV
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 686 DVYSFGVTLLEIICCRRSVEME---LEEE-SRAILTDWAYDCYVEGRLDVLIDSDEA-AM 740
D++S G+ +E+I E E L E RA+ LI ++ +
Sbjct: 198 DIWSLGIMAIEMI------EGEPPYLNENPLRALY---------------LIATNGTPEL 236
Query: 741 ADRSRLHKWLM--IAMWCIQEDPSKRPTMKVVLQ 772
+ +L + C++ D KR + K +LQ
Sbjct: 237 QNPEKLSAIFRDFLN-RCLEMDVEKRGSAKELLQ 269
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 70/297 (23%), Positives = 123/297 (41%), Gaps = 42/297 (14%)
Query: 506 FKEELGRGSFGIVYKGVLKTA---SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL 562
F ++LG+G+FG V +G +AVKKL +E R+F+ E+ + H ++
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 563 VQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
V+ G C A R L+ E++ G+L + L + D ++ + +I +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-GT 163
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ----SRTHTM--IRGTRGYVAP 673
IH D+ +NIL+++ KI DFGL+K+L D+ + I AP
Sbjct: 164 KR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----AP 217
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEII--CCRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731
E S DV+SFGV L E+ + + L
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---HLIE 274
Query: 732 LIDSDEAAMADRSRLHK---------WLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
L+ ++ RL + +M W + ++RP+ + + ++ + D
Sbjct: 275 LLKNNG-------RLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQIRD 322
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-35
Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 37/286 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+++LG G FG V+ T +AVK + + E F +E + + H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKH--TKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL 248
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNVP 623
+ ++ EFM G+L + + + L I S +IA G+A++ E+ N
Sbjct: 249 HAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN-- 304
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV---APEWFKNVP 680
IH D++ NIL+ KI+DFGL++++ ++ +T G + + APE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361
Query: 681 VSAKVDVYSFGVTLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
+ K DV+SFG+ L+EI+ R M E RA+ R+
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG--------YRMP-------- 405
Query: 739 AMAD-RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
+ L+ +M+ W + P +RPT + + +L+
Sbjct: 406 RPENCPEELYN-IMMRCW--KNRPEERPTFEYIQSVLDDFYTATES 448
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-35
Identities = 65/288 (22%), Positives = 108/288 (37%), Gaps = 36/288 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKHL 562
+G G FG V++G+ + A+ A+K + R +F E + + H H+
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
V+L+G E ++ E G L + L D I + +++ LAYL E
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKR 511
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ--SRTHTM--IRGTRGYVAPEWFK 677
+H DI +N+L+ K+ DFGLS+ + + I+ APE
Sbjct: 512 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 565
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735
++ DV+ FGV + EI+ ++ + I RL
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------ERL------ 611
Query: 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
L+ LM W DPS+RP + L +L+
Sbjct: 612 -PMPPNCPPTLYS-LMTKCW--AYDPSRRPRFTELKAQLSTILEEEKL 655
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 506 FKEELGRGSFGIVYKGVLKTAS---GTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKH 561
+LG G FG V G +AVK L + + K E+ + +H++
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 562 LVQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAY 615
+V+ G C E L+ EF+ +G+L + +PK + ++ +++I +G+ Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSL--KEY-LPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ----SRTHTM--IRGTRG 669
L +H D+ +N+L++ KI DFGL+K + +D+ + +
Sbjct: 142 L-GSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-- 196
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEII-CCRRSVEMELEEESRAILTDW------AYD 722
APE DV+SFGVTL E++ C T +
Sbjct: 197 --APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 723 CYVEG-RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
EG RL +++ LM W + PS R + + +++ E LL
Sbjct: 255 TLKEGKRL-------PCPPNCPDEVYQ-LMRKCW--EFQPSNRTSFQNLIEGFEALL 301
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 56/197 (28%), Positives = 83/197 (42%), Gaps = 18/197 (9%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLL 566
+ +GRGSFG V++ K +G AVKK+ E E+ A +V L
Sbjct: 63 QPRVGRGSFGEVHRMKDKQ-TGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLY 116
Query: 567 GFC--DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
G +N + E + G+L LI + + + + GL YLH I
Sbjct: 117 GAVREGPWVN--IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---I 171
Query: 625 IHCDIKPQNILLDHF-FSAKISDFGLSKLLFSDQSRTHTM----IRGTRGYVAPEWFKNV 679
+H D+K N+LL A + DFG + L D + I GT ++APE
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 680 PVSAKVDVYSFGVTLLE 696
P AKVD++S +L
Sbjct: 232 PCDAKVDIWSSCCMMLH 248
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 68/292 (23%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHL 562
F E +GRG FG VY G L G AVK L+R+ E +F +E + H ++
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 563 VQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+ LLG C + L+V +M +G L N + P I L++A+G+ +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-ASK 211
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD-----QSRTHTM--IRGTRGYVAP 673
+H D+ +N +LD F+ K++DFGL++ ++ ++T ++ A
Sbjct: 212 K--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----AL 265
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEIICCRRSV------EMELEEESRAILTDWAYDCYVEG 727
E + + K DV+SFGV L E++ + ++ + + +L
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELM----TRGAPPYPDVNTFDITVYLLQG--------R 313
Query: 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
RL L++ +M+ W RP+ ++ + +
Sbjct: 314 RL-------LQPEYCPDPLYE-VMLKCW--HPKAEMRPSFSELVSRISAIFS 355
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 83/285 (29%), Positives = 128/285 (44%), Gaps = 35/285 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
K +LG G +G VY+GV K S +AVK L E E EF E + + H +LVQL
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNVP 623
LG C ++ EFM G L + + + + + + ++ +I+ + YL E+ N
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNF- 132
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM----IRGTRGYVAPEWFKNV 679
IH D+ +N L+ K++DFGLS+L+ D H I+ T APE
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 680 PVSAKVDVYSFGVTLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737
S K DV++FGV L EI S ++L + + D R+ E
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRM-------E 232
Query: 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPN 782
++++ LM A W Q +PS RP+ + Q E + +
Sbjct: 233 RPEGCPEKVYE-LMRACW--QWNPSDRPSFAEIHQAFETMFQESS 274
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 59/275 (21%), Positives = 113/275 (41%), Gaps = 36/275 (13%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREF-KSEVSAIGRTHHKHLVQL 565
+++G GSFG V T G +K+++ +ERE + EV+ + H ++VQ
Sbjct: 30 QKIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI------RISLEIARGLAYLHEE 619
+E + +V ++ G L I + ++I L ++H+
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI----NAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
I+H DIK QNI L + ++ DFG++++L S I GT Y++PE +N
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENK 200
Query: 680 PVSAKVDVYSFGVTLLEIICCRRSVE-MELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
P + K D+++ G L E+ + + E ++ I + G +
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI---------ISGSFPPVSLHYSY 251
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773
+ + + +P RP++ +L+
Sbjct: 252 DLRS---------LVSQLFKRNPRDRPSVNSILEK 277
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 69/273 (25%), Positives = 103/273 (37%), Gaps = 37/273 (13%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR-LAQERERE-FKSEVSAIGR-THHKHLVQ 564
LG GS+G V+K V G AVK+ ++R +EV + + H V+
Sbjct: 63 SRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVP 623
L +E L E G +L A ++ + LA+LH +
Sbjct: 122 LEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---G 177
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
++H D+KP NI L K+ DFGL L G Y+APE +
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GDPRYMAPELLQG-SYGT 234
Query: 684 KVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID---SDEAAM 740
DV+S G+T+LE+ C E+ E L +G L S E
Sbjct: 235 AADVFSLGLTILEVACNM---ELPHGGEGWQQL--------RQGYLPPEFTAGLSSEL-- 281
Query: 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773
RS L + ++ DP R T + +L +
Sbjct: 282 --RSVL-------VMMLEPDPKLRATAEALLAL 305
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 60/307 (19%), Positives = 117/307 (38%), Gaps = 37/307 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQ 564
+ LG+G+ V++G K +G A+K + ++ R + E + + +HK++V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 565 LLGFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAYLHE 618
L +E R L+ EF G+L ++ P + L + + ++ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 619 ECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
I+H +IKP NI+ D K++DFG ++ D + ++ GT Y+ P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEYLHPD 185
Query: 675 WFKNVPV--------SAKVDVYSFGVTLLEIIC---------CRRSVEMELEEESRAILT 717
++ + A VD++S GVT R + + + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAM--WCIQEDPSKRPTMKVVLQMLE 775
+ D SR + L+ + ++ D K
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 776 GLLDVPN 782
+L N
Sbjct: 306 DILHRGN 312
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 76/311 (24%), Positives = 126/311 (40%), Gaps = 52/311 (16%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG----TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 560
LG G+FG VY+G + +AVK L + E++ +F E I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR------IRISLEIARGL 613
++V+ +G ++L R ++ E M G L + L P+P + ++ +IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHF---FSAKISDFGLSKLLFSDQ---SRTHTM--IR 665
YL EE + IH DI +N LL AKI DFG+++ ++ M ++
Sbjct: 195 QYL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDC 723
PE F ++K D +SFGV L EI +E +
Sbjct: 252 WM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEF 298
Query: 724 YVEG-RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL---D 779
G R+ + +++ +M W Q P RP ++L+ +E D
Sbjct: 299 VTSGGRM-------DPPKNCPGPVYR-IMTQCW--QHQPEDRPNFAIILERIEYCTQDPD 348
Query: 780 VPNPPGPSSFS 790
V N P +
Sbjct: 349 VINTALPIEYG 359
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 39/287 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E LG G FG V+ G T +AVK L + + + F +E + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGH--TKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 566 LGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNV 622
E + ++ E+M NG+L + + + + ++ +IA G+A++ EE N
Sbjct: 74 YAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERNY 130
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ--SRTHT--MIRGTRGYVAPEWFKN 678
IH D++ NIL+ S KI+DFGL++L+ ++ +R I+ T APE
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINY 184
Query: 679 VPVSAKVDVYSFGVTLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
+ K DV+SFG+ L EI+ R M E + + R+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------YRM------- 229
Query: 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
L++ LM W +E P RPT + +LE
Sbjct: 230 VRPDNCPEELYQ-LMRLCW--KERPEDRPTFDYLRSVLEDFFTATEG 273
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-34
Identities = 71/298 (23%), Positives = 109/298 (36%), Gaps = 52/298 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQ 564
++ LG GS G V G +AVK++ + E+ + + H ++++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIR 73
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLE-------IARGLAYLH 617
+ E L +L+ + D NL+++ IA G+A+LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 618 EECNVPIIHCDIKPQNILLDH-------------FFSAKISDFGLSKLLFSDQSRTHTMI 664
IIH D+KPQNIL+ ISDFGL K L S QS T +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 665 R---GTRGYVAPE-------WFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA 714
GT G+ APE ++ +D++S G I+ + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 715 ILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
I+ + L EA L+ M I DP KRPT VL+
Sbjct: 250 IIRG-IFSLDEMKCLHDRSLIAEA---------TDLISQM--IDHDPLKRPTAMKVLR 295
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 80/300 (26%), Positives = 132/300 (44%), Gaps = 51/300 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG----TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 560
ELG+GSFG+VY+GV K T +A+K ++ A RER EF +E S + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR---------IRISLEIA 610
H+V+LLG + L++ E M G L + L P N I+++ EIA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD---QSRTHTM--IR 665
G+AYL+ +H D+ +N ++ F+ KI DFG+++ ++ + + +R
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDC 723
+PE K+ + DV+SFGV L EI + E+
Sbjct: 206 WM----SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------VLRF 252
Query: 724 YVEG-RLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781
+EG LD + D L + LM W Q +P RP+ ++ ++ ++
Sbjct: 253 VMEGGLLDKPDNCPDM--------LFE-LMRMCW--QYNPKMRPSFLEIISSIKEEMEPG 301
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-34
Identities = 63/294 (21%), Positives = 122/294 (41%), Gaps = 37/294 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREF-KSEVSAIGRTHHKHLVQLL 566
ELG G+ G+V+K K SG +A K + + R E+ + + ++V
Sbjct: 39 SELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 567 G--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
G + D ++ + E M G+L ++ + + ++S+ + +GL YL E+ I
Sbjct: 98 GAFYSDGEIS--ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 153
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
+H D+KP NIL++ K+ DFG+S L + + GTR Y++PE + S +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 210
Query: 685 VDVYSFGVTLLEI------ICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
D++S G++L+E+ I + E+EL + L
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 739 AMADRSRLHKWLMI----------AMW----------CIQEDPSKRPTMKVVLQ 772
+ + I ++ C+ ++P++R +K ++
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 74/285 (25%), Positives = 120/285 (42%), Gaps = 31/285 (10%)
Query: 507 KEELGRGSFGIVYKGVLKTASG-TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQ 564
ELG G+FG V +GV + +A+K L + ++ + E E + + + ++V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 565 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
L+G C +LV E G G L L+ + + + +++ G+ YL EE N
Sbjct: 75 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN-- 130
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV---APEWFKNVP 680
+H D+ +N+LL + AKISDFGLSK L +D S +T + + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189
Query: 681 VSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
S++ DV+S+GVT+ E + + +M+ E I R+ E
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------KRM-------EC 234
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
L+ LM W RP V Q +
Sbjct: 235 PPECPPELYA-LMSDCW--IYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 65/287 (22%), Positives = 121/287 (42%), Gaps = 39/287 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHL 562
+G+G FG+VY G + A+K L R+ + ++ F E + +H ++
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 563 VQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
+ L+G ++ +M +G L + P I L++ARG+ YL E
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-AEQ 143
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD-----QSRTHTM--IRGTRGYVAP 673
+H D+ +N +LD F+ K++DFGL++ + Q H ++ T A
Sbjct: 144 K--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----AL 197
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDV 731
E + + K DV+SFGV L E++ ++ + + + RL
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG--------RRL-- 247
Query: 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
L++ +M W + DP+ RPT +V++ +E ++
Sbjct: 248 -----PQPEYCPDSLYQ-VMQQCW--EADPAVRPTFRVLVGEVEQIV 286
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 35/278 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+ +G+G FG V G + G +AVK + A + F +E S + + H +LVQL
Sbjct: 197 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQL 251
Query: 566 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNV 622
LG E L +V E+M G+L + + + + ++ SL++ + YL E N
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN- 309
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
+H D+ +N+L+ AK+SDFGL+K S Q ++ T APE + S
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 683 AKVDVYSFGVTLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740
K DV+SFG+ L EI R + L++ + ++ +A
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKM-------DAPD 409
Query: 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
++ +M W D + RPT + + LE +
Sbjct: 410 GCPPAVYD-VMKNCW--HLDAATRPTFLQLREQLEHIR 444
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 71/278 (25%), Positives = 114/278 (41%), Gaps = 31/278 (11%)
Query: 509 ELGRGSFGIVYKGVLKTASG-TAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
ELG G+FG V KG + +AVK K + + E +E + + + + ++V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
+G C+ + +LV E G L + I + +++ G+ YL EE N +
Sbjct: 84 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FV 139
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV---APEWFKNVPVS 682
H D+ +N+LL AKISDFGLSK L +D++ + + V APE S
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 683 AKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740
+K DV+SFGV + E + M+ E + + R+
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--------ERM-------GCPA 243
Query: 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
++ LM W D RP V L
Sbjct: 244 GCPREMYD-LMNLCW--TYDVENRPGFAAVELRLRNYY 278
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 75/283 (26%), Positives = 114/283 (40%), Gaps = 37/283 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAI--AVK--KLDRLAQERER-EFKSEVSAIGRTHHK 560
E+LG GSFG+V +G SG + AVK K D L+Q +F EV+A+ H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 561 HLVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHE 618
+L++L G + +V E G+L + L R ++++A G+ YL E
Sbjct: 82 NLIRLYGVVLTPPM--KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL-E 138
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV---APEW 675
IH D+ +N+LL KI DFGL + L + + M + APE
Sbjct: 139 SKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-HYVMQEHRKVPFAWCAPES 195
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEG-RLDVL 732
K S D + FGVTL E+ + + + + I EG RL
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--------EGERL--- 244
Query: 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
++ +M+ W P RPT + L
Sbjct: 245 ----PRPEDCPQDIYN-VMVQCW--AHKPEDRPTFVALRDFLL 280
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 75/303 (24%), Positives = 128/303 (42%), Gaps = 52/303 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKH 561
LG+G FG V + LK G +AVK K D +A EF E + + H H
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 562 LVQLLGFC------DEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLR----IRISLEI 609
+ +L+G +++ FM +G L + A I + +NL +R ++I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD---QSRTHTM--I 664
A G+ YL N IH D+ +N +L + ++DFGLS+ ++S + + +
Sbjct: 147 ACGMEYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYD 722
+ A E + + DV++FGVT+ EI+ ++ +E E Y+
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---------IYN 250
Query: 723 CYVEG-RLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780
+ G RL + +E ++ LM W DP +RP+ + LE +L
Sbjct: 251 YLIGGNRLKQPPECMEE--------VYD-LMYQCW--SADPKQRPSFTCLRMELENILGH 299
Query: 781 PNP 783
+
Sbjct: 300 LSV 302
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 64/309 (20%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG----TAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH 561
K ELG G+FG V+ S +AVK L ++F+ E + H+H
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR----IRI 605
+V+ G C + ++V+E+M +G L + + L + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 606 SLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ---SRTHT 662
+ +IA G+ YL + +H D+ +N L+ KI DFG+S+ ++S HT
Sbjct: 139 ASQIASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 663 M--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII-CCRR-----SVEMELEEESRA 714
M IR PE + + DV+SFGV L EI ++ S +E
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE----- 246
Query: 715 ILTDWAYDCYVE--GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ L E ++ +M+ W Q +P +R +K + +
Sbjct: 247 ---------CITQGRVL-------ERPRVCPKEVYD-VMLGCW--QREPQQRLNIKEIYK 287
Query: 773 MLEGLLDVP 781
+L L
Sbjct: 288 ILHALGKAT 296
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 76/303 (25%), Positives = 119/303 (39%), Gaps = 53/303 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG----TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 560
K ELG G+FG V+ +AVK L + A E R +F+ E + H+
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQ 103
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR--------------IRI 605
H+V+ G C E L+V+E+M +G L L P + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 606 SLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ---SRTHT 662
+ ++A G+ YL + +H D+ +N L+ KI DFG+S+ ++S T
Sbjct: 164 ASQVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 663 M--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTD 718
M IR PE + + DV+SFGV L EI + ++ E I
Sbjct: 221 MLPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
Query: 719 WAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
L E A ++ +M W Q +P +R ++K V L+ L
Sbjct: 277 --------REL-------ERPRACPPEVYA-IMRGCW--QREPQQRHSIKDVHARLQALA 318
Query: 779 DVP 781
P
Sbjct: 319 QAP 321
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
ELG G+FG VYK K +G A K ++ ++E ++ E+ + H ++V+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 568 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVPI 624
+ D L ++ EF G + ++ + + +I+ + ++ L +LH + I
Sbjct: 84 AYYHDGKL--WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-----WFKNV 679
IH D+K N+L+ +++DFG+S + + I GT ++APE K+
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDT 197
Query: 680 PVSAKVDVYSFGVTLLEII 698
P K D++S G+TL+E+
Sbjct: 198 PYDYKADIWSLGITLIEMA 216
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 49/284 (17%), Positives = 110/284 (38%), Gaps = 44/284 (15%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIG--RTHHKHLV 563
+++G G V++ + + A+K L+ + +++E++ + + H ++
Sbjct: 34 KQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
+L + +V E GN L + + D R + + +H+
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH-TMIRGTRGYVAPEWFKNVP-- 680
I+H D+KP N L+ K+ DFG++ + D + GT Y+ PE K++
Sbjct: 148 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 681 ---------VSAKVDVYSFGVTLLEIICCR---RSVEMELEEESRAILTDWAYDCYVEGR 728
+S K DV+S G L + + + + ++ + I + +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---- 262
Query: 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
D+ + + ++ C++ DP +R ++ +L
Sbjct: 263 -DIP--EKDL---------QDVL--KCCLKRDPKQRISIPELLA 292
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 64/287 (22%), Positives = 117/287 (40%), Gaps = 36/287 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKH 561
+ LG G FG V+KGV + +K ++ + + + AIG H H
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 562 LVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
+V+LLG C +L LV +++ G+L + + L + ++IA+G+ YL EE
Sbjct: 77 IVRLLGLCPGSSL--QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL-EE 133
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV---APEWF 676
++H ++ +N+LL +++DFG++ LL D + + + A E
Sbjct: 134 HG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESI 189
Query: 677 KNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLID 734
+ + DV+S+GVT+ E++ + L E + RL
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG--------ERL----- 236
Query: 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781
++ +M+ W D + RPT K + + P
Sbjct: 237 --AQPQICTIDVYM-VMVKCW--MIDENIRPTFKELANEFTRMARDP 278
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 6e-33
Identities = 40/217 (18%), Positives = 69/217 (31%), Gaps = 28/217 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTA----SGTAIAVKKLD-RLAQEREREFKSEVSAIGRTHHK 560
LG G+F VY+ + +K E + + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQH 127
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDW-----NLRIRISLEIARGLAY 615
++ +LV E GTL N I L I ++ + +
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 616 LHEECNVPIIHCDIKPQNILL-----------DHFFSAKISDFGLSKLL--FSDQSRTHT 662
+H+ IIH DIKP N +L D + D G S + F +
Sbjct: 188 VHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC 699
T G+ E N P + ++D + T+ ++
Sbjct: 245 KC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+ +G+G FG V G + G +AVK + A + F +E S + + H +LVQL
Sbjct: 25 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQL 79
Query: 566 LGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNV 622
LG +E +V E+M G+L + + + + ++ SL++ + YL E N
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNF 138
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
+H D+ +N+L+ AK+SDFGL+K S Q ++ T APE + S
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192
Query: 683 AKVDVYSFGVTLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740
K DV+SFG+ L EI R + L++ + ++ +A
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKM-------DAPD 237
Query: 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
+++ +M W D + RP+ + + LE +
Sbjct: 238 GCPPAVYE-VMKNCW--HLDAAMRPSFLQLREQLEHIKTHELH 277
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 49/297 (16%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKH 561
+ LG G FG V +G LK G +AVK KLD +Q EF SE + + H +
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 562 LVQLLGFC-----DEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLR----IRISLEIA 610
+++LLG C +++ FM G L + + ++ ++ ++IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD---QSRTHTM--IR 665
G+ YL N +H D+ +N +L + ++DFGLSK ++S + ++
Sbjct: 158 LGMEYL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDC 723
A E + ++K DV++FGVT+ EI + ++ E +L
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG----- 265
Query: 724 YVEGRLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
RL D DE L++ +M + W + DP RPT V+ LE LL+
Sbjct: 266 ---HRLKQPEDCLDE--------LYE-IMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 67/302 (22%), Positives = 120/302 (39%), Gaps = 41/302 (13%)
Query: 491 LRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLAQERER-E 546
LR E K + LG G+FG VYKG+ +A+K+L + E
Sbjct: 9 LRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 547 FKSEVSAIGRTHHKHLVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIR 604
E + + H+ +LLG C + L+ + M G L + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664
++IA+G+ YL E+ ++H D+ +N+L+ KI+DFGL+KLL +++ H
Sbjct: 122 WCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-- 176
Query: 665 RGTRGYV---APEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDW 719
G + + A E + + + DV+S+GVT+ E++ + E S +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 235
Query: 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
RL ++ +M+ W D RP + ++ +
Sbjct: 236 -------ERL-------PQPPICTIDVYM-IMVKCW--MIDADSRPKFRELIIEFSKMAR 278
Query: 780 VP 781
P
Sbjct: 279 DP 280
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 49/284 (17%), Positives = 110/284 (38%), Gaps = 44/284 (15%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIG--RTHHKHLV 563
+++G G V++ + + A+K L+ + +++E++ + + H ++
Sbjct: 15 KQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
+L + +V E GN L + + D R + + +H+
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH-TMIRGTRGYVAPEWFKNVP-- 680
I+H D+KP N L+ K+ DFG++ + D + GT Y+ PE K++
Sbjct: 129 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 681 ---------VSAKVDVYSFGVTLLEIICCR---RSVEMELEEESRAILTDWAYDCYVEGR 728
+S K DV+S G L + + + + ++ + I + +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---- 243
Query: 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
D+ + + ++ C++ DP +R ++ +L
Sbjct: 244 -DIP--EKDL---------QDVL--KCCLKRDPKQRISIPELLA 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 25/230 (10%)
Query: 484 STTSETNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ 541
S S L+ + K E+GRG++G V K V K SG +AVK++
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVD 60
Query: 542 ERERE-FKSEVSAIGRT-HHKHLVQLLG--FCDEALNRLLVYEFMGNGTLANLIFAIPKP 597
E+E++ ++ + R+ ++VQ G F + + E M + +
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW--ICMELMS-TSFDKFYKYV-YS 116
Query: 598 DWNLRI------RISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651
+ I +I+L + L +L E IIH DIKP NILLD + K+ DFG+S
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISG 174
Query: 652 LLFSDQSRTHTMIRGTRGYVAPEWFKNVPV----SAKVDVYSFGVTLLEI 697
L ++T G R Y+APE + DV+S G+TL E+
Sbjct: 175 QLVDSIAKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-32
Identities = 48/284 (16%), Positives = 109/284 (38%), Gaps = 44/284 (15%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIG--RTHHKHLV 563
+++G G V++ + + A+K L+ + +++E++ + + H ++
Sbjct: 62 KQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
+L + +V E GN L + + D R + + +H+
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH-TMIRGTRGYVAPEWFKNVP-- 680
I+H D+KP N L+ K+ DFG++ + D + G Y+ PE K++
Sbjct: 176 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 681 ---------VSAKVDVYSFGVTLLEIICCR---RSVEMELEEESRAILTDWAYDCYVEGR 728
+S K DV+S G L + + + + ++ + I + +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---- 290
Query: 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
D+ + + ++ C++ DP +R ++ +L
Sbjct: 291 -DIP--EKDL---------QDVL--KCCLKRDPKQRISIPELLA 320
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 62/296 (20%), Positives = 112/296 (37%), Gaps = 64/296 (21%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR-LAQEREREFK-SEVSAIGR-THHKHLVQ 564
E++G G FG V+K +K G A+K+ + LA + + EV A H H+V+
Sbjct: 17 EKIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 565 LLG-FCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNL---RIR-ISLEIARGLAYLHE 618
+ ++ + +L+ E+ G+LA+ I + ++ + L++ RGL Y+H
Sbjct: 76 YFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 619 ECNVPIIHCDIKPQNILLDH-------------------FFSAKISDFGLSKLLFSDQSR 659
++H DIKP NI + KI D G + S
Sbjct: 134 M---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----SS 186
Query: 660 THTMIRGTRGYVAPE-WFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTD 718
G ++A E +N K D+++ +T++ ++ I
Sbjct: 187 PQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP--LPRNGDQWHEI--- 240
Query: 719 WAYDCYVEGRLDVLID--SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+GRL + S E + L I DP +RP+ +++
Sbjct: 241 ------RQGRLPRIPQVLSQE--------FTELL---KVMIHPDPERRPSAMALVK 279
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-32
Identities = 75/319 (23%), Positives = 131/319 (41%), Gaps = 64/319 (20%)
Query: 506 FKEELGRGSFGIVYKGVLK------TASGTAIAVKKLDRLAQERER-EFKSEVS---AIG 555
+ LG G+FG V T +AVK L A E++ + SE+ IG
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 556 RTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR- 602
+ HK+++ LLG C + ++ E+ G L P+ L
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 603 ---IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD--- 656
+ + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ +
Sbjct: 191 KDLVSCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 657 QSRTHTM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEES 712
+ T+ ++ APE + + + DV+SFGV L EI S + +EE
Sbjct: 248 KKTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301
Query: 713 RAILTDWAYDCYVEG-RLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 770
+ EG R+D + ++E L+ +M W PS+RPT K +
Sbjct: 302 -------LFKLLKEGHRMDKPSNCTNE--------LYM-MMRDCW--HAVPSQRPTFKQL 343
Query: 771 LQMLEGLLDVPNPPGPSSF 789
++ L+ ++ + + +
Sbjct: 344 VEDLDRIVALTSNQEMGYY 362
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 70/298 (23%), Positives = 114/298 (38%), Gaps = 53/298 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG----TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 560
F EELG FG VYKG L + A+A+K L A+ R EF+ E R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR----IR 604
++V LLG + +++ + +G L L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD---QSRTH 661
+ +IA G+ YL + ++H D+ +N+L+ + KISD GL + +++ + +
Sbjct: 133 LVAQIAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 662 TM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILT 717
++ IR APE S D++S+GV L E+ ++ I
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245
Query: 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
L + ++ LMI W E PS+RP K + L
Sbjct: 246 R--------QVL-------PCPDDCPAWVYA-LMIECW--NEFPSRRPRFKDIHSRLR 285
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 10/193 (5%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG+G FG VY K + +A+K L + + E + + E+ H +++++
Sbjct: 22 LGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
+ + L+ EF G L + + D E+A L Y HE +IH
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIH 137
Query: 627 CDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVD 686
DIKP+N+L+ + KI+DFG S + R TM GT Y+ PE + KVD
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMC-GTLDYLPPEMIEGKTHDEKVD 194
Query: 687 VYSFGVTLLEIIC 699
++ GV E +
Sbjct: 195 LWCAGVLCYEFLV 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 478 ENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVK--K 535
++ NL F S + + +ELGRG F +V + + K ++G A K K
Sbjct: 5 HHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLK 63
Query: 536 LDRLAQEREREFKSEVSAIGR-THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI 594
R Q+ E E++ + ++ L + +L+ E+ G + +L +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC--L 121
Query: 595 PKPDWNLR----IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSA---KISDF 647
P+ + IR+ +I G+ YLH+ I+H D+KPQNILL + KI DF
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 648 GLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTL 694
G+S+ ++ GT Y+APE P++ D+++ G+
Sbjct: 179 GMSRK-IGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 71/235 (30%), Positives = 113/235 (48%), Gaps = 30/235 (12%)
Query: 484 STTSETNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ 541
S + +L L+D F+ E +G G++G VYKG +G A+K +D +
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMD-VTG 61
Query: 542 EREREFKSEVSAIGRT-HHKHLVQLLG-----FCDEALNRL-LVYEFMGNGTLANLIFAI 594
+ E E K E++ + + HH+++ G ++L LV EF G G++ +LI
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--- 118
Query: 595 PKPDWNLRIR------ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFG 648
K ++ I EI RGL++LH+ +IH DIK QN+LL K+ DFG
Sbjct: 119 -KNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 649 LSKLLFSDQSRTHTMIRGTRGYVAPE-----WFKNVPVSAKVDVYSFGVTLLEII 698
+S L R +T I GT ++APE + K D++S G+T +E+
Sbjct: 175 VSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 31/285 (10%)
Query: 507 KEELGRGSFGIVYKGVLKTASG-TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKHLVQ 564
ELG G+FG V +GV + +A+K L + ++ + E E + + + ++V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 565 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
L+G C +LV E G G L L+ + + + +++ G+ YL EE N
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN-- 456
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV---APEWFKNVP 680
+H ++ +N+LL + AKISDFGLSK L +D S +T + + APE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 515
Query: 681 VSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
S++ DV+S+GVT+ E + + +M+ E I R+ E
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------KRM-------EC 560
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783
L+ LM W RP V Q +
Sbjct: 561 PPECPPELYA-LMSDCW--IYKWEDRPDFLTVEQRMRACYYSLAS 602
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG+G FG VY K S +A+K L + E + + EV H ++++L
Sbjct: 17 LGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIH 626
G+ +A L+ E+ GT+ + + K D E+A L+Y H + +IH
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIH 132
Query: 627 CDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVD 686
DIKP+N+LL KI+DFG S + SR + GT Y+ PE + KVD
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLC-GTLDYLPPEMIEGRMHDEKVD 189
Query: 687 VYSFGVTLLEIIC 699
++S GV E +
Sbjct: 190 LWSLGVLCYEFLV 202
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 13/195 (6%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKHLVQLL 566
E++G+GSFG V+KG+ + +A+K +D A++ + + E++ + + ++ +
Sbjct: 28 EKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 567 G--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNVP 623
G D L ++ E++G G+ +L+ P P +I I EI +GL YLH E
Sbjct: 87 GSYLKDTKL--WIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---K 139
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IH DIK N+LL K++DFG++ L Q + +T + GT ++APE K +
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 198
Query: 684 KVDVYSFGVTLLEII 698
K D++S G+T +E+
Sbjct: 199 KADIWSLGITAIELA 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 15/226 (6%)
Query: 479 NNVQDSTTSETNLRFFSYDEL-KDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKK 535
VQ L+ D L K + F E+LG GS+G VYK + K +G +A+K+
Sbjct: 3 ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQ 61
Query: 536 LDRLAQEREREFKSEVSAIGRTHHKHLVQLLG--FCDEALNRLLVYEFMGNGTLANLIFA 593
+ + +E E+S + + H+V+ G F + L +V E+ G G+++++I
Sbjct: 62 VP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL--WIVMEYCGAGSVSDIIRL 117
Query: 594 IPKPDWNLRIR-ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652
K I I +GL YLH IH DIK NILL+ AK++DFG++
Sbjct: 118 RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174
Query: 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
L ++ +T+I GT ++APE + + + D++S G+T +E+
Sbjct: 175 LTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-31
Identities = 30/306 (9%), Positives = 65/306 (21%), Gaps = 58/306 (18%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKHL 562
E L G +V+ A+K A+ E A R +
Sbjct: 66 LVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124
Query: 563 VQLLGFC--------------------------DEALNRLLVYEFMGNGTLANLIFAIPK 596
+ N LL+ L L +
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF 183
Query: 597 -------PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649
++ ++ R A L + ++H P N+ + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 650 SKLLFSDQSRTHTMIRGTRGYVAPEWF--KNVPVSAKVDVYSFGVTLLEIICCRR-SVEM 706
+R Y E+ + ++ + G+++ + C +
Sbjct: 241 LW---KVGTRGPASS-VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 707 ELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 766
+ + R + D +R
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF----------LNFDRRRRLL 346
Query: 767 MKVVLQ 772
++
Sbjct: 347 PLEAME 352
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 76/360 (21%), Positives = 141/360 (39%), Gaps = 78/360 (21%)
Query: 470 FKWRR-RKYENNVQDSTTSET-NLRFFSYDELKDATDG----------FKEELGRGSFGI 517
K+++ +YE+ +Q + + + +F D + D F + LG G+FG
Sbjct: 1 HKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGK 60
Query: 518 VYKGVL----KTASGTAIAVKKLDRLAQERER-EFKSEV---SAIGRTHHKHLVQLLGFC 569
V KT +AVK L A ER SE+ + +G H+++V LLG C
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGAC 118
Query: 570 DEALNRLLVYEFMGNGTL-------------------ANLIFAIPKPDWNLR----IRIS 606
+ L++E+ G L + L + +
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178
Query: 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD---QSRTHTM 663
++A+G+ +L E + +H D+ +N+L+ H KI DFGL++ + SD R +
Sbjct: 179 YQVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 235
Query: 664 --IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDW 719
++ APE + K DV+S+G+ L EI + + ++ ++ +
Sbjct: 236 LPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN- 290
Query: 720 AYDCYVEGRLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
++D ++E ++ +M + W D KRP+ + L L
Sbjct: 291 ------GFKMDQPFYATEE--------IYI-IMQSCW--AFDSRKRPSFPNLTSFLGCQL 333
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 70/316 (22%), Positives = 123/316 (38%), Gaps = 65/316 (20%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG----TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 560
+ ++G G+FG V++ T +AVK L A + +F+ E + + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR----------------- 602
++V+LLG C L++E+M G L L P +L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 603 ------IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656
+ I+ ++A G+AYL E +H D+ +N L+ KI+DFGLS+ ++S
Sbjct: 171 LSCAEQLCIARQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 657 ---QSRTHTM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELE 709
++ + IR PE + + DV+++GV L EI M E
Sbjct: 228 DYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 710 EESRAILTDWAYDCYVEG-RLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767
E +G L + E L+ LM W + P+ RP+
Sbjct: 284 E---------VIYYVRDGNILACPENCPLE--------LYN-LMRLCW--SKLPADRPSF 323
Query: 768 KVVLQMLEGLLDVPNP 783
+ ++L+ + +
Sbjct: 324 CSIHRILQRMCERAEG 339
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 11/195 (5%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQER-EREFKSEVSAIGRTHHKHLVQLL 566
LG+GSF VY+ +G +A+K +D+ + + + ++EV + H +++L
Sbjct: 19 LGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEECNVPI 624
+ +++ LV E NG + + K + R +I G+ YLH I
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSHG---I 133
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
+H D+ N+LL + KI+DFGL+ L + +T+ GT Y++PE +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGLE 192
Query: 685 VDVYSFGVTLLEIIC 699
DV+S G ++
Sbjct: 193 SDVWSLGCMFYTLLI 207
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 79/309 (25%), Positives = 130/309 (42%), Gaps = 63/309 (20%)
Query: 506 FKEELGRGSFGIVYKG----VLKTASGTAIAVKKLDRLAQERER-EFKSEV---SAIGRT 557
F + LG G+FG V + ++K+ + +AVK L A ER SE+ S +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 558 HHKHLVQLLGFCDEALNRLLVYEFMGNGTL--------------ANLIFAIPKPDWNLR- 602
H ++V LLG C L++ E+ G L + + L
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 603 ---IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD--- 656
+ S ++A+G+A+L N IH D+ +NILL H KI DFGL++ + +D
Sbjct: 145 EDLLSFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 657 QSRTHTM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEES 712
+ + ++ APE N + + DV+S+G+ L E+ S M ++ +
Sbjct: 202 VVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256
Query: 713 RAILTDWAYDCYVEG-RLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 770
Y EG R+ E ++ +M W DP KRPT K +
Sbjct: 257 -------FYKMIKEGFRMLSPEHAPAE--------MYD-IMKTCW--DADPLKRPTFKQI 298
Query: 771 LQMLEGLLD 779
+Q++E +
Sbjct: 299 VQLIEKQIS 307
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 53/201 (26%), Positives = 80/201 (39%), Gaps = 17/201 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHK 560
E +G+G F +V + + + +G AVK K + K E S H
Sbjct: 28 LCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR----GLAYL 616
H+V+LL +V+EFM L I + ++ R L Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 617 HEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAP 673
H+ IIH D+KP +LL ++ K+ FG++ L + GT ++AP
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
Query: 674 EWFKNVPVSAKVDVYSFGVTL 694
E K P VDV+ GV L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRT-HHKHLVQL 565
ELGRG++G+V K SG +AVK++ +E++ ++ RT V
Sbjct: 13 MELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 566 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI------RISLEIARGLAYLH 617
G F + + + E M +L + I +I++ I + L +LH
Sbjct: 72 YGALFREGDV--WICMELMD-TSLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLH 126
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE--- 674
+ + +IH D+KP N+L++ K+ DFG+S L + G + Y+APE
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERIN 182
Query: 675 -WFKNVPVSAKVDVYSFGVTLLEI 697
S K D++S G+T++E+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIEL 206
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 71/294 (24%), Positives = 114/294 (38%), Gaps = 69/294 (23%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQ 564
KE++G GS+ + + + K A+ AVK +D+ +R+ E+ + R H +++
Sbjct: 26 VKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIIT 80
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI------------RISLEIARG 612
L D+ +V E M G L D +I + I +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGEL----L-----D---KILRQKFFSEREASAVLFTITKT 128
Query: 613 LAYLHEECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTR 668
+ YLH ++H D+KP NIL + S +I DFG +K L ++ T T
Sbjct: 129 VEYLHA-QG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTA 184
Query: 669 GYVAPEWFKNVPVSAKVDVYSFGVTLLEIICC-----RRSVEMELEEESRAILTDWAYDC 723
+VAPE + A D++S GV LL + + EE I
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGV-LLYTMLTGYTPFANGPDDTPEEILARIG------- 236
Query: 724 YVEGRLDVLID-----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
G+ + SD A K L+ M + DP +R T +VL+
Sbjct: 237 --SGKFSLSGGYWNSVSDTA---------KDLVSKMLHV--DPHQRLTAALVLR 277
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 74/309 (23%), Positives = 128/309 (41%), Gaps = 64/309 (20%)
Query: 506 FKEELGRGSFGIVYKGVL------KTASGTAIAVKKLDRLAQERER-EFKSEV---SAIG 555
+ LG G FG V K +AVK L A E++ + SE+ IG
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 556 RTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR- 602
+ HK+++ LLG C + ++ E+ G L P+ +
Sbjct: 145 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 603 ---IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD--- 656
+ + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ + +
Sbjct: 203 KDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 657 QSRTHTM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEES 712
+ T+ ++ APE + + + DV+SFGV + EI S + +EE
Sbjct: 260 KKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313
Query: 713 RAILTDWAYDCYVEG-RLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 770
+ EG R+D + ++E L+ +M W PS+RPT K +
Sbjct: 314 -------LFKLLKEGHRMDKPANCTNE--------LYM-MMRDCW--HAVPSQRPTFKQL 355
Query: 771 LQMLEGLLD 779
++ L+ +L
Sbjct: 356 VEDLDRILT 364
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 79/307 (25%), Positives = 125/307 (40%), Gaps = 60/307 (19%)
Query: 506 FKEELGRGSFGIVYKGVL----KTASGTAIAVKKLDRLAQERER-EFKSEVS---AIGRT 557
+ LGRG+FG V + KTA+ +AVK L A E SE+ IG
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH- 89
Query: 558 HHKHLVQLLGFC-DEALNRLLVYEFMGNGTL--------------ANLIFAIPKPDWNLR 602
H ++V LLG C +++ EF G L + K L
Sbjct: 90 -HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 603 --IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD---Q 657
I S ++A+G+ +L IH D+ +NILL KI DFGL++ ++ D
Sbjct: 149 HLICYSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 658 SRTHTM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESR 713
+ ++ APE + + + DV+SFGV L EI S ++++EE
Sbjct: 206 RKGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 714 AILTDWAYDCYVEGRLDVLID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
L + R+ + E +++ M+ W +PS+RPT +++
Sbjct: 262 RRLKE-------GTRMRAPDYTTPE--------MYQ-TMLDCW--HGEPSQRPTFSELVE 303
Query: 773 MLEGLLD 779
L LL
Sbjct: 304 HLGNLLQ 310
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 42/335 (12%), Positives = 99/335 (29%), Gaps = 82/335 (24%)
Query: 487 SETNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVK---KLDRLAQER 543
+ R S + T LG+ + +G + V +R
Sbjct: 58 TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNA 116
Query: 544 EREFKSEVSAIGR-------------------------THHKHLVQLLGFCD--EALNRL 576
++ K EV + K ++++ L+R
Sbjct: 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 176
Query: 577 LVYEFMGN------GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIK 630
+Y M + L + + R++++L++ R LA LH ++H ++
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 233
Query: 631 PQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK-----------NV 679
P +I+LD ++ F + + +RG+ PE
Sbjct: 234 PVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 680 PVSAKVDVYSFGVTLLEIICCRRSVEMEL--EEESRAILTDWAYDCYVEGRLDVLIDSDE 737
++ D ++ G+ + I C +L +++ ++W + ++
Sbjct: 289 LMTFSFDAWALGLVIYWIWC------ADLPITKDAALGGSEWIF----RSCKNI---PQP 335
Query: 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
L + ++ R ++
Sbjct: 336 V-----RAL-----L-EGFLRYPKEDRLLPLQAME 359
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 56/273 (20%)
Query: 468 IFFKWR-RRKYENNVQDSTTSETNLRF--------------FSYDELKDATDGFKEELGR 512
+ +K++ + KY+ + + E N F + L+ F + LG
Sbjct: 2 VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQ-----FGKTLGA 56
Query: 513 GSFGIVYKG----VLKTASGTAIAVKKLDRLAQERER-EFKSEV---SAIGRTHHKHLVQ 564
G+FG V + + K + +AVK L A E+ SE+ S +G H+++V
Sbjct: 57 GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QHENIVN 114
Query: 565 LLGFCDEALNRLLVYEFMGNGTLAN----------LIFAIPKPDWNLR----IRISLEIA 610
LLG C L++ E+ G L N A + + S ++A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD---QSRTHTM--IR 665
+G+A+L N IH D+ +N+LL + AKI DFGL++ + +D + + ++
Sbjct: 175 QGMAFL-ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
APE + + + DV+S+G+ L EI
Sbjct: 232 WM----APESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 47/194 (24%), Positives = 85/194 (43%), Gaps = 18/194 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E+LGRG FGIV++ V +S K + ++ K E+S + H++++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHL 66
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLR----IRISLEIARGLAYLHEEC 620
+ ++++EF+ + F I + L + ++ L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSH- 121
Query: 621 NVPIIHCDIKPQNILLDHFFSA--KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
I H DI+P+NI+ S+ KI +FG ++ L ++ Y APE ++
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQH 177
Query: 679 VPVSAKVDVYSFGV 692
VS D++S G
Sbjct: 178 DVVSTATDMWSLGT 191
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 58/312 (18%), Positives = 107/312 (34%), Gaps = 53/312 (16%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQL 565
+ L G F VY+ SG A+K+L +E+ R EV + + + H ++VQ
Sbjct: 33 RRVLAEGGFAFVYE-AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 566 LGFCDEALNR--------LLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAY 615
LL+ E + L + + ++I + R + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI----------- 664
+H PIIH D+K +N+LL + + K+ DFG + + + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 665 RGTRGYVAPE---WFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILT---D 718
T Y PE + N P+ K D+++ G L + + E + I+
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---DGAKLRIVNGKYS 267
Query: 719 WAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
LI +Q +P +R ++ V+ L+ +
Sbjct: 268 IPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQEIA 307
Query: 779 DVPNPPGPSSFS 790
N S +
Sbjct: 308 AARNVNPKSPIT 319
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 53/201 (26%), Positives = 83/201 (41%), Gaps = 24/201 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQERERE-FKSEVSAIGRTHHKHLVQLL 566
LG+G F ++ + A K + + L + +RE E+S H+H+V
Sbjct: 23 LGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYLHE 618
GF ++ +V E +L L R ++ AR G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEPEARYYLRQIVLGCQYLHR 133
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
+IH D+K N+ L+ KI DFGL+ + D R + GT Y+APE
Sbjct: 134 NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSK 189
Query: 679 VPVSAKVDVYSFGVTLLEIIC 699
S +VDV+S G + ++
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLV 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 53/201 (26%), Positives = 83/201 (41%), Gaps = 24/201 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQERERE-FKSEVSAIGRTHHKHLVQLL 566
LG+G F ++ + A K + + L + +RE E+S H+H+V
Sbjct: 49 LGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYLHE 618
GF ++ +V E +L L R ++ AR G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEPEARYYLRQIVLGCQYLHR 159
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
+IH D+K N+ L+ KI DFGL+ + D R + GT Y+APE
Sbjct: 160 NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSK 215
Query: 679 VPVSAKVDVYSFGVTLLEIIC 699
S +VDV+S G + ++
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLV 236
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG------TAIAVKKLDRLAQERER-EFKSEVS---AIG 555
+ LG G+FG V +AVK L A E++ + SE+ IG
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 556 RTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR- 602
+ HK+++ LLG C + ++ E+ G L P+ +
Sbjct: 99 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 603 ---IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD--- 656
+ + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ + +
Sbjct: 157 KDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 657 QSRTHTM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
+ T+ ++ APE + + + DV+SFGV + EI
Sbjct: 214 KKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 15/193 (7%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
EELG G+FG+V++ V K A+G K ++ + K+E+S + + HH L+ L
Sbjct: 55 ILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLI----FAIPKPDWNLRIRISLEIARGLAYLHEECN 621
++ +L+ EF+ G L + I + + + + +R + E GL ++HE
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEH-- 168
Query: 622 VPIIHCDIKPQNILLDHFFSA--KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
I+H DIKP+NI+ + ++ KI DFGL+ L + + T + APE
Sbjct: 169 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDRE 225
Query: 680 PVSAKVDVYSFGV 692
PV D+++ GV
Sbjct: 226 PVGFYTDMWAIGV 238
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREF-----------------KSEVS 552
L +G F + L A+KK ++ E++R+F K+E+
Sbjct: 39 LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 553 AIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR- 611
I +++ + G ++YE+M N ++ D N I +++ +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 612 -------GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664
+Y+H E N I H D+KP NIL+D K+SDFG S+ + +
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKKIKGS- 210
Query: 665 RGTRGYVAPEWFKNVPV--SAKVDVYSFGVTLLEIIC 699
RGT ++ PE+F N AKVD++S G+ L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTH-HKHLVQL 565
E+G G+ G V+K + +G IAVK++ R + E + ++ + ++H ++VQ
Sbjct: 31 GEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 566 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNV 622
G + + + E MG L + P + ++++ I + L YL E+
Sbjct: 90 FGTFITNTDVF--IAMELMGTCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKEKHG- 145
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-----WFK 677
+IH D+KP NILLD K+ DFG+S L D+++ + G Y+APE
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPT 202
Query: 678 NVPVSAKVDVYSFGVTLLEI 697
+ DV+S G++L+E+
Sbjct: 203 KPDYDIRADVWSLGISLVEL 222
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 42/208 (20%), Positives = 79/208 (37%), Gaps = 36/208 (17%)
Query: 580 EFMGNGTLANLI---FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL 636
+ L + + ++ + + + I ++IA + +LH + ++H D+KP NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFF 197
Query: 637 DHFFSAKISDFGLSKLLFSDQSR-----------THTMIRGTRGYVAPEWFKNVPVSAKV 685
K+ DFGL + D+ THT GT+ Y++PE S KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 686 DVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSR 745
D++S G+ L E + S +ME + + +L
Sbjct: 258 DIFSLGLILFE-LLYSFSTQMERVRIITDV---------RNLKFPLLFTQKYPQEHM--- 304
Query: 746 LHKWLMIAMWCIQEDPSKRPTMKVVLQM 773
M+ + P++RP +++
Sbjct: 305 -----MVQ-DMLSPSPTERPEATDIIEN 326
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 38/278 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKHLV 563
++LG G++G V K + A+K + ++ + EV+ + H +++
Sbjct: 41 RVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
+L F ++ N LV E G L + I K + I ++ G+ YLH+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--- 156
Query: 624 IIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680
I+H D+KP+N+LL + KI DFGLS +F +Q + + GT Y+APE +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKMKERL-GTAYYIAPEVLRK-K 213
Query: 681 VSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTDWAYDCYVEGRLDVLID----- 734
K DV+S GV L ++ + ++E R + +G+
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE---------KGKYTFDSPEWKNV 264
Query: 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
S+ A K L+ M +Q D +R + + L+
Sbjct: 265 SEGA---------KDLIKQM--LQFDSQRRISAQQALE 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKHLV 563
KEELG+G+F +V + V K +G A K ++ +L+ ++ + E + H ++V
Sbjct: 10 VKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRIS--------LEIARGLAY 615
+L E LV++ + G L I A R S +I +AY
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVA--------REFYSEADASHCIQQILESIAY 120
Query: 616 LHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
H I+H ++KP+N+LL + K++DFGL+ +D H GT GY++
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTPGYLS 175
Query: 673 PEWFKNVPVSAKVDVYSFGVTL 694
PE K P S VD+++ GV L
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQ 564
E LG G FG V+K A+G +A K + + + E K+E+S + + H +L+Q
Sbjct: 92 SKTEILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLR----IRISLEIARGLAYLHEE 619
L + + +LV E++ G L F I +NL I +I G+ ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 620 CNVPIIHCDIKPQNILLDHFFSA--KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
I+H D+KP+NIL + + KI DFGL++ + GT ++APE
Sbjct: 206 MY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVN 261
Query: 678 NVPVSAKVDVYSFGV 692
VS D++S GV
Sbjct: 262 YDFVSFPTDMWSVGV 276
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQERE--REFKSEVSAIGRTHHKHLVQ 564
++LG G VY T +A+K + ++ E + F+ EV + H+++V
Sbjct: 17 DKLGGGGMSTVYLA-EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
++ +E LV E++ TL+ I + + I + +I G+ + H+ I
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT-MIRGTRGYVAPEWFKNVPVSA 683
+H DIKPQNIL+D + KI DFG++K L S+ S T T + GT Y +PE K
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 684 KVDVYSFGVTLLEII 698
D+YS G+ L E++
Sbjct: 192 CTDIYSIGIVLYEML 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 20/199 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQERERE-FKSEVSAIGRTHH 559
EELG G F IV K K ++G A K + + RE + EVS + + H
Sbjct: 16 IGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLH 617
+++ L + + +L+ E + G L + + K + +I G+ YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 618 EECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAP 673
+ I H D+KP+NI+L K+ DFGL+ D + GT +VAP
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVAP 187
Query: 674 EWFKNVPVSAKVDVYSFGV 692
E P+ + D++S GV
Sbjct: 188 EIVNYEPLGLEADMWSIGV 206
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG----TAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 560
+ LG G FG V K G T +AVK L A E + SE + + + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTL--------------------ANLIFAIPKPDWN 600
H+++L G C + LL+ E+ G+L N +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 601 LR----IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656
L I + +I++G+ YL E ++H D+ +NIL+ KISDFGLS+ ++ +
Sbjct: 147 LTMGDLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 657 ---QSRTHTM--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
R+ ++ A E + + + DV+SFGV L EI+
Sbjct: 204 DSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 69/299 (23%), Positives = 112/299 (37%), Gaps = 71/299 (23%)
Query: 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHL 562
D + LG GSF I K V K S A AVK + + + ++ E++A+ H ++
Sbjct: 13 DLKDKPLGEGSFSICRKCVHK-KSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNI 68
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI------------RISLEIA 610
V+L + L+ LV E + G L F + RI I ++
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGEL----F-----E---RIKKKKHFSETEASYIMRKLV 116
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGT 667
++++H+ ++H D+KP+N+L + KI DFG ++L D T T
Sbjct: 117 SAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FT 172
Query: 668 RGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICC---------RRSVEMELEEESRAILTD 718
Y APE D++S GV +L + R E + I
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGV-ILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK-- 229
Query: 719 WAYDCYVEGRLDVLID-----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+G + S EA K L+ + + DP+KR M +
Sbjct: 230 -------KGDFSFEGEAWKNVSQEA---------KDLIQGL--LTVDPNKRLKMSGLRY 270
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 56/333 (16%), Positives = 102/333 (30%), Gaps = 54/333 (16%)
Query: 487 SETNLRFFSYDELKDATDGFK--EELGRG--SFGIVYKGVLKTASGTAIAVKK--LDRLA 540
NL F ++ +G+G V K +G + V++ L+ +
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACS 66
Query: 541 QEREREFKSEVSAIGRTHHKHLVQLLG--FCDEALNRLLVYEFMGNGTLANLI-FAIPKP 597
E + E+ +H ++V D L +V FM G+ +LI
Sbjct: 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW--VVTSFMAYGSAKDLICTHFMDG 124
Query: 598 DWNLRIR-ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656
L I I + + L Y+H +H +K +IL+ +S + + S
Sbjct: 125 MNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181
Query: 657 QSRTHTMIRGTRGYV------APEWFK--NVPVSAKVDVYSFGVTLLEII---------- 698
R + + V +PE + AK D+YS G+T E+
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
Query: 699 --------------CCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744
C + + EE + + A +
Sbjct: 242 ATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHP 301
Query: 745 RLHKW-----LMIAMWCIQEDPSKRPTMKVVLQ 772
+ + C+Q +P RP+ +L
Sbjct: 302 YHRTFSPHFHHFVEQ-CLQRNPDARPSASTLLN 333
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 37/208 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
F E LG G+F V+ + +G A+K + + R+ ++E++ + + H+++V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI------------RISLEIARGL 613
+ + LV + + G L F D RI + ++ +
Sbjct: 72 EDIYESTTHYYLVMQLVSGGEL----F-----D---RILERGVYTEKDASLVIQQVLSAV 119
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFF---SAKISDFGLSKLLFSDQSRTHTMIRGTRGY 670
YLHE I+H D+KP+N+L I+DFGLSK T GT GY
Sbjct: 120 KYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTAC-GTPGY 173
Query: 671 VAPEWFKNVPVSAKVDVYSFGV---TLL 695
VAPE P S VD +S GV LL
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-29
Identities = 73/304 (24%), Positives = 123/304 (40%), Gaps = 54/304 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG-TAIAVKKLDRLAQERER-EFKSEVSAIGR-THHKHL 562
F++ +G G+FG V K +K A+K++ A + + +F E+ + + HH ++
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR----IRIS 606
+ LLG C+ L E+ +G L L + +
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM--- 663
++ARG+ YL + IH D+ +NIL+ + AKI+DFGLS+ + TM
Sbjct: 149 ADVARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 664 -IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWA 720
+R A E + DV+S+GV L EI+ + M E
Sbjct: 204 PVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------L 250
Query: 721 YDCYVEG-RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
Y+ +G RL E + ++ LM W +E P +RP+ +L L +L+
Sbjct: 251 YEKLPQGYRL-------EKPLNCDDEVYD-LMRQCW--REKPYERPSFAQILVSLNRMLE 300
Query: 780 VPNP 783
Sbjct: 301 ERKT 304
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
EELG G+FG+V++ + A+G A K + + + + E+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLI----FAIPKPDWNLRIRISLEIARGLAYLHEECN 621
++ +++YEFM G L + + + + +R + GL ++H E N
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMH-ENN 275
Query: 622 VPIIHCDIKPQNILLDHFFSA--KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
+H D+KP+NI+ S K+ DFGL+ L D ++ + GT + APE +
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 680 PVSAKVDVYSFGV 692
PV D++S GV
Sbjct: 332 PVGYYTDMWSVGV 344
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 22/200 (11%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQERERE-FKSEVSAIGRTHH 559
EELG G F IV K K +G A K +L + RE + EV+ + H
Sbjct: 9 MGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKPDWNLRIRISLEIARGLAYL 616
+++ L + + +L+ E + G L + + + + + ++ I G+ YL
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ---ILDGVHYL 124
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSA----KISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
H + I H D+KP+NI+L K+ DFG++ + + GT +VA
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNIF-GTPEFVA 179
Query: 673 PEWFKNVPVSAKVDVYSFGV 692
PE P+ + D++S GV
Sbjct: 180 PEIVNYEPLGLEADMWSIGV 199
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 71/296 (23%), Positives = 122/296 (41%), Gaps = 60/296 (20%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKHLVQLL 566
E +G G+ +V +A+K+++ Q E E+ A+ + HH ++V
Sbjct: 21 EVIGSGATAVVQAAYCAP-KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 567 G--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR--------ISLEIARGLAYL 616
+ L LV + + G++ ++I I + I E+ GL YL
Sbjct: 80 TSFVVKDEL--WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF-----SDQSRTHTMIRGTRGYV 671
H+ IH D+K NILL S +I+DFG+S L + T + GT ++
Sbjct: 138 HKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWM 193
Query: 672 APEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEME---LEEE-SRAILTDWAYDCYVE 726
APE + V K D++SFG+T +E+ + + ++
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELA------TGAAPYHKYPPMKVLM---------- 237
Query: 727 GRLDVLIDSD-----EAAMADRSRLHKW-----LMIAMWCIQEDPSKRPTMKVVLQ 772
L + E + D+ L K+ MI++ C+Q+DP KRPT +L+
Sbjct: 238 -----LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPTAAELLR 287
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKHLV 563
KEELG+G+F +V + V K +G A K ++ +L+ ++ + E + H ++V
Sbjct: 33 VKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK---PDWNLRIRISLEIARGLAYLHEEC 620
+L E LV++ + G L I A D + I+ I +AY H
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---ILESIAYCHSNG 148
Query: 621 NVPIIHCDIKPQNILLDHFFSA---KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
I+H ++KP+N+LL K++DFGL+ +D H GT GY++PE K
Sbjct: 149 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTPGYLSPEVLK 203
Query: 678 NVPVSAKVDVYSFGVTL 694
P S VD+++ GV L
Sbjct: 204 KDPYSKPVDIWACGVIL 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKHLVQ 564
FK +LG G+FG V+ + +SG +K ++ +Q + ++E+ + H ++++
Sbjct: 26 FKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAYLHEEC 620
+ ++ N +V E G L I + L + ++ LAY H +
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 621 NVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
++H D+KP+NIL KI DFGL++ LF + GT Y+APE FK
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHSTNAA-GTALYMAPEVFK 199
Query: 678 NVPVSAKVDVYSFGVTL 694
V+ K D++S GV +
Sbjct: 200 R-DVTFKCDIWSAGVVM 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 39/279 (13%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHL 562
+ LG+GSFG V K +G AVK + + + + EV + + H ++
Sbjct: 30 GQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
++L F ++ LV E G L + I + + RI ++ G+ Y+H+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 623 PIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
I+H D+KP+N+LL + +I DFGLS F + I GT Y+APE
Sbjct: 147 -IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKI-GTAYYIAPEVLHG- 202
Query: 680 PVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTDWAYDCYVEGRLDVLID---- 734
K DV+S GV L ++ E + + + G+ +
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK---------GKYTFELPQWKK 253
Query: 735 -SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
S+ A K L+ M + PS R + + L
Sbjct: 254 VSESA---------KDLIRKM--LTYVPSMRISARDALD 281
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---------LAQEREREFKSEVSAIGR 556
KE LGRG +V + + K + AVK +D QE EV + +
Sbjct: 21 PKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 557 -THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR---- 611
+ H +++QL + LV++ M G L + + ++ +S + R
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--------KVTLSEKETRKIMR 131
Query: 612 ----GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGT 667
+ LH+ I+H D+KP+NILLD + K++DFG S + + GT
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVC-GT 186
Query: 668 RGYVAPEWFKNVPVSA------KVDVYSFGVTL 694
Y+APE + +VD++S GV +
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 24/201 (11%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQERERE-FKSEVSAIGRTHH 559
EELG G F IV K K ++G A K + + RE + EVS + + H
Sbjct: 16 IGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----IRISLEIARGLAY 615
+++ L + + +L+ E + G L + + +L +I G+ Y
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNY 130
Query: 616 LHEECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
LH + I H D+KP+NI+L K+ DFGL+ D + GT +V
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFV 185
Query: 672 APEWFKNVPVSAKVDVYSFGV 692
APE P+ + D++S GV
Sbjct: 186 APEIVNYEPLGLEADMWSIGV 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKHLVQ 564
E+G GSFG VY + +A+KK+ ++ +++ EV + + H + +Q
Sbjct: 60 REIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 565 LLG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECN 621
G + LV E+ G+ ++L+ KP + I ++ +GLAYLH
Sbjct: 119 YRGCYLREHTA--WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-- 173
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE---WFKN 678
+IH D+K NILL K+ DFG + ++ + ++ + GT ++APE
Sbjct: 174 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILAMDE 227
Query: 679 VPVSAKVDVYSFGVTLLEII 698
KVDV+S G+T +E+
Sbjct: 228 GQYDGKVDVWSLGITCIELA 247
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-28
Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLV 563
EELG+G+F +V + V +G A ++ L+ ++ + E H ++V
Sbjct: 15 LFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK---PDWNLRIRISLEIARGLAYLHEEC 620
+L E + L+++ + G L I A D + I+ I + + H+
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ---ILEAVLHCHQMG 130
Query: 621 NVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
++H ++KP+N+LL + K++DFGL+ + +Q GT GY++PE +
Sbjct: 131 ---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLR 186
Query: 678 NVPVSAKVDVYSFGVTL 694
P VD+++ GV L
Sbjct: 187 KDPYGKPVDLWACGVIL 203
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 62/290 (21%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKHLV 563
LG+GSFG V K + + AVK ++ + EV + + H +++
Sbjct: 26 IVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRIS--------LEIARGLAY 615
+L +++ + +V E G L + I R R S ++ G+ Y
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIK--------RKRFSEHDAARIIKQVFSGITY 136
Query: 616 LHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
+H+ I+H D+KP+NILL + KI DFGLS F ++ I GT Y+A
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRI-GTAYYIA 191
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEIIC-----CRRSVEMELEEESRAILTDWAYDCYVEG 727
PE + K DV+S GV L ++ ++ E ++ + + T G
Sbjct: 192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-EYDILK---RVET---------G 237
Query: 728 RLDVLID-----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ + SD+A K L+ M + PS R T L+
Sbjct: 238 KYAFDLPQWRTISDDA---------KDLIRKM--LTFHPSLRITATQCLE 276
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 12/194 (6%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKHLV 563
LG+GSFG V K + + AVK ++ + EV + + H +++
Sbjct: 26 IVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
+L +++ + +V E G L + I + + RI ++ G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 624 IIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680
I+H D+KP+NILL + KI DFGLS F ++ I GT Y+APE +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRI-GTAYYIAPEVLRG-T 198
Query: 681 VSAKVDVYSFGVTL 694
K DV+S GV L
Sbjct: 199 YDEKCDVWSAGVIL 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 58/200 (29%), Positives = 85/200 (42%), Gaps = 22/200 (11%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVK-------KLDRLAQEREREFKSEVSAIGRTH 558
EELG G F +V K K ++G A K K R RE + + EVS +
Sbjct: 15 TGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSRE-DIEREVSILKEIQ 72
Query: 559 HKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYL 616
H +++ L + + +L+ E + G L + + K +I G+ YL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSA----KISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
H I H D+KP+NI+L KI DFGL+ D I GT +VA
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTPEFVA 185
Query: 673 PEWFKNVPVSAKVDVYSFGV 692
PE P+ + D++S GV
Sbjct: 186 PEIVNYEPLGLEADMWSIGV 205
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 48/194 (24%), Positives = 78/194 (40%), Gaps = 11/194 (5%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQE---REREFKSEVSAIGRTHHKHLV 563
+GRG G VY+ T +A+K + L+ + R R + E GR H+V
Sbjct: 40 RLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVV 97
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP 623
+ F + + + LA ++ + I +I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---G 154
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT-MIRGTRGYVAPEWFKNVPVS 682
H D+KP+NIL+ A + DFG++ +D+ T GT Y+APE F +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 683 AKVDVYSFGVTLLE 696
+ D+Y+ L E
Sbjct: 214 YRADIYALTCVLYE 227
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 79/295 (26%), Positives = 120/295 (40%), Gaps = 53/295 (17%)
Query: 495 SYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAI 554
+ D L D + + ELGRG+ IVY+ K + A+K L + ++ ++E+ +
Sbjct: 47 NRDALSDFFE-VESELGRGATSIVYRCKQK-GTQKPYALKVLKK--TVDKKIVRTEIGVL 102
Query: 555 GRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK---PDWNLRIRISLEIAR 611
R H ++++L + LV E + G L + I D ++ +I
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK---QILE 159
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSA---KISDFGLSKLLFSDQSRTHTMIRGTR 668
+AYLHE I+H D+KP+N+L KI+DFGLSK + Q T+ GT
Sbjct: 160 AVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVC-GTP 214
Query: 669 GYVAPEWFKNVPVSAKVDVYSFGV---TLLEIICCRRS---VEMELEEESRAILTDWAYD 722
GY APE + +VD++S G+ LL C E + R IL
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILL----CGFEPFYDERGDQFMFRRIL------ 264
Query: 723 CYVEGRLDVLID-----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ S A K L+ + I DP KR T LQ
Sbjct: 265 ---NCEYYFISPWWDEVSLNA---------KDLVRKL--IVLDPKKRLTTFQALQ 305
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 74/292 (25%), Positives = 119/292 (40%), Gaps = 55/292 (18%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR-------------LAQEREREFKSEVS 552
+LG G++G V K + A+K + + ++ E +E+S
Sbjct: 40 KVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 553 AIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARG 612
+ H ++++L ++ LV EF G L I K D I +I G
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 613 LAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG 669
+ YLH+ I+H DIKP+NILL + + KI DFGLS FS + + GT
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKLRDRL-GTAY 213
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEIIC----CRRSVEMELEEESRAILTDWAYDCYV 725
Y+APE K + K DV+S GV + ++C + ++ + +
Sbjct: 214 YIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK---KVE--------- 260
Query: 726 EGRLDVLID-----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+G+ + SDEA K L+ M + D +KR T + L
Sbjct: 261 KGKYYFDFNDWKNISDEA---------KELIKLM--LTYDYNKRCTAEEALN 301
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 31/248 (12%)
Query: 471 KWRRRKYENNVQDSTTSETNLRFFSYDELKDATDG----------FKEELGRGSFGIVYK 520
K +RR NN + + + N F +D D + LG G+ G V
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 521 GVLKTASGTAIAVKKLDR--------LAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA 572
+ + +A++ + + + ++E+ + + +H ++++ F D
Sbjct: 154 AFER-KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212
Query: 573 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQ 632
+ +V E M G L + + + ++ + YLHE IIH D+KP+
Sbjct: 213 -DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPE 268
Query: 633 NILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV---SAKVD 686
N+LL + KI+DFG SK + + S T+ GT Y+APE +V + VD
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 687 VYSFGVTL 694
+S GV L
Sbjct: 327 CWSLGVIL 334
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 53/246 (21%), Positives = 88/246 (35%), Gaps = 56/246 (22%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHK 560
K +G+GS+G+V + + A+K K+ ++ + K+EV + + HH
Sbjct: 30 LKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLE------------ 608
++ +L ++ LV E G L + + ++
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 609 ----------------------------IARGLAYLHEECNVPIIHCDIKPQNILL--DH 638
I L YLH + I H DIKP+N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 639 FFSAKISDFGLSKLLFSDQSRTHTMIR---GTRGYVAPEWFKNV--PVSAKVDVYSFGVT 693
F K+ DFGLSK + + + + GT +VAPE K D +S GV
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 694 LLEIIC 699
L ++
Sbjct: 266 LHLLLM 271
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--------LAQEREREFKSEVSAIGR- 556
K+ +GRG +V + V + A+G AVK ++ +E + E I R
Sbjct: 98 PKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRET-HILRQ 155
Query: 557 -THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRIS--------L 607
H H++ L+ + + LV++ M G L + + ++ +S
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--------KVALSEKETRSIMR 207
Query: 608 EIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGT 667
+ +++LH I+H D+KP+NILLD ++SDFG S + + GT
Sbjct: 208 SLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLRELC-GT 262
Query: 668 RGYVAPE------WFKNVPVSAKVDVYSFGV---TLL 695
GY+APE + +VD+++ GV TLL
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 2e-26
Identities = 34/233 (14%), Positives = 69/233 (29%), Gaps = 45/233 (19%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK---KLDRLAQEREREFKSEVSAIGRT----HHK 560
LG+ + +G + V +R ++ K EV + + K
Sbjct: 84 TVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 561 HLVQLLGFCDEA-----------------------LNRLLVYEFMGN------GTLANLI 591
L F L+R +Y M + L +
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 592 FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651
+ R++++L++ R LA LH ++H ++P +I+LD ++ F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 652 LLFSDQSRTHTMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIIC 699
+ A ++ D ++ G+ + I C
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 10/192 (5%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+ +GRGS+G V V K + A KK+ + E FK E+ + H ++++L
Sbjct: 13 LENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
++ + LV E G L + + RI ++ +AY H+ +
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128
Query: 626 HCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
H D+KP+N L K+ DFGL+ F T + GT YV+P+ +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKV-GTPYYVSPQVLEG-LYG 185
Query: 683 AKVDVYSFGVTL 694
+ D +S GV +
Sbjct: 186 PECDEWSAGVMM 197
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 508 EELGRGSFGIVYKG---VLKTASGTAIAVKKLD-RLAQERE--REFKSEVSAIGRTHHKH 561
E LG G V+ +AVK L LA++ F+ E +H
Sbjct: 18 EILGFGGMSEVHLARDLRD----HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 562 LVQLL--GFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLH 617
+V + G + L +V E++ TL +++ I + + + L + H
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-THT-MIRGTRGYVAPEW 675
+ IIH D+KP NI++ + K+ DFG+++ + + T T + GT Y++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 676 FKNVPVSAKVDVYSFGVTLLEII 698
+ V A+ DVYS G L E++
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVL 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 45/215 (20%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--------LAQEREREFKSEVSAIGRT 557
+ LG G+ G V + + +A+K + + + ++E+ + +
Sbjct: 14 MSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 558 HHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI------------RI 605
+H ++++ F D + +V E M G L F D ++
Sbjct: 73 NHPCIIKIKNFFDAE-DYYIVLELMEGGEL----F-----D---KVVGNKRLKEATCKLY 119
Query: 606 SLEIARGLAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHT 662
++ + YLHE IIH D+KP+N+LL + KI+DFG SK + + S T
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRT 175
Query: 663 MIRGTRGYVAPE---WFKNVPVSAKVDVYSFGVTL 694
+ GT Y+APE + VD +S GV L
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKHLVQLL 566
LGRG FG V+ A+G A KKL RL + + + E + + H + +V L
Sbjct: 193 LGRGGFGEVF-ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 567 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL---RIRI-SLEIARGLAYLHEECN 621
+ E L LV M G + I+ + + + R + +I GL +LH+
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
II+ D+KP+N+LLD + +ISD GL+ L + Q++T GT G++APE
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY 366
Query: 682 SAKVDVYSFGVTLLEIICCR-----RSVEMELEEESRAILTD 718
VD ++ GVTL E+I R R ++E +E + +L
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 22/198 (11%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQL 565
K+ LG G G V + + +G A+K L + R+ EV + + H+V +
Sbjct: 34 KQVLGLGVNGKVLECFHR-RTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCI 87
Query: 566 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAYLHEE 619
L + + L++ E M G L + I + R I +I + +LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 620 CNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
I H D+KP+N+L + K++DFG +K + Q+ T T YVAPE
Sbjct: 148 N---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPC-YTPYYVAPEVL 201
Query: 677 KNVPVSAKVDVYSFGVTL 694
D++S GV +
Sbjct: 202 GPEKYDKSCDMWSLGVIM 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 26/205 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL----DRLAQEREREFKSEVSAIGRTHHKHLV 563
+ G G +Y + + +G + +K L D AQ +E + H +V
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM---AMAERQFLAEVVHPSIV 142
Query: 564 QLLGFCDEALNRL-----LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHE 618
Q+ F + +V E++G +L K I LEI L+YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS 200
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT-MIRGTRGYVAPEWFK 677
+ +++ D+KP+NI+L K+ D G + + GT G+ APE +
Sbjct: 201 ---IGLVYNDLKPENIMLTE-EQLKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVR 250
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRR 702
P A D+Y+ G TL +
Sbjct: 251 TGPTVAT-DIYTVGRTLAALTLDLP 274
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR--------LAQEREREFKSEVSAIGRTHH 559
LG G+FG V+ V K + VK + + + + + E++ + R H
Sbjct: 30 SPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGT-LANLIFAIPKPDWNLRIRISLEIARGLAYLHE 618
+++++L + LV E G+G L I P+ D L I ++ + YL
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
+ IIH DIK +NI++ F+ K+ DFG + +T GT Y APE
Sbjct: 149 KD---IIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGKLFYTFC-GTIEYCAPEVLMG 203
Query: 679 VP-VSAKVDVYSFGVTLLEIIC 699
P +++++S GVTL ++
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVF 225
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 61/306 (19%), Positives = 111/306 (36%), Gaps = 68/306 (22%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQL 565
++ LG G+ V + + AVK +++ EV + + H+++++L
Sbjct: 18 EDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI------------RISLEIARGL 613
+ F +E LV+E M G++ + I + ++A L
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILS------------HIHKRRHFNELEASVVVQDVASAL 124
Query: 614 AYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIR----- 665
+LH + I H D+KP+NIL + KI DF L + + +
Sbjct: 125 DFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 666 -GTRGYVAPEWFKNVPVSAK-----VDVYSFGVTLLEIICC--------RRSVEMELEEE 711
G+ Y+APE + A D++S GV +L I+ S E
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV-ILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 712 SRAILTDWAYDCYVEGRLDVLID-----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 766
+ + ++ EG+ + S A K L+ + + D +R +
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAA---------KDLISKL--LVRDAKQRLS 289
Query: 767 MKVVLQ 772
VLQ
Sbjct: 290 AAQVLQ 295
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 60/286 (20%), Positives = 123/286 (43%), Gaps = 36/286 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLVQL 565
+ +G+G+F V +G +A+K +D+ L ++ EV + +H ++V+L
Sbjct: 21 KTIGKGNFAKVKLAR-HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
+ L+ E+ G + + + A + +I + Y H++ I+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP-VSAK 684
H D+K +N+LLD + KI+DFG S F+ + G Y APE F+ +
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSN-EFTVGGKLDAFC-GAPPYAAPELFQGKKYDGPE 194
Query: 685 VDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV---LIDSDEAAMA 741
VDV+S GV L ++ + + ++ L + + G+ + + S +
Sbjct: 195 VDVWSLGVILYTLVSGS----LPFDGQNLKEL----RERVLRGKYRIPFYM--STDC--- 241
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ---MLEGLLDVPNPP 784
+ L ++L++ +P KR T++ +++ + G + P
Sbjct: 242 -ENLLKRFLVL-------NPIKRGTLEQIMKDRWINAGHEEDELKP 279
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 64/311 (20%), Positives = 108/311 (34%), Gaps = 64/311 (20%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR------LAQEREREFKSEVS----AIGRT 557
LG+G FG V+ G + +A+K + R EV+
Sbjct: 37 PLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 558 HHKHLVQLLGFCDEALNRLLVYEFMGNGT-LANLIFAIPKPDWNLRIRISLEIARGLAYL 616
H +++LL + + +LV E L + I ++ + +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 617 HEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
H ++H DIK +NIL+D AK+ DFG LL + GTR Y PEW
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPEW 209
Query: 676 FKNVP-VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734
+ V+S G+ L +++C G + +
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVC---------------------------GDIPF--E 240
Query: 735 SDEAAMADRSRLHKWL------MIAMWCIQEDPSKRPTMKVVLQ---MLEGLLDVP---- 781
D+ + + +I C+ PS RP+++ +L M DVP
Sbjct: 241 RDQEILEAELHFPAHVSPDCCALIR-RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPS 299
Query: 782 -NPPGPSSFSI 791
P P ++S+
Sbjct: 300 KGGPAPLAWSL 310
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 18/220 (8%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKHLVQLL 566
LG+G FG V A+G A KKL R+ + + +E + + + + +V L
Sbjct: 192 LGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 567 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL-RIRI-SLEIARGLAYLHEECNVP 623
+ E + L LV M G L I+ + + + R + EI GL LH E
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--- 306
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
I++ D+KP+NILLD +ISD GL+ + + GT GY+APE KN +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIKGRV-GTVGYMAPEVVKNERYTF 364
Query: 684 KVDVYSFGVTLLEIICCR-----RSVEMELEEESRAILTD 718
D ++ G L E+I + R +++ EE R +
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 51/199 (25%), Positives = 78/199 (39%), Gaps = 21/199 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQ 564
+ LG G G V + K + A+K L + R EV R + H+V+
Sbjct: 66 TSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVR 119
Query: 565 LLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAYLHE 618
++ + L+V E + G L + I + R I I + YLH
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 178
Query: 619 ECNVPIIHCDIKPQNILLDHFFSA---KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
N I H D+KP+N+L K++DFG +K + + T T YVAPE
Sbjct: 179 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPC-YTPYYVAPEV 234
Query: 676 FKNVPVSAKVDVYSFGVTL 694
D++S GV +
Sbjct: 235 LGPEKYDKSCDMWSLGVIM 253
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 64/308 (20%), Positives = 110/308 (35%), Gaps = 65/308 (21%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR------LAQEREREFKSEVSAIGRTHHK- 560
LG G FG VY G+ + + +A+K +++ EV + +
Sbjct: 49 PLLGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 561 -HLVQLLGFCDEALNRLLVYEF-MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHE 618
+++LL + + + +L+ E L + I L ++ + + H
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 619 ECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
++H DIK +NIL+D + K+ DFG LL GTR Y PEW +
Sbjct: 168 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIR 221
Query: 678 NVP-VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
V+S G+ L +++C G + + D
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVC---------------------------GDIP--FEHD 252
Query: 737 EAAMADRSRLHKWL------MIAMWCIQEDPSKRPTMKVVLQ---MLEGLL--------D 779
E + + + + +I WC+ PS RPT + + M + LL
Sbjct: 253 EEIIRGQVFFRQRVSSECQHLIR-WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHL 311
Query: 780 VPNPPGPS 787
PGPS
Sbjct: 312 HSLSPGPS 319
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 53/232 (22%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREF------------------- 547
K+E+G+GS+G+V T A+K L + R+ F
Sbjct: 18 KDEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 548 -------KSEVSAIGRTHHKHLVQLLGFCDEALNRLL--VYEFMGNGTLANLIFAIPKPD 598
E++ + + H ++V+L+ D+ L V+E + G + +P
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPT-- 130
Query: 599 WNLRIRISLEIAR--------GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS 650
+S + AR G+ YLH + IIH DIKP N+L+ KI+DFG+S
Sbjct: 131 ---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 651 KLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS---AKVDVYSFGVTLLEIIC 699
+ GT ++APE +DV++ GVTL +
Sbjct: 185 NEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 58/240 (24%), Positives = 100/240 (41%), Gaps = 39/240 (16%)
Query: 483 DSTTSETNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKK--LDR 538
+ N + + + D F+ G+G+FG V G K+ +G ++A+KK D
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDP 60
Query: 539 LAQERE-REFKSEVSAIGRTHHKHLVQLL---------GFCDEALNRLLVYEFMGNGTLA 588
+ RE + + + HH ++VQL D LN +V E++ + TL
Sbjct: 61 RFRNRELQIMQD----LAVLHHPNIVQLQSYFYTLGERDRRDIYLN--VVMEYVPD-TLH 113
Query: 589 NLIFAIPKPDWNLRIRISLE--------IARGLAYLHEECNVPIIHCDIKPQNILLDHFF 640
+ + ++ + R + LH V + H DIKP N+L++
Sbjct: 114 RCC----RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEAD 168
Query: 641 SA-KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW-FKNVPVSAKVDVYSFGVTLLEII 698
K+ DFG +K L + + +R Y APE F N + VD++S G E++
Sbjct: 169 GTLKLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 35/212 (16%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
+ +G GSFG+VY+ L SG +A+KK+ Q++ + + E+ + + H ++V+L
Sbjct: 60 KVIGNGSFGVVYQAKLCD-SGELVAIKKV---LQDKRFKNR-ELQIMRKLDHCNIVRLRY 114
Query: 568 F--------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLE--------IAR 611
F + LN LV +++ T+ + + + + + + R
Sbjct: 115 FFYSSGEKKDEVYLN--LVLDYVPE-TVYRVA----RHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGY 670
LAY+H + I H DIKPQN+LLD K+ DFG +K L + + +R Y
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222
Query: 671 VAPEW-FKNVPVSAKVDVYSFGVTLLEIICCR 701
APE F ++ +DV+S G L E++ +
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 27/203 (13%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLVQLLG 567
LG G++G V V + A+AVK +D E K E+ +H+++V+ G
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHENVVKFYG 72
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYLHEE 619
E + L E+ G L + I I + A+ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR--GTRGYVAPEWFK 677
I H DIKP+N+LLD + KISDFGL+ +F +R + + GT YVAPE K
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 678 NVP-VSAKVDVYSFGVTLLEIIC 699
+ VDV+S G+ L ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 20/221 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSE---VSAIGRTHHKHLV 563
+GRG FG VY G K +G A+K L R+ ++ +E +S + +V
Sbjct: 197 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 564 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
+ + ++L + + M G L + + EI GL ++H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WFKNVPV 681
+++ D+KP NILLD +ISD GL+ + H + GT GY+APE K V
Sbjct: 313 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV-GTHGYMAPEVLQKGVAY 368
Query: 682 SAKVDVYSFGVTLLEIIC----CRRSVEMELEEESRAILTD 718
+ D +S G L +++ R+ + E R LT
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 30/208 (14%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR----LAQEREREFKSEVSAIGRTHHKHLVQL 565
LG GS+G V + + + + AVK L + E K E+ + R HK+++QL
Sbjct: 13 LGEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 566 LG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAY 615
+ +E ++ +V E+ G + D R + A GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--ML-----DSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL--FSDQSRTHTMIRGTRGYVAP 673
LH + I+H DIKP N+LL + KIS G+++ L F+ T +G+ + P
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPP 180
Query: 674 EWFKNVPV--SAKVDVYSFGVTLLEIIC 699
E + KVD++S GVTL I
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKHLVQLLGF 568
LG G++G V V + A+AVK +D A + K E+ +H+++V+ G
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 569 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYLHEEC 620
E + L E+ G L + I I + A+ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR--GTRGYVAPEWFKN 678
I H DIKP+N+LLD + KISDFGL+ +F +R + + GT YVAPE K
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 679 VP-VSAKVDVYSFGVTLLEIIC 699
+ VDV+S G+ L ++
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLA 203
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 13/172 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHLV 563
+G GS+G+V K K +G +A+KK + + + K E+ + + H++LV
Sbjct: 31 GLVGEGSYGMVMKCRNKD-TGRIVAIKKF-LESDDDK-MVKKIAMREIKLLKQLRHENLV 87
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNV 622
LL C + LV+EF+ + T+ + + P ++ +I G+ + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
IIH DIKP+NIL+ K+ DFG ++ + + TR Y APE
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVATRWYRAPE 194
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 42/172 (24%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHLV 563
++G GS+G+V+K + +G +A+KK +++ K E+ + + H +LV
Sbjct: 9 GKIGEGSYGVVFKCRNRD-TGQIVAIKKF-LESEDDP-VIKKIALREIRMLKQLKHPNLV 65
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNV 622
LL LV+E+ + T+ + + + ++ I+ + + + + H+
Sbjct: 66 NLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
IH D+KP+NIL+ K+ DFG ++ L + S + TR Y +PE
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVATRWYRSPE 172
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 4e-21
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKHLVQLL 566
LG+G+FG V V + A+G A+K L + + + E +E + + H L L
Sbjct: 156 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 567 GFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRIRI-SLEIARGLAYLHEE 619
+ + +RL V E+ G L + F+ R R EI L YLH E
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALDYLHSE 267
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
N +++ D+K +N++LD KI+DFGL K D + T GT Y+APE ++
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDN 324
Query: 680 PVSAKVDVYSFGVTLLEIICCR 701
VD + GV + E++C R
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGR 346
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
+ +G GSFG+V++ L S +A+KK+ Q++ + + E+ + H ++V L
Sbjct: 46 KVIGNGSFGVVFQAKLVE-SDE-VAIKKV---LQDKRFKNR-ELQIMRIVKHPNVVDLKA 99
Query: 568 FCDEALNRL------LVYEFMGNGTLANLIFAIPKPDWNLRIRISLE--------IARGL 613
F ++ LV E++ T+ + L+ + + + R L
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRAS----RHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 614 AYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
AY+H ++ I H DIKPQN+LLD K+ DFG +K+L + + + +R Y A
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRA 209
Query: 673 PEW-FKNVPVSAKVDVYSFGVTLLEIICCR 701
PE F + +D++S G + E++ +
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQEREREF-KSEVSAIGRTHHKHL 562
F + LG GSF V + A+ A+K L+ + +E + + E + R H
Sbjct: 34 FGKILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 563 VQLLG-FCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRIRI-SLEIARGLA 614
V+L F D+ +L + NG L I F R + EI L
Sbjct: 93 VKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVSALE 144
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF--SDQSRTHTMIRGTRGYVA 672
YLH + IIH D+KP+NILL+ +I+DFG +K+L S Q+R ++ + GT YV+
Sbjct: 145 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVS 200
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEIIC 699
PE D+++ G + +++
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 26/202 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG G+FG V G +G +AVK L+R + + + K E+ + H H+++L
Sbjct: 19 LGVGTFGKVKIGE-HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYLHE 618
+ +V E++ G L + I R+ AR + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICK--------HGRVEEMEARRLFQQILSAVDYCHR 129
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
++H D+KP+N+LLD +AKI+DFGLS + SD T G+ Y APE
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSC-GSPNYAAPEVISG 184
Query: 679 VP-VSAKVDVYSFGVTLLEIIC 699
+VD++S GV L ++C
Sbjct: 185 RLYAGPEVDIWSCGVILYALLC 206
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 26/203 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFC 569
+G G+FG+ + +AVK ++R A E + E+ H ++V+
Sbjct: 28 IGSGNFGVARLMR-DKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 570 DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYLHEECN 621
+ ++ E+ G L I R S + AR G++Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICN--------AGRFSEDEARFFFQQLLSGVSYCHSMQ- 136
Query: 622 VPIIHCDIKPQNILLDHFFSA--KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
I H D+K +N LLD + KI DFG SK S+ + + GT Y+APE
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTV-GTPAYIAPEVLLRQ 192
Query: 680 P-VSAKVDVYSFGVTLLEIICCR 701
DV+S GVTL ++
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGA 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 1e-20
Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 560
E++G G++G V+K + + +A+K++ RL + E RE + + HK
Sbjct: 8 EKIGEGTYGTVFKAKNRE-THEIVALKRV-RLDDDDEGVPSSALRE----ICLLKELKHK 61
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEE 619
++V+L LV+EF + L + ++ ++ +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--THTMIRGTRGYVAPEWFK 677
++H D+KPQN+L++ K+++FGL++ F R + ++ T Y P+
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 678 NVPV-SAKVDVYSFGVTLLEIICCRR 702
+ S +D++S G E+ R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 24/178 (13%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 560
E++G G++G+VYK K +G +A+KK+ RL E E RE +S + +H
Sbjct: 9 EKIGEGTYGVVYKARNKL-TGEVVALKKI-RLDTETEGVPSTAIRE----ISLLKELNHP 62
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAYLHE 618
++V+LL LV+EF+ + L + A L + ++ +GLA+ H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--THTMIRGTRGYVAPE 674
++H D+KPQN+L++ + K++DFGL++ F R TH ++ T Y APE
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV--TLWYRAPE 173
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 53/177 (29%), Positives = 91/177 (51%), Gaps = 24/177 (13%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 560
E++G G++G+VYK G +A+K++ RL E E RE +S + HH
Sbjct: 27 EKVGEGTYGVVYKAKDSQ--GRIVALKRI-RLDAEDEGIPSTAIRE----ISLLKELHHP 79
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEE 619
++V L+ LV+EFM L ++ + +I+ ++ RG+A+ H+
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--THTMIRGTRGYVAPE 674
I+H D+KPQN+L++ + K++DFGL++ F R TH ++ T Y AP+
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV--TLWYRAPD 189
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 560
E+G G++G V+K G +A+K++ R+ E RE + + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAV-LRHLETFEHP 74
Query: 561 HLVQLL----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGL 613
++V+L + +L LV+E + + L + +P+P + ++ RGL
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 614 AYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVA 672
+LH ++H D+KPQNIL+ K++DFGL++ ++S Q T ++ T Y A
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVV--TLWYRA 187
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEII 698
PE + VD++S G E+
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMF 213
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKHLVQLL 566
LG+G+FG V V + A+G A+K L + + + E +E + T H L L
Sbjct: 13 LGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 567 GFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRIRI-SLEIARGLAYLHEE 619
+ + +RL V E+ G L + F R R EI L YLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSR 124
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
+++ DIK +N++LD KI+DFGL K SD + T GT Y+APE ++
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 180
Query: 680 PVSAKVDVYSFGVTLLEIICCR 701
VD + GV + E++C R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 51/175 (29%), Positives = 87/175 (49%), Gaps = 20/175 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 560
E++G G++G+VYK G A+KK+ RL +E E RE +S + H
Sbjct: 8 EKIGEGTYGVVYKAQNNY--GETFALKKI-RLEKEDEGIPSTTIRE----ISILKELKHS 60
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEE 619
++V+L +LV+E + + L L+ ++ + L++ G+AY H+
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
++H D+KPQN+L++ KI+DFGL++ F R +T T Y AP+
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPD 170
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG GSFG V + +A+K + R + + E+S + H H+++L
Sbjct: 17 LGEGSFGKVKLAT-HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYLHE 618
+ ++V E+ G G L + I + R++ + R + Y H
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYIVE--------KKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
I+H D+KP+N+LLD + KI+DFGLS + +D + T G+ Y APE
Sbjct: 127 HK---IVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSC-GSPNYAAPEVING 181
Query: 679 VP-VSAKVDVYSFGVTLLEIIC 699
+VDV+S G+ L ++
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLV 203
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAI---------GRTH 558
E+G G++G VYK SG +A+K + R+ +S +
Sbjct: 15 AEIGVGAYGTVYKARDPH-SGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 559 HKHLVQLL----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIAR 611
H ++V+L+ + ++ LV+E + + L + P P + + R
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGY 670
GL +LH C I+H D+KP+NIL+ + K++DFGL++ ++S Q T ++ T Y
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPVVV--TLWY 185
Query: 671 VAPEWFKNVPVSAKVDVYSFGVTLLEII 698
APE + VD++S G E+
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMF 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 39/285 (13%), Positives = 78/285 (27%), Gaps = 52/285 (18%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKHLVQ 564
G ++ + TA +A+ +D L + +E S + R + +
Sbjct: 37 IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
+L L+V E++ G+L + P P IR +A H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG--AIRAMQSLAAAADAAHRA---GV 150
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
P + +S G L + + +
Sbjct: 151 ALSIDHPSRVR--------VSIDGDVVL-------------AYPATMP-------DANPQ 182
Query: 685 VDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744
D+ G +L ++ +R L + +
Sbjct: 183 DDIRGIGASLYALL------------VNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR 230
Query: 745 RLHKWL-MIAMWCIQEDPSKRP--TMKVVLQMLEGLLDVPNPPGP 786
+ + +A +Q D R T+ ++Q + D GP
Sbjct: 231 DIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
LG G+FG V G +G +AVK L+R + + + + E+ + H H+++L
Sbjct: 24 LGVGTFGKVKVGK-HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYLHE 618
+ +V E++ G L + I R+ + +R G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICK--------NGRLDEKESRRLFQQILSGVDYCHR 134
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
++H D+KP+N+LLD +AKI+DFGLS + SD T G+ Y APE
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSC-GSPNYAAPEVISG 189
Query: 679 VP-VSAKVDVYSFGVTLLEIIC 699
+VD++S GV L ++C
Sbjct: 190 RLYAGPEVDIWSSGVILYALLC 211
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGT----AIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
LG+GSFG V+ + S A+ V K L K E + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 566 LGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRIRI-SLEIARGLAYLHE 618
+ + +L L+ +F+ G L + F ++ E+A L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLAELALALDHLHS 144
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
II+ D+KP+NILLD K++DFGLSK + + ++ GT Y+APE
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNR 200
Query: 679 VPVSAKVDVYSFGVTLLEIICCR 701
+ D +SFGV + E++
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGT 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 23/179 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 560
+LG G++G VYK + + +A+K++ RL E E RE VS + H+
Sbjct: 40 TKLGEGTYGEVYKAIDTV-TNETVAIKRI-RLEHEEEGVPGTAIRE----VSLLKELQHR 93
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
++++L L++E+ L + P + ++ G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 621 NVPIIHCDIKPQNILLDHFFSA-----KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
+H D+KPQN+LL ++ KI DFGL++ F R T T Y PE
Sbjct: 153 ---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEIITLWYRPPE 207
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
+G+GSFG V V K + A+K +++ + + R E+ + H LV L
Sbjct: 23 IGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 567 G-FCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRIRISL-EIARGLAYLHE 618
F DE + +V + + G L + F +++ + E+ L YL
Sbjct: 82 YSFQDE--EDMFMVVDLLLGGDLRYHLQQNVHFKEE------TVKLFICELVMALDYLQN 133
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
+ IIH D+KP NILLD I+DF ++ + +++ TM GT+ Y+APE F +
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAA-MLPRETQITTMA-GTKPYMAPEMFSS 188
Query: 679 VPV---SAKVDVYSFGVTLLEIICCRR 702
S VD +S GVT E++ RR
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 19/202 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
+GRG+FG V V + A+K L + + E F+ E + K + L
Sbjct: 82 IGRGAFGEVAV-VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 567 G-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYLHEECNVP 623
F D+ N L LV ++ G L L+ R L E+ + +H+
Sbjct: 141 YAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--- 195
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVS 682
+H DIKP NIL+D +++DFG L D + ++ + GT Y++PE + +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGG 254
Query: 683 AK-----VDVYSFGVTLLEIIC 699
D +S GV + E++
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLY 276
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER-EREFKSEVSAIGR--THHKHLVQ 564
+LGRG + V++ + + + VK L + +++ +RE K I +++
Sbjct: 42 RKLGRGKYSEVFEAI-NITNNEKVVVKILKPVKKKKIKREIK-----ILENLRGGPNIIT 95
Query: 565 LLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLAYLHEECN 621
L D LV+E + N L + D IR + EI + L Y H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD----IRFYMYEILKALDYCHSMG- 150
Query: 622 VPIIHCDIKPQNILLDHFFSA-KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP 680
I+H D+KP N+++DH ++ D+GL++ Q + +R + PE +
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQ 206
Query: 681 V-SAKVDVYSFGVTLLEII 698
+ +D++S G L +I
Sbjct: 207 MYDYSLDMWSLGCMLASMI 225
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 68/221 (30%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKHLVQL 565
LG+GSFG V + + AVK L D + Q+ + E E + L QL
Sbjct: 28 LGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 566 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRIRI-SLEIARGLAYLHE 618
C + ++RL V E++ G L F P + EIA GL +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIGLFFLQS 139
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
+ II+ D+K N++LD KI+DFG+ K D T T GT Y+APE
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAY 195
Query: 679 VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTD 718
P VD ++FGV L E++ + E E E+E ++I+
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 56/176 (31%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE--FKS----EVSAIGRTHHKH 561
+ LG G F VYK K + +A+KK+ +L E + E+ + H +
Sbjct: 16 DFLGEGQFATVYKARDKN-TNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEEC 620
++ LL N LV++FM L +I I+ L +GL YLH+
Sbjct: 74 IIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--THTMIRGTRGYVAPE 674
I+H D+KP N+LLD K++DFGL+K F +R TH ++ TR Y APE
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVV--TRWYRAPE 182
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 510 LGRGSFGIVY---KGVLKTASGTAIAVK---KLDRLAQEREREF-KSEVSAIGRTHHKHL 562
LG+G +G V+ K +G A+K K + ++ K+E + + H +
Sbjct: 25 LGKGGYGKVFQVRKVTGA-NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 563 VQLLGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRIRI-SLEIARGLAY 615
V L+ + + +L L+ E++ G L IF EI+ L +
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAEISMALGH 136
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
LH++ II+ D+KP+NI+L+H K++DFGL K D + THT GT Y+APE
Sbjct: 137 LHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEI 192
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCR 701
+ VD +S G + +++
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 3e-18
Identities = 68/221 (30%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKHLVQL 565
LG+GSFG V + + AVK L D + Q+ + E E + L QL
Sbjct: 349 LGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 566 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRIRI-SLEIARGLAYLHE 618
C + ++RL V E++ G L F P + EIA GL +L
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIGLFFLQS 460
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
+ II+ D+K N++LD KI+DFG+ K D T T GT Y+APE
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAY 516
Query: 679 VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTD 718
P VD ++FGV L E++ + E E E+E ++I+
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 49/239 (20%), Positives = 92/239 (38%), Gaps = 63/239 (26%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
+ LG GSFGIV + SG A+KK+ + + + RE + H ++++L+
Sbjct: 13 KTLGTGSFGIVCEVFD-IESGKRFALKKVLQDPRYKNRELD----IMKVLDHVNIIKLVD 67
Query: 568 FCDEALNRL--------------------------------------LVYEFMGNGTLAN 589
+ + ++ E++ + TL
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126
Query: 590 LIFAIPKPDWNLRIRISLE--------IARGLAYLHEECNVPIIHCDIKPQNILLD-HFF 640
++ K I + + R + ++H ++ I H DIKPQN+L++
Sbjct: 127 VL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDN 179
Query: 641 SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WFKNVPVSAKVDVYSFGVTLLEII 698
+ K+ DFG +K L + + +R Y APE + +D++S G E+I
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKHLVQL 565
+G+GSFG V A AVK L + +++E + SE + + + H LV L
Sbjct: 46 IGKGSFGKVLL-ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 566 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRIRI-SLEIARGLAYLHE 618
F + ++L V +++ G L F P R R + EIA L YLH
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASALGYLHS 157
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
I++ D+KP+NILLD ++DFGL K S T T GT Y+APE
Sbjct: 158 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHK 213
Query: 679 VPVSAKVDVYSFGVTLLEIICCR 701
P VD + G L E++
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 50/179 (27%), Positives = 91/179 (50%), Gaps = 23/179 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHLV 563
E+LG G++ VYKG+ KT +G +A+K++ +L + E S E+S + H+++V
Sbjct: 11 EKLGNGTYATVYKGLNKT-TGVYVALKEV-KL--DSEEGTPSTAIREISLMKELKHENIV 66
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRIS------LEIARGLAYLH 617
+L LV+EFM + L + + + + ++ ++ +GLA+ H
Sbjct: 67 RLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--THTMIRGTRGYVAPE 674
E I+H D+KPQN+L++ K+ DFGL++ F + ++ T Y AP+
Sbjct: 126 ENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVV--TLWYRAPD 178
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 34/213 (15%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE--REFKSEVSAIGRT-------- 557
+ GS+G V GV G +A+K++ + R
Sbjct: 28 RFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCK-RVLREIRLLN 84
Query: 558 --HHKHLVQLLG----FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EI 609
HH +++ L F + A+++L LV E M LA +I I+ + I
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG 669
GL LHE V +H D+ P NILL I DF L++ +D ++TH + R
Sbjct: 144 LLGLHVLHE-AGV--VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRW 198
Query: 670 YVAPE----WFKNVPVSAKVDVYSFGVTLLEII 698
Y APE + + VD++S G + E+
Sbjct: 199 YRAPELVMQFKGF---TKLVDMWSAGCVMAEMF 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 42/219 (19%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQEREREFKSEVSAIGRTHH--- 559
+LG G F V+ + T +A+K K+ A E E + V+ T
Sbjct: 25 RKLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 560 --KHLVQLLG---FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR-- 611
H+++LL + +V+E +G NL+ I K I L +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLG----ENLLALIKK---YEHRGIPLIYVKQI 136
Query: 612 ------GLAYLHEECNVPIIHCDIKPQNILLDH------FFSAKISDFGLSKLLFSDQSR 659
GL Y+H C IIH DIKP+N+L++ KI+D G +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEII 698
+T TR Y +PE P D++S + E+I
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKHLVQL 565
+GRGS+ V V + A+K + + + + + ++ ++E + ++H LV L
Sbjct: 17 IGRGSYAKVLL-VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 566 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRIRI-SLEIARGLAYLHE 618
C + +RL V E++ G L R S EI+ L YLHE
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHE 128
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
II+ D+K N+LLD K++D+G+ K T T GT Y+APE +
Sbjct: 129 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRG 184
Query: 679 VPVSAKVDVYSFGVTLLEIICCR 701
VD ++ GV + E++ R
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGR 207
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQLL 566
+GRG+FG V V ++ A+K L + + + F E + + +VQL
Sbjct: 77 IGRGAFGEVQL-VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 567 G-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
F D+ L +V E+M G L NL+ P+ R + E+ L +H +
Sbjct: 136 YAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIHS---MGF 189
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSK-LLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IH D+KP N+LLD K++DFG + R T + GT Y++PE K+
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 248
Query: 684 K----VDVYSFGVTLLEIIC 699
D +S GV L E++
Sbjct: 249 YYGRECDWWSVGVFLYEMLV 268
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 55/210 (26%), Positives = 85/210 (40%), Gaps = 33/210 (15%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
+GRG+F V V +G A+K + + + E F+ E + + + QL
Sbjct: 69 IGRGAFSEVAV-VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 567 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR--------GLAYLH 617
F + N L LV E+ G L L+ RI E+AR + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLS-------KFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWF 676
+H DIKP NILLD +++DFG L +D + R+ + GT Y++PE
Sbjct: 180 RLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEIL 235
Query: 677 KNVPVSAKVDVY-------SFGVTLLEIIC 699
+ V Y + GV E+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKHLVQL 565
+GRGS+ V V + A++ + + + + + ++ ++E + ++H LV L
Sbjct: 60 IGRGSYAKVLL-VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 566 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRIRI-SLEIARGLAYLHE 618
C + +RL V E++ G L R S EI+ L YLHE
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHE 171
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
II+ D+K N+LLD K++D+G+ K T T GT Y+APE +
Sbjct: 172 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRG 227
Query: 679 VPVSAKVDVYSFGVTLLEIICCR 701
VD ++ GV + E++ R
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 72/222 (32%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREF-KSE--VSAIGRTHHKHLVQ 564
LG+GSFG V +G AVK L D + Q+ + E +E + ++ +H L Q
Sbjct: 31 LGKGSFGKVML-ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-RNHPFLTQ 88
Query: 565 LLGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRIRI-SLEIARGLAYLH 617
L C + +RL V EF+ G L + F R R + EI L +LH
Sbjct: 89 LF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEIISALMFLH 141
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
++ II+ D+K N+LLDH K++DFG+ K + T T GT Y+APE +
Sbjct: 142 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQ 197
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTD 718
+ VD ++ GV L E++C E E E++ AIL D
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHLV 563
++LG G++ VYKG K + +A+K++ RL E E EVS + H ++V
Sbjct: 8 DKLGEGTYATVYKGKSKL-TDNLVALKEI-RL--EHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIARGLAYLHEECNV 622
L + LV+E++ + L + ++ ++ RGLAY H +
Sbjct: 64 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK-- 120
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
++H D+KPQN+L++ K++DFGL++ S ++T+ T Y P+
Sbjct: 121 -VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPD 170
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQERERE-FKSE--VSAIGRTHHKHLVQ 564
LG+GSFG V+ + A+K L D + + + E E V ++ H L
Sbjct: 25 LGKGSFGKVFL-AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 82
Query: 565 LLGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRIRI-SLEIARGLAYLH 617
+ + L V E++ G L I F + R + EI GL +LH
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIILGLQFLH 135
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFK 677
+ I++ D+K NILLD KI+DFG+ K ++T+T GT Y+APE
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 191
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTD 718
+ VD +SFGV L E++ + + EEE +I D
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
LG GSFG V V SG A+K L ++ + ++ E +E + + LV+L
Sbjct: 49 LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRIRISLEIARGLAYLHEECNVPII 625
+ N +V E++ G + + + I + + + R + +I YLH +I
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHSLD---LI 163
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
+ D+KP+N+L+D +++DFG +K + RT T+ GT +APE + + V
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTL-CGTPEALAPEIILSKGYNKAV 219
Query: 686 DVYSFGVTLLEIIC 699
D ++ GV + E+
Sbjct: 220 DWWALGVLIYEMAA 233
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 35/206 (16%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT----------HH 559
+G G+ GIV +A+KKL R F+++ A R +H
Sbjct: 33 IGSGAQGIVCA-AYDAILERNVAIKKLSRP-------FQNQTHAK-RAYRELVLMKCVNH 83
Query: 560 KHLVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARG 612
K+++ LL E + +V E M ANL I + R+ L ++ G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
+ +LH + IIH D+KP NI++ + KI DFGL++ + T ++ TR Y A
Sbjct: 140 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRA 194
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEII 698
PE + VD++S G + E+I
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMI 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 56/288 (19%), Positives = 95/288 (32%), Gaps = 74/288 (25%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQ 564
+ LG G G V + K + A+K L + R EV R + H+V+
Sbjct: 22 TSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVR 75
Query: 565 LLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAYLHE 618
++ + L+V E + G L + I + R I I + YLH
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 134
Query: 619 ECNVPIIHCDIKPQNILLDHFFSA---KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
N I H D+KP+N+L K++DFG +K Y
Sbjct: 135 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------EKY----- 175
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICC------RRSVEMELEEESRAILTDWAYDCYVEGRL 729
D++S GV ++ I+ C I G+
Sbjct: 176 ------DKSCDMWSLGV-IMYILLCGYPPFYSNHGLAISPGMKTRIR---------MGQY 219
Query: 730 DVLID-----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ S+E K L+ + ++ +P++R T+ +
Sbjct: 220 EFPNPEWSEVSEEV---------KMLIRNL--LKTEPTQRMTITEFMN 256
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 27/201 (13%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
LG GSFG V+ + +G A+K L + + + ++ E E + H ++++
Sbjct: 14 LGTGSFGRVHL-IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 567 G-FCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRIRI-SLEIARGLAYLHE 618
G F D ++ ++ +++ G L +L+ F P + + E+ L YLH
Sbjct: 73 GTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNP------VAKFYAAEVCLALEYLH- 123
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
+ II+ D+KP+NILLD KI+DFG +K T+T+ GT Y+APE
Sbjct: 124 SKD--IIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYTLC-GTPDYIAPEVVST 177
Query: 679 VPVSAKVDVYSFGVTLLEIIC 699
P + +D +SFG+ + E++
Sbjct: 178 KPYNKSIDWWSFGILIYEMLA 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 47/189 (24%), Positives = 88/189 (46%), Gaps = 35/189 (18%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKHLV 563
++G+G+FG V+K + +G +A+KK+ + E+E F E+ + H+++V
Sbjct: 23 AKIGQGTFGEVFKARHRK-TGQKVALKKV-LMENEKE-GFPITALREIKILQLLKHENVV 79
Query: 564 QLLGFCDEALNRL--------LVYEFMGN---GTLANLIFAIPKPDWNLRIR-ISLEIAR 611
L+ C + LV++F + G L+N++ + I+ + +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE----IKRVMQMLLN 135
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR------THTMIR 665
GL Y+H I+H D+K N+L+ K++DFGL++ FS T+ ++
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYTNRVV- 190
Query: 666 GTRGYVAPE 674
T Y PE
Sbjct: 191 -TLWYRPPE 198
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 48/208 (23%), Positives = 79/208 (37%), Gaps = 36/208 (17%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKHL 562
+ +G+GSFG V K +A+K K E + + + ++
Sbjct: 103 KVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 563 VQLLGFCD---------EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIAR 611
+ +L E L+ L YE + +L + + + I +
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNL-YELIKKNKFQGF---------SLPLVRKFAHSILQ 211
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSA--KISDFGLSKLLFSDQSRTHTMIRGTRG 669
L LH+ IIHCD+KP+NILL + K+ DFG S + + +R
Sbjct: 212 CLDALHK-NR--IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF 264
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEI 697
Y APE +D++S G L E+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKH 561
+ +G G+ GIV +A+KKL R A+ RE + +HK+
Sbjct: 68 KPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKN 122
Query: 562 LVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLA 614
++ LL E + LV E M ANL I + R+ L ++ G+
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
+LH + IIH D+KP NI++ + KI DFGL++ + T ++ TR Y APE
Sbjct: 179 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE 233
Query: 675 WFKNVPVSAKVDVYSFGVTLLEII 698
+ VD++S G + E++
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMV 257
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 38/214 (17%)
Query: 510 LGRGSFGIVY--KGVLKTASGTAIAVKKL--DRLAQER--------EREFKSEVSAIGRT 557
LG G++G V+ + + +G A+K L + Q+ ER+ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----- 116
Query: 558 HHKHLVQLLGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRIRI-SLEIA 610
LV L + + +L L+ +++ G L + F ++I EI
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVGEIV 169
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL-LFSDQSRTHTMIRGTRG 669
L +LH+ II+ DIK +NILLD ++DFGLSK + + R + GT
Sbjct: 170 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIE 225
Query: 670 YVAPE--WFKNVPVSAKVDVYSFGVTLLEIICCR 701
Y+AP+ + VD +S GV + E++
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 43/193 (22%), Positives = 77/193 (39%), Gaps = 38/193 (19%)
Query: 507 KEELGRGSFGIVYKGVLK-TASGTAIAVKKLDRLAQEREREFKSEVSAIGRT------HH 559
++GRG++G VYK K A+K++ +SA H
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKH 77
Query: 560 KHLVQLLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIR---------ISLE 608
+++ L F A ++ L++++ + L ++I N + + +
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 609 IARGLAYLHEECNVPIIHCDIKPQNILLDHFFSA----KISDFGLSKLLFSDQSRTHTMI 664
I G+ YLH ++H D+KP NIL+ KI+D G ++ LF+ + +
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADL 192
Query: 665 RG---TRGYVAPE 674
T Y APE
Sbjct: 193 DPVVVTFWYRAPE 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 38/209 (18%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKHL 562
+G+GSFG V K +A+K K + E ++ ++
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 563 VQLLGF-------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWN----LRIR-ISLEIA 610
V L C LV+E + NL + ++ R + ++
Sbjct: 119 VHLKRHFMFRNHLC-------LVFEMLS----YNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 611 RGLAYLH-EECNVPIIHCDIKPQNILLDHFFSA--KISDFGLSKLLFSDQSRTHTMIRGT 667
L +L E + IIHCD+KP+NILL + + KI DFG S + +
Sbjct: 168 TALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQS 221
Query: 668 RGYVAPEWFKNVPVSAKVDVYSFGVTLLE 696
R Y +PE +P +D++S G L+E
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 33/209 (15%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT---------- 557
+G G++G+V + +A+KK+ F+ + RT
Sbjct: 33 SYIGEGAYGMVCS-AYDNLNKVRVAIKKISP--------FEHQTYCQ-RTLREIKILLRF 82
Query: 558 HHKHLVQLLG-FCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARG 612
H++++ + + ++ +V + M L L+ + ++ +I RG
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICY-FLYQILRG 140
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR--GTRGY 670
L Y+H NV +H D+KP N+LL+ KI DFGL+++ D T + TR Y
Sbjct: 141 LKYIHS-ANV--LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 671 VAPEWFKNVPV-SAKVDVYSFGVTLLEII 698
APE N + +D++S G L E++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEML 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 36/208 (17%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKH 561
+G G++G V + SG +A+KKL R A+ RE + H++
Sbjct: 30 THVGSGAYGSVCS-AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLKHMQHEN 84
Query: 562 LVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EIARGLA 614
++ LL LV FM L ++ + +I+ + ++ +GL
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE---KIQYLVYQMLKGLK 140
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
Y+H V +H D+KP N+ ++ KI DFGL++ ++ T TR Y APE
Sbjct: 141 YIHS-AGV--VHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPE 193
Query: 675 ----WFKNVPVSAKVDVYSFGVTLLEII 698
W + VD++S G + E++
Sbjct: 194 VILSWMHY---NQTVDIWSVGCIMAEML 218
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 51/241 (21%), Positives = 89/241 (36%), Gaps = 74/241 (30%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT--------- 557
K +GRGS+G VY + +A+KK++R+ F+ + R
Sbjct: 31 KHLIGRGSYGYVYL-AYDKNTEKNVAIKKVNRM-------FEDLIDCK-RILREITILNR 81
Query: 558 -HHKHLVQLLG-FCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRIRISLE--- 608
++++L + L + +V E + L L + I L
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF----------KTPIFLTEEH 130
Query: 609 -------IARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661
+ G ++HE + IH D+KP N LL+ S K+ DFGL++ + S++
Sbjct: 131 IKTILYNLLLGENFIHE-SGI--IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 662 TMIRG---------------------TRGYVAPE---WFKNVPVSAKVDVYSFGVTLLEI 697
TR Y APE +N + +D++S G E+
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN--YTKSIDIWSTGCIFAEL 245
Query: 698 I 698
+
Sbjct: 246 L 246
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 34/217 (15%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL----DRLAQEREREFKSEVSAIGRTHHKHLV 563
+ LG G G+V+ V +A+KK+ + + RE K I R H ++V
Sbjct: 17 KPLGCGGNGLVFSAV-DNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRLDHDNIV 71
Query: 564 QLL-------------GFCDEALNRL-LVYEFMGNGT-LANLIFAIPKPDWNLRIRISLE 608
++ LN + +V E+M T LAN++ P + + R+ +
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--TDLANVLEQGPLLEEHARL-FMYQ 128
Query: 609 IARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQSRTHTMIR-- 665
+ RGL Y+H NV +H D+KP N+ ++ KI DFGL++++ S +
Sbjct: 129 LLRGLKYIHS-ANV--LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 666 GTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCR 701
T+ Y +P + + +D+++ G E++ +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 49/247 (19%), Positives = 87/247 (35%), Gaps = 81/247 (32%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT--------- 557
+ +G GS+G V + +A+KK+ R F+ + R
Sbjct: 58 RHLIGTGSYGHVCE-AYDKLEKRVVAIKKILR-------VFEDLIDCK-RILREIAILNR 108
Query: 558 -HHKHLVQLLGFC----DEALNRL-LVYEFMGNGT-LANLIFAIPKPDWNLRIRISLE-- 608
+H H+V++L E + L +V E + L R + L
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--SDFKKLF----------RTPVYLTEL 156
Query: 609 --------IARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660
+ G+ Y+H + +H D+KP N L++ S K+ DFGL++ + ++
Sbjct: 157 HIKTLLYNLLVGVKYVHS-AGI--LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 661 HTMIRG--------------------------TRGYVAPE---WFKNVPVSAKVDVYSFG 691
+ TR Y APE +N + +DV+S G
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN--YTEAIDVWSIG 271
Query: 692 VTLLEII 698
E++
Sbjct: 272 CIFAELL 278
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 51/221 (23%), Positives = 87/221 (39%), Gaps = 46/221 (20%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-------- 557
K LG G++G+V +G +A+KK+ F + A+ RT
Sbjct: 15 LKSLLGEGAYGVVCS-ATHKPTGEIVAIKKI--------EPFDKPLFAL-RTLREIKILK 64
Query: 558 --HHKHLVQLLG-FCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRIRISL-EI 609
H++++ + ++ ++ E M L +I D I+ + +
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSD--DHIQYFIYQT 121
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG--- 666
R + LH NV IH D+KP N+L++ K+ DFGL++++ +
Sbjct: 122 LRAVKVLHG-SNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 667 ------TRGYVAPE---WFKNVPVSAKVDVYSFGVTLLEII 698
TR Y APE S +DV+S G L E+
Sbjct: 179 MVEFVATRWYRAPEVMLTSAK--YSRAMDVWSCGCILAELF 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 31/183 (16%)
Query: 603 IRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662
I S ++A+G+ +L IH D+ +NILL KI DFGL++ ++ D
Sbjct: 196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----D 248
Query: 663 MIRGTRGYV-----APEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAI 715
+R + APE + + + DV+SFGV L EI S ++++EE
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308
Query: 716 LTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
L + R+ + +++ M+ W +PS+RPT +++ L
Sbjct: 309 LKE-------GTRMRAPDYTTP-------EMYQ-TMLDCW--HGEPSQRPTFSELVEHLG 351
Query: 776 GLL 778
LL
Sbjct: 352 NLL 354
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 42/153 (27%), Positives = 62/153 (40%), Gaps = 14/153 (9%)
Query: 506 FKEELGRGSFGIVYKGVL----KTASGTAIAVKKLDRLAQERER-EFKSEVS-AIGRTHH 559
+ LGRG+FG V + KTA+ +AVK L A E SE+ I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 560 KHLVQLLGFCDEALNRLLV-YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHE 618
++V LLG C + L+V EF G L+ + + R +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651
+ V I D+K + + S+ S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 33/207 (15%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKH 561
+ +G G++G V + +G +A+KKL R A+ RE + + H++
Sbjct: 31 QPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKHMRHEN 85
Query: 562 LVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAY 615
++ LL + LV FMG L L+ + ++ + ++ +GL Y
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF-LVYQMLKGLRY 143
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE- 674
+H + IH D+KP N+ ++ KI DFGL++ S+ T TR Y APE
Sbjct: 144 IHA-AGI--IHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEV 196
Query: 675 ---WFKNVPVSAKVDVYSFGVTLLEII 698
W + + VD++S G + E+I
Sbjct: 197 ILNWMRY---TQTVDIWSVGCIMAEMI 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 58/235 (24%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR------LAQE--RE----REFKSEVSA 553
++LG+G++GIV+K + +G +AVKK+ AQ RE E
Sbjct: 13 LVKKLGKGAYGIVWK-SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS----- 66
Query: 554 IGRTHHKHLVQLLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIR-ISLEIA 610
H+++V LL + + LV+++M L +I A + + + ++
Sbjct: 67 ----GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEP--VHKQYVVYQLI 119
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRG---- 666
+ + YLH + +H D+KP NILL+ K++DFGLS+ + + T+ +
Sbjct: 120 KVIKYLHS-GGL--LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 667 ----------------TRGYVAPE----WFKNVPVSAKVDVYSFGVTLLEIICCR 701
TR Y APE K + +D++S G L EI+C +
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILCGK 228
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 41/211 (19%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT---------- 557
+G G++G V T +G +AVKKL R F+S + A RT
Sbjct: 35 SPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRP-------FQSIIHAK-RTYRELRLLKHM 85
Query: 558 HHKHLVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIAR 611
H++++ LL E N + LV MG L N++ D +++ + +I R
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
GL Y+H + IIH D+KP N+ ++ KI DFGL++ + + TR Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYR 196
Query: 672 APE----WFKNVPVSAKVDVYSFGVTLLEII 698
APE W + VD++S G + E++
Sbjct: 197 APEIMLNWMHY---NQTVDIWSVGCIMAELL 224
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 47/224 (20%), Positives = 83/224 (37%), Gaps = 52/224 (23%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKHL 562
LG G+FG V + + + +A+K R A E ++ + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 563 VQLLGFCD---------EALNRLLVYEFM-GNGTLANLIFAIPKPDWNLRIR-ISLEIAR 611
V + + + E L + +EF+ N + +P +R ++ ++
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKNT-FEFLKENN---FQPYPLP------HVRHMAYQLCH 134
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSA-------------------KISDFGLSKL 652
L +LHE + H D+KP+NIL + +++DFG +
Sbjct: 135 ALRFLHE-NQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189
Query: 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLE 696
+ HT I TR Y PE + + DV+S G L E
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 51/251 (20%), Positives = 76/251 (30%), Gaps = 70/251 (27%)
Query: 510 LGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQEREREFKSEVSAIGRTH--HKHL 562
LG G F V+ +A+K + E V + +
Sbjct: 45 LGWGHFSTVWL-SWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 563 VQLLG-FCDEALN---RLLVYEFMGNGTLANLIFAIPKPDWNLRI--RISLEIARGLAYL 616
VQLL F +N +V+E +G+ L I L +I ++ +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 617 HEECNVPIIHCDIKPQNILL---------------------------------------- 636
H +C IIH DIKP+NILL
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 637 ---------DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDV 687
KI+D G + + T TR Y + E + D+
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276
Query: 688 YSFGVTLLEII 698
+S E+
Sbjct: 277 WSTACMAFELA 287
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 5e-11
Identities = 29/198 (14%), Positives = 53/198 (26%), Gaps = 53/198 (26%)
Query: 502 ATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKL--------DRLAQEREREFKSEV 551
T+ + E++G G FG V++ + T +A+K + + Q+ E E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD---HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 552 ---------SAIGRTHHKHLVQLL------GFCDEAL----------------------- 573
S + + L G L
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 574 NRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQN 633
++L + G + I ++ LA H D+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGN 192
Query: 634 ILLDHFFSAKISDFGLSK 651
+LL K+ K
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 52/235 (22%), Positives = 83/235 (35%), Gaps = 70/235 (29%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK-----KLDRLAQERE-------REFKSEVSAIG 555
++G G+FG V + AVK K + + E + + I
Sbjct: 41 RKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 556 R-----THHKHLV---QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIR-IS 606
+ ++ H+ + LG +YE + N I+
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPS--------LYEIITR----NNYNGFHIE----DIKLYC 143
Query: 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSA------------------------ 642
+EI + L YL + + + H D+KP+NILLD +
Sbjct: 144 IEILKALNYLRK-MS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 643 -KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLE 696
K+ DFG + + +S H I TR Y APE N+ D++SFG L E
Sbjct: 201 IKLIDFGCA----TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 55/232 (23%), Positives = 85/232 (36%), Gaps = 68/232 (29%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK-----------------KLDRLAQEREREFKSE 550
+ LG G+FG V + + A G +AVK L+ L +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFR 78
Query: 551 VSAIGRT--HHKHLV---QLLGFCDEALNRLLVYEFM-GNGTLANLIFAIPKPDWNLRIR 604
+ HH H+ +LLG Y+F+ NG L F + IR
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGLS--------TYDFIKENGFLP---FRLD------HIR 121
Query: 605 -ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSA-------------------KI 644
++ +I + + +LH + H D+KP+NIL K+
Sbjct: 122 KMAYQICKSVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 645 SDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLE 696
DFG + + H+ + TR Y APE + S DV+S G L+E
Sbjct: 179 VDFGSA----TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.0 bits (136), Expect = 7e-09
Identities = 38/281 (13%), Positives = 75/281 (26%), Gaps = 37/281 (13%)
Query: 13 LLPFLSAANN-ITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLF--LLAIWFNKIP 69
+PF + + +LS+ LSP++ F Q + N + +W
Sbjct: 6 RIPFNGVGTSVLPAYQTLSA---GQYLLSPNQRFKLLL-QGDGNLVIQDNGATVWVANEQ 61
Query: 70 ERTIVWHANGDNPAPRGSTLELTATGLLLKDPGGQAIWDGKPDKNVSDAA-------MLD 122
+ + AP G L D + +W S+ + D
Sbjct: 62 QPFSSTIPLRNKKAP---LAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQD 118
Query: 123 TGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFSNG 182
GN VL + + + + + +L GS LV + + N
Sbjct: 119 DGNIVLVD--SLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNL 176
Query: 183 SLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIVQLPQWSK 242
+ + + T + + VF + + ++ W
Sbjct: 177 VA--------YGPNGAATWNAGTQGKGAV----RAVFQGDGNLVVYGAGNAVL----WHS 220
Query: 243 LIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLP 283
L +G +A + + PT
Sbjct: 221 HTGGHASA-VLRLQANGSIAILDEKPVWARF-GFQPTYRHI 259
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 33/163 (20%), Positives = 72/163 (44%), Gaps = 18/163 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+G GSFG++++G + +A+K A + E+++ G + +
Sbjct: 16 RRIGEGSFGVIFEGT-NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGIPNV 71
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNVP 623
F E L+ +LV + +G +L +L + ++++ + ++ + +HE+
Sbjct: 72 YYFGQEGLHNVLVIDLLGP-SLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 126
Query: 624 IIHCDIKPQNILLDHFFSAK-----ISDFGLSKLLFSDQSRTH 661
+++ DIKP N L+ S + DFG+ K ++ H
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 169
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 34/175 (19%), Positives = 64/175 (36%), Gaps = 25/175 (14%)
Query: 510 LGRGSFGIVYKGV-LKTASGTAIAVKKLDRLAQER-EREFK-----SEVSAIGRTHHKHL 562
+G G FG++Y A V K++ E K ++ I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 563 VQLLGF----------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARG 612
+ LG R +V E +G L + + +++ + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKI--SDFGLSKLLFSDQSRTHTMIR 665
L Y+HE +H DIK N+LL + ++ +D+GLS + + H +
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY-RYCP-NGNHKQYQ 213
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 33/163 (20%), Positives = 73/163 (44%), Gaps = 18/163 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+++G G+FG + G + +A+K + A + E++ + Q+
Sbjct: 15 KKIGCGNFGELRLGK-NLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQV 70
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECNVP 623
F +V E +G +L +L F + ++L+ + I++++ + Y+H +
Sbjct: 71 YYFGPCGKYNAMVLELLGP-SLEDL-FDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--- 125
Query: 624 IIHCDIKPQNILLDHFFSAK-----ISDFGLSKLLFSDQSRTH 661
+I+ D+KP+N L+ + I DF L+K +++ H
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 26/204 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKHLV 563
++G GSFG +Y G A+G +A+K + E + + +
Sbjct: 15 RKIGSGSFGDIYLGT-DIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-----VGIP 68
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECN 621
+ E ++V E +G +L +L F ++L+ + ++ ++ + Y+H +
Sbjct: 69 TIRWCGAEGDYNVMVMELLGP-SLEDL-FNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 622 VPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRTHTMIR------GTRGYVA 672
IH D+KP N L+ I DFGL+K ++ H R GT Y +
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLE 696
+ S + D+ S G L+
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMY 207
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 43/204 (21%), Positives = 81/204 (39%), Gaps = 26/204 (12%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKHLV 563
++G GSFG +Y G + +A+K + + E + + +
Sbjct: 13 RKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGG-----TGIP 66
Query: 564 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEIARGLAYLHEECN 621
+ F E +LV + +G +L +L + +L+ + ++ ++ + ++H +
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS- 123
Query: 622 VPIIHCDIKPQNILLDHFFSAK---ISDFGLSKLLFSDQSRTHTMIR------GTRGYVA 672
+H DIKP N L+ A I DFGL+K + H R GT Y +
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLE 696
+ S + D+ S G L+
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMY 205
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 35/184 (19%), Positives = 66/184 (35%), Gaps = 40/184 (21%)
Query: 510 LGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQEREREFK-----SEVSAIGRTHHK 560
+G+G FG +Y + + S VK E K ++ I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 561 HLVQLLGFC----------DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-------I 603
++ LG + R ++ + G+ L + + N + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY------EANAKRFSRKTVL 155
Query: 604 RISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKI--SDFGLSKLLFSDQSRTH 661
++SL I L Y+HE +H DIK N+LL++ ++ D+GL+ + H
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY-RYCP-EGVH 210
Query: 662 TMIR 665
Sbjct: 211 KAYA 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 29/164 (17%), Positives = 65/164 (39%), Gaps = 26/164 (15%)
Query: 510 LGRGSFGIVYKG-------VLKTASGTAIAVK------KLDRLAQEREREFK-SEVSAIG 555
R + GI+Y+ ++K +L +R K +V+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 556 RTHHKHLV---QLLGF-CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--IRISLEI 609
+ + L+ +GF + R LV +G +L + + PK + R ++++ +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKI--SDFGLSK 651
L +LHE +H ++ +NI +D +++ + +G +
Sbjct: 169 LDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 3e-06
Identities = 55/318 (17%), Positives = 93/318 (29%), Gaps = 76/318 (23%)
Query: 52 LNDNSDLF-------LLAIWFNKIPERTIVWHANGDNP--APRGSTLELTATGLLLKDPG 102
L+ +S LL + + P+ D P + L+ ++D
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQ---------DLPREVLTTNPRRLSIIAESIRD-- 339
Query: 103 GQAIWDGKPDKNVSDAAMLDTGNFVLRASGNN--SDYAWQSFKS----PTDTILPTQILD 156
G A WD N L T ++ +S N + F P +PT +L
Sbjct: 340 GLATWDNWKHVNCDK---LTT---IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL- 392
Query: 157 LGSVLVSRLTETNFSKGRFELHFSNGSLEFIPVA-WPSRFQYKSY--YTSNTYSSNSSES 213
S++ + +++ +LH SL V P Y + +
Sbjct: 393 --SLIWFDVIKSDVMVVVNKLH--KYSL----VEKQPKESTISIPSIYLELKVKLENEYA 444
Query: 214 GHQLVFNESAEIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTN 273
H+ IV + + P D YF G + H KN
Sbjct: 445 LHRS---------IVDHYNIPKTFDSDDLIPPYLDQYF---YSHIG----H-HLKNIEHP 487
Query: 274 QSW--FPTRTLPDAMCRRLIKETGSGTCGFNSYCS----LRNGRPF-CDCPPGHVLVDPN 326
+ F L + I+ + S + L+ +P+ CD DP
Sbjct: 488 ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD-------NDPK 540
Query: 327 Y-RYRGCKPNFWQGCGPD 343
Y R +F +
Sbjct: 541 YERLVNAILDFLPKIEEN 558
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 7e-04
Identities = 94/656 (14%), Positives = 164/656 (25%), Gaps = 218/656 (33%)
Query: 126 FVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETN--FSKG---RFELHFS 180
FV +Y + T+ P+ + + RL N F+K R + +
Sbjct: 82 FV--EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK 139
Query: 181 --NGSLEFIPVAWPSRFQY------KSYYTSNTYSSNSSESGHQLVFNESAEIY-----I 227
LE P K++ + S + ++ F I+
Sbjct: 140 LRQALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQC--KMDFK----IFWLNLKN 191
Query: 228 VKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMC 287
+ ++++ Q KL+ + D + + D H N
Sbjct: 192 CNSPETVLEMLQ--KLLYQIDPNWTSRSD---------HSSNIKLRIHSIQAEL------ 234
Query: 288 RRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHVLV-DPNYRYRGCKPNFWQGCGPDDGS 346
RRL+K +P+ +C +LV N + +
Sbjct: 235 RRLLKS-----------------KPYENC----LLVLL----------NVQ-----NAKA 258
Query: 347 INAQELYEIREFNNVEWPLGDYERLEPSNQTECETSCL---QDCSCAVAIYDGNSCRKKK 403
NA FN C+ L + + +
Sbjct: 259 WNA--------FNL-----------------SCKI--LLTTRFKQVTDFLSAATTTHISL 291
Query: 404 LPLSNGWLRDTG---FSKVLFKVRKGDFPGFSDNSGSKKGRGPLF--LLGAFLLGGSILC 458
S D K L R D P P ++ + G
Sbjct: 292 DHHSMTLTPDEVKSLLLKYL-DCRPQDLPR------EVLTTNPRRLSIIAESIRDGLA-- 342
Query: 459 NAFLLLAILIFFKWRRRKYENNVQDSTTSETNLRFFSYDELKDATDGFKEELGRGSFGIV 518
W K+ N + +T E++L E + F +
Sbjct: 343 ------------TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM---FDR------LSVF 381
Query: 519 YKGVLKTASGTAIAVKKLDRLAQEREREFKSEV-------SAIGR-----THHKHLVQLL 566
I L + + + V S + + T + L
Sbjct: 382 PPSAH-------IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE 434
Query: 567 GFC----DEALNRLLV--YEFMGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHE 618
+ AL+R +V Y IPK +L Y H
Sbjct: 435 LKVKLENEYALHRSIVDHYN-------------IPKTFDSDDL----IPPYLDQYFYSH- 476
Query: 619 ECNVPII--HCDIKPQ--------NILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGT 667
I H + LD F KI + T ++
Sbjct: 477 ------IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY 530
Query: 668 RGYVAPEWFKNVPV-SAKV-DVYSFGVTLLE-IICCRRS--VEMELEEESRAILTD 718
+ Y+ N P V + F + E +IC + + + + L E AI +
Sbjct: 531 KPYI----CDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE 582
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 3e-04
Identities = 16/74 (21%), Positives = 30/74 (40%), Gaps = 8/74 (10%)
Query: 72 TIVWHANGDNPAPRGSTLELTATG-LLLKDPGGQAIWDGKPDKNVSD--AAMLDTGNFVL 128
T VW +N +G L + G ++ D G+++W + + + + GN V+
Sbjct: 38 TSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI 97
Query: 129 RASGNNSDYAWQSF 142
SD W +
Sbjct: 98 Y----GSDI-WSTG 106
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 796 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.76 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.74 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.73 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.64 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.47 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.44 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.4 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.4 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.36 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.29 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.2 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.09 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.02 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.83 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.82 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.76 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.71 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.65 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.64 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.49 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.4 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.31 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.18 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.94 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.85 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.41 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.21 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.15 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.58 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.37 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.24 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.05 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.89 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.69 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.09 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.97 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.14 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 81.81 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=444.31 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=205.8
Q ss_pred HHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.++||+|+||+||+|+++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+....+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45789999999999998642 35789999999877777778999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEee
Q 044281 582 MGNGTLANLIFAI---------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISD 646 (796)
Q Consensus 582 ~~~gsL~~~l~~~---------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 646 (796)
+++|+|.++|... ..++|.++++|+.|||+||+|||+. +||||||||+||||++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence 9999999999753 2588999999999999999999998 899999999999999999999999
Q ss_pred cCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhh
Q 044281 647 FGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCY 724 (796)
Q Consensus 647 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~ 724 (796)
||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+....+
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i-------- 273 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-------- 273 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH--------
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH--------
Confidence 999997654332 23345679999999999999999999999999999999999 89999866544322221
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
..+..... +.....++.+++.+||+.||++||||.||+++|+.+.+.
T Consensus 274 ~~g~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGRELER---------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCCCCC---------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCCCCC---------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 12221111 112234677899999999999999999999999988654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=444.68 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=213.1
Q ss_pred HHHHHHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccc
Q 044281 499 LKDATDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL 573 (796)
Q Consensus 499 l~~~~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 573 (796)
+...+..|.++||+|+||+||+|.+. ..+++.||||+++... ....++|.+|+.++++++|||||+++|+|.++.
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 33344567789999999999999873 2356899999997543 334578999999999999999999999999999
Q ss_pred cceeEEeecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc
Q 044281 574 NRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD 637 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~ 637 (796)
..+|||||+++|+|.++|... ..++|..+++|+.|||+||+|||++ +||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence 999999999999999999643 3578999999999999999999998 899999999999999
Q ss_pred CCCcEEEeecCCcccccCCC-CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHH
Q 044281 638 HFFSAKISDFGLSKLLFSDQ-SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAI 715 (796)
Q Consensus 638 ~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~ 715 (796)
+++++||+|||+|+...... ........||+.|||||++.++.++.++|||||||+||||+| |+.||......+....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999999765433 223345679999999999999999999999999999999998 8899987654432221
Q ss_pred HHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 716 LTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+..+..... +......+.+++.+||+.||++||||.||++.|+....
T Consensus 260 --------i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 260 --------IRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp --------HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred --------HHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 222222211 11223567789999999999999999999999997654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=438.89 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=211.2
Q ss_pred hHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.++||+|+||+||+|++.. .+++.||||+++....+..++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 356789999999999998642 3578999999987766777899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC-------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeec
Q 044281 581 FMGNGTLANLIFAI-------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDF 647 (796)
Q Consensus 581 ~~~~gsL~~~l~~~-------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 647 (796)
|+++|+|.++|... ..++|.++++|+.|||+||+|||++ +|+||||||+||||++++.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence 99999999999753 3689999999999999999999998 8999999999999999999999999
Q ss_pred CCcccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhh
Q 044281 648 GLSKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYV 725 (796)
Q Consensus 648 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 725 (796)
|+|+......... .....||+.|||||++.+..++.++|||||||+||||+| |+.||......+.... +.
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~--------i~ 244 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC--------IT 244 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--------HH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------HH
Confidence 9998764433222 223468999999999999999999999999999999999 8999987654432222 12
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 726 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+..... +....+++.+++.+||+.||++||||++|++.|+.+.+
T Consensus 245 ~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 QGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2222111 11223567789999999999999999999999988653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=424.10 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=198.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.++||+|+||+||+|+++ ..||||+++.. ..+..+.|.+|+.++++++|||||+++|+|.+ +..+|||||+
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp CEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 35678999999999999864 35999998642 34456789999999999999999999999865 5689999999
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC-Ccc
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-SRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-~~~ 660 (796)
++|+|.++|... ..+++.++++|+.|||+||+|||++ +||||||||+||||++++++||+|||+|+...... ...
T Consensus 114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 999999999764 5799999999999999999999998 89999999999999999999999999998764432 233
Q ss_pred eeeccCCCcccccccccC---CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 661 HTMIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.....||+.|||||++.+ .+++.++|||||||+||||+||+.||........... ....+.....+.
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~-------~~~~~~~~p~~~--- 260 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF-------MVGRGYASPDLS--- 260 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH-------HHHTTCCCCCST---
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH-------HHhcCCCCCCcc---
Confidence 445679999999999964 4689999999999999999999999976443221111 111111110000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.........+.+++.+||+.||++||||.||+++|+.+.
T Consensus 261 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 261 --KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp --TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred --cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 011123356778999999999999999999999998653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=421.94 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=207.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.++||+|+||+||+|+.+ .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..||||||+++
T Consensus 77 ~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 77 DNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred EEeEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 34567999999999999976 47899999999765555566789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
|+|.+++.. ..+++..+..++.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+..... .....
T Consensus 156 g~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~ 230 (346)
T 4fih_A 156 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 230 (346)
T ss_dssp EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCC
T ss_pred CcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccccc
Confidence 999999976 4689999999999999999999998 999999999999999999999999999997654332 23456
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+. .+....+ . ....
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--------~~~~~~~-~------~~~~ 295 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--------DNLPPRL-K------NLHK 295 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--------HSSCCCC-S------CGGG
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH--------cCCCCCC-C------cccc
Confidence 79999999999999999999999999999999999999998765544322221 1110000 0 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....+.+++.+||+.||++|||+.|+++.
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 23466789999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=419.07 Aligned_cols=249 Identities=24% Similarity=0.232 Sum_probs=202.8
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
+.++||+|+||+||+|+.+ .+|+.||||+++... .+.+|+.++++++|||||++++++.++...+|||||+++|
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eCcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 3467999999999999976 478999999996532 2357999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCcccccCCCCc----c
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQSR----T 660 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~----~ 660 (796)
+|.++|.....+++..+..++.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+.+..+... .
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 9999999888899999999999999999999998 999999999999999987 6999999999987543321 1
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+||+.|||||++.+..++.++|||||||++|||++|+.||......+....+. .+... ...
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--------~~~~~-------~~~ 277 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA--------SEPPP-------IRE 277 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH--------HSCCG-------GGG
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--------cCCCC-------chh
Confidence 234579999999999999999999999999999999999999997654332221111 11100 001
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.+......+.+++.+||+.||++|||+.|+++.|...+
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 11223456778999999999999999999999886543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=408.88 Aligned_cols=247 Identities=27% Similarity=0.410 Sum_probs=197.9
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc----cccceeEE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE----ALNRLLVY 579 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 579 (796)
+.++||+|+||+||+|..+ .+++.||+|++... .....+.|.+|++++++++|||||++++++.+ ....+|||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4567999999999999875 46889999999653 23345689999999999999999999999865 35579999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +.+|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 9999999999999888899999999999999999999997 123999999999999984 79999999999986432
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......+||+.|||||++.+ +++.++|||||||+||||++|+.||........ .......+.....+
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-------~~~~i~~~~~~~~~----- 251 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKPASF----- 251 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------HHHHHTTTCCCGGG-----
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-------HHHHHHcCCCCCCC-----
Confidence 23345679999999999875 699999999999999999999999965432211 11111122111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.....++.+++.+||+.||++|||+.|+++.
T Consensus 252 ---~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 252 ---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112356779999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=415.54 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=199.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccc----cceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL----NRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e~ 581 (796)
+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.++. ..+|||||
T Consensus 7 L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEECSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 457899999999999987 478999999976432 2333456777778899999999999998764 46899999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC-----CCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC-----NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-----~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+++|+|.++|... .++|+.+.+++.|+++||+|||+++ .++|+||||||+||||++++++||+|||+|+.....
T Consensus 83 ~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 83 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 9999999999764 5899999999999999999999862 458999999999999999999999999999976544
Q ss_pred CCc---ceeeccCCCcccccccccCC------CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHh--------HHHHHH
Q 044281 657 QSR---THTMIRGTRGYVAPEWFKNV------PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESR--------AILTDW 719 (796)
Q Consensus 657 ~~~---~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~--------~~l~~~ 719 (796)
... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+......+.. ... ..
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~-~~ 240 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-EE 240 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-HH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH-HH
Confidence 322 22345799999999999764 4678999999999999999998766432110000 000 00
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
......++....-+ +......+....+.+++.+||+.||++||||.||+++|+.+.+
T Consensus 241 ~~~~~~~~~~rp~~---p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 241 MRKVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHTTSCCCCCC---CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCC---CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111111111101 1112234556778899999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=419.79 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=199.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
|.+.++||+|+||+||+|+.+ .+++.||||+++.. .....+.|.+|++++++++|||||++++++.++...||||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp EEEEEEC------CEEEEEET-TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 445678999999999999865 47899999999643 234457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++|+|.++|... ..+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.+.... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 9999999999754 3568889999999999999999998 99999999999999999999999999998763221 1
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+....+ ..+.....
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------~~~~~~~~------- 245 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--------ISGSFPPV------- 245 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHTCCCCC-------
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HcCCCCCC-------
Confidence 223467999999999999999999999999999999999999999876554432222 11221111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+......+.+++.+||+.||++|||+.|+++
T Consensus 246 --~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 --SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122345778999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=412.49 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=208.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||+||+++.+ .+++.||||++++.. ....+.+.+|++++++++|||||++++++.+.+..|||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 456688999999999999976 578999999997532 2345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-c
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-R 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~ 659 (796)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..... .
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999999999999888999999999999999999999998 999999999999999999999999999998754433 2
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....+||+.|||||++.+..++.++||||+||++|||++|+.||......+....+. .+... +
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--------~~~~~--~------ 253 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--------KLEYD--F------ 253 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HTCCC--C------
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------cCCCC--C------
Confidence 3445789999999999999999999999999999999999999998765544332221 11111 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVL 771 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 771 (796)
+.....++.+++.+||+.||++|||++|++
T Consensus 254 --p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 --PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 011234567899999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=424.93 Aligned_cols=260 Identities=27% Similarity=0.344 Sum_probs=209.3
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCC----CCeEEEEEEecchhh-hhHHHHHHHHHHhcccCc-cCccccccccccc-cc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTA----SGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHH-KHLVQLLGFCDEA-LN 574 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~-~~ 574 (796)
..+.+.++||+|+||+||+|.+... .++.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+. ..
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 3455668899999999999987532 346899999976433 345789999999999965 8999999998664 56
Q ss_pred ceeEEeecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC
Q 044281 575 RLLVYEFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH 638 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~ 638 (796)
.+|||||+++|+|.++|+.. ..+++..++.++.|||+||+|||++ +||||||||+|||+++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCC
Confidence 89999999999999999753 3478999999999999999999998 8999999999999999
Q ss_pred CCcEEEeecCCcccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHH
Q 044281 639 FFSAKISDFGLSKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAIL 716 (796)
Q Consensus 639 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l 716 (796)
++.+||+|||+|+.+..+.... .....||+.|||||++.+..++.++|||||||+||||+| |+.||......+.
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~---- 296 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 296 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 9999999999999775544332 334678999999999999999999999999999999998 8999976432211
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 717 TDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
....+.++...... .....++.+++.+||+.||++||||.||+++|+.+++.
T Consensus 297 ---~~~~i~~g~~~~~p---------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 ---FCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp ---HHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 11112222211111 11234677899999999999999999999999987653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=423.00 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=207.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.++||+|+||.||+|+.+ .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||+++
T Consensus 154 ~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 154 DNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EeeeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 34578999999999999976 47899999999765555556789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
|+|.+++.. ..+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... .....
T Consensus 233 G~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~ 307 (423)
T 4fie_A 233 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 307 (423)
T ss_dssp EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCC
T ss_pred CcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccccc
Confidence 999999975 4589999999999999999999998 999999999999999999999999999997654332 23456
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+. .+....+.. ...
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--------~~~~~~~~~-------~~~ 372 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--------DNLPPRLKN-------LHK 372 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--------HSCCCCCSC-------TTS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH--------cCCCCCCcc-------ccc
Confidence 79999999999999999999999999999999999999998765544322221 111111000 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....+.+++.+||+.||++|||+.|+++.
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 23456789999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=398.87 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=192.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||+||+|..+ .+++.||||++++.. ......+.+|++++++++|||||++++++.+.+..++|||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHT-TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CEEEEEEEC---CCEEEEECT-TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 455678999999999999865 478999999996532 2335679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+ +|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+...... .
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~ 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--F 167 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--c
Confidence 99 679999999888999999999999999999999998 99999999999999999999999999998654322 2
Q ss_pred eeeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....||+.|||||++.+..+ +.++||||+||++|||++|+.||......+....+ ..+... +
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i--------~~~~~~--~------ 231 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI--------SNGVYT--L------ 231 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCC--C------
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HcCCCC--C------
Confidence 345679999999999998886 57999999999999999999999876544322222 111111 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 232 --p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 232 --PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01122456789999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=404.05 Aligned_cols=247 Identities=23% Similarity=0.257 Sum_probs=197.7
Q ss_pred HhHHHhhCCCccceEEEEEeeC--CCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+|+||+||+|+... .+++.||||++++.. ......+.+|++++++++|||||++++++.+++..+|||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4566889999999999998642 357899999996532 222346889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 181 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 181 (304)
T ss_dssp CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-
T ss_pred EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-
Confidence 9999999999999888999999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|||||++.+..++.++|||||||++|||++|+.||......+....+. .+... .
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--------~~~~~-~------- 245 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--------KAKLG-M------- 245 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC-C-------
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--------cCCCC-C-------
Confidence 2344679999999999999999999999999999999999999998766554332221 11111 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQ 772 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 772 (796)
+.....++.+++.+||+.||++||| ++|+++
T Consensus 246 --p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 --PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1112345678999999999999998 567764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=390.52 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=184.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccccc---------
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN--------- 574 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--------- 574 (796)
.+.+.||+|+||+||+|+.+ .+++.||||+++... ....+.+.+|++++++++|||||++++++.+.+.
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred EEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 44578999999999999875 478999999996533 3345679999999999999999999999865443
Q ss_pred ---ceeEEeecCCCCHHHHHhcCCCC---chhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecC
Q 044281 575 ---RLLVYEFMGNGTLANLIFAIPKP---DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFG 648 (796)
Q Consensus 575 ---~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfG 648 (796)
.++||||+++|+|.+++.....+ ++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence 68999999999999999876543 4566889999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCc-----------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHH
Q 044281 649 LSKLLFSDQSR-----------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILT 717 (796)
Q Consensus 649 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~ 717 (796)
+|+.+...... .....+||+.|||||++.+..++.++|||||||++|||++ ||....... ..+.
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~--~~~~ 238 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV--RTLT 238 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--HHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH--HHHH
Confidence 99977543321 1233579999999999999999999999999999999996 775432211 1111
Q ss_pred HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+. ........+..++.+||+.||++|||+.|+++.
T Consensus 239 -----~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 -----DVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -----HHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----HHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111 011222345678999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=391.06 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=203.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccc------cccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDE------ALNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 575 (796)
+.+.++||+|+||+||+|+.+ .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. ....
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRR-LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred eEEEEEEecccCeEEEEEEEC-CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 445678999999999999875 578999999996532 2345678899999999999999999998753 4678
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
||||||++ |+|.+++.....+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 99999996 68999999888999999999999999999999998 999999999999999999999999999987643
Q ss_pred CC---CcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc-----
Q 044281 656 DQ---SRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE----- 726 (796)
Q Consensus 656 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~----- 726 (796)
.. .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+.........+
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 32 2233456899999999998875 56999999999999999999999998776555444332221110000
Q ss_pred --Cccceeccc------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 --GRLDVLIDS------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 --~~~~~~~d~------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......+.. ............++.+++.+||+.||++|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 00000001123467789999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=374.12 Aligned_cols=290 Identities=41% Similarity=0.685 Sum_probs=241.6
Q ss_pred CCccccCHHHHHHHHHhH--HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-hHHHHHHHHHHhcccCccCcccc
Q 044281 489 TNLRFFSYDELKDATDGF--KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKHLVQL 565 (796)
Q Consensus 489 ~~~~~~~~~~l~~~~~~~--~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l 565 (796)
...+.+++.++.....++ .+.||+|+||.||+|..+ +++.||||++...... ....+.+|+.++++++||||+++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 345678888888777655 467999999999999754 5889999999764322 23478999999999999999999
Q ss_pred cccccccccceeEEeecCCCCHHHHHhcCC----CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc
Q 044281 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIP----KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS 641 (796)
Q Consensus 566 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 641 (796)
++++......++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+..+|+||||||+|||+++++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999998653 4899999999999999999999986668999999999999999999
Q ss_pred EEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHH-HHhHHHHHHH
Q 044281 642 AKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEE-ESRAILTDWA 720 (796)
Q Consensus 642 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~-~~~~~l~~~~ 720 (796)
+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..+.
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 999999999987655555555667999999999999999999999999999999999999999754322 1122233455
Q ss_pred HHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 721 YDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 721 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
...........+.+..............+.+++.+||+.||.+|||+.+|+++|++....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 555556666667776666667778889999999999999999999999999999875433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=376.41 Aligned_cols=196 Identities=18% Similarity=0.311 Sum_probs=167.2
Q ss_pred HhHHHhhCCCccceEEEEEeeC--CCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.++||+|+||+||+|+.+. .+++.||||++.... ....+.+|+++++.+ +|||||++++++.+.+..++|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 4456789999999999998653 457899999986532 345688999999988 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC-CcEEEeecCCcccccCCCC-
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF-FSAKISDFGLSKLLFSDQS- 658 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~~~~- 658 (796)
|+++|+|.+++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 999999999984 488999999999999999999998 99999999999999876 8999999999986543221
Q ss_pred --------------------------cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchh
Q 044281 659 --------------------------RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEME 707 (796)
Q Consensus 659 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~ 707 (796)
......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 112345799999999999875 5899999999999999999999999643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=370.69 Aligned_cols=271 Identities=38% Similarity=0.660 Sum_probs=227.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
+.+.||+|+||.||+|..+ +++.||||++........+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred ccceeecCCCeeEEEEEEC--CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 3467999999999999864 58899999997766566778999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC----CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC-Ccc
Q 044281 586 TLANLIFAIP----KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-SRT 660 (796)
Q Consensus 586 sL~~~l~~~~----~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-~~~ 660 (796)
+|.+++.... .+++..++.++.||++||+|||+. +|+||||||+||++++++.+||+|||+++...... ...
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999997643 578999999999999999999998 99999999999999999999999999998654322 222
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ...+.......+.+...+++.....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC-HHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH-HHHHhhhccccccHHHhcChhhccc
Confidence 334558999999999999999999999999999999999999997554332211 2233334444556666666655555
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPN 782 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (796)
........+.+++.+||+.||++|||+.||++.|+.++....
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 667788899999999999999999999999999998776544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=396.01 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=208.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.++||+|+||.||+++.+ .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+....+|||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~-~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 445678999999999999976 5789999999976555566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC--CcEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF--FSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~--~~~kl~DfGla~~~~~~~~~~ 660 (796)
+|+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+... ..
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~ 312 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QS 312 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--SE
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--Cc
Confidence 99999998654 5789999999999999999999998 99999999999999854 89999999999976433 23
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+||+.|||||++.+..++.++||||+||++|||++|+.||......+....+. .+... +....
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~--------~~~~~--~~~~~--- 379 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK--------SCDWN--MDDSA--- 379 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--------TTCCC--CCSGG---
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH--------hCCCC--CCccc---
Confidence 445679999999999999999999999999999999999999998766554332221 11110 01000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||++|||+.|++++
T Consensus 380 -~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 -FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123456789999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=393.40 Aligned_cols=246 Identities=22% Similarity=0.254 Sum_probs=197.9
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHH---HHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---ERER---EFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~---~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
.+.++||+|+||+||+++.+ .+|+.||||++++... .... ....++.+++.++|||||++++++.+...+|||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 35578999999999999976 5789999999975321 1222 334456777888999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||++||+|.++|.....+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+.+....
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 99999999999999888999999999999999999999998 99999999999999999999999999998764432
Q ss_pred cceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 659 RTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
....+||+.|||||++.. ..|+.++|+|||||++|||++|+.||............ . ........
T Consensus 347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~-~----~i~~~~~~------- 412 (689)
T 3v5w_A 347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-R----MTLTMAVE------- 412 (689)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH-H----HHHHCCCC-------
T ss_pred --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-H----hhcCCCCC-------
Confidence 234579999999999964 57999999999999999999999999765332211111 0 01111110
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQ 772 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 772 (796)
.+.....++.+++.+||+.||.+|++ +.||++
T Consensus 413 ---~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 ---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01112345678999999999999998 677764
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=353.87 Aligned_cols=227 Identities=19% Similarity=0.245 Sum_probs=180.6
Q ss_pred hhccccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCC-----CcEEE
Q 044281 16 FLSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPR-----GSTLE 90 (796)
Q Consensus 16 ~~~~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~-----~s~l~ 90 (796)
++++.|+|++|++|++ +++|+|++|+|+||||+++ ++|| |+ |++ |||+||||+|+.+ +++|+
T Consensus 10 ~~~~~~~l~~g~~l~~---~~~l~S~~g~F~lgf~~~~----~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~ 76 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSA---GQYLLSPNQRFKLLLQGDG----NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAP 76 (276)
T ss_dssp CCTTSSEECTTEEBCT---TCEEECTTSSEEEEECTTS----CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCC
T ss_pred ccccCCEecCCCEecC---CCEEEcCCCcEEEEEECCC----CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEE
Confidence 4567799999999985 5789999999999999432 3777 87 778 9999999999976 56899
Q ss_pred EecCc-eEE--ECCCCCeeeecCCCC-------ccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCcc----cc
Q 044281 91 LTATG-LLL--KDPGGQAIWDGKPDK-------NVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQI----LD 156 (796)
Q Consensus 91 l~~~g-l~l--~~~~~~~vWst~~~~-------~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~k----l~ 156 (796)
|+.+| |+| .|++|++||+++... +++.|+|+|+|||||++ +.+|||| ||||||||||| |.
T Consensus 77 l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~----~~~lWqS--~ptdtlLpg~~~~~~l~ 150 (276)
T 3m7h_A 77 LAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD----SLALWNG--TPAIPLVPGAIDSLLLA 150 (276)
T ss_dssp SEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE----EEEEEES--CTTSCCCCSCTTCEEEC
T ss_pred EeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC----CceeeCc--ccccccccccccccccc
Confidence 99999 888 788899999987532 34679999999999986 5689999 99999999999 77
Q ss_pred CcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcceeEEeccceEEEEecCceee
Q 044281 157 LGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIV 235 (796)
Q Consensus 157 ~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (796)
.|++| ++.+||++|.|+++++ +|+++++ ... ...||+++++... . ..+.++..|.+.++.+++..+
T Consensus 151 ~g~~L---~S~~dps~G~fsl~l~~dGnlvLy--~~~----~~~yW~Sgt~~~~---~-~~l~l~~dGnLvl~d~~~~~v 217 (276)
T 3m7h_A 151 PGSEL---VQGVVYGAGASKLVFQGDGNLVAY--GPN----GAATWNAGTQGKG---A-VRAVFQGDGNLVVYGAGNAVL 217 (276)
T ss_dssp SSEEE---CTTCEEEETTEEEEECTTSCEEEE--CTT----SSEEEECCCTTTT---C-CEEEECTTSCEEEECTTSCEE
T ss_pred cCccc---ccCCCCCCceEEEeecCCceEEEE--eCC----CeEEEECCCCCCc---c-EEEEEcCCCeEEEEeCCCcEE
Confidence 88888 5678999999999998 7766653 211 2689999998652 2 567888888888777665433
Q ss_pred eccccccccCCCceeEEEEEccCCcEEEEecCCCCCCCcceeEEEecCCc
Q 044281 236 QLPQWSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDA 285 (796)
Q Consensus 236 ~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~~~~~~~~~~~W~~~~~~p~~ 285 (796)
-..... . ...+|++|+.||++++|.| ...|..++.+|+.
T Consensus 218 WsS~t~---~--~~~~rl~Ld~dGnLvly~~------~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 218 WHSHTG---G--HASAVLRLQANGSIAILDE------KPVWARFGFQPTY 256 (276)
T ss_dssp EECSCT---T--CTTCEEEECTTSCEEEEEE------EEEEESSSCCTTS
T ss_pred EEecCC---C--CCCEEEEEcCCccEEEEcC------CCeEEccCccCCc
Confidence 222111 1 1247999999999999998 2468888888875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=362.01 Aligned_cols=261 Identities=30% Similarity=0.478 Sum_probs=200.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.+.||+|+||+||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 39 y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred ceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 34557899999999999975 47899999986532 34456899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC---CchhHHHHHHHHHHHHhhHhhhcCCCC--eeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 582 MGNGTLANLIFAIPK---PDWNLRIRISLEIARGLAYLHEECNVP--IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~---~~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+++++|.+++..... +++..++.++.||+.||+|||+. + |+||||||+|||+++++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999999987653 88999999999999999999998 7 999999999999999999999999999864332
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. ........
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~~~~~~---- 260 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-------FKCKRLEI---- 260 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-------HSCCCCCC----
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hcCCCCCC----
Confidence 2 22334568999999999999999999999999999999999999998665443222110 01110110
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCCCCC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPS 787 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp~p~ 787 (796)
+......+.+++.+||+.||.+|||+.+|++.|+.+++...||.+.
T Consensus 261 -----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 261 -----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred -----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 1112245778999999999999999999999999988877776554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=359.52 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=208.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||+||++... .+++.||+|++........+.|.+|++++++++||||+++++++.++...++||||+++
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEECCSSEEEEEEEET-TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eccceecCCCCEEEEEEEEC-CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 34578999999999999875 46889999999776667778999999999999999999999999999999999999999
Q ss_pred CCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc---
Q 044281 585 GTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT--- 660 (796)
Q Consensus 585 gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~--- 660 (796)
++|.+++.. ...+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 92 GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 999999987 46789999999999999999999998 89999999999999999999999999998764433211
Q ss_pred ----------eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 661 ----------HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 661 ----------~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+............
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------------- 234 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------------- 234 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------------
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------------
Confidence 11456999999999999999999999999999999999999887643221110000
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
..........+......+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 235 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 235 -NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000000000111222456779999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=359.91 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=209.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCC--CCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|..... .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+....++|||
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence 44557899999999999987532 3457999999764 33445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 99999999999765 5789999999999999999999998 8999999999999999999999999999976544322
Q ss_pred c--eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 660 T--HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 660 ~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+....
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--------~~~~~~~----- 274 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRLP----- 274 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------HTTCCCC-----
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--------HcCCCCC-----
Confidence 2 223346778999999999999999999999999999999 99999765544322211 1111000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~p 783 (796)
.+......+.+++.+||+.||++|||+.+|+++|+.++..+..
T Consensus 275 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 275 ----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 1112235677899999999999999999999999998765443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=363.34 Aligned_cols=256 Identities=26% Similarity=0.353 Sum_probs=208.1
Q ss_pred HhHHHhhCCCccceEEEEEeeC------CCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT------ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 575 (796)
+.+.+.||+|+||.||+|.... .++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+....
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 3456789999999999998642 345789999997643 34457899999999999 899999999999999999
Q ss_pred eeEEeecCCCCHHHHHhcCC----------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC
Q 044281 576 LLVYEFMGNGTLANLIFAIP----------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~ 639 (796)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence 99999999999999997643 468899999999999999999998 99999999999999999
Q ss_pred CcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHH
Q 044281 640 FSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILT 717 (796)
Q Consensus 640 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~ 717 (796)
+.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~-- 317 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-- 317 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH--
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--
Confidence 9999999999987644332 22233457889999999999999999999999999999999 9999876543322111
Q ss_pred HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
...+..... +......+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 318 ------~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 318 ------LKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ------HHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112211111 11223467789999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=350.21 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=210.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||++... .+++.||+|.+... .....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 345578999999999999865 46889999998432 23445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 999999999998888899999999999999999999998 89999999999999999999999999998765444334
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.... .. ...... ....
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-------~~-~~~~~~-----~~~~ 235 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK-------HI-QDSVPN-----VTTD 235 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-------HH-SSCCCC-----HHHH
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------Hh-hccCCC-----cchh
Confidence 4456699999999999999999999999999999999999999986654332111 01 111110 0011
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHcCcCCCCCCCC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVLQMLEGLLDVPNPPGP 786 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~evl~~L~~~~~~~~pp~p 786 (796)
........+.+++.+||+.||++|| +++++.+.|+.++.......+
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 1122335677899999999999999 999999999988766554443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.86 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=205.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||+||+|... .+++.||||++........+.+.+|+.++++++||||+++++++......++||||+++
T Consensus 23 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 23 TRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp CCCEEEEEETTEEEEEEEBT-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 34578999999999999864 46899999999766555667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 102 ~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 176 (297)
T 3fxz_A 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (297)
T ss_dssp CBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCC
T ss_pred CCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCc
Confidence 9999999765 588899999999999999999998 999999999999999999999999999987654333 23345
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+. ..+.. ... .+..
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-------~~~~~-~~~-------~~~~ 241 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------TNGTP-ELQ-------NPEK 241 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HHCSC-CCS-------CGGG
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCC-CCC-------Cccc
Confidence 69999999999999999999999999999999999999997655433222111 01110 000 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 23456789999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=351.92 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=212.9
Q ss_pred cccCHHHHHHHHHhH------------HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCc
Q 044281 492 RFFSYDELKDATDGF------------KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHH 559 (796)
Q Consensus 492 ~~~~~~~l~~~~~~~------------~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h 559 (796)
+.++++++..++... .+.||+|+||.||+|..+ .+++.||||++........+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 457788888777542 247999999999999875 4689999999976655667789999999999999
Q ss_pred cCcccccccccccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC
Q 044281 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 560 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~ 639 (796)
|||+++++++......++||||+++++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999998865 4689999999999999999999998 99999999999999999
Q ss_pred CcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH
Q 044281 640 FSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW 719 (796)
Q Consensus 640 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~ 719 (796)
+.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~--- 253 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--- 253 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence 9999999999987644322 233456999999999999999999999999999999999999999765443322111
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......... .......+.+++.+||+.||++|||+.++++.
T Consensus 254 -----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 -----RDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -----HHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----hcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111000 11122456779999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=357.18 Aligned_cols=265 Identities=25% Similarity=0.383 Sum_probs=205.8
Q ss_pred HHhHHHhhCCCccceEEEEEe---eCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccccc--cccee
Q 044281 503 TDGFKEELGRGSFGIVYKGVL---KTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLL 577 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 577 (796)
.+.+.+.||+|+||+||++.+ ...+++.||||++........+.+.+|+.++++++||||+++++++... ...++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 345567899999999999985 3356889999999876666678899999999999999999999988543 55799
Q ss_pred EEeecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 578 VYEFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 999999999999998754 589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CC--cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH--------HHHHHHHHhhhc
Q 044281 657 QS--RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA--------ILTDWAYDCYVE 726 (796)
Q Consensus 657 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~--------~l~~~~~~~~~~ 726 (796)
.. .......++..|+|||.+.+..++.++||||||+++|||++|..|+.......... ............
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence 32 22233457778999999999999999999999999999999999886543321110 000011111111
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 727 GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 727 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+... ..+......+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 248 ~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 248 NGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111 0112233567889999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=366.38 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=197.3
Q ss_pred HHhHHHhhCCCccceEEEEEeeC--CCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.+.||+|+||.||+|+++. .++..||||+++.. .....++|.+|+.++++++||||+++++++.+....++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 34456789999999999998652 35678999999754 3344578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++++|.+++.... .+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 9999999999998754 689999999999999999999998 899999999999999999999999999987654332
Q ss_pred cce--eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 659 RTH--TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 659 ~~~--~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+...
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i--------~~~~~~----- 269 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV--------DEGYRL----- 269 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH--------HTTEEC-----
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCC-----
Confidence 221 22335778999999999999999999999999999998 99999765443322111 111100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
..+......+.+++.+||+.||++||++.+|+++|+.++.
T Consensus 270 ----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 270 ----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 0011223567789999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=355.89 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=205.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+++++.++||||+++++++......++||||+
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 34578999999999999865 47899999999653 2344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 97 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~ 171 (328)
T 3fe3_A 97 SGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLD 171 (328)
T ss_dssp TTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GGG
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--ccc
Confidence 9999999998888899999999999999999999998 99999999999999999999999999998664332 234
Q ss_pred eccCCCcccccccccCCCCC-ccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPVS-AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s-~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...||+.|+|||.+.+..+. .++|||||||++|||++|+.||......+....+. .+....
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--------~~~~~~---------- 233 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--------RGKYRI---------- 233 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCCC----------
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCCCC----------
Confidence 45799999999999988875 79999999999999999999998765544332221 111110
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||.+|||+.|+++.
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11123456789999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.18 Aligned_cols=279 Identities=37% Similarity=0.617 Sum_probs=222.1
Q ss_pred CccccCHHHHHHHHHhHH--------HhhCCCccceEEEEEeeCCCCeEEEEEEecch----hhhhHHHHHHHHHHhccc
Q 044281 490 NLRFFSYDELKDATDGFK--------EELGRGSFGIVYKGVLKTASGTAIAVKKLDRL----AQEREREFKSEVSAIGRT 557 (796)
Q Consensus 490 ~~~~~~~~~l~~~~~~~~--------~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l 557 (796)
....|++.++..++.+|. +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.+++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l 87 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence 457899999999998886 4599999999999985 4789999998642 233457899999999999
Q ss_pred CccCcccccccccccccceeEEeecCCCCHHHHHhc---CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCE
Q 044281 558 HHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNI 634 (796)
Q Consensus 558 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NI 634 (796)
+||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Ni 164 (307)
T 2nru_A 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANI 164 (307)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence 999999999999999999999999999999999874 35689999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHh
Q 044281 635 LLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESR 713 (796)
Q Consensus 635 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~ 713 (796)
++++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 9999999999999999876543322 2234568999999998875 5899999999999999999999999764432211
Q ss_pred HHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 714 AILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
..+...... ....+...++... ........+.+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus 244 ~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIED--EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHT--TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhh--hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111110000 0111111222111 1224456678889999999999999999999999998864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=345.98 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=209.0
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.+.||+|+||.||++..+ ++..||+|++..... ..+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred heeeeeeeccCCCceEEEEEec--CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3445678999999999999765 577899999976432 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 9999999997654 589999999999999999999998 999999999999999999999999999987655443333
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.... .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~--~------ 226 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV--------SQGHRLY--R------ 226 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTCCCC--C------
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH--------HcCCCCC--C------
Confidence 34456778999999999999999999999999999999 99999765443322111 1111100 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
+......+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 -PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 011124577899999999999999999999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.33 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=207.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||++... +++.||+|++.... ...+++.+|++++++++||||+++++++.+....++||||++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred ceeeheecCCCccEEEEEEec--CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 345578999999999999875 57789999997643 234679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999764 4689999999999999999999998 8999999999999999999999999999876443322333
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.... .
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~--------~~~~~~~--~------- 228 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFRLY--K------- 228 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HTTCCCC--C-------
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--------hcCccCC--C-------
Confidence 3456788999999999999999999999999999999 89999765544322221 1111000 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+......+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11123457789999999999999999999999988653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=371.80 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=207.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.+.||+|+||.||+|.++ ++..||||+++... ...+.|.+|+.++++++||||+++++++. ....++||||+
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 3455678999999999999875 46889999997643 34678999999999999999999999986 56789999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999999754 3678889999999999999999998 89999999999999999999999999998764322222
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....+|+.|+|||.+....++.++|||||||++|||++ |+.||......+....+ ..+.... .
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i--------~~~~~~~--~----- 406 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ERGYRMP--R----- 406 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--------HHTCCCC--C-----
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCCC--C-----
Confidence 223346788999999999999999999999999999999 99999765444322221 1111000 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCC
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (796)
+......+.+++.+||+.||++|||+.+|+++|+.+....
T Consensus 407 --~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 407 --PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred --CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1122356778999999999999999999999999987543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=352.98 Aligned_cols=267 Identities=25% Similarity=0.359 Sum_probs=203.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccccccc----ceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN----RLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~lv~ 579 (796)
+.+.+.||+|+||+||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++..... .++||
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred chhhheecccCceEEEEEEEC---CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 345678999999999999863 7899999997643 334556779999999999999999999987554 59999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC-------CCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC-------NVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-------~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
||+++|+|.+++... .+++..++.++.||++||+|||+.. ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 102 e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 999999999999764 4899999999999999999999851 23799999999999999999999999999987
Q ss_pred ccCCCCc-ceeeccCCCcccccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH---------HHH
Q 044281 653 LFSDQSR-THTMIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA---------ILT 717 (796)
Q Consensus 653 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~---------~l~ 717 (796)
....... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ...
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 6543322 2233568999999999987 356678999999999999999999986532111000 000
Q ss_pred HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
... ...........+.. ..........+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 261 ~~~-~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 261 DMQ-EVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHH-HHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhh-hhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111 11111111111111 11223455678899999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=376.06 Aligned_cols=256 Identities=27% Similarity=0.374 Sum_probs=210.0
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.++||+|+||.||+|.++ .++..||||.++... ...++|.+|+.++++++||||++++++|.+....++||||+
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 3455678999999999999976 357899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999999999863 4588999999999999999999998 89999999999999999999999999999765433322
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+....+ ..+....
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~-------- 439 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKDYRME-------- 439 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--------HTTCCCC--------
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCCC--------
Confidence 333446788999999999999999999999999999999 88888765433221111 1111000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.+......+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 440 -~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 440 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1112235677899999999999999999999999988643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.25 Aligned_cols=246 Identities=26% Similarity=0.294 Sum_probs=204.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||+||++..+ .+++.||+|++++.. ......+.+|+.+++.++||||+++++++......++||||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 34578999999999999865 468999999997642 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 87 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~ 162 (337)
T 1o6l_A 87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 162 (337)
T ss_dssp CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCB
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Ccc
Confidence 99999999998888899999999999999999999998 99999999999999999999999999998643322 223
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .+... .
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--------~~~~~----------~ 224 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--------MEEIR----------F 224 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC----------C
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH--------cCCCC----------C
Confidence 44569999999999999999999999999999999999999998665443222221 11110 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
+......+.+++.+||+.||++|| ++.||++.
T Consensus 225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111234567899999999999999 89999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.46 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=209.2
Q ss_pred hHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.||+|+||.||+|.... .+++.||||.++... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 129 (343)
T 1luf_A 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 129 (343)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence 445789999999999999864 345899999997643 344578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcC------------------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEE
Q 044281 580 EFMGNGTLANLIFAI------------------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635 (796)
Q Consensus 580 e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIl 635 (796)
||+++++|.+++... ..+++..++.++.||++||+|||++ +|+||||||+|||
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl 206 (343)
T 1luf_A 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 206 (343)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEE
Confidence 999999999999763 4688899999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHh
Q 044281 636 LDHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESR 713 (796)
Q Consensus 636 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~ 713 (796)
+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 286 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH
Confidence 99999999999999987643322 22234557899999999999999999999999999999999 99999765543322
Q ss_pred HHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCC
Q 044281 714 AILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781 (796)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (796)
.. ...+...... ......+.+++.+||+.||++|||+.+|+++|+++.+..
T Consensus 287 ~~--------~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 287 YY--------VRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HH--------HHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HH--------HhCCCcCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 21 1222221111 112346778999999999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=361.66 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=205.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||+|..+ .+++.||||.++... ......|.+|++++++++||||+++++++......++||||+
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEEeeEeccCCCCeEEEEEEe-cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 345678999999999999976 367899999997542 233457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 195 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 195 QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 999999999764 3688999999999999999999998 899999999999999999999999999986433211111
Q ss_pred -eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 662 -TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 662 -~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
....+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+ ..+.....
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~~------- 336 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV--------EKGGRLPC------- 336 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH--------HTTCCCCC-------
T ss_pred CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCCCC-------
Confidence 12235678999999999999999999999999999998 89998765443322211 11111100
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 337 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 337 --PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1112345778999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.08 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=203.3
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCC------CeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTAS------GTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
.+.+.+.||+|+||.||+|..+... +..||+|.+........+.+.+|+.++++++||||+++++++.+....+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 3445678999999999999876432 1579999998776667788999999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCC-CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc--------EEEeec
Q 044281 577 LVYEFMGNGTLANLIFAIPK-PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS--------AKISDF 647 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~--------~kl~Df 647 (796)
+||||+++++|.+++..... +++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999987654 88999999999999999999998 8999999999999998887 999999
Q ss_pred CCcccccCCCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc
Q 044281 648 GLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 726 (796)
Q Consensus 648 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 726 (796)
|++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+............ .. ..
T Consensus 166 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~---~~---~~ 234 (289)
T 4fvq_A 166 GISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF---YE---DR 234 (289)
T ss_dssp CSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HH---TT
T ss_pred cccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH---hh---cc
Confidence 99975422 223457889999999987 77999999999999999999976555433222211111 00 00
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCC
Q 044281 727 GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPP 784 (796)
Q Consensus 727 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp 784 (796)
..... .....+.+++.+||+.||++|||+.++++.|+.++....++
T Consensus 235 ~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 235 HQLPA------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp CCCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred CCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 11110 01234667999999999999999999999999987644433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.91 Aligned_cols=264 Identities=26% Similarity=0.333 Sum_probs=213.4
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeC------CCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCccccccccccc
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKT------ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEA 572 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 572 (796)
...+.+.+.||+|+||.||+|.... ..+..||||++.... ......+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3445566889999999999998642 234689999997643 34457899999999999 999999999999999
Q ss_pred ccceeEEeecCCCCHHHHHhcCC----------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE
Q 044281 573 LNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL 636 (796)
Q Consensus 573 ~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll 636 (796)
...++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999997653 488999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhH
Q 044281 637 DHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRA 714 (796)
Q Consensus 637 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~ 714 (796)
++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987654332 22233457889999999999999999999999999999999 999987655443222
Q ss_pred HHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCC
Q 044281 715 ILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPP 784 (796)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp 784 (796)
.+ ..+..... +......+.+++.+||+.||++|||+.+|++.|+.++......
T Consensus 305 ~~--------~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 305 LL--------KEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HH--------HTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HH--------HcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 11 11111111 1112346778999999999999999999999999877654433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=351.55 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=205.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh------hHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE------REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
+.+.+.||+|+||.||++..+ .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 345678999999999999875 46899999999653321 34689999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC----cEEEeecCCcccc
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF----SAKISDFGLSKLL 653 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~DfGla~~~ 653 (796)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++ .+||+|||+++..
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999998888899999999999999999999998 999999999999998877 7999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+....+. .+... +
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~--------~~~~~--~ 237 (361)
T 2yab_A 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--------AVSYD--F 237 (361)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--------TTCCC--C
T ss_pred CCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hcCCC--C
Confidence 4422 2334569999999999999999999999999999999999999998765444322221 11110 0
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+... .......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 238 DEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 0112345678999999999999999999885
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=368.60 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=203.4
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.++||+|+||.||+|.++ ++..||||+++... ...++|.+|+.++++++||||+++++++.+ ...++||||+
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 3445678999999999999875 45789999997643 235689999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999753 4688999999999999999999998 89999999999999999999999999998765433333
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+....+ ..+....
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i--------~~~~~~~-------- 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMP-------- 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--------HTTCCCC--------
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCCC--------
Confidence 334457889999999999999999999999999999999 89998765443322111 1111100
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCC
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~p 783 (796)
.+....+.+.+++.+||+.||++|||+.+|++.|+.+.....|
T Consensus 402 -~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 402 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 0112235677899999999999999999999999998765444
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.37 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=205.3
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.+.||+|+||.||++..+ ++..||+|++..... ..+++.+|++++.+++|+||+++++++.+....++||||+
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3445678999999999999865 577899999976432 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99999999987 45789999999999999999999998 999999999999999999999999999987644332222
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.....
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~~~~-------- 242 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQGLRLYR-------- 242 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTCCCCC--------
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH--------hcccCCCC--------
Confidence 33446788999999999999999999999999999998 99999765544322221 11110000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+......+.+++.+||+.||++|||+.++++.|+.+++
T Consensus 243 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11112457789999999999999999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=346.14 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=205.7
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh------hHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE------REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
.+.+.+.||+|+||.||++..+ .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3455678999999999999875 46889999998653221 3568999999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC----cEEEeecCCccc
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF----SAKISDFGLSKL 652 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~DfGla~~ 652 (796)
+||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++ .+||+|||+++.
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999998888899999999999999999999998 999999999999999887 899999999987
Q ss_pred ccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.. ....
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--------~~~~-- 235 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--------VNYE-- 235 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH--------TCCC--
T ss_pred CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh--------cCCC--
Confidence 64322 22345699999999999999999999999999999999999999976654433222111 0000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
... .........+.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0001123456789999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.87 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=206.5
Q ss_pred HHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 503 TDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
.+.+.+.||+|+||.||+|... ..+++.||||++... .......+.+|+.++++++||||+++++++.+....++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 4456678999999999999853 235678999999653 34455689999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcC-------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC---cEEEeec
Q 044281 578 VYEFMGNGTLANLIFAI-------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF---SAKISDF 647 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Df 647 (796)
||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCC
Confidence 99999999999999753 3578899999999999999999998 999999999999999554 5999999
Q ss_pred CCcccccCCC-CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhh
Q 044281 648 GLSKLLFSDQ-SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYV 725 (796)
Q Consensus 648 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 725 (796)
|+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+....+ .
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i--------~ 300 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV--------T 300 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--------H
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------H
Confidence 9998653322 223334567899999999999999999999999999999998 99999766544322221 1
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 726 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+..... +......+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 301 ~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 301 SGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCC---------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 1111110 11123457789999999999999999999999976544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=353.68 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=198.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCe----EEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGT----AIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.+.||+|+||+||+|.... +++ .||+|.+.... ....++|.+|+.++++++||||+++++++.+.. .++|
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred cccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence 4455789999999999998653 333 46888885432 344678999999999999999999999998754 7899
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
+||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999999874 5789999999999999999999998 99999999999999999999999999998765443
Q ss_pred Cc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 658 SR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 658 ~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+....+ ..+....
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--------~~~~~~~---- 239 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERLP---- 239 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCCCC----
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH--------HcCCCCC----
Confidence 22 2233456889999999999999999999999999999999 99999765433322111 1111000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+......+.+++.+||+.||++||++.+++++|+.+..
T Consensus 240 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 240 -----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -----CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111223467789999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.32 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=194.5
Q ss_pred HHhHHHhhCCCccceEEEEEeeCC--CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.+.||+|+||.||+|..... .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 345567899999999999987532 35679999987533 344567999999999999999999999984 46789999
Q ss_pred eecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 9999999999998654 689999999999999999999998 999999999999999999999999999987654433
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ..+.....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i--------~~~~~~~~----- 238 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLPM----- 238 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCCCCC-----
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH--------HcCCCCCC-----
Confidence 33344457889999999999999999999999999999997 88898765433221111 11111110
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+......+.+++.+||+.||++|||+.++++.|+.++
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 239 ----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122346778999999999999999999999998765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=357.18 Aligned_cols=258 Identities=28% Similarity=0.375 Sum_probs=205.6
Q ss_pred HHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCccccccccccccc-c
Q 044281 503 TDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALN-R 575 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~-~ 575 (796)
.+.+.+.||+|+||.||+|.+. ..+++.||||+++... ....+.+.+|++++.++ +||||+++++++.+... .
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 102 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 102 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence 3445678999999999999853 3456899999997643 33456799999999999 89999999999877554 8
Q ss_pred eeEEeecCCCCHHHHHhcCCC-----------------------------------------------------------
Q 044281 576 LLVYEFMGNGTLANLIFAIPK----------------------------------------------------------- 596 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 596 (796)
++||||+++|+|.+++.....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 999999999999999976532
Q ss_pred -------CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-cceeeccCCC
Q 044281 597 -------PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTR 668 (796)
Q Consensus 597 -------~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~ 668 (796)
+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......+|+
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 78899999999999999999998 899999999999999999999999999987644332 2233456889
Q ss_pred cccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHH
Q 044281 669 GYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLH 747 (796)
Q Consensus 669 ~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 747 (796)
.|+|||++.+..++.++|||||||++|||++ |+.||......+... .....+..... +.....
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~ 323 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-------RRLKEGTRMRA---------PDYTTP 323 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-------HHHHHTCCCCC---------CTTCCH
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-------HHHHcCCCCCC---------CCCCCH
Confidence 9999999999999999999999999999998 999997543222111 11111111111 111224
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 748 KWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 748 ~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+.+++.+||+.||++|||+.+|+++|+.+++
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 57789999999999999999999999988653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=342.44 Aligned_cols=258 Identities=23% Similarity=0.323 Sum_probs=196.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcc--cCccCcccccccccc----ccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR--THHKHLVQLLGFCDE----ALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~----~~~~~l 577 (796)
+.+.+.||+|+||+||+|.. +++.||||++.... ...+..|.+++.. ++||||+++++++.. ....++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE---CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 34557899999999999986 58899999997532 3445555555554 899999999998654 355789
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhh--------hcCCCCeeeCCCCCCCEEEcCCCcEEEeecCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLH--------EECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH--------~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 649 (796)
||||+++|+|.+++.. ..+++..++.++.||+.||+||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999999999954 46899999999999999999999 65 899999999999999999999999999
Q ss_pred cccccCCCCcc---eeeccCCCcccccccccCC------CCCccchhHHHHHHHHHHHhC----------CCCCchhhHH
Q 044281 650 SKLLFSDQSRT---HTMIRGTRGYVAPEWFKNV------PVSAKVDVYSFGVTLLEIICC----------RRSVEMELEE 710 (796)
Q Consensus 650 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~k~DVwS~Gv~l~elltg----------~~p~~~~~~~ 710 (796)
++......... .....||+.|+|||.+.+. .++.++|||||||++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98765433322 2234699999999999876 456799999999999999999 7777543221
Q ss_pred HHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 711 ESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
..... ............... ............+.+++.+||+.||++|||+.+|++.|+++
T Consensus 240 ~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFE--DMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHH--HHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccchh--hhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11000 000001111111111 11122334567888999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=345.62 Aligned_cols=268 Identities=19% Similarity=0.261 Sum_probs=202.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccc----e
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNR----L 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~ 576 (796)
+.+.+.||+|+||.||++... .+++.||||++.... ......+.+|+.++++++||||+++++++...... +
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 345678999999999999865 468999999997532 23346789999999999999999999998776655 9
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||+++++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 9999999999999998888899999999999999999999998 8999999999999999999999999999876443
Q ss_pred CC--cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 657 QS--RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 657 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..... .......
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-------~~~~~~~---- 238 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-------VREDPIP---- 238 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------HHCCCCC----
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------hcCCCCC----
Confidence 22 2223456899999999999999999999999999999999999999866544322111 1111100
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHHcCcCCCCCCCCCcc
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV-VLQMLEGLLDVPNPPGPSSF 789 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e-vl~~L~~~~~~~~pp~p~~~ 789 (796)
...........+.+++.+||+.||++||+..+ +...|........|+.|...
T Consensus 239 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~ 291 (311)
T 3ork_A 239 ---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVL 291 (311)
T ss_dssp ---HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCC
T ss_pred ---cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCccc
Confidence 00111122356778999999999999996555 44566665554444444443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.29 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=204.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh---hHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE---REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.++||+|+||+||+|+.+ .+++.||||++++.... ....+.+|..++..++||||+++++++.+....++||||+
T Consensus 78 ~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 3467999999999999976 46889999999763322 2234889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 157 ~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 157 VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 99999999987 46789999999999999999999998 899999999999999999999999999987655544444
Q ss_pred eeccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 662 TMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+....... ......
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----~~p~~~--- 306 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----QFPTQV--- 306 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CCCSSC---
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc----cCCccc---
Confidence 4567999999999997 5678999999999999999999999998766554433332211110 000000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~ 773 (796)
......+.+++.+||+.+|++ ||+++|+++.
T Consensus 307 ------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 307 ------TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ------ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 012245677899999888888 9999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.28 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=205.8
Q ss_pred HHHhHHHhhCCCccceEEEEEe---eCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccc--ccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVL---KTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNR 575 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 575 (796)
..+.+.+.||+|+||.||++.+ ...+++.||||++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3345567899999999999984 23468999999997533 33457899999999999999999999999776 667
Q ss_pred eeEEeecCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 576 LLVYEFMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 999999999999999954 45789999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC--cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH-------HHHHHHHHhhh
Q 044281 655 SDQS--RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA-------ILTDWAYDCYV 725 (796)
Q Consensus 655 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~-------~l~~~~~~~~~ 725 (796)
.... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+.......... ...........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 4432 22234557888999999999999999999999999999999999865432211100 00000011111
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 726 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.+... ..+......+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 258 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11110 011223356788999999999999999999999998765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.10 Aligned_cols=267 Identities=20% Similarity=0.275 Sum_probs=206.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccc--cceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL--NRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 580 (796)
+.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 345578999999999999876 468899999997643 234567889999999999999999999987655 6789999
Q ss_pred ecCCCCHHHHHhcCC---CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE----cCCCcEEEeecCCcccc
Q 044281 581 FMGNGTLANLIFAIP---KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSKLL 653 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~DfGla~~~ 653 (796)
|+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999998653 389999999999999999999998 99999999999999 78888999999999876
Q ss_pred cCCCCcceeeccCCCccccccccc--------CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH-hHHHHHHHHHhh
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFK--------NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES-RAILTDWAYDCY 724 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~-~~~l~~~~~~~~ 724 (796)
.... ......||+.|+|||.+. +..++.++|||||||++|||++|+.||........ ...+.......
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 243 (319)
T 4euu_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK- 243 (319)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC-
T ss_pred CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC-
Confidence 4433 223456899999999986 57889999999999999999999999974322111 11111111111
Q ss_pred hcCccceec-----------cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 725 VEGRLDVLI-----------DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 725 ~~~~~~~~~-----------d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.......+. +..............+..++.+||+.||++|||+.|+++.....
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 001111000 00111123355667788899999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.56 Aligned_cols=247 Identities=27% Similarity=0.336 Sum_probs=201.2
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 578 (796)
.+.+.+.||+|+||+||+++.+ .+++.||||++++.. ....+.+.+|..++..+ +||||+++++++.+....++|
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 3455678999999999999876 468899999997642 23456788999999988 799999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 99999999999998888899999999999999999999998 99999999999999999999999999998543222
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+...
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--------~~~~~-------- 242 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--------NDEVV-------- 242 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC--------
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--------cCCCC--------
Confidence 23344579999999999999999999999999999999999999998766544332221 11111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTM------KVVLQ 772 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~------~evl~ 772 (796)
.+......+..++.+||+.||++||++ .++++
T Consensus 243 --~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 --YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011123456779999999999999998 67764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=344.79 Aligned_cols=256 Identities=27% Similarity=0.372 Sum_probs=208.1
Q ss_pred HhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.+.||+|+||.||++.... .+++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 4455789999999999998632 345899999997533 34457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCC------------------------CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCE
Q 044281 579 YEFMGNGTLANLIFAIPK------------------------PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNI 634 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~------------------------~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NI 634 (796)
|||+++++|.+++..... +++..++.++.||++||+|||++ +|+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence 999999999999986533 78889999999999999999998 899999999999
Q ss_pred EEcCCCcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHH
Q 044281 635 LLDHFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEES 712 (796)
Q Consensus 635 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~ 712 (796)
++++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999876443322 2223457888999999999999999999999999999999 9999876543322
Q ss_pred hHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 713 RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
...+ ..+..... +......+.+++.+||+.||++|||+.++++.|++++.
T Consensus 262 ~~~~--------~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 262 FNLL--------KTGHRMER---------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHHH--------HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh--------hcCCcCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111 11111111 11223567789999999999999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=343.61 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=204.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||.||++..+ .+++.+|+|.+... ......+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus 8 ~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 8 MIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred EeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 34578999999999999865 46899999998754 33456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC--CCcEEEeecCCcccccCCCCcce
Q 044281 585 GTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH--FFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 585 gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++..... ...
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~~~ 160 (321)
T 1tki_A 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNF 160 (321)
T ss_dssp CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEE
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--Ccc
Confidence 99999997654 789999999999999999999998 9999999999999987 789999999999876433 233
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||.+.+..++.++|||||||++|||++|..||......+....+. .+... .+.. .
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--------~~~~~--~~~~----~ 226 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM--------NAEYT--FDEE----A 226 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HTCCC--CCHH----H
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH--------cCCCC--CChh----h
Confidence 45568999999999999889999999999999999999999998765443222211 11110 0000 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11123467789999999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=355.22 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=204.9
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.+.+.||+|+||.||++... .+++.+|+|++... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~-~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEET-TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEEEEeccCCCeEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 3455678999999999999865 47899999998643 23445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc---CCCcEEEeecCCcccccCCC
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD---HFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~DfGla~~~~~~~ 657 (796)
|+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++......
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999999999888899999999999999999999998 999999999999998 46889999999998764433
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||......+....+ ..+..... .+ .
T Consensus 168 ~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i--------~~~~~~~~-~~-~ 236 (444)
T 3soa_A 168 Q-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--------KAGAYDFP-SP-E 236 (444)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHTCCCCC-TT-T
T ss_pred c-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH--------HhCCCCCC-cc-c
Confidence 2 233456999999999999999999999999999999999999999776544332222 11111100 00 0
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 237 ----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 237 ----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01123456789999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.38 Aligned_cols=263 Identities=18% Similarity=0.209 Sum_probs=199.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||++... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 345678999999999999865 4688999999975432 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++++|.+++.....+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++..........
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999999999998878899999999999999999999998 89999999999999999999999999998765443333
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ... ... . ..
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~-~~~---~---~~ 256 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI--------NQA-IPR---P---ST 256 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH--------HSC-CCC---G---GG
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh--------ccC-CCC---c---cc
Confidence 44556899999999999999999999999999999999999999865443221111 110 000 0 00
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHcCcCCCCCCC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVLQMLEGLLDVPNPPG 785 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~evl~~L~~~~~~~~pp~ 785 (796)
........+.+++.+||+.||++|| +++++++.|+..+....+..
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 1112234567799999999999999 99999999998877655443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.27 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=209.9
Q ss_pred HHhHHHhhCCCccceEEEEEe---eCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccc--cccccee
Q 044281 503 TDGFKEELGRGSFGIVYKGVL---KTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCD--EALNRLL 577 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~l 577 (796)
.+.+.+.||+|+||.||++.+ ...+++.||||++........+.+.+|++++++++|+||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 344567899999999999985 33568899999998766666778999999999999999999999875 4556789
Q ss_pred EEeecCCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 578 VYEFMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 9999999999999976 35689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCc--ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHH-------HHHHHHhhhcC
Q 044281 657 QSR--THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAIL-------TDWAYDCYVEG 727 (796)
Q Consensus 657 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l-------~~~~~~~~~~~ 727 (796)
... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+............ ..........+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 322 223345788899999999999999999999999999999999998765433211100 00001111111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.. ...+......+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 261 ~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 261 QR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 10 11122234567889999999999999999999999998755
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=349.57 Aligned_cols=251 Identities=26% Similarity=0.338 Sum_probs=205.1
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.+.+.||+|+||.||++..+ .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4556678999999999999875 46889999999643 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC---CcEEEeecCCcccccCCC
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF---FSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~DfGla~~~~~~~ 657 (796)
|+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++......
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999999998888899999999999999999999998 99999999999999865 459999999998764322
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+.... ....
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------~~~~~~~--~~~~ 253 (362)
T 2bdw_A 186 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--------KAGAYDY--PSPE 253 (362)
T ss_dssp --SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCC--CTTG
T ss_pred --ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCCC--Cccc
Confidence 233456999999999999999999999999999999999999999766544322222 1111110 0000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||++|||+.++++.
T Consensus 254 ----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 ----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01123456789999999999999999998864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=347.95 Aligned_cols=251 Identities=24% Similarity=0.285 Sum_probs=201.2
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-----hhHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-----EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
..+.+.+.||+|+||.||++..+ .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 44566788999999999999865 4689999999864321 13578999999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc---EEEeecCC
Q 044281 577 LVYEFMGNGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS---AKISDFGL 649 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~DfGl 649 (796)
+||||+++++|.+.+... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877543 3578999999999999999999998 9999999999999986654 99999999
Q ss_pred cccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcc
Q 044281 650 SKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729 (796)
Q Consensus 650 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (796)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...+..
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---------i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG---------IIKGKY 249 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHH---------HHHTCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHH---------HHcCCC
Confidence 987654322 2334569999999999999999999999999999999999999997653221111 111111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.. .... .......+.+++.+||+.||++|||+.++++
T Consensus 250 ~~--~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KM--NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 0000 0112346778999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.17 Aligned_cols=242 Identities=24% Similarity=0.300 Sum_probs=203.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||+++.+ .+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 34578999999999999865 4689999999976422 3356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 88 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~ 160 (318)
T 1fot_A 88 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T 160 (318)
T ss_dssp CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc----c
Confidence 99999999999888899999999999999999999998 9999999999999999999999999999865322 2
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. .+... .
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--------~~~~~----------~ 222 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--------NAELR----------F 222 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HCCCC----------C
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCCC----------C
Confidence 34569999999999999999999999999999999999999997655433222211 11110 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQ 772 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 772 (796)
+......+.+++.+||+.||++|| ++++|++
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111234567899999999999999 8999884
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.93 Aligned_cols=267 Identities=17% Similarity=0.162 Sum_probs=202.4
Q ss_pred HHhHHHhhCCCccceEEEEEeeCC----CCeEEEEEEecchhhhh-----------HHHHHHHHHHhcccCccCcccccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTA----SGTAIAVKKLDRLAQER-----------EREFKSEVSAIGRTHHKHLVQLLG 567 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~----~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g 567 (796)
.+.+.+.||+|+||.||+|.++.. .++.||||++....... ...+..|+..+..++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 345668899999999999987643 25789999986533211 123456777788899999999999
Q ss_pred ccccc----ccceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc--CCC
Q 044281 568 FCDEA----LNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD--HFF 640 (796)
Q Consensus 568 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~--~~~ 640 (796)
++... ...+|||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 98765 4579999999 99999999876 6789999999999999999999998 999999999999999 889
Q ss_pred cEEEeecCCcccccCCCCc------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH
Q 044281 641 SAKISDFGLSKLLFSDQSR------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA 714 (796)
Q Consensus 641 ~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~ 714 (796)
.+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999876433211 1133459999999999999999999999999999999999999998643222111
Q ss_pred HHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 715 ILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.. ...... ..+..+++.... ......++.+++..||+.||.+||++.+|+++|+.++..
T Consensus 272 ~~---~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 272 RD---SKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HH---HHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HH---HHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 11 000000 011111111110 011234677899999999999999999999999876653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.75 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=210.4
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
..+.+.+.||+|+||.||+|..+ .+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cceeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 33455678999999999999976 357899999997533 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++++|.+++... ..+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999999999864 4588999999999999999999998 8999999999999999999999999999877654444
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+ .......
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~--------~~~~~~~------- 232 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKDYRME------- 232 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--------HTTCCCC-------
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------hccCCCC-------
Confidence 4444557889999999999999999999999999999999 88888754433221111 1110000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 233 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 233 --RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 011223467789999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.15 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=198.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.+.||+|+||+||++..+ +++.||+|++..... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 344578999999999999874 588999999965322 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 985 777777654 4589999999999999999999998 99999999999999999999999999998764322 22
Q ss_pred eeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc------------C
Q 044281 661 HTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE------------G 727 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~------------~ 727 (796)
.....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.......... .
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 334568999999999876 568999999999999999999999997654433322221111100000 0
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......+.............++.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000111111111112233567889999999999999999999873
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=360.08 Aligned_cols=246 Identities=27% Similarity=0.363 Sum_probs=200.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccc-cceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL-NRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~~~ 583 (796)
.+.+.||+|+||.||+|..+ ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||++
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET---TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred EEEeeecCcCCeeEEEEEec---CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 34578999999999999873 6799999997643 4568999999999999999999999986655 7899999999
Q ss_pred CCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+|+|.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++..... .
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 343 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 343 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----c
Confidence 999999998654 368899999999999999999998 8999999999999999999999999999854322 1
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+.... +..+....
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~--------i~~~~~~~--------- 406 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKMD--------- 406 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH--------HHTTCCCC---------
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCCC---------
Confidence 22357889999999999999999999999999999998 9999875433222111 11121111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+......+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011223567789999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.99 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=197.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhccc-CccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.++||+|+||+||+++.+ .+++.||||++++... .....+.+|..++.++ +||||+++++++.+....++||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 345578999999999999976 4689999999976432 2234678899999887 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 208 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 208 (396)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-C
Confidence 9999999999999888899999999999999999999998 89999999999999999999999999998643222 2
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHh-HHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESR-AILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .............+...
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------- 280 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------- 280 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--------
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--------
Confidence 334567999999999999999999999999999999999999999643221110 00001111111111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTM 767 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 767 (796)
.+......+.+++.+||+.||++||++
T Consensus 281 --~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 --IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 011123456789999999999999995
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=340.00 Aligned_cols=263 Identities=16% Similarity=0.196 Sum_probs=207.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+|+.++.++ +|+|++++++++.+....++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 345578999999999999864 478999999986432 234678899999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc-----EEEeecCCcccccCC
Q 044281 583 GNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS-----AKISDFGLSKLLFSD 656 (796)
Q Consensus 583 ~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~kl~DfGla~~~~~~ 656 (796)
+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999999998654 589999999999999999999998 8999999999999987766 999999999977544
Q ss_pred CCc------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 657 QSR------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 657 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+........ ....
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~- 242 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPL- 242 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCH-
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-CccH-
Confidence 321 23445699999999999999999999999999999999999999976422111111111000000 0000
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCC
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~p 783 (796)
..........+.+++.+||+.||++||++.+|++.|+.+++....
T Consensus 243 --------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 243 --------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp --------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred --------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 000112235677899999999999999999999999987654333
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=345.38 Aligned_cols=256 Identities=15% Similarity=0.179 Sum_probs=203.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+|+.+++++ +|+||+++++++......++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNL-YTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp EEEEECCC-CTTSEEEEEET-TTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEeeccCCceEEEEEEC-CCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 34578999999999999864 478999999986532 234688999999999 9999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc-----EEEeecCCcccccCCC
Q 044281 584 NGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS-----AKISDFGLSKLLFSDQ 657 (796)
Q Consensus 584 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~kl~DfGla~~~~~~~ 657 (796)
+++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.+....
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99999999864 6789999999999999999999998 9999999999999998887 9999999999765433
Q ss_pred Cc------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccce
Q 044281 658 SR------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731 (796)
Q Consensus 658 ~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (796)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+........ ..
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-----~~ 239 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-----AT 239 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-----HS
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-----cC
Confidence 21 12456799999999999999999999999999999999999999976432221111111111000 00
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 732 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+. .. ..... .++.+++..||+.||.+||++.+|++.|+.+.
T Consensus 240 ---~~-~~-~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 240 ---PI-EV-LCENF-PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp ---CH-HH-HTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ---CH-HH-HhccC-hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 00 00 00001 16788999999999999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.84 Aligned_cols=245 Identities=25% Similarity=0.299 Sum_probs=197.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCH
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL 587 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 587 (796)
+.||+|+||.||+|... .+++.||+|+++.......+.+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 95 ~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EECC-----CEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred eEEecCcCEEEEEEEEc-CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56999999999999865 46889999999776556677899999999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE--cCCCcEEEeecCCcccccCCCCcceeec
Q 044281 588 ANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL--DHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 588 ~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll--~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||+ ++++.+||+|||+++...... .....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence 9888654 4688999999999999999999998 89999999999999 567899999999998764332 22334
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 744 (796)
.||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. .... +.... ...
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~--------~~~~--~~~~~----~~~ 314 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA--------CRWD--LEDEE----FQD 314 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------TCCC--SCSGG----GTT
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------ccCC--CChhh----hcc
Confidence 689999999999999999999999999999999999999987654432222211 1000 00000 011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 745 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
....+.+++.+||+.||++|||+.|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2346778999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=339.07 Aligned_cols=253 Identities=28% Similarity=0.417 Sum_probs=205.0
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.+.||+|+||.||+|..+ +++.||||.+.... ...+.+.+|++++++++||||+++++++.+ ...++||||+
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred hhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 3445678999999999999864 56789999997543 235689999999999999999999999864 5689999999
Q ss_pred CCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999997643 688999999999999999999998 99999999999999999999999999998765433322
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~------- 231 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVR------- 231 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--------HTTCCCCC-------
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH--------hcccCCCC-------
Confidence 333456788999999998899999999999999999999 88898765443322111 11111000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+......+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 232 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 11123467789999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=346.75 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=193.1
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCC--eEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccc---
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNR--- 575 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~--~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--- 575 (796)
.+.+.+.||+|+||.||+|.....++ ..||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 34456789999999999998764322 37999999653 334567899999999999999999999999877665
Q ss_pred ---eeEEeecCCCCHHHHHhcCC------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEee
Q 044281 576 ---LLVYEFMGNGTLANLIFAIP------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISD 646 (796)
Q Consensus 576 ---~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 646 (796)
++||||+++++|.+++.... .+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence 89999999999999986432 588999999999999999999998 899999999999999999999999
Q ss_pred cCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhh
Q 044281 647 FGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCY 724 (796)
Q Consensus 647 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~ 724 (796)
||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+....+
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------- 252 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-------- 252 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH--------
Confidence 999987644332 22233456889999999999999999999999999999999 88998765433221111
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
..+.... .+......+.+++.+||+.||++|||+.++++.|+.++.-
T Consensus 253 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 IGGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111110 0112234677899999999999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.23 Aligned_cols=258 Identities=28% Similarity=0.380 Sum_probs=208.7
Q ss_pred HHhHHHhhCCCccceEEEEEe----eCCCCeEEEEEEecchhh-hhHHHHHHHHHHhccc-CccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVL----KTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~----~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 576 (796)
.+.+.+.||+|+||.||+|.. +..+++.||||++..... ...+.+.+|+.++.++ +||||+++++++......+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 445667899999999999985 345678999999975432 3457899999999999 9999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCC------------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC
Q 044281 577 LVYEFMGNGTLANLIFAIP------------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH 638 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~ 638 (796)
+||||+++|+|.+++.... .+++..++.++.||++||+|||++ +|+||||||+||++++
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC
Confidence 9999999999999997653 378999999999999999999998 9999999999999999
Q ss_pred CCcEEEeecCCcccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHH
Q 044281 639 FFSAKISDFGLSKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAIL 716 (796)
Q Consensus 639 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l 716 (796)
++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~- 259 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK- 259 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH-
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH-
Confidence 9999999999998765443322 223457889999999999999999999999999999999 9999875432221111
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 717 TDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
....+.... .+......+.+++.+||+.||.+|||+.+++++|++++.
T Consensus 260 ------~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 260 ------MIKEGFRML---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp ------HHHHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HhccCCCCC---------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111111000 011123467789999999999999999999999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=347.28 Aligned_cols=259 Identities=26% Similarity=0.351 Sum_probs=208.9
Q ss_pred HHHhHHHhhCCCccceEEEEEeeC------CCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKT------ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEAL 573 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 573 (796)
..+.+.+.||+|+||.||+|.... .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+..
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 445566889999999999998642 356789999997543 34457899999999999 8999999999999999
Q ss_pred cceeEEeecCCCCHHHHHhcCC----------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc
Q 044281 574 NRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD 637 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~ 637 (796)
..++||||+++++|.+++.... .+++..++.++.||++||+|||+. +|+||||||+||+++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence 9999999999999999998653 378899999999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHH
Q 044281 638 HFFSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAI 715 (796)
Q Consensus 638 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~ 715 (796)
.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 9999999999999876543321 2223457889999999999899999999999999999999 9999976544432221
Q ss_pred HHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 716 LTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
+ ..+..... +......+.+++.+||+.||.+|||+.++++.|++++..
T Consensus 272 ~--------~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 272 L--------KEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp H--------HHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H--------hcCCCCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 11111110 112234577899999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.02 Aligned_cols=250 Identities=28% Similarity=0.359 Sum_probs=205.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+|..+ .+++.||+|.+..........+.+|+.++++++||||+++++++.+....++||||++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 445678999999999999875 4688999999976555556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC--CCcEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH--FFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~ 206 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 206 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc--c
Confidence 999999997654 689999999999999999999998 9999999999999974 5789999999998764432 2
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. ..... .+...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~--------~~~~~--~~~~~--- 273 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK--------RCDWE--FDEDA--- 273 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--------HCCCC--CCSST---
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCCC--CCccc---
Confidence 334569999999999999999999999999999999999999998765433222111 11100 01000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||++|||+.++++.
T Consensus 274 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 -FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01123457789999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.94 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=191.6
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh----hhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.+.||+|+||.||+|.. .++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 10 ~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp EEEEEEEEETTEEEEEEEE---TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred eeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 3457899999999999986 378999999865332 224678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC--------CCcEEEeecCCccc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH--------FFSAKISDFGLSKL 652 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~--------~~~~kl~DfGla~~ 652 (796)
|+++++|.+++.. ..+++..++.++.||++||+|||++...+|+||||||+||++++ ++.+||+|||+++.
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 9999999999864 57889999999999999999999983233999999999999986 77899999999986
Q ss_pred ccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||............ ........
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~- 234 (271)
T 3dtc_A 166 WHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-------AMNKLALP- 234 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-------HTSCCCCC-
T ss_pred ccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh-------hcCCCCCC-
Confidence 54322 22346899999999999999999999999999999999999999765433321111 01111000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.+......+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 235 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 --------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0112234677899999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.54 Aligned_cols=269 Identities=25% Similarity=0.350 Sum_probs=207.1
Q ss_pred hHHHhhCCCccceEEEEEee---CCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccc--ccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLK---TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 578 (796)
.+.+.||+|+||+||++.++ ..+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 45678999999999988643 2367899999997643 34457799999999999999999999999774 567899
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++++|.+++...+ +++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 114 ~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 99999999999997654 88999999999999999999998 899999999999999999999999999987654332
Q ss_pred --cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHH------H-HHHHHHhhhcCcc
Q 044281 659 --RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAI------L-TDWAYDCYVEGRL 729 (796)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~------l-~~~~~~~~~~~~~ 729 (796)
.......+|..|+|||.+.+..++.++||||||+++|||++|+.|+........... . ..........+..
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 122344578889999999999999999999999999999999999875433211000 0 0000111111111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCCCC
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGP 786 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp~p 786 (796)
...+......+.+++.+||+.||++|||+.++++.|+.+.+...++.|
T Consensus 270 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 270 ---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred ---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 111122335678899999999999999999999999987665444433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=347.92 Aligned_cols=245 Identities=26% Similarity=0.302 Sum_probs=202.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+|+||.||+++.+ .+++.||||+++... ......+..|..++..+ +||||+++++++.+....++||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 345578999999999999976 468999999997642 23456778899999876 9999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 173 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 173 (345)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-
Confidence 9999999999998878899999999999999999999998 999999999999999999999999999986432222
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+... +
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--------~~~~~--~------ 237 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--------MDNPF--Y------ 237 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC--C------
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--------hCCCC--C------
Confidence 2345679999999999999999999999999999999999999998765543322221 11110 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMK-VVL 771 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-evl 771 (796)
+......+.+++.+||+.||++||++. +|+
T Consensus 238 --p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 --PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111234567899999999999999997 664
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=345.62 Aligned_cols=250 Identities=27% Similarity=0.354 Sum_probs=199.9
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 34578999999999999865 468899999986432 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC-Cccee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-SRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~ 662 (796)
+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.... .....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 999999998888899999999999999999999998 99999999999999999999999999998764332 22233
Q ss_pred eccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...+ ...... ...
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~-----~~~~~~--~~~------ 230 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW-----KEKKTY--LNP------ 230 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHH-----HTTCTT--STT------
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHH-----hccccc--CCc------
Confidence 4679999999999988776 78999999999999999999999754332111 0010 111000 000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11123456779999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=336.04 Aligned_cols=252 Identities=29% Similarity=0.425 Sum_probs=206.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp EEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred eeeeEecCCCceeEEEEEec--CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 34578999999999999875 578999999976432 346799999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++|.+++... ..+++..++.++.||++||.|||+. +|+|+||||+||++++++.+||+|||+++............
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9999999865 4688999999999999999999998 89999999999999999999999999998664322222233
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.... . +
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i--------~~~~~~~--~-------~ 227 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFRLY--K-------P 227 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HTTCCCC--C-------C
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH--------hcCCcCC--C-------C
Confidence 456788999999999999999999999999999999 88998765443322211 1111100 0 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
......+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1123457789999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=347.98 Aligned_cols=260 Identities=24% Similarity=0.319 Sum_probs=206.2
Q ss_pred HHHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 575 (796)
..+.+.+.||+|+||.||+|... ..++..||||.+.... ....+.+.+|+.++.++ +||||+++++++......
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 34455678999999999999863 3456789999997532 23346799999999999 899999999999999999
Q ss_pred eeEEeecCCCCHHHHHhcCC-----------------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCC
Q 044281 576 LLVYEFMGNGTLANLIFAIP-----------------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQ 632 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~ 632 (796)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 99999999999999997653 268899999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEeecCCcccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHH
Q 044281 633 NILLDHFFSAKISDFGLSKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEE 710 (796)
Q Consensus 633 NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~ 710 (796)
|||++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 9999999999999999998765443322 233457889999999999999999999999999999998 99999765322
Q ss_pred HHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 711 ESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.... .....+.... .+......+..++.+||+.||.+|||+.+|+++|+.++..
T Consensus 282 ~~~~-------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 282 ANFY-------KLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHH-------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHH-------HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2111 1111111100 0111234677899999999999999999999999987653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=371.59 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=208.4
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.++||+|+||.||+|.++ ++..||||+++... ...++|.+|++++++++|+||+++++++.+ ...+|||||+
T Consensus 268 ~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 268 SLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 3456678999999999999875 45789999997643 235689999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999753 4688999999999999999999998 89999999999999999999999999998764322222
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....++..|+|||.+.+..++.++|||||||+||||++ |+.||......+....+ ..+....
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i--------~~~~~~~-------- 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMP-------- 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH--------HTTCCCC--------
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCCC--------
Confidence 223446788999999999999999999999999999999 89998765443322211 1111100
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCC
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~p 783 (796)
.+......+.+++.+||+.||++|||+.+|+++|+.+.....|
T Consensus 485 -~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 485 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred -CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 0112234677899999999999999999999999998765544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.26 Aligned_cols=263 Identities=19% Similarity=0.219 Sum_probs=198.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||+||+|..+ .+++.||||++.... ......+.+|+.++++++||||+++++++.++...++||||+
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 34578999999999999875 468899999986432 333577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 159 (292)
T 3o0g_A 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYS 159 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCCC
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cccc
Confidence 8744444445567899999999999999999999998 99999999999999999999999999998764322 2233
Q ss_pred eccCCCcccccccccCCC-CCccchhHHHHHHHHHHHhCCCCCchh-hHHHHhHHHHHHHHHhhhcCcc---ceecc---
Q 044281 663 MIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVTLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRL---DVLID--- 734 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gv~l~elltg~~p~~~~-~~~~~~~~l~~~~~~~~~~~~~---~~~~d--- 734 (796)
...||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+... ...+....+....... ..... ....+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP-TEEQWPSMTKLPDYKP 238 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC-CTTTCTTGGGSTTCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Chhhhhhhcccccccc
Confidence 456899999999998766 799999999999999999999886433 2222222211111000 00000 00000
Q ss_pred ------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 735 ------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 735 ------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..............+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000111233567789999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=355.87 Aligned_cols=249 Identities=21% Similarity=0.257 Sum_probs=203.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.++||+|+||+||+++.+ .+++.||+|++++... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 73 ~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 3467999999999999976 4688999999976322 12345889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++...........
T Consensus 152 ~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 152 PGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp TTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred CCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 999999999764 578899999999999999999998 9999999999999999999999999999876544433344
Q ss_pred eccCCCcccccccccCCC----CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 663 MIRGTRGYVAPEWFKNVP----VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~----~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
...||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+....... ... +
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~p---~---- 296 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL----TFP---D---- 296 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CCC---T----
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc----cCC---C----
Confidence 567999999999998765 7899999999999999999999998766554433332211110 000 0
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVLQM 773 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~ 773 (796)
.......+.+++.+||+.+|.+ ||++.||+++
T Consensus 297 ---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 ---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0112345677999999999988 9999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=339.20 Aligned_cols=264 Identities=24% Similarity=0.292 Sum_probs=192.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||+|..+ .+++.||+|++..... .....+.+|+.++++++||||+++++++......++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp ------------CEEEEEECS-SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred eeEeeEECCCCCEEEEEEEEC-CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 456688999999999999865 4688999999865332 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 583 GNGTLANLIFAI------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 583 ~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 5999988643 3578899999999999999999998 9999999999999999999999999999876432
Q ss_pred CCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc---------
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE--------- 726 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~--------- 726 (796)
. .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+..........
T Consensus 162 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 162 V-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp C-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred c-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 2 22234568999999999976 468999999999999999999999998765544333332211100000
Q ss_pred ---Cccceeccc----hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 ---GRLDVLIDS----DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 ---~~~~~~~d~----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......... .............+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000000 00000011123467889999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.22 Aligned_cols=242 Identities=22% Similarity=0.240 Sum_probs=203.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||+++.+ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 34578999999999999875 468899999996542 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 123 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~ 195 (350)
T 1rdq_E 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T 195 (350)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----c
Confidence 99999999998878899999999999999999999998 9999999999999999999999999999876432 2
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+....
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~~---------- 257 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--------VSGKVRF---------- 257 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCC----------
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH--------HcCCCCC----------
Confidence 3456899999999999999999999999999999999999999876544332222 1121110
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQ 772 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 772 (796)
+......+.+++.+||+.||.+||+ +.+|++
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1112345778999999999999998 888875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=341.09 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=199.0
Q ss_pred HHHhhCCCccceEEEEEeeCCC---CeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTAS---GTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.||+|+||.||+|..+..+ +..||||.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 3478999999999999876433 3469999997542 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 128 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (333)
T 1mqb_A 128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204 (333)
T ss_dssp CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence 9999999999765 5789999999999999999999998 89999999999999999999999999998765433221
Q ss_pred --eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 661 --HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 661 --~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+....
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~--------~~~~~~~------ 270 (333)
T 1mqb_A 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI--------NDGFRLP------ 270 (333)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HTTCCCC------
T ss_pred cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--------HCCCcCC------
Confidence 222346788999999999999999999999999999999 99999765443322111 1111100
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+......+.+++.+||+.||++||++.+|+++|+.++.
T Consensus 271 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 271 ---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011123457789999999999999999999999987654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=372.30 Aligned_cols=250 Identities=28% Similarity=0.376 Sum_probs=202.3
Q ss_pred HhhCCCccceEEEEEeeC-CCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
++||+|+||.||+|.+.. ..++.||||+++.... ...++|.+|++++++++|||||++++++.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 469999999999997643 3468999999976432 346789999999999999999999999964 557899999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC--ccee
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS--RTHT 662 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~--~~~~ 662 (796)
|+|.+++.....+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.+..... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999999888899999999999999999999998 899999999999999999999999999987654332 2223
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+ ..+.....
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i--------~~~~~~~~--------- 593 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--------EKGERMGC--------- 593 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--------HTTCCCCC---------
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCCCC---------
Confidence 3456789999999999999999999999999999998 99999876554432222 12211111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1122356778999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.93 Aligned_cols=247 Identities=27% Similarity=0.303 Sum_probs=203.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+|+||.||++..+ .+++.||||+++... ....+.+..|..++..+ +||||+++++++.+....++||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 345578999999999999875 467899999997642 23456788999999987 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 176 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 176 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-c
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998643222 2
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+...
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--------~~~~~--------- 239 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--------EHNVA--------- 239 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC---------
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH--------hCCCC---------
Confidence 2344579999999999999999999999999999999999999998765544322221 11111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~~ 773 (796)
.+......+..++.+||+.||.+||+ +.+|++.
T Consensus 240 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112346778999999999999995 5777643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=347.08 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=201.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||++..+ .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 345678999999999999865 468899999996532 2335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+... ..
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~ 170 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQ 170 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC--Cc
Confidence 999999999999888899999999999999999999998 9999999999999999999999999999876432 22
Q ss_pred eeeccCCCcccccccccC---CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 661 HTMIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .......
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-----~~~~~~~------- 238 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-----FETTVVT------- 238 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-----HHHCCCC-------
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-----HhhcccC-------
Confidence 345679999999999964 4589999999999999999999999975432221111111 0011100
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPT-MKVVLQ 772 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~evl~ 772 (796)
.+......+..++.+||+.||.+||+ +.+|++
T Consensus 239 ---~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 239 ---YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01122356778999999999999998 777764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.98 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=181.9
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEeecCCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+.||+|+||.||++..+ .+++.||||++... ....+.+|+.++..++ ||||+++++++.+....++||||+++|+
T Consensus 17 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK-KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEET-TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 56999999999999975 46899999999653 3457788999999996 9999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC---cEEEeecCCcccccCCCCcceee
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF---SAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++...... .....
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 168 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKT 168 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccccc
Confidence 999999988899999999999999999999998 999999999999998765 89999999998654332 22334
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.............. ....+..+.... ... ...
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~~--~~~----~~~ 241 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFSF--EGE----AWK 241 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCCC--CSH----HHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCCC--Ccc----ccc
Confidence 5689999999999999999999999999999999999999976543211111101 111122222110 000 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 223567789999999999999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=357.05 Aligned_cols=246 Identities=24% Similarity=0.282 Sum_probs=194.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||++... .+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred cEEeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 344578999999999999865 578999999997532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhh-cCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHE-ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+++|+|.+++.....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 304 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-A 304 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-c
Confidence 99999999999888889999999999999999999998 6 89999999999999999999999999998643322 2
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .....
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--------~~~~~--------- 367 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--------MEEIR--------- 367 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC---------
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH--------hCCCC---------
Confidence 2344679999999999999999999999999999999999999997665443322221 11110
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQ 772 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 772 (796)
.+......+.+++.+||+.||.+|| +++|+++
T Consensus 368 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 -FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0111224567899999999999999 9999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.68 Aligned_cols=265 Identities=17% Similarity=0.185 Sum_probs=197.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeC--CCCeEEEEEEecchhhh-----------hHHHHHHHHHHhcccCccCcccccccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLAQE-----------REREFKSEVSAIGRTHHKHLVQLLGFC 569 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~~ 569 (796)
.+.+.+.||+|+||.||+|.... .++..+|||+....... ....+.+|+..+..++|+||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 34556789999999999998753 15678999998653211 123467888999999999999999998
Q ss_pred cc----cccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC--cEE
Q 044281 570 DE----ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF--SAK 643 (796)
Q Consensus 570 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~--~~k 643 (796)
.. ....++||||+ +++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+|
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEE
Confidence 77 67889999999 999999998877899999999999999999999998 999999999999999887 999
Q ss_pred EeecCCcccccCCCC------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHH
Q 044281 644 ISDFGLSKLLFSDQS------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILT 717 (796)
Q Consensus 644 l~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~ 717 (796)
|+|||+++.+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~- 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT- 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH-
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH-
Confidence 999999987643221 1123456899999999999999999999999999999999999999653221111100
Q ss_pred HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
........ +. +..............+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 273 --~~~~~~~~-~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 273 --AKTNLLDE-LP---QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp --HHHHHHHT-TT---HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred --HHHhhccc-cc---HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 00000000 00 000000000123346788999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.62 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=197.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-------hHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-------REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
+.+.+.||+|+||.||+|... .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.. +
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred ceehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 445678999999999999875 46889999998542221 1167899999999999999999999987654 7
Q ss_pred eEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCC--eeeCCCCCCCEEEcCCCc-----EEEeecC
Q 044281 577 LVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVP--IIHCDIKPQNILLDHFFS-----AKISDFG 648 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~Dlk~~NIll~~~~~-----~kl~DfG 648 (796)
+||||+++++|.+.+... ..+++..++.++.||+.||+|||++ + |+||||||+|||++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 999999999998888654 4789999999999999999999998 7 999999999999988776 9999999
Q ss_pred CcccccCCCCcceeeccCCCcccccccc--cCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc
Q 044281 649 LSKLLFSDQSRTHTMIRGTRGYVAPEWF--KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 726 (796)
Q Consensus 649 la~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 726 (796)
+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||........... . .....
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~---~~~~~ 245 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI--N---MIREE 245 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH--H---HHHHS
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH--H---HHhcc
Confidence 9975322 23445689999999999 455678999999999999999999999975432221110 0 00111
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 727 GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 727 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
+..... +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 246 ~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 GLRPTI---------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCC---------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111 112234677899999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.08 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=201.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCC--CCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|..... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 33457899999999999987643 3457999999764 33456789999999999999999999999865 45689999
Q ss_pred ecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+++++|.+++... ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999999764 4589999999999999999999998 8999999999999999999999999999876544433
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+.....
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~--------~~~~~~~~------ 235 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------EKGDRLPK------ 235 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH--------HHTCCCCC------
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH--------hcCCCCCC------
Confidence 3344557889999999999999999999999999999998 99999654332221111 11110000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+......+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 236 ---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 11122457789999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=336.73 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=193.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||.||++.. .++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKW---RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp EEEEEEECCSSSEEEEEEE---TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred eeeeEeecCCCceEEEEEE---CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 3457899999999999986 3689999999753 345689999999999999999999999874 48999999999
Q ss_pred CCHHHHHhcCC---CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc-EEEeecCCcccccCCCCcc
Q 044281 585 GTLANLIFAIP---KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS-AKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 585 gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~-~kl~DfGla~~~~~~~~~~ 660 (796)
++|.+++.... .+++..++.++.||++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 99999998764 3678889999999999999999943238999999999999998886 799999999765322
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... . .....+......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~-~~~~~~~~~~~~------- 226 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-----M-WAVHNGTRPPLI------- 226 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH-----H-HHHHTTCCCCCB-------
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH-----H-HHHhcCCCCCcc-------
Confidence 223458999999999999999999999999999999999999997532211110 0 001111111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
......+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 227 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 227 --KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred --cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1122456779999999999999999999999987554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.53 Aligned_cols=247 Identities=22% Similarity=0.317 Sum_probs=193.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--------------------------hhHHHHHHHHHHhccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--------------------------EREREFKSEVSAIGRT 557 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~l 557 (796)
+.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred eEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 345578999999999999865 4689999999864321 1135689999999999
Q ss_pred CccCcccccccccc--cccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEE
Q 044281 558 HHKHLVQLLGFCDE--ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635 (796)
Q Consensus 558 ~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIl 635 (796)
+||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||++||+|||++ +|+||||||+|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLL 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence 99999999999876 567899999999999988654 35689999999999999999999998 8999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCC---CCccchhHHHHHHHHHHHhCCCCCchhhHHHH
Q 044281 636 LDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP---VSAKVDVYSFGVTLLEIICCRRSVEMELEEES 712 (796)
Q Consensus 636 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~ 712 (796)
++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++|||||||++|||++|+.||........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 99999999999999987644322 233456999999999998765 47889999999999999999999976543322
Q ss_pred hHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 713 RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
...+ ....... .. .......+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~--------~~~~~~~-~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 249 HSKI--------KSQALEF-PD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHH--------HHCCCCC-CS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHH--------hcccCCC-CC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111 1111100 00 0112345778999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=341.83 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=200.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.+.||+|+||.||+++.+ .+++.||||++.... ....+.+.+|..++.++ +||||+++++++.+....++|||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 34578999999999999875 468999999997542 23456788999999887 89999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++...... ..
T Consensus 91 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~ 166 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 166 (345)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CC
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-Cc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999998643222 22
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHh-HHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESR-AILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .............+...
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--------- 237 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--------- 237 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC---------
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC---------
Confidence 34457999999999999999999999999999999999999999653211100 00001111111111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTM------KVVLQ 772 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~------~evl~ 772 (796)
.+......+.+++.+||+.||++||++ .++++
T Consensus 238 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 238 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 011123457789999999999999995 56654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=339.90 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=192.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccccc---------
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN--------- 574 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--------- 574 (796)
.+.+.||+|+||.||+|+.+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 9 EPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred ceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 34578999999999999975 468899999986432 3345789999999999999999999998855432
Q ss_pred ------------------------------------------------ceeEEeecCCCCHHHHHhcCCC---CchhHHH
Q 044281 575 ------------------------------------------------RLLVYEFMGNGTLANLIFAIPK---PDWNLRI 603 (796)
Q Consensus 575 ------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~ 603 (796)
.++||||+++++|.+++..... .++..++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 6899999999999999987643 4556689
Q ss_pred HHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-----------cceeeccCCCcccc
Q 044281 604 RISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-----------RTHTMIRGTRGYVA 672 (796)
Q Consensus 604 ~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~y~a 672 (796)
.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 9999999999999998 899999999999999999999999999997754421 12233569999999
Q ss_pred cccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHH
Q 044281 673 PEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMI 752 (796)
Q Consensus 673 PE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 752 (796)
||.+.+..++.++|||||||++|||++|..|+...... + ......... .........+.++
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~-----~-----~~~~~~~~~---------~~~~~~~~~~~~l 305 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-----I-----TDVRNLKFP---------LLFTQKYPQEHMM 305 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH-----H-----HHHHTTCCC---------HHHHHHCHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH-----H-----HHhhccCCC---------cccccCChhHHHH
Confidence 99999999999999999999999999988775322111 0 001111111 0112233456789
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 044281 753 AMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 753 ~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.+||+.||++|||+.|+++.
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCCCcCCCHHHHhhc
Confidence 999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.24 Aligned_cols=247 Identities=24% Similarity=0.388 Sum_probs=200.9
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccc--ccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA--LNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e 580 (796)
.+.+.||+|+||.||+|+. +++.||||++... .....+.|.+|+.++++++||||+++++++.+. ...++|||
T Consensus 13 ~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp EEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHHHHhcCCCcceEEEEEE---CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 4557899999999999987 3789999999753 234456899999999999999999999999877 77899999
Q ss_pred ecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCC--eeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 581 FMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVP--IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
|+++|+|.+++.... .+++..++.++.||++||+|||+. + |+||||||+||++++++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999998765 489999999999999999999997 6 99999999999999999999999988764322
Q ss_pred CCcceeeccCCCcccccccccCCCCCc---cchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSA---KVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
....+|+.|+|||.+.+...+. ++||||||+++|||++|+.||......+....+ ...+.....
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~- 232 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-------ALEGLRPTI- 232 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH-------HHSCCCCCC-
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH-------HhcCCCCCC-
Confidence 2235789999999998765544 899999999999999999999765443322111 111111111
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+......+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 233 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 --------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11123457789999999999999999999999988653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=337.17 Aligned_cols=249 Identities=24% Similarity=0.256 Sum_probs=193.9
Q ss_pred HHHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhccc-CccCccccccccccccc
Q 044281 498 ELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALN 574 (796)
Q Consensus 498 ~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 574 (796)
++....+.+.++||+|+||+||+|... .+++.||||++... .......+..|+..+.++ +|+||+++++++.++..
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred chhhhheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 444455666778999999999999875 46899999998542 223344556666666555 99999999999999999
Q ss_pred ceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccc
Q 044281 575 RLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 653 (796)
.++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999999 66888887654 4689999999999999999999998 8999999999999999999999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..++....... .+..+...
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~~--- 270 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-----------QLRQGYLP--- 270 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-----------HHTTTCCC---
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------HHhccCCC---
Confidence 4322 2334568999999999876 79999999999999999999987765432211 11111110
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..........+.+++.+||+.||++|||+.|+++.
T Consensus 271 -----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 -----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 00111223567889999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.61 Aligned_cols=255 Identities=25% Similarity=0.434 Sum_probs=192.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCC--eEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccc-ccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCD-EALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~ 581 (796)
+.+.||+|+||.||+|.....++ ..||||.++... ....+.|.+|+.++++++||||+++++++. .....++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 45789999999999998764443 468999986533 345678999999999999999999999865 45678999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR- 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~- 659 (796)
+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 173 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred CCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 9999999999865 4578999999999999999999998 8999999999999999999999999999876433221
Q ss_pred --ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 660 --THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
......+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+.... ...+.... .
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~--------~~~~~~~~--~-- 317 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--------LLQGRRLL--Q-- 317 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH--------HHTTCCCC--C--
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH--------HHcCCCCC--C--
Confidence 1233457889999999999999999999999999999999 5566654322211111 11111110 0
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
+......+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 318 -----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 318 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111224577899999999999999999999999886654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=330.20 Aligned_cols=248 Identities=22% Similarity=0.305 Sum_probs=204.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+|..+ .++..||+|++........+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 445678999999999999865 4678999999987656667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE---cCCCcEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++....... .
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~ 164 (277)
T 3f3z_A 90 GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--M 164 (277)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--C
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--c
Confidence 999999998888899999999999999999999998 89999999999999 788999999999998764332 2
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+....+ ..+.... +..
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~---~~~--- 229 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--------REGTFTF---PEK--- 229 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCC---CHH---
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCCC---Cch---
Confidence 3345689999999998764 899999999999999999999999865544322211 1111100 000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
........+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00112346778999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=353.45 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=205.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 34578999999999999875 4689999999975432 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 98 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~ 172 (476)
T 2y94_A 98 VSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FL 172 (476)
T ss_dssp CSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--CB
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--cc
Confidence 99999999999888899999999999999999999998 99999999999999999999999999998764322 23
Q ss_pred eeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...........+ ..+....
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i--------~~~~~~~--------- 235 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--------CDGIFYT--------- 235 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH--------HTTCCCC---------
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH--------hcCCcCC---------
Confidence 34569999999999998776 68999999999999999999999865443322111 1111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHc
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ--MLEG 776 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~--~L~~ 776 (796)
+......+.+++.+||+.||++|||+.++++ .+..
T Consensus 236 -p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 236 -PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp -CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred -CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 0111245678999999999999999999997 3444
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=336.21 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=200.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 34578999999999999875 468899999985532 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 160 (311)
T 4agu_A 85 DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYD 160 (311)
T ss_dssp SEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccC
Confidence 9999999998888899999999999999999999998 999999999999999999999999999987643322 223
Q ss_pred eccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hhhcC------c
Q 044281 663 MIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVEG------R 728 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~~------~ 728 (796)
...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...... .+... .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 4468999999999976 67899999999999999999999999776554433222211100 00000 0
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+..............+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000111233457889999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=333.73 Aligned_cols=253 Identities=28% Similarity=0.370 Sum_probs=203.8
Q ss_pred HHH-hhCCCccceEEEEEee-CCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 506 FKE-ELGRGSFGIVYKGVLK-TASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~-~LG~G~fG~Vy~g~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+ .||+|+||.||+|... ..+++.||||++..... ...+++.+|+.+++.++||||+++++++ +....++||||
T Consensus 20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence 345 7999999999999654 23568999999975432 2356899999999999999999999999 56678999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc-
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT- 660 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~- 660 (796)
+++++|.+++.....+++..++.++.||++||+|||+. +|+|+||||+||+++.++.+||+|||+++.........
T Consensus 99 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (291)
T 1xbb_A 99 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175 (291)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence 99999999999888899999999999999999999998 99999999999999999999999999998765443322
Q ss_pred -eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 661 -HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 661 -~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.....
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~------ 241 (291)
T 1xbb_A 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--------EKGERMGC------ 241 (291)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--------HTTCCCCC------
T ss_pred ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCCCC------
Confidence 222346788999999999899999999999999999999 99999765543322211 11111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+......+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 242 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 242 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11223467789999999999999999999999987653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=366.98 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=199.9
Q ss_pred hhCCCccceEEEEEeeC-CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 509 ELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+||+|+||.||+|.++. .++..||||+++... ....++|.+|++++++++|||||++++++.. ...++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 69999999999998763 345789999997643 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc--eee
Q 044281 587 LANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT--HTM 663 (796)
Q Consensus 587 L~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~--~~~ 663 (796)
|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....... ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999754 4689999999999999999999998 89999999999999999999999999998764433211 122
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... +..+..... +
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~--------i~~~~~~~~---------p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------IEQGKRMEC---------P 561 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH--------HHTTCCCCC---------C
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--------HHcCCCCCC---------C
Confidence 345789999999999999999999999999999998 9999976554432221 112211111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 123356778999999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.93 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=199.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCe----EEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGT----AIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.||+|+||.||+|.... +++ .||+|.+.... ......+.+|+.++++++||||+++++++. +...++||
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 345789999999999998753 343 38888875432 223356788999999999999999999986 46688999
Q ss_pred eecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999999875 5788999999999999999999998 899999999999999999999999999998754432
Q ss_pred -cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 659 -RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 659 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+......
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~--- 239 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL--------EKGERLAQP--- 239 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH--------HTTCBCCCC---
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH--------HcCCCCCCC---
Confidence 22344567889999999999999999999999999999999 99999765433322211 111111100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 240 ------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 240 ------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0112245678999999999999999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=332.27 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=203.4
Q ss_pred hhCCCccceEEEEEee-CCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 509 ELGRGSFGIVYKGVLK-TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
.||+|+||.||+|... ..++..||||+++... ....+.+.+|++++++++||||+++++++ +....++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 7999999999999864 3357889999997643 34567899999999999999999999999 5567899999999999
Q ss_pred HHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc--eee
Q 044281 587 LANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT--HTM 663 (796)
Q Consensus 587 L~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~--~~~ 663 (796)
|.+++... ..+++..++.++.||++||.|||+. +|+||||||+||++++++.+||+|||+++......... ...
T Consensus 96 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 172 (287)
T 1u59_A 96 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172 (287)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccc
Confidence 99999754 5689999999999999999999998 99999999999999999999999999998765433221 223
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+..... +
T Consensus 173 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i--------~~~~~~~~---------~ 235 (287)
T 1u59_A 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI--------EQGKRMEC---------P 235 (287)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH--------HTTCCCCC---------C
T ss_pred ccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--------hcCCcCCC---------C
Confidence 346889999999998899999999999999999998 99999765443322211 11111111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
......+.+++.+||+.||++||++.++++.|+.+..
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1223567789999999999999999999999987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.20 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=207.4
Q ss_pred HHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
.+.+.+.||+|+||.||+|+... .+++.||||.+.... ......+.+|+.++++++|+||+++++++.+....++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 34556789999999999998652 346789999997543 2345679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcC----------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeec
Q 044281 578 VYEFMGNGTLANLIFAI----------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDF 647 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 647 (796)
||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||++++++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcC
Confidence 99999999999998752 3568899999999999999999998 8999999999999999999999999
Q ss_pred CCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhh
Q 044281 648 GLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYV 725 (796)
Q Consensus 648 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 725 (796)
|+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ .
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--------~ 254 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV--------M 254 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH--------H
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH--------H
Confidence 99986543322 11223346889999999999999999999999999999999 78888765443322211 1
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 726 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+..... .......+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus 255 ~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1211111 11223457789999999999999999999999988755
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.48 Aligned_cols=244 Identities=24% Similarity=0.327 Sum_probs=199.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 12 ~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 12 IIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 34578999999999999865 4688999999975322 2235789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+ +|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++....... ..
T Consensus 91 ~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~ 164 (336)
T 3h4j_B 91 A-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FL 164 (336)
T ss_dssp C-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--TT
T ss_pred C-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--cc
Confidence 9 689999998888899999999999999999999998 89999999999999999999999999998764332 23
Q ss_pred eeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........... ...+.. .
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------i~~~~~----------~ 226 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--------VNSCVY----------V 226 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC--------CCSSCC----------C
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH--------HHcCCC----------C
Confidence 34569999999999998876 7899999999999999999999975432211000 000000 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......+.+++.+||+.||.+|||+.|+++.
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011123456789999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=338.53 Aligned_cols=256 Identities=23% Similarity=0.297 Sum_probs=201.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccc----ccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCD----EALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~ 579 (796)
+.+.+.||+|+||.||++... .+++.||||++........+.+.+|+.++++++||||+++++++. .....++||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 445678999999999999865 468999999987655666778999999999999999999999986 345778999
Q ss_pred eecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 580 EFMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 580 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
||+++++|.+++.. ...+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999875 46789999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCc--------ceeeccCCCcccccccccCCC---CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhh
Q 044281 656 DQSR--------THTMIRGTRGYVAPEWFKNVP---VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCY 724 (796)
Q Consensus 656 ~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 724 (796)
.... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||......... +.. ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~----~~ 260 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VAL----AV 260 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HHH----HH
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hhH----Hh
Confidence 1110 012244799999999997654 689999999999999999999999653221110 000 00
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.. ... . .........+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 261 ~~-~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 261 QN-QLS-I-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HC-C---C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hc-cCC-C-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00 000 0 001122346778999999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=349.85 Aligned_cols=250 Identities=20% Similarity=0.249 Sum_probs=202.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||+||+++.+ .+++.||||++++... ...+.+.+|..++..++|+||+++++++.+....++||||+
T Consensus 65 ~~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~ 143 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143 (412)
T ss_dssp EEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence 3467999999999999875 4789999999976322 22345889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++..........
T Consensus 144 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 144 VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 999999999864 4789999999999999999999998 899999999999999999999999999987655443333
Q ss_pred eeccCCCccccccccc-------CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 662 TMIRGTRGYVAPEWFK-------NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~-------~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
....||+.|+|||++. +..++.++|||||||++|||++|+.||......+....+..+.... ....
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----~~p~--- 293 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL----SLPL--- 293 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CCC----
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc----CCCc---
Confidence 4467999999999997 4578999999999999999999999998766554433332211110 0000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKR---PTMKVVLQM 773 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~evl~~ 773 (796)
. ......++.+++.+||+ +|.+| |+++||+++
T Consensus 294 --~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 294 --V----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --c----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0 01123466779999999 99998 689998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=332.35 Aligned_cols=262 Identities=22% Similarity=0.261 Sum_probs=196.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp EEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred hhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 3457899999999999986 3688999999864322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++ +|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 86 898888764 6788999999999999999999998 99999999999999999999999999998764322 222
Q ss_pred eeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC--cccee------
Q 044281 662 TMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG--RLDVL------ 732 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~------ 732 (796)
....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+........... .....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 344689999999999764 589999999999999999999999986654433222211110000000 00000
Q ss_pred ---ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 733 ---IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 733 ---~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.............+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000111223567789999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=336.48 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=205.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh------hHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE------REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
.+.+.+.||+|+||.||++..+ .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3456688999999999999875 46889999998653221 3567999999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC----cEEEeecCCccc
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF----SAKISDFGLSKL 652 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~DfGla~~ 652 (796)
+||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||++++++ .+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999888899999999999999999999998 999999999999999888 799999999987
Q ss_pred ccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. .....
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~--------~~~~~-- 236 (321)
T 2a2a_A 169 IEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--------SVSYD-- 236 (321)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--------TTCCC--
T ss_pred cCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------hcccc--
Confidence 64432 2234568999999999999999999999999999999999999997665443222211 11100
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+... .......+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 01123457789999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.94 Aligned_cols=245 Identities=27% Similarity=0.286 Sum_probs=192.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHH-hcccCccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSA-IGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+|+||.||+++.+ .+++.||||++++.. ......+.+|..+ ++.++||||+++++++.+....++||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 345678999999999999975 468899999997643 2234566777776 56789999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...... .
T Consensus 119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~ 194 (373)
T 2r5t_A 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-S 194 (373)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-C
Confidence 9999999999998878889999999999999999999998 99999999999999999999999999998643322 2
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+... +
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--------~~~~~--~------ 258 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--------NKPLQ--L------ 258 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH--------HSCCC--C------
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--------hcccC--C------
Confidence 2345679999999999999999999999999999999999999998765544332221 11111 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVL 771 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 771 (796)
+......+.+++.+||+.||.+||++.+.+
T Consensus 259 --~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 259 --KPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp --CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred --CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 011224567799999999999999985433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.74 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=197.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCe----EEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGT----AIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.+.||+|+||.||+|.... +++ .|++|.+... .....+.+.+|+.++++++||||+++++++.... .++|
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 3455789999999999998753 333 4688887543 2345678999999999999999999999998754 7899
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
+||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 9999999999999764 5689999999999999999999998 89999999999999999999999999998764433
Q ss_pred Cc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 658 SR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 658 ~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+....+ ..+....
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--------~~~~~~~---- 239 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERLP---- 239 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCCCC----
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCCCC----
Confidence 22 2223446889999999999999999999999999999999 99999765443322211 1111100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.+......+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 240 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 240 -----QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111234577899999999999999999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.13 Aligned_cols=247 Identities=22% Similarity=0.263 Sum_probs=193.7
Q ss_pred HhHHHhhCCCccceEEEEEeeC--CCCeEEEEEEecchh----hhhHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLA----QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
+.+.+.||+|+||.||++.... .+++.||+|+++... ......+.+|+.++++++||||+++++++......++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 4456789999999999998642 468899999997532 2234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
||||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 999999999999998878889999999999999999999998 89999999999999999999999999998643222
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. .....
T Consensus 176 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--------~~~~~------- 239 (327)
T 3a62_A 176 T-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--------KCKLN------- 239 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--------HTCCC-------
T ss_pred c-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------hCCCC-------
Confidence 1 2234568999999999999999999999999999999999999998665443222111 11110
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQ 772 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 772 (796)
.+......+.+++.+||+.||++|| ++.++++
T Consensus 240 ---~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 ---LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0111234567899999999999999 7778875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=332.05 Aligned_cols=254 Identities=25% Similarity=0.427 Sum_probs=201.7
Q ss_pred HHhhCCCccceEEEEEeeCC--CCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccc-eeEEeec
Q 044281 507 KEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNR-LLVYEFM 582 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lv~e~~ 582 (796)
.+.||+|+||+||+|..... ++..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.... ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 36799999999999986532 334799999975333 4457899999999999999999999999776665 9999999
Q ss_pred CCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC---C
Q 044281 583 GNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ---S 658 (796)
Q Consensus 583 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~---~ 658 (796)
.+++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 99999999987 45688999999999999999999998 89999999999999999999999999998654322 1
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhh-HHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMEL-EEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+.... ...+....
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~--------~~~~~~~~------ 248 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF--------LAQGRRLP------ 248 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH--------HHTTCCCC------
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH--------hhcCCCCC------
Confidence 22234567889999999999999999999999999999999776654332 2111111 11111100
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.+......+.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus 249 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 249 ---QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0111234677899999999999999999999999886553
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=329.85 Aligned_cols=245 Identities=27% Similarity=0.369 Sum_probs=200.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||++..+ .+++.||+|++..... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 34578999999999999865 4678999999865322 2356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++...... ..
T Consensus 91 ~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~ 164 (279)
T 3fdn_A 91 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RR 164 (279)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc---cc
Confidence 99999999998888899999999999999999999998 9999999999999999999999999998654322 22
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+.. .... .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~----------~ 226 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--------VEFT----------F 226 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------TCCC----------C
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--------CCCC----------C
Confidence 345689999999999999999999999999999999999999986654433222211 0000 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQML 774 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 774 (796)
+......+.+++.+||+.||++|||+.|+++.-
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 111224567799999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.62 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=195.4
Q ss_pred HHHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccc
Q 044281 498 ELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 498 ~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 575 (796)
|+....+.+.+.||+|+||.||+|... ..||||+++.. .....+.|.+|+.++++++|+||+++++++ .....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 444445566788999999999999853 35999998643 234457899999999999999999999965 45668
Q ss_pred eeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 576 LLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999999654 5689999999999999999999998 89999999999999999999999999998654
Q ss_pred CCC-CcceeeccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 655 SDQ-SRTHTMIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 655 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+... .....+...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~ 244 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-------EMVGRGSLS 244 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH-------HHHHHTSCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH-------HHhcccccC
Confidence 322 22234456899999999986 6678999999999999999999999997643322111 111111111
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
..+.. ........+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 245 ~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLSK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchhh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11110 011223567889999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.13 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=206.7
Q ss_pred HhHHHhhCCCccceEEEEEe---eCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccc--cceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVL---KTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL--NRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv 578 (796)
+.+.+.||+|+||.||++.. ...+++.||||++........+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 34567899999999999985 23468999999998766666788999999999999999999999886544 67999
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
|||+++++|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999999875 4689999999999999999999998 99999999999999999999999999998765443
Q ss_pred Ccc--eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH--------HHHHHHHHhhhcC
Q 044281 658 SRT--HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA--------ILTDWAYDCYVEG 727 (796)
Q Consensus 658 ~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~--------~l~~~~~~~~~~~ 727 (796)
... .....++..|+|||.+.+..++.++||||||+++|||++|..|+.......... ............+
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 211 223456778999999999899999999999999999999999886442211100 0000011111111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.... .+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 280 ~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 280 GRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp CCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1100 11122356788999999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=335.63 Aligned_cols=264 Identities=23% Similarity=0.250 Sum_probs=199.3
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-----hhHHHHHHHHHHhccc---CccCcccccccccccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-----EREREFKSEVSAIGRT---HHKHLVQLLGFCDEAL 573 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~ 573 (796)
..+.+.+.||+|+||+||+|... .+++.||||++..... .....+.+|+.+++++ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECT-TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 34556688999999999999865 4688999999864221 1124566777776666 4999999999987655
Q ss_pred -----cceeEEeecCCCCHHHHHhcCCC--CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEee
Q 044281 574 -----NRLLVYEFMGNGTLANLIFAIPK--PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISD 646 (796)
Q Consensus 574 -----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 646 (796)
..++||||+. ++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 4789999997 599999987654 89999999999999999999998 899999999999999999999999
Q ss_pred cCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc
Q 044281 647 FGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 726 (796)
Q Consensus 647 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 726 (796)
||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+........ +
T Consensus 164 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~ 240 (308)
T 3g33_A 164 FGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-E 240 (308)
T ss_dssp CSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC-T
T ss_pred CccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-h
Confidence 99998654322 23445689999999999999999999999999999999999999987665544333222111100 0
Q ss_pred Cccceec-------c---chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 GRLDVLI-------D---SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 ~~~~~~~-------d---~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....... . ............+.+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 0 000001112233567889999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=334.44 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=199.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCC--CeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccc-cccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFC-DEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e 580 (796)
.+.+.||+|+||.||+|.....+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++ ..+...++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 34578999999999999865332 3468999987533 34457899999999999999999999985 45567899999
Q ss_pred ecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-
Q 044281 581 FMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS- 658 (796)
Q Consensus 581 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~- 658 (796)
|+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 99999999999764 4678999999999999999999998 899999999999999999999999999987643321
Q ss_pred --cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCC-CCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 659 --RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRR-SVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~-p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.......+|+.|+|||.+.+..++.++||||||+++|||++|+. |+......+....+ ..+.....
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~--- 253 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------LQGRRLLQ--- 253 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH--------HTTCCCCC---
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--------hcCCCCCC---
Confidence 12233457889999999999999999999999999999999555 44433222211111 11111110
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCC
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (796)
+......+.+++.+||+.||++|||+.++++.|+.++...
T Consensus 254 ------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 254 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1112245778999999999999999999999999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.20 Aligned_cols=251 Identities=23% Similarity=0.261 Sum_probs=191.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+++.+ .+++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 445678999999999999875 468899999996533 223568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc--EEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS--AKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~kl~DfGla~~~~~~~~~~~ 661 (796)
+|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++..... ...
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~ 174 (361)
T 3uc3_A 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP 174 (361)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCC
Confidence 999999998888899999999999999999999998 8999999999999987765 999999999853222 222
Q ss_pred eeccCCCcccccccccCCCCCcc-chhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAK-VDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k-~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....||+.|+|||.+.+..++.+ +|||||||++|||++|+.||............ ... ....... +.
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~~~-~~~~~~~--~~------ 242 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT---IQR-ILSVKYS--IP------ 242 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH---HHH-HHTTCCC--CC------
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH---HHH-HhcCCCC--CC------
Confidence 34568999999999988888766 89999999999999999999764332111111 001 0011100 00
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001122456789999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=339.77 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=197.0
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-----hhhHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
.+.+.+.||+|+||.||+|..+ .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred heeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 3455678999999999999865 568899999986532 2345789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcC----------------------------------------CCCchhHHHHHHHHHHHHhhHhh
Q 044281 578 VYEFMGNGTLANLIFAI----------------------------------------PKPDWNLRIRISLEIARGLAYLH 617 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~----------------------------------------~~~~~~~~~~i~~~ia~~l~yLH 617 (796)
||||+++|+|.+++... ..+++..+..++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988521 11246678889999999999999
Q ss_pred hcCCCCeeeCCCCCCCEEEcCCC--cEEEeecCCcccccCCCC---cceeeccCCCcccccccccC--CCCCccchhHHH
Q 044281 618 EECNVPIIHCDIKPQNILLDHFF--SAKISDFGLSKLLFSDQS---RTHTMIRGTRGYVAPEWFKN--VPVSAKVDVYSF 690 (796)
Q Consensus 618 ~~~~~~iiH~Dlk~~NIll~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~ 690 (796)
+. +|+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||.+.+ ..++.++|||||
T Consensus 186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 98 899999999999998766 899999999987643222 22345569999999999975 678999999999
Q ss_pred HHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 044281 691 GVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 770 (796)
Q Consensus 691 Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev 770 (796)
||++|||++|+.||......+....+. .+... .... ........+.+++.+||+.||.+||++.++
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~--------~~~~~--~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVL--------NKKLC--FENP----NYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC--TTSG----GGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHH--------hcccc--cCCc----ccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 999999999999997665443222211 11100 0000 011123467789999999999999999999
Q ss_pred HHH
Q 044281 771 LQM 773 (796)
Q Consensus 771 l~~ 773 (796)
++.
T Consensus 329 l~h 331 (345)
T 3hko_A 329 LQH 331 (345)
T ss_dssp HHS
T ss_pred hcC
Confidence 874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=335.67 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=194.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCC--CCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccccc-----
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN----- 574 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 574 (796)
+.+.+.||+|+||.||+|..... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 44557899999999999987643 4568999998643 23445779999999999999999999999877653
Q ss_pred ceeEEeecCCCCHHHHHh------cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecC
Q 044281 575 RLLVYEFMGNGTLANLIF------AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFG 648 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfG 648 (796)
.++||||+++++|.+++. ....+++..++.++.||++||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence 499999999999999984 335688999999999999999999998 89999999999999999999999999
Q ss_pred CcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhc
Q 044281 649 LSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVE 726 (796)
Q Consensus 649 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~ 726 (796)
+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--------~~ 264 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL--------LH 264 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--------HT
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH--------Hc
Confidence 9987644332 22233457889999999999999999999999999999999 88888654433221111 11
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 727 GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 727 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+..... +......+.+++.+||+.||.+|||+.++++.|+.+++
T Consensus 265 ~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 265 GHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 11223467789999999999999999999999988654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=346.31 Aligned_cols=266 Identities=17% Similarity=0.205 Sum_probs=201.0
Q ss_pred HhHHHhhCCC--ccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRG--SFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G--~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+| +||.||++..+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 4456789999 99999999975 468999999996543 344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 580 EFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 580 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+.......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999875 6789999999999999999999998 89999999999999999999999999987653322
Q ss_pred C------cceeeccCCCcccccccccC--CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc---
Q 044281 658 S------RTHTMIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE--- 726 (796)
Q Consensus 658 ~------~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~--- 726 (796)
. .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......................
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 1 11122468999999999987 679999999999999999999999997543221111000000000000
Q ss_pred ----------------Cccceeccc---------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 ----------------GRLDVLIDS---------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 ----------------~~~~~~~d~---------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......... .............+.+++.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000000 00000112233568889999999999999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=341.95 Aligned_cols=249 Identities=26% Similarity=0.326 Sum_probs=187.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+|..+ .+++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQK-GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 344578999999999999875 467899999997643 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++..... ..
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~ 206 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VL 206 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--cc
Confidence 999999999888899999999999999999999998 8999999999999975 899999999999865432 22
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... + .......... ..+
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~-----~~i~~~~~~~-~~~----- 273 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--F-----RRILNCEYYF-ISP----- 273 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--H-----HHHHTTCCCC-CTT-----
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--H-----HHHHhCCCcc-CCc-----
Confidence 23456899999999999999999999999999999999999999755433211 0 1111111110 000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+.+++.+||+.||++|||+.++++.
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011123467789999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=338.75 Aligned_cols=265 Identities=24% Similarity=0.329 Sum_probs=202.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.+.||+|+||.||++... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred heeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 344578999999999999865 468899999985432 23356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 106 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 181 (331)
T 4aaa_A 106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VY 181 (331)
T ss_dssp CSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-cc
Confidence 99999999988888899999999999999999999998 999999999999999999999999999986543322 22
Q ss_pred eeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH------------Hh-hhcC
Q 044281 662 TMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY------------DC-YVEG 727 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~------------~~-~~~~ 727 (796)
....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+..... .. ....
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 345689999999999875 789999999999999999999999977654433222211000 00 0111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...................+.+.+++.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111111122334678889999999999999999998853
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.99 Aligned_cols=268 Identities=21% Similarity=0.291 Sum_probs=198.6
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcc--cCccCccccccccccc----ccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR--THHKHLVQLLGFCDEA----LNR 575 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~~ 575 (796)
..+.+.+.||+|+||.||+|.. .++.||||++.... ...+..|.+++.. ++||||+++++++... ...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEE---CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3455668899999999999986 37899999986532 2334445555444 5999999999998776 678
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC-----CCCeeeCCCCCCCEEEcCCCcEEEeecCCc
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC-----NVPIIHCDIKPQNILLDHFFSAKISDFGLS 650 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-----~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 650 (796)
++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. +.+|+||||||+|||++.++.+||+|||++
T Consensus 111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 9999999999999999764 6889999999999999999999862 337999999999999999999999999999
Q ss_pred ccccCCCCcc---eeeccCCCcccccccccCCCCCcc------chhHHHHHHHHHHHhC----------CCCCchhhHHH
Q 044281 651 KLLFSDQSRT---HTMIRGTRGYVAPEWFKNVPVSAK------VDVYSFGVTLLEIICC----------RRSVEMELEEE 711 (796)
Q Consensus 651 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k------~DVwS~Gv~l~elltg----------~~p~~~~~~~~ 711 (796)
+.+....... .....||+.|+|||.+.+...+.+ +|||||||++|||++| +.|+.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 8764433221 124569999999999988776665 9999999999999999 55554322111
Q ss_pred HhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCC
Q 044281 712 SRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPN 782 (796)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (796)
.... ............ ..............++.+++.+||+.||++|||+.+|++.|+.+.+...
T Consensus 270 ~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 270 PSYE---DMREIVCIKKLR---PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCHH---HHHHHHTTSCCC---CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred Cchh---hhHHHHhhhccC---ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 0000 000111111111 1111112233566778899999999999999999999999998766543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.75 Aligned_cols=258 Identities=28% Similarity=0.373 Sum_probs=205.8
Q ss_pred HHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccc-cc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEAL-NR 575 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~ 575 (796)
.+.+.+.||+|+||.||+|... ..+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.... ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 3445678999999999999853 3467899999997643 33456799999999999 7999999999987654 48
Q ss_pred eeEEeecCCCCHHHHHhcCCC----------------CchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC
Q 044281 576 LLVYEFMGNGTLANLIFAIPK----------------PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~ 639 (796)
++||||+++++|.+++..... +++..++.++.||++||.|||+. +|+||||||+||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC
Confidence 999999999999999987543 78899999999999999999998 99999999999999999
Q ss_pred CcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHH
Q 044281 640 FSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILT 717 (796)
Q Consensus 640 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~ 717 (796)
+.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---- 260 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---- 260 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH----
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH----
Confidence 99999999999876544332 2233457889999999999999999999999999999998 99998654322111
Q ss_pred HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
......+..... +......+.+++.+||+.||.+|||+.+|++.|+.+++
T Consensus 261 ---~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 261 ---CRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp ---HHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011111111111 11123457789999999999999999999999988754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.36 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=205.2
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCC----CeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTAS----GTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 575 (796)
..+.+.+.||+|+||.||+|.....+ ...||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+....
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 33455678999999999999865322 2489999997643 33456799999999999 899999999999999999
Q ss_pred eeEEeecCCCCHHHHHhcC--------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc
Q 044281 576 LLVYEFMGNGTLANLIFAI--------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS 641 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 641 (796)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCe
Confidence 9999999999999998642 3578899999999999999999998 9999999999999999999
Q ss_pred EEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHH
Q 044281 642 AKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDW 719 (796)
Q Consensus 642 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~ 719 (796)
+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~--- 279 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL--- 279 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH---
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH---
Confidence 999999999876543322 2233456889999999999999999999999999999999 88888754322211111
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
. ..+.... . +......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 280 ~----~~~~~~~--~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 280 V----KDGYQMA--Q-------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp H----HHTCCCC--C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----hcCCCCC--C-------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1 1111000 0 1111245778999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=341.06 Aligned_cols=248 Identities=19% Similarity=0.286 Sum_probs=192.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCc--cCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHH--KHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+|+||.||++..+ +++.||||++... .....+.+.+|+.++.+++| +||+++++++......++||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 345678999999999999864 5889999998643 33445789999999999976 99999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
| +.+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9 56789999999988899999999999999999999998 899999999999997 578999999999876543322
Q ss_pred -ceeeccCCCcccccccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 660 -THTMIRGTRGYVAPEWFKN-----------VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... + .... ..
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~----~~~~-~~ 236 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--L----HAII-DP 236 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--H----HHHH-CT
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH--H----HHHh-cC
Confidence 2334579999999999865 67899999999999999999999999753222110 0 0000 10
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.... ..+......+.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~--------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NHEI--------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TSCC--------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cccc--------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0000 0011112456789999999999999999999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=329.50 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=201.9
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccc---------
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDE--------- 571 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------- 571 (796)
...+.+.+.||+|+||.||+|... .+++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 334455678999999999999875 468899999996543 356789999999999999999998754
Q ss_pred -------cccceeEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcE
Q 044281 572 -------ALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSA 642 (796)
Q Consensus 572 -------~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 642 (796)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+|+||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 45579999999999999999754 5788999999999999999999998 99999999999999999999
Q ss_pred EEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH
Q 044281 643 KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD 722 (796)
Q Consensus 643 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~ 722 (796)
||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ..
T Consensus 162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----------~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF----------FT 229 (284)
T ss_dssp EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH----------HH
T ss_pred EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH----------HH
Confidence 9999999987654322 23345899999999999999999999999999999999999987532111 01
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCCC
Q 044281 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPG 785 (796)
Q Consensus 723 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp~ 785 (796)
....+.+.. .....+.+++.+||+.||++|||+.|+++.|+.+...+....
T Consensus 230 ~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 230 DLRDGIISD------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp HHHTTCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred Hhhcccccc------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 111111111 112346678999999999999999999999998876655443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.04 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=203.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||+|..+ .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 34578999999999999865 468899999986532 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc---EEEeecCCcccccCCCCc
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS---AKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~DfGla~~~~~~~~~ 659 (796)
++++|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||++.......
T Consensus 88 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-- 162 (284)
T 3kk8_A 88 TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 162 (284)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC--
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc--
Confidence 9999999998888899999999999999999999998 8999999999999986655 9999999998654322
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+. .+..... .+.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--------~~~~~~~-~~~--- 230 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK--------AGAYDYP-SPE--- 230 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HTCCCCC-TTT---
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH--------hccccCC-chh---
Confidence 2234568999999999999999999999999999999999999997665443322221 1111100 000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 231 --~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 --WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01122456789999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=336.50 Aligned_cols=256 Identities=21% Similarity=0.265 Sum_probs=195.4
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecCCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+.||+|+||.||++... .+++.||||++..........+.+|+.++.++ +||||+++++++.+....++||||+++++
T Consensus 19 ~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCSSEEEEEEECS-SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ceecCCceEEEEEEEEc-CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 56999999999999865 46889999999765555567899999999885 79999999999999999999999999999
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc---EEEeecCCcccccCCCC-----
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS---AKISDFGLSKLLFSDQS----- 658 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~DfGla~~~~~~~~----- 658 (796)
|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.......
T Consensus 98 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 174 (316)
T 2ac3_A 98 ILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174 (316)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence 999998888899999999999999999999998 9999999999999998776 99999999986542221
Q ss_pred -cceeeccCCCcccccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH-------hHHHHHHHHHhhh
Q 044281 659 -RTHTMIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES-------RAILTDWAYDCYV 725 (796)
Q Consensus 659 -~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~-------~~~l~~~~~~~~~ 725 (796)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .............
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 254 (316)
T 2ac3_A 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254 (316)
T ss_dssp -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH
T ss_pred ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHh
Confidence 11223458999999999975 5688999999999999999999999975421100 0000000111111
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 726 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+.... ... ........+.+++.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~----~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 255 EGKYEF----PDK--DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HCCCCC----CHH--HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCccc----Cch--hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111110 000 001123467789999999999999999999884
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=338.42 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=194.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.+.||+|+||+||++... .+++.||||++..... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEEecCCeEEEEEEEC-CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 345578999999999999865 4789999999965332 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE-----cCCCcEEEeecCCcccccCC
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL-----DHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll-----~~~~~~kl~DfGla~~~~~~ 656 (796)
+++ +|.+++...+.+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 115 ~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 115 AEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp CSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 985 9999999888899999999999999999999998 89999999999999 45566999999999876432
Q ss_pred CCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc---------
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE--------- 726 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~--------- 726 (796)
. .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+..........
T Consensus 191 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 191 I-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 2 223344579999999999875 48999999999999999999999998765544332221111000000
Q ss_pred ---CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 ---GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 ---~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......................+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000001111111111133567889999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.74 Aligned_cols=262 Identities=20% Similarity=0.305 Sum_probs=196.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|... .+++.||||++... .......+.+|+.++++++|+||+++++++.+....++|||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp EEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 445678999999999999865 46889999998642 23445788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 581 FMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 581 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
|+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||+++.....
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999864 45688999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||........ .+ . .....+......
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~---~-~~~~~~~~~~~~--- 259 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SL---C-KKIEQCDYPPLP--- 259 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH--HH---H-HHHHTTCSCCCC---
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH--HH---H-HHhhcccCCCCc---
Confidence 22 22334689999999999999999999999999999999999999965422110 00 0 111111111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCC
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPP 784 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp 784 (796)
.......+.+++.+||+.||++|||+.+|++.|+.+.....+|
T Consensus 260 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 260 -----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 0112345778999999999999999999999999876544433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=337.60 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=202.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeE--EEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTA--IAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~--vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+|+||.||+|.... ++.. +|+|.+.... ....+.+.+|+.+++++ +||||+++++++.+....++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeecCCCceEEEEEEcc-CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 3456789999999999998764 4554 5999986532 33456789999999999 9999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC----------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 044281 580 EFMGNGTLANLIFAIP----------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAK 643 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 643 (796)
||+++++|.+++.... .+++..++.++.||++||+|||+. +|+||||||+|||++.++.+|
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEE
Confidence 9999999999997654 688999999999999999999998 999999999999999999999
Q ss_pred EeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHH
Q 044281 644 ISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYD 722 (796)
Q Consensus 644 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~ 722 (796)
|+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+
T Consensus 183 L~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~------ 254 (327)
T 1fvr_A 183 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL------ 254 (327)
T ss_dssp ECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG------
T ss_pred EcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh------
Confidence 9999999743221 11223456889999999999899999999999999999998 99999765543322111
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCC
Q 044281 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781 (796)
Q Consensus 723 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (796)
..+.... .+......+.+++.+||+.||++|||+.++++.|+.+++..
T Consensus 255 --~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 255 --PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp --GGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred --hcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111100 01112245778999999999999999999999998766543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=347.24 Aligned_cols=270 Identities=20% Similarity=0.275 Sum_probs=207.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccc--cceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL--NRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 580 (796)
+.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred eEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 345578999999999999875 468899999997643 234567889999999999999999999987655 6799999
Q ss_pred ecCCCCHHHHHhcCC---CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE----cCCCcEEEeecCCcccc
Q 044281 581 FMGNGTLANLIFAIP---KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSKLL 653 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~DfGla~~~ 653 (796)
|+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999997643 389999999999999999999998 89999999999999 78888999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccC--------CCCCccchhHHHHHHHHHHHhCCCCCchhhHHH-HhHHHHHHHHHhh
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKN--------VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTDWAYDCY 724 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~-~~~~l~~~~~~~~ 724 (796)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~- 243 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK- 243 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC-
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC-
Confidence 4322 2234568999999999865 567889999999999999999999997432211 111111111110
Q ss_pred hcCccceec-----------cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 725 VEGRLDVLI-----------DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 725 ~~~~~~~~~-----------d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.......+. +..............+..++.+||+.||++||++.++++.|+.++..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 000000000 00111122355667788899999999999999999999999887764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=345.16 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=190.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccC-ccCcccccccccccc--cceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTH-HKHLVQLLGFCDEAL--NRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lv 578 (796)
+.+.+.||+|+||.||+|... .+++.||||++... .......+.+|+.++..+. ||||+++++++...+ ..++|
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp EEEEEC-------CEEEEEET-TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 445578999999999999865 46899999998643 2344567889999999997 999999999986544 67999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC-
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ- 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~- 657 (796)
|||++ ++|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 90 ~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 90 FDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred ecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99998 589998876 4688899999999999999999998 99999999999999999999999999998753211
Q ss_pred -------------------CcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHH
Q 044281 658 -------------------SRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILT 717 (796)
Q Consensus 658 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~ 717 (796)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 112234579999999999986 678999999999999999999999998765544333322
Q ss_pred HHHHHhhh-------------------------cCccceeccchh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044281 718 DWAYDCYV-------------------------EGRLDVLIDSDE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 768 (796)
Q Consensus 718 ~~~~~~~~-------------------------~~~~~~~~d~~~----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 768 (796)
........ .......+.... ...........+.+++.+||+.||++|||+.
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 11100000 000000000000 0000001234678899999999999999999
Q ss_pred HHHHH
Q 044281 769 VVLQM 773 (796)
Q Consensus 769 evl~~ 773 (796)
|+++.
T Consensus 325 e~l~H 329 (388)
T 3oz6_A 325 DALKH 329 (388)
T ss_dssp HHTTS
T ss_pred HHhCC
Confidence 99876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.18 Aligned_cols=240 Identities=25% Similarity=0.348 Sum_probs=199.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--------hhHHHHHHHHHHhcccCccCcccccccccccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 575 (796)
+.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|+.++++++||||+++++++.+....
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 334567999999999999865 4689999999965321 1234678899999999999999999999999999
Q ss_pred eeEEeecCCC-CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 576 LLVYEFMGNG-TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 576 ~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
++||||+.+| +|.+++...+.+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999777 9999999988999999999999999999999998 89999999999999999999999999998764
Q ss_pred CCCCcceeeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....... ... .
T Consensus 182 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------~~~----~ 241 (335)
T 3dls_A 182 RGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------EAA----I 241 (335)
T ss_dssp TTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------TTC----C
T ss_pred CCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------hhc----c
Confidence 432 2334568999999999988877 889999999999999999999996422100 000 0
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.. +......+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 HP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 11123457789999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.26 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=193.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccc-----cccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFC-----DEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----~~~~~~~lv~ 579 (796)
.+.+.||+|+||.||+|+. +++.||||++...... ......|+..+..++|+||+++++.+ ......++||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred heeeecccCCCeEEEEEEE---CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 3457899999999999975 5789999999653322 12223444445568999999999743 3444668999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC------CCCeeeCCCCCCCEEEcCCCcEEEeecCCcccc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC------NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~------~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 653 (796)
||+++|+|.+++.... .++..++.++.||++||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.+
T Consensus 92 e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~ 170 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170 (336)
T ss_dssp CCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence 9999999999997654 488899999999999999999862 237999999999999999999999999999876
Q ss_pred cCCC-------CcceeeccCCCcccccccccC-------CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH-hHHHH-
Q 044281 654 FSDQ-------SRTHTMIRGTRGYVAPEWFKN-------VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES-RAILT- 717 (796)
Q Consensus 654 ~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~-~~~l~- 717 (796)
.... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+........ ...+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 250 (336)
T 3g2f_A 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250 (336)
T ss_dssp SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHH
T ss_pred ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhc
Confidence 5332 112224569999999999987 4567899999999999999999877643221100 00000
Q ss_pred --------HHHHHhh-hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 718 --------DWAYDCY-VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 718 --------~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
....... .......+.+ ...........+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 251 EVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 0000001 1111111111 1111233556788999999999999999999999999886643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.92 Aligned_cols=256 Identities=24% Similarity=0.303 Sum_probs=207.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|... .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 345578999999999999865 467899999996532 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++...... .
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---R 168 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---C
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc---c
Confidence 999999999998878899999999999999999999998 9999999999999999999999999999765332 2
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ...... +
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~--~------- 231 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--------VNVDLK--F------- 231 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCC--C-------
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH--------hccccC--C-------
Confidence 23456899999999999999999999999999999999999999765443322211 111110 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHcCcCCCCCC
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ--MLEGLLDVPNPP 784 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~--~L~~~~~~~~pp 784 (796)
+......+.+++.+||+.||.+|||+.++++ .+........||
T Consensus 232 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 232 -PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp -CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred -CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 1112245678999999999999999999986 444433333333
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.78 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=195.7
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.+.||+|+||.||++..+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred heeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 3456688999999999999865 468899999986543 23457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE---cCCCcEEEeecCCccccc
Q 044281 582 MGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 582 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~ 654 (796)
+++++|.+.+.. ...+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999998854 36789999999999999999999998 89999999999999 456889999999998654
Q ss_pred CCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||......+...... ........ .
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~------~~~~~~~~--~ 247 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT------YKEPNYAV--E 247 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCCCCCC---
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc------cCCccccc--c
Confidence 332 233456899999999986 578999999999999999999999998665443222110 01111000 0
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
. ......+.+++.+||+.||++|||+.|+++
T Consensus 248 ---~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 ---C----RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---c----CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 001245678999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=339.52 Aligned_cols=260 Identities=26% Similarity=0.380 Sum_probs=203.0
Q ss_pred HHHHHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCccccccccccccc
Q 044281 500 KDATDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN 574 (796)
Q Consensus 500 ~~~~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 574 (796)
....+.+.+.||+|+||.||+|... ..+++.||||.+... ......++.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3344556788999999999999853 245678999999643 34456689999999999999999999999999999
Q ss_pred ceeEEeecCCCCHHHHHhcCC-------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEE
Q 044281 575 RLLVYEFMGNGTLANLIFAIP-------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKI 644 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl 644 (796)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999998652 478889999999999999999998 8999999999999984 456999
Q ss_pred eecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHH
Q 044281 645 SDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYD 722 (796)
Q Consensus 645 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~ 722 (796)
+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~------ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV------ 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH------
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH------
Confidence 99999986543332 22234557889999999999999999999999999999998 88898765443322111
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 723 CYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 723 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
..+..... .......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 259 --~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 259 --TSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp --HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hcCCCCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11111110 11123457789999999999999999999999987544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.74 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=201.5
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh------hhHHHHHHHHHHhcccCccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ------EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 576 (796)
.+.+.+.||+|+||.||++..+ .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 3455678999999999999875 4688999999865321 13578999999999999999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC----cEEEeecCCccc
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF----SAKISDFGLSKL 652 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~DfGla~~ 652 (796)
+||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||++++++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999998878899999999999999999999998 999999999999998877 899999999987
Q ss_pred ccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
..... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ......
T Consensus 162 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~-- 229 (283)
T 3bhy_A 162 IEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--------SAVNYD-- 229 (283)
T ss_dssp CC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCC--
T ss_pred ccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh--------HhcccC--
Confidence 64322 223446899999999999999999999999999999999999999766544322211 111100
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
... .........+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 001112345778999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.75 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=197.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc----cccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE----ALNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 578 (796)
.+.+.||+|+||.||+|... .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 34567999999999999865 46889999998653 23445789999999999999999999998765 4557999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCC--eeeCCCCCCCEEEc-CCCcEEEeecCCcccccC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVP--IIHCDIKPQNILLD-HFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~ 655 (796)
|||+++++|.+++.....+++..++.++.||+.||.|||+. + |+|+||||+|||++ +++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999998878899999999999999999999998 6 99999999999998 789999999999975432
Q ss_pred CCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......... .....+......
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~~~~-- 251 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-------RRVTSGVKPASF-- 251 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-------HHHTTTCCCGGG--
T ss_pred c---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-------HHHhccCCcccc--
Confidence 2 2334568999999998874 58999999999999999999999997543222111 111111111100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++|||+.++++.
T Consensus 252 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11112457789999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.17 Aligned_cols=244 Identities=25% Similarity=0.315 Sum_probs=196.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+...+.||+|+||.||+|... .+++.||||++... .....+.+.+|++++++++||||+++++++......++|||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 334567999999999999864 47899999998642 23345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHh-cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIF-AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+. |+|.+++. ....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 997 57877775 456789999999999999999999998 8999999999999999999999999999865322
Q ss_pred ceeeccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 660 THTMIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
....||+.|+|||.+. +..++.++|||||||++|||++|+.||...........+ . .+......
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~-------~-~~~~~~~~--- 274 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------A-QNESPALQ--- 274 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------H-HSCCCCCC---
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------H-hcCCCCCC---
Confidence 2346899999999984 567899999999999999999999999765433221111 1 11111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+.+.+++.+||+.||++|||+.++++.
T Consensus 275 -----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 -----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11123456779999999999999999999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=346.94 Aligned_cols=261 Identities=24% Similarity=0.270 Sum_probs=194.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccc------cc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------NR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 575 (796)
+.+.+.||+|+||+||+|... .+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred eEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 334578999999999999865 46899999999653 3344567899999999999999999999986543 46
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 143 ~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 999999986 46666543 488899999999999999999998 899999999999999999999999999986543
Q ss_pred CCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh------------
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC------------ 723 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~------------ 723 (796)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.......
T Consensus 217 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred C--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 2 23345679999999999999999999999999999999999999998765443332222111000
Q ss_pred --hhcCc-------cceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 724 --YVEGR-------LDVLIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 724 --~~~~~-------~~~~~d~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.+.. ....+.... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000000 000111225678899999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=343.20 Aligned_cols=261 Identities=15% Similarity=0.164 Sum_probs=200.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCC-------CCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccc-----------
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTA-------SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL----------- 565 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~-------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------- 565 (796)
+.+.+.||+|+||.||+|..... +++.||||.+... ..+.+|+.++++++||||+++
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 44567899999999999987642 4789999998653 467899999999999999984
Q ss_pred ----cccccc-cccceeEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC
Q 044281 566 ----LGFCDE-ALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH 638 (796)
Q Consensus 566 ----~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~ 638 (796)
++++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 455544 66789999999 99999999876 6799999999999999999999998 9999999999999999
Q ss_pred CC--cEEEeecCCcccccCCCCc------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHH
Q 044281 639 FF--SAKISDFGLSKLLFSDQSR------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEE 710 (796)
Q Consensus 639 ~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~ 710 (796)
++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 9999999999876433211 123346899999999999999999999999999999999999999865421
Q ss_pred HHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 711 ESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
... +....... .. ....+.+.... .......+.+++.+||+.||++|||+.+|+++|+.+++.
T Consensus 275 ~~~--~~~~~~~~-~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 275 TED--IMKQKQKF-VD-KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp HHH--HHHHHHHH-HH-SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH--HHHHHHhc-cC-Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 111 11111111 11 11111111100 011125677899999999999999999999999887654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.64 Aligned_cols=261 Identities=23% Similarity=0.267 Sum_probs=200.2
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-----ccCcccccccccccccce
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~~ 576 (796)
..+.+.++||+|+||+||+|... .+++.||||++... ......+..|+.+++.++ ||||+++++++......+
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 34556688999999999999875 46889999999753 334556788898888886 999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC----------------
Q 044281 577 LVYEFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---------------- 638 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---------------- 638 (796)
+||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999 899999998654 588999999999999999999998 9999999999999975
Q ss_pred ---------CCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhH
Q 044281 639 ---------FFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELE 709 (796)
Q Consensus 639 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~ 709 (796)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 889999999999864332 2345689999999999999999999999999999999999999976554
Q ss_pred HHHhHHHHHHHH--------HhhhcC--------ccceeccchhhhh------------hcHHHHHHHHHHHHHhcccCC
Q 044281 710 EESRAILTDWAY--------DCYVEG--------RLDVLIDSDEAAM------------ADRSRLHKWLMIAMWCIQEDP 761 (796)
Q Consensus 710 ~~~~~~l~~~~~--------~~~~~~--------~~~~~~d~~~~~~------------~~~~~~~~l~~l~~~Cl~~dp 761 (796)
.+....+..... ...... ............. ......+.+.+++.+||+.||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 433222211100 000000 0000000000000 000011457789999999999
Q ss_pred CCCCCHHHHHH
Q 044281 762 SKRPTMKVVLQ 772 (796)
Q Consensus 762 ~~RPt~~evl~ 772 (796)
++|||+.|+++
T Consensus 345 ~~Rpta~elL~ 355 (360)
T 3llt_A 345 TLRPSPAELLK 355 (360)
T ss_dssp GGSCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.18 Aligned_cols=262 Identities=18% Similarity=0.238 Sum_probs=202.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccc-cccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFC-DEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~~~ 583 (796)
.+.+.||+|+||.||+|+.. .+++.||||++..... ..++.+|+.+++.++|++++..+.++ .+....++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 34578999999999999864 4689999999865322 34688999999999998877766665 5566679999999
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE---cCCCcEEEeecCCcccccCCCCc
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 8999999974 45789999999999999999999998 99999999999999 58899999999999876544321
Q ss_pred ------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 660 ------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 660 ------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... ..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~---- 239 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI---- 239 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH----
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-ch----
Confidence 1244569999999999999999999999999999999999999997532211111111101000000 00
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCC
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNP 783 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~p 783 (796)
..........+.+++.+||+.||++|||+.+|++.|+.+......
T Consensus 240 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 240 -----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -----HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 000111235677899999999999999999999999887654433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.50 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=201.9
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.+.||+|+||.||++... .+++.||+|.+..........+.+|+.++++++||||+++++++.+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 3445678999999999999865 468899999997655445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE---cCCCcEEEeecCCcccccCCCCc
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||++ ++++.+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--- 162 (304)
T 2jam_A 89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162 (304)
T ss_dssp CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence 9999999998878899999999999999999999998 89999999999999 78899999999999754321
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ .++.... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~~~--~~~--- 229 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI--------KEGYYEF--ESP--- 229 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHCCCCC--CTT---
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HcCCCCC--Ccc---
Confidence 223345899999999999999999999999999999999999999765443322211 1111110 000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+.+++.+||+.||++|||+.++++.
T Consensus 230 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 -FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011123467789999999999999999999873
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.01 Aligned_cols=259 Identities=19% Similarity=0.251 Sum_probs=200.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccc-cccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFC-DEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+|+.+++.++|++++..++.+ ......++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEeeeecCCCCeEEEEEEEc-CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 445678999999999999865 468999999875432 224588899999999988887777666 5666779999999
Q ss_pred CCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE---cCCCcEEEeecCCcccccCCCC
Q 044281 583 GNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 583 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~~~~~ 658 (796)
+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9999999974 45789999999999999999999998 89999999999999 7899999999999997654432
Q ss_pred ------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 659 ------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 659 ------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... ..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~--- 239 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI--- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH---
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hh---
Confidence 12234568999999999999999999999999999999999999997543221111111111110000 00
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
..........+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 240 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 240 ------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00001123567889999999999999999999999988665
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.25 Aligned_cols=246 Identities=23% Similarity=0.295 Sum_probs=204.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||++... .+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 34578999999999999875 467899999986532 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++|.+++.....+++..+..++.||++||+|||+. +|+|+||||+||++++++.+||+|||++........ ..
T Consensus 97 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (294)
T 2rku_A 97 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK 172 (294)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-cc
Confidence 99999999998878899999999999999999999998 999999999999999999999999999987643322 22
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..+... +
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~-~--------- 234 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--------KKNEYS-I--------- 234 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCC-C---------
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hhccCC-C---------
Confidence 3456899999999999999999999999999999999999999765543322111 111110 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01112456779999999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=338.91 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=185.4
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCcccccccc--------cccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGFC--------DEAL 573 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~--------~~~~ 573 (796)
.+.+.++||+|+||.||++... .+++.||||++........+.+.+|+.++.++. ||||+++++++ ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred eEEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 3456688999999999999865 468899999997666666778999999999996 99999999988 3445
Q ss_pred cceeEEeecCCCCHHHHHhc---CCCCchhHHHHHHHHHHHHhhHhhhcCCCC--eeeCCCCCCCEEEcCCCcEEEeecC
Q 044281 574 NRLLVYEFMGNGTLANLIFA---IPKPDWNLRIRISLEIARGLAYLHEECNVP--IIHCDIKPQNILLDHFFSAKISDFG 648 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~Dlk~~NIll~~~~~~kl~DfG 648 (796)
..++||||+. |+|.+++.. ...+++..++.++.||+.||+|||+. + |+||||||+|||+++++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 5789999996 699888864 45689999999999999999999998 7 9999999999999999999999999
Q ss_pred CcccccCCCCcc-----------eeeccCCCcccccccc---cCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH
Q 044281 649 LSKLLFSDQSRT-----------HTMIRGTRGYVAPEWF---KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA 714 (796)
Q Consensus 649 la~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~ 714 (796)
+++......... .....+|+.|+|||.+ .+..++.++|||||||++|||++|+.||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~- 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV- 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh-
Confidence 998765432211 1134589999999998 5677899999999999999999999999653322110
Q ss_pred HHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 715 ILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+.... .. .......+..++.+||+.||++|||+.|+++.|+.+..
T Consensus 263 -----------~~~~~~----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 263 -----------NGKYSI----PP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------CCC----CT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------cCcccC----Cc----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000000 00 00111235678999999999999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.73 Aligned_cols=248 Identities=19% Similarity=0.291 Sum_probs=193.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccC--ccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTH--HKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++ |+||+++++++......++||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 445678999999999999864 4889999998543 3345678999999999996 599999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
| +.+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 56889999999888889999999999999999999998 899999999999995 589999999999876543322
Q ss_pred -ceeeccCCCcccccccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 660 -THTMIRGTRGYVAPEWFKN-----------VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... + .. ...+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~--~----~~-~~~~ 283 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--L----HA-IIDP 283 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--H----HH-HHCT
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH--H----HH-HhCc
Confidence 2344579999999999865 46899999999999999999999999754322110 1 01 1111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...... +......+.+++.+||+.||++|||+.|+++.
T Consensus 284 ~~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHEIEF--------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSCCCC--------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCC--------CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111000 00112456789999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.14 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=204.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 334578999999999999875 467899999986532 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++++|.+++.....+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 122 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (335)
T 2owb_A 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R 197 (335)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred cCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-c
Confidence 999999999998878899999999999999999999998 999999999999999999999999999987643322 2
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..+... +
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~-~-------- 260 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--------KKNEYS-I-------- 260 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC-C--------
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--------hcCCCC-C--------
Confidence 23456899999999999999999999999999999999999999765443322111 111110 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 261 -~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 -PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112356779999999999999999999973
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=344.05 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=202.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||++... .+++.||+|++... .....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 334578999999999999875 46889999998653 2344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++++|.+++.....+++..+..++.||+.||+|||+.. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 114 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 188 (360)
T 3eqc_A 114 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 188 (360)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C--
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---ccc
Confidence 99999999988888999999999999999999999842 7999999999999999999999999999765322 123
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh--------hhcC-------
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC--------YVEG------- 727 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~--------~~~~------- 727 (796)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+....... ...+
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 3568999999999999999999999999999999999999997654433221110000000 0000
Q ss_pred -------ccceeccch----hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 728 -------RLDVLIDSD----EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 728 -------~~~~~~d~~----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
......+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000 000001112346788999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=332.31 Aligned_cols=266 Identities=23% Similarity=0.304 Sum_probs=204.4
Q ss_pred HHHHHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcc--cCccCcccccccccccc--
Q 044281 498 ELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR--THHKHLVQLLGFCDEAL-- 573 (796)
Q Consensus 498 ~l~~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~-- 573 (796)
+.....+.+.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 33344556678899999999999986 4889999999753 34567788888776 79999999999998776
Q ss_pred --cceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhh--------hcCCCCeeeCCCCCCCEEEcCCCcEE
Q 044281 574 --NRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLH--------EECNVPIIHCDIKPQNILLDHFFSAK 643 (796)
Q Consensus 574 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH--------~~~~~~iiH~Dlk~~NIll~~~~~~k 643 (796)
..++||||+++|+|.+++... .+++..++.++.||+.||+||| +. +|+||||||+|||++.++.+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEE
Confidence 789999999999999999764 6889999999999999999999 55 899999999999999999999
Q ss_pred EeecCCcccccCCCCc---ceeeccCCCcccccccccCC------CCCccchhHHHHHHHHHHHhC----------CCCC
Q 044281 644 ISDFGLSKLLFSDQSR---THTMIRGTRGYVAPEWFKNV------PVSAKVDVYSFGVTLLEIICC----------RRSV 704 (796)
Q Consensus 644 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwS~Gv~l~elltg----------~~p~ 704 (796)
|+|||+++........ ......||+.|+|||.+.+. .++.++|||||||++|||++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999876544322 22345689999999999876 334789999999999999999 6677
Q ss_pred chhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 705 EMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 705 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
......... ... .............+ ............+.+++.+||+.||++|||+.+|+++|+.+.+
T Consensus 268 ~~~~~~~~~--~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 268 YDLVPSDPS--VEE-MRKVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTSCSSCC--HHH-HHHHHTTSCCCCCC---CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCcCccc--HHH-HHHHHHHHHhCCCC---cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 543211100 000 11111111111111 1111234566788899999999999999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.18 Aligned_cols=256 Identities=26% Similarity=0.326 Sum_probs=196.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCC--eEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.+.||+|+||.||+|.+...++ ..||||+++.. .....+.+.+|++++++++||||+++++++.... .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 4456789999999999998764444 37899998653 2344578999999999999999999999998765 8899
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
+||+++++|.+++... ..+++..+..++.||++||.|||++ +|+|+||||+||+++.++.+||+|||+++......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999998764 5688999999999999999999998 99999999999999999999999999998765433
Q ss_pred Cc--ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 658 SR--THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 658 ~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ...+....
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~~~~~~--- 245 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------DKEGERLP--- 245 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTSCCCCC---
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH-------HccCCCCC---
Confidence 22 1223457888999999999899999999999999999999 99999765443322111 11111000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
........+.+++.+||+.||++|||+.++++.|+++..
T Consensus 246 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 246 ------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 011223567789999999999999999999999988754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=345.80 Aligned_cols=192 Identities=25% Similarity=0.340 Sum_probs=153.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc-----cccce
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE-----ALNRL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 576 (796)
+.+.+.||+|+||+||+|..+ .+++.||||++... .....+.+.+|++++++++|+||+++++++.. ....+
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp EEECCC-------CEEEEEEC-C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred eEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 445678999999999999875 46889999999653 23345678999999999999999999999843 35689
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||+. ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 134 lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 134 VVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 9999985 69999999888899999999999999999999998 9999999999999999999999999999876432
Q ss_pred CC--------------------------cceeeccCCCcccccccc-cCCCCCccchhHHHHHHHHHHHhC
Q 044281 657 QS--------------------------RTHTMIRGTRGYVAPEWF-KNVPVSAKVDVYSFGVTLLEIICC 700 (796)
Q Consensus 657 ~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwS~Gv~l~elltg 700 (796)
.. .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 21 123345689999999976 566799999999999999999993
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=338.58 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=197.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||++..+ .+++.||||+++.... .+.+|++++.++ +||||+++++++.+....++||||+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 445578999999999999875 4689999999965432 245678888887 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC----CcEEEeecCCcccccCCCC
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF----FSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~kl~DfGla~~~~~~~~ 658 (796)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++.......
T Consensus 99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 9999999999888899999999999999999999998 99999999999998543 3599999999987644332
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+..+..... ..
T Consensus 176 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-----~~i~~~~~~~~--~~-- 245 (342)
T 2qr7_A 176 -LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-----ARIGSGKFSLS--GG-- 245 (342)
T ss_dssp -CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH-----HHHHHCCCCCC--ST--
T ss_pred -ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH-----HHHccCCcccC--cc--
Confidence 233456899999999999888999999999999999999999999753211111111 11112221110 00
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+.+++.+||+.||++|||+.++++.
T Consensus 246 --~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 246 --YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011223467789999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.12 Aligned_cols=249 Identities=19% Similarity=0.210 Sum_probs=198.4
Q ss_pred HhHHHhhCCCccceEEEEEe----eCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC---ccCcccccccccccccce
Q 044281 504 DGFKEELGRGSFGIVYKGVL----KTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~----~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~ 576 (796)
+.+.+.||+|+||+||+|.. ...+++.||||+++... ..++..|++++.+++ |+||+++++++...+..+
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 44557899999999999952 23467899999997643 345666666666665 999999999999999999
Q ss_pred eEEeecCCCCHHHHHhc-----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-----------CC
Q 044281 577 LVYEFMGNGTLANLIFA-----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-----------FF 640 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-----------~~ 640 (796)
+||||+++|+|.+++.. ...+++..++.++.||++||+|||+. +|+||||||+|||++. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999973 45789999999999999999999998 8999999999999998 89
Q ss_pred cEEEeecCCcccccCC-CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH
Q 044281 641 SAKISDFGLSKLLFSD-QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW 719 (796)
Q Consensus 641 ~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~ 719 (796)
.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------- 293 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------- 293 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-------
Confidence 9999999999865422 23334556799999999999999999999999999999999999999864422110
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHcCcCC
Q 044281 720 AYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKR-PTMKVVLQMLEGLLDV 780 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Pt~~evl~~L~~~~~~ 780 (796)
. +........ ..+.+.+++..|++.+|.+| |++.++.+.|+..++.
T Consensus 294 --------~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 --------K----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------E----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------e----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 011111111 13345568888999999998 6889999888876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.65 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=179.2
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||.||+|... .+++.||||.+..... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 4578999999999999864 4688999999965332 22467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
++++|.+++... ..+++..++.++.||++||+|||+. +|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 169 (278)
T 3cok_A 94 HNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KH 169 (278)
T ss_dssp TTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-cc
Confidence 999999999875 5789999999999999999999998 999999999999999999999999999987643222 22
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||........... ..... .. .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~------~~----~ 231 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK--------VVLAD------YE----M 231 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSC------CC----C
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH--------Hhhcc------cC----C
Confidence 235689999999999999999999999999999999999999975432111000 00000 00 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11123456789999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=353.96 Aligned_cols=248 Identities=26% Similarity=0.301 Sum_probs=201.3
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.||+|+||.||++..+ .+++.||||++.... ......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 4468999999999999875 468999999997532 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...... .
T Consensus 267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--~ 341 (576)
T 2acx_A 267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--T 341 (576)
T ss_dssp CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc--c
Confidence 9999999998754 489999999999999999999998 99999999999999999999999999998764332 2
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ......
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i----~~~~~~---------- 407 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KEVPEE---------- 407 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH----HHCCCC----------
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh----hccccc----------
Confidence 334579999999999999999999999999999999999999997643211111111111 111100
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
.+......+.+++.+||+.||.+|| ++.||+++
T Consensus 408 ~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0111234677899999999999999 78888753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.05 Aligned_cols=251 Identities=27% Similarity=0.345 Sum_probs=202.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||+|..+ .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 345578999999999999865 468899999986533 334578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-cce
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-RTH 661 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~ 661 (796)
++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999999998877899999999999999999999998 999999999999999999999999999987643321 223
Q ss_pred eeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...+ ...... ...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~-----~~~~~~--~~~----- 230 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW-----KEKKTY--LNP----- 230 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHH-----HTTCTT--STT-----
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHh-----hhcccc--cCc-----
Confidence 34568999999999988775 78999999999999999999999754322110 1011 111100 000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 231 -~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01123456779999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=362.36 Aligned_cols=246 Identities=27% Similarity=0.310 Sum_probs=204.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc-CccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.++||+|+||.||++..+ .+++.||||++++.. ....+.+..|..++..+ +|+||+++++++.+....+|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 344568999999999999976 468899999997532 23346788899999987 7999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++++||+|||+++...... .
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 497 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 497 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-C
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC-c
Confidence 9999999999999888899999999999999999999998 99999999999999999999999999998643322 2
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .++...
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~~~~~--------- 560 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------MEHNVA--------- 560 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HSSCCC---------
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH--------HhCCCC---------
Confidence 334567999999999999999999999999999999999999999876554433222 111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTM-----KVVLQ 772 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~evl~ 772 (796)
.+.....++.+++.+||+.||++||++ +||++
T Consensus 561 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 011223567789999999999999997 77764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=328.34 Aligned_cols=246 Identities=26% Similarity=0.343 Sum_probs=192.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccc-cccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDE-ALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||++.. .++.||||.++... ..+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred ceEEeEEecCCCceEEEEEE---cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 34557899999999999986 47899999997542 45679999999999999999999998654 45789999999
Q ss_pred CCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++++|.+++.... .+++..++.++.||++||+|||+. +|+|+||||+||++++++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 170 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence 9999999997654 378889999999999999999998 8999999999999999999999999999864322
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ...+.....
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~--------~~~~~~~~~------- 235 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKMDA------- 235 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH--------HTTTCCCCC-------
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HhcCCCCCC-------
Confidence 122357889999999999999999999999999999998 9999875433221111 111111110
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 236 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 236 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1122346778999999999999999999999998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=346.40 Aligned_cols=235 Identities=14% Similarity=0.166 Sum_probs=182.2
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecc---hhhhhHHHHHHHH---HHhcccCccCcccccc-------ccccc
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEV---SAIGRTHHKHLVQLLG-------FCDEA 572 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~g-------~~~~~ 572 (796)
+.+.||+|+||.||+|... .+++.||||++.. ......+.+.+|+ +.+++++|||||++++ ++...
T Consensus 77 ~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EcceeecCCCEEEEEEEEC-CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 3578999999999999865 4688999999963 2334457899999 5566668999999984 43333
Q ss_pred c-----------------cceeEEeecCCCCHHHHHhcCCCCc-------hhHHHHHHHHHHHHhhHhhhcCCCCeeeCC
Q 044281 573 L-----------------NRLLVYEFMGNGTLANLIFAIPKPD-------WNLRIRISLEIARGLAYLHEECNVPIIHCD 628 (796)
Q Consensus 573 ~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~i~~~ia~~l~yLH~~~~~~iiH~D 628 (796)
+ ..++||||+ +|+|.+++.....++ +..++.++.||+.||+|||++ +|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 2 278999999 679999998643333 478889999999999999998 899999
Q ss_pred CCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCC-----------CCCccchhHHHHHHHHHH
Q 044281 629 IKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV-----------PVSAKVDVYSFGVTLLEI 697 (796)
Q Consensus 629 lk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DVwS~Gv~l~el 697 (796)
|||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++|||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999999999999999998532 23344567 999999999887 899999999999999999
Q ss_pred HhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 698 ICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 698 ltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
++|+.||........... +.... ......+.+++.+||+.||++|||+.++++
T Consensus 307 ltg~~Pf~~~~~~~~~~~----------------~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 307 WCADLPITKDAALGGSEW----------------IFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHSSCCC------CCSGG----------------GGSSC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHCCCCCcccccccchhh----------------hhhhc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999965432221110 00000 111245778999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=343.96 Aligned_cols=254 Identities=22% Similarity=0.251 Sum_probs=201.2
Q ss_pred HhHHHhhCCCccceEEEEEeeC--CCCeEEEEEEecchh----hhhHHHHHHHHHHhccc-CccCcccccccccccccce
Q 044281 504 DGFKEELGRGSFGIVYKGVLKT--ASGTAIAVKKLDRLA----QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 576 (796)
+.+.+.||+|+||.||++.... .+++.||||+++... ....+.+.+|++++.++ +|+||+++++++......+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 4456789999999999998642 368899999987532 12345677899999999 6999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 9999999999999998888899999999999999999999998 8999999999999999999999999999876544
Q ss_pred CCcceeeccCCCcccccccccC--CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... ....
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~~~----- 283 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----KSEP----- 283 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH----HCCC-----
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh----ccCC-----
Confidence 4434445679999999999986 3578999999999999999999999975432211111111110 0000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQML 774 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~L 774 (796)
..+......+.+++.+||+.||++|| ++.++++..
T Consensus 284 -----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 -----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00112234567899999999999999 999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=336.69 Aligned_cols=260 Identities=20% Similarity=0.244 Sum_probs=193.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhh-HHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.+.||+|+||+||+|... .+++.||||++....... ...+.+|+.++++++||||+++++++......++||||++
T Consensus 6 ~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 4568999999999999865 468899999996533221 2245679999999999999999999999999999999998
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 159 (324)
T 3mtl_A 84 KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDN 159 (324)
T ss_dssp EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccccc
Confidence 4888888765 4588999999999999999999998 99999999999999999999999999998653322 22334
Q ss_pred ccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch------
Q 044281 664 IRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD------ 736 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~------ 736 (796)
..+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+........ ...........
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSNEEFKTYN 238 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTSTTGGGCHHHHHTC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-hHhchhhhcchhhcccc
Confidence 468999999999876 5689999999999999999999999987665544333322111110 00000000000
Q ss_pred -------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 737 -------EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 737 -------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
............+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000011122346778999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=334.57 Aligned_cols=265 Identities=25% Similarity=0.263 Sum_probs=195.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccc------cc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------NR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 575 (796)
+.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+++++.++||||+++++++.... ..
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp EEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEeEEeeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 344578999999999999865 46899999999543 2334567899999999999999999999987653 45
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 9999999 7899999876 5688999999999999999999998 999999999999999999999999999987532
Q ss_pred CCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh-------hhcC
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC-------YVEG 727 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~-------~~~~ 727 (796)
. .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+....... +...
T Consensus 181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 2 234568999999999987 689999999999999999999999998665443322221111000 0000
Q ss_pred -------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcCcC
Q 044281 728 -------RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGLLD 779 (796)
Q Consensus 728 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~~~ 779 (796)
.+......... .........+.+++.+||+.||++|||+.|+++. ++....
T Consensus 257 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 00000000000 0011223467789999999999999999999984 454433
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=329.38 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=199.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccc--ccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCD--EALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e 580 (796)
.+.+.||+|+||.||++... .+++.||+|.+... .....+.+.+|+.++++++||||+++++++. .....++|||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 34578999999999999875 46889999999643 2344568999999999999999999999874 4567899999
Q ss_pred ecCCCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCCCC-----eeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 581 FMGNGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNVP-----IIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 581 ~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~-----iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
|+++++|.+++... ..+++..++.++.||+.||+|||+. + |+|+||||+||++++++.+||+|||+++
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999998753 3489999999999999999999998 6 9999999999999999999999999998
Q ss_pred cccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccce
Q 044281 652 LLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (796)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..+....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i--------~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------REGKFRR 235 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCC
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH--------hhccccc
Confidence 7543221 122346899999999999999999999999999999999999999866443322211 1222211
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 732 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
+. ......+.+++.+||+.||++||++.||++.+..
T Consensus 236 ~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 IP---------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CC---------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 1123467789999999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=340.85 Aligned_cols=245 Identities=22% Similarity=0.250 Sum_probs=187.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcc-cCccCcccccccccc----cccceeEEeec
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQLLGFCDE----ALNRLLVYEFM 582 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lv~e~~ 582 (796)
+.||+|+||+||++..+ .+++.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ....++||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~-~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEEC-CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 57999999999999865 47899999999642 346678887754 589999999998865 66789999999
Q ss_pred CCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccccCCC
Q 044281 583 GNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 583 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~~~ 657 (796)
++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999999998753 589999999999999999999998 9999999999999997 7899999999998654322
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ......+.... ...
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~i~~~~~~~-~~~-- 289 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYEF-PNP-- 289 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH----HHHHHHTCCCC-CTT--
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH----HHHHHcCcccC-CCc--
Confidence 233456899999999999999999999999999999999999999754322110000 00011111110 000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+.+++.+||+.||++|||+.|+++.
T Consensus 290 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 ---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001123467789999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=345.14 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=190.2
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--------hhhHHHHHHHHHHhcccCccCccccccccccccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--------QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN 574 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 574 (796)
.+.+.+.||+|+||+||+|..+ .+++.||||++.... ......+.+|+.++++++||||+++++++.. ..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred cEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 4556678999999999999865 468899999986532 1122358899999999999999999999854 45
Q ss_pred ceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC---CcEEEeecCCcc
Q 044281 575 RLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF---FSAKISDFGLSK 651 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~DfGla~ 651 (796)
.++||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccce
Confidence 789999999999999998888899999999999999999999998 89999999999999754 459999999998
Q ss_pred cccCCCCcceeeccCCCcccccccccC---CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 652 LLFSDQSRTHTMIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ......+.
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-------~~~i~~~~ 361 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------KDQITSGK 361 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-------HHHHHTTC
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-------HHHHhcCC
Confidence 76432 22344669999999999863 67889999999999999999999999753221110 01111111
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..... .........+.+++.+||+.||++|||+.|+++.
T Consensus 362 ~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 362 YNFIP------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCCH------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCc------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11100 0011123567789999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=333.09 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=199.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccc--------cc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDE--------AL 573 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~ 573 (796)
+.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|+.++++++||||+++++++.. ..
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred eeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 445678999999999999875 4688999999854322 234578899999999999999999999876 34
Q ss_pred cceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 574 NRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
..++||||+++ +|.+.+... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 67899999986 676666554 6789999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCC---CcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 653 LFSDQ---SRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 653 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
+.... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+........ ...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT-PEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-hhh
Confidence 64322 222344568999999999876 4589999999999999999999999987665544433322111100 000
Q ss_pred ccee-----------ccchh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVL-----------IDSDE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~-----------~d~~~----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.... ..... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 00000 000000112457789999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=330.44 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=199.7
Q ss_pred HHhHH-HhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhccc-CccCcccccccccccccceeE
Q 044281 503 TDGFK-EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 503 ~~~~~-~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 578 (796)
.+.+. +.||+|+||.||++..+ .+++.||+|++.... ......+.+|+.++.++ +||||+++++++.+....++|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 33343 78999999999999875 468999999986532 23357889999999998 569999999999999999999
Q ss_pred EeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccc
Q 044281 579 YEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLL 653 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~ 653 (796)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999998654 6789999999999999999999998 8999999999999997 789999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+.. ......
T Consensus 185 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------~~~~~~- 253 (327)
T 3lm5_A 185 GHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--------VNVDYS- 253 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------TCCCCC-
T ss_pred CCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh--------cccccC-
Confidence 4322 22345689999999999999999999999999999999999999977654433222211 000000
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..........+.+++.+||+.||++|||+.++++.
T Consensus 254 -----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 254 -----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00011123456789999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=346.53 Aligned_cols=251 Identities=25% Similarity=0.310 Sum_probs=203.6
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
..+.+.+.||+|+||+||++..+ .+++.||||++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 34556788999999999999865 468899999996532 234578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc---CCCcEEEeecCCcccccCC
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD---HFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~DfGla~~~~~~ 656 (796)
||+++++|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999998888899999999999999999999998 899999999999995 4567999999999866433
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+....+ ..+.......
T Consensus 178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~~~~~-- 244 (486)
T 3mwu_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--------ETGKYAFDLP-- 244 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCSCSG--
T ss_pred C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCCCCc--
Confidence 2 2334569999999999976 5999999999999999999999999876544332222 1111111000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
. .......+.+++.+||+.||.+|||+.++++.
T Consensus 245 ~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 245 Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp G----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred c----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 11123457789999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.89 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=200.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--------hhhHHHHHHHHHHhccc-CccCcccccccccccccce
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--------QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 576 (796)
+.+.||+|+||.||+|..+ .+|+.||||++.... ....+.+.+|+.+++++ +||||+++++++......+
T Consensus 98 ~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 176 (365)
T 2y7j_A 98 PKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176 (365)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEE
T ss_pred cceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEE
Confidence 3468999999999999875 468899999985432 12245688999999999 8999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||+++++.+||+|||++..+...
T Consensus 177 lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 9999999999999998878899999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCcceeeccCCCcccccccccC------CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKN------VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ..+...
T Consensus 254 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~~~ 323 (365)
T 2y7j_A 254 E--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------MEGQYQ 323 (365)
T ss_dssp C--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCC
T ss_pred c--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCC
Confidence 2 2334568999999999863 36889999999999999999999999765433322111 111111
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
. .. .. .......+.+++.+||+.||++|||+.++++.
T Consensus 324 ~--~~-~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 324 F--SS-PE---WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp C--CH-HH---HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C--CC-cc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 00 00 01123457789999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=359.84 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=203.2
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCC--CCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
..+.+.+.||+|+||.||+|.+... .+..||||++.... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence 3445667899999999999987532 35689999987533 3445789999999999999999999999854 568999
Q ss_pred EeecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
|||+++|+|.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 99999999999998654 688999999999999999999998 99999999999999999999999999998765444
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
........+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+....+ ..+.....
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i--------~~~~~~~~---- 613 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLPM---- 613 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HHTCCCCC----
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------HcCCCCCC----
Confidence 333344557889999999999999999999999999999997 88999765443322211 11111110
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+......+.+++.+||+.||++|||+.+|++.|+.++
T Consensus 614 -----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 614 -----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1122346778999999999999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.07 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=194.4
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||+|..+ .+++.||||.+..... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEeeecCCCCeEEEEEEEC-CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 34578999999999999875 4688999999965322 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++....... ..
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 167 (276)
T 2h6d_A 93 VSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FL 167 (276)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred cCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--ce
Confidence 99999999998878899999999999999999999998 89999999999999999999999999998764322 22
Q ss_pred eeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||...........+ ..+... .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~-~-------- 230 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--------RGGVFY-I-------- 230 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC-C--------
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh--------hcCccc-C--------
Confidence 33458999999999988765 68999999999999999999999765443322111 111100 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++|||+.++++.
T Consensus 231 -~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 -PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01112456779999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.44 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=202.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
...+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 34578999999999999865 468899999996533 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+++|.+++.. ..+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ....
T Consensus 104 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 178 (303)
T 3a7i_A 104 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT 178 (303)
T ss_dssp TEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCC
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCc
Confidence 9999999865 5688999999999999999999998 899999999999999999999999999987644332 2234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..+....+ ..
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~---------~~ 241 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI--------PKNNPPTL---------EG 241 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCC---------CS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh--------hcCCCCCC---------cc
Confidence 56899999999999999999999999999999999999999765443322211 11111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+..++.+||+.||++|||+.++++.
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 122457789999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=347.86 Aligned_cols=247 Identities=28% Similarity=0.356 Sum_probs=198.7
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.||+|+||.||+++.+ .+++.||||++..... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 357999999999999875 4689999999975432 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 584 NGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 584 ~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 99999998764 3688999999999999999999998 9999999999999999999999999999876443322
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ....+...
T Consensus 346 -~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~----~i~~~~~~--------- 411 (543)
T 3c4z_A 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RVLEQAVT--------- 411 (543)
T ss_dssp -BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH----HHHHCCCC---------
T ss_pred -cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH----HHhhcccC---------
Confidence 2345799999999999999999999999999999999999999976432111111111 11111110
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTM-----KVVLQ 772 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~evl~ 772 (796)
.+......+..++.+||+.||++||++ .+|++
T Consensus 412 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 412 -YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 011223456779999999999999975 56653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=346.78 Aligned_cols=250 Identities=25% Similarity=0.323 Sum_probs=199.2
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.+.+.||+|+||+||++..+ .++..||+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3555678999999999999875 468899999986532 2335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccccCCC
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~~~ 657 (796)
|+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 999999999998888899999999999999999999998 8999999999999976 4559999999998765332
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
......||+.|+|||++. ..++.++|||||||++|||++|..||......+....+. .+.... ....
T Consensus 194 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--------~~~~~~--~~~~ 260 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE--------KGKYTF--DSPE 260 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HTCCCC--CSGG
T ss_pred --cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCCCC--Cchh
Confidence 233456999999999986 469999999999999999999999998765544322221 111110 0000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......+.+++.+||+.||.+|||+.++++.
T Consensus 261 ----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 261 ----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 01123456789999999999999999999853
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.40 Aligned_cols=246 Identities=27% Similarity=0.341 Sum_probs=194.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCCH
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTL 587 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 587 (796)
..||+|+||.||+|... .+++.||||.+........+.+.+|+.+++.++||||+++++++.+....++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEET-TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEEC-CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 37999999999999865 46889999999765555567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCC---CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccccCCCCcceee
Q 044281 588 ANLIFAIP---KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 588 ~~~l~~~~---~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
.+++.... .+++..+..++.||+.||.|||+. +|+|+||||+||+++. ++.+||+|||+++....... ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 99997652 456888899999999999999998 9999999999999997 89999999999987643221 2234
Q ss_pred ccCCCcccccccccCCC--CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 664 IRGTRGYVAPEWFKNVP--VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
..||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........... .. .. ......+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~--~~--~~~~~~~--------- 247 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KV--GM--FKVHPEI--------- 247 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HH--HH--HCCCCCC---------
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hh--cc--ccccccc---------
Confidence 56899999999997654 88999999999999999999999975432221110 00 00 0000000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++||++.++++.
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11123456789999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.86 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=197.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+|..+ .+++.||+|.+.... ....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp EEEEEECC----CEEEEEEET-TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 445578999999999999865 468899999996532 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHHh-cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIF-AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++|.+++. ....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 183 (314)
T 3com_A 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRN 183 (314)
T ss_dssp TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBC
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccC
Confidence 999999987 456789999999999999999999998 899999999999999999999999999987643322 223
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ......... ..
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~-------~~ 248 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI--------PTNPPPTFR-------KP 248 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCCS-------SG
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------hcCCCcccC-------Cc
Confidence 446899999999999999999999999999999999999999765433221111 011100000 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
......+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112346778999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.15 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=196.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+|... .+++.||+|.+........+.+.+|+.++++++||||+++++++......++||||++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred eeecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 345578999999999999875 4688999999987666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
+++|.+++.. ...+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++....... ....
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 175 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRD 175 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC--
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccc
Confidence 9999998875 46789999999999999999999998 89999999999999999999999999976432111 1122
Q ss_pred eccCCCcccccccc-----cCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 663 MIRGTRGYVAPEWF-----KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 663 ~~~gt~~y~aPE~~-----~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
...||+.|+|||.+ .+..++.++||||||+++|||++|+.|+...........+ ..+.......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~--- 244 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--------AKSDPPTLLT--- 244 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCCSS---
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH--------hccCCcccCC---
Confidence 34589999999998 4677899999999999999999999999765443221111 1111111100
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++|||+.++++.
T Consensus 245 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 ----PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ----ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11223457789999999999999999999763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=331.93 Aligned_cols=264 Identities=25% Similarity=0.239 Sum_probs=198.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh-----hHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE-----REREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.+.||+|+||.||+|... .+++.||||++...... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred cEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 445578999999999999875 46889999999653221 124688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
|||+++ +|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999986 888888765 4688999999999999999999998 89999999999999999999999999998764332
Q ss_pred CcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc--cceecc
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR--LDVLID 734 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~d 734 (796)
.......+|+.|+|||.+.+. .++.++|||||||++|||++|..||......+....+.........+.. ...+.+
T Consensus 167 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 167 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 223345689999999999764 5899999999999999999999999776544332222111110000000 000000
Q ss_pred c--------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 735 S--------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 735 ~--------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
. .............+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000011223567889999999999999999999976
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=321.60 Aligned_cols=246 Identities=24% Similarity=0.289 Sum_probs=195.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh----hhhHHHHHHHHHHhcccCccCcccccccc--cccccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA----QEREREFKSEVSAIGRTHHKHLVQLLGFC--DEALNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lv 578 (796)
.+.+.||+|+||.||++... .+++.||+|.+.... ......+.+|+.++++++|+||+++++++ .+....++|
T Consensus 8 ~i~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 8 LMGDLLGEGSYGKVKEVLDS-ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp CCCCEEEECSSCEEEEEEBT-TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eEeeEEecCCCeEEEEEEEC-CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 34578999999999999865 468899999997643 23457899999999999999999999998 455678999
Q ss_pred EeecCCCCHHHHHhc--CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 579 YEFMGNGTLANLIFA--IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
|||++++ |.+++.. ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999876 7777665 35688999999999999999999998 9999999999999999999999999999876433
Q ss_pred C-CcceeeccCCCcccccccccCCC--CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 657 Q-SRTHTMIRGTRGYVAPEWFKNVP--VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 657 ~-~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
. ........||+.|+|||.+.+.. .+.++||||||+++|||++|+.||......+....+ ..+....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i--------~~~~~~~-- 232 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--------GKGSYAI-- 232 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHCCCCC--
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH--------hcCCCCC--
Confidence 2 22233456899999999998654 378999999999999999999999865443322211 1111110
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++|||+.++++.
T Consensus 233 --------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 --------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11122456779999999999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=348.00 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=205.6
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
..+.+.+.||+|+||.||++..+ .+++.||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 34556688999999999999865 468899999985432 23467899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE---cCCCcEEEeecCCcccccC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~~ 655 (796)
|||+.+++|.+.+.....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999999888999999999999999999999998 89999999999999 5678999999999987643
Q ss_pred CCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.. ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||......+....+ ..+.......
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~~~~~- 249 (484)
T 3nyv_A 182 SK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--------EKGKYTFELP- 249 (484)
T ss_dssp CC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCCCSG-
T ss_pred cc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HcCCCCCCCc-
Confidence 32 2334569999999999976 6999999999999999999999999876554332222 1111111000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+.+++.+||+.||++|||+.++++.
T Consensus 250 -----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 250 -----QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 011123457789999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.57 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=181.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||.||++... .+++.||||++.... ....+++.+|+.++++++||||+++++++......++||||+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CEEEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 345578999999999999865 357899999986533 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--------CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 583 GNGTLANLIFA--------IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 583 ~~gsL~~~l~~--------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999999873 34688999999999999999999998 89999999999999999999999999998664
Q ss_pred CCCC----cceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcc
Q 044281 655 SDQS----RTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729 (796)
Q Consensus 655 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (796)
.... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||............ . .+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------~-~~~~ 244 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-------L-QNDP 244 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-------H-TSSC
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-------h-ccCC
Confidence 3321 11234568999999999976 56899999999999999999999999764332211100 0 1111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...................+.+++.+||+.||.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 10000000000011122457789999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=322.27 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=195.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|... .+++.||+|++... ......++.+|+..+..+ +||||+++++++.+....++|||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhcCCCceEEEEEEEc-CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 445578999999999999875 46889999998652 234467888999999998 99999999999999999999999
Q ss_pred ecCCCCHHHHHhcC----CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC------------------
Q 044281 581 FMGNGTLANLIFAI----PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH------------------ 638 (796)
Q Consensus 581 ~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~------------------ 638 (796)
|+++++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------------------
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999764 5689999999999999999999998 9999999999999984
Q ss_pred -CCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHH
Q 044281 639 -FFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAIL 716 (796)
Q Consensus 639 -~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l 716 (796)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..++......
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------ 237 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW------ 237 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH------
T ss_pred CceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH------
Confidence 4479999999998764332 23489999999999876 6678999999999999999998876543211
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 717 TDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+....+.. .....+.+++.+||+.||++|||+.++++.
T Consensus 238 -----~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 -----HEIRQGRLPRIPQ---------VLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----HHHHTTCCCCCSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----HHHHcCCCCCCCc---------ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111222221111 122457789999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=344.54 Aligned_cols=258 Identities=17% Similarity=0.231 Sum_probs=200.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCc-cCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHH-KHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.++||+|+||.||+|... .+++.||||++..... ..++..|+++++.++| +++..+..++.+....+|||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 345578999999999999865 4688999998765322 3457889999999977 45556666667778889999999
Q ss_pred CCCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE---cCCCcEEEeecCCcccccCCCC
Q 044281 583 GNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL---DHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 583 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~~~~~ 658 (796)
+++|.+++.. ...+++..++.|+.||+.||+|||+. +|+||||||+|||| ++++.+||+|||+++.+.....
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9999999975 46789999999999999999999998 99999999999999 6899999999999997754432
Q ss_pred c------ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 659 R------THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 659 ~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
. ......||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+....... ....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-----~~~~ 236 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-----VATS 236 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-----HHSC
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-----cccc
Confidence 1 2235679999999999999999999999999999999999999997643221111111111110 0000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
++.. ......++.+++..||+.||++||++.+|+++|+.++
T Consensus 237 ~~~l-----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 237 IEAL-----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHH-----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHH-----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0000 0112356788999999999999999999999998763
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.47 Aligned_cols=196 Identities=27% Similarity=0.358 Sum_probs=165.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccc-----ccce
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA-----LNRL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 576 (796)
+.+.+.||+|+||.||+|..+ .+++.||||++... .....+.+.+|++++++++|+||+++++++... ...+
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred EEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 445678999999999999875 46899999999753 233456889999999999999999999998766 5689
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||++ ++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 9999987 59999999888899999999999999999999998 8999999999999999999999999999976433
Q ss_pred CC---------------------cceeeccCCCcccccccc-cCCCCCccchhHHHHHHHHHHHhCCCCC
Q 044281 657 QS---------------------RTHTMIRGTRGYVAPEWF-KNVPVSAKVDVYSFGVTLLEIICCRRSV 704 (796)
Q Consensus 657 ~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwS~Gv~l~elltg~~p~ 704 (796)
.. .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 21 123456799999999986 5667999999999999999999854443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=345.79 Aligned_cols=249 Identities=27% Similarity=0.336 Sum_probs=200.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-------------hhHHHHHHHHHHhcccCccCccccccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-------------EREREFKSEVSAIGRTHHKHLVQLLGFCD 570 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 570 (796)
+.+.++||+|+||+||++..+ .+++.||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 345578999999999999875 4688999999865321 23467899999999999999999999999
Q ss_pred ccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC---cEEEeec
Q 044281 571 EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF---SAKISDF 647 (796)
Q Consensus 571 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Df 647 (796)
+....++||||+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999998888899999999999999999999998 999999999999999776 6999999
Q ss_pred CCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 648 GLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 648 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
|+++...... ......||+.|+|||.+.+ .++.++|||||||++|||++|..||......+....+. .+
T Consensus 194 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--------~~ 262 (504)
T 3q5i_A 194 GLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE--------KG 262 (504)
T ss_dssp TTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HC
T ss_pred CCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------cC
Confidence 9998764432 2334569999999999874 69999999999999999999999998765544322221 11
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.... +... .......+.+++.+||+.||.+|||+.|+++.
T Consensus 263 ~~~~--~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYYF--DFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCC--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCC--Cccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110 0000 01123457789999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.74 Aligned_cols=248 Identities=24% Similarity=0.294 Sum_probs=201.2
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---------hhhHHHHHHHHHHhcccC-ccCccccccccccccc
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---------QEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALN 574 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 574 (796)
.+.+.||+|+||.||++..+ .+++.||||++.... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred ceeeeecCCCceEEEEEEEc-CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 34578999999999999875 468999999985432 123467889999999995 9999999999999999
Q ss_pred ceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 575 RLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
.++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 999999999999999998888899999999999999999999998 89999999999999999999999999998764
Q ss_pred CCCCcceeeccCCCccccccccc------CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFK------NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||...........+ ..+.
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~ 245 (298)
T 1phk_A 176 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--------MSGN 245 (298)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTC
T ss_pred CCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH--------hcCC
Confidence 332 223456899999999985 456889999999999999999999999765443322211 1111
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
..... + ........+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~-~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 YQFGS-P-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCCT-T-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCc-c-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11000 0 01122356778999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=337.76 Aligned_cols=199 Identities=25% Similarity=0.300 Sum_probs=169.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc------CccCccccccccccccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT------HHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~l 577 (796)
+.+.+.||+|+||.||+|... .+++.||||++... .....++.+|+.+++.+ +|+||+++++++......++
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 445678999999999999865 46899999999763 23345667777777766 57799999999999999999
Q ss_pred EEeecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc--EEEeecCCcccc
Q 044281 578 VYEFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS--AKISDFGLSKLL 653 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~kl~DfGla~~~ 653 (796)
||||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 69999887654 489999999999999999999998 9999999999999999887 999999999754
Q ss_pred cCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES 712 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~ 712 (796)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 307 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 322 2335689999999999999999999999999999999999999987655443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.03 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=193.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccc------------
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDE------------ 571 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------ 571 (796)
+.+.+.||+|+||.||+|... .+++.||||++..... ...+|+++++.++||||+++++++..
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred EEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 345678999999999999865 4789999999864322 23479999999999999999999843
Q ss_pred --------------------------cccceeEEeecCCCCHHHHHh----cCCCCchhHHHHHHHHHHHHhhHhhhcCC
Q 044281 572 --------------------------ALNRLLVYEFMGNGTLANLIF----AIPKPDWNLRIRISLEIARGLAYLHEECN 621 (796)
Q Consensus 572 --------------------------~~~~~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~ 621 (796)
....++||||+++ +|.+.+. ....+++..+..++.||++||+|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 2337899999985 7766664 456789999999999999999999998
Q ss_pred CCeeeCCCCCCCEEEc-CCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHh
Q 044281 622 VPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIIC 699 (796)
Q Consensus 622 ~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~ellt 699 (796)
+|+||||||+|||++ +++.+||+|||+++.+.... ......+|+.|+|||.+.+. .++.++|||||||++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 68999999999998764333 23345689999999998875 48999999999999999999
Q ss_pred CCCCCchhhHHHHhHHHHHHHHHh-----------hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044281 700 CRRSVEMELEEESRAILTDWAYDC-----------YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 768 (796)
Q Consensus 700 g~~p~~~~~~~~~~~~l~~~~~~~-----------~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 768 (796)
|+.||......+....+....... +.+...............+......+.+++.+||+.||++|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 999998765544333222111100 000011111111111111222345678899999999999999999
Q ss_pred HHHH
Q 044281 769 VVLQ 772 (796)
Q Consensus 769 evl~ 772 (796)
|+++
T Consensus 318 e~l~ 321 (383)
T 3eb0_A 318 EAMA 321 (383)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9984
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=324.51 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=202.5
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC------cccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH------LVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~ 576 (796)
.+.+.+.||+|+||.||++.....+++.||||+++... ...+.+.+|+.+++.++|++ ++++++++......+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 34556789999999999998755578999999997542 34567888999999887765 899999999999999
Q ss_pred eEEeecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC----------------
Q 044281 577 LVYEFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---------------- 638 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---------------- 638 (796)
+||||+ +++|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 889999998765 678899999999999999999998 9999999999999987
Q ss_pred ---CCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHH
Q 044281 639 ---FFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAI 715 (796)
Q Consensus 639 ---~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~ 715 (796)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 678999999999864322 2345689999999999999999999999999999999999999976654433222
Q ss_pred HHHHHHH----hhhcCccceec---------------------cc-hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 044281 716 LTDWAYD----CYVEGRLDVLI---------------------DS-DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 769 (796)
Q Consensus 716 l~~~~~~----~~~~~~~~~~~---------------------d~-~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 769 (796)
+...... .+......... .. ...........+.+.+++.+||+.||++|||+.|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 2111100 00000000000 00 0000112344567889999999999999999999
Q ss_pred HHHH
Q 044281 770 VLQM 773 (796)
Q Consensus 770 vl~~ 773 (796)
+++.
T Consensus 326 ll~h 329 (339)
T 1z57_A 326 ALKH 329 (339)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.92 Aligned_cols=259 Identities=24% Similarity=0.264 Sum_probs=181.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCccccccccccc------ccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA------LNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 575 (796)
+.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp EEEEEECC----CCEEEEEET-TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEeeEEeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 344578999999999999865 57899999999653 233456788999999999999999999998654 567
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred EEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 9999999 6799988876 5689999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----h---hcC
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----Y---VEG 727 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~---~~~ 727 (796)
. .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....... + ...
T Consensus 185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 2 334568999999999987 688999999999999999999999998765443332222111000 0 000
Q ss_pred c-------cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 R-------LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~-------~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
. +......... .........+.+++.+||+.||++|||+.++++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000000000 0001112457789999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.13 Aligned_cols=258 Identities=23% Similarity=0.246 Sum_probs=190.9
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccccc------ccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEA------LNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv 578 (796)
.+.+.||+|+||.||+|+.. .+++.||||++.... ..+.+|++++++++|+||+++++++... ...++|
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 34578999999999999975 468899999986432 2235799999999999999999988432 235799
Q ss_pred EeecCCCCHHHHHh----cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC-CcEEEeecCCcccc
Q 044281 579 YEFMGNGTLANLIF----AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF-FSAKISDFGLSKLL 653 (796)
Q Consensus 579 ~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~ 653 (796)
|||+++ +|.+++. ....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++.+
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999986 5655553 356789999999999999999999998 99999999999999955 67899999999876
Q ss_pred cCCCCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------Hhhh
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY-------DCYV 725 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~ 725 (796)
..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+..... ....
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 43322 2345689999999999765 799999999999999999999999987654333222211100 0000
Q ss_pred ----cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 726 ----EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 726 ----~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.....+................+.+++.+||+.||.+|||+.|+++.
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000111100001111111223567889999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.23 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=200.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhh-----------------HHHHHHHHHHhcccCccCccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER-----------------EREFKSEVSAIGRTHHKHLVQLL 566 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~ 566 (796)
+.+.+.||+|+||.||++.. +++.||||.+....... .+.+.+|+.++++++||||++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred eEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 34557899999999999986 68999999997543221 17899999999999999999999
Q ss_pred ccccccccceeEEeecCCCCHHHH------Hhc--CCCCchhHHHHHHHHHHHHhhHhhh-cCCCCeeeCCCCCCCEEEc
Q 044281 567 GFCDEALNRLLVYEFMGNGTLANL------IFA--IPKPDWNLRIRISLEIARGLAYLHE-ECNVPIIHCDIKPQNILLD 637 (796)
Q Consensus 567 g~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~~~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~Dlk~~NIll~ 637 (796)
+++.+....++||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ . +|+|+||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence 999999999999999999999998 665 5678999999999999999999998 7 899999999999999
Q ss_pred CCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCC-CCCc-cchhHHHHHHHHHHHhCCCCCchhhH-HHHhH
Q 044281 638 HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV-PVSA-KVDVYSFGVTLLEIICCRRSVEMELE-EESRA 714 (796)
Q Consensus 638 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DVwS~Gv~l~elltg~~p~~~~~~-~~~~~ 714 (796)
.++.+||+|||++...... ......+|+.|+|||.+.+. .++. ++||||||+++|||++|+.||..... .+...
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 9999999999999875432 33445689999999999887 6666 99999999999999999999976543 22111
Q ss_pred HHHHHHHHhhhcCccceecc---------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 715 ILTDWAYDCYVEGRLDVLID---------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d---------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+ ..+......+ ..............+.+++.+||+.||.+|||+.|+++.
T Consensus 264 ~i--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 264 NI--------RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HH--------TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH--------hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 1111110000 000000012233567889999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.27 Aligned_cols=263 Identities=22% Similarity=0.258 Sum_probs=198.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccc-----cccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA-----LNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 577 (796)
+.+.+.||+|+||.||++... .+++.||||++.... ......+.+|++++.+++||||+++++++... ...++
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred EEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 445678999999999999865 468899999997533 33447789999999999999999999998654 36789
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 108 v~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999998 499998876 4588999999999999999999998 99999999999999999999999999998764332
Q ss_pred Cc--ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccce---
Q 044281 658 SR--THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV--- 731 (796)
Q Consensus 658 ~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~--- 731 (796)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.........+ ....
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~ 261 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE-DLNCIIN 261 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH-HHHTCCC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH-HHHHhhh
Confidence 21 1234579999999998754 458999999999999999999999997654433222221110000000 0000
Q ss_pred ---------ecc--chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 732 ---------LID--SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 732 ---------~~d--~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
... ..............+.+++.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000111223567889999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.99 Aligned_cols=263 Identities=21% Similarity=0.261 Sum_probs=197.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCccccccccccc-----ccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA-----LNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv 578 (796)
.+.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred EEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 34578999999999999865 468999999996532 33456788999999999999999999987654 677999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+. ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 93 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp ECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 99997 599998876 4688999999999999999999998 999999999999999999999999999987643221
Q ss_pred c---------ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 659 R---------THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 659 ~---------~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+............
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 1 1123468999999998764 77899999999999999999999999876544332222111110000000
Q ss_pred cceecc--------------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVLID--------------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~~d--------------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...... ..............+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000000011233567789999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=328.42 Aligned_cols=261 Identities=23% Similarity=0.240 Sum_probs=190.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccc------cc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------NR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 575 (796)
+.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred eeEeeeeEecCCEEEEEEEEC-CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 344578999999999999865 46899999999653 2344567899999999999999999999987654 67
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 999999975 7888775 3578899999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHH---------------H
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDW---------------A 720 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~---------------~ 720 (796)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+... .
T Consensus 180 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 180 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred c--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2 2233456899999999999999999999999999999999999999765543322211110 0
Q ss_pred HHhhhcC-c-----cceeccch---hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 721 YDCYVEG-R-----LDVLIDSD---EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 721 ~~~~~~~-~-----~~~~~d~~---~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
....... . ....+... ............+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000 0 00000000 0000112235678899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.17 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=182.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.+.+.||+|+||+||++... .+++.||||++.... ....+.+.++...++.++||||+++++++.+....++||||
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 345578999999999999865 468999999997532 22234455566668889999999999999999999999999
Q ss_pred cCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 582 MGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 582 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
+++ +|.+++.. ...+++..++.++.||+.||+|||++. +|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 88 MDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred hcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 985 88777653 467899999999999999999999853 79999999999999999999999999998764332
Q ss_pred CcceeeccCCCcccccccc----cCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 658 SRTHTMIRGTRGYVAPEWF----KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
. .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... + .......... ..
T Consensus 165 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~~~~~~~-~~ 235 (290)
T 3fme_A 165 A--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--L----KQVVEEPSPQ-LP 235 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--H----HHHHHSCCCC-CC
T ss_pred c--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--H----HHHhccCCCC-cc
Confidence 2 2334689999999996 5667899999999999999999999999753221110 0 0111111111 00
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.......+.+++.+||+.||++|||+.|+++
T Consensus 236 --------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 --------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1112345778999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.03 Aligned_cols=250 Identities=12% Similarity=0.044 Sum_probs=176.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhccc--CccCcccccc-------ccccc
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRT--HHKHLVQLLG-------FCDEA 572 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~g-------~~~~~ 572 (796)
.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.+++.+ +||||++++. ++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 35578999999999999865 468999999997633 23455677885544444 6999888553 22211
Q ss_pred -----------------ccceeEEeecCCCCHHHHHhcC-CCCchhHH------HHHHHHHHHHhhHhhhcCCCCeeeCC
Q 044281 573 -----------------LNRLLVYEFMGNGTLANLIFAI-PKPDWNLR------IRISLEIARGLAYLHEECNVPIIHCD 628 (796)
Q Consensus 573 -----------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~------~~i~~~ia~~l~yLH~~~~~~iiH~D 628 (796)
...++||||++ |+|.+++... ..+.+..+ +.++.||++||+|||++ +|+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD 219 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence 34799999999 8999999863 34455666 78889999999999998 899999
Q ss_pred CCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccC--CCCCccchhHHHHHHHHHHHhCCCCCch
Q 044281 629 IKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVTLLEIICCRRSVEM 706 (796)
Q Consensus 629 lk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gv~l~elltg~~p~~~ 706 (796)
|||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986532 1224457799999999987 7899999999999999999999999976
Q ss_pred hhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 707 ELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 707 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
........ +........................+.+++.+||+.||++|||+.++++
T Consensus 296 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 53221100 0000000000000000001122356778999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.47 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=195.0
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--------hhHHHHHHHHHHhcccCccCcccccccccccc
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKHLVQLLGFCDEAL 573 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 573 (796)
..+.+.+.||+|+||.||+|..+ .+++.||||.+..... .....+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 34556688999999999999875 4689999999865321 12345889999999999999999999987654
Q ss_pred cceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc---EEEeecCCc
Q 044281 574 NRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS---AKISDFGLS 650 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~DfGla 650 (796)
.++||||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 899999999999999998888899999999999999999999998 9999999999999987654 999999999
Q ss_pred ccccCCCCcceeeccCCCccccccccc---CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 651 KLLFSDQSRTHTMIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 651 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
+..... .......||+.|+|||.+. ...++.++|||||||++|||++|+.||.......... . ....+
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~----~~~~~ 235 (322)
T 2ycf_A 165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---D----QITSG 235 (322)
T ss_dssp EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH---H----HHHHT
T ss_pred eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH---H----HHHhC
Confidence 875332 1223456899999999974 5678999999999999999999999997543221100 0 01111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
..... +. ........+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~--~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYNFI--PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCCC--HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccC--ch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11100 00 01112356778999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.66 Aligned_cols=262 Identities=20% Similarity=0.250 Sum_probs=191.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccc--------------
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCD-------------- 570 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------- 570 (796)
.+.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEECC-----CEEEEEET-TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 34578999999999999875 468999999997666666788999999999999999999998763
Q ss_pred ccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc-CCCcEEEeecCC
Q 044281 571 EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGL 649 (796)
Q Consensus 571 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~DfGl 649 (796)
+....++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++ +++.+||+|||+
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 4467789999998 599999865 4678899999999999999999998 899999999999997 567999999999
Q ss_pred cccccCCCC--cceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-----
Q 044281 650 SKLLFSDQS--RTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY----- 721 (796)
Q Consensus 650 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~----- 721 (796)
++....... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 987643221 12233457899999998865 6789999999999999999999999986654332222211000
Q ss_pred --HhhhcCccceeccc------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 722 --DCYVEGRLDVLIDS------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 722 --~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..... .+...+.. .............+.+++.+||+.||++|||+.++++.
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 248 DRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000 00000000 00000111234567889999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=322.28 Aligned_cols=258 Identities=18% Similarity=0.262 Sum_probs=195.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCcccccccccc--cccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGFCDE--ALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~e 580 (796)
+.+.+.||+|+||+||+|... .+++.||||+++.. ..+.+.+|+.++++++ |+||+++++++.+ ....++|||
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred eEEEEEecccCCeEEEEEEEC-CCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 345678999999999999865 46889999999753 2467899999999997 9999999999987 567799999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~ 659 (796)
|+++++|.+++.. +++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc-
Confidence 9999999998854 77889999999999999999998 899999999999999776 899999999987643322
Q ss_pred ceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHH-HhHHHHH-----HHHHhhhcCccc--
Q 044281 660 THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE-SRAILTD-----WAYDCYVEGRLD-- 730 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~-~~~~l~~-----~~~~~~~~~~~~-- 730 (796)
.....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+.. ............
T Consensus 187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 234468999999999987 678999999999999999999999995332111 1100000 000000000000
Q ss_pred ------------eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 731 ------------VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 731 ------------~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..................+.+++.+||+.||++|||++|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000001111134567889999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=334.56 Aligned_cols=195 Identities=22% Similarity=0.343 Sum_probs=152.5
Q ss_pred HhhCCCccceEEEEEeeC-CCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccc--cccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFC--DEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lv~e~~~~ 584 (796)
++||+|+||+||+|..+. .+++.||||++.... ....+.+|+.++++++||||+++++++ ......++||||+++
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 104 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence 479999999999998653 357899999997532 234688999999999999999999999 456778999999975
Q ss_pred CCHHHHHhcC---------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE----cCCCcEEEeecCCcc
Q 044281 585 GTLANLIFAI---------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL----DHFFSAKISDFGLSK 651 (796)
Q Consensus 585 gsL~~~l~~~---------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~DfGla~ 651 (796)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 787777522 2488999999999999999999998 89999999999999 778999999999998
Q ss_pred cccCCCC--cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhh
Q 044281 652 LLFSDQS--RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMEL 708 (796)
Q Consensus 652 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~ 708 (796)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 7653322 223446789999999999874 58999999999999999999999996543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=327.70 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=195.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||.||+|..+ ..+|+|++.... ....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred EEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 45678999999999999864 249999986432 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC----
Q 044281 583 GNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ---- 657 (796)
Q Consensus 583 ~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~---- 657 (796)
++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++......
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 9999999998754 689999999999999999999998 899999999999998 6799999999987653221
Q ss_pred CcceeeccCCCcccccccccC---------CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 658 SRTHTMIRGTRGYVAPEWFKN---------VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+ ..+.
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~ 259 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--------GTGM 259 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH--------HTTC
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--------ccCC
Confidence 122233458999999999874 45789999999999999999999999865544322111 1111
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
....... .....+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 260 ~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 260 KPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111110 1123467799999999999999999999999987764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.73 Aligned_cols=264 Identities=21% Similarity=0.285 Sum_probs=197.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhccc---CccCccccccccc-----ccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKHLVQLLGFCD-----EAL 573 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 573 (796)
+.+.+.||+|+||.||++.....+++.||+|++..... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 34557899999999999987545789999999864322 1123566677776665 8999999999987 567
Q ss_pred cceeEEeecCCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 574 NRLLVYEFMGNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
..++||||++ |+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7899999998 69999997653 488999999999999999999998 89999999999999999999999999998
Q ss_pred cccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----hhcC
Q 044281 652 LLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----YVEG 727 (796)
Q Consensus 652 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~~~~ 727 (796)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...........+....... +...
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 654222 2334568999999999999999999999999999999999999998765443322221111000 0000
Q ss_pred -ccc-eecc---chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 -RLD-VLID---SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 -~~~-~~~d---~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
... ..+. ..............+.+++.+||+.||++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0000 000001111233567789999999999999999999953
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=333.10 Aligned_cols=263 Identities=22% Similarity=0.249 Sum_probs=197.3
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC--------ccCccccccccc---
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH--------HKHLVQLLGFCD--- 570 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~--- 570 (796)
..+.+.++||+|+||+||+|+.. .+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 34556678999999999999865 46899999999753 334567889999999885 788999999987
Q ss_pred -ccccceeEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-------
Q 044281 571 -EALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF------- 640 (796)
Q Consensus 571 -~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~------- 640 (796)
.....++||||+ +++|.+.+... ..+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 667889999999 45665555443 46899999999999999999999863 799999999999999775
Q ss_pred ------------------------------------------cEEEeecCCcccccCCCCcceeeccCCCcccccccccC
Q 044281 641 ------------------------------------------SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678 (796)
Q Consensus 641 ------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 678 (796)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999876432 233468999999999999
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCCCchhhHH------HHhHHHHHHHHH----hhhc-----------Cccceeccch-
Q 044281 679 VPVSAKVDVYSFGVTLLEIICCRRSVEMELEE------ESRAILTDWAYD----CYVE-----------GRLDVLIDSD- 736 (796)
Q Consensus 679 ~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~------~~~~~l~~~~~~----~~~~-----------~~~~~~~d~~- 736 (796)
..++.++|||||||++|||++|+.||...... .....+...... .+.. +....+.+..
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999999753211 111111110000 0000 0000000000
Q ss_pred --------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 737 --------EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 737 --------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
............+.+++.+||+.||++|||+.|+++.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011234566778899999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.58 Aligned_cols=249 Identities=29% Similarity=0.394 Sum_probs=187.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccc------------
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDE------------ 571 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------ 571 (796)
+.+.+.||+|+||.||+|... .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred chhhheeccCCcEEEEEEEEc-CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 344578999999999999865 46889999999653 3445789999999999999999999998754
Q ss_pred -cccceeEEeecCCCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCC
Q 044281 572 -ALNRLLVYEFMGNGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649 (796)
Q Consensus 572 -~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 649 (796)
....++||||+++++|.+++.... .+++..++.++.||++||+|||++ +|+|+||||+||+++.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 456789999999999999998543 567888999999999999999998 899999999999999999999999999
Q ss_pred cccccCCC-------------CcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHH
Q 044281 650 SKLLFSDQ-------------SRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAI 715 (796)
Q Consensus 650 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~ 715 (796)
++...... ........||+.|+|||.+.+. .++.++|||||||++|||++ |+........ .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~--~ 237 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN--I 237 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH--H
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH--H
Confidence 98764321 1122345689999999999864 78999999999999999998 4443221111 1
Q ss_pred HHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 716 LTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
. ......... +. ..........+.+++.+||+.||.+|||+.++++.
T Consensus 238 ~-----~~~~~~~~~--~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 L-----KKLRSVSIE--FP----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H-----HHHHSTTCC--CC----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred H-----Hhccccccc--cC----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 111111100 00 01112233456789999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=329.99 Aligned_cols=259 Identities=21% Similarity=0.221 Sum_probs=189.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-----------hhhHHHHHHHHHHhcccCccCccccccccc----
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-----------QEREREFKSEVSAIGRTHHKHLVQLLGFCD---- 570 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---- 570 (796)
+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 26 ~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 103 (362)
T 3pg1_A 26 VQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103 (362)
T ss_dssp EEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred EeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence 4478999999999999864 58899999985422 122378999999999999999999999984
Q ss_pred -ccccceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecC
Q 044281 571 -EALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFG 648 (796)
Q Consensus 571 -~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfG 648 (796)
.....++||||++ |+|.+.+... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 104 PAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred CCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecC
Confidence 3345799999998 5887777654 4789999999999999999999998 89999999999999999999999999
Q ss_pred CcccccCCCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----
Q 044281 649 LSKLLFSDQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC---- 723 (796)
Q Consensus 649 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~---- 723 (796)
+++...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.......
T Consensus 180 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 998543322 2234568999999999977 678999999999999999999999998765443322222111000
Q ss_pred -----------hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 724 -----------YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 724 -----------~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
............ ............+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPAR-AWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCC-CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhHHHHhhcccCChh-hHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000000000 0011111223567889999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=330.95 Aligned_cols=259 Identities=22% Similarity=0.239 Sum_probs=191.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccccccc------cee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN------RLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~l 577 (796)
+.+.+.||+|+||.||+|... .+..||+|++..... ...+|+++++.++||||+++++++..... .++
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 445678999999999999875 344588888754221 22469999999999999999999855443 789
Q ss_pred EEeecCCCCHHHHH---hcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc-CCCcEEEeecCCcccc
Q 044281 578 VYEFMGNGTLANLI---FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLL 653 (796)
Q Consensus 578 v~e~~~~gsL~~~l---~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~ 653 (796)
||||++++.+..+. .....+++..+..++.||++||+|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 99999875444333 2356788999999999999999999998 999999999999999 7999999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-----------
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY----------- 721 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~----------- 721 (796)
..... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.....
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 43332 2345689999999999765 589999999999999999999999987654443322221110
Q ss_pred HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 722 DCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 722 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..+.+......................+.+++.+||+.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0011111111111111111112233567889999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.99 Aligned_cols=258 Identities=22% Similarity=0.259 Sum_probs=194.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccc------e
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNR------L 576 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~------~ 576 (796)
.+.+.||+|+||.||+|... .+++.||||++... .......+.+|+.+++.++||||+++++++...... +
T Consensus 45 ~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 45 VSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 34578999999999999865 47899999999753 233457889999999999999999999999877665 9
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||+. ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp EEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred EEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 9999998 588887743 488999999999999999999998 9999999999999999999999999999865322
Q ss_pred CCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh---hhcC----c
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC---YVEG----R 728 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~---~~~~----~ 728 (796)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....... +... .
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 234568999999999987 788999999999999999999999998765443322221110000 0000 0
Q ss_pred ----cceeccch--hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 ----LDVLIDSD--EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ----~~~~~d~~--~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...+.... ............+.+++.+||+.||++|||+.|+++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 0000011224567889999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=327.28 Aligned_cols=272 Identities=23% Similarity=0.300 Sum_probs=200.1
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-----------ccCcccccccc
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-----------HKHLVQLLGFC 569 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~ 569 (796)
...+.+.+.||+|+||.||+|... .+++.||||++... ......+.+|+.++++++ |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 344556788999999999999865 46899999999753 234567888999988876 89999999998
Q ss_pred cccc----cceeEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc------
Q 044281 570 DEAL----NRLLVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD------ 637 (796)
Q Consensus 570 ~~~~----~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~------ 637 (796)
.... ..++||||+ +++|.+++... ..+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 7654 679999999 88999999764 45889999999999999999999853 799999999999994
Q ss_pred CCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHH------
Q 044281 638 HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEE------ 711 (796)
Q Consensus 638 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~------ 711 (796)
+.+.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999876432 233468999999999999999999999999999999999999997543211
Q ss_pred HhHHHHHHHHH----hhhcC-----------ccceecc-------c--hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 044281 712 SRAILTDWAYD----CYVEG-----------RLDVLID-------S--DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767 (796)
Q Consensus 712 ~~~~l~~~~~~----~~~~~-----------~~~~~~d-------~--~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 767 (796)
....+...... .+..+ ....+.. . ......+......+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11111000000 00000 0000000 0 00111234566788899999999999999999
Q ss_pred HHHHHH--HHcCcCCC
Q 044281 768 KVVLQM--LEGLLDVP 781 (796)
Q Consensus 768 ~evl~~--L~~~~~~~ 781 (796)
.|+++. +.+.....
T Consensus 329 ~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 329 GGLVNHPWLKDTLGME 344 (373)
T ss_dssp HHHHTCGGGTTCTTCT
T ss_pred HHHhhChhhhcccCcc
Confidence 999974 45544433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.14 Aligned_cols=250 Identities=25% Similarity=0.313 Sum_probs=201.2
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
..+.+.+.||+|+||.||++..+ .+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++|+
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 34555678999999999999865 468899999986532 234578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC---CcEEEeecCCcccccCC
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF---FSAKISDFGLSKLLFSD 656 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~DfGla~~~~~~ 656 (796)
||+++++|.+.+.....+++..++.++.||+.||.|||+. +|+|+||||+||+++.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999999998777899999999999999999999998 89999999999999754 47999999999876433
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccch
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (796)
.. .....+|+.|+|||.+.+ .++.++||||||+++|||++|+.||......+....+ ..+.......
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~-- 244 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--------ETGKYAFDLP-- 244 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCCCSG--
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCCCCCch--
Confidence 22 223457889999999876 4899999999999999999999999765543322211 1111110000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 737 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
. .......+.+++.+||+.||++|||+.++++
T Consensus 245 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp G----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 0112345778999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.60 Aligned_cols=262 Identities=20% Similarity=0.189 Sum_probs=184.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccccccccccc-------ce
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN-------RL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------~~ 576 (796)
+.+.+.||+|+||.||+|... .+++.||||++.... .....+.+|++.+..++||||+++++++..... .+
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp EEEC----------CEEEEET-TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 345578999999999999875 468899999985432 223456778888888999999999999865443 68
Q ss_pred eEEeecCCCCHHHHH----hcCCCCchhHHHHHHHHHHHHhhHhh--hcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCC
Q 044281 577 LVYEFMGNGTLANLI----FAIPKPDWNLRIRISLEIARGLAYLH--EECNVPIIHCDIKPQNILLDH-FFSAKISDFGL 649 (796)
Q Consensus 577 lv~e~~~~gsL~~~l----~~~~~~~~~~~~~i~~~ia~~l~yLH--~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGl 649 (796)
+||||++++ |...+ .....+++..+..++.||+.||.||| +. +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 103 VVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 999999874 44333 35567889999999999999999999 66 8999999999999996 89999999999
Q ss_pred cccccCCCCcceeeccCCCcccccccccCCC-CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHH-------
Q 044281 650 SKLLFSDQSRTHTMIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY------- 721 (796)
Q Consensus 650 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~------- 721 (796)
++...... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...........+.....
T Consensus 179 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 98764332 223456899999999987654 89999999999999999999999987655443332221110
Q ss_pred HhhhcCcc-ceeccc------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 722 DCYVEGRL-DVLIDS------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 722 ~~~~~~~~-~~~~d~------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........ ....+. .............+.+++.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000 000000 00000111235678899999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.76 Aligned_cols=246 Identities=27% Similarity=0.395 Sum_probs=190.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccc------ccccee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDE------ALNRLL 577 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~l 577 (796)
.+.+.||+|+||.||+|... .+++.||||++.... .....+.+|+.+++++ +||||+++++++.. ....++
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 34578999999999999875 468899999986532 3346789999999998 89999999999876 457899
Q ss_pred EEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 578 VYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 99999999999999865 4688899999999999999999998 899999999999999999999999999986543
Q ss_pred CCCcceeeccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
... ......||+.|+|||.+. +..++.++|||||||++|||++|+.||...........+ ......
T Consensus 182 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~ 252 (326)
T 2x7f_A 182 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNPAP 252 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCC
T ss_pred Ccc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh--------hcCccc
Confidence 221 223346899999999997 567899999999999999999999999765433322111 011111
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
... .......+.+++.+||+.||.+||++.++++
T Consensus 253 ~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 253 RLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 110 1112346778999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.66 Aligned_cols=262 Identities=19% Similarity=0.269 Sum_probs=199.1
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC------cccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH------LVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~ 576 (796)
.+.+.+.||+|+||.||++.....+++.||+|+++.. ....+.+.+|+.++++++|++ ++.+.+++......+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 3456678999999999999876555589999999753 334567888999999988776 888999999999999
Q ss_pred eEEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEE------------------
Q 044281 577 LVYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILL------------------ 636 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll------------------ 636 (796)
+||||+ +++|.+.+... ..+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999 55666666554 3689999999999999999999998 99999999999999
Q ss_pred -cCCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHH
Q 044281 637 -DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAI 715 (796)
Q Consensus 637 -~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~ 715 (796)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 67889999999999864322 2335689999999999999999999999999999999999999986554433222
Q ss_pred HHHHHHH----hhhcCccce-------eccch---------------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 044281 716 LTDWAYD----CYVEGRLDV-------LIDSD---------------EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 769 (796)
Q Consensus 716 l~~~~~~----~~~~~~~~~-------~~d~~---------------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 769 (796)
+...... .+....... ..+.. ............+.+++.+||+.||++|||+.|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 2111100 000000000 00000 000112234557889999999999999999999
Q ss_pred HHHH
Q 044281 770 VLQM 773 (796)
Q Consensus 770 vl~~ 773 (796)
+++.
T Consensus 331 ~l~h 334 (355)
T 2eu9_A 331 ALLH 334 (355)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9853
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=322.75 Aligned_cols=201 Identities=26% Similarity=0.330 Sum_probs=168.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-cc-----Cccccccccccccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HK-----HLVQLLGFCDEALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~l 577 (796)
+.+.+.||+|+||+||+|... .+++.||||+++.. .....++..|+.++..++ |+ +|+++++++......++
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred EEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 445678999999999999865 46889999999753 233566778888887774 44 49999999999999999
Q ss_pred EEeecCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc--CCCcEEEeecCCcccc
Q 044281 578 VYEFMGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD--HFFSAKISDFGLSKLL 653 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~DfGla~~~ 653 (796)
||||++ ++|.+++... ..+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++..
T Consensus 134 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 999996 5999999765 4688999999999999999999953 23899999999999995 5788999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES 712 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~ 712 (796)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 212 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 212 GQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp TCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 332 2345689999999999999999999999999999999999999987654443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=319.65 Aligned_cols=248 Identities=19% Similarity=0.277 Sum_probs=191.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccC--ccCcccccccccccccceeEE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTH--HKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~ 579 (796)
+.+.+.||+|+||.||++..+ +++.||||++... .......+.+|+.++.+++ |+||+++++++......++||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 445678999999999999864 5789999998542 3345578999999999997 599999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
| +.+++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||+++ +.+||+|||+++........
T Consensus 108 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp C-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred e-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 9 56889999999888899999999999999999999998 9999999999999975 89999999999876443322
Q ss_pred -ceeeccCCCcccccccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 660 -THTMIRGTRGYVAPEWFKN-----------VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... + .......
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~----~~~~~~~ 256 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--L----HAIIDPN 256 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--H----HHHHCTT
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--H----HHHHhcc
Confidence 2234568999999999875 47889999999999999999999999754322110 0 0111111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
..... +......+.+++.+||+.||++||++.|+++.
T Consensus 257 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 257 HEIEF---------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SCCCC---------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCC---------cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 10000 00112456779999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=319.55 Aligned_cols=257 Identities=22% Similarity=0.235 Sum_probs=193.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCccccccccccccc------ce
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN------RL 576 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 576 (796)
.+.+.||+|+||.||+|..+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++..... .+
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 27 VSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 34578999999999999865 468999999996532 3335678999999999999999999999977654 49
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||++ ++|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 106 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp EEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred EEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 9999998 588887753 488999999999999999999998 8999999999999999999999999999864322
Q ss_pred CCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH-------hhhcC-
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVEG- 727 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~~- 727 (796)
.....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... .+.+.
T Consensus 180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 233468999999999887 67899999999999999999999999876543332222111000 00000
Q ss_pred ------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 ------RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ------~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+........ ..........+.+++.+||+.||++|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 00111234567889999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=328.80 Aligned_cols=244 Identities=28% Similarity=0.330 Sum_probs=182.9
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecCCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
.+.||+|+||+||.+.. .+++.||||++... ..+.+.+|+.++.++ +||||+++++++.+....++||||+. |
T Consensus 20 ~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGS--FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred cCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 36799999999976543 36899999998653 234678899999876 89999999999999999999999996 6
Q ss_pred CHHHHHhcCCCC-------chhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC-------------CcEEEe
Q 044281 586 TLANLIFAIPKP-------DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF-------------FSAKIS 645 (796)
Q Consensus 586 sL~~~l~~~~~~-------~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~-------------~~~kl~ 645 (796)
+|.+++...... .+..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999865432 2334678999999999999998 99999999999999754 489999
Q ss_pred ecCCcccccCCCCc---ceeeccCCCcccccccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhH
Q 044281 646 DFGLSKLLFSDQSR---THTMIRGTRGYVAPEWFKN-------VPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRA 714 (796)
Q Consensus 646 DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~ 714 (796)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+..
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~- 249 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN- 249 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH-
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH-
Confidence 99999977543322 1234569999999999976 678999999999999999999 89998654332211
Q ss_pred HHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 715 ILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+ ..... .... ...........++.+++.+||+.||++|||+.+|++
T Consensus 250 -i---~~~~~---~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 -I---IRGIF---SLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -H---HHTCC---CCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H---hcCCC---Cccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 11100 0000 011123345567889999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.20 Aligned_cols=252 Identities=20% Similarity=0.231 Sum_probs=169.5
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccc----cccceeEEeecC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDE----ALNRLLVYEFMG 583 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e~~~ 583 (796)
+.||+|+||.||++..+ .+++.||||++..... .. .+....++.++|+||+++++++.. ....++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~-~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHR-RTGQKCALKLLYDSPK-AR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEESSHH-HH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEEC-CCCCEEEEEEecCcHH-HH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 46999999999999876 4688999999965321 11 222233556799999999999876 455799999999
Q ss_pred CCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccccCCCC
Q 044281 584 NGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 584 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~~~~ 658 (796)
+|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-- 184 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-- 184 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc--
Confidence 999999998764 689999999999999999999998 8999999999999986 455999999999865322
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......+|+.|+|||.+.+..++.++||||||+++|||++|+.||............. .....+... . .
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~-~-~---- 253 (336)
T 3fhr_A 185 -ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK----RRIRLGQYG-F-P---- 253 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C-C-C----
T ss_pred -ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH----Hhhhccccc-c-C----
Confidence 2234568999999999999999999999999999999999999997654332111100 000000000 0 0
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHcCcCC
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ--MLEGLLDV 780 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~--~L~~~~~~ 780 (796)
..........+.+++.+||+.||++|||+.|+++ .+......
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 297 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGS
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccC
Confidence 0001122346778999999999999999999998 44544333
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=320.52 Aligned_cols=242 Identities=25% Similarity=0.359 Sum_probs=191.1
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh------hhHHHHHHHHHHhccc----CccCccccccccc
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ------EREREFKSEVSAIGRT----HHKHLVQLLGFCD 570 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~g~~~ 570 (796)
...+.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|+.++.++ +|+||+++++++.
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 344556688999999999999865 4688999999965432 1223456788888888 8999999999999
Q ss_pred ccccceeEEee-cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc-CCCcEEEeecC
Q 044281 571 EALNRLLVYEF-MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFG 648 (796)
Q Consensus 571 ~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~DfG 648 (796)
.....++|+|| +.+++|.+++.....+++..++.++.||++||+|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999 78999999998878899999999999999999999998 899999999999999 88999999999
Q ss_pred CcccccCCCCcceeeccCCCcccccccccCCCCC-ccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 649 LSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS-AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 649 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
+++...... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||....... ..
T Consensus 186 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------------~~ 248 (312)
T 2iwi_A 186 SGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL--------------EA 248 (312)
T ss_dssp SCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HT
T ss_pred hhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh--------------hh
Confidence 998764322 2345689999999999877664 58999999999999999999997542110 00
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
... + .......+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~--~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 ELH--F--------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CCC--C--------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ccC--C--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 01122456789999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.45 Aligned_cols=239 Identities=24% Similarity=0.377 Sum_probs=196.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhh------hHHHHHHHHHHhcccC--ccCcccccccccccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQE------REREFKSEVSAIGRTH--HKHLVQLLGFCDEALNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 575 (796)
+.+.+.||+|+||.||+|... .+++.||||++...... ....+.+|+.++++++ |+||+++++++......
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 445678999999999999865 46899999999654321 2245778999999986 59999999999999999
Q ss_pred eeEEeecCC-CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc-CCCcEEEeecCCcccc
Q 044281 576 LLVYEFMGN-GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLL 653 (796)
Q Consensus 576 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~ 653 (796)
++|+|++.+ ++|.+++.....+++..++.++.||++||+|||+. +|+||||||+|||++ +++.+||+|||+++..
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999976 89999998888899999999999999999999998 999999999999999 7899999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... .+...
T Consensus 201 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------------~~~~~-- 261 (320)
T 3a99_A 201 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQVF-- 261 (320)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCCCC--
T ss_pred ccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------------ccccc--
Confidence 432 2234568999999999987766 688999999999999999999997542110 00000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.. ......+.+++.+||+.||++|||+.+|++.
T Consensus 262 ~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 262 FR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc--------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1112456789999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.11 Aligned_cols=249 Identities=28% Similarity=0.369 Sum_probs=173.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHH-HhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVS-AIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||.||++..+ .+++.||||++.... .....++..|+. +++.++||||+++++++......++||||++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp C-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred ehheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 4578999999999999865 468999999996532 233445666665 7778899999999999999999999999998
Q ss_pred CCCHHHHHhc-----CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 584 NGTLANLIFA-----IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 584 ~gsL~~~l~~-----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
+ +|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 180 (327)
T 3aln_A 105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI- 180 (327)
T ss_dssp E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-
Confidence 6 88777763 567889999999999999999999852 79999999999999999999999999998764322
Q ss_pred cceeeccCCCcccccccc----cCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 659 RTHTMIRGTRGYVAPEWF----KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
......||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ . . .....+....+..
T Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~----~-~~~~~~~~~~~~~ 252 (327)
T 3aln_A 181 -AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--Q----L-TQVVKGDPPQLSN 252 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCCCCC
T ss_pred -ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--H----H-HHHhcCCCCCCCC
Confidence 22234689999999999 566789999999999999999999999975322110 0 0 0011111111111
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
. ........+.+++.+||+.||++|||+.+|++
T Consensus 253 ~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 253 S-----EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-----SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c-----ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 01112346778999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=335.85 Aligned_cols=271 Identities=23% Similarity=0.268 Sum_probs=200.6
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccc------cccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE------ALNR 575 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 575 (796)
.+.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 3556688999999999999865 46889999998653 34446779999999999999999999998765 6778
Q ss_pred eeEEeecCCCCHHHHHhcCC---CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc---EEEeecCC
Q 044281 576 LLVYEFMGNGTLANLIFAIP---KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS---AKISDFGL 649 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~DfGl 649 (796)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998754 588999999999999999999998 8999999999999997665 99999999
Q ss_pred cccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhH-HHHH-HHHHhh---
Q 044281 650 SKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRA-ILTD-WAYDCY--- 724 (796)
Q Consensus 650 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~-~l~~-~~~~~~--- 724 (796)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+.. ......
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 98764332 2234568999999999999999999999999999999999999997543221100 0000 000000
Q ss_pred -hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHcCcC
Q 044281 725 -VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV-----VLQMLEGLLD 779 (796)
Q Consensus 725 -~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e-----vl~~L~~~~~ 779 (796)
..+.....................+.+++.+||+.||++|||+.+ .++.++.+++
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000000000000011122335567888999999999999999977 4455554443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.86 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=174.0
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.||+|+||.||+|..+ .+++.||||++..... ...+.+.++..+++.++||||+++++++.+....++||||+
T Consensus 29 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEC------CEEEEEET-TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred ccceeeecCCeeEEEEEEe-cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 4467999999999999875 4688999999965322 22334555556788889999999999999999999999999
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++.+..+... ...+++..+..++.||++||.|||+.. +|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 182 (318)
T 2dyl_A 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--AKD 182 (318)
T ss_dssp SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--ccc
Confidence 4556555543 467899999999999999999999831 79999999999999999999999999998654322 223
Q ss_pred eccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 663 MIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
...+|+.|+|||.+. ...++.++||||||+++|||++|+.||........ .+. .. ..+.......
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~~-~~~~~~~~~~--- 252 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLT----KV-LQEEPPLLPG--- 252 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHH----HH-HHSCCCCCCS---
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHH----HH-hccCCCCCCc---
Confidence 446899999999994 56788999999999999999999999975322111 010 00 1111111100
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.......+.+++.+||+.||.+||++.++++
T Consensus 253 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 ----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112245677999999999999999999886
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=342.14 Aligned_cols=238 Identities=24% Similarity=0.319 Sum_probs=190.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCccccccccccccc-----cee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN-----RLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~l 577 (796)
+.+.+.||+|+||.||++.+...+++.||||++... .......+.+|+.++++++||||+++++++..... .+|
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 445678999999999999976546899999998643 23445678999999999999999999999987766 699
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++++ .+||+|||+++.....
T Consensus 162 v~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred EEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 9999999999987765 789999999999999999999998 89999999999999985 9999999999876432
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
....||+.|+|||++.+.. +.++|||||||++|||++|..|+...... .+..
T Consensus 235 ----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------------~~~~--- 286 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------------------GLPE--- 286 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------------SCCT---
T ss_pred ----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------------cccc---
Confidence 3456899999999997754 89999999999999999998887532110 0000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHcC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPT-MKVVLQMLEGL 777 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~evl~~L~~~ 777 (796)
..........+.+++.+||+.||++||+ ++++.+.|.++
T Consensus 287 -~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 287 -DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0011122356778999999999999994 66666666543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=321.46 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=180.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEeecCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
..+.||+|+||+|+.... .+++.||||++..... ..+.+|+++++++ +|||||++++++.+....++||||++
T Consensus 28 ~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred cCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 446899999999654322 3688999999965322 2356799999998 89999999999999999999999997
Q ss_pred CCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-----CCcEEEeecCCcccccCCCC
Q 044281 585 GTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-----FFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 585 gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~kl~DfGla~~~~~~~~ 658 (796)
|+|.+++.... ......++.++.||++||+|||+. +|+||||||+|||++. ...+||+|||+++.......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 59999997654 445566789999999999999998 8999999999999943 34688999999987653321
Q ss_pred --cceeeccCCCccccccccc---CCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 659 --RTHTMIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 659 --~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
.......||+.|+|||++. ...++.++|||||||++|||++ |..||............ .......
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~--------~~~~~~~- 249 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--------GACSLDC- 249 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT--------TCCCCTT-
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh--------ccCCccc-
Confidence 2233466999999999997 4567889999999999999999 88888654333221110 1111110
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.. ........+.+++.+||+.||++|||+.+|++
T Consensus 250 ~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 LH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp SC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 11223345678999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=300.92 Aligned_cols=232 Identities=15% Similarity=0.095 Sum_probs=180.9
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|+..+.+++|+||+++++++.+.+..++||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 3455678999999999999865 468999999997542 234578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
||+++++|.+++... .....+.+++.||+.||+|||++ +|+||||||+|||+++++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999653 34556888999999999999998 99999999999999999999998543
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
|++ .++.++|||||||++|||++|+.||......+..... ......... ...
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~--~~~ 226 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------ERDTAGQPI--EPA 226 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------CBCTTSCBC--CHH
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------HHHhccCCC--Chh
Confidence 333 3789999999999999999999999754321100000 000000000 000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
.........+.+++.+||+.||++| |+.|+++.|+.+...
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 1112233457789999999999999 999999999876554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=295.66 Aligned_cols=235 Identities=20% Similarity=0.229 Sum_probs=178.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHh-cccCccCcccccccccc----cccceeEEeec
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAI-GRTHHKHLVQLLGFCDE----ALNRLLVYEFM 582 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lv~e~~ 582 (796)
+.||+|+||.||++... .+++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEc-CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 56999999999999865 46889999999642 3567788887 55699999999999876 77789999999
Q ss_pred CCCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccccCCC
Q 044281 583 GNGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 583 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~~~ 657 (796)
++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 9999999998754 689999999999999999999998 8999999999999998 7899999999987432
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
+..++.++|||||||++|||++|+.||............ ...........
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--------~~~~~~~~~~~-- 221 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYEF-- 221 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS--------CCSSCTTCCSS--
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH--------HHHHhhccccC--
Confidence 245678999999999999999999999754332211000 00000000000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcCcCCCCCC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGLLDVPNPP 784 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~~~~~~pp 784 (796)
...........+.+++.+||+.||++|||+.|+++. +......+.+|
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~ 270 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence 000001224567889999999999999999999974 44444433333
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=277.22 Aligned_cols=208 Identities=16% Similarity=0.229 Sum_probs=153.3
Q ss_pred ccccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-e
Q 044281 18 SAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-L 96 (796)
Q Consensus 18 ~~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l 96 (796)
++.++|++|++|++ +++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| .++.|+|+.|| |
T Consensus 6 ~~~~~i~~g~~L~~---g~~l--~~g~f~l~f~~~gn------l~l-y~~---~~~vW~an~~~~--~~~~l~l~~dGnL 68 (236)
T 1dlp_A 6 GLSHEGSHPQTLHA---AQSL--ELSSFRFTMQSDCN------LVL-FDS---DVRVWASNTAGA--TGCRAVLQSDGLL 68 (236)
T ss_dssp CSSSSSCSCSCCCT---TCEE--CSTTEEEEECTTSC------EEE-EES---SSEEECCCCCSC--SCCBCCBCSSSCB
T ss_pred eccceeCCCCEECC---CCEE--EcCCEEEEECCCCc------EEE-EEC---CEEEEECCCCCC--CCeEEEEcCCCcE
Confidence 66799999999986 4667 59999999985442 233 432 799999999999 56789999999 9
Q ss_pred EEECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeeccccCcccc----------cCCccccCc-ceEEe
Q 044281 97 LLKDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTI----------LPTQILDLG-SVLVS 163 (796)
Q Consensus 97 ~l~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtl----------Lpg~kl~~~-~~L~S 163 (796)
||.|++|.+||++++. .+...|+|+|+|||||++ .++||||||||||+ +||||++.+ ++|+|
T Consensus 69 vl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~-----~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s 143 (236)
T 1dlp_A 69 VILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG-----PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA 143 (236)
T ss_dssp CCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC-----SEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS
T ss_pred EEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEec-----CCEEECCCCCCcccccCCccceEEecCCcCCCccceEEc
Confidence 9999999999998753 233479999999999973 28999999998655 777776654 46764
Q ss_pred ccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcceeEEeccceEEEEecCce-eeeccccc
Q 044281 164 RLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQ-IVQLPQWS 241 (796)
Q Consensus 164 ~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (796)
..||++|.|+|+++ +|++.++ ... ..||+++++... ....+.++.+|.++++..+++ +++...
T Consensus 144 ---~~d~s~G~~~l~l~~dG~LvL~--~~~-----~~~W~s~~~~~~---~~~~~~L~~~Gnl~ly~~~~~~vw~s~~-- 208 (236)
T 1dlp_A 144 ---TQSLQLSPYRLSMETDCNLVLF--DRD-----DRVWSTNTAGKG---TGCRAVLQPNGRMDVLTNQNIAVWTSGN-- 208 (236)
T ss_dssp ---SCCCBCSSCEEEEETTTEEEEE--BTT-----BCCSCCCCCSSC---SSCEEEEETTTEEEEEETTTEEEEECCC--
T ss_pred ---CcEeecCcEEEEECCCCcEEEE--cCC-----EeEEeCCCcCCC---CceEEEECCCCcEEEEeCCCcEEEEeCC--
Confidence 78999999999999 6655543 222 479999988542 223456777776655554443 333321
Q ss_pred cccCCCceeEEEEEccCCcEEEEe
Q 044281 242 KLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 242 ~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
... ...+|++|++||++++|.
T Consensus 209 --~~~-~~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 209 --SRS-AGRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp --CCS-SSCCEEEECSSSCEEEEC
T ss_pred --CCC-CCCEEEEEcCCCcEEEeC
Confidence 111 235799999999999995
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.95 Aligned_cols=242 Identities=17% Similarity=0.100 Sum_probs=182.2
Q ss_pred HHHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--------hhhHHHHHHHHHHhcccC--------------
Q 044281 501 DATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--------QEREREFKSEVSAIGRTH-------------- 558 (796)
Q Consensus 501 ~~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~-------------- 558 (796)
...+.+.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 34566678899999999999986 57999999997532 122367888888888876
Q ss_pred ------------ccCcccccccccc-------------cccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHh
Q 044281 559 ------------HKHLVQLLGFCDE-------------ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGL 613 (796)
Q Consensus 559 ------------h~niv~l~g~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l 613 (796)
||||+++++++.+ ....++||||+++|++.+.+.. ..+++..+..++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 6677777777665 6788999999999976666644 5678999999999999999
Q ss_pred hHhh-hcCCCCeeeCCCCCCCEEEcCCC--------------------cEEEeecCCcccccCCCCcceeeccCCCcccc
Q 044281 614 AYLH-EECNVPIIHCDIKPQNILLDHFF--------------------SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672 (796)
Q Consensus 614 ~yLH-~~~~~~iiH~Dlk~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 672 (796)
+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 77 899999999999999887 8999999999876432 3469999999
Q ss_pred cccccCCCCCccchhHHHHHH-HHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHH
Q 044281 673 PEWFKNVPVSAKVDVYSFGVT-LLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLM 751 (796)
Q Consensus 673 PE~~~~~~~s~k~DVwS~Gv~-l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 751 (796)
||++.+.. +.++||||++++ .+++++|..||........ +.. .......... ............++.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~---~~~---~~~~~~~~~~----~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY---LTD---KMLKQMTFKT----KCNTPAMKQIKRKIQE 314 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH---HHH---HHHHTCCCSS----CCCSHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH---HHH---hhhhhhccCc----ccchhhhhhcCHHHHH
Confidence 99998776 899999998777 7888999999854211000 000 0000001000 0111122345667889
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 044281 752 IAMWCIQEDPSKRPTMKVVL 771 (796)
Q Consensus 752 l~~~Cl~~dp~~RPt~~evl 771 (796)
++.+||+.| |+.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 888887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-33 Score=313.69 Aligned_cols=233 Identities=16% Similarity=0.153 Sum_probs=173.2
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh---hhHHHHHHHHHHhcccCc-cCccccccc--------------
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ---EREREFKSEVSAIGRTHH-KHLVQLLGF-------------- 568 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~g~-------------- 568 (796)
.+.||+|+||.||+|... .+++.||||++..... ...+.|.+|+.+++.++| +|...+..+
T Consensus 83 ~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred ecccccCCCEEEEEEEec-CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 367999999999999965 4688999999873222 235679999999999977 332222211
Q ss_pred -------ccc-----cccceeEEeecCCCCHHHHHhc-------CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCC
Q 044281 569 -------CDE-----ALNRLLVYEFMGNGTLANLIFA-------IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDI 629 (796)
Q Consensus 569 -------~~~-----~~~~~lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dl 629 (796)
... ....+++|+++ +++|.+++.. ...+++..++.++.||++||+|||+. +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 111 12335666654 6799988841 23467888999999999999999998 9999999
Q ss_pred CCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCcccccccc----------cCCCCCccchhHHHHHHHHHHHh
Q 044281 630 KPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF----------KNVPVSAKVDVYSFGVTLLEIIC 699 (796)
Q Consensus 630 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DVwS~Gv~l~ellt 699 (796)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999999864322 334557 999999999 66678899999999999999999
Q ss_pred CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 044281 700 CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVL 771 (796)
Q Consensus 700 g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 771 (796)
|+.||......+.... ++.... ...+.+.+++.+||+.||++||++.+++
T Consensus 313 g~~Pf~~~~~~~~~~~----------------~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEW----------------IFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGSCSGG----------------GGSSCC------CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhhhHHH----------------HHhhcc------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999976543221110 011000 1124577899999999999999976653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=283.42 Aligned_cols=186 Identities=19% Similarity=0.097 Sum_probs=132.3
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecch----------hhhhHHHHHHHHHHhccc-CccCccccccccccccccee
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRL----------AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 577 (796)
.++.|++|.+.++... ..|+.+++|.+... .+...++|.+|+++|+++ +|+||++++++++++...||
T Consensus 241 ~~~~~~~~~h~~~rr~-~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRY-FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEE-EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccccc-cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4566777766654422 34778999998542 223346799999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
||||++|++|.++|.....++.. +|+.||+.||+|+|++ +||||||||+|||+++++++||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999999988777654 5889999999999999 99999999999999999999999999998765433
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS 703 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p 703 (796)
. .....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 2334679999999999976 467789999999999888765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=252.34 Aligned_cols=182 Identities=16% Similarity=0.217 Sum_probs=145.8
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--------hhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--------QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
.+.||+|+||.||++.. .++.+++|+..... ....+.+.+|++++++++||||+++..++......+||
T Consensus 341 ~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 46899999999999954 46788998863211 11235689999999999999999777777788888999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++++|.+++.. +..++.||++||.|||++ +|+||||||+|||+++ .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999876 568999999999999998 8999999999999999 999999999997644322
Q ss_pred cc------eeeccCCCcccccccccC--CCCCccchhHHHHHHHHHHHhCCCCC
Q 044281 659 RT------HTMIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVTLLEIICCRRSV 704 (796)
Q Consensus 659 ~~------~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gv~l~elltg~~p~ 704 (796)
.. .....||+.|||||++.. ..|+.+.|+|+..+-..+-+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 235679999999999987 67888999999998888887766654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=204.47 Aligned_cols=140 Identities=16% Similarity=0.069 Sum_probs=115.5
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhh------------------hhHHHHHHHHHHhcccCccCcccccccc
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ------------------EREREFKSEVSAIGRTHHKHLVQLLGFC 569 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g~~ 569 (796)
+.||+|+||.||+|.. .+++.||||.++.... .....+.+|+.++++++ | +++.+++
T Consensus 96 ~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred CEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 7899999999999987 4789999999964221 13467899999999998 5 7777755
Q ss_pred cccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCC
Q 044281 570 DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649 (796)
Q Consensus 570 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 649 (796)
+.+..++||||+++++|.+ +.. .....++.||++||.|||+. +|+||||||+|||++ ++.+||+|||+
T Consensus 171 -~~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 171 -AWEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp -EEETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred -eccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 3466799999999999988 421 33457999999999999998 999999999999999 99999999999
Q ss_pred cccccCCCCcceeeccCCCcccccccccC
Q 044281 650 SKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678 (796)
Q Consensus 650 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 678 (796)
++. +..++|||++..
T Consensus 239 a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 239 SVE--------------VGEEGWREILER 253 (282)
T ss_dssp CEE--------------TTSTTHHHHHHH
T ss_pred CeE--------------CCCCCHHHHHHH
Confidence 973 345789998853
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=3.1e-18 Score=153.29 Aligned_cols=105 Identities=14% Similarity=0.250 Sum_probs=88.0
Q ss_pred ccccccccCccccccCCCCeee--eCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc
Q 044281 18 SAANNITLGSSLSSTNKNSSWL--SPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG 95 (796)
Q Consensus 18 ~~~~~i~~~~~l~~~~~~~~~~--S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g 95 (796)
+++++|.+|++|.+ +++|+ |++|.|+|+|+.+++ . +||++ +++||+||++.| ..++.++|..+|
T Consensus 6 ~~~~~l~~g~~L~~---g~~l~~~S~~g~~~L~~~~dgn----l---vly~~---~~~vW~sn~~~~-~~~~~l~l~~dG 71 (119)
T 1b2p_A 6 SKQPDDNHPQILHA---TESLEILFGTHVYRFIMQTDCN----L---VLYDN---NNPIWATNTGGL-GNGCRAVLQPDG 71 (119)
T ss_dssp CSCSSSCCCCEEET---TCEEEEEETTEEEEEEECTTSC----E---EEEET---TEEEEECCCTTS-CSSCEEEECTTS
T ss_pred ecCcccCCCCEEcC---CCEEEEeCCCCCEEEEEecCCC----E---EEEEC---CEEEEeCCCccC-CCceEEEEccCC
Confidence 66889999999986 46799 999999999997553 2 57875 799999999987 335689999999
Q ss_pred -eEEECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeec
Q 044281 96 -LLLKDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQS 141 (796)
Q Consensus 96 -l~l~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQS 141 (796)
|||.|.++.++|++.+. .+...++|+|+|||||++ .++|||
T Consensus 72 NLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~-----~~~W~S 115 (119)
T 1b2p_A 72 VLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-----DALWAT 115 (119)
T ss_dssp CEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-----SEEEEC
T ss_pred EEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC-----ccEeCC
Confidence 99999999999998642 334579999999999986 279998
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-17 Score=145.72 Aligned_cols=102 Identities=19% Similarity=0.361 Sum_probs=83.3
Q ss_pred ccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEE
Q 044281 20 ANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 98 (796)
Q Consensus 20 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l 98 (796)
+|+|.+|+.|.+ +++|+| |.|.|.|...++ |.++. ..++||+|||++|...++.|+|+.|| |+|
T Consensus 1 kn~L~~g~~L~~---g~~L~s--g~y~l~~q~DgN------Lvly~----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL 65 (105)
T 4h3o_A 1 RNILDNNEGLYA---GQSLDV--EPYHFIMQDDCN------LVLYD----HSTSTWASNTEIGGKSGCSAVLQSDGNFVV 65 (105)
T ss_dssp CCEECTTEEECT---TCEEEE--TTEEEEECTTSC------EEEEE----TTEEEEECCCCCTTCCSCEEEECTTSCEEE
T ss_pred CCCcCCCCEEcC---CCEEEE--CCEEEEECCCCe------EEEEE----CCEEEEEecCCCCCCccEEEEEeCCccEEE
Confidence 367899999975 577987 889999854332 56654 36899999999999888899999999 999
Q ss_pred ECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeec
Q 044281 99 KDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQS 141 (796)
Q Consensus 99 ~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQS 141 (796)
.|+++.+||+|++. .+...|+|+|+|||||++. .||||
T Consensus 66 ~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~-----~~W~S 105 (105)
T 4h3o_A 66 YDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS-----DIWST 105 (105)
T ss_dssp ECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES-----EEEEC
T ss_pred ECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC-----cEecC
Confidence 99999999998753 3345799999999999752 59998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.9e-17 Score=146.23 Aligned_cols=107 Identities=20% Similarity=0.384 Sum_probs=86.9
Q ss_pred ccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEE
Q 044281 20 ANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 98 (796)
Q Consensus 20 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l 98 (796)
.|+|.+|+.|.+ +++|+ ++|.|+|+|+..++ . |||+ ..++||.||++.|. .+..++|..+| |||
T Consensus 1 ~d~l~~g~~L~~---g~~l~-~~~~~~l~~~~dGn----l---vl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl 65 (110)
T 3a0c_A 1 VNSLSSPNSLFT---GHSLE-VGPSYRLIMQGDCN----F---VLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLVI 65 (110)
T ss_dssp CCEEETTCEECT---TCEEE-ETTTEEEEECTTSC----E---EEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEE
T ss_pred CCEeCCCCEECC---CCEEE-ECCCEEEEEcCCCc----E---EEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEEE
Confidence 368999999975 56799 99999999976542 2 6776 37999999999873 35689999999 999
Q ss_pred ECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeeccccCc
Q 044281 99 KDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPT 146 (796)
Q Consensus 99 ~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PT 146 (796)
.|.++.++|++.+. .+...++|+|+|||||++. .+||||+||.
T Consensus 66 ~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~-----~~W~S~~~~~ 110 (110)
T 3a0c_A 66 YDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP-----VVWATGSGPA 110 (110)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-----EEEECSCCC-
T ss_pred ECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC-----CEecCCCcCC
Confidence 99999999998643 2334799999999999742 6999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.2e-17 Score=146.26 Aligned_cols=107 Identities=17% Similarity=0.354 Sum_probs=86.5
Q ss_pred ccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEE
Q 044281 20 ANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 98 (796)
Q Consensus 20 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l 98 (796)
.|+|.+||+|.+ +++|+ +|.|+|+|+..++ .. +|+ ..++||+||++.|. .++.|.|..+| |+|
T Consensus 2 ~dtl~~gq~L~~---g~~L~--~g~~~L~~~~dgn----lv---ly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl 65 (115)
T 2dpf_A 2 DNVLLSGQTLHA---DHSLQ--AGAYTLTIQNKCN----LV---KYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLVI 65 (115)
T ss_dssp CCEEETTCEEET---TEEEE--ETTEEEEECTTSC----EE---EEE---TTEEEEECSCTTSC-SSCEEEECTTSCEEE
T ss_pred CCEeCCCCEECC---CCEEE--CCCEEEEEcCCCc----EE---EEe---CCEEEEeCCCCCCC-CceEEEECCCCcEEE
Confidence 478999999986 56788 8999999975442 33 365 37899999999884 45689999999 999
Q ss_pred ECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeeccccCcc
Q 044281 99 KDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTD 147 (796)
Q Consensus 99 ~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTD 147 (796)
.|.++.++|++... .+...++|+|+|||||++. ++||||.+++.
T Consensus 66 ~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~-----~~W~S~~~~~~ 111 (115)
T 2dpf_A 66 YDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP-----VLWSLGPNGCR 111 (115)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-----EEECSSTTCBC
T ss_pred ECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC-----CEEECCCCCCc
Confidence 99989999998652 3345799999999999742 79999998764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=172.95 Aligned_cols=135 Identities=19% Similarity=0.180 Sum_probs=104.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeE--EEEEEecchhh------------------------hhHHHHHHHHHHhcccCc
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTA--IAVKKLDRLAQ------------------------EREREFKSEVSAIGRTHH 559 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~--vavK~l~~~~~------------------------~~~~~~~~E~~~l~~l~h 559 (796)
+.+.||+|+||.||+|... .+|+. ||||+++.... .....+.+|+.++.+++|
T Consensus 51 i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3467999999999999873 25778 99998643211 112468899999999988
Q ss_pred cCc--ccccccccccccceeEEeecCC-C----CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhh-hcCCCCeeeCCCCC
Q 044281 560 KHL--VQLLGFCDEALNRLLVYEFMGN-G----TLANLIFAIPKPDWNLRIRISLEIARGLAYLH-EECNVPIIHCDIKP 631 (796)
Q Consensus 560 ~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH-~~~~~~iiH~Dlk~ 631 (796)
+++ +.++++ ...+|||||+.+ | +|.++... .++..+..++.||+.||.||| +. +|+||||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp 199 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE 199 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence 864 333332 467899999942 4 67666433 235567899999999999999 77 999999999
Q ss_pred CCEEEcCCCcEEEeecCCcccc
Q 044281 632 QNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 632 ~NIll~~~~~~kl~DfGla~~~ 653 (796)
+|||+++ .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.1e-16 Score=137.83 Aligned_cols=106 Identities=16% Similarity=0.417 Sum_probs=84.4
Q ss_pred cccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEEE
Q 044281 21 NNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 99 (796)
Q Consensus 21 ~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l~ 99 (796)
|+|.+||+|.+ +++| ++|.|+|+|+.+++ . +||++ .++||+||++.+ ..++.++|..+| |||.
T Consensus 2 dtl~~gq~L~~---g~~L--~~~~~~L~~~~dgn----l---vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~ 65 (112)
T 1xd5_A 2 DRLNSGHQLDT---GGSL--AEGGYLFIIQNDCN----L---VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVIY 65 (112)
T ss_dssp CEEETTEEECT---TCEE--EETTEEEEECTTSC----E---EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEEE
T ss_pred CCCCCCCEECC---CCEE--eCCCEEEEEcCCCc----E---EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEEE
Confidence 78999999986 4668 58999999987653 2 35764 689999999864 234689999999 9999
Q ss_pred CCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeeccccC
Q 044281 100 DPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSP 145 (796)
Q Consensus 100 ~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~P 145 (796)
| ++.++|++... .+...++|+++|||||++. .+.++||||+|.
T Consensus 66 d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~--~~~~~W~S~~~~ 110 (112)
T 1xd5_A 66 S-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN--SNNAIWATHTNV 110 (112)
T ss_dssp E-TTEEEEECCCCCSCCCCEEEECTTSCEEEECT--TSCEEEECCCCC
T ss_pred c-CCEEEEECCccCCCCCEEEEEeCCCcEEEECC--CCceEEECCCcc
Confidence 9 88899998642 3334799999999999853 356899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=3.1e-15 Score=131.85 Aligned_cols=100 Identities=18% Similarity=0.387 Sum_probs=79.8
Q ss_pred cccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEEE
Q 044281 21 NNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 99 (796)
Q Consensus 21 ~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l~ 99 (796)
++|.+||.|.+ +++|+ +|.|.|+|...++ .+| |.. .++||+||++.+ ..+..|.|..+| |+|.
T Consensus 2 ntL~~gq~L~~---g~~L~--~g~~~L~~q~dGn----Lvl---y~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl~ 65 (109)
T 3dzw_A 2 NILYSGETLSP---GEFLN--NGRYVFIMQEDCN----LVL---YDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVVY 65 (109)
T ss_dssp CEEETTEEECT---TCEEE--ETTEEEEECTTSC----EEE---EET---TEEEEECCCTTS-SSSCEEEECTTSCEEEE
T ss_pred CCcCCCCEeCC---CCEEE--CCCEEEEEcCCCc----EEE---EeC---CEEEEECCcccC-CCCEEEEEeCCCCEEEE
Confidence 68999999975 46686 7999999976542 443 654 589999999986 334689999999 9999
Q ss_pred CCCCCeeeecCCC-C-ccceEEeecCccEEEEEcCCCCcceeec
Q 044281 100 DPGGQAIWDGKPD-K-NVSDAAMLDTGNFVLRASGNNSDYAWQS 141 (796)
Q Consensus 100 ~~~~~~vWst~~~-~-~~~~a~lldsGNlVl~~~~~~~~~lWQS 141 (796)
|.++.++|++++. . ....|+|+|+|||||++. .+|||
T Consensus 66 ~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~-----~~W~s 104 (109)
T 3dzw_A 66 SPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT-----ARWAT 104 (109)
T ss_dssp CTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES-----CCCCC
T ss_pred CCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC-----CEEeC
Confidence 9999999998753 2 234799999999999852 79998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.2e-15 Score=161.90 Aligned_cols=138 Identities=11% Similarity=0.013 Sum_probs=96.7
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--------------hhHHHHHHHHHHhcccCccCccccccccc
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--------------EREREFKSEVSAIGRTHHKHLVQLLGFCD 570 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 570 (796)
.+.+.||+|+||.||+|... +|+.||||+++.... ........++++.+...|+|++++.....
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp EEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34567999999999999864 689999998753110 01122233333333444555555543221
Q ss_pred ------ccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC----
Q 044281 571 ------EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF---- 640 (796)
Q Consensus 571 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~---- 640 (796)
.....+|||||+++++|..+.. ......++.||+.+|.|||+. +||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccc
Confidence 1223479999999988866532 223457889999999999998 899999999999998876
Q ss_pred ------cEEEeecCCcccc
Q 044281 641 ------SAKISDFGLSKLL 653 (796)
Q Consensus 641 ------~~kl~DfGla~~~ 653 (796)
.+.|+||+-+...
T Consensus 247 ~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECCCTTCEET
T ss_pred ccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.6e-13 Score=120.87 Aligned_cols=102 Identities=18% Similarity=0.277 Sum_probs=77.8
Q ss_pred ccccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-e
Q 044281 18 SAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-L 96 (796)
Q Consensus 18 ~~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l 96 (796)
.|.|+|.+||.|.. +++|+| |.|.|-| +..+ + |.+ |.. ++||.+|++.. ..+..|.|..+| |
T Consensus 4 ~~~dtL~~gq~L~~---g~~L~s--g~~~L~~-q~dG---n--Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNL 66 (110)
T 3r0e_B 4 FTNNLLFSGQVLYG---DGRLTA--KNHQLVM-QGDC---N--LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGEL 66 (110)
T ss_dssp CBTTEEETTCEEET---TEEEEC--SSCEEEE-CTTS---C--EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCE
T ss_pred cccCEECCCCEecC---CCEEEe--CCEEEEE-cCCC---e--EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcE
Confidence 46799999999985 567997 4588855 3332 1 344 654 47999999863 234589999999 9
Q ss_pred EEECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeec
Q 044281 97 LLKDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQS 141 (796)
Q Consensus 97 ~l~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQS 141 (796)
+|.|.++.++|++++. .+...|+|+|+|||||++ ..+|+|
T Consensus 67 vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~-----~~~W~t 108 (110)
T 3r0e_B 67 IIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG-----PAIFET 108 (110)
T ss_dssp EEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-----SEEEES
T ss_pred EEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec-----CCEecC
Confidence 9999999999998752 233579999999999975 379987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.44 E-value=7.9e-13 Score=117.07 Aligned_cols=105 Identities=15% Similarity=0.244 Sum_probs=80.4
Q ss_pred ccccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-e
Q 044281 18 SAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-L 96 (796)
Q Consensus 18 ~~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l 96 (796)
.+.|+|.+||.|.. ++.|. +|.|.|-|...++ |.++..+ ..++||.+|+..+- .+..|.|..+| |
T Consensus 4 ~~~~tL~~gq~L~~---g~~L~--~g~~~L~~q~dGN------LvL~~~~--~~~~vWssnt~~~~-~~~~l~l~~dGNL 69 (113)
T 3mez_B 4 RVRNVLFSSQVMYD---NAQLA--TRDYSLVMRDDCN------LVLTKGS--KTNIVWESGTSGRG-QHCFMRLGHSGEL 69 (113)
T ss_dssp CCSSEEETTCEEET---TCEEE--ETTEEEEECTTSC------EEEEETT--TTEEEEECCCTTSC-SSCEEEECTTSCE
T ss_pred ccCCEeCCCCEECC---CCEeE--cCCEEEEEcCCCE------EEEEECC--CCEEEEECCcccCC-cCEEEEEeCCCcE
Confidence 35789999999975 45686 4888888843221 5554331 36899999998763 34689999999 9
Q ss_pred EEECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeec
Q 044281 97 LLKDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQS 141 (796)
Q Consensus 97 ~l~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQS 141 (796)
+|.|.++.++|++++. .+...|+|+|+|||||++ ..+|+|
T Consensus 70 Vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~-----~~~W~s 111 (113)
T 3mez_B 70 DITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG-----PAVWST 111 (113)
T ss_dssp EEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC-----SEEEES
T ss_pred EEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec-----CCEecC
Confidence 9999999999998752 233579999999999974 479997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.9e-13 Score=118.49 Aligned_cols=86 Identities=16% Similarity=0.341 Sum_probs=67.1
Q ss_pred CCCcEEEEecCc-eEEECCCCCeeeecCCCC--ccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCccccCcce
Q 044281 84 PRGSTLELTATG-LLLKDPGGQAIWDGKPDK--NVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSV 160 (796)
Q Consensus 84 ~~~s~l~l~~~g-l~l~~~~~~~vWst~~~~--~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~ 160 (796)
....+|.+..|| |+|.+ .+++||+++... ....++|+|+|||||++. ++.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~--~~~~~W~S~------------------ 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ--SNRVIWQTK------------------ 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT--TCCEEEECC------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC--CCcEEEecC------------------
Confidence 345689999999 99998 588999987532 235799999999999864 457999999
Q ss_pred EEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccc
Q 044281 161 LVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTY 206 (796)
Q Consensus 161 L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (796)
+++++|.|++.++ +|+++++- . .||+++++
T Consensus 78 -------t~~~~g~~~l~l~~dGnlvl~~---~------~~W~S~~~ 108 (110)
T 3a0c_A 78 -------TNGKEDHYVLVLQQDRNVVIYG---P------VVWATGSG 108 (110)
T ss_dssp -------CCCSSSCCEEEECTTSCEEEEC---S------EEEECSCC
T ss_pred -------CCCCCCCEEEEEeCCccEEEEC---C------CEecCCCc
Confidence 3567799999998 78877642 1 58988765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.40 E-value=7.7e-13 Score=117.25 Aligned_cols=88 Identities=19% Similarity=0.336 Sum_probs=68.8
Q ss_pred CcEEEEecCc-eEEECCCCCeeeecCCCC--ccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCccccCcceEE
Q 044281 86 GSTLELTATG-LLLKDPGGQAIWDGKPDK--NVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLV 162 (796)
Q Consensus 86 ~s~l~l~~~g-l~l~~~~~~~vWst~~~~--~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~ 162 (796)
..+|.|..+| |+|.+. +++||+++... ....|+|+|+|||||++ ++.++||||+
T Consensus 20 ~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d---~~~~~W~S~~------------------- 76 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS---GSRAIWASNT------------------- 76 (112)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE---TTEEEEECCC-------------------
T ss_pred CEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc---CCEEEEECCc-------------------
Confidence 3589999999 999887 78999987532 23579999999999987 3469999994
Q ss_pred eccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccC
Q 044281 163 SRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSS 208 (796)
Q Consensus 163 S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (796)
++++|.|++.++ +|+++++- ..+ ..||++++|.+
T Consensus 77 ------~~~~g~~~l~l~~dGnlvl~~--~~~----~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ------NRQNGNYYLILQRDRNVVIYD--NSN----NAIWATHTNVG 111 (112)
T ss_dssp ------CCSCCCCEEEECTTSCEEEEC--TTS----CEEEECCCCCC
T ss_pred ------cCCCCCEEEEEeCCCcEEEEC--CCC----ceEEECCCccC
Confidence 456789999998 78877653 111 57999999865
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.6e-12 Score=112.89 Aligned_cols=105 Identities=22% Similarity=0.414 Sum_probs=80.0
Q ss_pred cccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eE
Q 044281 19 AANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LL 97 (796)
Q Consensus 19 ~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~ 97 (796)
|.|+|.+||.|.. +++| .+|.|.|.|...++ .. .|.. +|.+|+..+ ..+..|+|..+| |+
T Consensus 2 ~~dtL~~gq~L~~---g~~L--~~g~~~L~~q~dGN----Lv---l~~~------~Wssnt~~~-~~~~~l~l~~dGnLv 62 (109)
T 3r0e_A 2 GTNYLLSGQTLDT---EGHL--KNGDFDLVMQDDCN----LV---LYNG------NWQSNTANN-GRDCKLTLTDYGELV 62 (109)
T ss_dssp CCSEEETTCEECT---TCEE--EETTEEEEECTTSC----EE---EETT------TEECCCTTS-CSSCEEEECTTSCEE
T ss_pred ccCCcCCCCCcCC---CCEe--ECCCEEEEEecCCe----EE---EEeC------eEEcCCCCC-CCcEEEEEcCCCeEE
Confidence 6789999999975 4567 47999998854332 22 2542 699999875 335689999999 99
Q ss_pred EECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeeccccCcccccCC
Q 044281 98 LKDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPT 152 (796)
Q Consensus 98 l~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg 152 (796)
|.|.++.++|++++. .....|+|+|+|||||++ ..+|+| +|.+||
T Consensus 63 l~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~-----~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 63 IKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG-----PSVFKI-----DPWVRG 109 (109)
T ss_dssp EECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC-----SEEEEE-----CTTSCC
T ss_pred EEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe-----cCEECC-----CCccCC
Confidence 999999999998753 233579999999999974 479997 566554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.29 E-value=8.6e-12 Score=111.33 Aligned_cols=83 Identities=18% Similarity=0.295 Sum_probs=65.1
Q ss_pred cEEEEecCc-eEEECCCCCeeeecCCC-C-ccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCccccCcceEEe
Q 044281 87 STLELTATG-LLLKDPGGQAIWDGKPD-K-NVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVS 163 (796)
Q Consensus 87 s~l~l~~~g-l~l~~~~~~~vWst~~~-~-~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S 163 (796)
.+|.+..+| |+|.+. +++||+++.. . ....++|+|+|||||++. ++.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~--~~~~lW~S~--------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN--ENVTVWQSP--------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT--TCCEEEECS---------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC--CCcEEEcCC---------------------
Confidence 378888888 999887 8899998753 2 235799999999999864 457999999
Q ss_pred ccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccc
Q 044281 164 RLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTY 206 (796)
Q Consensus 164 ~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (796)
+++++|.|++.++ +|+++++- ..||++++.
T Consensus 88 ----~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~~ 118 (119)
T 1b2p_A 88 ----VAGKAGHYVLVLQPDRNVVIYG---------DALWATQTV 118 (119)
T ss_dssp ----CCCCSSCEEEEECTTSCEEEEE---------SEEEECCCC
T ss_pred ----CCCCCCCEEEEEECCCcEEEEC---------ccEeCCCCC
Confidence 4567899999998 77776642 268988763
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=4.3e-11 Score=106.44 Aligned_cols=86 Identities=21% Similarity=0.414 Sum_probs=67.4
Q ss_pred CcEEEEecCc-eEEECCCCCeeeecCCCC--ccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCccccCcceEE
Q 044281 86 GSTLELTATG-LLLKDPGGQAIWDGKPDK--NVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLV 162 (796)
Q Consensus 86 ~s~l~l~~~g-l~l~~~~~~~vWst~~~~--~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~ 162 (796)
...|.+..+| |+|.+ .+++||+++... ....++|+++|||||++. ++.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~--~~~~vW~S~~~------------------ 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH--NNNDVWGSACW------------------ 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT--TCCEEEECCCC------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC--CceEEEEcCCC------------------
Confidence 4588888888 99987 578999987532 235799999999999864 45699999998
Q ss_pred eccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccC
Q 044281 163 SRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSS 208 (796)
Q Consensus 163 S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (796)
+++|.|++.++ +|+++++- . .||++++|..
T Consensus 80 -------~~~g~~~l~l~~dGnlvl~~---~------~~W~S~~~~~ 110 (115)
T 2dpf_A 80 -------GDNGKYALVLQKDGRFVIYG---P------VLWSLGPNGC 110 (115)
T ss_dssp -------CSSSCCEEEECTTSCEEEEC---S------EEECSSTTCB
T ss_pred -------CCCCCEEEEEeCCCeEEEEC---C------CEEECCCCCC
Confidence 35688999998 78877651 1 6999999854
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.09 E-value=2.8e-10 Score=100.19 Aligned_cols=99 Identities=14% Similarity=0.256 Sum_probs=73.6
Q ss_pred cccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEEE
Q 044281 21 NNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 99 (796)
Q Consensus 21 ~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l~ 99 (796)
|+|.+||.|.+ ++.| .+|.|.|-|...++ . -+ |.. .. ||.+|+..+ ..+..|.|..+| |||.
T Consensus 3 ~~l~~gq~L~~---g~~L--~~g~~~L~~q~dGn----L--vl-~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLVl~ 65 (111)
T 3mez_A 3 NVLLTGDVIHT---DNQL--SYESAAFVMQGDCN----L--VL-YNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLEIH 65 (111)
T ss_dssp TEEETTCEECT---TCEE--EETTEEEEECTTSC----E--EE-ECS---SC-CEECCCTTS-CSSCEEEECTTSCEEEE
T ss_pred CEeCCCCEeCC---CCEE--ecCCEEEEEccCCe----E--EE-ECC---CC-EEECCcccC-CcCEEEEEcCCCcEEEE
Confidence 68999999975 4567 37899999843321 3 22 543 23 999999876 334689999999 9999
Q ss_pred CCCCC-eeeecCC----CCccceEEeecCccEEEEEcCCCCcceeec
Q 044281 100 DPGGQ-AIWDGKP----DKNVSDAAMLDTGNFVLRASGNNSDYAWQS 141 (796)
Q Consensus 100 ~~~~~-~vWst~~----~~~~~~a~lldsGNlVl~~~~~~~~~lWQS 141 (796)
|.++. ++|++++ ..+...+.|+|+|||||++ ..+|+|
T Consensus 66 ~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~-----~~~W~s 107 (111)
T 3mez_A 66 SANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG-----PAIWST 107 (111)
T ss_dssp CSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC-----SEEEEC
T ss_pred eCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec-----cCEEcc
Confidence 98876 5999763 1233468999999999974 479987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.7e-10 Score=117.66 Aligned_cols=137 Identities=16% Similarity=0.037 Sum_probs=106.4
Q ss_pred HHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEeecCCC
Q 044281 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 507 ~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
...++.|+.+.||+... +++.+++|............+.+|+.+++.+. |..+.++++++......++||||++|.
T Consensus 19 ~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp EECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred EeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence 34577788899999863 36789999987532222346888999998884 677889999998888889999999999
Q ss_pred CHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhc----------------------------------------------
Q 044281 586 TLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE---------------------------------------------- 619 (796)
Q Consensus 586 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~---------------------------------------------- 619 (796)
+|.+.+. +......++.+++++|+.||+.
T Consensus 96 ~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 96 LCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp EHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred ehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 9987632 1233457889999999999981
Q ss_pred ----------CCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 620 ----------CNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 620 ----------~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999876667799999875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.4e-09 Score=112.15 Aligned_cols=110 Identities=14% Similarity=0.312 Sum_probs=81.8
Q ss_pred ccccccCcc----ccccCCCCeeeeCCCeeeeeeeecC-CCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecC
Q 044281 20 ANNITLGSS----LSSTNKNSSWLSPSRDFAFGFRQLN-DNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTAT 94 (796)
Q Consensus 20 ~~~i~~~~~----l~~~~~~~~~~S~~g~F~lGF~~~~-~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~ 94 (796)
.||+.+|+. |.. +++|+| ..+++.|+|+.. ...+.++| |++ ..+++|.+++.++-. ..+.+..+
T Consensus 136 tdtlLpg~~~~~~l~~---g~~L~S-~~dps~G~fsl~l~~dGnlvL---y~~--~~~~yW~Sgt~~~~~--~~l~l~~d 204 (276)
T 3m7h_A 136 AIPLVPGAIDSLLLAP---GSELVQ-GVVYGAGASKLVFQGDGNLVA---YGP--NGAATWNAGTQGKGA--VRAVFQGD 204 (276)
T ss_dssp TSCCCCSCTTCEEECS---SEEECT-TCEEEETTEEEEECTTSCEEE---ECT--TSSEEEECCCTTTTC--CEEEECTT
T ss_pred cccccccccccccccc---Cccccc-CCCCCCceEEEeecCCceEEE---EeC--CCeEEEECCCCCCcc--EEEEEcCC
Confidence 478888888 543 466765 568888888763 12223443 432 257899999988732 68899999
Q ss_pred c-eEEECCCCCeeeecCCC-CccceEEeecCccEEEEEcCCCCcceeecccc
Q 044281 95 G-LLLKDPGGQAIWDGKPD-KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKS 144 (796)
Q Consensus 95 g-l~l~~~~~~~vWst~~~-~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~ 144 (796)
| |++.|.++.++|++.+. .....|+|+++|||||++. +.+||||||
T Consensus 205 GnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~----~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE----KPVWARFGF 252 (276)
T ss_dssp SCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE----EEEEESSSC
T ss_pred CeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC----CCeEEccCc
Confidence 9 99999988999998752 3346799999999999863 579999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.88 E-value=1.7e-09 Score=111.31 Aligned_cols=129 Identities=16% Similarity=0.037 Sum_probs=95.2
Q ss_pred hC-CCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC--cccccccccccccceeEEeecCCCC
Q 044281 510 LG-RGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH--LVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 510 LG-~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
++ .|..+.||+... .+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||+++.+
T Consensus 27 ~~~gg~~~~v~~~~~--~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSA--QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp CSCTTSSCEEEEEEC--TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cccCCCCceEEEEec--CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 44 555699999864 35678999997653 2245778888888885544 4568888877778899999999988
Q ss_pred HHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC----------------------------------------------
Q 044281 587 LANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC---------------------------------------------- 620 (796)
Q Consensus 587 L~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------------- 620 (796)
|. ... . ....++.++++.|+.||+..
T Consensus 102 l~--~~~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 102 LL--SSH---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TT--TSC---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cC--cCc---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 84 211 1 12356777888888888642
Q ss_pred ---------CCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 621 ---------NVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 621 ---------~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667899999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.83 E-value=6.3e-09 Score=112.72 Aligned_cols=140 Identities=18% Similarity=0.259 Sum_probs=103.6
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEec--chh-hhhHHHHHHHHHHhcccC--ccCccccccccccc---ccceeEE
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLA-QEREREFKSEVSAIGRTH--HKHLVQLLGFCDEA---LNRLLVY 579 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lv~ 579 (796)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..++++++++.+. ...++||
T Consensus 44 ~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECS---SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEEC---CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45889999999998753 4678888876 322 122356788999998886 45678888888776 3478999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC---------------------------------------
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC--------------------------------------- 620 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------- 620 (796)
||+++..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999998774421 234567778889999999999999731
Q ss_pred ----------------CCCeeeCCCCCCCEEEcCCCc--EEEeecCCccc
Q 044281 621 ----------------NVPIIHCDIKPQNILLDHFFS--AKISDFGLSKL 652 (796)
Q Consensus 621 ----------------~~~iiH~Dlk~~NIll~~~~~--~kl~DfGla~~ 652 (796)
...++|+|+++.||++++++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997653 68999999874
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.82 E-value=1.1e-08 Score=90.01 Aligned_cols=84 Identities=10% Similarity=0.269 Sum_probs=62.4
Q ss_pred cEEEEecCc-eEEECCCCCeeeecCCC-C-ccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCccccCcceEEe
Q 044281 87 STLELTATG-LLLKDPGGQAIWDGKPD-K-NVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVS 163 (796)
Q Consensus 87 s~l~l~~~g-l~l~~~~~~~vWst~~~-~-~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S 163 (796)
..|.+..|| |||.+.++ +|++++. . ....++|+|+|||||++.++ ..++|||.-+
T Consensus 22 ~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~-~~~vW~S~t~------------------- 79 (111)
T 3mez_A 22 AAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS-NTPVWVYPRS------------------- 79 (111)
T ss_dssp EEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC-SSCSEEESSS-------------------
T ss_pred EEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC-CEEEEEeccc-------------------
Confidence 489999999 99999877 9998753 2 23578999999999986432 2359999721
Q ss_pred ccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeecccc
Q 044281 164 RLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNT 205 (796)
Q Consensus 164 ~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (796)
.....|.|.+.++ +|+++++- .++|.+++
T Consensus 80 ----~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t 109 (111)
T 3mez_A 80 ----VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA 109 (111)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred ----cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence 1113478999998 89999874 46787765
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.76 E-value=2e-08 Score=88.65 Aligned_cols=90 Identities=11% Similarity=0.217 Sum_probs=64.8
Q ss_pred CCCCCCC-cEEEEecCc-eEEECC-CCCeeeecCCC-C-ccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCcc
Q 044281 80 DNPAPRG-STLELTATG-LLLKDP-GGQAIWDGKPD-K-NVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQI 154 (796)
Q Consensus 80 ~~pv~~~-s~l~l~~~g-l~l~~~-~~~~vWst~~~-~-~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~k 154 (796)
++|+.++ .+|.+..|| |+|.+. .++++|++++. . ....++|+|+|||||++. ++.++|||=.+ +
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~--~~~~iW~S~t~-------~-- 86 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD--RLNTVFVSNTV-------G-- 86 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT--TSCEEEECSCC-------C--
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC--CCCEEEECCCc-------C--
Confidence 4455433 489999999 999988 58999998753 2 235799999999999865 34689997321 0
Q ss_pred ccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeecccc
Q 044281 155 LDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNT 205 (796)
Q Consensus 155 l~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (796)
..|.|.+.++ +|+++++- .+.|.+++
T Consensus 87 ----------------~~~~~~~~L~~dGnlvly~---------~~~W~s~~ 113 (113)
T 3mez_B 87 ----------------QEGDYVLILQINGQAVVYG---------PAVWSTAA 113 (113)
T ss_dssp ----------------SSSCCEEEECTTSCEEEEC---------SEEEESCC
T ss_pred ----------------CCCCEEEEEcCCceEEEec---------CCEecCCC
Confidence 1255888887 89999873 35676653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.71 E-value=7.7e-09 Score=109.21 Aligned_cols=188 Identities=18% Similarity=0.106 Sum_probs=120.3
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccC--cccccccccccc---cceeEEeec
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKH--LVQLLGFCDEAL---NRLLVYEFM 582 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~g~~~~~~---~~~lv~e~~ 582 (796)
.++.|....||+.. ..+++|+.... .....+.+|+.+++.+ .+.. +.+++....... ..++|||++
T Consensus 27 ~~~~G~~n~v~~v~------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp EEEECSSEEEEEST------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred ecCCCCcceEEEEC------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 47889999999752 35888887543 3356788899999887 3333 345555543333 347899999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhc-------------------------------------------
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE------------------------------------------- 619 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~------------------------------------------- 619 (796)
+|.+|..... ..++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988865433 2355666777788888888888751
Q ss_pred ------------CCCCeeeCCCCCCCEEEcC--CCcEEEeecCCcccccCCCCcceee-------------ccCCCcccc
Q 044281 620 ------------CNVPIIHCDIKPQNILLDH--FFSAKISDFGLSKLLFSDQSRTHTM-------------IRGTRGYVA 672 (796)
Q Consensus 620 ------------~~~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~-------------~~gt~~y~a 672 (796)
....++|+|++|.||++++ ...+.|+||+.+............. .....+...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 1135899999999999998 5568999999987532211000000 000001111
Q ss_pred -cccccCCCCCccchhHHHHHHHHHHHhCCCCCchhh
Q 044281 673 -PEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMEL 708 (796)
Q Consensus 673 -PE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~ 708 (796)
|+.... .....+.|+++.++|++.+|..++....
T Consensus 257 ~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~~~g 291 (304)
T 3sg8_A 257 IPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWYEEG 291 (304)
T ss_dssp HHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHHHHH
T ss_pred cHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHHHHH
Confidence 221111 1223689999999999999998765443
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.65 E-value=2e-07 Score=94.13 Aligned_cols=137 Identities=17% Similarity=0.279 Sum_probs=83.6
Q ss_pred cEEEEecCc-eEEECCCCCeeeecCCC-CccceEEeecCccEEEEEcCCCCcceeeccccCcccccCCccccCcceEEec
Q 044281 87 STLELTATG-LLLKDPGGQAIWDGKPD-KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSR 164 (796)
Q Consensus 87 s~l~l~~~g-l~l~~~~~~~vWst~~~-~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S~ 164 (796)
..|.+..+| ++|.+. +++||+++.. .....++|.++|||||++. ++.++|+|+++
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~--~~~~vW~s~~~-------------------- 84 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTA--QNTIRWSSGTK-------------------- 84 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCT--TTCCSCCCCCC--------------------
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcC--CCcEEEeCCcc--------------------
Confidence 356666666 777765 7899998753 2445789999999999764 46789999975
Q ss_pred cCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCC------------C------------------CCC
Q 044281 165 LTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSN------------S------------------SES 213 (796)
Q Consensus 165 ~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~------------------~~~ 213 (796)
.++|.|.+.++ +|+++++- ..+|++..+... . ...
T Consensus 85 -----~~~~~~~~~l~d~Gnlvl~~---------~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~G 150 (236)
T 1dlp_A 85 -----GSIGNYVLVLQPDRTVTIYG---------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLS 150 (236)
T ss_dssp -----CCSSCCEEEECSSSCEEEEC---------SEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBCS
T ss_pred -----ccCCcEEEEEeCCCCEEEec---------CCEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeecC
Confidence 12356778876 78888751 146665444210 0 012
Q ss_pred cceeEEeccceEEEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEe
Q 044281 214 GHQLVFNESAEIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
.+.+.++..+.+++...+..+ |...........++.|+.+|++.+|.
T Consensus 151 ~~~l~l~~dG~LvL~~~~~~~-----W~s~~~~~~~~~~~~L~~~Gnl~ly~ 197 (236)
T 1dlp_A 151 PYRLSMETDCNLVLFDRDDRV-----WSTNTAGKGTGCRAVLQPNGRMDVLT 197 (236)
T ss_dssp SCEEEEETTTEEEEEBTTBCC-----SCCCCCSSCSSCEEEEETTTEEEEEE
T ss_pred cEEEEECCCCcEEEEcCCEeE-----EeCCCcCCCCceEEEECCCCcEEEEe
Confidence 344556666655544332211 22211121233578899999998886
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.64 E-value=6.3e-08 Score=84.75 Aligned_cols=94 Identities=24% Similarity=0.348 Sum_probs=68.9
Q ss_pred cccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcceeEEeccce
Q 044281 146 TDTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAE 224 (796)
Q Consensus 146 TDtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (796)
+|||+|||.|..|..| +.|+|.|.++ +|+++++- .||.+++... .....+.+..+|.
T Consensus 3 ~dtL~~gq~L~~g~~L---------~~g~~~L~~q~dGNLvl~~----------~~Wssnt~~~---~~~~~l~l~~dGn 60 (109)
T 3r0e_A 3 TNYLLSGQTLDTEGHL---------KNGDFDLVMQDDCNLVLYN----------GNWQSNTANN---GRDCKLTLTDYGE 60 (109)
T ss_dssp CSEEETTCEECTTCEE---------EETTEEEEECTTSCEEEET----------TTEECCCTTS---CSSCEEEECTTSC
T ss_pred cCCcCCCCCcCCCCEe---------ECCCEEEEEecCCeEEEEe----------CeEEcCCCCC---CCcEEEEEcCCCe
Confidence 7999999999999999 3499999998 89998862 2687766532 2345678888888
Q ss_pred EEEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEe
Q 044281 225 IYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
+.+...++..+- ..........++++|+.||++++|.
T Consensus 61 Lvl~d~~~~~vW----ss~t~~~~~~~~~~L~~dGNlvly~ 97 (109)
T 3r0e_A 61 LVIKNGDGSTVW----KSGAQSVKGNYAAVVHPDGRLVVFG 97 (109)
T ss_dssp EEEECTTSCEEE----ECCCCCSSSCCEEEEETTTEEEEEC
T ss_pred EEEEeCCCCEEE----cCCCcCCCcCEEEEEcCCCeEEEEe
Confidence 887766554332 1112223345789999999999995
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.49 E-value=4.2e-07 Score=79.64 Aligned_cols=96 Identities=19% Similarity=0.164 Sum_probs=68.7
Q ss_pred cccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcceeEEeccce
Q 044281 146 TDTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAE 224 (796)
Q Consensus 146 TDtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (796)
+|||+|||.|..|+.|+| |.|.|.++ +|+++++- . ..||.+++... .....+.+..+|.
T Consensus 6 ~dtL~~gq~L~~g~~L~s---------g~~~L~~q~dGnLvl~~---~-----~~vW~snt~~~---~~~~~l~l~~dGN 65 (110)
T 3r0e_B 6 NNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVLYG---G-----KYGWQSNTHGN---GEHCFLRLNHKGE 65 (110)
T ss_dssp TTEEETTCEEETTEEEEC---------SSCEEEECTTSCEEEEC---S-----SSCEECCCTTS---SSSCEEEECTTSC
T ss_pred cCEECCCCEecCCCEEEe---------CCEEEEEcCCCeEEEEC---C-----eEEEECCCcCC---CcCEEEEEeCCCc
Confidence 799999999999999986 78999998 88988852 1 36888776532 2335678888888
Q ss_pred EEEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEe
Q 044281 225 IYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
+.+...++..+=.. .......-++++|+.||+|++|.
T Consensus 66 Lvl~d~~~~~iW~S----~t~~~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 66 LIIKDDDFKTIWSS----RSSSKQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp EEEECTTCCEEEEC----CCCCSSSCCEEEECTTSCEEEEC
T ss_pred EEEEeCCCCEEEEc----CCcCCCCCEEEEEcCCccEEEec
Confidence 88776655432111 11111123689999999999995
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.9e-06 Score=75.44 Aligned_cols=96 Identities=16% Similarity=0.295 Sum_probs=69.6
Q ss_pred ccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcceeEEeccceE
Q 044281 147 DTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEI 225 (796)
Q Consensus 147 DtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (796)
+||+|||.|..|..|+ .|+|.|.++ +|+++++-. . ..+|.+++... .....+.+..+|.+
T Consensus 2 ntL~~gq~L~~g~~L~---------~g~~~L~~q~dGnLvly~~--~-----~~vW~snt~~~---~~~~~l~l~~dGNL 62 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN---------NGRYVFIMQEDCNLVLYDV--D-----KPIWATNTGGL---DRRCHLSMQSDGNL 62 (109)
T ss_dssp CEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEET--T-----EEEEECCCTTS---SSSCEEEECTTSCE
T ss_pred CCcCCCCEeCCCCEEE---------CCCEEEEEcCCCcEEEEeC--C-----EEEEECCcccC---CCCEEEEEeCCCCE
Confidence 7999999999999995 499999998 899888642 1 67898876532 23456788888888
Q ss_pred EEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEe
Q 044281 226 YIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
.+...++..+ |..........++++|+.||+|++|.
T Consensus 63 vl~~~~~~~~----W~S~t~~~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 63 VVYSPRNNPI----WASNTGGENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp EEECTTSCEE----EECCCCCSSSCEEEEECTTSCEEEEE
T ss_pred EEECCCCCEE----EECCCCCCCCCEEEEEeCCCEEEEEC
Confidence 7776555432 11112222345789999999999996
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.6e-06 Score=72.21 Aligned_cols=97 Identities=19% Similarity=0.276 Sum_probs=70.6
Q ss_pred ccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcceeEEeccceE
Q 044281 147 DTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEI 225 (796)
Q Consensus 147 DtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (796)
|||+|||.|..|+.|+| |.|+|.|+ +|+++++- .. .++|.+++.... .....+.+..+|.+
T Consensus 2 n~L~~g~~L~~g~~L~s---------g~y~l~~q~DgNLvly~--~~-----~~vW~ant~~~~--~~~~~L~l~~dGnL 63 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV---------EPYHFIMQDDCNLVLYD--HS-----TSTWASNTEIGG--KSGCSAVLQSDGNF 63 (105)
T ss_dssp CEECTTEEECTTCEEEE---------TTEEEEECTTSCEEEEE--TT-----EEEEECCCCCTT--CCSCEEEECTTSCE
T ss_pred CCcCCCCEEcCCCEEEE---------CCEEEEECCCCeEEEEE--CC-----EEEEEecCCCCC--CccEEEEEeCCccE
Confidence 89999999999999987 89999999 99999874 22 568888766442 23346788888888
Q ss_pred EEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEe
Q 044281 226 YIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
.+...++..+ |.........-++++|..||+|.+|.
T Consensus 64 vL~d~~~~~v----Wss~t~~~~~~~~l~L~ddGNlVly~ 99 (105)
T 4h3o_A 64 VVYDSSGRSL----WASHSTRGSGNYILILQDDGNVIIYG 99 (105)
T ss_dssp EEECTTCCEE----EECCCCCCSSCEEEEECTTSCEEEEE
T ss_pred EEECCCcEEE----EEecCCCCCCCEEEEEeCCCeEEEEC
Confidence 7776666543 12112222334678999999999984
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.3e-05 Score=82.69 Aligned_cols=134 Identities=16% Similarity=0.086 Sum_probs=92.6
Q ss_pred hCCCccc-eEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEeecCCCCH
Q 044281 510 LGRGSFG-IVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEFMGNGTL 587 (796)
Q Consensus 510 LG~G~fG-~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 587 (796)
+..|..| .||+.... .++..+++|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 32 ~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGK-PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EECSSSSCEEEEEECC-TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred ccCCCcCCeEEEEEec-CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 4445555 58886543 34567889986543 2456788888888773 44467888998888889999999999887
Q ss_pred HHHHhcCCCCchhHHHHHHHHHHHHhhHhhhc------------------------------------------------
Q 044281 588 ANLIFAIPKPDWNLRIRISLEIARGLAYLHEE------------------------------------------------ 619 (796)
Q Consensus 588 ~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~------------------------------------------------ 619 (796)
.+..... ......+..+++..|+-||..
T Consensus 108 ~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 108 FQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred cccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 6654321 122234445555555555531
Q ss_pred -------CCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 620 -------CNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 620 -------~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
....++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01238999999999999988777899999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.4e-05 Score=82.25 Aligned_cols=134 Identities=18% Similarity=0.157 Sum_probs=89.4
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCcc---Cccccccccc-ccccceeEEeecCC
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHK---HLVQLLGFCD-EALNRLLVYEFMGN 584 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~e~~~~ 584 (796)
.++.|....||+. +..+++|+... ......+..|+.+++.+.+. .+.+++.++. .....++|||+++|
T Consensus 26 ~l~~G~~n~v~~v------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 26 SLGEGFRNYAILV------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEECSSEEEEEE------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred ecCCCcceeEEEE------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 4677888889976 34678888643 23346788999999998643 3556666663 44557899999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhc---------------------------------------------
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE--------------------------------------------- 619 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~--------------------------------------------- 619 (796)
.++...... .++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 887653211 123334444444444444444432
Q ss_pred ------------CCCCeeeCCCCCCCEEEcC---CCc-EEEeecCCccc
Q 044281 620 ------------CNVPIIHCDIKPQNILLDH---FFS-AKISDFGLSKL 652 (796)
Q Consensus 620 ------------~~~~iiH~Dlk~~NIll~~---~~~-~kl~DfGla~~ 652 (796)
....++|+|+++.||++++ ++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999997 455 48999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=1.7e-05 Score=85.41 Aligned_cols=81 Identities=2% Similarity=-0.063 Sum_probs=53.5
Q ss_pred Hhh-CCCccceEEEEEee--CC---CCeEEEEEEecchh---hhhHHHHHHHHHHhcccC-c--cCccccccccccc---
Q 044281 508 EEL-GRGSFGIVYKGVLK--TA---SGTAIAVKKLDRLA---QEREREFKSEVSAIGRTH-H--KHLVQLLGFCDEA--- 572 (796)
Q Consensus 508 ~~L-G~G~fG~Vy~g~~~--~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~--- 572 (796)
+.| +.|....+|+.... .. +++.+++|+..... ......+.+|+.+++.+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 346 78888999987643 00 15678888875432 101245677888888774 3 3567788877655
Q ss_pred ccceeEEeecCCCCHH
Q 044281 573 LNRLLVYEFMGNGTLA 588 (796)
Q Consensus 573 ~~~~lv~e~~~~gsL~ 588 (796)
...++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999986654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00012 Score=79.86 Aligned_cols=75 Identities=17% Similarity=0.153 Sum_probs=46.9
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-------hhHHHHHHHHHHhcccCc--c-Cccccccccccccccee
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-------EREREFKSEVSAIGRTHH--K-HLVQLLGFCDEALNRLL 577 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~~~l 577 (796)
+.||.|.++.||++.... +++.++||....... .....+..|.++++.+.+ + .+.+++.+ +....++
T Consensus 36 ~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EECCCCceEEEEEEEECC-CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999997542 457899997643211 112345678888877632 3 33455544 3445689
Q ss_pred EEeecCCC
Q 044281 578 VYEFMGNG 585 (796)
Q Consensus 578 v~e~~~~g 585 (796)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.001 Score=70.59 Aligned_cols=31 Identities=19% Similarity=0.131 Sum_probs=27.9
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 621 ~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3579999999999999888899999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00081 Score=73.93 Aligned_cols=79 Identities=10% Similarity=-0.034 Sum_probs=48.7
Q ss_pred CCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeeccCCCcccccccccCC---CCCccchhHHHHHHHHHHH
Q 044281 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV---PVSAKVDVYSFGVTLLEII 698 (796)
Q Consensus 622 ~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwS~Gv~l~ell 698 (796)
..++|+|+++.|||+++++ ++|+||+.+...............-...|.+|+..... .-....++......+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4799999999999999876 99999998875321110000000012346666655421 1123456668888888877
Q ss_pred hCC
Q 044281 699 CCR 701 (796)
Q Consensus 699 tg~ 701 (796)
+++
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0014 Score=68.72 Aligned_cols=74 Identities=15% Similarity=0.157 Sum_probs=57.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC---ccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...++++++++......++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND---EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEES---SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEE---CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3588999999999764 4568889987543 2456888888888874 35678888888777788999999998
Q ss_pred CCH
Q 044281 585 GTL 587 (796)
Q Consensus 585 gsL 587 (796)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0015 Score=67.68 Aligned_cols=73 Identities=23% Similarity=0.292 Sum_probs=50.8
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCcc---CcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHK---HLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
+.+|.|..+.||+..+. +|+.+.+|+...........|..|+..|+.+... -++++++. +..++||||++.
T Consensus 21 ~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA--DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecc
Confidence 35789999999998764 6889999987654333334578888888877422 23444443 245799999987
Q ss_pred CC
Q 044281 585 GT 586 (796)
Q Consensus 585 gs 586 (796)
+.
T Consensus 95 ~~ 96 (288)
T 3f7w_A 95 RP 96 (288)
T ss_dssp CC
T ss_pred cC
Confidence 64
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.004 Score=68.46 Aligned_cols=74 Identities=14% Similarity=0.181 Sum_probs=48.5
Q ss_pred HhhCCCccceEEEEEeeCC------CCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCc-ccccccccccccceeEEe
Q 044281 508 EELGRGSFGIVYKGVLKTA------SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL-VQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 580 (796)
+.|+.|....+|+...... ++..+++|+..... ....+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3477888899999876421 24688999884421 11345578888888754444 566776553 38999
Q ss_pred ecCCCCH
Q 044281 581 FMGNGTL 587 (796)
Q Consensus 581 ~~~~gsL 587 (796)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0047 Score=66.42 Aligned_cols=139 Identities=17% Similarity=0.215 Sum_probs=81.0
Q ss_pred hhCCCccceEEEEEeeC------CCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC-cccccccccccccceeEEee
Q 044281 509 ELGRGSFGIVYKGVLKT------ASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH-LVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~ 581 (796)
.|..|-...+|+..... .+++.+++|+.... ......+.+|..+++.+...+ ..++++++.++ +||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 46667778899887531 13468999986432 223455668888888774333 35677776553 99999
Q ss_pred cCCCCHHH--------------HH---hcCC-----CCc--hhHHHHHHHHHHH-------------------HhhHhhh
Q 044281 582 MGNGTLAN--------------LI---FAIP-----KPD--WNLRIRISLEIAR-------------------GLAYLHE 618 (796)
Q Consensus 582 ~~~gsL~~--------------~l---~~~~-----~~~--~~~~~~i~~~ia~-------------------~l~yLH~ 618 (796)
+++.+|.. .| +... ... |.+..++..++.. .+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 99865431 11 1111 112 3444444443322 1222221
Q ss_pred ----c-CCCCeeeCCCCCCCEEEcCC----CcEEEeecCCccc
Q 044281 619 ----E-CNVPIIHCDIKPQNILLDHF----FSAKISDFGLSKL 652 (796)
Q Consensus 619 ----~-~~~~iiH~Dlk~~NIll~~~----~~~kl~DfGla~~ 652 (796)
. ....++|+|+.+.||+++++ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 23468999999999999876 7899999998763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.39 E-value=0.015 Score=56.42 Aligned_cols=102 Identities=10% Similarity=-0.006 Sum_probs=66.8
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
-+|.++|... .+++++++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc------------
Confidence 4789998764 688999999999999999877622111 1 1233456899999999998764 2111
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS 703 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p 703 (796)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122467888774 4567889999999999998854443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0043 Score=64.67 Aligned_cols=70 Identities=14% Similarity=0.185 Sum_probs=41.9
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCc-ccccccccccccceeEEeec-CCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL-VQLLGFCDEALNRLLVYEFM-GNG 585 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~-~~g 585 (796)
+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++++. ...-++++||+ ++.
T Consensus 24 ~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp EEEESCSSEEEEEE-------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eEcCCcccccccee-------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 45788888999987 35788887543211 1123457777766643333 3555544 33457899999 654
Q ss_pred CH
Q 044281 586 TL 587 (796)
Q Consensus 586 sL 587 (796)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.012 Score=62.08 Aligned_cols=31 Identities=29% Similarity=0.332 Sum_probs=27.3
Q ss_pred CCeeeCCCCCCCEEEcCC----CcEEEeecCCccc
Q 044281 622 VPIIHCDIKPQNILLDHF----FSAKISDFGLSKL 652 (796)
Q Consensus 622 ~~iiH~Dlk~~NIll~~~----~~~kl~DfGla~~ 652 (796)
..++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6899999998874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.05 E-value=0.016 Score=60.82 Aligned_cols=138 Identities=12% Similarity=0.119 Sum_probs=74.7
Q ss_pred hhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC--cccccccc------cccccceeEEe
Q 044281 509 ELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH--LVQLLGFC------DEALNRLLVYE 580 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv~e 580 (796)
.|+.|....+|+.... ++ .+++|...... ....+..|+.++..+...+ +.+++... ...+..+++++
T Consensus 29 ~i~~G~~n~~~~v~~~--~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTT--KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EECC---EEEEEEEES--SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred ccCCCcccceEEEEeC--Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 4667888889987653 33 68889886521 1224455666666653222 33444321 11244689999
Q ss_pred ecCCCCHHH-----------H---Hh----cC--CC------CchhHHHH------------HHHHHHHHhhHhhhc---
Q 044281 581 FMGNGTLAN-----------L---IF----AI--PK------PDWNLRIR------------ISLEIARGLAYLHEE--- 619 (796)
Q Consensus 581 ~~~~gsL~~-----------~---l~----~~--~~------~~~~~~~~------------i~~~ia~~l~yLH~~--- 619 (796)
|++|..+.. . ++ .. +. ..|...+. +...+.+.++.+++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998864311 0 11 10 10 01222110 001133344455432
Q ss_pred -CCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 620 -CNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 620 -~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13469999999999999987666899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.89 E-value=0.032 Score=58.61 Aligned_cols=137 Identities=14% Similarity=0.064 Sum_probs=74.6
Q ss_pred hCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC--ccccccc-----ccccccceeEEeec
Q 044281 510 LGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH--LVQLLGF-----CDEALNRLLVYEFM 582 (796)
Q Consensus 510 LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lv~e~~ 582 (796)
++ |....||+... .+|+.+++|...... .....+..|..++..+.... +++++.. ....+..+++||++
T Consensus 34 l~-g~~n~~y~v~~--~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 34 LN-SYENRVYQFQD--EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EC-CSSSEEEEECC--TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ec-CcccceEEEEc--CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 55 77778998654 346679999986321 12345566777777664222 4455543 11123446899999
Q ss_pred CCCCHH-----------HHH---h----cC-----CCCchhHH----HHH---------------HHHHHHHhhHhhhc-
Q 044281 583 GNGTLA-----------NLI---F----AI-----PKPDWNLR----IRI---------------SLEIARGLAYLHEE- 619 (796)
Q Consensus 583 ~~gsL~-----------~~l---~----~~-----~~~~~~~~----~~i---------------~~~ia~~l~yLH~~- 619 (796)
++..+. ..+ + .. +..++... ..+ ...+...++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 011 1 00 11111110 000 00111112222211
Q ss_pred ---CCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 620 ---CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 620 ---~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.78 E-value=0.016 Score=63.99 Aligned_cols=74 Identities=15% Similarity=0.077 Sum_probs=45.3
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCc-ccccccccccccceeEEeecCCCC
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL-VQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+.|+.|-...+|+..... ++..+++|+....... .-+...|..+++.+...++ .++++++.. .+||||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS-KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETT-TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECC-CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 357888889999987532 2478889987442211 1112577888887754444 467776642 25999998754
Q ss_pred H
Q 044281 587 L 587 (796)
Q Consensus 587 L 587 (796)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.021 Score=61.32 Aligned_cols=74 Identities=18% Similarity=0.107 Sum_probs=41.9
Q ss_pred hhCCCccceEEEEEeeCC-------CCeEEEEEEecchhhhhHHHHHHHHHHhcccCccC-cccccccccccccceeEEe
Q 044281 509 ELGRGSFGIVYKGVLKTA-------SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH-LVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~-------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e 580 (796)
.|+.|....+|+...... .+..+++|+....... ..+...|..+++.+...+ ..++++.. .-++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 467788889999875320 1257888887543221 112356777777764334 34565543 2378999
Q ss_pred ecCCCCH
Q 044281 581 FMGNGTL 587 (796)
Q Consensus 581 ~~~~gsL 587 (796)
|+++.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.09 E-value=0.089 Score=55.60 Aligned_cols=31 Identities=29% Similarity=0.322 Sum_probs=27.7
Q ss_pred CCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 622 ~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.14 E-value=0.63 Score=50.49 Aligned_cols=74 Identities=11% Similarity=0.080 Sum_probs=44.6
Q ss_pred hhCCCccceEEEEEeeCCC------CeEEEEEEecchhhhhHHHHHHHHHHhcccCccC-cccccccccccccceeEEee
Q 044281 509 ELGRGSFGIVYKGVLKTAS------GTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKH-LVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~~------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~ 581 (796)
.|..|-...+|+......+ +..+++|+...... ...+..+|..+++.+...+ ..++++.+. -++||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 4667778889988764211 46889988754221 1112356777777664333 345555332 3789999
Q ss_pred cCCCCH
Q 044281 582 MGNGTL 587 (796)
Q Consensus 582 ~~~gsL 587 (796)
+++.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998653
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=81.81 E-value=5.2 Score=40.31 Aligned_cols=61 Identities=10% Similarity=0.089 Sum_probs=33.4
Q ss_pred CCeEEEeecCCC-CC-----CCCcEEEEecC-c-eEEECCC-CCeeeecCC--CC-----ccceEEeecCccEEEEE
Q 044281 70 ERTIVWHANGDN-PA-----PRGSTLELTAT-G-LLLKDPG-GQAIWDGKP--DK-----NVSDAAMLDTGNFVLRA 130 (796)
Q Consensus 70 ~~t~VW~ANr~~-pv-----~~~s~l~l~~~-g-l~l~~~~-~~~vWst~~--~~-----~~~~a~lldsGNlVl~~ 130 (796)
...++|...+.. |. .++..+-...+ + ++.+|.+ |.++|.-.. .. -.+.+.++.+||+++.+
T Consensus 154 ~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~ 230 (276)
T 3no2_A 154 NGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN 230 (276)
T ss_dssp TSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred CCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence 356677777643 32 12223333333 3 6666766 778887421 11 13456777788887775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 796 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-09 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-09 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 0.003 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 4e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 0.001 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 6e-05 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (581), Expect = 2e-69
Identities = 66/278 (23%), Positives = 121/278 (43%), Gaps = 23/278 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+ +G GSFG VYKG A+ + + ++ + FK+EV + +T H +++
Sbjct: 12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPI 624
+G+ +V ++ +L + + I + I I+ + A+G+ YLH + I
Sbjct: 70 MGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SI 125
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-SRTHTMIRGTRGYVAPEWFK---NVP 680
IH D+K NI L + KI DFGL+ + S + G+ ++APE + P
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 681 VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740
S + DVY+FG+ L E++ + +R + Y+ L + + AM
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
+ C+++ +RP +L +E L
Sbjct: 243 KR---------LMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (556), Expect = 1e-65
Identities = 74/310 (23%), Positives = 136/310 (43%), Gaps = 42/310 (13%)
Query: 494 FSYDELKDATDGFKEE-----------LGRGSFGIVYKGVLKTAS--GTAIAVKKLDR-L 539
F++++ +A F +E +G G FG V G LK +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 540 AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-D 598
+++ R+F SE S +G+ H +++ L G ++ +++ EFM NG+L + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 599 WNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658
+ + IA G+ YL + +H D+ +NIL++ K+SDFGLS+ L D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 659 RTHTM----IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEES 712
+ + APE + ++ DV+S+G+ + E++ +M ++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 713 RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
AI D+ RL +D A + + C Q+D + RP ++
Sbjct: 244 NAIEQDY--------RLPPPMDCPSALHQ----------LMLDCWQKDRNHRPKFGQIVN 285
Query: 773 MLEGLLDVPN 782
L+ ++ PN
Sbjct: 286 TLDKMIRNPN 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-64
Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 25/272 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E LG G FG V+ G T +AVK L + + + F +E + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIARGLAYLHEECNVP 623
+ ++ E+M NG+L + + N + ++ +IA G+A++ E
Sbjct: 74 YAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IH D++ NIL+ S KI+DFGL++L+ ++ + + APE +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 684 KVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743
K DV+SFG+ L EI+ R + G V D+ +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNP-------EVIQNLERGYRMVRPDNCPEELYQ- 241
Query: 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
+ C +E P RPT + +LE
Sbjct: 242 --------LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-63
Identities = 71/275 (25%), Positives = 116/275 (42%), Gaps = 23/275 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
F +E+G G FG+V+ G +A+K + A E +F E + + H LVQL
Sbjct: 9 FVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 65
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
G C E LV+EFM +G L++ + + + L++ G+AYL E C +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
IH D+ +N L+ K+SDFG+++ + DQ + T + + +PE F S+K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 685 VDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744
DV+SFGV + E+ + + I + R
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNS----------------EVVEDISTGFRLYKPRL 226
Query: 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
I C +E P RP +L+ L + +
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 7e-63
Identities = 63/271 (23%), Positives = 107/271 (39%), Gaps = 23/271 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
F +ELG G FG+V G + +A+K + E EF E + H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYGKWRG--QYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPI 624
G C + ++ E+M NG L N + + + + ++ + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
+H D+ +N L++ K+SDFGLS+ + D+ + + + PE S+K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 685 VDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744
D+++FGV + EI + Y+ + I
Sbjct: 182 SDIWAFGVLMWEIYSLGK----------------MPYERFTNSETAEHIAQGLRLYRPHL 225
Query: 745 RLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
K I C E +RPT K++L +
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-62
Identities = 68/304 (22%), Positives = 125/304 (41%), Gaps = 37/304 (12%)
Query: 498 ELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAI 554
ELKD D F+ ELG G+ G+V+K K SG +A K + + R E+ +
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 555 GRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLA 614
+ ++V G + E M G+L ++ + + ++S+ + +GL
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 118
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
YL E+ I+H D+KP NIL++ K+ DFG+S L + + GTR Y++PE
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPE 173
Query: 675 WFKNVPVSAKVDVYSFGVTLLEIICCRR--------SVEMELEEESRAILTDWAYDCYVE 726
+ S + D++S G++L+E+ R +E+ + +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 727 GRLDVLIDSDEAAMADRSRLHKWLMIAMW------------------CIQEDPSKRPTMK 768
GR D L +++ C+ ++P++R +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 769 VVLQ 772
++
Sbjct: 294 QLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-62
Identities = 60/296 (20%), Positives = 115/296 (38%), Gaps = 27/296 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+E +G+G FG V++G + G +AVK +ER ++E+ H++++
Sbjct: 7 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGF 62
Query: 566 LGFCDE----ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC- 620
+ ++ LV ++ +G+L + + I+++L A GLA+LH E
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 621 ----NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH---TMIRGTRGYVAP 673
I H D+K +NIL+ + I+D GL+ S GT+ Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 674 EWF------KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAI---LTDWAYDCY 724
E K+ + D+Y+ G+ EI + + + +D + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 725 VEGRLDVLIDSD-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
+ + + + L I C + + R T + + L L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-61
Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 31/275 (11%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
+ +G+G FG V G + G +AVK + + F +E S + + H +LVQL
Sbjct: 11 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 566 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIARGLAYLHEECNV 622
LG E L +V E+M G+L + + + + + ++ SL++ + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 122
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
+H D+ +N+L+ AK+SDFGL+K S T + + APE + S
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFS 178
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
K DV+SFG+ L EI R + + +G D A+ +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777
+ C D + RP+ + + LE +
Sbjct: 232 ---------VMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-60
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 25/272 (9%)
Query: 509 ELGRGSFGIVYKGVLK-TASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
ELG G+FG V +GV + +A+K L + ++ + E E + + + ++V+L+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPII 625
G C +A +LV E G G L + + + + +++ G+ YL E+ +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFV 131
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH--TMIRGTRGYVAPEWFKNVPVSA 683
H D+ +N+LL + AKISDFGLSK L +D S + + + APE S+
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 684 KVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743
+ DV+S+GVT+ E + + +++ +G+ +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMECPPECPPELYA- 243
Query: 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
+ C RP V Q +
Sbjct: 244 --------LMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 4e-60
Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 30/293 (10%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA 553
+ L+ + +LG+G FG V+ G T +A+K L E F E
Sbjct: 14 IPRESLR-----LEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPE-AFLQEAQV 65
Query: 554 IGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIAR 611
+ + H+ LVQL E +V E+M G+L + + + ++ +IA
Sbjct: 66 MKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 612 GLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYV 671
G+AY+ +H D++ NIL+ K++DFGL++L+ ++ + +
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 672 APEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDV 731
APE + K DV+SFG+ L E+ R + D G
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMP 234
Query: 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPP 784
++ D + C +++P +RPT + + LE P
Sbjct: 235 CPPECPESLHD---------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-60
Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 28/274 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKHLV 563
F E+GRGSF VYKG+ + +A +L +L + + FK E + H ++V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 564 QLLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
+ + + +LV E M +GTL + + +I +GL +LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 130
Query: 620 CNVPIIHCDIKPQNILL-DHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN 678
PIIH D+K NI + S KI D GL+ L + ++ + GT ++APE ++
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 187
Query: 679 VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
VDVY+FG+ +LE+ S Y G D
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPY-------SECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
I CI+++ +R ++K +L
Sbjct: 240 PEVKE--------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 8e-60
Identities = 67/272 (24%), Positives = 110/272 (40%), Gaps = 25/272 (9%)
Query: 509 ELGRGSFGIVYKGVLK-TASGTAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKHLVQL 565
ELG G+FG V KG + +AVK L A + E +E + + + + ++V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
+G C+ + +LV E G L + I + +++ G+ YL E +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 129
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS--RTHTMIRGTRGYVAPEWFKNVPVSA 683
H D+ +N+LL AKISDFGLSK L +D++ + T + + APE S+
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 684 KVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743
K DV+SFGV + E + Y + +++ E
Sbjct: 190 KSDVWSFGVLMWEAFSYGQ----------------KPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
+ + C D RP V L
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 8e-60
Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 27/281 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGT--AIAVKKLDRLAQERE-REFKSEVSAIGRTHHKHL 562
F E +GRG FG VY G L G AVK L+R+ E +F +E + H ++
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 563 VQLLGFCDEALNR-LLVYEFMGNGTLANLIF-AIPKPDWNLRIRISLEIARGLAYLHEEC 620
+ LLG C + L+V +M +G L N I P I L++A+G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH---TMIRGTRGYVAPEWFK 677
+ +H D+ +N +LD F+ K++DFGL++ ++ + + T + ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737
+ K DV+SFGV L E++ ++ ++GR + +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQPEYCP 260
Query: 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
+ + + + C RP+ ++ + +
Sbjct: 261 DPLYE---------VMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-59
Identities = 58/278 (20%), Positives = 106/278 (38%), Gaps = 24/278 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHL 562
+G G FG V++G+ + A+A+K + RE F E + + H H+
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECN 621
V+L+G E ++ E G L + + D I + +++ LAYL +
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
+H DI +N+L+ K+ DFGLS+ + + + ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 682 SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741
++ DV+ FGV + EI+ ++ G + + +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERLPMPPNCPPTLY 239
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779
+ C DPS+RP + L +L+
Sbjct: 240 S---------LMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 2e-59
Identities = 74/275 (26%), Positives = 117/275 (42%), Gaps = 23/275 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
K +LG G +G VY+GV K +AVK L E E EF E + + H +LVQL
Sbjct: 21 MKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 78
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIARGLAYLHEECNVP 623
LG C ++ EFM G L + + + + + ++ +I+ + YL ++
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 135
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSA 683
IH D+ +N L+ K++DFGLS+L+ D H + + APE S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 684 KVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743
K DV++FGV L EI S ++ ++ L++ D
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYELLEKDYRMERPE 239
Query: 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
K + C Q +PS RP+ + Q E +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-58
Identities = 60/277 (21%), Positives = 112/277 (40%), Gaps = 29/277 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLV 563
+G GS+G K K+ G + K+LD + + ++ SEV+ + H ++V
Sbjct: 8 VLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 564 QLLGFCDEALNRLL--VYEFMGNGTLANLIFAIPKP----DWNLRIRISLEIARGLAYLH 617
+ + N L V E+ G LA++I K D +R+ ++ L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 618 E--ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
+ ++H D+KP N+ LD + K+ DFGL+++L D S + T Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG-TPYYMSPEQ 185
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735
+ + K D++S G L E+ ++E EG+ +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRIPYR 237
Query: 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ + I + RP+++ +L+
Sbjct: 238 YSDELNE---------IITRMLNLKDYHRPSVEEILE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-58
Identities = 70/286 (24%), Positives = 125/286 (43%), Gaps = 28/286 (9%)
Query: 506 FKEE--LGRGSFGIVYKGVLKTASG---TAIAVKKLDRLAQERER-EFKSEVSAIGRTHH 559
+ +G G FG VYKG+LKT+SG +A+K L E++R +F E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHE 618
++++L G + +++ E+M NG L + + + IA G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM--IRGTRGYVAPEWF 676
+H D+ +NIL++ K+SDFGLS++L D T+T + + APE
Sbjct: 129 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 677 KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
++ DV+SFG+ + E++ EL + I+
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------------EVMKAINDG 229
Query: 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPN 782
+ M C Q++ ++RP ++ +L+ L+ P+
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 3e-58
Identities = 59/304 (19%), Positives = 120/304 (39%), Gaps = 49/304 (16%)
Query: 506 FKEELGRGSFGIVYKGVLKTA----SGTAIAVKKLDR-LAQEREREFKSEVSAIGRTHHK 560
+ ++G G+FG V++ T +AVK L + + + +F+ E + + +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIF------------------------AIPK 596
++V+LLG C L++E+M G L + P
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 597 PDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS- 655
++ I+ ++A G+AYL E +H D+ +N L+ KI+DFGLS+ ++S
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 656 DQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAI 715
D + ++ PE + + DV+++GV L EI + E
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---- 249
Query: 716 LTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
+G + ++ + + + C + P+ RP+ + ++L+
Sbjct: 250 ---EVIYYVRDGNILACPENCPLELYN---------LMRLCWSKLPADRPSFCSIHRILQ 297
Query: 776 GLLD 779
+ +
Sbjct: 298 RMCE 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 7e-58
Identities = 78/310 (25%), Positives = 128/310 (41%), Gaps = 48/310 (15%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVL----KTASGTAIAVKKLDRLAQERERE-FK 548
F + L F + LG G+FG V + K+ + +AVK L A ERE
Sbjct: 20 FPRNRLS-----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 549 SEVSAIGR-THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIF--------------- 592
SE+ + +H ++V LLG C L++ E+ G L N +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 593 ---AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649
D + S ++A+G+A+L + IH D+ +NILL H KI DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGL 191
Query: 650 SKLLFSDQSRTH-TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMEL 708
++ + +D + R ++APE N + + DV+S+G+ L E+ S +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 709 EEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 768
+S+ + ++ +L A I C DP KRPT K
Sbjct: 252 PVDSK-------FYKMIKEGFRMLSPEHAPAEMYD--------IMKTCWDADPLKRPTFK 296
Query: 769 VVLQMLEGLL 778
++Q++E +
Sbjct: 297 QIVQLIEKQI 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 72/326 (22%), Positives = 129/326 (39%), Gaps = 58/326 (17%)
Query: 483 DSTTSETNLRF-FSYDELKDATDGFKEELGRGSFGIVYKGVL----KTASGTAIAVKKLD 537
D E +L++ F + L+ F + LG G+FG V KT +AVK L
Sbjct: 22 DFREYEYDLKWEFPRENLE-----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 76
Query: 538 RLAQERERE-FKSEVSAIGR-THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP 595
A ERE SE+ + + H+++V LLG C + L++E+ G L N + +
Sbjct: 77 EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136
Query: 596 KP-----------------------DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQ 632
+ + + + ++A+G+ +L + +H D+ +
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193
Query: 633 NILLDHFFSAKISDFGLSKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFG 691
N+L+ H KI DFGL++ + SD + R ++APE + K DV+S+G
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253
Query: 692 VTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKW 749
+ L EI + + ++ ++ + ++D + E
Sbjct: 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQN-------GFKMDQPFYATEEIYI-------- 298
Query: 750 LMIAMWCIQEDPSKRPTMKVVLQMLE 775
I C D KRP+ + L
Sbjct: 299 --IMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 4e-57
Identities = 75/331 (22%), Positives = 135/331 (40%), Gaps = 53/331 (16%)
Query: 489 TNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLK-TASGTAIAVKKLDRLA-QERERE 546
T ++++K F++ +G G+FG V K +K A+K++ A ++ R+
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 547 FKSEVSAIGR-THHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-------- 597
F E+ + + HH +++ LLG C+ L E+ +G L + +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 598 --------DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649
+ + ++ARG+ YL ++ IH D+ +NIL+ + AKI+DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 173
Query: 650 SKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS--VEME 707
S+ + TM R ++A E + DV+S+GV L EI+ + M
Sbjct: 174 SR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 708 LEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767
E + + RL+ ++ D+ + C +E P +RP+
Sbjct: 232 CAELYEKLPQGY--------RLEKPLNCDDEVYD----------LMRQCWREKPYERPSF 273
Query: 768 KVVLQMLEGLL----DVPNPPGPSSFSIAGT 794
+L L +L N F+ AG
Sbjct: 274 AQILVSLNRMLEERKTYVNTTLYEKFTYAGI 304
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-57
Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 28/270 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKHL 562
LG+G FG VY K S +A+K L + E+ E + + EV H ++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
++L G+ +A L+ E+ GT+ + + K D E+A L+Y H +
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--- 125
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
+IH DIKP+N+LL KI+DFG S S + T + GT Y+ PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHD 182
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
KVD++S GV E + + E +E Y E A
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEFTFPDFVTEGARD- 233
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ ++ +PS+RP ++ VL+
Sbjct: 234 ---------LISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-56
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 30/281 (10%)
Query: 501 DATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH 558
+ D ++ ELG G+FG VYK K + A K +D ++E ++ E+ +
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 559 HKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLH 617
H ++V+LL N ++ EF G + ++ + +P + + + L YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF- 676
+ IIH D+K NIL K++DFG+S R + I GT ++APE
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 677 ----KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732
K+ P K DV+S G+TL+E+ ++ L +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP----------------PHHELNPMRVLLKI 227
Query: 733 IDSDEAAMADRSRLHKWLM-IAMWCIQEDPSKRPTMKVVLQ 772
S+ +A SR C++++ R T +LQ
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 63/296 (21%), Positives = 116/296 (39%), Gaps = 29/296 (9%)
Query: 491 LRFFSYDELKDATDGFKEELGRGSFGIVYKGVLK---TASGTAIAVKKLDRLAQER-ERE 546
LR E K + LG G+FG VYKG+ +A+K+L + +E
Sbjct: 3 LRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 57
Query: 547 FKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRIS 606
E + + H+ +LLG C + +L+ L + +
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 117
Query: 607 LEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM-IR 665
++IA+G+ YL + ++H D+ +N+L+ KI+DFGL+KLL +++ H +
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 666 GTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYV 725
++A E + + + DV+S+GVT+ E++ YD
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS----------------KPYDGIP 218
Query: 726 EGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781
+ +++ E MI + C D RP + ++ + P
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 22/270 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKHLVQ 564
+ LG G++G V V + + A+AVK +D + A + K E+ +H+++V+
Sbjct: 9 LVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
G E + L E+ G L + I R ++ G+ YLH I
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLL-FSDQSRTHTMIRGTRGYVAPEWFKNVPV-S 682
H DIKP+N+LLD + KISDFGL+ + ++++ R + GT YVAPE K +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
VDV+S G+ L ++ + +S +DW +
Sbjct: 185 EPVDVWSCGIVLTAMLAGEL--PWDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAP---- 236
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
L + + E+PS R T+ + +
Sbjct: 237 -------LALLHKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 5e-55
Identities = 69/280 (24%), Positives = 108/280 (38%), Gaps = 31/280 (11%)
Query: 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRLA---QEREREFKSEVSAIGRTHHK 560
E+LG GSFG+V +G SG ++AVK L E +F EV+A+ H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEE 619
+L++L G +V E G+L + + R ++++A G+ YL +
Sbjct: 72 NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS--DQSRTHTMIRGTRGYVAPEWFK 677
IH D+ +N+LL KI DFGL + L D + + APE K
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 678 NVPVSAKVDVYSFGVTLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735
S D + FGVTL E+ + + + + I + RL D
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-------GERLPRPEDC 240
Query: 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLE 775
+ + + C P RPT + L
Sbjct: 241 PQDIYN----------VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-55
Identities = 64/266 (24%), Positives = 117/266 (43%), Gaps = 23/266 (8%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLG 567
E++G+G+ G VY + A+G +A+++++ Q ++ +E+ + + ++V L
Sbjct: 26 EKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHC 627
+V E++ G+L +++ D + E + L +LH +IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 628 DIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDV 687
DIK NILL S K++DFG + +QS+ TM+ GT ++APE KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 688 YSFGVTLLEIICCRRSVEMELEEES-RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRL 746
+S G+ +E+I E + I T+ + +L S
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL-----SAIF-------- 246
Query: 747 HKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ + C+ D KR + K +LQ
Sbjct: 247 -RDFL--NRCLDMDVEKRGSAKELLQ 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 5e-54
Identities = 65/282 (23%), Positives = 106/282 (37%), Gaps = 35/282 (12%)
Query: 500 KDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLD---RLAQEREREFKSEVSAI 554
D F E+G GSFG VY + +A+KK+ + + E+ ++ EV +
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 555 GRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLA 614
+ H + +Q G LV E+ L ++ +GLA
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 615 YLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE 674
YLH +IH D+K NILL K+ DFG + ++ S GT ++APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPE 181
Query: 675 WFKNV---PVSAKVDVYSFGVTLLEIICCRRS-VEMELEEESRAILTDWAYDCYVEGRLD 730
+ KVDV+S G+T +E+ + M I + + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ C+Q+ P RPT +V+L+
Sbjct: 242 YFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 7e-54
Identities = 78/300 (26%), Positives = 133/300 (44%), Gaps = 36/300 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTA----SGTAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 560
ELG+GSFG+VY+GV K T +A+K ++ A RER EF +E S + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 561 HLVQLLGFCDEALNRLLVYEFMGNGTLANLIF----------AIPKPDWNLRIRISLEIA 610
H+V+LLG + L++ E M G L + + + P + I+++ EIA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 611 RGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS-DQSRTHTMIRGTRG 669
G+AYL+ +H D+ +N ++ F+ KI DFG+++ ++ D R
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729
+++PE K+ + DV+SFGV L EI L E +EG L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLRFVMEGGL 253
Query: 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPSSF 789
D+ + + + C Q +P RP+ ++ ++ ++ P S +
Sbjct: 254 LDKPDNCPDMLFE---------LMRMCWQYNPKMRPSFLEIISSIKEEME-PGFREVSFY 303
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-51
Identities = 79/309 (25%), Positives = 121/309 (39%), Gaps = 47/309 (15%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVL----KTASGTAIAVKKLDR-LAQEREREFK 548
F D LK + LGRG+FG V + KTA+ +AVK L R
Sbjct: 10 FPRDRLK-----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 64
Query: 549 SEVSAIGRT-HHKHLVQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--------- 597
SE+ + HH ++V LLG C + L ++ EF G L+ + +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 598 -------DWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLS 650
I S ++A+G+ +L IH D+ +NILL KI DFGL+
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 651 KLLFSDQSRTH-TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELE 709
+ ++ D R ++APE + + + DV+SFGV L EI S ++
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241
Query: 710 EESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 769
+ + EG D M + C +PS+RPT
Sbjct: 242 ID------EEFCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSE 286
Query: 770 VLQMLEGLL 778
+++ L LL
Sbjct: 287 LVEHLGNLL 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 69/298 (23%), Positives = 117/298 (39%), Gaps = 44/298 (14%)
Query: 506 FKEELGRGSFGIVYKGVL------KTASGTAIAVKKLDRLAQERE-REFKSEVSAIGR-T 557
+ LG G+FG V K T +AVK L A E++ + SE+ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 558 HHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP----------------DWNL 601
HK+++ LLG C + ++ E+ G L + A P
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 602 RIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661
+ + ++ARG+ YL + IH D+ +N+L+ KI+DFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 662 TM-IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA 720
T R ++APE + + + DV+SFGV L EI S + E
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------EL 246
Query: 721 YDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
+ EG + + + C PS+RPT K +++ L+ ++
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (445), Expect = 2e-49
Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 23/270 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
EELG G+FG+V++ + A+G A K + + + + E+ + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPI 624
++ +++YEFM G L + + + ++ +GL ++HE
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 625 IHCDIKPQNILLDHFFS--AKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
+H D+KP+NI+ S K+ DFGL+ L D ++ + GT + APE + PV
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
D++S GV ++ E ++E+ + ++ + S++
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI---SEDG---- 256
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
K + + DP+ R T+ L+
Sbjct: 257 -----KDFI--RKLLLADPNTRMTIHQALE 279
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 6e-48
Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 20/280 (7%)
Query: 496 YDELKDATDGFK--EELGRGSFGIVYKGVLKTASGTAIAVKKLDR-LAQEREREFKSEVS 552
+ + +D D + + LG G+F V K + +A+K + + + +E ++E++
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEGKEGSMENEIA 59
Query: 553 AIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARG 612
+ + H ++V L + + L+ + + G L + I R+ ++
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 613 LAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVA 672
+ YLH+ V LD ISDFGLSK+ D + GT GYVA
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVA 177
Query: 673 PEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732
PE P S VD +S GV ++C E + + + Y+ D+
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI- 236
Query: 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
SD A +++DP KR T + LQ
Sbjct: 237 --SDSA-----------KDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (433), Expect = 1e-47
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 23/270 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
EELG G+FG+V++ V K A+G K ++ + K+E+S + + HH L+ L
Sbjct: 33 ILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPI 624
++ +L+ EF+ G L + I A I + GL ++HE I
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 625 IHCDIKPQNILLDHFFSA--KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
+H DIKP+NI+ + ++ KI DFGL+ L + + T + APE PV
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
D+++ GV ++ E + E+ + ++ + V S EA
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV---SPEA---- 259
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
K + +Q++P KR T+ L+
Sbjct: 260 -----KDFI--KNLLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 58/276 (21%), Positives = 98/276 (35%), Gaps = 26/276 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHL 562
F + LG GSF V + A+K L++ + + + E + R H
Sbjct: 12 FGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
V+L + + NG L I I D + EI L YLH +
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH-TMIRGTRGYVAPEWFKNVPV 681
IIH D+KP+NILL+ +I+DFG +K+L + + GT YV+PE
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 682 SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741
D+++ G + +++ E + ++ D A
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA-- 237
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777
+ L+ + D +KR + +
Sbjct: 238 ------RDLV--EKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-45
Identities = 55/270 (20%), Positives = 106/270 (39%), Gaps = 24/270 (8%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E+LGRG FGIV++ V + S K + ++ K E+S + H++++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHL 66
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPI 624
+ ++++EF+ + I + + ++ L +LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 625 IHCDIKPQNILLDHFFSA--KISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
H DI+P+NI+ S+ KI +FG ++ L ++ Y APE ++ VS
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
D++S G + ++ E ++ + + Y E ++ S EA
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI---SIEA---- 234
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ + ++ R T LQ
Sbjct: 235 -------MDFVDRLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (407), Expect = 5e-45
Identities = 64/283 (22%), Positives = 104/283 (36%), Gaps = 36/283 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD---------RLAQEREREFKSEVSAIGR 556
KE LGRG +V + + K + AVK +D QE EV + +
Sbjct: 7 PKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 557 TH-HKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAY 615
H +++QL + LV++ M G L + + +I + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 125
Query: 616 LHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
LH+ I+H D+KP+NILLD + K++DFG S L D + GT Y+APE
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEI 180
Query: 676 F------KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 729
+ +VD++S GV + ++ + ++ Y
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
D SD + + P KR T + L
Sbjct: 241 DY---SDTVK-----------DLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (404), Expect = 1e-44
Identities = 55/285 (19%), Positives = 101/285 (35%), Gaps = 30/285 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHL 562
E LG G V+ +AVK L F+ E +H +
Sbjct: 11 LGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 563 VQLLGFCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHE 618
V + + +V E++ TL +++ I + + + L + H+
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM--IRGTRGYVAPEWF 676
IIH D+KP NI++ + K+ DFG+++ + + + GT Y++PE
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 677 KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
+ V A+ DVYS G L E++ + D V + +
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP---------------FTGDSPVSVAYQHVREDP 231
Query: 737 EAAMADRSRLHKWLM-IAMWCIQEDPSKRP-TMKVVLQMLEGLLD 779
A L L + + + ++P R T + L + +
Sbjct: 232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (397), Expect = 1e-43
Identities = 53/278 (19%), Positives = 101/278 (36%), Gaps = 18/278 (6%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E++G G++G+VYK G A+KK+ ++ + E+S + H ++V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNY--GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
+LV+E + L + L++ G+AY H+ ++
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
H D+KPQN+L++ KI+DFGL++ + I + S +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 686 DVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSR 745
D++S G E++ E + + + +V
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 746 LHKWLMIA-----------MWCIQEDPSKRPTMKVVLQ 772
W ++ DP++R T K L+
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 2e-43
Identities = 57/269 (21%), Positives = 93/269 (34%), Gaps = 29/269 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLD------RLAQEREREFKSEVSAIGRTHH 559
+GRG FG VY +G A+K LD + + + +S +
Sbjct: 8 VHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 560 KHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
+V + + + M G L + + EI GL ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF-KN 678
+++ D+KP NILLD +ISD GL+ + GT GY+APE K
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 180
Query: 679 VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738
V + D +S G L +++ ++ I VE S E
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSF---SPEL 236
Query: 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTM 767
+ L+ +Q D ++R
Sbjct: 237 ---------RSLL--EGLLQRDVNRRLGC 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-43
Identities = 66/267 (24%), Positives = 106/267 (39%), Gaps = 27/267 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRT-HHKH 561
+ LG+GSFG V+ K + A+K L + L + E + H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 562 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECN 621
L + N V E++ G L I + K D + + EI GL +LH +
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 622 VPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPV 681
I++ D+K NILLD KI+DFG+ K ++ GT Y+APE
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQKY 180
Query: 682 SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741
+ VD +SFGV L E++ + + EEE + ++ A
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNPFYPRWLEKEA-- 230
Query: 742 DRSRLHKWLMIAMWCIQEDPSKRPTMK 768
K L++ ++ +P KR ++
Sbjct: 231 ------KDLLVKLF--VREPEKRLGVR 249
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-43
Identities = 67/298 (22%), Positives = 105/298 (35%), Gaps = 22/298 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR-----LAQEREREFKSEVSAIGRTHHKHL 562
+ LG G F VYK K + +A+KK+ R E+ + H ++
Sbjct: 4 DFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
+ LL N LV++FM + + L +GL YLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV-PV 681
I+H D+KP N+LLD K++DFGL+K F +R +T TR Y APE
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 682 SAKVDVYSFGVTLLEIICCR-----RSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
VD+++ G L E++ S +L + T L +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 737 EAAMADRSRLHKWLM-----IAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPGPSSF 789
+ + +P R T L+M + + P P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM-KYFSNRPGPTPGCQL 295
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 4e-43
Identities = 51/283 (18%), Positives = 94/283 (33%), Gaps = 26/283 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQL 565
++G GSFG +Y G A+G +A+K + + + E +
Sbjct: 11 LGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 566 LGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
+ +C E ++V E +G F K + ++ ++ + Y+H +
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 625 IHCDIKPQNIL---LDHFFSAKISDFGLSKLLFSDQSRTH------TMIRGTRGYVAPEW 675
IH D+KP N L I DFGL+K ++ H + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 676 FKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735
+ S + D+ S G L+ + R + + ++VL
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-SEKKMSTPIEVLCKG 243
Query: 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
+ A +C +P + Q+ L
Sbjct: 244 YPSEFAT---------YLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 31/289 (10%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERER------EF 547
F + + D D EELG G F +V K K+ +G A K + + + R +
Sbjct: 3 FRQENVDDYYD-TGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 548 KSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISL 607
+ EVS + H +++ L + + +L+ E + G L + +
Sbjct: 61 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120
Query: 608 EIARGLAYLHEECNVPIIHCDIKPQNILLDHF----FSAKISDFGLSKLLFSDQSRTHTM 663
+I G+ YLH I H D+KP+NI+L KI DFGL+ + D
Sbjct: 121 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 175
Query: 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC 723
I GT +VAPE P+ + D++S GV ++ + ++E+ A ++ Y
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-- 233
Query: 724 YVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ ++ ++ S L K + + +DP KR T++ LQ
Sbjct: 234 ----------EFEDEYFSNTSALAKDFI--RRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 9e-42
Identities = 60/294 (20%), Positives = 99/294 (33%), Gaps = 33/294 (11%)
Query: 507 KEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQL 565
+ LG G G V + K + A+K L + + EV R + H+V++
Sbjct: 17 SQVLGLGINGKVLQIFNKR-TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 70
Query: 566 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKP--DWNLRIRISLEIARGLAYLHEE 619
+ + L+V E + G L + I I I + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 620 CNVPIIHCDIKPQNILLDHFF---SAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
I H D+KP+N+L K++DFG +K S S T T YVAPE
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 677 KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
D++S GV + ++C + E +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGLLDVPNPPGPSS 788
E + ++ +P++R T+ + + VP P +S
Sbjct: 246 EEVKM----------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 61/285 (21%), Positives = 107/285 (37%), Gaps = 25/285 (8%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEV---SAIGRTHHKHL 562
E+G G++G V+K G +A+K++ + EV + H ++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 563 VQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYL 616
V+L C D LV+E + L P + ++ RGL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 617 HEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF 676
H ++H D+KPQNIL+ K++DFGL+++ T + T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVL 187
Query: 677 KNVPVSAKVDVYSFGVTLLEIICCRR-----SVEMELEEESRAILTDWAYDCYVEGRLDV 731
+ VD++S G E+ + S +L + I D + L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 732 LIDSDEAAMADRSRLHKWLMIA----MWCIQEDPSKRPTMKVVLQ 772
++A + + + C+ +P+KR + L
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (381), Expect = 2e-41
Identities = 41/285 (14%), Positives = 90/285 (31%), Gaps = 28/285 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQ 564
+G GSFG++++G + +A+K R + + + E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
+ F E L+ +LV + +G L K + ++ + +HE+ +
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122
Query: 625 IHCDIKPQNILLD-----HFFSAKISDFGLSKLLFSDQSRTHTM------IRGTRGYVAP 673
++ DIKP N L+ + + DFG+ K ++ H + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 674 EWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733
S + D+ + G + + + ++ + + L L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPLRELC 241
Query: 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778
+ P + + +L
Sbjct: 242 AGFPEEFYK---------YMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (383), Expect = 2e-41
Identities = 58/264 (21%), Positives = 105/264 (39%), Gaps = 29/264 (10%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHL 562
LG GSFG V+ + +G A+K L + + ++ E + H +
Sbjct: 8 ILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
+++ G +A ++ +++ G L +L+ + + + E+ L YLH +
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
II+ D+KP+NILLD KI+DFG +K + + GT Y+APE P +
Sbjct: 125 -IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
+D +SFG+ + E++ + Y+ + L +E
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAELRFPPFFNEDVKD- 230
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPT 766
+ I D S+R
Sbjct: 231 ---------LLSRLITRDLSQRLG 245
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-41
Identities = 53/285 (18%), Positives = 107/285 (37%), Gaps = 24/285 (8%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKHLVQLL 566
+G G++G+V + +A+KK+ + + E+ + R H++++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 567 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRIRISLEIARGLAYLHEECNVP 623
+ ++ + ++ + K + +I RGL Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---N 129
Query: 624 IIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--THTMIRGTRGYVAPEWFKN-VP 680
++H D+KP N+LL+ KI DFGL+++ D T TR Y APE N
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 681 VSAKVDVYSFGVTLLEIICCR-----RSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735
+ +D++S G L E++ R + +L + + D L
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 736 DEAAMADRSRLHKW--------LMIAMWCIQEDPSKRPTMKVVLQ 772
++ ++ L + + +P KR ++ L
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-40
Identities = 56/281 (19%), Positives = 104/281 (37%), Gaps = 22/281 (7%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E++G G++G+VYK K +G +A+KK+ D + E+S + +H ++V+L
Sbjct: 8 EKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRIRISLEIARGLAYLHEECNVPI 624
L LV+EF+ + + L ++ +GLA+ H +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
+H D+KPQN+L++ + K++DFGL++ + S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 685 VDVYSFGVTLLEIICCR-------------RSVEMELEEESRAILTDWAYDCYVEGRLDV 731
VD++S G E++ R R + + Y
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
+ + L+ + DP+KR + K L
Sbjct: 244 ARQDFSKVVPPLDEDGRSLL--SQMLHYDPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 60/278 (21%), Positives = 101/278 (36%), Gaps = 42/278 (15%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKL------DRLAQEREREFKSEVSAIGRTHH 559
LG G FG VY G+ + +A+K + D EV + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 560 KH--LVQLLGFCDEALNRLLVYEFM-GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYL 616
+++LL + + + +L+ E L + I L ++ + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 617 HEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEW 675
H ++H DIK +NIL+D + K+ DFG LL + +T GTR Y PEW
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEW 180
Query: 676 FKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734
+ V+S G+ L +++C + E + I + V
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD----IPFEHDEEIIRGQVFFRQRV--------- 227
Query: 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
S E + WC+ PS RPT + +
Sbjct: 228 SSECQ-----------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 47/279 (16%), Positives = 101/279 (36%), Gaps = 18/279 (6%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKHLVQL 565
E++G G++G V+K + + +A+K++ D + E+ + HK++V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 566 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPII 625
LV+EF D + ++ +GL + H ++
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 626 HCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKV 685
H D+KPQN+L++ K+++FGL++ + F S +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 686 DVYSFGVTLLEIICCRR-----SVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740
D++S G E+ R + + + +L + +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 741 ADRSRLHKWLMIA-------MWCIQEDPSKRPTMKVVLQ 772
A S ++ + ++ +P +R + + LQ
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 66/321 (20%), Positives = 115/321 (35%), Gaps = 41/321 (12%)
Query: 494 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSA 553
SY + K +G GSFG+VY+ L SG +A+KK+ + +R E+
Sbjct: 20 VSYTDTK--------VIGNGSFGVVYQAKLCD-SGELVAIKKVLQ----DKRFKNRELQI 66
Query: 554 IGRTHHKHLVQLLGFCDEALNR------LLVYEFMGNGTLANLIFAIPKP---DWNLRIR 604
+ + H ++V+L F + + LV +++
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 605 ISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQSRTHTM 663
++ R LAY+H I H DIKPQN+LLD K+ DFG +K L + +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSY 182
Query: 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRR-----SVEMELEEESRAILTD 718
I F ++ +DV+S G L E++ + S +L E + + T
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 719 WAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLM------IAMWCIQEDPSKRPTMKVVLQ 772
+ +++ + + ++ P+ R T
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 773 M--LEGLLDVPNPPGPSSFSI 791
+ L D PN P+
Sbjct: 303 HSFFDELRD-PNVKLPNGRDT 322
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 8e-38
Identities = 55/293 (18%), Positives = 111/293 (37%), Gaps = 32/293 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKHLVQL 565
++G+G+FG V+K + +G +A+KK+ + + E+ + H+++V L
Sbjct: 16 AKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 566 LGFCDEALNR--------LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLH 617
+ C + LV++F + L + K + R+ + GL Y+H
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134
Query: 618 EECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIR---GTRGYVAPE 674
I+H D+K N+L+ K++DFGL++ ++ T Y PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 675 WFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAY----------DC 723
+D++ G + E+ ++ E+ A+++ D
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 724 YVEGRLDVLIDSDEAAMADRSRLHKWLMIA----MWCIQEDPSKRPTMKVVLQ 772
Y L+ + + DR + + A + DP++R L
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-37
Identities = 63/266 (23%), Positives = 102/266 (38%), Gaps = 26/266 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHL 562
+ + LG+G+FG V K A+G A+K L + +A++ +E + T H L
Sbjct: 9 YLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 563 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
L V E+ G L + EI L YLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 124
Query: 623 PIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVS 682
+++ DIK +N++LD KI+DFGL K SD + GT Y+APE ++
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYG 183
Query: 683 AKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742
VD + GV + E++C R + E ++ + + A
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEIRFPRTLSPEA--- 232
Query: 743 RSRLHKWLMIAMWCIQEDPSKRPTMK 768
K L+ +++DP +R
Sbjct: 233 -----KSLL--AGLLKKDPKQRLGGG 251
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-35
Identities = 71/328 (21%), Positives = 121/328 (36%), Gaps = 44/328 (13%)
Query: 494 FSYDELKDATDGFK------EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE--R 545
F E+ + + +G G++G V V +G +A+KKL R Q +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAK 62
Query: 546 EFKSEVSAIGRTHHKHLVQLLGFC------DEALNRLLVYEFMGNGTLANLIFAIPKPDW 599
E+ + H++++ LL D+ + LV FMG + K
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGE 120
Query: 600 NLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659
+ + ++ +GL Y+H IH D+KP N+ ++ KI DFGL++
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQA----DS 173
Query: 660 THTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCR---------------RS 703
T TR Y APE N + + VD++S G + E+I +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 704 VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSK 763
V E L Y++G ++ + + + S L L+ + D +
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL--EKMLVLDAEQ 291
Query: 764 RPTMKVVLQM--LEGLLDVPNPPGPSSF 789
R T L E L D + P +
Sbjct: 292 RVTAGEALAHPYFESLHDTEDEPQVQKY 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 8e-35
Identities = 55/261 (21%), Positives = 102/261 (39%), Gaps = 29/261 (11%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKHLVQ 564
+ LG GSFG V K SG A+K LD+ + ++ +E + + LV+
Sbjct: 47 KTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 565 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPI 624
L + N +V E++ G + + + I + + +I YLH +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 625 IHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAK 684
I+ D+KP+N+L+D +++DFG +K + + GT +APE + +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKA 218
Query: 685 VDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADRS 744
VD ++ GV + E+ + + Y+ V G++
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSHFSSDLK---- 266
Query: 745 RLHKWLMIAMWCIQEDPSKRP 765
+ +Q D +KR
Sbjct: 267 ------DLLRNLLQVDLTKRF 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 1e-34
Identities = 54/292 (18%), Positives = 114/292 (39%), Gaps = 37/292 (12%)
Query: 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR-THHKHLVQ 564
+LGRG + V++ + T + + VK L ++++ K E+ + +++
Sbjct: 39 LVRKLGRGKYSEVFEAINIT-NNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIIT 94
Query: 565 LLGFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNV 622
L + ++R LV+E + N L + D EI + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMG-- 149
Query: 623 PIIHCDIKPQNILLDH-FFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPE-WFKNVP 680
I+H D+KP N+++DH ++ D+GL++ Q + + +R + PE
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQM 206
Query: 681 VSAKVDVYSFGVTLLEIICCR------RSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734
+D++S G L +I + +L ++ + T+ YD + +++
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 735 -SDEAAMADRSRLHKWLMIAMW-------------CIQEDPSKRPTMKVVLQ 772
+D R R +++ ++ D R T + ++
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-33
Identities = 67/299 (22%), Positives = 114/299 (38%), Gaps = 45/299 (15%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKHLVQL 565
+ +G G+ GIV +A+KKL R Q + E+ + +HK+++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 566 LGFC------DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEE 619
L +E + LV E M + + D + ++ G+ +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 138
Query: 620 CNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNV 679
IH D+KP NI++ + KI DFGL++ + S T TR Y APE +
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 680 PVSAKVDVYSFGVTLLEIICCR-----RSVEMELEEESRAILT---------DWAYDCYV 725
VD++S G + E++ + R + + + T YV
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 726 EGR------------LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772
E R D L +D ++ + L+ + DP+KR ++ LQ
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL--SKMLVIDPAKRISVDDALQ 310
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 6e-33
Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 26/271 (9%)
Query: 506 FKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLAQERE----REFKSEVSAIGR-TH 558
+ LG G++G V+ + +G A+K L + ++ ++E +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 559 HKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHE 618
LV L L+ +++ G L + + + EI L +LH+
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 619 ECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWF-- 676
+ II+ DIK +NILLD ++DFGLSK +D++ GT Y+AP+
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 677 KNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSD 736
+ VD +S GV + E++ ++ E+ S+A + ++ +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI----SRRILKSEPPYPQEMS 260
Query: 737 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 767
A + + +DP KR
Sbjct: 261 ALAKD----------LIQRLLMKDPKKRLGC 281
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 64/306 (20%), Positives = 110/306 (35%), Gaps = 32/306 (10%)
Query: 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKHLVQL 565
+G G++G V +G +AVKKL R Q + E+ + H++++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 566 LGFCDEA-----LNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC 620
L A N + + + G N I K + + +I RGL Y+H
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKN-V 679
IH D+KP N+ ++ KI DFGL++ T TR Y APE N +
Sbjct: 142 I---IHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 680 PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739
+ VD++S G + E++ R + ++ E + +S
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 740 MADRSRLHKWLMIAMW-------------CIQEDPSKRPTMKVVLQM--LEGLLDVPNPP 784
+ +++ K ++ + D KR T L D + P
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314
Query: 785 GPSSFS 790
+
Sbjct: 315 VADPYD 320
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 4e-27
Identities = 60/324 (18%), Positives = 104/324 (32%), Gaps = 52/324 (16%)
Query: 497 DELKDATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGR 556
+ KDA +LG G F V+ + T +A+K + R + + E+ + R
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIV-RGDKVYTEAAEDEIKLLQR 65
Query: 557 THHKHLVQLLGFCDEALNRLLVY--EFMGNGTLANLIFAIPKPDWNLRI----------- 603
+ + + +LL + NG ++F + + I
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 604 ---RISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQSR 659
+IS ++ GL Y+H C IIH DIKP+N+L++ + ++ L +
Sbjct: 126 YVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 660 THTM-IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTD 718
H TR Y +PE P D++S + E+I E +
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 719 WAYDCYVEGRLDVLI----DSDEAAMADRSRLHKWLMIAMW------------------- 755
A + G L + R L + W
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 756 -------CIQEDPSKRPTMKVVLQ 772
+Q DP KR ++
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 1e-19
Identities = 28/207 (13%), Positives = 58/207 (28%), Gaps = 31/207 (14%)
Query: 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVK----------KLDRLAQEREREFKSEVSA 553
D + +G G V+ + VK K+ + F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEK--FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59
Query: 554 IGRTHHKHLVQLLGFCD----EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEI 609
R + L +L G ++ E + + + + I
Sbjct: 60 SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMI 112
Query: 610 ARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMIRGTRG 669
+A + I+H D+ N+L+ I DF S + + ++
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEV--GEEGWREILERDVR 166
Query: 670 YVAPEWFKNVPVSAKVDVYSFGVTLLE 696
+ +F + D+ S +L+
Sbjct: 167 NII-TYFSR-TYRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 54.2 bits (130), Expect = 1e-09
Identities = 19/111 (17%), Positives = 35/111 (31%), Gaps = 13/111 (11%)
Query: 35 NSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTAT 94
N L + D L ++ + T VW +N +G L +
Sbjct: 6 NGEGLYAGQSLDVEPYHFIMQED-CNLVLYDHS----TSVWASNTGILGKKGCKAVLQSD 60
Query: 95 G-LLLKDPGGQAIW--DGKPDKNVSDAAMLDTGNFVLRASGNNSDYAWQSF 142
G ++ D G+++W + + GN V+ S W +
Sbjct: 61 GNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD-----IWSTG 106
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.8 bits (129), Expect = 2e-09
Identities = 13/111 (11%), Positives = 29/111 (26%), Gaps = 11/111 (9%)
Query: 48 GFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGS-TLELTATGLLLKDPGGQAI 106
G + +N + I ++ + L + L+ +
Sbjct: 1 GSVVVANNGNS----ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRV 56
Query: 107 WDGKPDKNVSD--AAMLDTGNFVLRASGNNSDYAWQSF--KSPTDTILPTQ 153
W + A + G + + N + W S +S + Q
Sbjct: 57 WSTNTAGKGTGCRAVLQPNGRMDVLTNQNIA--VWTSGNSRSAGRYVFVLQ 105
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 36.1 bits (83), Expect = 0.003
Identities = 27/148 (18%), Positives = 52/148 (35%), Gaps = 28/148 (18%)
Query: 124 GNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFSNGS 183
G+ V+ +GN+ Y+ Q + T+ TQ L L R + ++ +
Sbjct: 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSP-------------YRLSME-TDCN 46
Query: 184 LEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIVQLPQWSKL 243
L V + + S T+ +G + V + + ++ N V W+
Sbjct: 47 L----VLFDRDDRVWSTNTAGKG------TGCRAVLQPNGRMDVLTNQNIAV----WTSG 92
Query: 244 IPRTDHYFRATLDFDGVLAEYAHPKNSS 271
R+ + L D LA Y ++
Sbjct: 93 NSRSAGRYVFVLQPDRNLAIYGGALWTT 120
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 41.7 bits (97), Expect = 4e-05
Identities = 22/133 (16%), Positives = 46/133 (34%), Gaps = 26/133 (19%)
Query: 17 LSAANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWH 76
L++ + + G SL+ + F + ND + ++ N VW
Sbjct: 4 LNSGHQLDTGGSLAEGG-----------YLFIIQ--NDCNL----VLYDNNRA----VWA 42
Query: 77 ANGDNPAPRGSTLELTATGLL-LKDPGGQAIWDGKPDKNVSDAAML-DTGNFVLRASGNN 134
+ + A G L++ G L + +N + +L N V+ + NN
Sbjct: 43 SGTNGKA-SGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNN 101
Query: 135 SDYAWQSFKSPTD 147
+ W + + +
Sbjct: 102 A--IWATHTNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 37.1 bits (85), Expect = 0.001
Identities = 23/132 (17%), Positives = 39/132 (29%), Gaps = 27/132 (20%)
Query: 146 TDTILPTQILDLGSVLVSRLTETNFSKGRFELHFSNGSLEFIPVAWPSRFQYKSYYTSNT 205
+D + LD G L G + N + V + + ++ + S T
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQN---DCNLVLYDN---NRAVWASGT 45
Query: 206 YSSNSSESGHQLVFNESAEIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265
SG L + I I W+ R + + L D + Y
Sbjct: 46 NGKA---SGCVLKMQNDGNLVIYSGSRAI-----WASNTNRQNGNYYLILQRDRNVVIYD 97
Query: 266 HPKN----SSTN 273
+ N + TN
Sbjct: 98 NSNNAIWATHTN 109
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.7 bits (95), Expect = 6e-05
Identities = 13/82 (15%), Positives = 22/82 (26%), Gaps = 4/82 (4%)
Query: 63 IWFNKIPERTIVWHANGDNPAPRGS-TLELTATG-LLLKDPGGQAIWDGKPDKNVSDAAM 120
I F E + + S + + L+L D + A +
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 121 LDTGNFVLRASGNNSDYAWQSF 142
G V+ + N W S
Sbjct: 63 QSDGLLVILTAQNT--IRWSSG 82
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.0 bits (93), Expect = 1e-04
Identities = 20/144 (13%), Positives = 45/144 (31%), Gaps = 27/144 (18%)
Query: 133 NNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHF-SNGSLEFIPVAW 191
NN ++ Q + + T+ L E F + ++ +L V +
Sbjct: 1 NNIIFSKQPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNL----VLY 45
Query: 192 PSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIVQLPQWSKLIPRTDHYF 251
+ + +NT +G + V + ++ N+ V W + ++
Sbjct: 46 DN---NNPIWATNTGGLG---NGCRAVLQPDGVLVVITNENVTV----WQSPVAGKAGHY 95
Query: 252 RATLDFDGVLAEYAHPK-NSSTNQ 274
L D + Y + T +
Sbjct: 96 VLVLQPDRNVVIYGDALWATQTVR 119
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 796 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.7 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.7 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.67 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.6 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.42 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.3 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.0 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.82 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.8 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.51 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.42 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.35 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.99 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.46 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.4 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.32 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.32 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.42 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.92 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.69 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 89.6 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.58 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.47 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.68 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.37 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 84.76 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 84.24 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.56 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 83.04 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.56 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 81.69 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 80.37 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-49 Score=417.45 Aligned_cols=268 Identities=24% Similarity=0.381 Sum_probs=206.7
Q ss_pred ccCHHHHHHHHHhHH-----------HhhCCCccceEEEEEeeCCC--CeEEEEEEecch-hhhhHHHHHHHHHHhcccC
Q 044281 493 FFSYDELKDATDGFK-----------EELGRGSFGIVYKGVLKTAS--GTAIAVKKLDRL-AQEREREFKSEVSAIGRTH 558 (796)
Q Consensus 493 ~~~~~~l~~~~~~~~-----------~~LG~G~fG~Vy~g~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~ 558 (796)
.++|+++.+++..|. ++||+|+||+||+|.++..+ ...||||++... .....++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 356667777776663 46999999999999876432 246899998653 3444578999999999999
Q ss_pred ccCcccccccccccccceeEEeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc
Q 044281 559 HKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD 637 (796)
Q Consensus 559 h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~ 637 (796)
|||||+++|++.++...++||||+++|+|.+++... +.+++.+++.++.|||+||+|||++ +|+||||||+||||+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVN 162 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEEC
Confidence 999999999999999999999999999999988764 5789999999999999999999998 899999999999999
Q ss_pred CCCcEEEeecCCcccccCCCCcc----eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHH
Q 044281 638 HFFSAKISDFGLSKLLFSDQSRT----HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEES 712 (796)
Q Consensus 638 ~~~~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~ 712 (796)
+++.+||+|||+++.+....... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||......+.
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~ 242 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999775443221 122457899999999999999999999999999999998 8899876554432
Q ss_pred hHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 713 RAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
...+ ..+.... .+....+.+.+++.+||+.||++||||.||++.|+.+++.
T Consensus 243 ~~~i--------~~~~~~~---------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 243 INAI--------EQDYRLP---------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHH--------HTTCCCC---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHH--------HcCCCCC---------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 2211 1111110 1122335677899999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=409.78 Aligned_cols=252 Identities=29% Similarity=0.431 Sum_probs=196.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.++||+|+||+||+|.++ +++.||||+++... ...++|.+|++++++++|||||+++|+|.+.+..++||||+++
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 34578999999999999875 56789999997633 3457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
|+|.+++... ..+++..++.++.|||+||+|||++ +|+||||||+|||+++++.+||+|||+++............
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999998765 5678999999999999999999998 89999999999999999999999999999775554444445
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCC-CchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS-VEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..||+.|+|||++.+..++.++|||||||++|||+|++.| +......+....+ ..+.... . +
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i--------~~~~~~~--~-------p 224 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFRLY--K-------P 224 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH--------HHTCCCC--C-------C
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HhcCCCC--C-------c
Confidence 6789999999999999999999999999999999996554 4433332222111 1111110 1 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
....+++.+++.+||+.||++||||+||+++|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1123467789999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-49 Score=412.26 Aligned_cols=257 Identities=27% Similarity=0.381 Sum_probs=211.7
Q ss_pred HHHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 502 ATDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 502 ~~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
..+.+.++||+|+||+||+|+++ .+++.||||+++... ...++|.+|++++++++|||||+++|+|.++...++||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 34456688999999999999976 367899999997643 3456899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 582 MGNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
+++|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||||++++.+||+|||+|+........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999754 5789999999999999999999998 8999999999999999999999999999987655544
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+.......... .....+.....
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~-------~~i~~~~~~~~------- 237 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKDYRMER------- 237 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHHHTTCCCCC-------
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH-------HHHhcCCCCCC-------
Confidence 4445568999999999999999999999999999999999887765433222111 11111111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+....+++.+++.+||+.||++||||.||++.|+.+.+
T Consensus 238 --~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 238 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred --CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223567889999999999999999999999988754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=401.15 Aligned_cols=249 Identities=28% Similarity=0.367 Sum_probs=202.8
Q ss_pred HhhCCCccceEEEEEeeC-CCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 508 EELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
++||+|+||+||+|.++. ..++.||||+++... ....++|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998763 345789999996532 2335689999999999999999999999865 467899999999
Q ss_pred CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc--ee
Q 044281 585 GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT--HT 662 (796)
Q Consensus 585 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~--~~ 662 (796)
|+|.+++.....+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999988999999999999999999999998 89999999999999999999999999999775443322 23
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...||+.|||||.+.+..++.++|||||||++|||++ |+.||......+....+ ..+.....
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i--------~~~~~~~~--------- 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--------EKGERMGC--------- 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--------HTTCCCCC---------
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH--------HcCCCCCC---------
Confidence 4568999999999999999999999999999999998 89999765444322221 22221111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
+.....++.+++.+||+.||++||||++|+++|+..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 111234677899999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=404.89 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=199.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.++++++|||||++++++.+ ...++||||+
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 34578999999999999853 35999998643 34456789999999999999999999998865 5689999999
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-cc
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-RT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 660 (796)
++|+|.+++... ..+++..++.++.|||+||+|||++ +|+||||||+||||++++.+||+|||+|+....... ..
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999999754 5689999999999999999999998 899999999999999999999999999987654332 33
Q ss_pred eeeccCCCcccccccccC---CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 661 HTMIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.....||+.|||||++.+ ..++.++|||||||++|||+||+.||............ . ..+......
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~---~----~~~~~~p~~---- 231 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---V----GRGYLSPDL---- 231 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---H----HHTSCCCCG----
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH---H----hcCCCCCcc----
Confidence 345679999999999964 35899999999999999999999999765433221111 1 111111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
........+.+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01112223567789999999999999999999999987654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=405.17 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=204.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||+||+|.++ +++.||||+++... ...++|.+|+.++++++|||||+++|++.+ ...++||||++
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred eEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 445678999999999999975 57899999997643 345689999999999999999999998865 56799999999
Q ss_pred CCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+|+|.+++... ..+++..+++|+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+.+........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999987654 3689999999999999999999998 899999999999999999999999999998765544444
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhh-HHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMEL-EEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....||+.|+|||++.+..++.++|||||||++|||+||+.|+.... ..+.... +..+.....
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~--------i~~~~~~~~-------- 231 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--------LERGYRMVR-------- 231 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCCCC--------
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHhcCCCCC--------
Confidence 45678999999999999999999999999999999999776654332 2221111 112211111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
+....+++.+++.+||+.||++||||.+|+++|+...
T Consensus 232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1112345778999999999999999999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=396.81 Aligned_cols=244 Identities=27% Similarity=0.376 Sum_probs=206.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||+||+|+.+ .+++.||+|++.+.. ....+.+.+|++++++++|||||++++++.++...++|||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 345678999999999999976 468999999996532 2335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|.+++.....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+..... .
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---C
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---c
Confidence 999999999999888899999999999999999999998 9999999999999999999999999999865432 2
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ ..+... +
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--------~~~~~~--~------- 223 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------SRVEFT--F------- 223 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCC--C-------
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC--C-------
Confidence 34567999999999999999999999999999999999999999876554432222 111111 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+....+++.+++.+||+.||++|||++|+++
T Consensus 224 -p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 -PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112345677999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=394.99 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=209.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNG 585 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 585 (796)
+.++||+|+||+||+|+++ +++.||||+++... ...++|++|+.++++++||||++++|+|.++...++||||+++|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCEETTEEEEEEEET--TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred EeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 5678999999999999975 67899999997643 34578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceeec
Q 044281 586 TLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTMI 664 (796)
Q Consensus 586 sL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 664 (796)
+|..++... ..+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.............
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp EHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred cHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 999987654 5788999999999999999999998 999999999999999999999999999987765554444456
Q ss_pred cCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 665 RGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 665 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
.+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+....+ .++.... .+ .
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i--------~~~~~~~--~p-------~ 224 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQGLRLY--RP-------H 224 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------HTTCCCC--CC-------T
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH--------HhCCCCC--Cc-------c
Confidence 78999999999999999999999999999999998 78899876554432222 1221111 11 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
...+++.+++.+||+.||++|||+++|++.|..+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1224677899999999999999999999999654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=398.83 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=206.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.++||+|+||+||+|..+ .+|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 345578999999999999865 4689999999976555556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.+..... ....
T Consensus 101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~ 175 (293)
T d1yhwa1 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (293)
T ss_dssp TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccc
Confidence 9999998866 4688999999999999999999998 999999999999999999999999999997654332 2344
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhcH
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMADR 743 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 743 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+... .. .+.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-------~~~~~~-~~-------~~~ 240 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------TNGTPE-LQ-------NPE 240 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HHCSCC-CS-------SGG
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH-------hCCCCC-CC-------Ccc
Confidence 569999999999999999999999999999999999999997655433222111 111100 00 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 744 SRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 744 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 223467789999999999999999999763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=398.56 Aligned_cols=249 Identities=27% Similarity=0.337 Sum_probs=201.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
.+.+.||+|+||+||+|+.+ .+++.||||+++... .+..+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 45578999999999999976 468999999986532 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC-Cccee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ-SRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~ 662 (796)
+|+|.+++.....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+...... .....
T Consensus 87 gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 87 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 999999998888899999999999999999999998 89999999999999999999999999999775443 23344
Q ss_pred eccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 663 MIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
..+||+.|||||++.+..+ +.++|||||||++|||++|+.||........... . ........ . .
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~--~-----~~~~~~~~--~------~ 228 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--D-----WKEKKTYL--N------P 228 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH--H-----HHTTCTTS--T------T
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH--H-----HhcCCCCC--C------c
Confidence 5679999999999988876 5789999999999999999999975432211110 0 00110000 0 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
......++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112245667999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=398.71 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=199.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCC---eEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASG---TAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
..+.||+|+||+||+|.++..++ ..||||+++... .....+|.+|++++++++|||||+++|++.+....++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 34679999999999999875432 479999996533 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR- 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~- 659 (796)
+.++++.+++... ..+++..+++++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 91 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 167 (283)
T d1mqba_ 91 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167 (283)
T ss_dssp CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred cccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence 9999999987755 5789999999999999999999998 8999999999999999999999999999976544322
Q ss_pred -ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 -THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 -~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......||+.|||||++.+..++.++|||||||++|||++++.|+........ ....+.++.....
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-------~~~~i~~~~~~~~------ 234 (283)
T d1mqba_ 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLPT------ 234 (283)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCCCC------
T ss_pred eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-------HHHHHhccCCCCC------
Confidence 22345689999999999999999999999999999999997766654332211 1111222211111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCC
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (796)
+.....++.+++.+||+.||++||||.||+++|+.+++.+
T Consensus 235 ---~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 235 ---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp ---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 1122356778999999999999999999999999877643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=396.60 Aligned_cols=248 Identities=26% Similarity=0.363 Sum_probs=202.9
Q ss_pred hhCCCccceEEEEEeeC-CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCCCC
Q 044281 509 ELGRGSFGIVYKGVLKT-ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+||+|+||+||+|.++. .++..||||+++... ....++|.+|++++++++|||||+++|++.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 49999999999998753 345689999997543 3445789999999999999999999999865 56899999999999
Q ss_pred HHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc--ceee
Q 044281 587 LANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR--THTM 663 (796)
Q Consensus 587 L~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~--~~~~ 663 (796)
|.+++... ..+++..+.+++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence 99997654 5789999999999999999999998 9999999999999999999999999999987554332 2234
Q ss_pred ccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhhc
Q 044281 664 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMAD 742 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 742 (796)
..||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.... +..+......
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~--------i~~~~~~~~p--------- 234 (285)
T d1u59a_ 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------IEQGKRMECP--------- 234 (285)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH--------HHTTCCCCCC---------
T ss_pred cccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCCCCC---------
Confidence 568999999999999999999999999999999998 8999976544332221 2223222111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 743 RSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 743 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.....++.+++.+||+.||++||||.+|++.|+..
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12234677899999999999999999999999753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=399.66 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=203.4
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.+.+.||+|+||+||+|+++ +++.||||+++.. ....+.|.+|+.++++++|+|||+++|++.+ +..++||||+
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 3556688999999999999875 4568999999754 3345789999999999999999999999855 5689999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
++|+|..++... ..++|..++.++.||++||+|||++ +|+||||||+||||++++++||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999988653 5689999999999999999999998 89999999999999999999999999999775554444
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHH-HHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEE-ESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
.....||+.|+|||++.++.++.++|||||||++|||++|+.|+...... +.... +..+.....
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~--------i~~~~~~~~------- 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------VERGYRMPC------- 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCCCC-------
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH--------HHhcCCCCC-------
Confidence 45567899999999999999999999999999999999987776544322 21111 111111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCCCCCC
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVPNPPG 785 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~~pp~ 785 (796)
+....+++.+++.+||+.||++||||++|+++|+.......|+.
T Consensus 236 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~ 279 (285)
T d1fmka3 236 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279 (285)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred --CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence 11223467789999999999999999999999999877655543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=391.35 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=196.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc----cccceeEE
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE----ALNRLLVY 579 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 579 (796)
+.++||+|+||+||+|+.+ .+++.||+|++... .....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4467999999999999875 46889999998653 23445679999999999999999999999864 34578999
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc-CCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD-HFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++|+|.+++.....+++..+..++.||++||+|||++ +.+|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 9999999999999888899999999999999999999997 12399999999999997 578999999999986432
Q ss_pred cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 659 RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
.......||+.|||||++.+ +++.++|||||||++|||++|+.||......... ......+.....+
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~-------~~~i~~~~~~~~~----- 234 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------YRRVTSGVKPASF----- 234 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-------HHHHTTTCCCGGG-----
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH-------HHHHHcCCCCccc-----
Confidence 22345679999999999875 6999999999999999999999999654322211 1111122111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+.....++.+++.+||+.||++|||+.|+++
T Consensus 235 ---~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 ---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112235677999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=393.55 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=191.6
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccc--cccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDE--ALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e 580 (796)
.+.+.||+|+||+||+|+.+ .+|+.||||.+.... ....+.+.+|++++++++|||||++++++.+ ....++|||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred EEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 45578999999999999865 468999999986532 3345679999999999999999999998854 456789999
Q ss_pred ecCCCCHHHHHhc----CCCCchhHHHHHHHHHHHHhhHhhhcC--CCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 581 FMGNGTLANLIFA----IPKPDWNLRIRISLEIARGLAYLHEEC--NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 581 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+.. ..+|+||||||+|||+++++.+||+|||+|+.+.
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 9999999999863 467899999999999999999999862 1249999999999999999999999999999765
Q ss_pred CCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
.... ......||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ .++....+.
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i--------~~~~~~~~~- 235 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------REGKFRRIP- 235 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHTCCCCCC-
T ss_pred cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH--------HcCCCCCCC-
Confidence 4332 234467999999999999999999999999999999999999999876554332222 222222111
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
....+++.+++.+||+.||++|||+.|+++
T Consensus 236 --------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 236 --------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112346778999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=398.57 Aligned_cols=246 Identities=24% Similarity=0.290 Sum_probs=203.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||+||+|..+ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 446688999999999999875 468999999997532 2345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-c
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS-R 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~ 659 (796)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999999999888999999999999999999999998 999999999999999999999999999997754332 2
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+... +
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~--~------ 229 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--------IKLEYD--F------ 229 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HTTCCC--C------
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH--------HcCCCC--C------
Confidence 334567999999999999999999999999999999999999999876544332222 111111 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVL 771 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 771 (796)
+.....++.+++.+||+.||++|||++|++
T Consensus 230 --p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 230 --PEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 011234567899999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=405.65 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=202.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.++||+|+||+||+|+.+ .+++.||+|+++.. .......+.+|+.++++++|||||++++++.+....++||||+
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEET-TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 345578999999999999865 47899999998653 2334568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++|+|.+++.+...+++..+..++.||++||.|||+.. +|+||||||+|||+++++++||+|||+|+...... ..
T Consensus 87 ~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~ 161 (322)
T d1s9ja_ 87 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 161 (322)
T ss_dssp TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---C-
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---cc
Confidence 99999999998888999999999999999999999731 79999999999999999999999999999764322 23
Q ss_pred eccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhh--------hcC------c
Q 044281 663 MIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCY--------VEG------R 728 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~--------~~~------~ 728 (796)
...||+.|+|||++.+.+++.++||||+||++|||++|+.||......+............. ..+ .
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 45799999999999999999999999999999999999999976433221111000000000 000 0
Q ss_pred cc--------eecc----chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LD--------VLID----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~--------~~~d----~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.. ...+ .............++.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 0000 000000011123467889999999999999999999873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=398.24 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=203.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecCC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMGN 584 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 584 (796)
.+.+.||+|+||+||+|+.+ .+++.||||+++.......+.|.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 34578999999999999875 46889999999766556667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 585 GTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 585 gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
|+|.+++.+ ...+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~ 169 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 169 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccc
Confidence 999998765 45689999999999999999999998 89999999999999999999999999997653221 12234
Q ss_pred ccCCCccccccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 664 IRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 664 ~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
..||+.|+|||++. +..++.++|||||||++|||++|+.||......+....+ ..+....+..
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--------~~~~~~~~~~---- 237 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--------AKSEPPTLAQ---- 237 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--------HHSCCCCCSS----
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--------HcCCCCCCCc----
Confidence 56999999999984 556899999999999999999999999765443322111 1111111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+......+.+++.+||+.||++|||++|+++.
T Consensus 238 ---~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 238 ---PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223467789999999999999999999763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=402.67 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=203.8
Q ss_pred HHhHHHhhCCCccceEEEEEeeCCC----CeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKTAS----GTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 576 (796)
.+.+.++||+|+||+||+|+....+ ...||+|.+.... ......|.+|+.++.++ +|||||++++++.+....+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 3456688999999999999876322 2479999986533 33446789999999998 8999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCC-----------------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCC
Q 044281 577 LVYEFMGNGTLANLIFAIP-----------------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQN 633 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~N 633 (796)
+||||+++|+|.++|.... .+++..++.++.||++||+|||++ +|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence 9999999999999997542 478899999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeecCCcccccCCCCcc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHH
Q 044281 634 ILLDHFFSAKISDFGLSKLLFSDQSRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEE 711 (796)
Q Consensus 634 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~ 711 (796)
||++.++.+||+|||+|+......... .....||+.|||||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998765544332 234568999999999999999999999999999999998 899997643322
Q ss_pred HhHHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHc
Q 044281 712 SRAILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEG 776 (796)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~ 776 (796)
.... ....+.... .+....+++.+++.+||+.||++||||+||+++|..
T Consensus 275 ~~~~-------~~~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 NFYK-------LIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHH-------HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH-------HHhcCCCCC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1111 111111110 011223467789999999999999999999999963
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-46 Score=393.28 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=208.2
Q ss_pred hHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.++||+|+||+||+|+.+. .+++.||||+++.... +..++|.+|++++++++||||++++++|......+++|
T Consensus 16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~ 95 (301)
T d1lufa_ 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 95 (301)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence 456789999999999998753 3567999999975433 34578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC------------------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEE
Q 044281 580 EFMGNGTLANLIFAIP------------------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNIL 635 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~------------------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIl 635 (796)
||+++|+|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL 172 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence 9999999999996432 378889999999999999999998 8999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCC-CCCchhhHHHHh
Q 044281 636 LDHFFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCR-RSVEMELEEESR 713 (796)
Q Consensus 636 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~-~p~~~~~~~~~~ 713 (796)
|+.++.+||+|||+|+.+..... .......+|+.|+|||.+.+..++.++|||||||++|||++|. .||......+..
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~ 252 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 252 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHH
Confidence 99999999999999987644332 2334556889999999999999999999999999999999996 466655444332
Q ss_pred HHHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 714 AILTDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.. +.++...... .....++.+++.+||+.||++||||.||+++|+++.+
T Consensus 253 ~~--------v~~~~~~~~p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 253 YY--------VRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HH--------HHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HH--------HHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22 2233322211 1122457789999999999999999999999998864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-46 Score=392.38 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=191.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||+||+|..+ .+++.||||++.... ......+.+|+.++++++|||||++++++.++...++||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 456688999999999999865 468899999996533 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc---CCCcEEEeecCCcccccCCCCc
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD---HFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~DfGla~~~~~~~~~ 659 (796)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+|+......
T Consensus 90 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 90 SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 9999999999888999999999999999999999998 999999999999994 57899999999998654322
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAA 739 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 739 (796)
......||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ ..+.... ...
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~~--~~~--- 231 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI--------LKAEYEF--DSP--- 231 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HTTCCCC--CTT---
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------hccCCCC--CCc---
Confidence 233467999999999999999999999999999999999999999866544332222 1111110 000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 740 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 740 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
........+.+++.+||+.||++|||+.|+++.
T Consensus 232 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 -YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011223457789999999999999999999884
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-46 Score=392.84 Aligned_cols=244 Identities=25% Similarity=0.295 Sum_probs=201.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+...++||+|+||+||+|+.. .+++.||||+++... ....+.+.+|+.++++++|||||++++++.++...++|||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 344578999999999999865 478999999986432 3344679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 999999988888888899999999999999999999998 899999999999999999999999999986532
Q ss_pred eeeccCCCcccccccccC---CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 661 HTMIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||......+....+ ..+......
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i--------~~~~~~~~~---- 235 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNESPALQ---- 235 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCCS----
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCCCCC----
Confidence 234569999999999864 46899999999999999999999999765443322111 111111111
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
+....+.+.+++.+||+.||++|||+.|+++
T Consensus 236 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112346778999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=388.56 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=195.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCC--CCeEEEEEEecchhh-hhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTA--SGTAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.+.||+|+||.||+|++... .+..||||.++.... ...+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEE
Confidence 44567899999999999987543 245799999965433 345679999999999999999999999964 67899999
Q ss_pred ecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 659 (796)
|+++|+|.+++... ..+++..++.++.||++||.|||++ +|+||||||+||++++++.+||+|||+|+.+......
T Consensus 88 ~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred eccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 99999999987654 5689999999999999999999998 9999999999999999999999999999977554444
Q ss_pred ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhh
Q 044281 660 THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEA 738 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 738 (796)
......||+.|+|||.+.+..++.++|||||||++|||++ |..||......+.... +.++.....
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~--------i~~~~~~~~------ 230 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--------IENGERLPM------ 230 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH--------HHTTCCCCC------
T ss_pred eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCCCC------
Confidence 4455678999999999999999999999999999999998 7888876544332211 122221111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 739 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 739 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
+....+.+.+++.+||+.||++|||+.||++.|+.+++
T Consensus 231 ---~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 231 ---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223567789999999999999999999999987653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-45 Score=393.56 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=207.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||.||+|+.+ .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 456688999999999999875 4789999999977666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc--CCCcEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD--HFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+... ..
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~ 181 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QS 181 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc--cc
Confidence 9999999864 45799999999999999999999998 999999999999996 4688999999999876433 23
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+....+. .+... +....
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--------~~~~~--~~~~~--- 248 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK--------SCDWN--MDDSA--- 248 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HTCCC--SCCGG---
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCCC--CCccc---
Confidence 345679999999999999999999999999999999999999998765544322221 11100 00000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.....+.+.+++.+||+.||++|||+.|++++
T Consensus 249 -~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 -FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123456789999999999999999999885
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.2e-45 Score=392.96 Aligned_cols=250 Identities=28% Similarity=0.361 Sum_probs=207.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.+.+.||+|+||+||+|+.+ .+++.||||+++.........+.+|+.++++++|||||++++++.++...++||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 456688999999999999865 4689999999976555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc--CCCcEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD--HFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+|+|.+.+.... .+++..+..++.||+.||+|||++ +|+||||||+||||+ +++.+||+|||+|+.+.... .
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~ 184 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 184 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC--c
Confidence 999998876654 689999999999999999999998 999999999999998 67899999999999765432 3
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+... +...
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~~~~~--~~~~---- 250 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--------KRCDWE--FDED---- 250 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HHCCCC--CCSS----
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC--CCcc----
Confidence 44567999999999999999999999999999999999999999876544332221 111111 0000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.......++.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011123456789999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=388.80 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=203.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCC--eEEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccc-cccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE-ALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~ 581 (796)
|.++||+|+||+||+|++...++ ..||||+++.. .....++|.+|++++++++|||||+++|++.+ +...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 45789999999999999764433 46899999753 34455789999999999999999999999865 4578999999
Q ss_pred cCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCc-
Q 044281 582 MGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSR- 659 (796)
Q Consensus 582 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~- 659 (796)
+++|+|.+++... ..+++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999998865 4677888999999999999999998 8999999999999999999999999999976544322
Q ss_pred --ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 660 --THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 660 --~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ + ......+......
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~----~~~i~~g~~~~~p---- 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---I----TVYLLQGRRLLQP---- 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------C----HHHHHTTCCCCCC----
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCCCCc----
Confidence 22335689999999999999999999999999999999999888865432211 1 1111222211111
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDV 780 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~ 780 (796)
....+++.+++.+||+.||++||+|.||+++|+.+++.
T Consensus 257 -----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11224577899999999999999999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=384.11 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=205.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh------hhHHHHHHHHHHhcccCccCccccccccccccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ------EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 577 (796)
+.+.+.||+|+||+||+|+.+ .+|+.||||++++... ...+.|.+|+.++++++|||||++++++.+....+|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 455688999999999999975 4789999999864221 235789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC----cEEEeecCCcccc
Q 044281 578 VYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF----SAKISDFGLSKLL 653 (796)
Q Consensus 578 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~DfGla~~~ 653 (796)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+|+..
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999998888899999999999999999999998 999999999999998776 5999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceec
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLI 733 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (796)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+....
T Consensus 168 ~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--------~~~~~~-- 235 (293)
T d1jksa_ 168 DFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--------AVNYEF-- 235 (293)
T ss_dssp TTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------TTCCCC--
T ss_pred CCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH--------hcCCCC--
Confidence 4332 2334568999999999999999999999999999999999999998765544322221 111100
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 734 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 734 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
. ..........+.+++.+||+.||++|||++|+++.
T Consensus 236 ~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 236 E----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011123456789999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=382.30 Aligned_cols=245 Identities=27% Similarity=0.355 Sum_probs=193.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccc-cccceeEEeecC
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDE-ALNRLLVYEFMG 583 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~~~ 583 (796)
.+.+.||+|+||.||+|.++ ++.||||+++.. ...++|.+|++++++++||||++++|+|.+ ....++||||++
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred EEeEEEecCCCeEEEEEEEC---CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 35578999999999999973 678999999763 334679999999999999999999998855 466899999999
Q ss_pred CCCHHHHHhcCC--CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 584 NGTLANLIFAIP--KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 584 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+|+|.++|.... .+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~ 157 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 157 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----C
Confidence 999999997643 589999999999999999999998 8999999999999999999999999999865332 2
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
....+|..|+|||++.+..++.++|||||||++|||+| |+.|+......+.... +..+......+
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~--------i~~~~~~~~~~------ 223 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKMDAPD------ 223 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH--------HTTTCCCCCCT------
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH--------HHcCCCCCCCc------
Confidence 33457889999999999999999999999999999998 5667665433322111 12222222111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
....++.+++.+||+.||.+||||.+|+++|+.+.
T Consensus 224 ---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 12246678999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=384.00 Aligned_cols=245 Identities=26% Similarity=0.308 Sum_probs=206.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEee
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
.+.+.||+|+||.||+++.+ .+++.||||++++.. ....+.+.+|+.+|++++||||+++++++.+....++||||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 45578999999999999865 478999999997532 23457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcce
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTH 661 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 661 (796)
+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....... ..
T Consensus 87 ~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~~ 162 (337)
T d1o6la_ 87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 162 (337)
T ss_dssp CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CB
T ss_pred cCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc-cc
Confidence 99999999999888899999999999999999999998 999999999999999999999999999987643332 33
Q ss_pred eeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhhh
Q 044281 662 TMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAMA 741 (796)
Q Consensus 662 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 741 (796)
...+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+ ..+... .
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i--------~~~~~~-~--------- 224 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------LMEEIR-F--------- 224 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC-C---------
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH--------hcCCCC-C---------
Confidence 4567999999999999999999999999999999999999999877654432221 111111 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 044281 742 DRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQ 772 (796)
Q Consensus 742 ~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 772 (796)
+.....++.+++.+||+.||.+||+ ++|+++
T Consensus 225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1112345678999999999999995 788876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=378.86 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=195.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCC--eEEEEEEecch---hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASG--TAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.+.||+|+||+||+|+++..++ ..||||+++.. ..+..++|.+|+.++++++|||||+++|++.+ ...++||
T Consensus 11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~ 89 (273)
T d1u46a_ 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT 89 (273)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence 456789999999999998765444 47899998653 23445789999999999999999999999976 4678999
Q ss_pred eecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 580 EFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
||+++|++.+.+... ..+++..++.++.|||+||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp ECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 999999999877654 5689999999999999999999998 899999999999999999999999999998754433
Q ss_pred cc--eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 659 RT--HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 659 ~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
.. .....+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+ ..++.....
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i-------~~~~~~~~~--- 236 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------DKEGERLPR--- 236 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTSCCCCCC---
T ss_pred cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH-------HhCCCCCCC---
Confidence 22 234567889999999999999999999999999999998 89999766554432211 112211111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
+......+.+++.+||+.||++||||.+|++.|+++
T Consensus 237 ------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 ------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111224577899999999999999999999999753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-45 Score=384.84 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=201.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCCe--EEEEEEecch-hhhhHHHHHHHHHHhccc-CccCcccccccccccccceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGT--AIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 581 (796)
+.++||+|+||+||+|+++. ++. .||||+++.. ..+..++|.+|++++.++ +|||||+++|+|.+.+..++||||
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 45789999999999999874 343 6888988543 334456899999999998 799999999999999999999999
Q ss_pred cCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEe
Q 044281 582 MGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKIS 645 (796)
Q Consensus 582 ~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 645 (796)
+++|+|.++|... ..+++..+++++.|||+||.|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence 9999999999754 5689999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCC-CCchhhHHHHhHHHHHHHHHhh
Q 044281 646 DFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRR-SVEMELEEESRAILTDWAYDCY 724 (796)
Q Consensus 646 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~-p~~~~~~~~~~~~l~~~~~~~~ 724 (796)
|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||......+.... +
T Consensus 170 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~--------i 239 (309)
T d1fvra_ 170 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK--------L 239 (309)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------G
T ss_pred cccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH--------H
Confidence 999998643222 2223458999999999999999999999999999999999775 5655443332211 1
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcCCC
Q 044281 725 VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLDVP 781 (796)
Q Consensus 725 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (796)
.++..... +....+++.+++.+||+.||++||||+||++.|+++++..
T Consensus 240 ~~~~~~~~---------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 PQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GGTCCCCC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 22211111 1122356778999999999999999999999999877543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-44 Score=381.26 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=205.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.++||+|+||+||+|+.+ .+|+.||||++++.. ....+.+.+|+.++++++|||||++++++.+....++|||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 345678999999999999975 468999999997532 2345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 999999999999998999999999999999999999998 9999999999999999999999999999876432
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+....+. .+... +
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--------~~~~~--~------- 220 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--------NAELR--F------- 220 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HCCCC--C-------
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH--------cCCCC--C-------
Confidence 234679999999999999999999999999999999999999998765544322221 11111 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQM 773 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 773 (796)
+......+.+++.+||+.||.+|| |+++++++
T Consensus 221 -p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 221 -PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111224567799999999999996 89999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=385.07 Aligned_cols=258 Identities=28% Similarity=0.367 Sum_probs=195.5
Q ss_pred HHhHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCccccccccccc-ccc
Q 044281 503 TDGFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEA-LNR 575 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~ 575 (796)
.+.+.++||+|+||.||+|.... .+++.||||+++... ....+.+.+|...+.++ +|+||+++++++.+. ...
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 34556789999999999998753 245789999997533 34456788888888877 789999999987654 567
Q ss_pred eeEEeecCCCCHHHHHhcC----------------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC
Q 044281 576 LLVYEFMGNGTLANLIFAI----------------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~ 639 (796)
++||||+++|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||||+++
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCC
Confidence 9999999999999999753 2478999999999999999999998 89999999999999999
Q ss_pred CcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCC-CCchhhHHHHhHHHH
Q 044281 640 FSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRR-SVEMELEEESRAILT 717 (796)
Q Consensus 640 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~-p~~~~~~~~~~~~l~ 717 (796)
+.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||++|.. ||......+..
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~---- 246 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---- 246 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH----
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence 99999999999876544332 2334679999999999999999999999999999999999764 66543322111
Q ss_pred HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.....++......+ ....++.+++.+||+.||++||||.||+++|+.+++
T Consensus 247 ---~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 ---CRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ---HHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHhcCCCCCCCc---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11112222111111 123457789999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=386.73 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=198.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCe----EEEEEEecch-hhhhHHHHHHHHHHhcccCccCcccccccccccccceeE
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGT----AIAVKKLDRL-AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
+.+.++||+|+||+||+|.+.. +++ .||+|+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..+++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 3455789999999999998753 333 6899998653 334567899999999999999999999999865 56788
Q ss_pred EeecCCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 044281 579 YEFMGNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 657 (796)
+||+.+|+|.+.+... ..+++..+++++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 9999999998887754 5789999999999999999999998 89999999999999999999999999999875544
Q ss_pred Ccc-eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccc
Q 044281 658 SRT-HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDS 735 (796)
Q Consensus 658 ~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (796)
... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+....+ ..+....
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i--------~~~~~~~---- 233 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERLP---- 233 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH--------HHTCCCC----
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCCCC----
Confidence 322 334568999999999999999999999999999999998 67787655433322211 1111111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcC
Q 044281 736 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGL 777 (796)
Q Consensus 736 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~ 777 (796)
.+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 234 -----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 234 -----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 0112234677899999999999999999999998765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-44 Score=375.68 Aligned_cols=257 Identities=20% Similarity=0.251 Sum_probs=201.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCccccccccccccc----ce
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALN----RL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~ 576 (796)
+.+.+.||+|+||+||+|+.. .+++.||||+++... ......|.+|++++++++|||||++++++..... .+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 345678999999999999865 478999999996532 2345679999999999999999999999876543 68
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||+++++|.+++.....+++.++..++.||++||+|||++ +|+||||||+|||++.++..+|+|||.++.....
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999999998888899999999999999999999998 9999999999999999999999999999865433
Q ss_pred CC--cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 657 QS--RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 657 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ...+...
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~-------~~~~~~~---- 233 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-------VREDPIP---- 233 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------HHCCCCC----
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH-------HhcCCCC----
Confidence 22 2334567999999999999999999999999999999999999999876544322111 1111110
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHcCc
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVLQMLEGLL 778 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~evl~~L~~~~ 778 (796)
.........+++.+++.+||+.||++|| |++++++.|.++.
T Consensus 234 ---~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0001112235677899999999999999 8999999887653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=379.74 Aligned_cols=256 Identities=26% Similarity=0.320 Sum_probs=203.8
Q ss_pred HhHHHhhCCCccceEEEEEeeCC------CCeEEEEEEecchhh-hhHHHHHHHHHHhccc-CccCcccccccccccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTA------SGTAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 575 (796)
+.+.+.||+|+||.||+|+.... ++..||||+++.... ....++.+|+..+.++ +|||||+++++|.++...
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 34557899999999999986532 235799999976443 3457889999999888 899999999999999999
Q ss_pred eeEEeecCCCCHHHHHhcCC----------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCC
Q 044281 576 LLVYEFMGNGTLANLIFAIP----------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHF 639 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~ 639 (796)
++||||+++|+|.++|.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCC
Confidence 99999999999999997542 478999999999999999999998 89999999999999999
Q ss_pred CcEEEeecCCcccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHh-CCCCCchhhHHHHhHHHH
Q 044281 640 FSAKISDFGLSKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIIC-CRRSVEMELEEESRAILT 717 (796)
Q Consensus 640 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~ 717 (796)
+.+||+|||+++........ ......+|+.|+|||.+.++.++.++|||||||++|||++ |..||..........
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~--- 248 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--- 248 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH---
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH---
Confidence 99999999999977554432 2344568999999999999999999999999999999998 577776554433221
Q ss_pred HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 718 DWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+.++...... ......+.+++.+||+.||++|||+.||++.|++++.
T Consensus 249 -----~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 -----LLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----HHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHcCCCCCCC---------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22222211111 1123457789999999999999999999999998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=376.85 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=197.7
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccc----cceeEEee
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL----NRLLVYEF 581 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e~ 581 (796)
+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++++|.+.. ..++||||
T Consensus 7 l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEECCSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 456799999999999986 578999999975432 2233445666777889999999999997654 56899999
Q ss_pred cCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcC-----CCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 582 MGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEEC-----NVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 582 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-----~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+++|+|.++|... .++|..+++++.|+|.||+|||+.. ..+|+||||||+||||++++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 83 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred ccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 9999999999864 6899999999999999999999742 348999999999999999999999999999987544
Q ss_pred CCc---ceeeccCCCcccccccccCCC------CCccchhHHHHHHHHHHHhCCCCCchhhHHHH--------hHHHHHH
Q 044281 657 QSR---THTMIRGTRGYVAPEWFKNVP------VSAKVDVYSFGVTLLEIICCRRSVEMELEEES--------RAILTDW 719 (796)
Q Consensus 657 ~~~---~~~~~~gt~~y~aPE~~~~~~------~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~--------~~~l~~~ 719 (796)
... ......||+.|+|||++.+.. ++.++|||||||+||||++|..|+........ .... ..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~ 240 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-EE 240 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-HH
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH-HH
Confidence 322 233467999999999987643 67799999999999999999877643211100 0000 11
Q ss_pred HHHhhhcCccceeccchh-hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 720 AYDCYVEGRLDVLIDSDE-AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 720 ~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
.......+.. .+.. ......+....+.+++.+||+.||++||||.||+++|+.+.
T Consensus 241 ~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 241 MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111111111 1111 12223445677889999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=382.45 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=207.1
Q ss_pred hHHHhhCCCccceEEEEEeeC----CCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccccceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKT----ASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 579 (796)
.+.++||+|+||+||+|.++. .+++.||||+++... .+....|.+|+.++++++|||||+++|+|......++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 456789999999999998742 235789999997533 334467999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcC----------CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCC
Q 044281 580 EFMGNGTLANLIFAI----------PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGL 649 (796)
Q Consensus 580 e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 649 (796)
||+++|+|.+++... ..+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence 999999999988632 3468899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCc-ceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCC-CCCchhhHHHHhHHHHHHHHHhhhcC
Q 044281 650 SKLLFSDQSR-THTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCR-RSVEMELEEESRAILTDWAYDCYVEG 727 (796)
Q Consensus 650 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~-~p~~~~~~~~~~~~l~~~~~~~~~~~ 727 (796)
|+.+...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+ .|+......+....+ ..+
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i--------~~~ 251 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV--------MEG 251 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH--------HTT
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HhC
Confidence 9976543322 223345899999999999999999999999999999999986 566554443322221 222
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 728 RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 728 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
...... ......+.+++.+||+.||++||||++|+++|++.++
T Consensus 252 ~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 221111 1122467889999999999999999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=384.03 Aligned_cols=257 Identities=28% Similarity=0.373 Sum_probs=207.1
Q ss_pred HHhHHHhhCCCccceEEEEEee----CCCCeEEEEEEecchh-hhhHHHHHHHHHHhccc-CccCcccccccccccccce
Q 044281 503 TDGFKEELGRGSFGIVYKGVLK----TASGTAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKHLVQLLGFCDEALNRL 576 (796)
Q Consensus 503 ~~~~~~~LG~G~fG~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 576 (796)
.+.+.++||+|+||.||+|++. ..+++.||||+++... .....+|.+|+.+++++ +|||||+++|+|.+....+
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~ 103 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence 4456688999999999999864 3466799999997543 33456799999999998 7999999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCC------------------CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC
Q 044281 577 LVYEFMGNGTLANLIFAIP------------------KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH 638 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~ 638 (796)
+||||+++|+|.+++.... .+++..+.+++.||++||+|||++ +|+||||||+||+++.
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccccc
Confidence 9999999999999997542 578899999999999999999998 8999999999999999
Q ss_pred CCcEEEeecCCcccccCCCC-cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCC-CchhhHHHHhHHH
Q 044281 639 FFSAKISDFGLSKLLFSDQS-RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRS-VEMELEEESRAIL 716 (796)
Q Consensus 639 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p-~~~~~~~~~~~~l 716 (796)
++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++++.| +......+....+
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999997754433 233446789999999999999999999999999999999995555 4433222211111
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 717 TDWAYDCYVEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
...+..... +......+.+++.+||+.||++||||.+|+++|++++
T Consensus 261 -------i~~~~~~~~---------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 261 -------IKEGFRMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp -------HHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HhcCCCCCC---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 111111110 1112356788999999999999999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=375.17 Aligned_cols=260 Identities=24% Similarity=0.231 Sum_probs=200.4
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhh-----HHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQER-----EREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
++||+|+||+||+|+.+ .+++.||||+++...... .+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57999999999999875 468999999996533221 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
.++++..++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....... ...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 9988888877777899999999999999999999998 999999999999999999999999999987644332 233
Q ss_pred eccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC-----------ccc
Q 044281 663 MIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG-----------RLD 730 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~-----------~~~ 730 (796)
...||+.|+|||.+.. ..++.++|||||||++|||++|+.||......+....+.........+. ...
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 4568999999999865 4679999999999999999999999987665544333322111100000 000
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...... .........+.+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~-~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIP-LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCC-HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCC-hHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000 000111223567889999999999999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-43 Score=368.93 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=204.0
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---------hhhHHHHHHHHHHhcccC-ccCccccccccccccc
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---------QEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALN 574 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 574 (796)
.+.+.||+|+||+||+|+.+ .+++.||||+++... ....+.+.+|+.++++++ ||||+++++++.++..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred EEceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 34578999999999999865 478999999985421 122356889999999996 9999999999999999
Q ss_pred ceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccccc
Q 044281 575 RLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLF 654 (796)
Q Consensus 575 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 654 (796)
.+|||||+++|+|.++|.....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999999888999999999999999999999998 99999999999999999999999999999765
Q ss_pred CCCCcceeeccCCCcccccccccC------CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCc
Q 044281 655 SDQSRTHTMIRGTRGYVAPEWFKN------VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 728 (796)
Q Consensus 655 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 728 (796)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+. ++.
T Consensus 162 ~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~--------~~~ 231 (277)
T d1phka_ 162 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--------SGN 231 (277)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HTC
T ss_pred CCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH--------hCC
Confidence 432 2344679999999999853 357889999999999999999999998766544332221 111
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 729 LDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 729 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
... ... ......+++.+++.+||+.||++|||+.||++.
T Consensus 232 ~~~--~~~----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 232 YQF--GSP----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCC--CTT----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCC--CCc----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 110 000 111233567789999999999999999999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-43 Score=379.96 Aligned_cols=243 Identities=22% Similarity=0.232 Sum_probs=204.7
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
+.+.++||+|+||.||+|+.+ .+|+.||||+++... ....+.+.+|+++++.++|||||++++++.+....++|||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 345578999999999999875 478999999996532 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+.+|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+.+...
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 999999999999888899999999999999999999998 9999999999999999999999999999976432
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...........+ ..+....
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--------~~~~~~~--------- 257 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--------VSGKVRF--------- 257 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCC---------
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH--------hcCCCCC---------
Confidence 23456999999999999999999999999999999999999999876544332222 1111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQ 772 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 772 (796)
+......+.+++.+||+.||.+|+ |++++++
T Consensus 258 -p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 -PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111234577899999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=377.32 Aligned_cols=245 Identities=26% Similarity=0.306 Sum_probs=202.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHHHHHHHhc-ccCccCcccccccccccccceeEEe
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFKSEVSAIG-RTHHKHLVQLLGFCDEALNRLLVYE 580 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv~e 580 (796)
.+.++||+|+||+||+|+.+ .+++.||||++++.. ....+.+..|..++. .++|||||++++++.++...++|||
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 45678999999999999976 578999999997532 233456677777665 6899999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 660 (796)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...... ..
T Consensus 84 y~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~~ 159 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AK 159 (320)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred ecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-cc
Confidence 999999999999888899999999999999999999998 89999999999999999999999999998654333 23
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+... +
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--------~~~~~--~------- 222 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--------MDNPF--Y------- 222 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC--C-------
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--------cCCCC--C-------
Confidence 344679999999999999999999999999999999999999998766554332221 11110 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMK-VVLQ 772 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-evl~ 772 (796)
+.....++.+++.+||+.||++||++. ++++
T Consensus 223 -p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 -PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111234577899999999999999996 6753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=373.38 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=204.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
|.+.++||+|+||+||+|+.+ .+++.||||.++.... ....+.+|+++|++++|||||++++++.+....+|||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 345678999999999999865 4789999999976433 34568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC--CCcEEEeecCCcccccCCCCcc
Q 044281 584 NGTLANLIFAIP-KPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH--FFSAKISDFGLSKLLFSDQSRT 660 (796)
Q Consensus 584 ~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~ 660 (796)
+|+|.+++...+ .+++.++..++.||++||+|||+. +|+||||||+|||++. ...+||+|||+++..... ..
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~ 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DN 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CE
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--Cc
Confidence 999999998765 689999999999999999999998 9999999999999985 458999999999876432 23
Q ss_pred eeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchhhhh
Q 044281 661 HTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDEAAM 740 (796)
Q Consensus 661 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 740 (796)
.....+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+....+. .+... ++...
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~--------~~~~~--~~~~~--- 226 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM--------NAEYT--FDEEA--- 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HTCCC--CCHHH---
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCCC--CChhh---
Confidence 344568999999999999999999999999999999999999998766544332221 11110 01000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 741 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 741 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
......++.+++.+||+.||++|||+.|+++
T Consensus 227 -~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 -FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112345678999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.3e-43 Score=380.22 Aligned_cols=246 Identities=22% Similarity=0.250 Sum_probs=196.3
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh---hhhHHHHH---HHHHHhcccCccCcccccccccccccceeE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA---QEREREFK---SEVSAIGRTHHKHLVQLLGFCDEALNRLLV 578 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 578 (796)
.+.+.||+|+||.||+|+.+ .+|+.||||++.... ......+. .|+.+++.++|||||++++++.+.+..++|
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eeeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 34578999999999999865 468999999996432 12223343 457778888999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC
Q 044281 579 YEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 579 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 658 (796)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 99999999999999888899999999999999999999998 99999999999999999999999999998764432
Q ss_pred cceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 659 RTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 659 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||............ ........ ..
T Consensus 162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-----~~~~~~~~-~~----- 228 (364)
T d1omwa3 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----RMTLTMAV-EL----- 228 (364)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-----HHSSSCCC-CC-----
T ss_pred --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HhcccCCC-CC-----
Confidence 234569999999999964 56899999999999999999999999764332211111 10001110 00
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVLQ 772 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 772 (796)
+.....++.+++.+||+.||++||| ++|+++
T Consensus 229 ----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 229 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1112345678999999999999999 688875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=374.13 Aligned_cols=254 Identities=22% Similarity=0.246 Sum_probs=197.0
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhccc-CccCcccccccccc----cccceeEEeec
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKHLVQLLGFCDE----ALNRLLVYEFM 582 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e~~ 582 (796)
+.||+|+||+||+|+.. .+++.||||++++. ..+.+|+.++.++ +|||||++++++.+ ....++||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEECSSCEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEeeeccCeEEEEEEEC-CCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 45999999999999865 46899999999653 3567889887654 89999999999865 46689999999
Q ss_pred CCCCHHHHHhcC--CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC---CCcEEEeecCCcccccCCC
Q 044281 583 GNGTLANLIFAI--PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH---FFSAKISDFGLSKLLFSDQ 657 (796)
Q Consensus 583 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~~~ 657 (796)
++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++ .+.+||+|||+|+......
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999875 4689999999999999999999998 9999999999999985 5679999999998765433
Q ss_pred CcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceeccchh
Q 044281 658 SRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLIDSDE 737 (796)
Q Consensus 658 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 737 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ......+... .
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~i~~~~~~----~-- 236 (335)
T d2ozaa1 169 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYE----F-- 236 (335)
T ss_dssp --CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSS----C--
T ss_pred --ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHHHhcCCCC----C--
Confidence 234457999999999999999999999999999999999999999765432211111 0111111110 0
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcCcCCCC
Q 044281 738 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGLLDVPN 782 (796)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~~~~~~ 782 (796)
.........+++.+++.+||+.||++|||+.|+++. +.+....+.
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 283 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence 001112234567889999999999999999999884 444333333
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=365.35 Aligned_cols=263 Identities=24% Similarity=0.277 Sum_probs=197.6
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.++||+|+||+||+|+.. .+++.||||+++.... .....+.+|++++++++|||||++++++.++...++||||+.
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence 4478999999999999975 4688999999965322 234689999999999999999999999999999999999998
Q ss_pred CCCHHHHHhc-CCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 584 NGTLANLIFA-IPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 584 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
++.+...... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 85 ~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~ 160 (298)
T d1gz8a_ 85 QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYT 160 (298)
T ss_dssp EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTT
T ss_pred CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-ccce
Confidence 6555444333 45689999999999999999999998 89999999999999999999999999998764333 2333
Q ss_pred eccCCCcccccccccCCC-CCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc--Cccceeccc----
Q 044281 663 MIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE--GRLDVLIDS---- 735 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d~---- 735 (796)
...||+.|+|||.+.... ++.++|||||||++|||++|+.||......+....+.......... .......+.
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence 456999999999887665 5789999999999999999999998665443322221111000000 000000000
Q ss_pred -----hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 736 -----DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 736 -----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
............++.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000111223567889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.3e-42 Score=358.98 Aligned_cols=261 Identities=21% Similarity=0.240 Sum_probs=199.4
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeecC
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFMG 583 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 583 (796)
+.++||+|+||+||+|+.+ +++.||||+++... ....+.+.+|+.++++++|||||++++++...+..++++||+.
T Consensus 6 ~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 6 GLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 4578999999999999874 67899999996532 2335789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCcceee
Q 044281 584 NGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHTM 663 (796)
Q Consensus 584 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 663 (796)
++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ ....
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 159 (286)
T d1ob3a_ 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTH 159 (286)
T ss_dssp EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred hhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccce
Confidence 988888888788899999999999999999999998 999999999999999999999999999987644332 2233
Q ss_pred ccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcC--ccce---------
Q 044281 664 IRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG--RLDV--------- 731 (796)
Q Consensus 664 ~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~~--------- 731 (796)
..+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+........... ....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 4589999999998754 569999999999999999999999976654433222211110000000 0000
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 732 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 732 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
.................+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000001111222356778999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=363.90 Aligned_cols=239 Identities=24% Similarity=0.386 Sum_probs=194.6
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh------hhHHHHHHHHHHhcccC--ccCcccccccccccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ------EREREFKSEVSAIGRTH--HKHLVQLLGFCDEALNR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 575 (796)
+.+.+.||+|+||+||+|+.. .+++.||||+++.... .....+.+|+.++++++ |||||++++++.+.+..
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred EEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 445678999999999999865 4689999999864321 11234678999999986 89999999999999999
Q ss_pred eeEEeecCC-CCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-CCcEEEeecCCcccc
Q 044281 576 LLVYEFMGN-GTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-FFSAKISDFGLSKLL 653 (796)
Q Consensus 576 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~ 653 (796)
++||||+.+ +++.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++. ++.+||+|||+|+..
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceec
Confidence 999999975 68888888888899999999999999999999998 9999999999999985 579999999999865
Q ss_pred cCCCCcceeeccCCCcccccccccCCCC-CccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . .+.. .
T Consensus 162 ~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-----~---------~~~~--~ 222 (273)
T d1xwsa_ 162 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----I---------RGQV--F 222 (273)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----H---------HCCC--C
T ss_pred ccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-----h---------hccc--C
Confidence 332 2344679999999999987766 56789999999999999999999754211 0 0110 0
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
+.+ ....++.+++.+||+.||++|||++|+++.
T Consensus 223 ~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 FRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111 112456789999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=362.47 Aligned_cols=265 Identities=22% Similarity=0.255 Sum_probs=196.1
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhh--hhHHHHHHHHHHhccc---CccCccccccccc-----ccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKHLVQLLGFCD-----EAL 573 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 573 (796)
+.+.++||+|+||+||+|+....+++.||||+++.... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 34557899999999999987544578899999864321 1223456677766655 7999999999984 345
Q ss_pred cceeEEeecCCCCHHHHHh-cCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCccc
Q 044281 574 NRLLVYEFMGNGTLANLIF-AIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKL 652 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 652 (796)
..+++|||++++.+..... ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 6789999999887765544 345788999999999999999999998 899999999999999999999999999986
Q ss_pred ccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc----C-
Q 044281 653 LFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE----G- 727 (796)
Q Consensus 653 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~----~- 727 (796)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.......... .
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 4322 23345679999999999999999999999999999999999999998766554333332211100000 0
Q ss_pred ccce-e---ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 728 RLDV-L---IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 728 ~~~~-~---~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.... . ..............+.+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0 00000001111223456779999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=354.54 Aligned_cols=266 Identities=20% Similarity=0.237 Sum_probs=198.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc--------cc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE--------AL 573 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~ 573 (796)
+.+.++||+|+||+||+|+.. .+++.||||++... .......+.+|+++|++++|+||+++++++.. ..
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred EEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 345578999999999999865 57899999998543 22334678999999999999999999998754 34
Q ss_pred cceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccc
Q 044281 574 NRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLL 653 (796)
Q Consensus 574 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 653 (796)
..++||||+.++.+.........++...+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeec
Confidence 5789999999888877777777888999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCC---cceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc---
Q 044281 654 FSDQS---RTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE--- 726 (796)
Q Consensus 654 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~--- 726 (796)
..... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.........+
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 53322 222335699999999998765 68999999999999999999999998765554443332222111000
Q ss_pred ----Cccceeccchhh-------hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 727 ----GRLDVLIDSDEA-------AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 727 ----~~~~~~~d~~~~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
......+..... ..........+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000000 00011112356779999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-40 Score=352.31 Aligned_cols=258 Identities=19% Similarity=0.244 Sum_probs=194.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCccccc-ccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLL-GFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-g~~~~~~~~~lv~e~~ 582 (796)
+.+.+.||+|+||+||+|+.. .+++.||||++.... ...++..|++++++++|+|++..+ ++..+....++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 445678999999999999865 468999999886532 234678899999999877766554 5556777788999999
Q ss_pred CCCCHHHHH-hcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEc---CCCcEEEeecCCcccccCCCC
Q 044281 583 GNGTLANLI-FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLD---HFFSAKISDFGLSKLLFSDQS 658 (796)
Q Consensus 583 ~~gsL~~~l-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~DfGla~~~~~~~~ 658 (796)
.+ +|...+ .....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+.....
T Consensus 86 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 GP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 55 555554 4456899999999999999999999998 899999999999986 456799999999998754332
Q ss_pred ------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCcccee
Q 044281 659 ------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVL 732 (796)
Q Consensus 659 ------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (796)
.......||+.|||||.+.+..++.++|||||||++|||++|+.||..................... ..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~---- 236 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TP---- 236 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SC----
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CC----
Confidence 2234567999999999999999999999999999999999999999765433322211111111000 00
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCc
Q 044281 733 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLL 778 (796)
Q Consensus 733 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~ 778 (796)
..........++.+++..||+.+|++||+++++.+.|+.+.
T Consensus 237 -----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00001112356778999999999999999999999887653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=355.37 Aligned_cols=267 Identities=21% Similarity=0.243 Sum_probs=196.1
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh-hhhHHHHHHHHHHhcccCccCcccccccccccc----cceeEE
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL----NRLLVY 579 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~ 579 (796)
.+.++||+|+||+||+|+.+ .+++.||||+++... ....+.+.+|+.+|++++||||+++++++.... ..++++
T Consensus 11 ~~~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 11 TNLSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEECC---CCCEEEEEET-TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeeccCeEEEEEEEC-CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 34578999999999999865 578999999997543 334567899999999999999999999986654 235666
Q ss_pred eecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCC-
Q 044281 580 EFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQS- 658 (796)
Q Consensus 580 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~- 658 (796)
+|+.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 90 ~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 777899999999764 688999999999999999999998 999999999999999999999999999987644322
Q ss_pred -cceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhc---C------
Q 044281 659 -RTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVE---G------ 727 (796)
Q Consensus 659 -~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~---~------ 727 (796)
.......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+............... .
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 22344669999999999854 567899999999999999999999997654433221111100000000 0
Q ss_pred -----ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcC
Q 044281 728 -----RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGL 777 (796)
Q Consensus 728 -----~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~ 777 (796)
..... ..............++.+++.+||+.||.+|||+.|+++. |+..
T Consensus 246 ~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 246 RNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00000 0000000011122457789999999999999999999985 5443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-40 Score=354.81 Aligned_cols=271 Identities=24% Similarity=0.258 Sum_probs=193.2
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccc------cc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEAL------NR 575 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 575 (796)
+.+.++||+|+||+||+|+.+ .+++.||||+++.. .....+.+.+|+++|++++|||||++++++.... ..
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp EEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 344578999999999999865 46899999999753 2334567899999999999999999999987654 46
Q ss_pred eeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccC
Q 044281 576 LLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFS 655 (796)
Q Consensus 576 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 655 (796)
++||||+ +.+|..++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 99 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence 9999999 4577776654 5789999999999999999999998 999999999999999999999999999986533
Q ss_pred CCCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHH----hhhcC---
Q 044281 656 DQSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYD----CYVEG--- 727 (796)
Q Consensus 656 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~----~~~~~--- 727 (796)
. .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||.................. .+...
T Consensus 174 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 174 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 2 2345689999999998764 5689999999999999999999999765443322211110000 00000
Q ss_pred -------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcCcCCCCCCC
Q 044281 728 -------RLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGLLDVPNPPG 785 (796)
Q Consensus 728 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~~~~~~pp~ 785 (796)
........... .........+.+++.+||+.||++|||+.|++++ |+.+.+....|.
T Consensus 250 ~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~ 315 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315 (346)
T ss_dssp HHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C
T ss_pred hhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccccc
Confidence 00000000000 0011122456789999999999999999999986 666554444333
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=355.81 Aligned_cols=260 Identities=22% Similarity=0.228 Sum_probs=192.5
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcccccccccc------ccccee
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLVQLLGFCDE------ALNRLL 577 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~l 577 (796)
+...++||+|+||+||+|+.+ .+++.||||++..... .+.+|+++|++++|+||+++++++.. ....+|
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 334568999999999999976 4689999999965322 23479999999999999999999843 234689
Q ss_pred EEeecCCCCHHHHH---hcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCcccc
Q 044281 578 VYEFMGNGTLANLI---FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLL 653 (796)
Q Consensus 578 v~e~~~~gsL~~~l---~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~ 653 (796)
||||++++.+..+. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876544433 3456789999999999999999999998 999999999999999765 8999999999876
Q ss_pred cCCCCcceeeccCCCcccccccccC-CCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHH-------HHhh-
Q 044281 654 FSDQSRTHTMIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA-------YDCY- 724 (796)
Q Consensus 654 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~- 724 (796)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.... ....
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4433 2234568999999998865 578999999999999999999999997665443322221110 0000
Q ss_pred ---hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 725 ---VEGRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 725 ---~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
.+......................+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111111111111111112233467789999999999999999999964
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=343.63 Aligned_cols=264 Identities=17% Similarity=0.198 Sum_probs=202.5
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccccccceeEEeec
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
.+.++||+|+||+||+|+.. .+++.||||+++.. .......+.+|+.+++.++||||+++++++.+....++++|++
T Consensus 5 ~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 5 EKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 34578999999999999976 57899999998542 2344678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCCCCccee
Q 044281 583 GNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSDQSRTHT 662 (796)
Q Consensus 583 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 662 (796)
.+++|..++.....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++....... ...
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~ 159 (292)
T d1unla_ 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS 159 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCC
T ss_pred cccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-cce
Confidence 9999999998888999999999999999999999998 999999999999999999999999999987644332 223
Q ss_pred eccCCCcccccccccCCC-CCccchhHHHHHHHHHHHhCCCCCchhh-HHHHhHHHHHHHHHhhhc-----------Ccc
Q 044281 663 MIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVTLLEIICCRRSVEMEL-EEESRAILTDWAYDCYVE-----------GRL 729 (796)
Q Consensus 663 ~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gv~l~elltg~~p~~~~~-~~~~~~~l~~~~~~~~~~-----------~~~ 729 (796)
...+++.|+|||.+.... ++.++|||||||++|||++|+.||.... ..+....+.......... ...
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 345788899999987665 6899999999999999999999974332 222211111111110000 000
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 730 DVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 730 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...................+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000011112223456789999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.2e-40 Score=343.83 Aligned_cols=259 Identities=16% Similarity=0.209 Sum_probs=200.0
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCc-cCcccccccccccccceeEEeec
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHH-KHLVQLLGFCDEALNRLLVYEFM 582 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~ 582 (796)
+.+.++||+|+||+||+|+.. .+++.||||.++... ....+.+|+++++.++| +|++.+++++.++...++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 345678999999999999965 468999999985432 23456788888888865 89999999999999999999998
Q ss_pred CCCCHHHHHhcC-CCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcC-----CCcEEEeecCCcccccCC
Q 044281 583 GNGTLANLIFAI-PKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDH-----FFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 583 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~kl~DfGla~~~~~~ 656 (796)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 68999988765 4689999999999999999999998 9999999999999974 578999999999986543
Q ss_pred CC------cceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccc
Q 044281 657 QS------RTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 730 (796)
Q Consensus 657 ~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (796)
.. .......||+.|||||.+.+..++.++|||||||++|||++|+.||................... ......
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~ 238 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLR 238 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CCCChH
Confidence 21 12334679999999999999999999999999999999999999997543221111110000000 000000
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHcCcC
Q 044281 731 VLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQMLEGLLD 779 (796)
Q Consensus 731 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L~~~~~ 779 (796)
.+ .....+++.+++..|++.+|++||+++.+.+.|+.+++
T Consensus 239 ~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 239 EL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred Hh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 00 01112456778889999999999999999998877543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=353.92 Aligned_cols=252 Identities=22% Similarity=0.247 Sum_probs=202.6
Q ss_pred HhHHHhhCCCccceEEEEEee--CCCCeEEEEEEecchh----hhhHHHHHHHHHHhcccCc-cCcccccccccccccce
Q 044281 504 DGFKEELGRGSFGIVYKGVLK--TASGTAIAVKKLDRLA----QEREREFKSEVSAIGRTHH-KHLVQLLGFCDEALNRL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~ 576 (796)
+.+.++||+|+||+||+|... ..+|+.||||.++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 456689999999999999863 2367899999986532 1234568899999999966 89999999999999999
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
++|||+.+|+|.+++.....+.......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999999999999888888899999999999999999998 8999999999999999999999999999877554
Q ss_pred CCcceeeccCCCcccccccccCC--CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHhhhcCccceecc
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNV--PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDVLID 734 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (796)
.........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+..... .....
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~----~~~~~---- 254 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----KSEPP---- 254 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH----HCCCC----
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc----cCCCC----
Confidence 44444556799999999999764 468899999999999999999999976544332222211111 11100
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044281 735 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVLQ 772 (796)
Q Consensus 735 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 772 (796)
.+.....++.+++.+||+.||++|| |++|+++
T Consensus 255 ------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 255 ------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1112345678899999999999999 4788886
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=344.33 Aligned_cols=260 Identities=22% Similarity=0.243 Sum_probs=187.8
Q ss_pred hHHHhhCCCccceEEEEEeeCCCCeEEEEEEecch--hhhhHHHHHHHHHHhcccCccCcccccccccc------cccce
Q 044281 505 GFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKHLVQLLGFCDE------ALNRL 576 (796)
Q Consensus 505 ~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~ 576 (796)
.+.++||+|+||+||+|... .+|+.||||++... .......+.+|+.++++++|||||++++++.. ....+
T Consensus 20 ~i~~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEECSCC--CEEEEEEET-TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EEEEEeecCcCeEEEEEEEC-CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 34578999999999999865 47899999999643 23345678999999999999999999999853 46779
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+||||+.++.+. .+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 99 iv~Ey~~~~l~~-~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEECCSEEHHH-HHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEeccchHHHH-hhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccc
Confidence 999999775554 433 4578999999999999999999998 9999999999999999999999999998865432
Q ss_pred CCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHH---------------H
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWA---------------Y 721 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~---------------~ 721 (796)
.......+|+.|+|||.+.+..++.++||||+||+++||++|+.||...........+.... .
T Consensus 173 --~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred --cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 23344568999999999999999999999999999999999999997654332221111100 0
Q ss_pred HhhhcC-cc-----ceeccch---hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044281 722 DCYVEG-RL-----DVLIDSD---EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM 773 (796)
Q Consensus 722 ~~~~~~-~~-----~~~~d~~---~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 773 (796)
...... .. ...+... ............+.+++.+||+.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00 0000000 0111223455678889999999999999999999865
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-38 Score=340.63 Aligned_cols=257 Identities=18% Similarity=0.276 Sum_probs=192.4
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCcccccccccc--cccceeEEe
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGFCDE--ALNRLLVYE 580 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~e 580 (796)
+.+.++||+|+||+||+|+.. .+++.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ....++|||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 455678999999999999865 478999999997532 457889999999995 9999999999864 456789999
Q ss_pred ecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCC-cEEEeecCCcccccCCCCc
Q 044281 581 FMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFF-SAKISDFGLSKLLFSDQSR 659 (796)
Q Consensus 581 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~ 659 (796)
|+++++|..+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+......
T Consensus 113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-- 184 (328)
T d3bqca1 113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 184 (328)
T ss_dssp CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--
T ss_pred ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC--
Confidence 99999987764 4688999999999999999999998 999999999999998655 69999999998764432
Q ss_pred ceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHh-HHHHHHH-----HHhhhcCcc---
Q 044281 660 THTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESR-AILTDWA-----YDCYVEGRL--- 729 (796)
Q Consensus 660 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~-~~l~~~~-----~~~~~~~~~--- 729 (796)
......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||......... ..+.... .........
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 23445689999999998765 4799999999999999999999998654322111 1110000 000000000
Q ss_pred ---cee--------ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044281 730 ---DVL--------IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQ 772 (796)
Q Consensus 730 ---~~~--------~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 772 (796)
... ...............++.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000111122346778999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=341.45 Aligned_cols=265 Identities=23% Similarity=0.238 Sum_probs=194.9
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh--hhhHHHHHHHHHHhcccCccCccccccccccc-----ccce
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKHLVQLLGFCDEA-----LNRL 576 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 576 (796)
+.+.++||+|+||+||+|+.. .+++.||||+++... ....+.+.+|++++++++|+|+|++++++... ...+
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEET-TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 345578999999999999865 578999999997532 33456789999999999999999999988533 3447
Q ss_pred eEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 044281 577 LVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDFGLSKLLFSD 656 (796)
Q Consensus 577 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 656 (796)
+++||+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC--
Confidence 77888899999999865 4689999999999999999999998 99999999999999999999999999997542
Q ss_pred CCcceeeccCCCcccccccccCC-CCCccchhHHHHHHHHHHHhCCCCCchhhHHHHhHHHHHHHHHh----hhc-----
Q 044281 657 QSRTHTMIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVTLLEIICCRRSVEMELEEESRAILTDWAYDC----YVE----- 726 (796)
Q Consensus 657 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----~~~----- 726 (796)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+....... ...
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 223345688999999987665 46899999999999999999999997665443322221111000 000
Q ss_pred -----CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHcCc
Q 044281 727 -----GRLDVLIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVLQM--LEGLL 778 (796)
Q Consensus 727 -----~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--L~~~~ 778 (796)
............ .........+.+++.+||+.||++|||+.|++++ +....
T Consensus 251 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000000000 0001123456789999999999999999999973 54443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-34 Score=310.26 Aligned_cols=277 Identities=22% Similarity=0.235 Sum_probs=191.3
Q ss_pred HhHHHhhCCCccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-----------ccCccccccccccc
Q 044281 504 DGFKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-----------HKHLVQLLGFCDEA 572 (796)
Q Consensus 504 ~~~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~ 572 (796)
|.+.++||+|+||+||+|+.. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 556789999999999999865 478999999997643 23456778888887775 57899999887654
Q ss_pred c--cceeEEeecCCCCH-HHHH--hcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCc------
Q 044281 573 L--NRLLVYEFMGNGTL-ANLI--FAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFS------ 641 (796)
Q Consensus 573 ~--~~~lv~e~~~~gsL-~~~l--~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~------ 641 (796)
. ..++++++...+.. .... .....+++..+..++.||++||+|||+.. +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 3 34566666554432 2222 23457788899999999999999999832 8999999999999986553
Q ss_pred EEEeecCCcccccCCCCcceeeccCCCcccccccccCCCCCccchhHHHHHHHHHHHhCCCCCchhhHHHH---hHHHHH
Q 044281 642 AKISDFGLSKLLFSDQSRTHTMIRGTRGYVAPEWFKNVPVSAKVDVYSFGVTLLEIICCRRSVEMELEEES---RAILTD 718 (796)
Q Consensus 642 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gv~l~elltg~~p~~~~~~~~~---~~~l~~ 718 (796)
+|++|||.+..... ......||+.|+|||.+.+..++.++||||+||+++||++|+.||........ ...+..
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999986532 22345689999999999999999999999999999999999999875432110 000100
Q ss_pred HHHH-----------------hhhcC----ccceeccch------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 044281 719 WAYD-----------------CYVEG----RLDVLIDSD------EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVL 771 (796)
Q Consensus 719 ~~~~-----------------~~~~~----~~~~~~d~~------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 771 (796)
.... ..... ......... ...........++.+++.+||+.||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000 00000 000000000 01112345667889999999999999999999999
Q ss_pred HH--HHc---CcCCCCCCCCCc
Q 044281 772 QM--LEG---LLDVPNPPGPSS 788 (796)
Q Consensus 772 ~~--L~~---~~~~~~pp~p~~ 788 (796)
+. ++. ..+...|+.|..
T Consensus 327 ~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 327 NHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp TCGGGTTCTTCTTCCCTTSCTT
T ss_pred cCcccCCCCCcccCCCCCcccC
Confidence 85 443 333455555544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.4e-21 Score=190.39 Aligned_cols=162 Identities=15% Similarity=0.086 Sum_probs=119.1
Q ss_pred HHHhhCCCccceEEEEEeeCCCCeEEEEEEecchh------------------hhhHHHHHHHHHHhcccCccCcccccc
Q 044281 506 FKEELGRGSFGIVYKGVLKTASGTAIAVKKLDRLA------------------QEREREFKSEVSAIGRTHHKHLVQLLG 567 (796)
Q Consensus 506 ~~~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~g 567 (796)
+.++||+|+||+||+|+.. +|+.||||+++... ......+..|...+.++.|.+++..++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3468999999999999864 68899999874211 011234567888899999999988776
Q ss_pred cccccccceeEEeecCCCCHHHHHhcCCCCchhHHHHHHHHHHHHhhHhhhcCCCCeeeCCCCCCCEEEcCCCcEEEeec
Q 044281 568 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRIRISLEIARGLAYLHEECNVPIIHCDIKPQNILLDHFFSAKISDF 647 (796)
Q Consensus 568 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 647 (796)
+. ..+++|||+++..+.. ++......++.|++++|+|||+. +|+||||||+|||++++ .++|+||
T Consensus 82 ~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred ec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence 53 3479999998866543 34455678999999999999998 99999999999999965 5899999
Q ss_pred CCcccccCCCCcceeeccCCCcccc------cccccCCCCCccchhHHHHHHH
Q 044281 648 GLSKLLFSDQSRTHTMIRGTRGYVA------PEWFKNVPVSAKVDVYSFGVTL 694 (796)
Q Consensus 648 Gla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~k~DVwS~Gv~l 694 (796)
|+|+......... |.. .|. ..+.|..++|+||..--+
T Consensus 147 G~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9998653222111 111 112 245778899999975443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.70 E-value=2.4e-17 Score=144.09 Aligned_cols=109 Identities=17% Similarity=0.369 Sum_probs=84.8
Q ss_pred ccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEE
Q 044281 20 ANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 98 (796)
Q Consensus 20 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l 98 (796)
.|+|.+||.|.+ +++|+ +|.|.|.|...++ |.|+. ..++||.||++.|.. ++.|.|..+| |+|
T Consensus 1 tDtL~~gq~L~~---g~~l~--~g~~~l~~q~DGN------Lvly~----~~~~vW~s~~~~~~~-~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDT---GGSLA--EGGYLFIIQNDCN------LVLYD----NNRAVWASGTNGKAS-GCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECT---TCEEE--ETTEEEEECTTSC------EEEEE----TTEEEEECCCTTSCS-SEEEEECTTSCEEE
T ss_pred CCEecCCCEecC---CCEEE--ECCEEEEEcCCCC------EEEEc----CCcEEEEccCccCCC-CcEEEEeccccEEE
Confidence 378999999986 56787 4999999975442 45654 368999999998853 4689999999 999
Q ss_pred ECCCCCeeeecC-C-CCccceEEeecCccEEEEEcCCCCcceeeccccCcc
Q 044281 99 KDPGGQAIWDGK-P-DKNVSDAAMLDTGNFVLRASGNNSDYAWQSFKSPTD 147 (796)
Q Consensus 99 ~~~~~~~vWst~-~-~~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~PTD 147 (796)
.|.+ .++|+++ + ..+...|+|+|+|||||++. ++.++|||+.+|+|
T Consensus 65 ~~~~-~~~w~s~t~~~~~~~~l~L~ddGNlvly~~--~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 65 YSGS-RAIWASNTNRQNGNYYLILQRDRNVVIYDN--SNNAIWATHTNVGN 112 (112)
T ss_dssp EETT-EEEEECCCCCSCCCCEEEECTTSCEEEECT--TSCEEEECCCCCCC
T ss_pred EecC-CeEEEEeeccCCCceEEEEcCCCCEEEECC--CCcEEecCCCccCC
Confidence 9874 5566654 3 33445799999999999864 45689999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.70 E-value=6e-17 Score=140.10 Aligned_cols=105 Identities=20% Similarity=0.347 Sum_probs=84.4
Q ss_pred ccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEE
Q 044281 20 ANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 98 (796)
Q Consensus 20 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l 98 (796)
+|+|.+|+.|.+ +++|. +|.|.|+|...++ |.++. ..++||+||++.|+...++|.|..+| |+|
T Consensus 1 ~~~L~~g~~L~~---g~~l~--~g~~~l~~q~dgn------Lvl~~----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl 65 (109)
T d1kj1a_ 1 RNLLTNGEGLYA---GQSLD--VEPYHFIMQEDCN------LVLYD----HSTSVWASNTGILGKKGCKAVLQSDGNFVV 65 (109)
T ss_dssp CCEEETTCEEET---TCEEE--ETTEEEEECTTSC------EEEEE----TTEEEEECCCCCTTCCCCEEEECTTSCEEE
T ss_pred CCCccCCCEEeC---CCEEE--eCCEEEEecCCCe------EEEEe----CCEEEEEeCCCCCCceeEEEEEcCCceEEE
Confidence 468999999986 46676 5889999964332 45543 35789999999999888899999999 999
Q ss_pred ECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeecccc
Q 044281 99 KDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKS 144 (796)
Q Consensus 99 ~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~ 144 (796)
.|++|.+||++++. .+...|+|+|+|||||++ ..+|||+-|
T Consensus 66 ~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~-----~~~W~S~t~ 108 (109)
T d1kj1a_ 66 YDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG-----SDIWSTGTY 108 (109)
T ss_dssp ECSSSCEEEECCCCCCSSCCEEEECTTSCEEEEC-----CEEEECCCC
T ss_pred EeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEEC-----CCEecCCCc
Confidence 99999999998643 444579999999999974 259999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.67 E-value=1.3e-16 Score=137.98 Aligned_cols=104 Identities=18% Similarity=0.337 Sum_probs=82.6
Q ss_pred ccccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEE
Q 044281 20 ANNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 98 (796)
Q Consensus 20 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l 98 (796)
.|+|.+|+.|.+ ++.|. +|.|.|.|...++ |.|+.. .++||.||++.|- ..+.|.+..+| |+|
T Consensus 1 ~~~L~~g~~L~~---G~~l~--ng~~~l~~q~DGN------Lvly~~----~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl 64 (108)
T d1jpca_ 1 DNILYSGETLST---GEFLN--YGSFVFIMQEDCN------LVLYDV----DKPIWATNTGGLS-RSCFLSMQTDGNLVV 64 (108)
T ss_dssp CCEEETTEEECT---TCEEE--ETTEEEEECTTSC------EEEEET----TEEEEECCCTTSC-SSCEEEECTTSCEEE
T ss_pred CCCccCCCEecC---CCEEE--cCCEEEEECCCCe------EEEEeC----CceeeEeCCCCCC-CccEEEEeccceEEE
Confidence 367899999975 46675 6999999986553 566653 5789999999884 34589999999 999
Q ss_pred ECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeecccc
Q 044281 99 KDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQSFKS 144 (796)
Q Consensus 99 ~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD~ 144 (796)
.|++|.+||++++. .....|+|+|+|||||++. .+||||+|
T Consensus 65 ~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~-----~~W~S~t~ 107 (108)
T d1jpca_ 65 YNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT-----DRWATGTH 107 (108)
T ss_dssp ECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC-----CCCCCCCC
T ss_pred ECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC-----CcccCCCC
Confidence 99999999998642 2334689999999999742 49999988
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=1e-15 Score=134.47 Aligned_cols=98 Identities=14% Similarity=0.239 Sum_probs=80.5
Q ss_pred EEEeccCCCCeEEEeecCCCCCCCCc-EEEEecCc-eEEECCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcc
Q 044281 62 AIWFNKIPERTIVWHANGDNPAPRGS-TLELTATG-LLLKDPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDY 137 (796)
Q Consensus 62 giw~~~~~~~t~VW~ANr~~pv~~~s-~l~l~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~ 137 (796)
-|||.++++++.+|++|++.|+..+. +|.+..|| |+|.+. +.++|++++. .....|+|+|+|||||++. ++++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~--~~~~ 87 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN--QNIA 87 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET--TTEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC--CCCE
Confidence 69999999999999999999998765 99999999 999886 6789987643 2335799999999999875 4578
Q ss_pred eeeccccCcccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeee
Q 044281 138 AWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFI 187 (796)
Q Consensus 138 lWQSFD~PTDtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~ 187 (796)
|||||. +.++|.|.+.++ +|++++|
T Consensus 88 lW~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 88 VWTSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EEECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EEEeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 999983 346688999998 8999887
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.42 E-value=6.3e-14 Score=121.51 Aligned_cols=107 Identities=17% Similarity=0.239 Sum_probs=86.9
Q ss_pred EEeccCCCCeEEEeecCCCCCCCCc-EEEEecCc-eEEECCCCCeeeecCC-CCccceEEeecCccEEEEEcCCCCccee
Q 044281 63 IWFNKIPERTIVWHANGDNPAPRGS-TLELTATG-LLLKDPGGQAIWDGKP-DKNVSDAAMLDTGNFVLRASGNNSDYAW 139 (796)
Q Consensus 63 iw~~~~~~~t~VW~ANr~~pv~~~s-~l~l~~~g-l~l~~~~~~~vWst~~-~~~~~~a~lldsGNlVl~~~~~~~~~lW 139 (796)
|||.-.++.+..|+.+.+.++.++. +|.+..|| |+|.+ ++.++|++++ ...+..+.|+|+|||||++. ++.+||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~--~~~~vW 79 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTA--QNTIRW 79 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCT--TTCCSC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEcc--CCCEEE
Confidence 7888777888899999999998766 89999999 99987 5788999874 34567899999999999654 567999
Q ss_pred eccccCcccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccc
Q 044281 140 QSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTY 206 (796)
Q Consensus 140 QSFD~PTDtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (796)
||+- +.++|.|.+.++ +|++++| . .++|.+++-
T Consensus 80 sS~t-------------------------~~~~g~y~l~Lq~DGNlvlY---~------~~~Wssgt~ 113 (115)
T d1dlpa1 80 SSGT-------------------------KGSIGNYVLVLQPDRTVTIY---G------PGLWDSGTS 113 (115)
T ss_dssp CCCC-------------------------CCCSSCCEEEECSSSCEEEE---C------SEEEECSCC
T ss_pred EcCC-------------------------CCCCCCEEEEECCCCcEEEe---C------CCeecCCCC
Confidence 9873 346899999998 8998876 1 368887663
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.30 E-value=6.7e-12 Score=109.34 Aligned_cols=100 Identities=16% Similarity=0.293 Sum_probs=76.3
Q ss_pred cccccCccccccCCCCeeeeCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEEE
Q 044281 21 NNITLGSSLSSTNKNSSWLSPSRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 99 (796)
Q Consensus 21 ~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l~ 99 (796)
++|.++|+|. ..+..|.|.|.|-..|+ |.+ |. ..++||.||+..|.. ..+|.|..+| |+|.
T Consensus 15 ~~l~~~q~l~-------~~~~~~~y~l~mQ~DGN------LVL-y~---~~~~vWssnt~~~~~-~~~l~l~~dGnLvL~ 76 (119)
T d1b2pa_ 15 QILHATESLE-------ILFGTHVYRFIMQTDCN------LVL-YD---NNNPIWATNTGGLGN-GCRAVLQPDGVLVVI 76 (119)
T ss_dssp CEEETTCEEE-------EEETTEEEEEEECTTSC------EEE-EE---TTEEEEECCCTTSCS-SCEEEECTTSCEEEE
T ss_pred CEEeCCCeEE-------EecCCceEEEEECCCCc------EEE-EE---CCeEEEEecCCCCCc-ceEEEEEeCCCEEEE
Confidence 4666777663 56789999999865443 333 43 367899999987743 4689999999 9999
Q ss_pred CCCCCeeeecCCC--CccceEEeecCccEEEEEcCCCCcceeeccc
Q 044281 100 DPGGQAIWDGKPD--KNVSDAAMLDTGNFVLRASGNNSDYAWQSFK 143 (796)
Q Consensus 100 ~~~~~~vWst~~~--~~~~~a~lldsGNlVl~~~~~~~~~lWQSFD 143 (796)
|++|.+||++++. .+...++|+|+|||||++ ..+|||-.
T Consensus 77 d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg-----~~~W~S~T 117 (119)
T d1b2pa_ 77 TNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-----DALWATQT 117 (119)
T ss_dssp CTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-----SEEEECCC
T ss_pred CCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC-----CCEeccCC
Confidence 9999999998653 233468999999999973 36999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.00 E-value=2e-10 Score=99.10 Aligned_cols=85 Identities=15% Similarity=0.258 Sum_probs=64.0
Q ss_pred CCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCc-eEEECCCCCeeeecCCC--CccceE
Q 044281 42 SRDFAFGFRQLNDNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLKDPGGQAIWDGKPD--KNVSDA 118 (796)
Q Consensus 42 ~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VW~ANr~~pv~~~s~l~l~~~g-l~l~~~~~~~vWst~~~--~~~~~a 118 (796)
+|.|.|.|...|+ |.++. ..++||.+|...+ ..+++.|..+| |+|.|.++.+||++.+. .+...+
T Consensus 25 ~g~~~l~~q~DGN------LvL~~----~~~~vW~s~t~~~--~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l 92 (115)
T d1dlpa1 25 LSSFRFTMQSDCN------LVLFD----SDVRVWASNTAGA--TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVL 92 (115)
T ss_dssp STTEEEEECTTSC------EEEEE----SSSEEECCCCCSC--SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEE
T ss_pred cCCEEEEECCCCe------EEEEc----CCeeEEEcccCCC--CceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEE
Confidence 5779998865443 55654 2467999997643 35689999999 99999999999997642 333469
Q ss_pred EeecCccEEEEEcCCCCcceeeccc
Q 044281 119 AMLDTGNFVLRASGNNSDYAWQSFK 143 (796)
Q Consensus 119 ~lldsGNlVl~~~~~~~~~lWQSFD 143 (796)
+|+++|||||++ ..+|+|-.
T Consensus 93 ~Lq~DGNlvlY~-----~~~Wssgt 112 (115)
T d1dlpa1 93 VLQPDRTVTIYG-----PGLWDSGT 112 (115)
T ss_dssp EECSSSCEEEEC-----SEEEECSC
T ss_pred EECCCCcEEEeC-----CCeecCCC
Confidence 999999999963 36999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.82 E-value=6.8e-09 Score=90.20 Aligned_cols=111 Identities=20% Similarity=0.272 Sum_probs=74.4
Q ss_pred EEeecCccEEEEEcCCCCcceeeccccCcccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCcccc
Q 044281 118 AAMLDTGNFVLRASGNNSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQ 196 (796)
Q Consensus 118 a~lldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~ 196 (796)
+.++|+||+||.+. +|+|.|++||.++|.|. .|.|+|.++ +|+++++- ..
T Consensus 3 ~v~~~~~n~il~~~--------~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~--~~---- 53 (120)
T d1dlpa2 3 VVVANNGNSILYST--------QGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFD--RD---- 53 (120)
T ss_dssp CCCSSCCCEECCCC----------CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEB--TT----
T ss_pred EEEEeCCCeEEEcC--------CCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEec--CC----
Confidence 45667777776421 67899999999999984 478999998 99998863 22
Q ss_pred ceeeeccccccCCCCCCcceeEEeccceEEEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEe
Q 044281 197 YKSYYTSNTYSSNSSESGHQLVFNESAEIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
..+|.+.+... +....+.+..+|.+.+...++..+=... .....-.++++|+.||++++|.
T Consensus 54 -~~vW~s~t~~~---~~~~~~~l~~~GnLvl~d~~~~~lW~S~----t~~~~~~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 54 -DRVWSTNTAGK---GTGCRAVLQPNGRMDVLTNQNIAVWTSG----NSRSAGRYVFVLQPDRNLAIYG 114 (120)
T ss_dssp -BCCSCCCCCSS---CSSCEEEEETTTEEEEEETTTEEEEECC----CCCSSSCCEEEECSSSCEEEEC
T ss_pred -cEEEEEccccC---CCcEEEEEeCCeeEEEEcCCCCEEEEeC----CCCCCCcEEEEECCCCcEEEeC
Confidence 45777665422 2345678888888877776665432111 1111223589999999999994
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.80 E-value=2e-08 Score=86.45 Aligned_cols=110 Identities=17% Similarity=0.201 Sum_probs=78.0
Q ss_pred cccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcceeEEeccce
Q 044281 146 TDTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAE 224 (796)
Q Consensus 146 TDtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (796)
||||+|||.|..|+.|++ |+|+|.++ +|+++++.. . .++|.+++... .....+.+..+|.
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~--~-----~~vW~s~~~~~---~~~~~l~l~~dGn 61 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDN--N-----RAVWASGTNGK---ASGCVLKMQNDGN 61 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEET--T-----EEEEECCCTTS---CSSEEEEECTTSC
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcC--C-----cEEEEccCccC---CCCcEEEEecccc
Confidence 899999999999999976 99999998 999988642 1 56888776533 2345688889898
Q ss_pred EEEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEecCCCCCCCcceeEEEecCCccc
Q 044281 225 IYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDAMC 287 (796)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~~~~~~~~~~~W~~~~~~p~~~C 287 (796)
+.+...++.+.... .......++++|..||+|++|.- . ....|+...+.|
T Consensus 62 Lvl~~~~~~~w~s~-----t~~~~~~~~l~L~ddGNlvly~~---~-----~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 62 LVIYSGSRAIWASN-----TNRQNGNYYLILQRDRNVVIYDN---S-----NNAIWATHTNVG 111 (112)
T ss_dssp EEEEETTEEEEECC-----CCCSCCCCEEEECTTSCEEEECT---T-----SCEEEECCCCCC
T ss_pred EEEEecCCeEEEEe-----eccCCCceEEEEcCCCCEEEECC---C-----CcEEecCCCccC
Confidence 87776655443222 12223446899999999999952 1 234566655444
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.51 E-value=2.7e-07 Score=79.53 Aligned_cols=104 Identities=13% Similarity=0.197 Sum_probs=75.8
Q ss_pred ceeeccccCcccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcc
Q 044281 137 YAWQSFKSPTDTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGH 215 (796)
Q Consensus 137 ~lWQSFD~PTDtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (796)
+-||++|.|.+||-+||.|.. ..+.|+|+|.|+ ||+++++- .. .++|.+.+... ....
T Consensus 5 ~s~~~~~~~~~~l~~~q~l~~-----------~~~~~~y~l~mQ~DGNLVLy~--~~-----~~vWssnt~~~---~~~~ 63 (119)
T d1b2pa_ 5 FSKQPDDNHPQILHATESLEI-----------LFGTHVYRFIMQTDCNLVLYD--NN-----NPIWATNTGGL---GNGC 63 (119)
T ss_dssp ECSCSSSCCCCEEETTCEEEE-----------EETTEEEEEEECTTSCEEEEE--TT-----EEEEECCCTTS---CSSC
T ss_pred EeeecCCCCCCEEeCCCeEEE-----------ecCCceEEEEECCCCcEEEEE--CC-----eEEEEecCCCC---Ccce
Confidence 358999999999999998732 236899999999 99999862 22 56888876532 3346
Q ss_pred eeEEeccceEEEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEe
Q 044281 216 QLVFNESAEIYIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
.+.+..+|.+.+...++..+=.. ........+|++|+.||+|++|.
T Consensus 64 ~l~l~~dGnLvL~d~~g~~vWsS----~t~~~~~~~~l~Lq~DGNlvlYg 109 (119)
T d1b2pa_ 64 RAVLQPDGVLVVITNENVTVWQS----PVAGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp EEEECTTSCEEEECTTCCEEEEC----SCCCCSSCEEEEECTTSCEEEEE
T ss_pred EEEEEeCCCEEEECCCCcEEEEC----CCcCCCCceEEEEcCCCCEEEEC
Confidence 78899999888887776544221 11222234689999999999995
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.42 E-value=1.2e-06 Score=74.25 Aligned_cols=96 Identities=14% Similarity=0.181 Sum_probs=69.9
Q ss_pred ccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcceeEEeccceE
Q 044281 147 DTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEI 225 (796)
Q Consensus 147 DtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (796)
|||+|||.|..|..|.+ |+|+|.|+ +|+++++- .. .++|.+++... +....+.+...|.+
T Consensus 2 ~~L~~g~~L~~G~~l~n---------g~~~l~~q~DGNLvly~--~~-----~~vW~s~~~~~---~~~~~l~l~~~Gnl 62 (108)
T d1jpca_ 2 NILYSGETLSTGEFLNY---------GSFVFIMQEDCNLVLYD--VD-----KPIWATNTGGL---SRSCFLSMQTDGNL 62 (108)
T ss_dssp CEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEE--TT-----EEEEECCCTTS---CSSCEEEECTTSCE
T ss_pred CCccCCCEecCCCEEEc---------CCEEEEECCCCeEEEEe--CC-----ceeeEeCCCCC---CCccEEEEeccceE
Confidence 89999999999999954 99999998 99998863 22 56888776533 33456788888877
Q ss_pred EEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEe
Q 044281 226 YIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
.+...++..+=.. ........++++|..||+|++|.
T Consensus 63 vl~~~~g~~vWsS----~t~~~~~~~~l~L~ddGNlVly~ 98 (108)
T d1jpca_ 63 VVYNPSNKPIWAS----NTGGQNGNYVCILQKDRNVVIYG 98 (108)
T ss_dssp EEECTTCCEEEEC----CCCCSCSCEEEEECTTSCEEEEE
T ss_pred EEECCCccceEEc----cccCCCCcEEEEEcCCCCEEEeC
Confidence 7776666544222 12223334578999999999995
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.35 E-value=1.1e-06 Score=74.49 Aligned_cols=97 Identities=16% Similarity=0.206 Sum_probs=69.8
Q ss_pred ccccCCccccCcceEEeccCCCCCCCCceeEeee-CCceeeeeccCCccccceeeeccccccCCCCCCcceeEEeccceE
Q 044281 147 DTILPTQILDLGSVLVSRLTETNFSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTYSSNSSESGHQLVFNESAEI 225 (796)
Q Consensus 147 DtlLpg~kl~~~~~L~S~~s~~d~s~G~f~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (796)
|||.|||.|..|+.|++ |.|+|.|+ +|+++++.. . ..+|.+++-... .....+.++.+|.+
T Consensus 2 ~~L~~g~~L~~g~~l~~---------g~~~l~~q~dgnLvl~~~--~-----~~vW~ant~~~~--~~~~~l~l~~dGnL 63 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLYDH--S-----TSVWASNTGILG--KKGCKAVLQSDGNF 63 (109)
T ss_dssp CEEETTCEEETTCEEEE---------TTEEEEECTTSCEEEEET--T-----EEEEECCCCCTT--CCCCEEEECTTSCE
T ss_pred CCccCCCEEeCCCEEEe---------CCEEEEecCCCeEEEEeC--C-----EEEEEeCCCCCC--ceeEEEEEcCCceE
Confidence 89999999999999965 89999999 999988642 2 568887655332 23456788888988
Q ss_pred EEEecCceeeeccccccccCCCceeEEEEEccCCcEEEEe
Q 044281 226 YIVKNDGQIVQLPQWSKLIPRTDHYFRATLDFDGVLAEYA 265 (796)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~ 265 (796)
.+...++..+=.. .......-++++|..||+|++|.
T Consensus 64 vl~~~~g~~vW~s----~t~~~~~~~~l~L~ddGNlvly~ 99 (109)
T d1kj1a_ 64 VVYDAEGRSLWAS----HSVRGNGNYVLVLQEDGNVVIYG 99 (109)
T ss_dssp EEECSSSCEEEEC----CCCCCSSCCEEEECTTSCEEEEC
T ss_pred EEEeCCCcEEEEE----eeECCCCCEEEEEeCCCcEEEEC
Confidence 7777666544222 11112233588999999999994
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.99 E-value=8.1e-06 Score=81.19 Aligned_cols=130 Identities=16% Similarity=0.042 Sum_probs=87.0
Q ss_pred ccceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccC-ccCcccccccccccccceeEEeecCCCCHHHHHh
Q 044281 514 SFGIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKHLVQLLGFCDEALNRLLVYEFMGNGTLANLIF 592 (796)
Q Consensus 514 ~fG~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 592 (796)
+...||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+...++..++||+++++.++.+...
T Consensus 26 s~~~v~rv~~---~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 26 SPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp SSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCcEEEEEe---CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 3468998652 45678889886654444445677887777663 4446678888888888899999999988755432
Q ss_pred cCCCCchhHHHHHHHHHHHHhhHhhhc-----------------------------------------------------
Q 044281 593 AIPKPDWNLRIRISLEIARGLAYLHEE----------------------------------------------------- 619 (796)
Q Consensus 593 ~~~~~~~~~~~~i~~~ia~~l~yLH~~----------------------------------------------------- 619 (796)
.. .....++.++++.++.||+.
T Consensus 103 ~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 103 DE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp TC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred cc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 11 11222344444444444421
Q ss_pred ---CCCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 620 ---CNVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 620 ---~~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
....++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01238999999999999987777899999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.46 E-value=0.00014 Score=71.43 Aligned_cols=73 Identities=16% Similarity=0.076 Sum_probs=48.7
Q ss_pred hCCCcc-ceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCc--cCcccccccccccccceeEEeecCCCC
Q 044281 510 LGRGSF-GIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHH--KHLVQLLGFCDEALNRLLVYEFMGNGT 586 (796)
Q Consensus 510 LG~G~f-G~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~gs 586 (796)
+..|.. ..||+... .++..+++|....... ..+..|...++.+.. -.+.+++++..++...++|||++++.+
T Consensus 18 ~~~G~s~~~v~r~~~--~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA--QGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEEC--TTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEe--CCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 344443 57898764 3566788888654322 245667776666532 335677888788888899999998866
Q ss_pred H
Q 044281 587 L 587 (796)
Q Consensus 587 L 587 (796)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.31 E-value=0.00035 Score=73.45 Aligned_cols=76 Identities=18% Similarity=0.190 Sum_probs=45.1
Q ss_pred HhhCCCccceEEEEEeeCCCCeEEEEEEecchhh-------hhHHHHHHHHHHhccc-Cc--cCccccccccccccccee
Q 044281 508 EELGRGSFGIVYKGVLKTASGTAIAVKKLDRLAQ-------EREREFKSEVSAIGRT-HH--KHLVQLLGFCDEALNRLL 577 (796)
Q Consensus 508 ~~LG~G~fG~Vy~g~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l-~h--~niv~l~g~~~~~~~~~l 577 (796)
+.||.|....||+.... .+++.++||.-..... ........|.+.|+.+ .+ ..+++++.+ +....++
T Consensus 32 ~eig~G~~N~vfrV~~~-~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEeCCCceEeEEEEEeC-CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 46899999999998754 3467899996532110 0112344566666654 22 345555554 4456689
Q ss_pred EEeecCCCC
Q 044281 578 VYEFMGNGT 586 (796)
Q Consensus 578 v~e~~~~gs 586 (796)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.40 E-value=0.0044 Score=62.84 Aligned_cols=67 Identities=12% Similarity=0.014 Sum_probs=40.2
Q ss_pred ceEEEEEeeCCCCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCcc--ccccc-----ccccccceeEEeecCCC
Q 044281 516 GIVYKGVLKTASGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHLV--QLLGF-----CDEALNRLLVYEFMGNG 585 (796)
Q Consensus 516 G~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~g~-----~~~~~~~~lv~e~~~~g 585 (796)
-.||++..+ +|+.+++|..+... ...+++..|...+..|....+. ..+.. .......+.++++++|.
T Consensus 36 N~vy~v~~~--dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDE--DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCT--TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcC--CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 369988764 68889999976432 1245567777777766433322 22211 12334457889988764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.32 E-value=0.016 Score=60.34 Aligned_cols=73 Identities=15% Similarity=0.199 Sum_probs=47.5
Q ss_pred hhCCCccceEEEEEeeCC------CCeEEEEEEecchhhhhHHHHHHHHHHhcccCccCc-ccccccccccccceeEEee
Q 044281 509 ELGRGSFGIVYKGVLKTA------SGTAIAVKKLDRLAQEREREFKSEVSAIGRTHHKHL-VQLLGFCDEALNRLLVYEF 581 (796)
Q Consensus 509 ~LG~G~fG~Vy~g~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~ 581 (796)
.|+.|-.-.+|+...... ..+.|.+++.... .......+|..+++.+.-.++ .++++++.+ .+|+||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 477788888999876432 2346777776532 223345678888887743344 477787754 589999
Q ss_pred cCCCCH
Q 044281 582 MGNGTL 587 (796)
Q Consensus 582 ~~~gsL 587 (796)
+++..|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.32 E-value=0.017 Score=35.55 Aligned_cols=32 Identities=28% Similarity=0.532 Sum_probs=25.4
Q ss_pred cccccccccCCCCCCCCCccccCCCCCCccCCCCCceee
Q 044281 285 AMCRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHVLV 323 (796)
Q Consensus 285 ~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 323 (796)
|.|.+ .+.|| +|-|+..-+.-.|.|-+||+|.
T Consensus 2 dECsi------gnpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSV------GNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGT------TCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred Ccccc------CCccC-CceeeecccceEEeecCCcCCC
Confidence 56777 58898 7889755566789999999974
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.42 E-value=0.23 Score=49.04 Aligned_cols=31 Identities=19% Similarity=0.218 Sum_probs=27.7
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEeecCCcc
Q 044281 621 NVPIIHCDIKPQNILLDHFFSAKISDFGLSK 651 (796)
Q Consensus 621 ~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 651 (796)
..++||+|+.++||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4479999999999999998878899999875
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.92 E-value=0.038 Score=36.69 Aligned_cols=26 Identities=23% Similarity=0.491 Sum_probs=22.6
Q ss_pred CCCCCCCccccCCCCCCccCCCCCce
Q 044281 296 SGTCGFNSYCSLRNGRPFCDCPPGHV 321 (796)
Q Consensus 296 ~g~CG~~g~C~~~~~~~~C~Cl~GF~ 321 (796)
...|..+|.|....++..|.|++||+
T Consensus 10 ~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 10 ANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp SCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred CCCCCCCcEeECCCCCEEeECCCCCc
Confidence 47899999997666778999999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.69 E-value=0.081 Score=35.16 Aligned_cols=26 Identities=27% Similarity=0.549 Sum_probs=21.8
Q ss_pred CCCCCCccccCCCCCCccCCCCCcee
Q 044281 297 GTCGFNSYCSLRNGRPFCDCPPGHVL 322 (796)
Q Consensus 297 g~CG~~g~C~~~~~~~~C~Cl~GF~~ 322 (796)
+.|+.++.|....++..|.|++||+.
T Consensus 11 ~~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 11 PDVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp TTSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred cCCCCCCEeECCCCCeEeECCCCccc
Confidence 45667899987678899999999985
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.60 E-value=0.079 Score=34.35 Aligned_cols=25 Identities=24% Similarity=0.494 Sum_probs=21.7
Q ss_pred CCCCCCccccCCCCCCccCCCCCce
Q 044281 297 GTCGFNSYCSLRNGRPFCDCPPGHV 321 (796)
Q Consensus 297 g~CG~~g~C~~~~~~~~C~Cl~GF~ 321 (796)
..|...|.|........|.|++||+
T Consensus 6 ~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 6 SPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CCCCCCcEEECCCCCEEEECCCCCC
Confidence 7899999997656678999999996
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.58 E-value=0.031 Score=37.08 Aligned_cols=27 Identities=37% Similarity=0.851 Sum_probs=22.6
Q ss_pred CCCCCCCccccCCCCCCccCCCCCceee
Q 044281 296 SGTCGFNSYCSLRNGRPFCDCPPGHVLV 323 (796)
Q Consensus 296 ~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 323 (796)
++.|. ++.|.+..++-.|.|++||.+.
T Consensus 9 ~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 9 PLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp SSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred CCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 67885 7899866788999999999864
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.47 E-value=0.069 Score=34.63 Aligned_cols=25 Identities=28% Similarity=0.546 Sum_probs=21.7
Q ss_pred CCCCCCccccCCCCCCccCCCCCce
Q 044281 297 GTCGFNSYCSLRNGRPFCDCPPGHV 321 (796)
Q Consensus 297 g~CG~~g~C~~~~~~~~C~Cl~GF~ 321 (796)
..|...|.|.....+..|.|++||+
T Consensus 7 ~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 7 NPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp CCCCSSCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCCEEECCCCCEEEeCCCCCc
Confidence 7899999997656678999999996
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.68 E-value=0.074 Score=35.38 Aligned_cols=28 Identities=32% Similarity=0.673 Sum_probs=22.7
Q ss_pred CCCCCCCccccCCCCCCccCCCCCceeeC
Q 044281 296 SGTCGFNSYCSLRNGRPFCDCPPGHVLVD 324 (796)
Q Consensus 296 ~g~CG~~g~C~~~~~~~~C~Cl~GF~~~~ 324 (796)
++.|. ++.|....++..|.|++||.+..
T Consensus 10 ~~~c~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 37 (43)
T d1uzka2 10 PGLCQ-GGKCINTFGSFQCRCPTGYYLNE 37 (43)
T ss_dssp GGGGB-TSEEEECSSCEEEECCTTCCBCT
T ss_pred CCCcC-CCEEECCCCCeEeECCCCCeECc
Confidence 57785 68998777889999999998643
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.37 E-value=0.14 Score=32.30 Aligned_cols=26 Identities=31% Similarity=0.663 Sum_probs=21.8
Q ss_pred CCCCCCCccccCCCCCCccCCCCCce
Q 044281 296 SGTCGFNSYCSLRNGRPFCDCPPGHV 321 (796)
Q Consensus 296 ~g~CG~~g~C~~~~~~~~C~Cl~GF~ 321 (796)
...|-..|.|.....+..|.|++||+
T Consensus 5 ~~PC~ngg~C~~~~~~y~C~C~~g~~ 30 (35)
T d2vj3a3 5 SSPCLHNGRCLDKINEFQCECPTGFT 30 (35)
T ss_dssp TCCSTTTCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCCcEEECCCCCeEEECCCCCC
Confidence 37899999997555678999999996
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.76 E-value=0.11 Score=33.62 Aligned_cols=30 Identities=23% Similarity=0.420 Sum_probs=24.7
Q ss_pred cccccccccCCCCCCCCCccccCCCCCCccCCCCCce
Q 044281 285 AMCRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHV 321 (796)
Q Consensus 285 ~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~Cl~GF~ 321 (796)
|.|.. ..|-..|.|........|.|++||+
T Consensus 4 d~C~~-------~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 4 DQCES-------NPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CTTTT-------CCCCTTCEEEEETTEEEEECCTTCC
T ss_pred ccCCC-------CCCCCCcEEEcCCCCEEEECCCCCC
Confidence 56764 7899999997556678999999996
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.24 E-value=0.24 Score=32.36 Aligned_cols=26 Identities=31% Similarity=0.641 Sum_probs=20.5
Q ss_pred CCCCCCCccccCCCCCCccCCCCCceee
Q 044281 296 SGTCGFNSYCSLRNGRPFCDCPPGHVLV 323 (796)
Q Consensus 296 ~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 323 (796)
.+.| ..+|....++..|.|++||...
T Consensus 7 ~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 7 PDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp TTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred CCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 4566 4689766788999999999863
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.56 E-value=0.15 Score=33.93 Aligned_cols=27 Identities=26% Similarity=0.503 Sum_probs=21.7
Q ss_pred CCCCCCCccccCCCCCCccCCCCCceee
Q 044281 296 SGTCGFNSYCSLRNGRPFCDCPPGHVLV 323 (796)
Q Consensus 296 ~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 323 (796)
...|. ++.|.+..++..|.|++||+..
T Consensus 10 ~~~C~-~~~C~Nt~Gsy~C~C~~Gy~~~ 36 (44)
T d1lmja1 10 PDLCG-RGQCVNTPGDFECKCDEGYESG 36 (44)
T ss_dssp SSTTT-TSCEEEETTEEEECCCSSEEEC
T ss_pred CCCCC-CCEeEcCCCCeEEeCCCCCccC
Confidence 46675 6899866788999999999853
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=83.04 E-value=0.16 Score=32.44 Aligned_cols=25 Identities=20% Similarity=0.426 Sum_probs=21.5
Q ss_pred CCCCCCccccCCCCCCccCCCCCce
Q 044281 297 GTCGFNSYCSLRNGRPFCDCPPGHV 321 (796)
Q Consensus 297 g~CG~~g~C~~~~~~~~C~Cl~GF~ 321 (796)
..|-..|.|........|.|++||+
T Consensus 8 ~PC~ngg~C~~~~~~y~C~C~~g~~ 32 (37)
T d2c4fl1 8 SPCQNGGSCKDQLQSYICFCLPAFE 32 (37)
T ss_dssp CCCCTTCEEEEETTEEEEECCTTEE
T ss_pred CCCCCCCEEECCCCCeEEECCCCCc
Confidence 7899999997555678999999996
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.56 E-value=0.17 Score=33.52 Aligned_cols=32 Identities=34% Similarity=0.775 Sum_probs=23.8
Q ss_pred cccccccccCCCCCCCCCccccCCCCCCccCCCCCceee
Q 044281 285 AMCRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHVLV 323 (796)
Q Consensus 285 ~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 323 (796)
+.|.. ...| -.+.|....++..|.|++||++.
T Consensus 4 dEC~~------~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 4 NECLD------PTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CGGGS------TTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred cccCC------CCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 45655 3444 47899866778999999999864
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.69 E-value=0.14 Score=33.31 Aligned_cols=26 Identities=15% Similarity=0.359 Sum_probs=22.4
Q ss_pred CCCCCCCccccCCCCCCccCCCCCce
Q 044281 296 SGTCGFNSYCSLRNGRPFCDCPPGHV 321 (796)
Q Consensus 296 ~g~CG~~g~C~~~~~~~~C~Cl~GF~ 321 (796)
...|.+++.|....++..|.|.+||.
T Consensus 6 ~~~C~~~A~C~Nt~Gsy~C~C~~Gy~ 31 (40)
T d1gl4a2 6 RHQCSVHAECRDYATGFCCRCVANYT 31 (40)
T ss_dssp GGGSCTTEEEEECSSCEEEEECTTEE
T ss_pred CCCCCCCCEeecCCCCeEeECCCCCc
Confidence 35799999998667788999999996
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.37 E-value=0.3 Score=33.09 Aligned_cols=31 Identities=29% Similarity=0.577 Sum_probs=24.5
Q ss_pred CCcccccccccCCCCCCCCCccccCCCCCCccCCCCCce
Q 044281 283 PDAMCRRLIKETGSGTCGFNSYCSLRNGRPFCDCPPGHV 321 (796)
Q Consensus 283 p~~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~Cl~GF~ 321 (796)
+.+.|+- +.|+ +|.|....++..|.|++||.
T Consensus 7 ~~~~C~~-------~PC~-nG~C~~~~~~y~C~C~~G~~ 37 (48)
T d1autl1 7 LEHPCAS-------LCCG-HGTCIDGIGSFSCDCRSGWE 37 (48)
T ss_dssp SCCSSSS-------TTTT-SEEECCCSSCCCEEECTTEE
T ss_pred CCCcccC-------CCCC-CCEEECCCCCCeEeCCCCCc
Confidence 3467875 7897 59997655678999999996
|